,median,median_perc,mean,std,min,max,over_threshold,names
hsa:347411,0.0,0.0,2.548418052631579e-09,1.504209713835271e-08,0.0,1.4702658e-07,False,MPC1L; mitochondrial pyruvate carrier 1
hsa:8907,9.973377e-10,8.305356297049505e-07,1.0367310835922814e-06,2.1056885567408743e-06,0.0,9.547794e-06,False,AP1M1; adaptor related protein complex 1 subunit mu
hsa:5810,0.0,0.0,5.846042632631579e-06,1.851823510466595e-05,0.0,0.00013230485,False,RAD1; RAD1 checkpoint DNA
hsa:7358,6.8048735e-07,0.0005666776556611697,0.00011896207983907202,0.00023253128488285655,0.0,0.0016421132,False,UGDH; UDP-glucose
hsa:406910,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125A; microRNA
hsa:55304,0.0,0.0,2.873446310643275e-06,1.005746635178154e-05,0.0,9.156104e-05,False,SPTLC3; serine palmitoyltransferase long chain base subunit
hsa:5528,0.0,0.0,1.6931394775526316e-05,3.910462811046553e-05,0.0,0.000191152,False,PPP2R5D; protein phosphatase 2 regulatory subunit
hsa:2767,0.0,0.0,0.00046924412279649103,0.0007421672775688085,0.0,0.004764327,False,GNA11; G protein subunit alpha
hsa:727,1.1073113e-05,0.0092211643841891,3.9346117740116965e-05,5.729733449163843e-05,0.0,0.00023713504,False,C5; complement
hsa:10999,2.5629872e-05,0.021343344266217226,0.0002539000724538013,0.0004226662388419889,0.0,0.0029261848,False,SLC27A4; solute carrier family 27 member
hsa:7469,0.0,0.0,4.6847724939198244e-05,0.00014361071321742098,0.0,0.0009959246,False,NELFA; negative elongation factor complex member
hsa:5279,0.0,0.0,2.192625146578947e-05,3.770841664414755e-05,0.0,0.00023841378,False,PIGC; phosphatidylinositol glycan anchor biosynthesis class
hsa:100133941,0.0003454852,0.28770372175416686,0.00075774861878538,0.0012186028230904275,0.0,0.0072389017,False,CD24; CD24
hsa:302,0.0,0.0,1.3990587402748535e-07,2.4389797728862497e-07,0.0,1.4995688e-06,False,ANXA2; annexin
hsa:5948,0.0,0.0,1.6322798741520476e-05,4.085835310856479e-05,0.0,0.00029733934,False,RBP2; retinol binding protein
hsa:2691,0.0,0.0,4.633909018210527e-06,3.2151290258199906e-05,0.0,0.00040647606,False,GHRH; growth hormone releasing
hsa:390154,0.0,0.0,1.3223990643274854e-09,1.7292611653308746e-08,0.0,2.2613024e-07,False,OR5T3; olfactory receptor family 5 subfamily T member
hsa:25942,2.136149e-06,0.001778883777138476,8.94243990356725e-05,0.0002575034671678208,0.0,0.0016306458,False,SIN3A; SIN3 transcription regulator family member
hsa:6550,0.0,0.0,7.710801158479533e-06,3.5511016303918386e-05,0.0,0.00038818704,False,SLC9A3; solute carrier family 9 member
hsa:391112,0.0,0.0,3.0986267543859645e-08,3.359541737764452e-07,0.0,4.343878e-06,False,OR6Y1; olfactory receptor family 6 subfamily Y member
hsa:6249,1.5227086e-09,1.2680396479127817e-06,6.410794960327484e-07,1.0170870139291136e-06,0.0,6.626233e-06,False,CLIP1; CAP-Gly domain containing linker protein
hsa:390748,0.0,0.0,6.436577165672514e-08,3.7271177900064475e-07,0.0,4.1066087e-06,False,PABPN1L; PABPN1 like
hsa:221955,6.4301855e-07,0.0005354754125269847,8.472534417516374e-06,1.729385109452039e-05,0.0,8.308723e-05,False,DAGLB; diacylglycerol lipase
hsa:51209,7.4538995e-08,6.207254689148835e-05,1.517887353923977e-06,7.323446228206116e-06,0.0,6.615806e-05,False,RAB9B; RAB9B
hsa:134864,0.0,0.0,7.237160343859649e-08,5.527570163451936e-07,0.0,6.442609e-06,False,TAAR1; trace amine associated receptor
hsa:2660,0.0,0.0,6.514151733163741e-06,1.987171990556432e-05,0.0,0.0001278433,False,MSTN;
hsa:23057,3.0129044e-05,0.025090041749096778,0.00011285016195117542,0.00015375781924388326,0.0,0.0006739559,False,NMNAT2; nicotinamide nucleotide adenylyltransferase
hsa:4726,0.0,0.0,5.846122377192984e-06,1.1086992672918966e-05,0.0,6.8257796e-05,False,NDUFS6; NADH:ubiquinone oxidoreductase subunit
hsa:808,0.0,0.0,0.0005043315762397661,0.0009695363621597713,0.0,0.0043115215,False,CALM3; calmodulin
hsa:1138,1.4230766e-07,0.00011850708341812203,4.1051093733024276e-05,7.669685696627098e-05,0.0,0.00044343885,False,CHRNA5; cholinergic receptor nicotinic alpha 5
hsa:64750,2.2592712e-05,0.018814141175714696,0.00013453360453274853,0.0002386178333538575,0.0,0.0014215499,False,SMURF2; SMAD specific E3 ubiquitin protein ligase
hsa:219437,0.0,0.0,5.428299546783626e-07,6.740493903435059e-06,0.0,8.810872e-05,False,OR5L1; olfactory receptor family 5 subfamily L member
hsa:29990,0.00040190702,0.33468914284353246,0.0017514087595774854,0.0030884320414353897,0.0,0.017240683,False,PILRB; paired immunoglobin like type 2 receptor
hsa:6091,1.01555095e-07,8.457027622195678e-05,7.980670568888889e-07,1.9851490899632043e-06,0.0,1.7070632e-05,False,ROBO1; roundabout guidance receptor
hsa:3183,0.0,0.0,1.1156072039181288e-07,1.9408256732824535e-07,0.0,9.40064e-07,False,HNRNPC; heterogeneous nuclear ribonucleoprotein
hsa:5437,0.0,0.0,2.8223720764210496e-05,8.53471515235525e-05,0.0,0.0006573968,False,POLR2H; RNA polymerase II
hsa:135250,0.0,0.0,3.941684683625732e-09,1.3987511086269855e-08,0.0,1.1484587e-07,False,RAET1E; retinoic acid early transcript
hsa:5833,0.0,0.0,0.00037786834706608205,0.0007732378906610968,0.0,0.0032922723,False,PCYT2; phosphate cytidylyltransferase 2
hsa:51103,0.0,0.0,2.5970550510116964e-08,8.231364915378348e-08,0.0,4.6238256e-07,False,NDUFAF1; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:89953,0.0,0.0,5.025547732865495e-07,1.1251010850531948e-06,0.0,5.9421654e-06,False,KLC4; kinesin light chain
hsa:2218,0.0,0.0,3.605304700818714e-05,6.868859393516483e-05,0.0,0.0003548325,False,FKTN;
hsa:10681,0.00011266735,0.0938240362110427,0.00030930813320935663,0.0004576218350322644,0.0,0.0031217462,False,GNB5; G protein subunit beta
hsa:23463,2.5172704e-07,0.00020962636394890438,2.2935476137286533e-05,5.666389449754536e-05,0.0,0.00033178288,False,ICMT; isoprenylcysteine carboxyl
hsa:661,1.05558e-06,0.000879037060369774,0.00017776364215204673,0.0003279411494909123,0.0,0.0020745469,False,POLR3D; RNA polymerase III subunit
hsa:6898,1.2581912e-06,0.0010477620775603159,1.5577625874892982e-05,7.728996674665708e-05,0.0,0.0008348994,False,TAT; tyrosine
hsa:348327,2.4873048e-08,2.0713097061668737e-05,8.727678363976608e-08,1.7291969126906929e-07,0.0,1.0135689e-06,False,ZNF530; zinc finger protein
hsa:10239,5.472496e-07,0.00045572356398618257,2.2544667309918137e-06,4.771919015801515e-06,0.0,4.5996676e-05,False,AP3S2; adaptor related protein complex 3 subunit sigma
hsa:4759,0.0,0.0,3.462640707602339e-08,3.1783172876099245e-07,-0.0,3.283483e-06,False,NEU2; neuraminidase
hsa:1789,7.786997e-08,6.484642520688389e-05,0.00016899545228497658,0.0005132686058003266,0.0,0.0032327438,False,DNMT3B; DNA methyltransferase 3
hsa:1938,5.1503703e-06,0.004288984604035499,2.0210523367894732e-05,2.7430718307678678e-05,0.0,0.00014681475,False,EEF2; eukaryotic translation elongation factor
hsa:84455,1.8253002e-05,0.015200236098641129,0.00011795088037619886,0.0002861313935891478,0.0,0.0021611655,False,EFCAB7; EF-hand calcium binding domain
hsa:57172,4.9966525e-07,0.00041609756961000417,7.327002712345029e-06,2.3508303550891646e-05,0.0,0.00024477555,False,CAMK1G; calcium/calmodulin dependent protein kinase
hsa:7919,0.0,0.0,4.3775295885380127e-07,8.630690571228168e-07,0.0,4.397027e-06,False,DDX39B; DExD-box helicase
hsa:57493,0.0,0.0,7.117073760479534e-07,2.005926178917283e-06,0.0,1.0346009e-05,False,HEG1; heart development protein with EGF like domains
hsa:5805,3.967688e-07,0.00033041027643422843,1.654991457190643e-05,3.95765710852023e-05,0.0,0.0001891617,False,PTS; 6-pyruvoyltetrahydropterin
hsa:10423,2.4094174e-05,0.020064487660810017,0.00013483298425545615,0.00034397028881570136,0.0,0.0023082464,False,CDIPT; CDP-diacylglycerol--inositol
hsa:720,0.0,0.0,6.265342096701754e-05,0.00018467676805555944,0.0,0.0011450079,False,C4A; complement C4A (Rodgers blood
hsa:79158,0.0,0.0,2.7365631490584795e-07,7.066007879744226e-07,0.0,3.829715e-06,False,GNPTAB; N-acetylglucosamine-1-phosphate transferase subunits alpha and
hsa:27085,4.364371e-08,3.634441590597672e-05,1.4493022089426898e-07,2.7703777286144766e-07,0.0,1.5538895e-06,False,MTBP; MDM2 binding
hsa:54576,0.0,0.0,8.040989042362574e-06,4.5261651696672354e-05,0.0,0.00045896973,False,UGT1A8; UDP glucuronosyltransferase family 1 member
hsa:26531,0.0,0.0,1.3977329905847954e-06,1.3505122038548465e-05,0.0,0.00016813274,False,OR11A1; olfactory receptor family 11 subfamily A member
hsa:26986,3.186635e-07,0.0002653678795421886,2.236693121859649e-06,4.0620263566248305e-06,0.0,1.7082279e-05,False,PABPC1; poly(A) binding protein cytoplasmic
hsa:9423,1.7993539e-08,1.4984167593369412e-05,5.505151753553215e-06,2.603003451229314e-05,0.0,0.00025528003,False,NTN1; netrin
hsa:60436,4.9883486e-08,4.1540606012274554e-05,4.805206250875847e-05,0.00010640686912670509,0.0,0.00079022534,False,TGIF2; TGFB induced factor homeobox
hsa:411,2.1576502e-06,0.0017967889587849851,3.878162853807018e-05,7.261106103071752e-05,0.0,0.00043615184,False,ARSB; arylsulfatase
hsa:1456,0.0,0.0,1.2415915139181284e-05,2.12254911361339e-05,0.0,0.00011616405,False,CSNK1G3; casein kinase 1 gamma
hsa:4092,6.590129e-08,5.487947501485058e-05,5.478105019649125e-06,1.5106033366614822e-05,0.0,0.00013233826,False,SMAD7; SMAD family member
hsa:962,2.6618284e-07,0.00022166446995441167,7.330076394298248e-06,1.6370891038449585e-05,0.0,0.00012710622,False,CD48; CD48
hsa:8526,0.0,0.0,0.00010074778545906434,0.0002069225163532501,0.0,0.0011833321,False,DGKE; diacylglycerol kinase
hsa:54626,1.6397204e-09,1.36548153644854e-06,7.526113774269007e-09,1.90884402374449e-08,0.0,1.816103e-07,False,HES2; hes family bHLH transcription factor
hsa:26497,0.0,0.0,7.785469514327484e-07,7.328916068231367e-06,0.0,9.039329e-05,False,OR10D3; olfactory receptor family 10 subfamily D member
hsa:8440,0.0,0.0,1.700318157349123e-05,6.241939538173527e-05,0.0,0.0005939009,False,NCK2; NCK adaptor protein
hsa:84920,0.0,0.0,2.7123179744943865e-05,5.467303885502036e-05,0.0,0.00033364168,False,ALG10; ALG10
hsa:9973,4.1376604e-09,3.4456477337808813e-06,2.5698887664970747e-08,4.286336822578452e-08,0.0,2.6726892e-07,False,CCS; copper chaperone for superoxide
hsa:7010,0.0,0.0,8.692368267672512e-06,2.2123255094674223e-05,0.0,0.00014330828,False,TEK; TEK receptor tyrosine
hsa:5573,0.0,0.0,1.1135399848538017e-07,2.9607430603863834e-07,0.0,2.2463862e-06,False,PRKAR1A; protein kinase cAMP-dependent type I regulatory subunit
hsa:81537,0.0,0.0,3.20686371397661e-06,1.1150742801910899e-05,0.0,9.08139e-05,False,SGPP1; sphingosine-1-phosphate phosphatase
hsa:55024,4.5110912e-08,3.756623228469615e-05,8.173800106327486e-07,2.2120938621121712e-06,0.0,1.460982e-05,False,BANK1; B cell scaffold protein with ankyrin repeats
hsa:605,0.0,0.0,2.4739815929766087e-06,8.263903921461479e-06,0.0,4.917698e-05,False,BCL7A; BAF chromatin remodeling complex subunit
hsa:841,0.0,0.0,1.065671971146199e-05,7.252013641746637e-05,0.0,0.0008819795,False,CASP8; caspase
hsa:57154,1.6267826e-05,0.013547075489917373,6.963800523391812e-05,0.00011391791052631971,0.0,0.0007671338,False,SMURF1; SMAD specific E3 ubiquitin protein ligase
hsa:11285,6.1792314e-05,0.05145771429167474,0.0010572973472173098,0.0029061302042880702,0.0,0.017281758,False,B4GALT7; beta-1
hsa:6793,0.0,0.0,4.842563393801169e-06,1.6029322261238974e-05,0.0,0.00016111154,False,STK10; serine/threonine kinase
hsa:10746,0.0,0.0,5.611949978479532e-06,1.7987690295583765e-05,0.0,0.00017696383,False,MAP3K2; mitogen-activated protein kinase kinase kinase
hsa:3883,0.0,0.0,7.50600111111111e-09,5.846921202295527e-08,0.0,6.8607227e-07,False,KRT33A; keratin
hsa:4669,1.5585072e-05,0.012978510275423249,7.1133509577193e-05,0.00016032754951118174,0.0,0.0011395018,False,NAGLU;
hsa:100130933,1.7800943e-08,1.4823782760690718e-05,5.206523362839764e-07,1.8424928212017063e-06,0.0,1.33715785e-05,False,SMIM6; small integral membrane protein
hsa:3640,0.0,0.0,3.05120380181462e-06,1.052293054504697e-05,0.0,8.7876186e-05,False,INSL3; insulin like
hsa:712,1.461044e-05,0.012166882877952367,0.00016755551871695915,0.000276764035276682,0.0,0.0015569356,False,C1QA; complement C1q A
hsa:27115,0.0,0.0,3.699369841111111e-07,1.8777236627768867e-06,0.0,1.7896216e-05,False,PDE7B; phosphodiesterase
hsa:2940,0.0,0.0,5.7729890058479525e-08,6.123994300171724e-07,0.0,7.896695e-06,False,GSTA3; glutathione S-transferase alpha
hsa:5010,0.0,0.0,6.15940833368421e-07,1.2596140481302302e-06,0.0,6.7366745e-06,False,CLDN11; claudin
hsa:80704,2.9876237e-06,0.002487951604557748,8.729720511812869e-05,0.00015090308803476123,0.0,0.0006683463,False,SLC19A3; solute carrier family 19 member
hsa:9140,3.528245e-05,0.02938155434040389,0.00031404842190491236,0.0005520956768565984,0.0,0.003604015,False,ATG12; autophagy related
hsa:6122,0.0,0.0,5.945748706678361e-07,1.2838402994550296e-06,0.0,6.2548515e-06,False,RPL3; ribosomal protein
hsa:30,2.3542665e-05,0.019605217070113458,0.00020111802507590651,0.00043259071425800696,0.0,0.0023120863,False,ACAA1; acetyl-CoA acyltransferase
hsa:5467,5.2274586e-06,0.004353180091465066,2.6567059402339186e-05,5.5212997789509015e-05,0.0,0.0004816722,False,PPARD; peroxisome proliferator activated receptor
hsa:26053,8.016462e-08,6.675730111451524e-05,1.1638212553388889e-05,8.337925239315175e-05,0.0,0.0007564926,False,AUTS2; activator of transcription and developmental regulator
hsa:4824,1.3804503e-08,1.1495736691663092e-05,5.4552593526315805e-08,9.98893169371434e-08,0.0,6.597477e-07,False,NKX3-1; NK3 homeobox
hsa:10673,0.0,0.0,3.968758230093568e-06,7.112864179892744e-06,0.0,4.4837532e-05,False,TNFSF13B; TNF superfamily member
hsa:23127,0.0,0.0,1.214600495504679e-05,4.437996414786165e-05,0.0,0.00038829533,False,COLGALT2; collagen beta(1-O)galactosyltransferase
hsa:1175,0.0,0.0,3.0143341476023395e-06,9.622933139836421e-06,0.0,0.00010165598,False,AP2S1; adaptor related protein complex 2 subunit sigma
hsa:51385,0.0,0.0,1.2999853320409357e-07,2.955482856694966e-07,0.0,1.5720938e-06,False,ZNF589; zinc finger protein
hsa:1967,0.0,0.0,1.7776793591812862e-08,4.149816219708367e-08,0.0,2.0119235e-07,False,EIF2B1; eukaryotic translation initiation factor 2B subunit
hsa:134111,0.0,0.0,2.0491222992690062e-07,4.911246247922493e-07,0.0,3.1188486e-06,False,UBE2QL1; ubiquitin conjugating enzyme E2 Q family like
hsa:57801,0.0,0.0,3.318345837994152e-07,9.057621978386786e-07,0.0,5.2819573e-06,False,HES4; hes family bHLH transcription factor
hsa:114879,0.0,0.0,7.874292458040936e-05,0.0001936869235270718,0.0,0.0010282118,False,OSBPL5; oxysterol binding protein like
hsa:2994,0.0,0.0,1.4282826457497078e-06,5.559579119827975e-06,0.0,5.9129023e-05,False,GYPB; glycophorin B (MNS blood
hsa:9992,0.0,0.0,2.767759977298246e-06,9.91836608791695e-06,0.0,8.255996e-05,False,KCNE2; potassium voltage-gated channel subfamily E regulatory subunit
hsa:92421,0.0,0.0,4.8314026039766066e-08,1.4824641268157917e-07,0.0,1.2057604e-06,False,CHMP4C; charged multivesicular body protein
hsa:326,0.0,0.0,5.594317649412282e-06,2.4081996322438348e-05,0.0,0.00020483056,False,AIRE; autoimmune
hsa:3164,0.0,0.0,7.1045602748538e-07,2.2385733286145112e-06,0.0,1.5172763e-05,False,NR4A1; nuclear receptor subfamily 4 group A member
hsa:285659,0.0,0.0,2.0247544385964914e-07,2.3104666178363214e-06,0.0,2.9969495e-05,False,OR2V2; olfactory receptor family 2 subfamily V member
hsa:4524,0.0,0.0,5.942461148023391e-05,0.00020407443464401894,0.0,0.0013506003,False,MTHFR; methylenetetrahydrofolate
hsa:6494,4.9497226e-07,0.00041218946967068665,7.491773767128652e-06,1.386534064026505e-05,0.0,8.8246336e-05,False,SIPA1; signal-induced proliferation-associated
hsa:23067,9.8152896e-08,8.173708593059754e-05,1.903952513749123e-05,6.717554316573142e-05,0.0,0.0005232402,False,SETD1B; SET domain containing 1B
hsa:9101,3.5438075e-06,0.002951115147422609,1.5211635998830412e-05,3.189401614077963e-05,0.0,0.00019371534,False,USP8; ubiquitin specific peptidase
hsa:8813,0.0,0.0,0.00010727007476477778,0.00026085558938276617,0.0,0.0013209818,False,DPM1; dolichyl-phosphate mannosyltransferase subunit 1
hsa:1730,2.2573008e-08,1.8797732617161553e-05,1.4142505236842107e-07,3.324666292152377e-07,0.0,2.6513364e-06,False,DIAPH2; diaphanous related formin
hsa:58511,7.8711466e-08,6.554718324526366e-05,1.8725653231415216e-05,6.421002814108245e-05,0.0,0.0005142607,False,DNASE2B; deoxyribonuclease 2
hsa:390197,0.0,0.0,4.074676567251462e-08,3.604403713351624e-07,0.0,3.4323286e-06,False,OR4D10; olfactory receptor family 4 subfamily D member
hsa:100132074,0.0,0.0,2.0181856356947365e-05,8.54811820701974e-05,0.0,0.00084495294,False,FOXO6; forkhead box
hsa:146909,0.0,0.0,5.5380606934502914e-08,1.1242080880967148e-07,0.0,6.1229247e-07,False,KIF18B; kinesin family member
hsa:567,0.0,0.0,1.8769656484368426e-05,6.234278356460036e-05,0.0,0.00041587878,False,B2M;
hsa:129807,6.727744e-07,0.0005602546759772243,3.536056897181286e-05,7.966570097187103e-05,0.0,0.00059365743,False,NEU4; neuraminidase
hsa:2048,1.8466868e-07,0.00015378333580549694,8.055738734795326e-07,1.4282515625003553e-06,0.0,9.755242e-06,False,EPHB2; EPH receptor
hsa:581,7.926966e-05,0.06601202078753998,0.00038634628432748536,0.0005476133592766638,0.0,0.0026650825,False,BAX; BCL2 associated X
hsa:4326,1.552313e-06,0.0012926927909715845,3.059796557438596e-05,9.490433962194606e-05,0.0,0.0010373546,False,MMP17; matrix metallopeptidase
hsa:29101,0.0,0.0,5.587807462739212e-07,1.600108306672292e-06,0.0,8.049939e-06,False,SSU72; SSU72 homolog
hsa:5019,0.0,0.0,4.822515884257312e-05,0.00012767806874149602,0.0,0.00068899133,False,OXCT1; 3-oxoacid CoA-transferase
hsa:4157,2.9400292e-06,0.002448317157741998,5.694164852573099e-05,0.000184512394617285,0.0,0.0017213965,False,MC1R; melanocortin 1
hsa:653,0.0,0.0,6.203748592397661e-06,5.071374655753119e-05,0.0,0.0006268901,False,BMP5; bone morphogenetic protein
hsa:6139,4.8133165e-07,0.0004008302153118977,1.2289512229590642e-06,2.1798048231067364e-06,0.0,1.35496175e-05,False,RPL17; ribosomal protein
hsa:22985,6.0099365e-09,5.004790649660858e-06,2.709483622426901e-07,5.233950804119826e-07,0.0,2.6409252e-06,False,ACIN1; apoptotic chromatin condensation inducer
hsa:11041,1.9182692e-06,0.0015974437925745826,0.00010021579575011698,0.0002556306573323337,0.0,0.0013929391,False,B4GAT1; beta-1
hsa:54567,0.0,0.0,4.631853949239766e-05,0.00014184813114891443,0.0,0.0010550346,False,DLL4; delta like canonical Notch ligand
hsa:7270,1.0086418e-05,0.00839949149129462,0.00012387321808011702,0.0002796902491951865,0.0,0.0014588444,False,TTF1; transcription termination factor
hsa:79724,0.0,0.0,5.577547254678364e-08,1.401414920542002e-07,0.0,9.471619e-07,False,ZNF768; zinc finger protein
hsa:390078,0.0,0.0,6.825427025730995e-07,6.568849285741481e-06,0.0,8.5704516e-05,False,OR52E6; olfactory receptor family 52 subfamily E member
hsa:51073,2.4630433e-08,2.0511058773332833e-05,2.0952245282573096e-07,4.793271577349272e-07,0.0,2.6418127e-06,False,MRPL4; mitochondrial ribosomal protein
hsa:51292,0.0,0.0,8.795170535633334e-07,2.814282753903302e-06,0.0,1.3685201e-05,False,GMPR2; guanosine monophosphate reductase
hsa:10610,0.0,0.0,7.21664687146199e-06,2.3073792910221413e-05,0.0,0.00019023905,False,ST6GALNAC2; ST6 N-acetylgalactosaminide alpha-2
hsa:57132,7.461716e-09,6.2137639003714625e-06,2.926063950349708e-06,4.811834153562893e-06,0.0,2.2075637e-05,False,CHMP1B; charged multivesicular body protein
hsa:9545,7.768081e-07,0.0006468890171236945,7.269057324853803e-06,2.0969064964680474e-05,0.0,0.00016736255,False,RAB3D; RAB3D
hsa:4642,0.0,0.0,5.050474603508773e-07,9.075048635534998e-07,0.0,4.7762182e-06,False,MYO1D; myosin
hsa:79324,0.0,0.0,1.553723639766082e-07,1.93007138701751e-06,0.0,2.5229006e-05,False,OR51G1; olfactory receptor family 51 subfamily G member
hsa:118788,0.0,0.0,4.387888273617544e-06,9.979616231387467e-06,0.0,6.387643e-05,False,PIK3AP1; phosphoinositide-3-kinase adaptor protein
hsa:81300,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4P4; olfactory receptor family 4 subfamily P member
hsa:991,2.8475633e-06,0.002371315932898362,3.678255772732572e-05,0.00011357749334924316,0.0,0.0010041661,False,CDC20; cell division cycle
hsa:8569,0.0,0.0,3.6236096357602335e-06,1.279849905904831e-05,0.0,9.359667e-05,False,MKNK1; MAPK interacting serine/threonine kinase
hsa:28987,1.9199672e-07,0.00015988578066033707,1.6216715155091212e-06,2.9465183931420065e-06,0.0,1.5455236e-05,False,NOB1; NIN1 (RPN12) binding protein 1
hsa:5743,0.0,0.0,6.253708154152047e-06,3.4564513594654154e-05,0.0,0.0003297878,False,PTGS2; prostaglandin-endoperoxide synthase
hsa:7327,1.6293836e-08,1.3568735386789442e-05,9.00438905356725e-07,1.8188980991024512e-06,0.0,1.1192122e-05,False,UBE2G2; ubiquitin conjugating enzyme E2
hsa:10465,0.0,0.0,7.441088123274855e-07,2.0811738748569055e-06,0.0,1.14243985e-05,False,PPIH; peptidylprolyl isomerase
hsa:79443,0.0,0.0,9.566639808070174e-08,2.333692031767305e-07,0.0,1.3041721e-06,False,FYCO1; FYVE and coiled-coil domain autophagy adaptor
hsa:51119,0.0,0.0,1.189611573516082e-06,2.549126313055032e-06,0.0,1.2678768e-05,False,SBDS; SBDS ribosome maturation
hsa:7291,5.2746948e-08,4.3925161630001826e-05,2.692805929837426e-07,5.500551772187597e-07,0.0,3.6279803e-06,False,TWIST1; twist family bHLH transcription factor
hsa:9653,0.0,0.0,1.7637954987134508e-05,3.165513592813395e-05,0.0,0.0001375632,False,HS2ST1; heparan sulfate 2-O-sulfotransferase
hsa:8764,0.00015620685,0.13008167096157774,0.0005072902820818713,0.0007289356621329333,0.0,0.004094963,False,TNFRSF14; TNF receptor superfamily member
hsa:8408,0.0,0.0,3.0770406586549693e-06,4.708994672886404e-06,0.0,1.7939443e-05,False,ULK1; unc-51 like autophagy activating kinase
hsa:5214,0.0,0.0,0.00011673263014912278,0.0002792713230172235,0.0,0.0016402685,False,PFKP; phosphofructokinase
hsa:51196,0.0,0.0,3.3401139477192977e-06,9.212938743984115e-06,0.0,7.450589e-05,False,PLCE1; phospholipase C epsilon
hsa:55626,0.0,0.0,1.939987788146199e-06,4.514941530033607e-06,0.0,2.2641416e-05,False,AMBRA1; autophagy and beclin 1 regulator
hsa:1001,0.0,0.0,1.539790724894737e-06,4.301900408323536e-06,0.0,3.4993354e-05,False,CDH3; cadherin
hsa:29775,2.2980123e-07,0.00019136758719240447,3.374298104502924e-07,3.739998762300861e-07,0.0,1.6731026e-06,False,CARD10; caspase recruitment domain family member
hsa:11035,0.0,0.0,1.8489798089473687e-06,1.0241979353990863e-05,0.0,0.00013285904,False,RIPK3; receptor interacting serine/threonine kinase
hsa:9486,0.0,0.0,4.585110790292398e-05,9.539743775173705e-05,0.0,0.0004864374,False,CHST10; carbohydrate sulfotransferase
hsa:55131,0.0,0.0,5.868091960959064e-07,1.796522026698575e-06,0.0,1.8961326e-05,False,RBM28; RNA binding motif protein
hsa:8883,1.0082937e-08,8.396592679260339e-06,2.7334301806666664e-08,4.674416756650055e-08,0.0,3.3487527e-07,False,NAE1; NEDD8 activating enzyme E1 subunit
hsa:10641,0.0,0.0,5.779514000000001e-07,1.2341238526496324e-06,0.0,6.106599e-06,False,NPRL2; NPR2 like
hsa:3134,0.0,0.0,7.823067966666663e-05,0.00015331504286276312,0.0,0.00096093374,False,HLA-F; major histocompatibility complex
hsa:2572,0.0,0.0,5.610742733746785e-05,0.00026418342925887294,0.0,0.0020921102,False,GAD2; glutamate decarboxylase
hsa:2567,4.920136e-06,0.004097256376645539,6.941554841415203e-05,0.00021347713181632365,0.0,0.0025270944,False,GABRG3; gamma-aminobutyric acid type A receptor subunit
hsa:2056,7.537646e-06,0.006276994810386692,2.064776833222222e-05,4.012233971386294e-05,0.0,0.00038637937,False,EPO;
hsa:171558,1.8005672e-07,0.00014994271381479706,5.286181033064327e-06,1.5796922787979536e-05,0.0,0.0001569705,False,PTCRA; pre T cell antigen receptor
hsa:23620,0.0,0.0,2.120650038310526e-07,8.898755840405235e-07,0.0,8.278086e-06,False,NTSR2; neurotensin receptor
hsa:9479,0.0,0.0,1.7108557476198832e-07,3.440000962976534e-07,0.0,1.8379493e-06,False,MAPK8IP1; mitogen-activated protein kinase 8 interacting protein
hsa:5664,4.713496e-06,0.0039251763655096614,0.00029180523127350877,0.0005011862392703803,0.0,0.002390797,False,PSEN2; presenilin
hsa:8243,5.258822e-08,4.3792980464653514e-05,4.4878276225573105e-06,8.513435276677591e-06,0.0,3.7167174e-05,False,SMC1A; structural maintenance of chromosomes
hsa:4939,0.0,0.0,4.281589679963155e-06,9.784236689990464e-06,0.0,6.475544e-05,False,OAS2; 2'-5'-oligoadenylate synthetase
hsa:7161,0.0,0.0,1.5207740341871347e-06,5.616208434397532e-06,0.0,4.562594e-05,False,TP73; tumor protein
hsa:10193,2.0529498e-09,1.7095994214353392e-06,7.277346576263156e-07,1.389181184139358e-06,0.0,9.670581e-06,False,RNF41; ring finger protein
hsa:8673,3.6966305e-06,0.003078378908271517,1.9851228246292394e-05,4.271744348963506e-05,0.0,0.00031655855,False,VAMP8; vesicle associated membrane protein
hsa:3305,8.3819705e-06,0.006980108289685448,3.0149548683222214e-05,4.279788021997503e-05,0.0,0.00022256443,False,HSPA1L; heat shock protein family A (Hsp70) member 1
hsa:55331,5.012633e-08,4.1742835000971234e-05,1.539654116265497e-05,3.128895559097288e-05,0.0,0.00018673114,False,ACER3; alkaline ceramidase
hsa:81442,0.0,0.0,1.2867758479532164e-08,1.682677765265073e-07,0.0,2.2003867e-06,False,OR6N2; olfactory receptor family 6 subfamily N member
hsa:7772,4.294191e-09,3.5759990084184427e-06,3.003892510309941e-08,7.947568567968085e-08,0.0,4.430773e-07,False,ZNF229; zinc finger protein
hsa:26039,3.0701804e-06,0.002556700916672253,2.8337947568397655e-05,6.834412345468886e-05,0.0,0.000609142,False,SS18L1; SS18L1 subunit of BAF chromatin remodeling
hsa:390326,0.0,0.0,1.1249718407017543e-07,1.0755514110017273e-06,0.0,1.2276313e-05,False,OR6C76; olfactory receptor family 6 subfamily C member
hsa:8924,0.0,0.0,4.071348876865496e-07,8.140513001490088e-07,0.0,4.048031e-06,False,HERC2; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:654254,3.2260636e-09,2.6865130672331137e-06,2.43922253505848e-08,4.406609162082937e-08,0.0,2.4705693e-07,False,ZNF732; zinc finger protein
hsa:4040,0.0,0.0,2.7827190612011695e-05,8.016652276079481e-05,0.0,0.00084172765,False,LRP6; LDL receptor related protein
hsa:3373,6.6965144e-06,0.00557654022707882,4.816723466473684e-05,8.537519796854892e-05,0.0,0.00050473167,False,HYAL1; hyaluronidase
hsa:6718,0.0,0.0,2.7250171646198834e-06,1.7939435759598543e-05,0.0,0.00021604693,False,AKR1D1; aldo-keto reductase family 1 member
hsa:10282,6.792159e-07,0.0005656188522825463,4.435201018307017e-05,0.00010621116705530014,0.0,0.00081031915,False,BET1; Bet1 golgi vesicular membrane trafficking
hsa:387748,0.0,0.0,2.455623200292397e-07,9.98530419597694e-07,0.0,9.7190195e-06,False,OR56B1; olfactory receptor family 56 subfamily B member
hsa:5871,0.0,0.0,8.731656960058479e-08,2.5045171765014157e-07,0.0,1.6494199e-06,False,MAP4K2; mitogen-activated protein kinase kinase kinase kinase
hsa:9615,0.0,0.0,1.2662891975672515e-08,7.073154787545256e-08,0.0,7.033729e-07,False,GDA; guanine
hsa:64377,0.0,0.0,4.433624966953217e-07,1.1427858214824094e-06,0.0,7.1677796e-06,False,CHST8; carbohydrate sulfotransferase
hsa:53637,0.0,0.0,5.201591941812866e-07,1.3368137987254167e-06,0.0,7.3471474e-06,False,S1PR5; sphingosine-1-phosphate receptor
hsa:3467,0.0,0.0,2.9194960476116958e-06,7.1271676748781635e-06,0.0,4.3092685e-05,False,IFNW1; interferon omega
hsa:81399,0.0,0.0,2.0180137761309938e-05,8.689036777467832e-05,0.0,0.0010032045,False,OR4F16; olfactory receptor family 4 subfamily F member
hsa:4200,2.076214e-07,0.00017289727460340003,3.1715402099941525e-06,6.06436331405542e-06,0.0,3.247672e-05,False,ME2; malic enzyme
hsa:8835,3.2237276e-05,0.02684567757002697,0.00024302863839239773,0.0004939617910466045,0.0,0.0027596983,False,SOCS2; suppressor of cytokine signaling
hsa:11027,0.0,0.0,6.835221825964912e-06,2.6052000219181448e-05,0.0,0.00017777199,False,LILRA2; leukocyte immunoglobulin like receptor
hsa:55173,0.0,0.0,7.117895184502922e-08,2.1722583487431876e-07,0.0,1.3112111e-06,False,MRPS10; mitochondrial ribosomal protein
hsa:116028,6.205763e-06,0.005167865689830719,0.00011853980847805846,0.0001966328282181542,0.0,0.000981088,False,RMI2; RecQ mediated genome instability
hsa:6332,0.0,0.0,1.3405524247543858e-07,4.521550369718012e-07,0.0,3.3547012e-06,False,SCN7A; sodium voltage-gated channel alpha subunit
hsa:1003,1.2161773e-06,0.0010127748902787554,4.478373059239768e-06,7.002587157940521e-06,0.0,3.3022567e-05,False,CDH5; cadherin
hsa:79735,3.2521694e-08,2.7082527418106932e-05,2.9953651864093565e-06,7.407206384326045e-06,0.0,3.7914924e-05,False,TBC1D17; TBC1 domain family member
hsa:2564,0.0,0.0,2.1084183948713446e-05,8.855135617397698e-05,0.0,0.00069226435,False,GABRE; gamma-aminobutyric acid type A receptor subunit
hsa:1075,1.5156908e-06,0.0012621955562453922,4.614311044807017e-06,7.664628448062685e-06,0.0,4.5156703e-05,False,CTSC; cathepsin
hsa:4358,1.2538809e-06,0.0010441726637391827,0.00024853918372442704,0.0008434322300895702,0.0,0.004738107,False,MPV17; mitochondrial inner membrane protein
hsa:6164,0.0,0.0,3.019486870175439e-07,6.562287748002585e-07,0.0,4.9340324e-06,False,RPL34; ribosomal protein
hsa:4998,0.0,0.0,7.465335010467836e-07,1.917043721192831e-06,0.0,9.814071e-06,False,ORC1; origin recognition complex subunit
hsa:55110,1.6535004e-08,1.3769568682016005e-05,3.8241890730643276e-07,8.46895988416431e-07,0.0,4.252704e-06,False,MAGOHB; mago homolog B
hsa:441669,-0.0,0.0,2.476984385964912e-08,2.1909341617994213e-07,0.0,2.4812275e-06,False,OR4Q3; olfactory receptor family 4 subfamily Q member
hsa:2879,1.2898433e-06,0.0010741204482556024,7.122593193918131e-05,0.00024881000511658454,0.0,0.0021694829,False,GPX4; glutathione peroxidase
hsa:79143,3.2291414e-08,2.6890761133920087e-05,3.986633975654389e-06,9.354262590951381e-06,0.0,4.174571e-05,False,MBOAT7; membrane bound O-acyltransferase domain containing
hsa:79798,0.0,0.0,5.545151495321637e-07,1.128979220900039e-06,0.0,5.878628e-06,False,ARMC5; armadillo repeat containing
hsa:6585,4.957439e-08,4.128320549387514e-05,2.3894863748039786e-05,9.963992340937717e-05,0.0,0.0010032123,False,SLIT1; slit guidance ligand
hsa:10434,4.5096695e-06,0.0037554393040027554,1.81403818162117e-05,3.514374535553668e-05,0.0,0.00021276089,False,LYPLA1; lysophospholipase
hsa:653509,0.0,0.0,2.4825674652090634e-07,1.606542364754538e-06,0.0,1.9205316e-05,False,SFTPA1; surfactant protein
hsa:4646,0.0,0.0,2.2732890043859654e-07,3.044419122622624e-07,0.0,1.2430542e-06,False,MYO6; myosin
hsa:11186,6.903443e-05,0.05748860570634432,0.00031795650381871346,0.0005605645050963951,0.0,0.0036663273,False,RASSF1; Ras association domain family member
hsa:11283,0.0,0.0,7.774440152280702e-07,8.013325915250582e-06,-0.0,0.00010117105,False,CYP4F8; cytochrome P450 family 4 subfamily F member
hsa:56895,0.0,0.0,8.137890080061988e-05,0.00022200432142919775,0.0,0.0011912776,False,AGPAT4; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:55361,0.0,0.0,2.1272184924853803e-06,4.523846816043516e-06,0.0,1.9832349e-05,False,PI4K2A; phosphatidylinositol 4-kinase type 2
hsa:10327,6.8121967e-06,0.005672874970943629,0.00014205855521228072,0.0002845688683419924,0.0,0.0017542271,False,AKR1A1; aldo-keto reductase family 1 member
hsa:7694,0.0,0.0,4.747859819298245e-08,1.0340455679663508e-07,0.0,5.313001e-07,False,ZNF135; zinc finger protein
hsa:403277,0.0,0.0,4.2603482748538006e-08,3.8407156185482414e-07,0.0,4.191345e-06,False,OR5K3; olfactory receptor family 5 subfamily K member
hsa:759,0.0,0.0,4.670768568245613e-05,0.0002771145640371343,0.0,0.0031539157,False,CA1; carbonic anhydrase
hsa:5740,4.9625766e-07,0.0004132598899490164,1.5148838370116962e-05,4.794012047805693e-05,0.0,0.00031723434,False,PTGIS; prostaglandin I2
hsa:51121,0.0,0.0,8.831248520467834e-08,2.4261205707623643e-07,0.0,2.322699e-06,False,RPL26L1; ribosomal protein L26 like
hsa:7639,0.0,0.0,3.548918546842105e-08,6.112944113146685e-08,0.0,3.4775704e-07,False,ZNF85; zinc finger protein
hsa:51052,0.0,0.0,4.992778655475438e-07,2.98282055391711e-06,0.0,3.0039835e-05,False,PRLH; prolactin releasing
hsa:406908,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR124-2; microRNA
hsa:729,0.0,0.0,4.841825188888889e-07,1.5507299776795305e-06,0.0,1.1863136e-05,False,C6; complement
hsa:391121,0.0,0.0,1.2567958479532164e-07,1.6434738281668735e-06,0.0,2.1491209e-05,False,OR10J4; olfactory receptor family 10 subfamily J member 4
hsa:23475,0.0,0.0,3.187783376636257e-05,0.0001200524628391104,0.0,0.0014500237,False,QPRT; quinolinate
hsa:9956,6.905552e-08,5.75061684600941e-05,1.5940229682941523e-05,4.2468699555873625e-05,0.0,0.00039738166,False,HS3ST2; heparan sulfate-glucosamine 3-sulfotransferase
hsa:1675,8.789891e-06,0.007319805174037717,6.678639216023393e-05,0.000151425884607535,0.0,0.0010701207,False,CFD; complement factor
hsa:57534,8.2797335e-08,6.894970155256011e-05,7.35251481102339e-07,1.631517698721388e-06,0.0,8.605178e-06,False,MIB1; MIB E3 ubiquitin protein ligase
hsa:5713,0.0,0.0,2.9645853564912285e-06,7.005919709490064e-06,0.0,6.4786276e-05,False,PSMD7; proteasome 26S subunit
hsa:64215,0.0,0.0,1.2782556723953217e-07,2.939905756761893e-07,0.0,2.2961556e-06,False,DNAJC1; DnaJ heat shock protein family (Hsp40) member
hsa:386653,0.0,0.0,2.2978567629157893e-06,6.185541860911824e-06,0.0,4.2018513e-05,False,IL31; interleukin
hsa:57472,0.0,0.0,1.9724803162731e-06,7.61403373089571e-06,0.0,6.746577e-05,False,CNOT6; CCR4-NOT transcription complex subunit
hsa:6361,3.7749076e-05,0.0314356437207177,8.28651552430994e-05,0.00012922427381212762,0.0,0.0007092773,False,CCL17; C-C motif chemokine ligand
hsa:817,0.0,0.0,0.00029101284867076024,0.0004898667300136219,0.0,0.0020017822,False,CAMK2D; calcium/calmodulin dependent protein kinase II
hsa:64979,3.398378e-09,2.830008343418132e-06,6.669839481169593e-08,1.289593683317223e-07,0.0,6.126921e-07,False,MRPL36; mitochondrial ribosomal protein
hsa:164,2.8225616e-08,2.3504957005405617e-05,2.2557355097397653e-06,4.579204495716161e-06,0.0,3.692096e-05,False,AP1G1; adaptor related protein complex 1 subunit gamma
hsa:391013,0.0,0.0,1.713119866421053e-05,4.8547187720514034e-05,0.0,0.0003940974,False,PLA2G2C; phospholipase A2 group
hsa:6884,7.228687e-08,6.0197083791026736e-05,1.4723892826725149e-06,3.7375996305099894e-06,0.0,3.6519e-05,False,TAF13; TATA-box binding protein associated factor
hsa:6160,7.20999e-08,6.0041384024853316e-05,5.497739548450292e-07,1.2074049730480151e-06,0.0,5.5721944e-06,False,RPL31; ribosomal protein
hsa:1508,0.0,0.0,2.653972321461989e-06,7.284236056041425e-06,0.0,3.67772e-05,False,CTSB; cathepsin
hsa:329,0.0,0.0,0.0005255083247777779,0.0010012904904352993,0.0,0.0044069807,False,BIRC2; baculoviral IAP repeat containing
hsa:7498,1.876142e-06,0.0015623622544158364,0.0003732167613923393,0.0012860952684211914,0.0,0.011102743,False,XDH; xanthine
hsa:390275,0.0,0.0,5.310308888859649e-06,3.4344530293761995e-05,0.0,0.00031442745,False,OR8A1; olfactory receptor family 8 subfamily A member
hsa:9319,0.0,0.0,8.671357523678361e-07,2.6100457774472147e-06,0.0,1.4603294e-05,False,TRIP13; thyroid hormone receptor interactor
hsa:64769,0.0,0.0,5.53014929733918e-07,1.320693458418334e-06,0.0,6.541659e-06,False,MEAF6; MYST/Esa1 associated factor
hsa:116071,0.0,0.0,1.2031534607391814e-06,3.3575248875696455e-06,0.0,2.1740747e-05,False,BATF2; basic leucine zipper ATF-like transcription factor
hsa:253959,0.0,0.0,1.1830200761520468e-06,3.0651778311320076e-06,0.0,1.6739461e-05,False,RALGAPA1; Ral GTPase activating protein catalytic subunit alpha
hsa:2243,0.0,0.0,4.104455947426901e-07,3.889508328820022e-06,0.0,4.8584876e-05,False,FGA; fibrinogen alpha
hsa:10972,2.988846e-07,0.00024889694781427815,3.016539966175438e-06,6.3679615278496415e-06,0.0,5.2851366e-05,False,TMED10; transmembrane p24 trafficking protein
hsa:65005,3.2486955e-08,2.705359842320348e-05,3.8831585672807016e-07,7.393939136754651e-07,0.0,3.5187347e-06,False,MRPL9; mitochondrial ribosomal protein
hsa:3839,0.0,0.0,3.4999303938596484e-07,1.0557665884601789e-06,0.0,6.3555212e-06,False,KPNA3; karyopherin subunit alpha
hsa:64388,1.1308983e-07,9.417585755785205e-05,2.07171603713655e-05,6.2943372709808e-05,0.0,0.0005855487,False,GREM2; gremlin 2
hsa:51284,0.0,0.0,8.958041398596488e-07,2.772812063419424e-06,0.0,1.8804762e-05,False,TLR7; toll like receptor
hsa:4082,0.0,0.0,6.805897170730995e-06,2.085293141936708e-05,0.0,0.00012014801,False,MARCKS; myristoylated alanine rich protein kinase C
hsa:390162,0.0,0.0,8.612070175438597e-10,1.126174307682526e-08,-0.0,1.472664e-07,False,OR5M9; olfactory receptor family 5 subfamily M member
hsa:9353,9.902847e-08,8.246622251436779e-05,2.7917554204912295e-07,3.5830124431781326e-07,0.0,1.6544237e-06,False,SLIT2; slit guidance ligand
hsa:4690,0.0,0.0,2.17950552922807e-05,5.127733220014153e-05,0.0,0.00032025352,False,NCK1; NCK adaptor protein
hsa:1360,0.0,0.0,2.2545551923976603e-09,1.3092469088694578e-08,0.0,1.19051094e-07,False,CPB1; carboxypeptidase
hsa:2550,9.951045e-05,0.08286759264487142,0.0007781435937988304,0.0013193724815406865,0.0,0.008396424,False,GABBR1; gamma-aminobutyric acid type B receptor subunit
hsa:10370,0.0,0.0,5.387671094736841e-07,1.153463583026552e-06,0.0,6.8871823e-06,False,CITED2; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain
hsa:5063,4.322968e-06,0.0035999631319204614,4.396165739538012e-05,7.667845886085131e-05,0.0,0.000551836,False,PAK3; p21 (RAC1) activated kinase
hsa:284349,6.902352e-09,5.747952037474593e-06,4.4130101231578935e-08,7.940869723967282e-08,0.0,3.875362e-07,False,ZNF283; zinc finger protein
hsa:3918,1.2775594e-09,1.063890997767836e-06,2.1767629628294743e-05,4.966998239192535e-05,0.0,0.00031055574,False,LAMC2; laminin subunit gamma
hsa:125919,0.0,0.0,2.9314910444912287e-08,5.7668841463993244e-08,0.0,2.8634898e-07,False,ZNF543; zinc finger protein
hsa:2197,3.3209588e-07,0.0002765537298131011,1.6375374130818709e-06,2.3972643268212267e-06,0.0,1.0538351e-05,False,FAU; FAU ubiquitin like and ribosomal protein S30
hsa:23293,2.1296538e-07,0.00017734748820149288,9.873493924713453e-07,1.5617017259215863e-06,0.0,6.6876687e-06,False,SMG6; SMG6 nonsense mediated mRNA decay
hsa:5531,0.0,0.0,4.3756308577192975e-06,1.019304643134908e-05,0.0,5.839044e-05,False,PPP4C; protein phosphatase 4 catalytic
hsa:53828,0.0,0.0,5.933510277695907e-07,6.406938651701459e-06,0.0,8.2717794e-05,False,FXYD4; FXYD domain containing ion transport regulator
hsa:3434,1.3966265e-07,0.0001163044442860348,2.6448994776783614e-07,3.8667328075957054e-07,0.0,2.2358727e-06,False,IFIT1; interferon induced protein with tetratricopeptide repeats
hsa:56923,0.0,0.0,5.23666857552468e-07,1.944288443203627e-06,0.0,1.6137403e-05,False,NMUR2; neuromedin U receptor
hsa:26476,0.0,0.0,8.014115204678363e-08,9.573452411870118e-07,0.0,1.24647e-05,False,OR10J1; olfactory receptor family 10 subfamily J member
hsa:93408,0.0,0.0,2.843555476608187e-09,1.8455027157563075e-08,0.0,2.057295e-07,False,MYL10; myosin light chain
hsa:5817,0.0,0.0,9.478537267479533e-05,0.0002403427162342976,0.0,0.0014125766,False,PVR; PVR cell adhesion
hsa:10998,0.00022689938,0.18895106386529137,0.000410742325736842,0.0005089459290814886,0.0,0.0025717837,False,SLC27A5; solute carrier family 27 member
hsa:10148,0.0,0.0,3.790698230807018e-06,1.9010771258186347e-05,0.0,0.00019136429,False,EBI3; Epstein-Barr virus induced
hsa:4312,0.0,0.0,1.3501693856701751e-05,4.457394031368477e-05,0.0,0.0004124416,False,MMP1; matrix metallopeptidase
hsa:8390,-0.0,0.0,8.101465905497077e-06,3.638683029359103e-05,0.0,0.0003013528,False,OR1G1; olfactory receptor family 1 subfamily G member
hsa:283208,0.0,0.0,2.8753730491228066e-08,9.799820586888655e-08,0.0,7.462354e-07,False,P4HA3; prolyl 4-hydroxylase subunit alpha
hsa:4007,6.9866495e-08,5.8181510054320385e-05,5.596778513976606e-07,1.1988023897821805e-06,0.0,8.902553e-06,False,PRICKLE3; prickle planar cell polarity protein
hsa:4637,6.0707293e-06,0.005055416016003198,0.00010265888794513449,0.0002314389166984515,0.0,0.0014156937,False,MYL6; myosin light chain
hsa:286151,0.0,0.0,1.6307200948829947e-06,5.747027297455838e-06,0.0,4.155372e-05,False,FBXO43; F-box protein
hsa:51639,5.6088435e-08,4.670779384143423e-05,4.86630788292398e-07,1.148521265361728e-06,0.0,6.5406916e-06,False,SF3B6; splicing factor 3b subunit
hsa:714,0.0,0.0,0.00020448035577602338,0.0003930322477058903,0.0,0.002605928,False,C1QC; complement C1q C
hsa:5509,0.0,0.0,1.4035674166842105e-06,4.854670962166137e-06,0.0,4.8829846e-05,False,PPP1R3D; protein phosphatase 1 regulatory subunit
hsa:9997,0.0,0.0,1.2624879900961988e-05,3.675357628293971e-05,0.0,0.00017456734,False,SCO2; synthesis of cytochrome C oxidase
hsa:5520,0.0,0.0,1.484434767385965e-05,3.06474884697743e-05,0.0,0.00016321041,False,PPP2R2A; protein phosphatase 2 regulatory subunit
hsa:5627,0.0,0.0,2.730974981777778e-06,1.4224331025677485e-05,0.0,0.00017107745,False,PROS1; protein
hsa:10993,0.0,0.0,1.1046471409941523e-05,2.7739300815516122e-05,0.0,0.00020907707,False,SDS; serine
hsa:3932,0.0,0.0,9.453762031192977e-05,0.000269144754950366,0.0,0.0018764451,False,LCK; LCK proto-oncogene
hsa:5915,3.0845572e-07,0.0002568673235217057,1.842057406888889e-05,5.3888339821665615e-05,0.0,0.000382883,False,RARB; retinoic acid receptor
hsa:11031,2.7438332e-09,2.2849344154616325e-06,2.8446804858771933e-07,7.104182817184355e-07,0.0,4.08495e-06,False,RAB31; RAB31
hsa:9518,0.0,0.0,6.263419450450294e-06,2.1831674633151848e-05,0.0,0.000192968,False,GDF15; growth differentiation factor
hsa:5830,7.1963194e-07,0.0005992754173874056,6.471270242237194e-05,0.00021897919290446763,0.0,0.0012492039,False,PEX5; peroxisomal biogenesis factor
hsa:65003,9.834506e-08,8.189711101412403e-05,2.879995497590643e-07,4.1674286700913645e-07,0.0,2.3310038e-06,False,MRPL11; mitochondrial ribosomal protein
hsa:4217,2.60001e-06,0.0021651652620663674,2.8840780847953213e-05,8.345053333590167e-05,0.0,0.0007754367,False,MAP3K5; mitogen-activated protein kinase kinase kinase
hsa:23566,0.0,0.0,2.457185423742398e-06,2.3226743304594776e-05,0.0,0.00030263345,False,LPAR3; lysophosphatidic acid receptor
hsa:5198,5.6234104e-08,4.6829100089702485e-05,3.3312807975298253e-06,6.1396422335214486e-06,0.0,2.7665163e-05,False,PFAS; phosphoribosylformylglycinamidine
hsa:2010,0.0,0.0,0.00015809867632163746,0.0005366426959428312,0.0,0.0034990432,False,EMD;
hsa:5331,7.3426556e-05,0.061146160347218204,0.0006073747450175439,0.001041580548631521,0.0,0.006498534,False,PLCB3; phospholipase C beta
hsa:23193,5.0248633e-07,0.00041844683150419313,5.3418392165748533e-05,0.00014098164661998757,0.0,0.0012605237,False,GANAB; glucosidase II alpha
hsa:7422,0.0,0.0,6.152760706140351e-05,9.613487738889127e-05,0.0,0.00044292357,False,VEGFA; vascular endothelial growth factor
hsa:6124,2.4020406e-07,0.00020003057162061124,1.6683752848011696e-06,2.9380164196917015e-06,0.0,1.13216065e-05,False,RPL4; ribosomal protein
hsa:2119,1.922975e-07,0.00016013625600755664,2.714110112167251e-06,8.460714794775434e-06,0.0,8.235039e-05,False,ETV5; ETS variant transcription factor
hsa:1394,2.9513922e-05,0.024577797262986038,6.765180642228077e-05,0.00012281166798379747,0.0,0.0011024035,False,CRHR1; corticotropin releasing hormone receptor
hsa:83658,0.0,0.0,3.317177188959065e-07,6.82330011016893e-07,0.0,3.2864086e-06,False,DYNLRB1; dynein light chain roadblock-type
hsa:5660,0.0,0.0,1.4622933931520473e-05,3.5281650952410894e-05,0.0,0.00021619345,False,PSAP;
hsa:84557,1.1208075e-05,0.009333554349650386,2.7891184609707605e-05,3.5165383231465726e-05,0.0,0.00018078795,False,MAP1LC3A; microtubule associated protein 1 light chain 3
hsa:6713,0.0,0.0,1.6300348578947363e-05,6.225803655307904e-05,0.0,0.00063758524,False,SQLE; squalene
hsa:3831,5.2191225e-09,4.346238181956598e-06,6.552432425619884e-07,1.4219012037315935e-06,0.0,9.517183e-06,False,KLC1; kinesin light chain
hsa:1855,2.8388004e-05,0.023640186045515627,0.00019090541732923974,0.00039722718564644683,0.0,0.0021737074,False,DVL1; dishevelled segment polarity protein
hsa:1285,0.0,0.0,1.8146722601695903e-06,5.954763106282885e-06,0.0,4.6794572e-05,False,COL4A3; collagen type IV alpha 3
hsa:26828,0.0,0.0,4.258593233918129e-09,3.681858828470356e-08,0.0,3.880652e-07,False,RNU5F-1; RNA
hsa:10793,5.2375406e-09,4.3615759038550775e-06,4.631753469467833e-08,9.958677852805996e-08,0.0,5.305596e-07,False,ZNF273; zinc finger protein
hsa:4324,8.784646e-07,0.0007315437386298616,3.0203451459368436e-05,7.222339656569215e-05,0.0,0.00058372563,False,MMP15; matrix metallopeptidase
hsa:4702,1.5178539e-07,0.00012639968835396624,2.2857926187134507e-06,3.1700385144496202e-06,0.0,1.4419036e-05,False,NDUFA8; NADH:ubiquinone oxidoreductase subunit
hsa:8228,4.9451705e-06,0.004118103923290821,0.00020828724720555557,0.00042163795120116025,0.0,0.0023914964,False,PNPLA4; patatin like phospholipase domain containing
hsa:29883,4.45659e-07,0.0003711237208807794,3.1454740147701775e-05,0.00011831474597142109,0.0,0.0009828744,False,CNOT7; CCR4-NOT transcription complex subunit
hsa:211,0.0,0.0,0.0001549702181976608,0.0004744899571143322,0.0,0.0036146154,False,ALAS1; 5'-aminolevulinate synthase
hsa:10095,0.0,0.0,5.897087836549707e-07,1.246964197763063e-06,0.0,7.1738555e-06,False,ARPC1B; actin related protein 2/3 complex subunit
hsa:391211,0.0,0.0,7.665466292397661e-08,9.832489473673471e-07,0.0,1.2856671e-05,False,OR2G6; olfactory receptor family 2 subfamily G member
hsa:81929,0.0,0.0,1.0059695678947374e-06,2.826873902568911e-06,0.0,2.4297613e-05,False,SEH1L; SEH1 like
hsa:5734,0.0,0.0,1.8335973518479538e-05,5.0327252674414914e-05,0.0,0.00034443534,False,PTGER4; prostaglandin E receptor
hsa:122876,0.0,0.0,1.0334132324450293e-06,4.902430651243288e-06,0.0,5.7235895e-05,False,GPHB5; glycoprotein hormone subunit beta
hsa:79544,0.0,0.0,3.6747439971052633e-06,4.783002473559156e-05,0.0,0.00062546955,False,OR4K1; olfactory receptor family 4 subfamily K member
hsa:27006,1.07085626e-07,8.917584066285553e-05,6.65936824230994e-06,2.324740256236054e-05,0.0,0.00022150195,False,FGF22; fibroblast growth factor
hsa:23569,0.0,0.0,2.2133577368070163e-07,8.033659004008855e-07,0.0,7.875862e-06,False,PADI4; peptidyl arginine deiminase
hsa:126017,0.0,0.0,2.0545405098011697e-08,4.242662987536455e-08,0.0,2.2434047e-07,False,ZNF813; zinc finger protein
hsa:247,5.956526e-07,0.0004960312913333076,2.0511939898900596e-05,5.732070075465601e-05,0.0,0.0005045479,False,ALOX15B; arachidonate 15-lipoxygenase type
hsa:8740,7.8411276e-08,6.52971992221177e-05,2.764931735453449e-05,0.00013768145349204056,0.0,0.0016722056,False,TNFSF14; TNF superfamily member
hsa:8396,6.5535587e-06,0.00545749348662229,0.00011219428647098249,0.00018391507487620437,0.0,0.0008260565,False,PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:282890,0.0,0.0,2.7925723859649117e-09,2.0992027369622043e-08,0.0,2.6952716e-07,False,ZNF311; zinc finger protein
hsa:113,0.00027666969,0.23039742226171078,0.0005705234646081872,0.0007238122465534643,0.0,0.0030396054,False,ADCY7; adenylate cyclase
hsa:51460,0.0,0.0,4.20086442296193e-05,0.00014622270985082165,0.0,0.0008453141,False,SFMBT1; Scm like with four mbt domains
hsa:407014,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR25; microRNA
hsa:2560,0.0,0.0,5.7672996441578933e-05,0.00014140400229630283,0.0,0.0010159904,False,GABRB1; gamma-aminobutyric acid type A receptor subunit
hsa:26212,1.1497953e-06,0.0009574951027292886,0.00011408043723141282,0.00027714762727782554,0.0,0.0018503008,False,OR2B6; olfactory receptor family 2 subfamily B member
hsa:3827,0.0,0.0,1.5291800121315787e-05,0.00012312000268083234,0.0,0.0015494156,False,KNG1; kininogen
hsa:338398,0.0,0.0,3.8776881871345025e-08,3.184139442692212e-07,0.0,3.4338786e-06,False,TAS2R60; taste 2 receptor member
hsa:390081,0.0,0.0,4.466238179356726e-07,1.4236846757554098e-06,0.0,9.121359e-06,False,OR52E4; olfactory receptor family 52 subfamily E member
hsa:6753,0.0,0.0,3.7724062504438598e-06,1.0464454552978316e-05,0.0,8.792824e-05,False,SSTR3; somatostatin receptor
hsa:6133,1.18922486e-07,9.903301739830766e-05,1.2997945468672511e-06,2.506475660669735e-06,0.0,1.1743298e-05,False,RPL9; ribosomal protein
hsa:4940,0.0,0.0,1.4629482289614036e-05,3.550784730536488e-05,0.0,0.0002499907,False,OAS3; 2'-5'-oligoadenylate synthetase
hsa:5741,0.0,0.0,1.745241475730994e-06,1.8580441209631376e-05,0.0,0.00024256665,False,PTH; parathyroid
hsa:442910,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR345; microRNA
hsa:3145,2.4412174e-07,0.00020329303008957567,0.00019099386804972106,0.0004520570067362037,0.0,0.0024733588,False,HMBS; hydroxymethylbilane
hsa:10810,0.0,0.0,5.721836156871346e-06,1.7381474549135768e-05,0.0,0.0001009342,False,WASF3; WASP family member
hsa:64425,1.13235545e-08,9.4297202112743e-06,7.096067769051873e-05,0.00026271726385396384,0.0,0.0019254424,False,POLR1E; RNA polymerase I subunit
hsa:84321,1.1545883e-07,9.614864862628457e-05,4.858759422637429e-07,7.420762586423429e-07,0.0,3.934546e-06,False,THOC3; THO complex subunit
hsa:57657,0.0,0.0,8.081942394264329e-05,0.0001581457155770295,0.0,0.0007944187,False,HCN3; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:120796,0.0,0.0,1.3966469111111113e-07,1.8082878134484492e-06,0.0,2.3646642e-05,False,OR56A1; olfactory receptor family 56 subfamily A member
hsa:283869,0.0,0.0,5.218153618375671e-06,1.8294635466951268e-05,0.0,0.00013805703,False,NPW; neuropeptide
hsa:9451,0.0,0.0,1.5708074619298244e-06,5.066393268173014e-06,0.0,3.1678166e-05,False,EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase
hsa:7039,0.0,0.0,2.8364012533918123e-06,1.0144273574868447e-05,0.0,9.569633e-05,False,TGFA; transforming growth factor
hsa:9791,0.0,0.0,2.39042889196538e-05,7.259764922860295e-05,0.0,0.0003746137,False,PTDSS1; phosphatidylserine synthase
hsa:9902,1.508678e-07,0.00012563556283413382,1.2041364876625726e-06,2.103907202195614e-06,0.0,9.711381e-06,False,MRC2; mannose receptor C type
hsa:2740,0.0,0.0,1.8884953584210526e-07,8.02769689770376e-07,0.0,6.4041487e-06,False,GLP1R; glucagon like peptide 1
hsa:3060,0.0,0.0,9.731652388165907e-06,3.022681284085802e-05,0.0,0.00030822644,False,HCRT; hypocretin neuropeptide
hsa:5481,4.9143546e-07,0.00040924419003757895,0.0001519924477062573,0.0005152892051524156,0.0,0.0034435324,False,PPID; peptidylprolyl isomerase
hsa:3297,2.0402597e-06,0.0016990317068141848,2.7774933988479556e-05,5.2703604133572575e-05,0.0,0.00029728425,False,HSF1; heat shock transcription factor
hsa:284654,1.3740675e-08,1.1442583754425476e-05,1.53960646562193e-06,5.970379335353156e-06,0.0,4.6915204e-05,False,RSPO1; R-spondin
hsa:11224,0.0,0.0,4.598309367251462e-07,8.387529476406058e-07,0.0,4.5698935e-06,False,RPL35; ribosomal protein
hsa:3480,8.3962186e-05,0.06991973432961991,0.0003461292030871345,0.0006808310207333985,0.0,0.0042926855,False,IGF1R; insulin like growth factor 1
hsa:440515,0.0,0.0,1.292977037391813e-07,3.470124946596838e-07,0.0,1.7208149e-06,False,ZNF506; zinc finger protein
hsa:6517,0.0,0.0,2.5854331584795324e-07,1.1135915274637796e-06,0.0,1.0126427e-05,False,SLC2A4; solute carrier family 2 member
hsa:100505767,0.0,0.0,8.881177478070173e-07,3.3843376887569856e-06,0.0,2.4132465e-05,False,SPDYE18; speedy/RINGO cell cycle regulator family member
hsa:222546,3.9583933e-06,0.003296362578127104,5.098633926198828e-05,0.00012575285344640545,0.0,0.0008986977,False,RFX6; regulatory factor
hsa:3033,1.1312646e-05,0.009420636128804906,0.0001519230537426901,0.0002641094679021776,0.0,0.0011653311,False,HADH; hydroxyacyl-CoA
hsa:199857,1.18362436e-07,9.856663426708114e-05,6.106240910403508e-05,0.00012697021668638052,0.0,0.0006838812,False,ALG14; ALG14 UDP-N-acetylglucosaminyltransferase
hsa:3707,0.0,0.0,5.915534207495321e-06,1.7341703957904033e-05,0.0,0.00011569118,False,ITPKB; inositol-trisphosphate 3-kinase
hsa:8671,0.0,0.0,1.647508458894737e-05,6.366566749608589e-05,0.0,0.0006401937,False,SLC4A4; solute carrier family 4 member
hsa:56656,0.0,0.0,3.458982456140351e-09,3.617774086651311e-08,0.0,4.5325334e-07,False,OR2S2; olfactory receptor family 2 subfamily S member
hsa:390036,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR52K1; olfactory receptor family 52 subfamily K member
hsa:10825,0.0,0.0,9.681410533391814e-05,0.00023076301971610192,0.0,0.0014064314,False,NEU3; neuraminidase
hsa:6187,1.2020642e-07,0.00010010221686122739,9.602616847953217e-07,2.0618832625662493e-06,0.0,1.0906065e-05,False,RPS2; ribosomal protein
hsa:901,0.0,0.0,4.1714877351461996e-05,9.896374084347299e-05,0.0,0.00047797296,False,CCNG2; cyclin
hsa:25873,1.0371544e-07,8.636930928262913e-05,1.043513976654971e-06,2.3683198129956315e-06,0.0,1.1828455e-05,False,RPL36; ribosomal protein
hsa:4299,0.0,0.0,1.57262108651462e-07,3.0920745003933416e-07,0.0,1.7721857e-06,False,AFF1; ALF transcription elongation factor
hsa:84971,0.0,0.0,0.0009525294640274168,0.0023585969915847103,0.0,0.012628288,False,ATG4D; autophagy related 4D cysteine
hsa:25824,3.9945007e-08,3.3264311117802574e-05,2.620937669853801e-06,5.111331912038704e-06,0.0,3.0928844e-05,False,PRDX5; peroxiredoxin
hsa:8633,0.0,0.0,3.421492873221913e-05,0.0001410921832724836,0.0,0.0014520282,False,UNC5C; unc-5 netrin receptor
hsa:1510,7.902148e-09,6.58053482306115e-06,1.5677506046757312e-07,6.63476526883786e-07,0.0,7.24802e-06,False,CTSE; cathepsin
hsa:23250,0.0,0.0,0.00011393266548624564,0.000264128744841523,0.0,0.0011851585,False,ATP11A; ATPase phospholipid transporting
hsa:2935,0.0,0.0,1.7640738716637432e-07,4.5903071163959457e-07,0.0,2.7148574e-06,False,GSPT1; G1 to S phase transition
hsa:1410,3.222509e-09,2.6835529646025315e-06,5.8340842664092984e-05,0.00018954343095980218,0.0,0.0011039561,False,CRYAB; crystallin alpha
hsa:7095,6.1333515e-07,0.0005107564820074788,1.9539318326257315e-06,3.375623588608328e-06,0.0,2.1230851e-05,False,SEC62; SEC62 homolog
hsa:390433,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4K13; olfactory receptor family 4 subfamily K member
hsa:64744,4.7759464e-08,3.9771821026730376e-05,1.3899540584245615e-06,3.355739307426352e-06,0.0,1.9257473e-05,False,SMAP2; small
hsa:221458,1.7087688e-09,1.4229817757096442e-06,1.1816538250555558e-08,2.5835749361588353e-08,0.0,1.6245453e-07,False,KIF6; kinesin family member
hsa:7043,0.0,0.0,5.699898694152048e-05,0.0001797390794172598,0.0,0.0010409466,False,TGFB3; transforming growth factor beta
hsa:8528,0.0,0.0,7.056757719450293e-05,0.0002599593701834525,0.0,0.0021071325,False,DDO; D-aspartate
hsa:8394,1.1760591e-05,0.009793663522282746,3.7129875652631564e-05,6.507114098493031e-05,0.0,0.00035540343,False,PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:125476,0.0,0.0,7.268889855783622e-08,1.7681545708543167e-07,0.0,1.2890591e-06,False,INO80C; INO80 complex subunit
hsa:84445,0.0,0.0,2.8727848264327474e-07,5.338888399936691e-07,0.0,2.455648e-06,False,LZTS2; leucine zipper tumor suppressor
hsa:26279,0.0002711107,0.22576815851265813,0.0004535565901778947,0.0005824899985654486,0.0,0.0031397038,False,PLA2G2D; phospholipase A2 group
hsa:1271,3.4544708e-05,0.02876719772224958,0.0003036211329257309,0.00046096404615041196,0.0,0.0028072433,False,CNTFR; ciliary neurotrophic factor
hsa:25981,0.0,0.0,1.0659343815906432e-07,2.746940755289014e-07,0.0,1.8350116e-06,False,DNAH1; dynein axonemal heavy chain
hsa:54776,8.429411e-06,0.007019614492590458,0.0001033250920947544,0.0002534362441151053,0.0,0.0017006305,False,PPP1R12C; protein phosphatase 1 regulatory subunit
hsa:1907,3.6399686e-06,0.0030311935599218265,4.485978844627487e-05,0.00010770272250402694,0.0,0.00074394984,False,EDN2; endothelin
hsa:64960,0.0,0.0,3.6561254469723376e-07,7.657790259599379e-07,0.0,4.1076078e-06,False,MRPS15; mitochondrial ribosomal protein
hsa:26275,0.0001678305,0.13976129650087096,0.0006048265396900585,0.0009644628110700463,0.0,0.006625402,False,HIBCH; 3-hydroxyisobutyryl-CoA
hsa:84874,2.5960134e-08,2.161837082756913e-05,9.553163056432745e-08,1.7242678356890136e-07,0.0,7.9041337e-07,False,ZNF514; zinc finger protein
hsa:115653,0.0,0.0,3.5398702456140344e-07,1.919584540890846e-06,0.0,1.9180861e-05,False,KIR3DL3; killer cell immunoglobulin like receptor
hsa:11060,0.0,0.0,2.67902986894737e-07,7.104057984064184e-07,0.0,3.5997375e-06,False,WWP2; WW domain containing E3 ubiquitin protein ligase
hsa:3382,0.00014114587,0.11753959969697633,0.00031158712548608186,0.0003669494999913371,0.0,0.0015020203,False,ICA1; islet cell autoantigen
hsa:23291,7.2645526e-05,0.06049575553160916,0.0008282617956257308,0.001681835038527593,0.0,0.0098762745,False,FBXW11; F-box and WD repeat domain containing
hsa:10965,0.0,0.0,0.000256530647565731,0.0005445586530818811,0.0,0.002488146,False,ACOT2; acyl-CoA thioesterase
hsa:3681,0.0,0.0,7.4165340678366094e-06,3.133264571187454e-05,0.0,0.00025153,False,ITGAD; integrin subunit alpha
hsa:25759,0.00028517313,0.23747868460149626,0.0006531274788818712,0.0009682113710029345,0.0,0.00518812,False,SHC2; SHC adaptor protein
hsa:59277,3.4173905e-08,2.8458410535019534e-05,2.167086039853801e-07,4.052765958818121e-07,0.0,2.6133298e-06,False,NTN4; netrin
hsa:5698,1.787928e-07,0.0001488901810637573,5.722509725578947e-06,1.0287499942557779e-05,0.0,4.5263296e-05,False,PSMB9; proteasome 20S subunit beta
hsa:1140,0.0,0.0,8.557089672187135e-06,1.9704635943930457e-05,0.0,0.00012459003,False,CHRNB1; cholinergic receptor nicotinic beta 1
hsa:53358,6.7885395e-07,0.0005653174374546785,2.384873687216374e-05,6.24929487897741e-05,0.0,0.0005441552,False,SHC3; SHC adaptor protein
hsa:2769,4.650542e-07,0.00038727512541031177,7.087266830894735e-06,2.7274262793934136e-05,0.0,0.00030807723,False,GNA15; G protein subunit alpha
hsa:406889,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7F2; microRNA
hsa:407047,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-2; microRNA
hsa:4741,0.0,0.0,4.26930080625731e-08,8.678436909915789e-08,0.0,4.6546495e-07,False,NEFM; neurofilament medium
hsa:4855,0.0,0.0,6.52864393111111e-05,0.0001497405795392858,0.0,0.0007213378,False,NOTCH4; notch receptor
hsa:93661,0.0,0.0,6.065706444444445e-09,4.8314277232929426e-08,0.0,5.4166804e-07,False,CAPZA3; capping actin protein of muscle Z-line subunit alpha
hsa:2494,0.0,0.0,2.3802545263157896e-07,1.1248403214892889e-06,0.0,1.1074078e-05,False,NR5A2; nuclear receptor subfamily 5 group A member
hsa:4914,8.822276e-05,0.07346773869162743,0.00024851820599567243,0.00036595197179193354,0.0,0.0018969817,False,NTRK1; neurotrophic receptor tyrosine kinase
hsa:492,9.683298e-05,0.08063792236120912,0.0001798647904230994,0.00020029993818199924,0.0,0.0011437049,False,ATP2B3; ATPase plasma membrane Ca2+ transporting
hsa:27113,5.7133893e-05,0.04757840177930731,0.00020703195617892395,0.00031806178164846103,0.0,0.0015045524,False,BBC3; BCL2 binding component
hsa:9524,0.0,0.0,3.46436989746199e-05,0.00011192262298054105,0.0,0.00081781234,False,TECR; trans-2
hsa:2170,3.5328637e-06,0.002942001668784065,0.00010521601449649126,0.00037013752253816675,0.0,0.0027840384,False,FABP3; fatty acid binding protein
hsa:57819,3.7231393e-07,0.00031004541821739496,1.6785189432748536e-06,2.7238505509228194e-06,0.0,1.5606422e-05,False,LSM2; LSM2 homolog
hsa:6502,2.8401907e-06,0.0023651763805846745,2.8794703676257307e-05,7.689791869752697e-05,0.0,0.0007879197,False,SKP2; S-phase kinase associated protein
hsa:196403,0.0,0.0,0.00030931521264905847,0.0006989412648329095,0.0,0.003895612,False,DTX3; deltex E3 ubiquitin ligase
hsa:7574,0.0,0.0,5.0411914175438636e-08,1.246294906076544e-07,0.0,5.78876e-07,False,ZNF26; zinc finger protein
hsa:10744,0.0,0.0,7.33378767345029e-08,2.7127743650160804e-07,0.0,2.6291698e-06,False,PTTG2; pituitary tumor-transforming
hsa:5934,0.0,0.0,3.6257639285380117e-06,6.079146148426721e-06,0.0,2.8070273e-05,False,RBL2; RB transcriptional corepressor like
hsa:5519,0.0,0.0,0.0001328183332319883,0.0003540864305929405,0.0,0.0019698704,False,PPP2R1B; protein phosphatase 2 scaffold subunit
hsa:51564,0.0,0.0,2.269075805695906e-05,6.02117091275531e-05,0.0,0.000423194,False,HDAC7; histone deacetylase
hsa:1107,0.0,0.0,2.1183025993567256e-07,4.822818566546588e-07,0.0,3.7193054e-06,False,CHD3; chromodomain helicase DNA binding protein
hsa:1471,0.0,0.0,8.747776312046784e-06,2.577235380148399e-05,0.0,0.00023093911,False,CST3; cystatin
hsa:3123,0.00019226628,0.1601102574692888,0.0005530209393567251,0.0009408366309607736,0.0,0.004354111,False,HLA-DRB1; major histocompatibility complex
hsa:11311,8.514039e-09,7.090088685304392e-06,7.528058098298245e-07,2.1208723864983665e-06,0.0,2.0025873e-05,False,VPS45; vacuolar protein sorting 45
hsa:4881,2.8255258e-06,0.00235296414599647,4.428816878888888e-05,0.00013698231828791768,0.0,0.0015364999,False,NPR1; natriuretic peptide receptor
hsa:4311,0.0,0.0,2.3446588304093568e-07,2.832883845802493e-06,0.0,3.692787e-05,False,MME; membrane
hsa:5018,8.785357e-07,0.0007316029473444947,0.00018367441948273107,0.0005402547630458711,0.0,0.0030677281,False,OXA1L; OXA1L mitochondrial inner membrane
hsa:279,0.0,0.0,2.642777148403509e-05,9.862007229710777e-05,0.0,0.0010892404,False,AMY2A; amylase alpha
hsa:219959,0.0,0.0,1.6130224385964914e-07,1.8980671248994518e-06,0.0,2.4756933e-05,False,OR1S1; olfactory receptor family 1 subfamily S member
hsa:100129543,0.0,0.0,8.85677174461988e-09,1.8154695635528772e-08,0.0,1.09347475e-07,False,ZNF730; zinc finger protein
hsa:3346,0.0,0.0,2.695378370467837e-07,2.0373898402895957e-06,0.0,2.183169e-05,False,HTN1; histatin
hsa:126231,2.5164086e-09,2.095545973240511e-06,4.137778444982456e-08,7.2923393368566e-08,0.0,3.9053543e-07,False,ZNF573; zinc finger protein
hsa:136,0.0,0.0,1.8022127548245607e-06,5.290441458168881e-06,0.0,5.4094744e-05,False,ADORA2B; adenosine A2b
hsa:7301,0.0,0.0,0.00011251286419883045,0.00019256030371144606,0.0,0.0010297928,False,TYRO3; TYRO3 protein tyrosine
hsa:135152,0.0,0.0,3.5731661936257316e-06,1.1127672613635016e-05,0.0,8.094106e-05,False,B3GAT2; beta-1
hsa:4481,3.204488e-09,2.66854592878817e-06,3.486981761526315e-07,5.894548437278248e-07,0.0,2.7770782e-06,False,MSR1; macrophage scavenger receptor
hsa:10667,0.0,0.0,1.1382578612777778e-06,2.7970287758865504e-06,0.0,1.714984e-05,False,FARS2; phenylalanyl-tRNA synthetase 2
hsa:5029,0.0,0.0,7.473339190181286e-06,3.080752744875756e-05,0.0,0.00035200015,False,P2RY2; purinergic receptor
hsa:7135,0.0,0.0,1.715843098421053e-08,7.829955933432088e-08,0.0,7.342736e-07,False,TNNI1; troponin I1
hsa:5606,0.0,0.0,6.543851837017543e-05,0.0002150036025420542,0.0,0.001288259,False,MAP2K3; mitogen-activated protein kinase kinase
hsa:139760,0.0,0.0,5.475406050526315e-07,4.18414390091078e-06,0.0,5.2396324e-05,False,GPR119; G protein-coupled receptor
hsa:5979,0.0,0.0,1.0008939444511696e-05,3.5555145731256856e-05,0.0,0.00031034395,False,RET; ret
hsa:2288,7.423137e-07,0.0006181637135226228,4.5495457296391825e-05,0.00012586820952388257,0.0,0.00068816857,False,FKBP4; FKBP prolyl isomerase
hsa:57118,2.4348094e-06,0.0020275940218047834,3.140990146480994e-05,9.437570858815525e-05,0.0,0.00079183566,False,CAMK1D; calcium/calmodulin dependent protein kinase
hsa:1785,0.0,0.0,0.0001258527187089474,0.00045232496808598533,0.0,0.004092727,False,DNM2; dynamin
hsa:64968,0.0,0.0,3.365455368656726e-07,7.950932744671085e-07,0.0,4.108819e-06,False,MRPS6; mitochondrial ribosomal protein
hsa:801,0.0,0.0,0.0002345182132163743,0.0006347414747289118,0.0,0.003680873,False,CALM1; calmodulin
hsa:4515,3.503429e-07,0.0002917489843852874,5.51994223438538e-07,6.63032841550311e-07,0.0,3.8081755e-06,False,MTCP1; mature T cell proliferation
hsa:324,5.4497188e-05,0.045382678658120575,0.0001711819902485381,0.00021000074827041298,0.0,0.0010967011,False,APC; APC regulator of WNT signaling
hsa:2146,0.0,0.0,0.00022487450082219116,0.000608644575226181,0.0,0.0035556734,False,EZH2; enhancer of zeste 2 polycomb repressive complex 2
hsa:5584,0.0,0.0,3.7424814210526312e-06,6.776881444201955e-06,0.0,3.6474357e-05,False,PRKCI; protein kinase C
hsa:1499,0.0,0.0,0.0001793929121836258,0.0003759458285618401,0.0,0.0017839761,False,CTNNB1; catenin beta
hsa:24148,0.0,0.0,3.108413809146198e-07,9.411351012507483e-07,0.0,5.2880737e-06,False,PRPF6; pre-mRNA processing factor
hsa:597,8.748835e-07,0.0007285615680536,4.2920805194152055e-06,1.1786454850781165e-05,0.0,8.503578e-05,False,BCL2A1; BCL2 related protein
hsa:9310,0.0,0.0,9.519510918128656e-08,2.5519256078566675e-07,0.0,1.3676023e-06,False,ZNF235; zinc finger protein
hsa:22954,2.7443154e-08,2.285335968797723e-05,2.0653662362865494e-07,3.2000011253528e-07,0.0,2.0613927e-06,False,TRIM32; tripartite motif containing
hsa:346606,0.0,0.0,1.8460976116959067e-06,9.374984439294084e-06,0.0,0.00010746658,False,MOGAT3; monoacylglycerol O-acyltransferase
hsa:6785,1.4678593e-06,0.0012223637470475323,0.00029873035662210525,0.0008358842713486362,0.0,0.0041163764,False,ELOVL4; ELOVL fatty acid elongase
hsa:8793,3.5723756e-06,0.0029749053088924645,4.198258024900585e-05,0.00012663270798166323,0.0,0.0009639745,False,TNFRSF10D; TNF receptor superfamily member
hsa:51805,7.1647926e-05,0.059665001470879615,0.0006263420408915203,0.0013094745247580583,0.0,0.006737214,False,COQ3; coenzyme Q3
hsa:51176,0.0,0.0,1.6095234520467835e-06,7.691278668396843e-06,0.0,5.565181e-05,False,LEF1; lymphoid enhancer binding factor
hsa:5739,0.0,0.0,5.54651294674269e-06,2.308767453274142e-05,0.0,0.00025904505,False,PTGIR; prostaglandin I2
hsa:26119,0.0,0.0,2.6414784444789478e-06,9.666802511795141e-06,0.0,7.4183605e-05,False,LDLRAP1; low density lipoprotein receptor adaptor protein
hsa:23683,3.1888273e-08,2.6555044390940365e-05,2.581815548710527e-06,6.984578917460091e-06,0.0,3.813478e-05,False,PRKD3; protein kinase
hsa:5558,0.0,0.0,4.098669142009181e-06,1.200767882652512e-05,0.0,8.8188324e-05,False,PRIM2; DNA primase subunit
hsa:65220,0.0,0.0,8.865062944350876e-05,0.0002081734207952414,0.0,0.0013653059,False,NADK; NAD
hsa:362,1.1457445e-06,0.0009541217882252756,4.218254624319165e-05,0.00011004775364071033,0.0,0.00070644805,False,AQP5; aquaporin
hsa:2045,5.2435126e-08,4.3665491027831815e-05,1.2342588150140356e-05,4.4724453143098315e-05,0.0,0.00032849782,False,EPHA7; EPH receptor
hsa:8678,0.00016242894,0.1352631330042047,0.0010745858051286548,0.001792845923509621,0.0,0.008516361,False,BECN1; beclin
hsa:6208,3.4035563e-07,0.00028343205865543345,2.0663293402239777e-06,3.0143784028152985e-06,0.0,1.1844733e-05,False,RPS14; ribosomal protein
hsa:6019,0.0,0.0,1.0660575838567254e-05,2.2431470626527433e-05,0.0,0.0001230966,False,RLN2; relaxin
hsa:5977,6.948953e-08,5.786759144515548e-05,4.497543194730991e-06,1.4159946883205088e-05,0.0,8.976665e-05,False,DPF2; double PHD fingers
hsa:50509,0.0,0.0,1.2272414032783627e-05,4.9482805099199024e-05,0.0,0.00031581137,False,COL5A3; collagen type V alpha 3
hsa:406956,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR181B2; microRNA
hsa:9844,8.5254084e-07,0.0007099556583478068,4.1660033414084804e-05,0.00010648866421869113,0.0,0.0009257157,False,ELMO1; engulfment and cell motility
hsa:64211,0.0,0.0,8.226601136047954e-07,8.874963516024051e-06,0.0,0.00011572357,False,LHX5; LIM homeobox
hsa:1120,1.8247509e-06,0.0015195661788240582,6.028138710305849e-05,9.15464258081865e-05,0.0,0.0004000276,False,CHKB; choline kinase
hsa:5802,1.190846e-06,0.0009916801826418689,1.8228270960005842e-05,4.2817610031766794e-05,0.0,0.00039795198,False,PTPRS; protein tyrosine phosphatase receptor type
hsa:144165,0.0,0.0,1.282284745222222e-07,2.698225564446182e-07,0.0,1.4542768e-06,False,PRICKLE1; prickle planar cell polarity protein
hsa:259290,0.00017586711,0.14645380491305982,0.0004674153450701761,0.0007640204893322775,0.0,0.0054950374,False,TAS2R31; taste 2 receptor member
hsa:130399,6.8062946e-07,0.0005667959981426956,1.3173601079239185e-05,4.6309441854491675e-05,0.0,0.0005194074,False,ACVR1C; activin A receptor type
hsa:311,0.0,0.0,9.632575824736844e-09,1.9420733098428994e-08,0.0,8.987421e-08,False,ANXA11; annexin
hsa:7133,0.0,0.0,6.60318973099415e-06,3.73760258445441e-05,0.0,0.00039558666,False,TNFRSF1B; TNF receptor superfamily member
hsa:86,0.0,0.0,6.024579665087719e-07,9.97046060032559e-07,0.0,4.552995e-06,False,ACTL6A; actin like
hsa:6752,0.0,0.0,2.260655256239766e-05,4.3802601724471165e-05,0.0,0.00025846294,False,SSTR2; somatostatin receptor
hsa:100506013,0.0,0.0,6.938671497076024e-10,5.045975824942481e-09,0.0,5.691155e-08,False,APELA; apelin receptor early endogenous
hsa:10802,1.7464455e-07,0.00014543571481233255,7.429634099672518e-07,1.3328219137888845e-06,0.0,6.9861794e-06,False,SEC24A; SEC24 homolog A
hsa:7805,2.1828596e-08,1.817782153871749e-05,1.8855071697228071e-06,3.0875490147689588e-06,0.0,1.6457529e-05,False,LAPTM5; lysosomal protein transmembrane
hsa:54205,0.00011149371,0.09284668437079148,0.0006559486958187135,0.00156108811392611,0.0,0.009611417,False,CYCS; cytochrome c
hsa:8189,0.0,0.0,1.8564643913239766e-05,5.9506898627708625e-05,0.0,0.00035024303,False,SYMPK; symplekin scaffold
hsa:6642,1.0808028e-08,9.00041414342277e-06,8.177595978251463e-07,2.297679810318963e-06,0.0,1.2846628e-05,False,SNX1; sorting nexin
hsa:1066,0.0,0.0,1.4161870854684203e-05,4.711615340725803e-05,0.0,0.00038821582,False,CES1; carboxylesterase
hsa:10568,2.0769582e-07,0.00017295924805688786,4.329346712274854e-06,2.6726859202640613e-05,0.0,0.00033604642,False,SLC34A2; solute carrier family 34 member
hsa:151056,0.0,0.0,3.826719791345029e-05,0.00012089675610413314,0.0,0.00079518964,False,PLB1; phospholipase
hsa:788,8.659079e-09,7.210871132145022e-06,8.741066620056139e-07,2.3648586101266242e-06,0.0,1.1185952e-05,False,SLC25A20; solute carrier family 25 member
hsa:126792,4.0133575e-05,0.03342134162273807,0.0006080855899801169,0.001191138845723549,0.0,0.007120653,False,B3GALT6; beta-1
hsa:2520,0.0,0.0,8.427897567994153e-07,3.3960645149015033e-06,0.0,2.9691471e-05,False,GAST;
hsa:3604,3.3309007e-08,2.773816441872357e-05,2.882429637327485e-06,1.2316411892738574e-05,0.0,0.000128465,False,TNFRSF9; TNF receptor superfamily member
hsa:283189,0.0,0.0,2.3674583486549706e-06,2.3499653074080908e-05,0.0,0.00030065482,False,OR9G4; olfactory receptor family 9 subfamily G member
hsa:2834,0.0,0.0,1.1080575236927894e-05,2.7428461069371067e-05,0.0,0.00021875533,False,PRLHR; prolactin releasing hormone
hsa:8531,0.0,0.0,6.144679243767837e-06,1.6211018393608147e-05,0.0,0.00012346906,False,YBX3; Y-box binding protein
hsa:2556,0.00029111328,0.2424253603571524,0.0009904645026435673,0.0013674094369253505,0.0,0.006238055,False,GABRA3; gamma-aminobutyric acid type A receptor subunit
hsa:6389,1.7373803e-06,0.0014468080786452528,8.905520332801169e-05,0.0002958721015639388,0.0,0.0018040136,False,SDHA; succinate dehydrogenase complex flavoprotein subunit
hsa:8623,0.0,0.0,2.771640177690059e-05,9.548931980532483e-05,0.0,0.0007438236,False,ASMTL; acetylserotonin O-methyltransferase
hsa:92344,1.41795745e-05,0.011808078483652786,9.043110658739733e-05,0.0002158087001025605,0.0,0.0014987374,False,GORAB; golgin
hsa:29850,2.6779451e-05,0.022300659244544614,0.00013171011719766078,0.00025586820228053376,0.0,0.0020363817,False,TRPM5; transient receptor potential cation channel subfamily M member
hsa:64837,7.821356e-09,6.513255069578331e-06,3.182306798076023e-06,9.6059887559895e-06,0.0,4.8647653e-05,False,KLC2; kinesin light chain
hsa:1345,0.0,0.0,1.5753778626959064e-05,4.675463779992611e-05,0.0,0.00030285405,False,COX6C; cytochrome c oxidase subunit
hsa:153527,0.0,0.0,2.1367389114970755e-07,4.445994109421831e-07,0.0,2.0354755e-06,False,ZMAT2; zinc finger matrin-type
hsa:11176,0.0,0.0,5.397610383292399e-06,1.625169026219192e-05,0.0,8.8540415e-05,False,BAZ2A; bromodomain adjacent to zinc finger domain
hsa:1977,5.3110252e-06,0.004422770400498106,2.042337738824562e-05,3.9036440589291366e-05,0.0,0.0002866495,False,EIF4E; eukaryotic translation initiation factor
hsa:2527,0.0,0.0,2.0166200020175444e-06,1.3976189452984894e-05,-0.0,0.0001720037,False,FUT5; fucosyltransferase
hsa:1791,0.0,0.0,1.8694035712456146e-05,9.141929041447651e-05,0.0,0.0010963634,False,DNTT; DNA
hsa:64127,0.0,0.0,6.000955245512866e-06,2.1545749102187983e-05,0.0,0.00017732808,False,NOD2; nucleotide binding oligomerization domain containing
hsa:6489,0.00031895537,0.26561093506314404,0.0013923456507274848,0.002132494559450253,0.0,0.008999853,False,ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2
hsa:10946,5.9216827e-08,4.9312970623264425e-05,8.825609116684212e-07,2.5571641143130917e-06,0.0,1.5333682e-05,False,SF3A3; splicing factor 3a subunit
hsa:50808,6.952201e-09,5.789463925178389e-06,1.4323432161134498e-06,3.1238042040920323e-06,0.0,1.562937e-05,False,AK3; adenylate kinase
hsa:285126,0.0,0.0,5.50000025900994e-08,1.3953224042932959e-07,0.0,1.081148e-06,False,DNAJC5G; DnaJ heat shock protein family (Hsp40) member C5
hsa:3784,0.0,0.0,9.060558166666668e-06,4.066234159914773e-05,0.0,0.00042379968,False,KCNQ1; potassium voltage-gated channel subfamily Q member
hsa:5860,1.8191901e-06,0.0015149354077926781,2.7852083000549708e-05,4.7767681023983766e-05,0.0,0.0002558777,False,QDPR; quinoid dihydropteridine
hsa:6591,0.0,0.0,1.3795953780046784e-06,4.353465501031319e-06,0.0,2.4111436e-05,False,SNAI2; snail family transcriptional repressor
hsa:7538,0.0,0.0,1.4587597547444442e-06,4.417790342200559e-06,0.0,2.2908971e-05,False,ZFP36; ZFP36 ring finger
hsa:342908,4.805731e-09,4.001985307762457e-06,9.907974587116964e-08,2.2611680087408856e-07,0.0,1.4848309e-06,False,ZNF404; zinc finger protein
hsa:100996746,2.589799e-08,2.1566620245822964e-05,5.7009846960964894e-06,1.95574254370551e-05,0.0,0.000142998,False,SPDYE11; speedy/RINGO cell cycle regulator family member
hsa:9588,0.0,0.0,0.00014293762379184206,0.0004000003994845435,0.0,0.0028758056,False,PRDX6; peroxiredoxin
hsa:3071,0.0,0.0,8.706143762105264e-07,1.9002537837632154e-06,0.0,8.226576e-06,False,NCKAP1L; NCK associated protein 1
hsa:2,0.0,0.0,3.0826039699999997e-06,1.3411954147601883e-05,0.0,0.00016453571,False,A2M;
hsa:6240,1.26436325e-05,0.010529018686594798,0.00029860265056273104,0.0005847180429654373,0.0,0.0029008011,False,RRM1; ribonucleotide reductase catalytic subunit
hsa:129401,5.069447e-08,4.221595510127484e-05,2.614763541739767e-07,5.09469983752763e-07,0.0,3.0724818e-06,False,NUP35; nucleoporin
hsa:5290,0.0,0.0,0.00028722526180409365,0.0005804563192391671,0.0,0.0027355242,False,PIK3CA; phosphatidylinositol-4
hsa:197257,1.4749636e-10,1.2282798718206288e-07,3.3645131485532167e-07,8.814165531141635e-07,0.0,7.2510425e-06,False,LDHD; lactate dehydrogenase
hsa:53832,0.0,0.0,7.21363274325965e-06,5.021529879245678e-05,0.0,0.00059071404,False,IL20RA; interleukin 20 receptor subunit
hsa:6873,3.4787206e-07,0.00028969138578523434,1.0154373425672505e-06,1.7539588209181896e-06,0.0,1.2758228e-05,False,TAF2; TATA-box binding protein associated factor
hsa:257194,5.212469e-07,0.00043406974620858443,2.7588592509781292e-06,4.971567719047322e-06,0.0,3.05908e-05,False,NEGR1; neuronal growth regulator
hsa:7173,2.1106985e-06,0.001757689805383667,1.8715148167631582e-05,4.32868424347477e-05,0.0,0.00032361026,False,TPO; thyroid
hsa:4175,6.701789e-08,5.580932664296867e-05,2.0016817152046782e-05,4.2910299697041524e-05,0.0,0.00027214424,False,MCM6; minichromosome maintenance complex component
hsa:7424,0.0,0.0,2.7814991417847956e-05,8.170718965684201e-05,0.0,0.00052224856,False,VEGFC; vascular endothelial growth factor
hsa:23433,0.0,0.0,5.524981957192985e-07,1.2941331580010366e-06,0.0,1.04632245e-05,False,RHOQ; ras homolog family member
hsa:343170,0.0,0.0,2.842832622222222e-07,1.2195993406080653e-06,0.0,1.0926473e-05,False,OR14K1; olfactory receptor family 14 subfamily K member
hsa:8302,0.0,0.0,1.5501212765730995e-07,5.285148720182144e-07,0.0,3.1832187e-06,False,KLRC4; killer cell lectin like receptor
hsa:26245,0.0,0.0,1.7173091285614036e-06,9.723102041580623e-06,0.0,7.4473086e-05,False,OR2M4; olfactory receptor family 2 subfamily M member
hsa:55062,0.0,0.0,4.246933216374269e-08,4.4517924513045317e-07,0.0,5.5842816e-06,False,WIPI1; WD repeat domain
hsa:4267,0.0,0.0,1.5716565081403512e-06,5.151374929424451e-06,0.0,6.22902e-05,False,CD99; CD99 molecule (Xg blood
hsa:51116,0.0,0.0,1.2411203601409353e-07,3.047297431973426e-07,0.0,1.7248333e-06,False,MRPS2; mitochondrial ribosomal protein
hsa:60673,0.0,0.0,1.1487161653801173e-05,2.89193960203641e-05,0.0,0.00016449473,False,ATG101; autophagy related
hsa:238,1.5459128e-06,0.0012873630073514148,1.2466866833333329e-05,2.3350263196392867e-05,0.0,0.00011727527,False,ALK; ALK receptor tyrosine
hsa:6141,3.254092e-08,2.709853792088519e-05,2.5121257525731e-07,5.214283965795869e-07,0.0,3.4376512e-06,False,RPL18; ribosomal protein
hsa:51091,2.0409421e-05,0.016995999772342344,6.129071089947368e-05,0.00010003729240780776,0.0,0.0006327744,False,SEPSECS; Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA
hsa:10189,2.4290761e-08,2.022819600938323e-05,6.789139325087717e-07,9.308338754031718e-07,0.0,4.407783e-06,False,ALYREF; Aly/REF export
hsa:92579,0.0004616265,0.38442069909318805,0.0010565281834210526,0.0014827697256790423,0.0,0.011432097,False,G6PC3; glucose-6-phosphatase catalytic subunit
hsa:1875,0.0,0.0,3.0140002053713464e-05,9.377856061722886e-05,0.0,0.00074717734,False,E2F5; E2F transcription factor
hsa:55367,0.0,0.0,3.7242818142690064e-05,0.00010021291309532156,0.0,0.0004664417,False,PIDD1; p53-induced death domain protein
hsa:10445,5.0580105e-08,4.212071734249844e-05,1.986506170677778e-06,6.283874013546174e-06,0.0,3.2709646e-05,False,MCRS1; microspherule protein
hsa:495,0.0,0.0,9.12156254768421e-07,3.972626939921259e-06,0.0,4.413112e-05,False,ATP4A; ATPase H+/K+ transporting subunit
hsa:11253,3.8424664e-06,0.003199824142959916,0.0002459075439482454,0.0004244979136951693,0.0,0.0017271554,False,MAN1B1; mannosidase alpha class 1B member
hsa:6506,7.421503e-06,0.0061802764173681385,5.485548923684211e-05,0.00011817931840825889,0.0,0.0010819988,False,SLC1A2; solute carrier family 1 member
hsa:5554,1.4603558e-05,0.012161151874097175,0.00011629328469847949,0.00016511439838993528,0.0,0.00079969864,False,PRH1; proline rich protein HaeIII subfamily
hsa:2918,3.286815e-05,0.027371039576150353,0.00016474125899837425,0.00034058920883766,0.0,0.002144335,False,GRM8; glutamate metabotropic receptor
hsa:53349,8.911753e-09,7.421286079559592e-06,4.984843648259065e-07,9.876601293913487e-07,0.0,4.4789967e-06,False,ZFYVE1; zinc finger FYVE-type containing
hsa:3385,2.2851249e-07,0.00019029438552016652,2.08428965774035e-06,5.727276322445415e-06,0.0,6.439112e-05,False,ICAM3; intercellular adhesion molecule
hsa:3718,2.9685443e-05,0.024720631833204956,0.0001759051235333333,0.0002774830505067441,0.0,0.001444174,False,JAK3; Janus kinase
hsa:887,0.0,0.0,1.149917454362573e-05,7.471065144175714e-05,0.0,0.0009291395,False,CCKBR; cholecystokinin B
hsa:122786,0.0,0.0,3.1541382888888884e-05,8.754840121700841e-05,0.0,0.00053819607,False,FRMD6; FERM domain containing
hsa:6850,1.6686449e-06,0.0013895684909689607,3.0159549876081877e-05,8.192976957141811e-05,0.0,0.0006816879,False,SYK; spleen associated tyrosine
hsa:114786,0.0,0.0,8.07845780953216e-08,2.2743387203880944e-07,0.0,1.4726639e-06,False,XKR4; XK related
hsa:11146,0.0,0.0,7.462029346333333e-08,1.5138029533934399e-07,0.0,6.5356505e-07,False,GLMN; glomulin
hsa:406959,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR183; microRNA
hsa:27343,0.0,0.0,2.782272393477193e-05,6.883336742414334e-05,0.0,0.00041126297,False,POLL; DNA polymerase
hsa:6810,4.2660645e-06,0.003552576590526393,0.00011164611642847958,0.00026153249641938225,0.0,0.0015060402,False,STX4; syntaxin
hsa:341416,0.0,0.0,1.5465459649122807e-07,2.0223712717779705e-06,0.0,2.6445936e-05,False,OR6C2; olfactory receptor family 6 subfamily C member
hsa:117145,0.0,0.0,6.584105110330409e-05,0.00021464669356066434,0.0,0.0012174774,False,THEM4; thioesterase superfamily member
hsa:5048,2.322084e-06,0.0019337216443014137,3.159224863107601e-05,7.266978300798593e-05,0.0,0.0006464494,False,PAFAH1B1; platelet activating factor acetylhydrolase 1b regulatory subunit
hsa:89,2.146741e-08,1.7877042933887238e-05,1.9316470429245606e-06,1.0841267829457947e-05,0.0,0.00013149677,False,ACTN3; actinin alpha
hsa:10870,0.0,0.0,2.713803807517368e-05,9.17874594073398e-05,0.0,0.00052921247,False,HCST; hematopoietic cell signal
hsa:80824,1.6052404e-07,0.00013367682244858753,0.00010023263718728656,0.00019434980175336172,0.0,0.0010803085,False,DUSP16; dual specificity phosphatase
hsa:4233,0.0,0.0,5.052815925029241e-06,1.6742499449055003e-05,0.0,0.0001422019,False,MET; MET proto-oncogene
hsa:7224,0.0,0.0,3.1681503370175426e-06,1.2216907476057222e-05,0.0,0.000106232255,False,TRPC5; transient receptor potential cation channel subfamily C member
hsa:50836,2.9887078e-05,0.024888543917241844,7.96266254777778e-05,0.00012713725323120005,0.0,0.00076588785,False,TAS2R8; taste 2 receptor member
hsa:2352,0.0,0.0,2.0997421509139183e-05,0.0001361878123137186,0.0,0.0016868723,False,FOLR3; folate receptor
hsa:26689,-0.0,0.0,5.742761298046784e-06,2.6165257991307843e-05,0.0,0.0002511349,False,OR4D1; olfactory receptor family 4 subfamily D member
hsa:9569,6.054323e-07,0.0005041753625920453,0.00010087153396291226,0.00028754980811105947,0.0,0.0017699802,False,GTF2IRD1; GTF2I repeat domain containing
hsa:6259,0.0,0.0,1.293533419876199e-06,2.2858801483288097e-06,0.0,1.2934168e-05,False,RYK; receptor like tyrosine
hsa:84284,0.0,0.0,6.85896501571345e-05,0.0001528295626630796,0.0,0.00096170563,False,NTPCR; nucleoside-triphosphatase
hsa:147686,0.0,0.0,4.955758951988306e-08,1.1177952409005327e-07,0.0,6.0347793e-07,False,ZNF418; zinc finger protein
hsa:64422,0.0,0.0,0.0002545150130854795,0.0006735753375209161,0.0,0.0038722118,False,ATG3; autophagy related
hsa:1261,3.26892e-06,0.0027222018486367317,5.189318388590642e-05,0.00016647073563079247,0.0,0.0014596058,False,CNGA3; cyclic nucleotide gated channel subunit alpha
hsa:2107,5.613227e-07,0.000467442975545979,1.2186456149748542e-06,1.7586043426499242e-06,0.0,7.8291105e-06,False,ETF1; eukaryotic translation termination factor
hsa:4085,0.0,0.0,6.546476526900586e-05,0.0001656127657204231,0.0,0.0009715619,False,MAD2L1; mitotic arrest deficient 2 like
hsa:1432,0.0,0.0,0.00017102476049707605,0.00033996737690799987,0.0,0.0016130541,False,MAPK14; mitogen-activated protein kinase
hsa:6655,0.00018079192,0.15055495357567153,0.0002163288487894737,0.00024150308129452448,0.0,0.001291887,False,SOS2; SOS Ras/Rho guanine nucleotide exchange factor
hsa:127077,0.0,0.0,3.568447701754386e-07,2.94523232714654e-06,0.0,3.4037497e-05,False,OR2T11; olfactory receptor family 2 subfamily T member
hsa:440,0.0,0.0,0.0001444911944707894,0.00041208883268122385,0.0,0.0026224921,False,ASNS; asparagine synthetase
hsa:3675,0.0,0.0,0.00018492506285847947,0.00039524291927497626,0.0,0.0017848533,False,ITGA3; integrin subunit alpha
hsa:7855,6.699359e-06,0.00557890907531574,3.8420151032514614e-05,7.493623729122964e-05,0.0,0.0006312426,False,FZD5; frizzled class receptor
hsa:4259,0.0,0.0,0.000644060414637427,0.0013135685216643827,0.0,0.005933348,False,MGST3; microsomal glutathione S-transferase
hsa:8720,7.368446e-09,6.136093059108186e-06,2.67772895585965e-07,5.46581546040806e-07,0.0,3.6115619e-06,False,MBTPS1; membrane bound transcription factor peptidase
hsa:4629,0.0,0.0,1.229646533775439e-06,4.0704271294496445e-06,0.0,3.613571e-05,False,MYH11; myosin heavy chain
hsa:11105,-0.0,0.0,5.898008449774211e-07,2.6547746442493024e-06,0.0,2.1328486e-05,False,PRDM7; PR/SET domain
hsa:9475,6.210733e-06,0.005172004470586357,5.255233972982457e-05,0.00010171812789644427,0.0,0.0009863063,False,ROCK2; Rho associated coiled-coil containing protein kinase
hsa:5731,6.418822e-08,5.345291140336908e-05,4.406119196924561e-06,1.5612138113435547e-05,0.0,0.0001072182,False,PTGER1; prostaglandin E receptor
hsa:10213,0.0,0.0,3.6889620584561403e-06,1.0483990720413147e-05,0.0,7.430378e-05,False,PSMD14; proteasome 26S subunit
hsa:8821,0.0,0.0,8.265107709356725e-08,2.704923405391824e-07,0.0,2.8439385e-06,False,INPP4B; inositol polyphosphate-4-phosphatase type II
hsa:966,0.0,0.0,4.962007118736843e-05,0.00019518449136747857,0.0,0.0016655106,False,CD59; CD59 molecule (CD59 blood
hsa:28514,0.0,0.0,3.961402515415204e-05,8.986387488247653e-05,0.0,0.00053522945,False,DLL1; delta like canonical Notch ligand
hsa:574467,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR520A; microRNA
hsa:1390,0.0,0.0,2.380010776119299e-06,7.072342856138909e-06,0.0,4.993553e-05,False,CREM; cAMP responsive element
hsa:84699,5.32294e-06,0.004432692481976435,6.711198466736845e-05,0.00031835473604977904,0.0,0.0027299498,False,CREB3L3; cAMP responsive element binding protein 3 like
hsa:6233,2.0996638e-06,0.0017485006295276807,1.8034703409473674e-05,3.652725800424763e-05,0.0,0.00018244912,False,RPS27A; ribosomal protein
hsa:8884,9.514052e-05,0.07922852178219718,0.0008965954241935669,0.001470103746489096,0.0,0.006650496,False,SLC5A6; solute carrier family 5 member
hsa:1909,0.0,0.0,1.2041966125730996e-06,3.282784593340081e-06,0.0,2.4343539e-05,False,EDNRA; endothelin receptor type
hsa:23643,0.0,0.0,2.5172320334035074e-05,6.469993207375525e-05,0.0,0.00044677692,False,LY96; lymphocyte antigen
hsa:5340,0.0,0.0,1.0608716561152047e-05,4.7379448408246855e-05,0.0,0.00037491185,False,PLG;
hsa:10690,9.006001e-05,0.07499771352931323,0.0004830695724183038,0.0007237577990965948,0.0,0.0032133537,False,FUT9; fucosyltransferase
hsa:2735,0.0,0.0,0.0,0.0,0.0,0.0,False,GLI1; GLI family zinc finger
hsa:26260,0.0,0.0,7.634174877321637e-07,1.706879485358372e-06,0.0,7.189986e-06,False,FBXO25; F-box protein
hsa:100310812,7.896945e-08,6.576202010934069e-05,4.327379937000002e-06,1.4766372014347301e-05,0.0,0.00010192709,False,SPDYE2B; speedy/RINGO cell cycle regulator family member
hsa:3601,0.0,0.0,2.133093628014035e-05,5.565571611436429e-05,0.0,0.00043864455,False,IL15RA; interleukin 15 receptor subunit
hsa:29992,0.0,0.0,0.00015674998609473684,0.0003878842385749126,0.0,0.0025821028,False,PILRA; paired immunoglobin like type 2 receptor
hsa:11221,0.0,0.0,4.9987837280701744e-08,9.064193743035802e-08,0.0,3.9750375e-07,False,DUSP10; dual specificity phosphatase
hsa:3909,0.0,0.0,3.4262699161198844e-05,9.867284962972453e-05,0.0,0.00073953543,False,LAMA3; laminin subunit alpha
hsa:10782,1.14895165e-07,9.567925509416639e-05,1.6080263239941518e-06,2.948538610876338e-06,0.0,1.9309131e-05,False,ZNF274; zinc finger protein
hsa:4647,0.0,0.0,4.8830226674269004e-08,1.281641806364987e-07,0.0,8.61426e-07,False,MYO7A; myosin
hsa:2786,0.00016716668,0.13920849862537626,0.0005860133780134503,0.0009788889534340184,0.0,0.0059060794,False,GNG4; G protein subunit gamma
hsa:100526767,0.0,0.0,1.3394944861760824e-05,7.016735581005417e-05,0.0,0.00065362855,False,RNF103-CHMP3; RNF103-CHMP3
hsa:343171,0.0,0.0,3.4096621446783625e-06,2.6143408002128753e-05,0.0,0.00032920184,False,OR2W3; olfactory receptor family 2 subfamily W member
hsa:5027,0.0,0.0,1.4017597590643275e-08,1.062543332530384e-07,0.0,1.0269091e-06,False,P2RX7; purinergic receptor P2X
hsa:7421,0.0,0.0,6.930407719040937e-06,2.224786491422233e-05,0.0,0.00016276441,False,VDR; vitamin D
hsa:55650,4.6737702e-07,0.00038920945996057625,1.770722022087719e-05,4.122448977180758e-05,0.0,0.00024599067,False,PIGV; phosphatidylinositol glycan anchor biosynthesis class
hsa:1915,6.5446e-06,0.005450033105303268,3.801843245222221e-05,6.405899239996815e-05,0.0,0.00033081797,False,EEF1A1; eukaryotic translation elongation factor 1 alpha
hsa:57521,1.030858e-06,0.0008584497489329701,0.00030712441938742684,0.0008759383147924316,0.0,0.009615239,False,RPTOR; regulatory associated protein of MTOR complex
hsa:5146,0.0,0.0,3.133733830986549e-08,1.2589562030925245e-07,0.0,1.0273822e-06,False,PDE6C; phosphodiesterase
hsa:719,0.0,0.0,4.4255654440842104e-05,0.00016250892957495383,0.0,0.0013483948,False,C3AR1; complement C3a receptor
hsa:2122,0.0,0.0,3.4443722500175437e-06,8.84124350266878e-06,0.0,4.6689398e-05,False,MECOM; MDS1 and EVI1 complex
hsa:11211,0.0,0.0,3.6579663899122806e-06,1.0490962622726915e-05,0.0,0.00010314019,False,FZD10; frizzled class receptor
hsa:729759,0.0,0.0,2.850106720105262e-05,0.00012590351738262163,0.0,0.0014884126,False,OR4F29; olfactory receptor family 4 subfamily F member
hsa:3284,0.0,0.0,3.6952765875731e-06,1.477185234364614e-05,0.0,0.00016868973,False,HSD3B2; hydroxy-delta-5-steroid dehydrogenase
hsa:51540,4.061046e-05,0.03381846887840267,0.0004853767870309941,0.0008690412932539172,0.0,0.0044866744,False,SCLY; selenocysteine
hsa:8843,0.0,0.0,1.2807986897660821e-08,4.629628574312396e-08,0.0,3.8575985e-07,False,HCAR3; hydroxycarboxylic acid receptor
hsa:2145,1.5079566e-08,1.2557548805672702e-05,5.303823614538014e-06,1.2498574671925528e-05,0.0,7.767297e-05,False,EZH1; enhancer of zeste 1 polycomb repressive complex 2
hsa:1635,0.0,0.0,1.8282828568935679e-06,5.4821189404437395e-06,0.0,4.2334057e-05,False,DCTD; dCMP
hsa:2002,1.1538117e-06,0.0009608397705415521,2.6623919744268995e-05,5.658890392775212e-05,0.0,0.00045354068,False,ELK1; ETS transcription factor
hsa:10607,0.0,0.0,2.491641186059649e-07,7.12796771454944e-07,0.0,5.511922e-06,False,TBL3; transducin beta like
hsa:574452,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR494; microRNA
hsa:4323,0.0,0.0,1.086283167563158e-05,5.041040857427945e-05,0.0,0.0004005599,False,MMP14; matrix metallopeptidase
hsa:54512,0.0,0.0,2.3254652480701765e-07,3.5037939161361984e-07,0.0,1.6875744e-06,False,EXOSC4; exosome component
hsa:5409,0.0,0.0,0.00015775727459187134,0.0004601610590174556,0.0,0.0033001914,False,PNMT; phenylethanolamine
hsa:6173,6.85311e-07,0.0005706945630639744,1.6875071094853804e-06,2.043174755736204e-06,0.0,7.5633184e-06,False,RPL36A; ribosomal protein
hsa:55605,0.0,0.0,1.1970096481929825e-07,3.1346544096374185e-07,0.0,1.9299648e-06,False,KIF21A; kinesin family member
hsa:1017,0.0,0.0,5.4906867709766065e-05,0.00019156088297020052,0.0,0.0013815135,False,CDK2; cyclin dependent kinase
hsa:7148,0.0,0.0,2.11527407794152e-06,5.582397209311384e-06,0.0,5.933667e-05,False,TNXB; tenascin
hsa:5783,0.0,0.0,3.596259632380118e-07,6.221954984061099e-07,0.0,2.9515036e-06,False,PTPN13; protein tyrosine phosphatase non-receptor type
hsa:341799,0.0,0.0,6.098999122807017e-07,4.785613968121608e-06,0.0,4.9168728e-05,False,OR6S1; olfactory receptor family 6 subfamily S member
hsa:2643,0.0,0.0,3.455876033157894e-06,9.510518534009681e-06,0.0,6.183714e-05,False,GCH1; GTP cyclohydrolase
hsa:88,5.534673e-06,0.004609013702446009,8.836382510116958e-05,0.00016610884363333936,0.0,0.0009665924,False,ACTN2; actinin alpha
hsa:1562,3.3595625e-05,0.027976846322671226,8.68277092507602e-05,0.00014620284081515598,0.0,0.0012754936,False,CYP2C18; cytochrome P450 family 2 subfamily C member
hsa:10058,0.00013512657,0.1125270115677168,0.0010654559425664328,0.0026237390848683232,0.0,0.014914965,False,ABCB6; ATP binding cassette subfamily B member 6 (Langereis blood
hsa:6482,0.0,0.0,5.743043401929822e-05,9.822492785582601e-05,0.0,0.00062992825,False,ST3GAL1; ST3 beta-galactoside alpha-2
hsa:26086,0.0,0.0,0.00011169920220897656,0.0002456652467016872,0.0,0.0016915934,False,GPSM1; G protein signaling modulator
hsa:26585,4.6702326e-07,0.00038891486537705205,3.090528027905849e-05,0.0001027398471493903,0.0,0.00084333186,False,GREM1; gremlin 1
hsa:3099,0.0,0.0,9.695288238596493e-06,3.064493899507221e-05,0.0,0.00016486079,False,HK2; hexokinase
hsa:1808,1.1264082e-06,0.0009380194328278374,3.219499038231576e-05,0.00011273582094191949,0.0,0.0010412191,False,DPYSL2; dihydropyrimidinase like
hsa:79133,5.9558968e-08,4.959788945354918e-05,3.3281794745614027e-07,5.609907371161254e-07,0.0,2.3152434e-06,False,NDUFAF5; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:9031,0.0,0.0,7.54940983447661e-06,2.477614816478726e-05,0.0,0.00015971086,False,BAZ1B; bromodomain adjacent to zinc finger domain
hsa:4314,0.0,0.0,3.185158061988304e-07,1.3900079803446109e-06,0.0,1.4379779e-05,False,MMP3; matrix metallopeptidase
hsa:25984,3.9559515e-07,0.0003294329162664505,1.0182533896035085e-05,2.7531060407123877e-05,0.0,0.0001661853,False,KRT23; keratin
hsa:4087,7.333662e-05,0.06107126590334715,0.00028475550737871346,0.00041925478196462037,0.0,0.0021396002,False,SMAD2; SMAD family member
hsa:100506658,3.6311437e-06,0.0030238446009096653,3.9233855417426314e-05,8.626006970872226e-05,0.0,0.00050647877,False,OCLN;
hsa:1027,0.00018626612,0.15511360822607814,0.0002634505896409357,0.0003008887724720063,0.0,0.0015895598,False,CDKN1B; cyclin dependent kinase inhibitor
hsa:130589,0.0,0.0,6.222176514266082e-05,0.00018565851574174315,0.0,0.001120162,False,GALM; galactose
hsa:57148,0.0,0.0,3.216795685906433e-07,6.289914931396056e-07,0.0,3.0105025e-06,False,RALGAPB; Ral GTPase activating protein non-catalytic subunit
hsa:6881,5.3912984e-08,4.4896181218972186e-05,1.737665061380118e-06,8.497675721271763e-06,0.0,0.00010422209,False,TAF10; TATA-box binding protein associated factor
hsa:1495,0.0,0.0,4.737024281836257e-05,0.0001321180835555834,0.0,0.0009519616,False,CTNNA1; catenin alpha
hsa:100137049,0.0003415254,0.2844061877428629,0.0010839656381026908,0.0019212843873834774,0.0,0.009259788,False,PLA2G4B; phospholipase A2 group
hsa:162966,6.7951973e-09,5.658718675254007e-06,2.3814259876959072e-08,4.087015369249372e-08,0.0,3.4292614e-07,False,ZNF600; zinc finger protein
hsa:5244,0.0,0.0,0.00024613410489824565,0.00045467337090564794,0.0,0.002733561,False,ABCB4; ATP binding cassette subfamily B member
hsa:6539,0.0,0.0,6.697459318479532e-06,1.701860266822131e-05,0.0,0.000100283716,False,SLC6A12; solute carrier family 6 member
hsa:54831,1.9811194e-08,1.6497824642542777e-05,3.030872427029239e-06,7.151437921382851e-06,0.0,5.0855586e-05,False,BEST2; bestrophin
hsa:79633,7.427431e-05,0.06185212975178888,0.000245536757502924,0.00044242686058129367,2.422401e-07,0.003630293,False,FAT4; FAT atypical cadherin
hsa:58510,0.0,0.0,3.1373475320894747e-06,2.4750941353839942e-05,0.0,0.00032128292,False,PRODH2; proline dehydrogenase
hsa:51763,1.5916737e-07,0.00013254705188767138,2.00337935688497e-05,6.270424788512191e-05,0.0,0.0004121404,False,INPP5K; inositol polyphosphate-5-phosphatase
hsa:390437,0.0,0.0,6.3796368421052624e-09,8.34245768736773e-08,0.0,1.0909179e-06,False,OR4N5; olfactory receptor family 4 subfamily N member
hsa:4359,1.3481936e-07,0.00011227118162084758,4.584482957005849e-06,1.027597404364121e-05,0.0,6.121608e-05,False,MPZ; myelin protein
hsa:2318,0.0,0.0,5.32348351871345e-07,1.5343285062013678e-06,0.0,1.330711e-05,False,FLNC; filamin
hsa:8800,4.5134746e-07,0.00037586080111764547,0.00012794323144614037,0.00043520031777740254,0.0,0.0027158633,False,PEX11A; peroxisomal biogenesis factor 11
hsa:3329,9.038318e-05,0.07526683420874984,0.00014433068765582459,0.0001905638711636803,0.0,0.0009261568,False,HSPD1; heat shock protein family D (Hsp60) member
hsa:84679,0.0,0.0,3.13751338565614e-05,9.479393429565276e-05,0.0,0.00063653657,False,SLC9A7; solute carrier family 9 member
hsa:122742,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4L1; olfactory receptor family 4 subfamily L member
hsa:163051,0.0,0.0,5.912997457251462e-08,1.0895183304997854e-07,0.0,4.4853968e-07,False,ZNF709; zinc finger protein
hsa:6519,1.04576675e-05,0.00870865050259054,2.854572921590059e-05,4.832564402472484e-05,0.0,0.00037075908,False,SLC3A1; solute carrier family 3 member
hsa:6170,1.7044896e-07,0.00014194182604964587,6.213088457748536e-07,8.586026713838466e-07,0.0,3.3848557e-06,False,RPL39; ribosomal protein
hsa:158,2.3258744e-05,0.019368781100109055,0.00015335732166518718,0.0004419496103926742,0.0,0.00254036,False,ADSL; adenylosuccinate
hsa:219436,0.0,0.0,9.582644795321637e-08,8.069672130357521e-07,0.0,8.105255e-06,False,OR5D14; olfactory receptor family 5 subfamily D member
hsa:152002,0.0,0.0,2.947846087157894e-05,6.871554219025121e-05,0.0,0.0003686109,False,XXYLT1; xyloside xylosyltransferase
hsa:3458,5.876192e-06,0.004893414560571802,5.631719554137428e-05,0.00013885978615942577,0.0,0.0010458968,False,IFNG; interferon
hsa:4758,1.2338763e-05,0.01027513779734301,0.00014997908910116962,0.00028226052322158015,0.0,0.0016843713,False,NEU1; neuraminidase
hsa:90423,3.1692016e-05,0.02639161085074731,0.00016616987857514615,0.0002340412694165812,0.0,0.0012327863,False,ATP6V1E2; ATPase H+ transporting V1 subunit
hsa:4718,0.0,0.0,8.906969396023391e-08,5.153119278944679e-07,0.0,5.8352407e-06,False,NDUFC2; NADH:ubiquinone oxidoreductase subunit
hsa:115362,0.0,0.0,5.233234459064328e-08,1.3736871533238562e-07,0.0,1.1132612e-06,False,GBP5; guanylate binding protein
hsa:314,0.00010395714,0.08657058560227464,0.00032205534492222226,0.0005088189488142026,0.0,0.0032994114,False,AOC2; amine oxidase copper containing
hsa:23192,6.8748814e-06,0.0057250758220569135,0.00023543524345528594,0.0005070542606196305,0.0,0.0028253759,False,ATG4B; autophagy related 4B cysteine
hsa:2829,1.0331803e-07,8.603836504518476e-05,1.1096041975716374e-05,3.0217776223647366e-05,0.0,0.00018186068,False,XCR1; X-C motif chemokine receptor
hsa:26538,0.0,0.0,1.1366300567251463e-07,1.271305013585854e-06,0.0,1.6515045e-05,False,OR10H2; olfactory receptor family 10 subfamily H member
hsa:9636,0.0,0.0,3.0039811543859653e-07,7.558782298865788e-07,0.0,4.5739494e-06,False,ISG15; ISG15 ubiquitin like
hsa:9069,7.316056e-06,0.006092465146877212,0.00011808892095011707,0.0001996842797607673,0.0,0.0008644418,False,CLDN12; claudin
hsa:400720,1.5258225e-08,1.2706327564429598e-05,5.6513389361988344e-08,8.692274791905049e-08,0.0,4.124535e-07,False,ZNF772; zinc finger protein
hsa:1376,7.815476e-06,0.006508358483895602,0.00011624741838438592,0.0003365699993839848,0.0,0.0027652134,False,CPT2; carnitine palmitoyltransferase
hsa:90576,0.0,0.0,1.5677243501988303e-08,3.805826014493288e-08,0.0,3.0954462e-07,False,ZNF799; zinc finger protein
hsa:6820,0.0,0.0,2.8142252244269005e-07,1.4417793686286524e-06,0.0,1.4086494e-05,False,SULT2B1; sulfotransferase family 2B member
hsa:5217,2.215785e-07,0.00018452008685380925,3.0140549399953214e-05,8.7473994735165e-05,0.0,0.000402997,False,PFN2; profilin
hsa:116150,6.1436066e-07,0.0005116104781951479,0.00011490040746251051,0.00039484925834017197,0.0,0.0025428024,False,NUS1; NUS1 dehydrodolichyl diphosphate synthase
hsa:1622,0.0,0.0,4.1347711062719294e-05,0.0001299934602577901,0.0,0.0010028349,False,DBI; diazepam binding inhibitor
hsa:8766,0.0,0.0,0.0001117152156842105,0.00030270219632689,0.0,0.0016267186,False,RAB11A; RAB11A
hsa:3111,0.0,0.0,7.848935522807019e-06,2.571630027769315e-05,0.0,0.00021358242,False,HLA-DOA; major histocompatibility complex
hsa:4747,0.0,0.0,2.7988118339122803e-08,5.531410069253927e-08,0.0,3.2590168e-07,False,NEFL; neurofilament light
hsa:126541,0.0,0.0,5.088633157894737e-09,6.654251308804048e-08,0.0,8.7015627e-07,False,OR10H4; olfactory receptor family 10 subfamily H member
hsa:64145,0.0,0.0,1.9131926210818712e-07,4.2332385479678686e-07,0.0,2.0678433e-06,False,RBSN; rabenosyn
hsa:26354,6.207707e-10,5.169484561015621e-07,3.1193196330508774e-06,7.953292621672073e-06,0.0,4.2166193e-05,False,GNL3; G protein nucleolar
hsa:11232,0.0,0.0,5.483582232473683e-07,1.6723223679068798e-06,0.0,1.0161233e-05,False,POLG2; DNA polymerase gamma 2
hsa:64983,5.527352e-09,4.602917120169945e-06,1.3141433755847957e-07,2.3102941129764778e-07,0.0,8.883873e-07,False,MRPL32; mitochondrial ribosomal protein
hsa:8452,0.0,0.0,0.00010130681994970759,0.00034190258697567823,0.0,0.0027338532,False,CUL3; cullin
hsa:9429,0.0,0.0,7.790228871368421e-05,0.00029375148309176524,0.0,0.0026690923,False,ABCG2; ATP binding cassette subfamily G member 2 (Junior blood
hsa:391196,0.0,0.0,4.100728011695906e-07,3.880043243816523e-06,0.0,4.3107386e-05,False,OR2M7; olfactory receptor family 2 subfamily M member
hsa:58494,0.0,0.0,9.213069888011694e-07,2.3609001066766682e-06,0.0,1.970738e-05,False,JAM2; junctional adhesion molecule
hsa:8683,1.965664e-07,0.00016369119386827068,4.5049299571695904e-07,5.22669716445344e-07,0.0,1.9316565e-06,False,SRSF9; serine and arginine rich splicing factor
hsa:390037,0.0,0.0,3.923434702982456e-06,1.3659019754522446e-05,0.0,9.787104e-05,False,OR52I1; olfactory receptor family 52 subfamily I member
hsa:26063,1.7138615e-06,0.0014272227352175404,0.00013812680278992395,0.0004931551309876996,0.0,0.0030171615,False,DECR2; 2
hsa:493911,6.9647313e-06,0.0057998985659233355,0.00012046087564892981,0.00027598135562539644,0.0,0.0014837991,False,PHOSPHO2; phosphatase
hsa:146198,5.2909304e-09,4.40603640220265e-06,1.0708726320116956e-07,2.5607283564525356e-07,0.0,1.3020908e-06,False,ZFP90; ZFP90 zinc finger
hsa:55284,0.0,0.0,3.8209472786491233e-07,1.1450762694302693e-06,0.0,6.6838884e-06,False,UBE2W; ubiquitin conjugating enzyme E2
hsa:5797,3.5076712e-07,0.0002921022547217376,4.36731902206082e-05,0.00012054643310980186,0.0,0.0006595213,False,PTPRM; protein tyrosine phosphatase receptor type
hsa:1727,0.0,0.0,2.5924767582970747e-05,6.149374016098685e-05,0.0,0.00034484803,False,CYB5R3; cytochrome b5 reductase
hsa:5801,3.5917548e-08,2.9910433893793226e-05,3.83624320946316e-07,1.0035941850127732e-06,0.0,7.753064e-06,False,PTPRR; protein tyrosine phosphatase receptor type
hsa:250,0.0,0.0,1.2565577670760233e-07,7.776641157195962e-07,0.0,8.802583e-06,False,ALPP; alkaline phosphatase
hsa:23410,3.412829e-05,0.02842042452210837,0.00024308223421421057,0.000465216634670593,0.0,0.0028226261,False,SIRT3; sirtuin
hsa:165324,0.0,0.0,4.8953184805847956e-08,9.300651177282914e-08,0.0,5.234766e-07,False,UBXN2A; UBX domain protein
hsa:79814,3.515397e-08,2.927456227773094e-05,2.6694451551543864e-06,8.392326839582619e-06,0.0,8.731591e-05,False,AGMAT;
hsa:54926,2.493146e-07,0.00020761739810461178,5.189163371988303e-07,6.434444458283981e-07,0.0,2.9164926e-06,False,UBE2R2; ubiquitin conjugating enzyme E2
hsa:115727,0.0,0.0,9.931032506432752e-08,1.491410567941663e-07,0.0,6.688631e-07,False,RASGRP4; RAS guanyl releasing protein
hsa:1849,0.0,0.0,2.0428457613010702e-05,6.670533771859424e-05,0.0,0.00073328195,False,DUSP7; dual specificity phosphatase
hsa:8925,0.0,0.0,7.052762049021054e-07,1.4423297087065918e-06,0.0,7.3479846e-06,False,HERC1; HECT and RLD domain containing E3 ubiquitin protein ligase family member
hsa:50834,2.1178644e-07,0.00017636572277210586,5.1727065017193e-05,0.00011102073705893106,0.0,0.0009063503,False,TAS2R1; taste 2 receptor member
hsa:260425,3.5421783e-07,0.000294975842677732,1.3142359700391813e-06,2.6974124339486264e-06,0.0,1.5279478e-05,False,MAGI3; membrane associated guanylate kinase
hsa:8325,0.0,0.0,1.8944077755731e-05,4.354709030165003e-05,0.0,0.00041298743,False,FZD8; frizzled class receptor
hsa:90321,0.0,0.0,1.0106760240350885e-07,2.0592737668514079e-07,0.0,8.1514287e-07,False,ZNF766; zinc finger protein
hsa:6786,2.7283397e-06,0.0022720321620134437,4.851354794408186e-06,5.527119617166183e-06,0.0,3.2132077e-05,False,STIM1; stromal interaction molecule
hsa:55256,7.489192e-07,0.0006236644612653545,8.653307724290055e-05,0.0002278237264826956,0.0,0.0014817239,False,ADI1; acireductone dioxygenase
hsa:9245,0.0,0.0,8.108630483915789e-06,2.9306056502968073e-05,0.0,0.0002233291,False,GCNT3; glucosaminyl (N-acetyl) transferase 3
hsa:81696,0.0,0.0,1.3797874269005848e-09,1.8043061872283037e-08,0.0,2.3594365e-07,False,OR5V1; olfactory receptor family 5 subfamily V member
hsa:548596,2.2778115e-06,0.0018968536018458717,8.887792334564328e-05,0.00017934846906057818,0.0,0.00082483195,False,CKMT1A; creatine kinase
hsa:2200,2.904477e-07,0.00024187109683696355,3.736751477678946e-05,0.00014321306309282691,0.0,0.0014051601,False,FBN1; fibrillin
hsa:3695,1.4892854e-06,0.0012402063889687405,6.333356104152045e-05,0.00013824803616254097,0.0,0.0011125546,False,ITGB7; integrin subunit beta
hsa:2585,0.0,0.0,7.849393214976609e-06,2.6118555781630946e-05,0.0,0.00023074896,False,GALK2; galactokinase
hsa:80145,0.0,0.0,2.714631174724562e-07,6.707054376644625e-07,0.0,3.6946633e-06,False,THOC7; THO complex subunit
hsa:1504,0.0,0.0,1.6151220953216374e-07,8.830102332567392e-07,0.0,8.144114e-06,False,CTRB1; chymotrypsinogen
hsa:1740,7.130867e-07,0.0005938248513203954,1.1764757761421047e-05,2.6266895114285067e-05,0.0,0.00016823731,False,DLG2; discs large MAGUK scaffold protein
hsa:8106,9.636583e-07,0.0008024890195275901,6.256508147615824e-05,0.00017623452169093318,0.0,0.0008118723,False,PABPN1; poly(A) binding protein nuclear
hsa:55233,0.00015718494,0.13089617801777156,0.0006691492564619881,0.001195752117502281,0.0,0.008314353,False,MOB1A; MOB kinase activator
hsa:22936,0.0,0.0,5.250442118461988e-06,1.8281581941934633e-05,0.0,0.00018527507,False,ELL2; elongation factor for RNA polymerase II
hsa:26013,0.0,0.0,0.00017595163114791018,0.0006869689860175583,0.0,0.0047417046,False,L3MBTL1; L3MBTL histone methyl-lysine binding protein
hsa:89801,1.1854915e-07,9.872212084857179e-05,9.596456474596492e-07,2.0045864178657892e-06,0.0,1.1804442e-05,False,PPP1R3F; protein phosphatase 1 regulatory subunit
hsa:140469,0.0,0.0,1.171906452801169e-09,2.9376486762334724e-09,0.0,2.3213461e-08,False,MYO3B; myosin
hsa:8942,0.0,0.0,1.2141551392555553e-05,5.1631834987526774e-05,0.0,0.0005293111,False,KYNU;
hsa:7089,0.0,0.0,4.79594205597076e-06,1.4087365270684163e-05,0.0,7.569742e-05,False,TLE2; TLE family member 2
hsa:79981,0.0,0.0,2.2573907829122808e-05,9.649020415355339e-05,0.0,0.0008284105,False,FRMD1; FERM domain containing
hsa:55627,5.240379e-06,0.004363939589025461,4.3660909059532164e-05,9.017402191763449e-05,0.0,0.00059809745,False,SMPD4; sphingomyelin phosphodiesterase
hsa:1108,0.0,0.0,6.007263040175439e-07,1.187516240289723e-06,0.0,8.273951e-06,False,CHD4; chromodomain helicase DNA binding protein
hsa:390058,-0.0,0.0,1.6364316461988305e-07,1.0668669297338652e-06,0.0,9.132132e-06,False,OR51B6; olfactory receptor family 51 subfamily B member
hsa:2074,2.6939531e-07,0.00022433966291498887,1.7406929243181287e-06,3.528006605684033e-06,0.0,2.0180667e-05,False,ERCC6; ERCC excision repair 6
hsa:23600,7.705271e-05,0.06416584976214469,0.0001985590529488304,0.0003392660265107843,0.0,0.0022262568,False,AMACR; alpha-methylacyl-CoA
hsa:55711,8.5985613e-07,0.000716047485606141,8.556376623163743e-05,0.00017277203009351947,0.0,0.00094570336,False,FAR2; fatty acyl-CoA reductase
hsa:408,0.0,0.0,6.210444959812867e-05,0.00015554689004948082,0.0,0.0013030908,False,ARRB1; arrestin beta
hsa:256435,0.0,0.0,0.00014218066626900587,0.0003561682449442419,0.0,0.0019207635,False,ST6GALNAC3; ST6 N-acetylgalactosaminide alpha-2
hsa:23418,6.239809e-10,5.196217587135849e-07,2.62436253226959e-06,8.801512824483416e-06,0.0,8.075659e-05,False,CRB1; crumbs cell polarity complex component
hsa:2768,2.4477107e-05,0.02038337613789236,0.0001377073031553218,0.00021118135326556457,0.0,0.0010006498,False,GNA12; G protein subunit alpha
hsa:2246,0.0,0.0,3.715985400643275e-06,2.200236397755851e-05,0.0,0.0002676173,False,FGF1; fibroblast growth factor
hsa:406885,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7C; microRNA
hsa:8398,9.71288e-05,0.0808842672551997,0.0002449892149415205,0.00033323437066314163,0.0,0.0019191949,False,PLA2G6; phospholipase A2 group
hsa:11069,0.0,0.0,1.725360236163743e-05,4.776634710670591e-05,0.0,0.0004613432,False,RAPGEF4; Rap guanine nucleotide exchange factor
hsa:2069,0.0,0.0,2.0253213148128656e-08,7.206247828220196e-08,0.0,5.478541e-07,False,EREG;
hsa:3859,5.7834023e-07,0.0004816143690414549,9.72509646532047e-06,3.2653347325138506e-05,0.0,0.00033096553,False,KRT12; keratin
hsa:340024,0.0,0.0,1.9325919820479528e-05,7.264062206083475e-05,0.0,0.000531093,False,SLC6A19; solute carrier family 6 member
hsa:7768,0.0,0.0,8.318459338561403e-08,2.085626215411566e-07,0.0,1.0606105e-06,False,ZNF225; zinc finger protein
hsa:168417,0.0,0.0,1.4816032953532169e-08,4.264483281135707e-08,0.0,3.8679775e-07,False,ZNF679; zinc finger protein
hsa:219988,0.0,0.0,2.104989342397661e-07,3.882776823558607e-07,0.0,2.3265056e-06,False,PATL1; PAT1 homolog 1
hsa:55971,2.3162983e-08,1.928903587195196e-05,3.6466122831754386e-07,7.066609416228552e-07,0.0,3.4868654e-06,False,BAIAP2L1; BAR/IMD domain containing adaptor protein 2 like
hsa:1803,0.0,0.0,3.422359393473685e-06,7.581831826683608e-06,0.0,5.275829e-05,False,DPP4; dipeptidyl peptidase
hsa:7186,9.894788e-05,0.08239911097692372,0.00023480431364561403,0.0004425527311580688,0.0,0.0023174123,False,TRAF2; TNF receptor associated factor
hsa:148206,0.0,0.0,6.586016952105261e-08,1.8726151802404988e-07,0.0,8.581698e-07,False,ZNF714; zinc finger protein
hsa:5345,0.0,0.0,2.602207792045615e-06,7.491351602897766e-06,0.0,6.424461e-05,False,SERPINF2; serpin family F member
hsa:6457,0.0,0.0,2.3023479327565492e-07,5.737405172903789e-07,0.0,3.2391135e-06,False,SH3GL3; SH3 domain containing GRB2 like 3
hsa:7336,9.449242e-09,7.86888147786298e-06,3.708767454239767e-07,9.15494877573225e-07,0.0,5.7973816e-06,False,UBE2V2; ubiquitin conjugating enzyme E2
hsa:10907,0.0,0.0,6.615649980970762e-08,1.4802280552302832e-07,0.0,7.185162e-07,False,TXNL4A; thioredoxin like
hsa:58477,1.5736673e-06,0.0013104756412512925,0.00010528371124449121,0.0003292968847870331,0.0,0.0022130997,False,SRPRB; SRP receptor subunit
hsa:2558,0.0,0.0,2.1349719885614033e-05,7.697061134793749e-05,0.0,0.00083472516,False,GABRA5; gamma-aminobutyric acid type A receptor subunit
hsa:5867,2.1648806e-07,0.0001802810093669407,5.952216559070174e-07,1.0123368188047448e-06,0.0,9.037583e-06,False,RAB4A; RAB4A
hsa:80010,1.1005068e-05,0.009164499728954193,0.0001727443392899415,0.0003283799969132114,0.0,0.002094601,False,RMI1; RecQ mediated genome instability
hsa:2960,1.4794759e-07,0.00012320375016805222,2.1306088398713444e-06,4.327869525088994e-06,0.0,3.1434833e-05,False,GTF2E1; general transcription factor IIE subunit
hsa:11258,1.4920482e-07,0.0001242507118037489,5.22284168559649e-07,1.1785033532642017e-06,0.0,6.578267e-06,False,DCTN3; dynactin subunit
hsa:10714,5.5741425e-06,0.004641882033841322,2.9280270428584766e-05,5.6419220147929674e-05,0.0,0.00035850657,False,POLD3; DNA polymerase delta 3
hsa:8897,1.4020673e-06,0.0011675752835716726,2.883354774010525e-05,6.960039405140706e-05,0.0,0.00037148345,False,MTMR3; myotubularin related protein
hsa:968,0.0,0.0,3.4325980172192984e-06,9.173565003137204e-06,0.0,6.969642e-05,False,CD68; CD68
hsa:8484,0.0,0.0,6.351957289107428e-07,3.7115515345110085e-06,0.0,4.539607e-05,False,GALR3; galanin receptor
hsa:83744,2.353848e-08,1.9601732000201516e-05,6.385790169473685e-08,1.105970565330151e-07,0.0,6.2865223e-07,False,ZNF484; zinc finger protein
hsa:1812,0.0,0.0,3.0467912676081874e-06,8.957683617969994e-06,0.0,6.0834805e-05,False,DRD1; dopamine receptor
hsa:3952,0.0,0.0,1.3217458140754386e-06,4.342858084579244e-06,0.0,2.98648e-05,False,LEP;
hsa:5193,7.871847e-09,6.555301584494425e-06,2.1538493166257297e-06,3.922850423917151e-06,0.0,1.9446401e-05,False,PEX12; peroxisomal biogenesis factor
hsa:9306,0.0,0.0,8.503735925204676e-06,2.126985587832646e-05,0.0,0.00012978497,False,SOCS6; suppressor of cytokine signaling
hsa:147700,0.0,0.0,5.8659932306608164e-09,2.645418788233795e-08,0.0,2.490976e-07,False,KLC3; kinesin light chain
hsa:2073,1.5964218e-07,0.0001329424511815517,1.0038714583742692e-06,1.910252030217274e-06,0.0,1.3034212e-05,False,ERCC5; ERCC excision repair 5
hsa:5073,0.0,0.0,1.3688624501345036e-05,5.3939856670478844e-05,0.0,0.00048094548,False,PARN; poly(A)-specific
hsa:26100,0.0,0.0,1.5693823770380117e-06,3.250702578338621e-06,0.0,1.6908967e-05,False,WIPI2; WD repeat domain
hsa:5211,0.0,0.0,8.691536969005848e-05,0.00019033018562701626,0.0,0.0015212684,False,PFKL; phosphofructokinase
hsa:9829,4.7962676e-08,3.994104636172333e-05,1.4724734021181293e-06,4.182909383162399e-06,0.0,2.5253354e-05,False,DNAJC6; DnaJ heat shock protein family (Hsp40) member
hsa:9132,0.0,0.0,8.298354992473686e-06,2.2782428065450775e-05,0.0,0.000120852004,False,KCNQ4; potassium voltage-gated channel subfamily Q member
hsa:375790,0.0,0.0,7.2752421138538e-05,0.0001475750447046818,0.0,0.00078554347,False,AGRN;
hsa:4992,0.0,0.0,5.117320756284797e-06,1.8434434434523976e-05,0.0,0.0001429302,False,OR1F1; olfactory receptor family 1 subfamily F member
hsa:9348,2.6926826e-05,0.022423386168862993,0.0004934608767333625,0.0012675189454796508,0.0,0.0071626836,False,NDST3; N-deacetylase and N-sulfotransferase
hsa:6888,0.0,0.0,4.364586126695906e-06,8.183082803240782e-06,0.0,4.0577845e-05,False,TALDO1; transaldolase
hsa:23417,4.9636897e-06,0.004133525836483947,0.0003979523050147193,0.0007763766927921248,0.0,0.0043548313,False,MLYCD; malonyl-CoA
hsa:79923,4.946143e-09,4.1189137752596065e-06,6.711723180587722e-07,2.4122913080440758e-06,0.0,1.9982164e-05,False,NANOG; Nanog
hsa:338662,0.0,0.0,2.4142282614035085e-07,2.31591286671225e-06,0.0,2.8352037e-05,False,OR8D4; olfactory receptor family 8 subfamily D member
hsa:2561,0.0,0.0,4.843193025183042e-05,0.0001811313460136447,0.0,0.001599785,False,GABRB2; gamma-aminobutyric acid type A receptor subunit
hsa:4887,0.0,0.0,1.6814800487352926e-05,4.228059920086649e-05,0.0,0.00029146444,False,NPY2R; neuropeptide Y receptor
hsa:815,0.0,0.0,6.554523437777778e-05,0.00022378473266110337,0.0,0.0016753698,False,CAMK2A; calcium/calmodulin dependent protein kinase II
hsa:3684,0.0,0.0,1.1390509537426901e-05,2.7946361253888413e-05,0.0,0.00016879964,False,ITGAM; integrin subunit alpha
hsa:6404,0.0,0.0,1.0049067557894736e-06,3.7659419829533977e-06,0.0,3.8139682e-05,False,SELPLG; selectin P
hsa:9064,0.0,0.0,1.5551160728070174e-07,3.264338639510738e-07,0.0,1.9069844e-06,False,MAP3K6; mitogen-activated protein kinase kinase kinase
hsa:3717,0.0,0.0,0.00013606489045263158,0.0002851711177280186,0.0,0.0017946879,False,JAK2; Janus kinase
hsa:399968,-0.0,0.0,9.162326742568535e-07,2.2329277038111806e-06,0.0,1.6773425e-05,False,PATE4; prostate and testis expressed
hsa:80339,1.4604655e-06,0.0012162065403773018,1.0064933426011695e-05,3.515610386121547e-05,0.0,0.00029172588,False,PNPLA3; patatin like phospholipase domain containing
hsa:54657,0.0,0.0,2.029872626900585e-05,0.00010108174060240844,0.0,0.0010803042,False,UGT1A4; UDP glucuronosyltransferase family 1 member
hsa:2492,0.0,0.0,1.948891694736842e-08,1.8330732357994074e-07,0.0,2.0506588e-06,False,FSHR; follicle stimulating hormone
hsa:27089,0.0,0.0,7.579833519637426e-05,0.00017066476394802686,0.0,0.0008658478,False,UQCRQ; ubiquinol-cytochrome c reductase complex III subunit
hsa:27005,3.5924336e-07,0.00029916086618897713,2.577093373853801e-06,4.119147610746385e-06,0.0,2.0057694e-05,False,USP21; ubiquitin specific peptidase
hsa:119679,0.0,0.0,2.2993722807017547e-08,3.0068194215472716e-07,0.0,3.9319266e-06,False,OR52J3; olfactory receptor family 52 subfamily J member
hsa:7251,4.0546092e-06,0.0033764866254724804,5.418358321891227e-05,0.00011628472468828388,0.0,0.00079061877,False,TSG101; tumor susceptibility
hsa:25915,0.0,0.0,5.955221202397663e-08,1.6529960116121653e-07,0.0,9.0117607e-07,False,NDUFAF3; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:2160,0.0,0.0,7.420454067388889e-08,2.8063545776636596e-07,0.0,3.100691e-06,False,F11; coagulation factor
hsa:574031,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR363; microRNA
hsa:5438,0.0,0.0,2.9112773257525134e-05,0.00010753374203521595,0.0,0.0006264951,False,POLR2I; RNA polymerase II subunit
hsa:444,2.1326328e-07,0.00017759556522103112,1.432080809936842e-05,3.3784322393582486e-05,0.0,0.00021769898,False,ASPH; aspartate
hsa:6218,2.536874e-07,0.00021125885896744064,1.1473980812923983e-06,1.7336092259074149e-06,0.0,7.010321e-06,False,RPS17; ribosomal protein
hsa:3931,0.0,0.0,2.3517538187134515e-05,6.062733782098543e-05,0.0,0.00032995403,False,LCAT; lecithin-cholesterol
hsa:9073,0.0,0.0,2.162146405146199e-07,2.82069843158983e-06,0.0,3.688589e-05,False,CLDN8; claudin
hsa:392517,0.0,0.0,2.5034133391812865e-09,1.6220068294083865e-08,0.0,1.6959606e-07,False,NCBP2L; nuclear cap binding protein subunit 2
hsa:442184,0.0,0.0,5.163144187134502e-08,4.4950978226315774e-07,0.0,5.573255e-06,False,OR2B3; olfactory receptor family 2 subfamily B member
hsa:79058,0.0,0.0,1.220191069969298e-05,3.4586784892350526e-05,0.0,0.00024200065,False,ASPSCR1; ASPSCR1 tether for SLC2A4
hsa:58484,0.0,0.0,4.298007217894736e-06,1.0566049913769857e-05,0.0,7.6975404e-05,False,NLRC4; NLR family CARD domain containing
hsa:10284,0.0,0.0,2.403341135163742e-07,4.71619143116996e-07,0.0,2.1596447e-06,False,SAP18; Sin3A associated protein
hsa:51096,5.038828e-09,4.196097456212611e-06,1.6129867373502919e-06,3.0995882757029174e-06,0.0,1.4216413e-05,False,UTP18; UTP18 small subunit processome
hsa:3588,2.105564e-06,0.0017534140368142847,0.0002896540488837427,0.0007401249676634277,0.0,0.00587627,False,IL10RB; interleukin 10 receptor subunit
hsa:93100,0.0,0.0,2.606862551478948e-05,9.888666713594413e-05,0.0,0.001104834,False,NAPRT; nicotinate
hsa:5685,1.17126206e-07,9.753716043739422e-05,6.648544688615203e-06,1.871723442417608e-05,0.0,0.00012396174,False,PSMA4; proteasome 20S subunit alpha
hsa:85366,3.3523887e-05,0.0279171063118366,6.707349420188304e-05,8.958974028525988e-05,0.0,0.00053804636,False,MYLK2; myosin light chain kinase
hsa:390083,0.0,0.0,5.841651035497075e-07,2.6182177127035926e-06,0.0,2.0929032e-05,False,OR56A3; olfactory receptor family 56 subfamily A member
hsa:56623,5.701914e-08,4.748284091249606e-05,0.0001063162692859707,0.0003227414407254364,0.0,0.0019551215,False,INPP5E; inositol polyphosphate-5-phosphatase
hsa:83700,0.0,0.0,1.900080962421052e-05,5.4150176541320714e-05,0.0,0.00029800832,False,JAM3; junctional adhesion molecule
hsa:6723,0.0,0.0,3.828474327970762e-05,6.907345551509554e-05,0.0,0.0005473623,False,SRM; spermidine
hsa:8972,0.0,0.0,1.2462322375497072e-05,2.739479135395792e-05,0.0,0.000200312,False,MGAM;
hsa:256933,0.0,0.0,3.4991868488888895e-06,7.408675529522344e-06,0.0,5.0167797e-05,False,NPB; neuropeptide
hsa:7534,5.205639e-06,0.004335009761369342,1.7514438521052633e-05,2.5280580753860765e-05,0.0,0.00014466203,False,YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:163131,1.6496308e-08,1.3737344484808718e-05,5.8791953808421066e-08,1.058590644200369e-07,0.0,6.949858e-07,False,ZNF780B; zinc finger protein
hsa:9748,4.1378428e-08,3.445799627867367e-05,1.913740231795907e-06,3.978174880681787e-06,0.0,1.8783143e-05,False,SLK; STE20 like
hsa:1806,0.0,0.0,4.165961929005848e-05,9.920106513007633e-05,0.0,0.0008931167,False,DPYD; dihydropyrimidine
hsa:113278,0.0,0.0,4.396995967251462e-07,1.628298843165048e-06,0.0,1.2803901e-05,False,SLC52A3; solute carrier family 52 member
hsa:650,0.0,0.0,9.144775985204681e-06,3.9988957180163964e-05,0.0,0.0004540209,False,BMP2; bone morphogenetic protein
hsa:1384,2.66459e-07,0.0002218944429309665,2.8315566472601176e-05,8.802683459812795e-05,0.0,0.00054636924,False,CRAT; carnitine
hsa:390927,0.0,0.0,2.6562946818011696e-08,4.9523496888368776e-08,0.0,2.158078e-07,False,ZNF793; zinc finger protein
hsa:4613,0.0,0.0,1.6335964750567254e-05,7.391122981673677e-05,0.0,0.00085923617,False,MYCN; MYCN proto-oncogene
hsa:3821,3.7029025e-07,0.00030836019329997605,1.7604584701695904e-05,6.318334312918936e-05,0.0,0.00048351206,False,KLRC1; killer cell lectin like receptor
hsa:11313,1.1973606e-07,9.971052331671581e-05,1.6234129520900584e-05,3.898059159384135e-05,0.0,0.00019206361,False,LYPLA2; lysophospholipase
hsa:152586,0.0,0.0,6.413921573054967e-06,3.1054858804428875e-05,0.0,0.0003043204,False,MGAT4D; MGAT4 family member
hsa:101954277,0.0,0.0,3.46276850877193e-09,1.6498809580130526e-08,0.0,1.1310996e-07,False,RNVU1-19; RNA
hsa:990,5.7954562e-08,4.8261816077888755e-05,1.118775810222807e-06,1.827361439763424e-06,0.0,9.508262e-06,False,CDC6; cell division cycle
hsa:3593,4.684801e-06,0.003901280527726347,3.094419101847953e-05,6.679736024796609e-05,0.0,0.0005589604,False,IL12B; interleukin
hsa:4501,1.2701919e-06,0.0010577556924927507,3.4863322801218753e-05,8.059634120008611e-05,0.0,0.00047281414,False,MT1X; metallothionein
hsa:8454,2.2034892e-05,0.018349615082935873,0.0004768431859883039,0.0006897572279838735,0.0,0.0025429719,False,CUL1; cullin
hsa:4821,-0.0,0.0,2.5102703333333337e-08,3.216901791159183e-07,-0.0,4.2067145e-06,False,NKX2-2; NK2 homeobox
hsa:71,0.0,0.0,0.0004960589439181285,0.0008965577037305889,0.0,0.0058199465,False,ACTG1; actin gamma
hsa:29089,8.755441e-06,0.007291116844655066,0.0001158326814311345,0.0001754273544636198,0.0,0.0008847138,False,UBE2T; ubiquitin conjugating enzyme E2
hsa:166378,6.6783294e-08,5.561396619827049e-05,7.33914874916491e-07,1.3871492710534037e-06,0.0,7.728572e-06,False,AFG2A; AFG2 AAA ATPase homolog
hsa:5690,0.0,0.0,1.7037274374853802e-06,3.5479922540189954e-06,0.0,2.5852101e-05,False,PSMB2; proteasome 20S subunit beta
hsa:54905,2.627619e-08,2.1881567304531777e-05,7.831843383771637e-06,2.0426462037756197e-05,0.0,0.00012918281,False,CYP2W1; cytochrome P450 family 2 subfamily W member
hsa:7423,2.9535602e-06,0.002459585134080943,4.278034149064328e-05,9.968491659324423e-05,0.0,0.0007234542,False,VEGFB; vascular endothelial growth factor
hsa:129642,2.2287639e-05,0.018560090821295144,0.00022850735408830704,0.0003954550638003032,0.0,0.0019602035,False,MBOAT2; membrane bound O-acyltransferase domain containing
hsa:8295,0.0,0.0,4.7299244789415226e-07,9.599247115700147e-07,0.0,4.1068183e-06,False,TRRAP; transformation/transcription domain associated
hsa:5500,0.0,0.0,6.190714348538009e-05,0.00018336858905173306,0.0,0.001579156,False,PPP1CB; protein phosphatase 1 catalytic subunit
hsa:10621,6.4006877e-06,0.005330189753645361,0.00028223092543198843,0.0006409728830691681,0.0,0.0031951761,False,POLR3F; RNA polymerase III subunit
hsa:41,0.0,0.0,5.5324175708947366e-05,0.00011129528459451417,0.0,0.0004921441,False,ASIC1; acid sensing ion channel subunit
hsa:80264,1.4878241e-09,1.2389894874962624e-06,5.54940269239766e-08,1.0611720906272178e-07,0.0,5.166587e-07,False,ZNF430; zinc finger protein
hsa:55666,1.0778501e-08,8.975825455420403e-06,7.056318026964912e-07,1.1584764879576302e-06,0.0,6.230673e-06,False,NPLOC4; NPL4 homolog
hsa:55500,0.0,0.0,3.775955275319297e-06,1.034064918962246e-05,0.0,4.7519618e-05,False,ETNK1; ethanolamine kinase
hsa:3274,3.0786748e-06,0.002563774650927928,1.0432644857128653e-05,2.2328356858793553e-05,0.0,0.0001576123,False,HRH2; histamine receptor
hsa:4644,1.5534272e-07,0.00012936206439933013,1.1138620182561403e-06,2.5498128487126225e-06,0.0,1.9855828e-05,False,MYO5A; myosin
hsa:11073,0.0,0.0,1.2034838303397662e-05,3.475113845593221e-05,0.0,0.00024357696,False,TOPBP1; DNA topoisomerase II binding protein
hsa:158326,2.181761e-06,0.0018168672917916392,2.353549659611696e-05,6.018339791292492e-05,0.0,0.00038531443,False,FREM1; FRAS1 related extracellular matrix
hsa:10556,1.7379791e-07,0.00014473067309423308,2.9075369626624917e-06,5.141398307775442e-06,0.0,2.377802e-05,False,RPP30; ribonuclease P/MRP subunit
hsa:10499,1.2551528e-06,0.0010452318418565061,5.5366044822730994e-05,9.91327748082469e-05,0.0,0.00057810306,False,NCOA2; nuclear receptor coactivator
hsa:8777,1.3367885e-07,0.00011132141887645841,1.9730077696023392e-06,3.2606093006038168e-06,0.0,1.7833587e-05,False,MPDZ; multiple PDZ domain crumbs cell polarity complex
hsa:29881,3.9542474e-06,0.0032929100688444475,1.6481339866280705e-05,3.678455581510986e-05,0.0,0.0003102596,False,NPC1L1; NPC1 like intracellular cholesterol transporter
hsa:7074,0.0,0.0,4.920021142222223e-05,0.00011799673481262599,0.0,0.00091024843,False,TIAM1; TIAM Rac1 associated GEF
hsa:64919,0.0,0.0,1.2729801996707603e-05,3.663028190145226e-05,0.0,0.00022046934,False,BCL11B; BCL11 transcription factor
hsa:466,0.0,0.0,7.47411436017544e-06,2.0821024391106206e-05,0.0,0.00020394525,False,ATF1; activating transcription factor
hsa:81931,0.0,0.0,8.346874386894736e-08,1.9063733421475873e-07,0.0,9.367297e-07,False,ZNF93; zinc finger protein
hsa:4929,0.0,0.0,1.568091168649123e-06,4.48803140700649e-06,0.0,2.8487202e-05,False,NR4A2; nuclear receptor subfamily 4 group A member
hsa:91661,2.010674e-08,1.674394136230257e-05,9.030404978801171e-08,1.8031930371556825e-07,0.0,9.683068e-07,False,ZNF765; zinc finger protein
hsa:100289678,4.901188e-08,4.081477379108747e-05,1.33529855908772e-07,1.7236209566535163e-07,0.0,7.414508e-07,False,ZNF783; zinc finger protein
hsa:7637,0.0,0.0,5.7204450610526286e-08,1.2756806136402652e-07,0.0,7.364157e-07,False,ZNF84; zinc finger protein
hsa:55614,0.0,0.0,1.728613991345029e-08,5.1415506328890535e-08,0.0,3.2424896e-07,False,KIF16B; kinesin family member
hsa:6637,3.3273203e-08,2.770834854222962e-05,2.475508427222222e-07,4.0182618476874494e-07,0.0,2.674126e-06,False,SNRPG; small nuclear ribonucleoprotein polypeptide
hsa:26056,0.0,0.0,4.162314825180702e-07,1.0962773996973254e-06,0.0,6.2299496e-06,False,RAB11FIP5; RAB11 family interacting protein
hsa:8936,0.0,0.0,0.00019234633373099418,0.0003390035829145568,0.0,0.0019114123,False,WASF1; WASP family member
hsa:3567,5.6646513e-05,0.04717253478440117,0.00012381788057426904,0.00020509616610329831,0.0,0.0015804038,False,IL5; interleukin
hsa:94030,0.0,0.0,2.4362472333403504e-05,4.8522246267519365e-05,0.0,0.00032587408,False,LRRC4B; leucine rich repeat containing
hsa:2787,2.944985e-07,0.00024524441134097646,0.00017413531855730994,0.0003946375155816574,0.0,0.0025576951,False,GNG5; G protein subunit gamma
hsa:4068,8.108666e-08,6.752513238371638e-05,2.1966519613656067e-05,8.590848109138647e-05,0.0,0.0007378292,False,SH2D1A; SH2 domain containing
hsa:128367,0.0,0.0,3.9159152046783624e-08,5.120723594600228e-07,0.0,6.696215e-06,False,OR10X1; olfactory receptor family 10 subfamily X member
hsa:4634,0.0,0.0,3.6546870155321636e-05,9.194258154005727e-05,0.0,0.0007127195,False,MYL3; myosin light chain
hsa:79924,0.0,0.0,6.934480461426902e-06,2.8860946553528648e-05,0.0,0.00033169525,False,ADM2; adrenomedullin
hsa:124,0.0,0.0,5.44349371140351e-05,0.00016681174846543232,0.0,0.001350985,False,ADH1A; alcohol dehydrogenase 1A (class I)
hsa:51175,5.327432e-08,4.4364332069571856e-05,5.53460435966573e-07,1.4910578069244406e-06,0.0,8.395384e-06,False,TUBE1; tubulin epsilon
hsa:10393,0.0,0.0,3.3032021645029226e-06,8.881658074672455e-06,0.0,5.8512458e-05,False,ANAPC10; anaphase promoting complex subunit
hsa:26007,1.5117062e-05,0.012588773699679433,0.00014583749797578957,0.0003447383651885138,0.0,0.0021959364,False,TKFC; triokinase and FMN
hsa:8643,0.0,0.0,6.242504887251462e-06,2.1627903904643485e-05,0.0,0.00017450663,False,PTCH2; patched
hsa:22905,8.606352e-09,7.166962582265225e-06,3.1800983073976617e-07,6.158420366632244e-07,0.0,3.3293102e-06,False,EPN2; epsin
hsa:1299,0.0,0.0,3.065174514619883e-06,1.629862541085582e-05,0.0,0.00018509458,False,COL9A3; collagen type IX alpha 3
hsa:200316,0.0,0.0,7.695832165491226e-06,2.4123200303524553e-05,0.0,0.00024302737,False,APOBEC3F; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:5874,1.7567294e-06,0.0014629210932768305,2.271996628363976e-05,4.562800410431098e-05,0.0,0.00027938705,False,RAB27B; RAB27B
hsa:283459,1.516508e-06,0.0012628760817249712,1.903568594209357e-05,5.417204403751299e-05,0.0,0.00029452977,False,GATC; glutamyl-tRNA amidotransferase subunit
hsa:8650,1.9838218e-07,0.00016520328950619316,6.989560323638071e-05,0.00017997739984423764,0.0,0.0009249426,False,NUMB; NUMB endocytic adaptor
hsa:119695,0.0,0.0,4.04579649122807e-09,5.2905654154184064e-08,0.0,6.918312e-07,False,OR52R1; olfactory receptor family 52 subfamily R member
hsa:6944,9.532575e-08,7.938277255872978e-05,7.661850511029241e-06,1.745383755345719e-05,0.0,9.245275e-05,False,VPS72; vacuolar protein sorting 72
hsa:79482,0.0,0.0,7.325274853801169e-08,9.57903984641368e-07,0.0,1.252622e-05,False,OR5AL1; olfactory receptor family 5 subfamily AL member 1
hsa:6885,0.00011055269,0.0920630474559682,0.00019107981869005843,0.00025721683699134933,0.0,0.0014313613,False,MAP3K7; mitogen-activated protein kinase kinase kinase
hsa:6809,1.0000864e-07,8.328246169610925e-05,1.142649795181287e-05,2.527803670659275e-05,0.0,0.00015035228,False,STX3; syntaxin
hsa:9047,2.582753e-06,0.0021507944492896937,6.871716631790641e-05,0.00018942105119882272,0.0,0.0011211958,False,SH2D2A; SH2 domain containing
hsa:8065,1.08118485e-07,9.003595674987543e-05,2.809203650453217e-07,4.4591261663771296e-07,0.0,2.495776e-06,False,CUL5; cullin
hsa:343406,0.0,0.0,1.1112853616959066e-05,4.823826661031059e-05,0.0,0.0003722949,False,OR10R2; olfactory receptor family 10 subfamily R member
hsa:114548,0.0,0.0,2.04519422574386e-05,4.973331155628683e-05,0.0,0.00035298764,False,NLRP3; NLR family pyrin domain containing
hsa:5366,0.0,0.0,0.00014237724028422224,0.0003615879379593921,0.0,0.0022971646,False,PMAIP1; phorbol-12-myristate-13-acetate-induced protein
hsa:613,1.026704e-06,0.0008549904943537091,1.9600980759479518e-05,4.948068481271213e-05,0.0,0.0004268911,False,BCR; BCR activator of RhoGEF and
hsa:8450,0.0,0.0,1.3777518501754392e-06,2.863961822214516e-06,0.0,1.9197763e-05,False,CUL4B; cullin
hsa:2322,1.6864009e-07,0.00014043548473265325,6.48168244220468e-06,2.5403196904264507e-05,0.0,0.00020688768,False,FLT3; fms related receptor tyrosine kinase
hsa:255231,7.861048e-08,6.54630868844208e-05,2.4451329410335083e-06,9.314172716731406e-06,0.0,5.949346e-05,False,MCOLN2; mucolipin TRP cation channel
hsa:91662,0.0,0.0,3.569290185380117e-09,1.0203041745649028e-08,0.0,7.156848e-08,False,NLRP12; NLR family pyrin domain containing
hsa:10913,0.0,0.0,3.2659022887894745e-07,1.6408260951141582e-06,0.0,1.8129163e-05,False,EDAR; ectodysplasin A
hsa:10390,3.6055604e-05,0.030025400396006617,0.0014216325045663743,0.00281556100672652,0.0,0.012814436,False,CEPT1; choline/ethanolamine phosphotransferase
hsa:51069,0.0,0.0,3.5321138446479537e-07,7.898340501391131e-07,0.0,3.4829386e-06,False,MRPL2; mitochondrial ribosomal protein
hsa:57568,3.7172993e-07,0.0003095590906597907,1.8491806365016367e-06,3.232043810012218e-06,0.0,1.6262891e-05,False,SIPA1L2; signal induced proliferation associated 1 like
hsa:2358,5.729796e-09,4.771502901114543e-06,2.839325751597076e-06,1.5814355967343792e-05,0.0,0.00019939586,False,FPR2; formyl peptide receptor
hsa:3133,1.8212231e-06,0.0015166283939649547,0.00012897396751286553,0.00019719626004420916,0.0,0.0009943774,False,HLA-E; major histocompatibility complex
hsa:154141,0.0,0.0,9.896329398245616e-07,5.281826959166756e-06,0.0,5.6718705e-05,False,MBOAT1; membrane bound O-acyltransferase domain containing
hsa:10459,2.3864282e-06,0.001987304448465802,3.446701304444443e-05,9.984409697275371e-05,0.0,0.0006267308,False,MAD2L2; mitotic arrest deficient 2 like
hsa:2697,0.0,0.0,3.185536366081871e-05,9.511802533083502e-05,0.0,0.00063316955,False,GJA1; gap junction protein alpha
hsa:3418,0.0,0.0,0.00022728346606023392,0.00038141932941612743,0.0,0.0018074039,False,IDH2; isocitrate dehydrogenase (NADP(+))
hsa:54437,4.8779757e-08,4.062147274373511e-05,6.8172132394678375e-06,2.301443504090407e-05,0.0,0.00014875483,False,SEMA5B; semaphorin
hsa:638,0.0,0.0,1.767829466743275e-06,4.6817068122969115e-06,0.0,3.1689655e-05,False,BIK; BCL2 interacting
hsa:147949,0.0,0.0,1.0206260278830405e-07,2.8866667079439985e-07,0.0,1.4592704e-06,False,ZNF583; zinc finger protein
hsa:55902,4.5045313e-06,0.003751160454248505,0.00030789673572233917,0.0008359795189105669,0.0,0.004213583,False,ACSS2; acyl-CoA synthetase short chain family member
hsa:6232,0.0,0.0,1.4673555588257308e-06,4.118276398867943e-06,0.0,2.1155403e-05,False,RPS27; ribosomal protein
hsa:85409,0.0,0.0,7.970470640643274e-07,3.9529708916870645e-06,0.0,4.511431e-05,False,NKD2; NKD inhibitor of WNT signaling pathway
hsa:201595,0.0,0.0,0.0001289870336783625,0.00041344718442140735,0.0,0.001997896,False,STT3B; STT3 oligosaccharyltransferase complex catalytic subunit
hsa:51010,2.7344143e-07,0.00022770908013651956,3.050499473432807e-05,0.0001161799667546949,0.0,0.00094949035,False,EXOSC3; exosome component
hsa:1768,8.630449e-09,7.187029423285071e-06,3.134500053192982e-07,1.2014468702794184e-06,0.0,9.331217e-06,False,DNAH6; dynein axonemal heavy chain
hsa:9230,0.0,0.0,9.682827520877194e-05,0.0003728349527428115,0.0,0.0035711327,False,RAB11B; RAB11B
hsa:83933,0.0,0.0,1.2708686584502925e-05,3.594764780539451e-05,0.0,0.00024441446,False,HDAC10; histone deacetylase
hsa:51020,1.5383144e-08,1.281035419485489e-05,1.3939828993021642e-05,4.403402565162014e-05,0.0,0.00044346476,False,HDDC2; HD domain containing
hsa:9229,0.0,0.0,3.6488007946257294e-07,1.178912119826178e-06,0.0,7.902814e-06,False,DLGAP1; DLG associated protein
hsa:5257,0.0,0.0,2.0099012617719298e-06,3.2599491079031335e-06,0.0,1.3570384e-05,False,PHKB; phosphorylase kinase regulatory subunit
hsa:283927,3.9373154e-07,0.00032788099006845914,9.093612556763978e-05,0.00030519816096520835,0.0,0.0017630197,False,NUDT7; nudix hydrolase
hsa:203228,0.0,0.0,8.768673666842107e-08,1.9409884375169845e-07,0.0,8.642632e-07,False,C9orf72; C9orf72-SMCR8 complex
hsa:127608,0.0,0.0,4.664860011695907e-07,3.663311881628796e-06,0.0,3.8155584e-05,False,OR2AJ1; olfactory receptor family 2 subfamily AJ member
hsa:116,0.0,0.0,6.952455463157895e-06,3.1127860738766356e-05,0.0,0.00023758745,False,ADCYAP1; adenylate cyclase activating polypeptide
hsa:79501,0.0,0.0,1.6245738471929822e-06,1.0755911312151985e-05,0.0,9.431109e-05,False,OR4F5; olfactory receptor family 4 subfamily F member
hsa:6169,2.9222624e-08,2.4335218076556213e-05,1.4707507565497075e-06,2.8989794127412233e-06,0.0,1.287313e-05,False,RPL38; ribosomal protein
hsa:390181,0.0,0.0,9.428127733923975e-06,2.7334148530972914e-05,0.0,0.00024835055,False,OR5AK2; olfactory receptor family 5 subfamily AK member
hsa:800,7.2781944e-07,0.0006060935798495378,3.9728274274695894e-05,9.804913807332234e-05,0.0,0.00059540186,False,CALD1; caldesmon
hsa:8089,4.503677e-08,3.7504490336449746e-05,6.053469858107017e-06,1.6604127732875305e-05,0.0,0.000106715146,False,YEATS4; YEATS domain containing
hsa:23474,0.0,0.0,7.224819628152051e-05,0.00013735746384970797,0.0,0.00070382736,False,ETHE1; ETHE1 persulfide
hsa:7223,1.355878e-07,0.00011291110208037747,3.449960406789473e-06,1.713830920910879e-05,0.0,0.00020899986,False,TRPC4; transient receptor potential cation channel subfamily C member
hsa:5092,0.0,0.0,8.678649119181284e-06,1.9914683950387106e-05,0.0,0.00016149132,False,PCBD1; pterin-4 alpha-carbinolamine dehydratase
hsa:776,0.00038131088,0.3175376523259361,0.000587810373017544,0.0007033167687845219,0.0,0.0032778617,False,CACNA1D; calcium voltage-gated channel subunit alpha1
hsa:2523,1.1377431e-08,9.474586010344965e-06,4.929624990654384e-05,0.00011616439727380791,0.0,0.0008335063,False,FUT1; fucosyltransferase 1 (H blood
hsa:8702,0.0,0.0,0.000145773979748421,0.00039487370623707,0.0,0.002077893,False,B4GALT4; beta-1
hsa:55157,4.931444e-07,0.0004106673143805453,1.975357821688304e-05,5.942619581054971e-05,0.0,0.00037301602,False,DARS2; aspartyl-tRNA synthetase 2
hsa:64981,0.0,0.0,1.4468693040362577e-07,2.707429449847486e-07,0.0,1.5070763e-06,False,MRPL34; mitochondrial ribosomal protein
hsa:7728,0.0,0.0,3.453180775438598e-08,5.1426223249751306e-08,0.0,2.1014255e-07,False,ZNF175; zinc finger protein
hsa:64784,0.0,0.0,2.7794770955081866e-06,1.1508920969330502e-05,0.0,8.111147e-05,False,CRTC3; CREB regulated transcription coactivator
hsa:30815,1.06677235e-05,0.008883575196837338,4.27842878183041e-05,7.927135939291957e-05,0.0,0.00059116166,False,ST6GALNAC6; ST6 N-acetylgalactosaminide alpha-2
hsa:7477,0.0,0.0,0.0,0.0,0.0,0.0,False,WNT7B; Wnt family member
hsa:3882,1.8417477e-07,0.00015337203093567447,2.3584436969643273e-05,8.13518419367947e-05,0.0,0.0008542261,False,KRT32; keratin
hsa:8030,7.010967e-07,0.0005838401468414988,1.931319347780702e-05,3.944136710393415e-05,0.0,0.0002466562,False,CCDC6; coiled-coil domain containing
hsa:619552,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR483; microRNA
hsa:219417,0.0,0.0,2.868176783625731e-07,3.621933307937725e-06,0.0,4.73423e-05,False,OR8U1; olfactory receptor family 8 subfamily U member
hsa:6595,0.0,0.0,1.6793872466959067e-06,5.245837327901593e-06,0.0,4.049969e-05,False,SMARCA2; SWI/SNF related
hsa:7462,8.023541e-08,6.681625167582141e-05,1.329166051138187e-06,2.494999557207069e-06,0.0,1.2464336e-05,False,LAT2; linker for activation of T cells family member
hsa:25791,0.0,0.0,2.5934604363304103e-07,7.121884961563792e-07,0.0,4.198222e-06,False,NGEF; neuronal guanine nucleotide exchange
hsa:27177,0.0,0.0,5.304238106432749e-08,4.3741113783649474e-07,0.0,5.2288938e-06,False,IL36B; interleukin 36
hsa:4744,1.06269775e-08,8.849643856662431e-06,5.282452162808189e-08,8.949680755056027e-08,0.0,4.5668543e-07,False,NEFH; neurofilament heavy
hsa:55790,8.932014e-07,0.0007438158481348326,0.00020844900360011693,0.0006462976586448287,0.0,0.0046096905,False,CSGALNACT1; chondroitin sulfate N-acetylgalactosaminyltransferase
hsa:8644,0.0,0.0,2.327929849064328e-05,6.342387458322391e-05,0.0,0.00037401114,False,AKR1C3; aldo-keto reductase family 1 member
hsa:29984,0.0,0.0,2.0535985350877202e-08,5.520975833007585e-08,0.0,3.9415656e-07,False,RHOD; ras homolog family member
hsa:6857,1.9851147e-07,0.00016531095609852647,7.853609385143859e-05,0.00024222833913995571,0.0,0.0015434377,False,SYT1; synaptotagmin
hsa:80700,2.5728493e-08,2.1425471167002318e-05,5.632477585953217e-07,1.8793497122844939e-06,0.0,1.6978316e-05,False,UBXN6; UBX domain protein
hsa:350,-0.0,0.0,1.6509998104912278e-06,1.4406076113244609e-05,0.0,0.00017711968,False,APOH; apolipoprotein
hsa:3805,1.7610199e-09,1.4664940185951547e-06,1.359171402532164e-07,6.29687493855516e-07,0.0,7.2223047e-06,False,KIR2DL4; killer cell immunoglobulin like receptor
hsa:1665,3.22461e-08,2.6853025779561732e-05,3.6845328425146195e-07,5.451947760024251e-07,0.0,2.8703737e-06,False,DHX15; DEAH-box helicase
hsa:155061,0.0,0.0,5.0741148402923976e-08,9.462740415684708e-08,0.0,4.4813393e-07,False,ZNF746; zinc finger protein
hsa:123876,0.0,0.0,2.9940227610426895e-06,3.696127873211584e-05,0.0,0.00048346643,False,ACSM2A; acyl-CoA synthetase medium chain family member
hsa:1956,0.0,0.0,2.0330183040935672e-06,2.658516401373686e-05,0.0,0.00034764613,False,EGFR; epidermal growth factor
hsa:1080,1.6805403e-06,0.0013994744170455465,4.8982163028070176e-05,0.00013009265303039883,0.0,0.0007878389,False,CFTR; CF transmembrane conductance
hsa:5550,0.00020114229,0.16750177847026712,0.00045652275090094137,0.000584821673872164,0.0,0.002859966,False,PREP; prolyl
hsa:4636,0.0,0.0,8.800732780701758e-06,1.7978897322537058e-05,0.0,7.9456324e-05,False,MYL5; myosin light chain
hsa:8915,0.0,0.0,2.36512548005848e-05,5.326195031503918e-05,0.0,0.00034612836,False,BCL10; BCL10 immune signaling
hsa:83756,1.26461755e-05,0.010531136376627311,0.0001063174574807602,0.00022095151618205884,0.0,0.0013848711,False,TAS1R3; taste 1 receptor member
hsa:7054,0.0,0.0,0.00014396157442982455,0.00028856488720195345,0.0,0.0020136489,False,TH; tyrosine
hsa:8833,2.5546249e-06,0.002127370698993376,5.8916739915000014e-05,0.0001705411406152001,0.0,0.001305428,False,GMPS; guanine monophosphate
hsa:8973,0.0,0.0,6.446007344590644e-07,4.180288906665199e-06,0.0,4.6699468e-05,False,CHRNA6; cholinergic receptor nicotinic alpha 6
hsa:23002,1.9125382e-07,0.0001592671287039257,7.687611780058482e-06,2.295117002156421e-05,0.0,0.0001301389,False,DAAM1; dishevelled associated activator of morphogenesis
hsa:29922,5.860679e-06,0.004880496068446604,0.0003646655858720469,0.0005980946439294669,0.0,0.0027970665,False,NME7; NME/NM23 family member
hsa:574461,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR520E; microRNA
hsa:6868,0.0,0.0,0.00016488235896250058,0.00048194480835203905,0.0,0.002461953,False,ADAM17; ADAM metallopeptidase domain
hsa:277,0.0,0.0,3.442633387017544e-06,1.1662512159543773e-05,0.0,0.00012575444,False,AMY1B; amylase alpha
hsa:6580,6.1513283e-06,0.005122535048221261,4.7597006276315796e-05,0.00010574608825109057,0.0,0.00064447,False,SLC22A1; solute carrier family 22 member
hsa:2180,5.7439323e-05,0.04783274942642902,0.00011583851251169584,0.00017852016676476133,0.0,0.0011896379,False,ACSL1; acyl-CoA synthetase long chain family member
hsa:170712,0.0,0.0,1.3885313662105266e-06,1.2067133789824657e-05,0.0,0.00015125716,False,COX7B2; cytochrome c oxidase subunit
hsa:5313,0.0,0.0,7.457564766900583e-07,4.819447749700333e-06,0.0,5.632028e-05,False,PKLR; pyruvate kinase
hsa:121129,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR2AP1; olfactory receptor family 2 subfamily AP member
hsa:659,9.780023e-06,0.008144340237849124,0.00010301924288479536,0.0002325213457493905,0.0,0.0016501019,False,BMPR2; bone morphogenetic protein receptor type
hsa:2939,0.0,0.0,1.4723827312748537e-06,1.3160919668149626e-05,0.0,0.00014515634,False,GSTA2; glutathione S-transferase alpha
hsa:116444,0.0,0.0,1.2546457617046787e-05,3.2846450115314775e-05,0.0,0.00025968553,False,GRIN3B; glutamate ionotropic receptor NMDA type subunit
hsa:23428,0.0,0.0,3.484465664526315e-05,7.180549903498019e-05,0.0,0.00041551358,False,SLC7A8; solute carrier family 7 member
hsa:26272,0.0,0.0,1.636921577195322e-07,4.323653035656579e-07,0.0,2.4611213e-06,False,FBXO4; F-box protein
hsa:8099,7.3669504e-08,6.134847594219226e-05,9.926075226005852e-06,2.355271895338799e-05,0.0,0.00014333059,False,CDK2AP1; cyclin dependent kinase 2 associated protein
hsa:5469,5.597018e-06,0.00466093166747827,1.631692433824561e-05,2.7851754543427534e-05,0.0,0.00014899192,False,MED1; mediator complex subunit
hsa:6446,0.0,0.0,6.283585695906433e-07,2.2202253447738493e-06,0.0,1.52214125e-05,False,SGK1; serum/glucocorticoid regulated kinase
hsa:5518,0.0001295048,0.1078454676062217,0.0004092282153871346,0.0005664893697464287,0.0,0.0031882117,False,PPP2R1A; protein phosphatase 2 scaffold subunit
hsa:9843,0.0,0.0,1.7854618244935666e-05,0.00010188001936057913,0.0,0.0013049601,False,HEPH;
hsa:5709,2.5185147e-09,2.0972998336327547e-06,4.173891771998245e-06,7.38596371555711e-06,0.0,6.254576e-05,False,PSMD3; proteasome 26S subunit
hsa:54963,0.0,0.0,0.0002490942733392574,0.0005575677435915413,0.0,0.002236561,False,UCKL1; uridine-cytidine kinase 1 like
hsa:3276,6.1376545e-06,0.0051111481548014506,6.972727981228072e-05,0.00014255836048987806,0.0,0.0007230224,False,PRMT1; protein arginine methyltransferase
hsa:1364,1.6456261e-06,0.0013703995238748135,2.8708120752729234e-05,9.348861723645412e-05,0.0,0.0009480758,False,CLDN4; claudin
hsa:7334,0.0,0.0,6.447190722456141e-07,1.204724846085916e-06,0.0,6.8475238e-06,False,UBE2N; ubiquitin conjugating enzyme E2
hsa:284161,8.51805e-07,0.0007093428856252252,1.3658392461695904e-05,3.104983673497979e-05,0.0,0.00028361205,False,GDPD1; glycerophosphodiester phosphodiesterase domain containing
hsa:92483,0.0,0.0,1.8000792363450291e-06,9.358833510729731e-06,0.0,9.798966e-05,False,LDHAL6B; lactate dehydrogenase A like
hsa:3357,0.0,0.0,2.5981192737894737e-05,9.602189388757356e-05,0.0,0.0009639648,False,HTR2B; 5-hydroxytryptamine receptor
hsa:219447,0.0,0.0,2.5761988304093566e-09,3.3688171080666225e-08,0.0,4.4053e-07,False,OR5AS1; olfactory receptor family 5 subfamily AS member
hsa:2781,2.5205536e-06,0.0020989977330457673,0.00011182948557491225,0.00021707253111499602,0.0,0.0012130146,False,GNAZ; G protein subunit alpha
hsa:56302,0.0,0.0,8.78680100502924e-08,3.407952802127393e-07,0.0,3.6680187e-06,False,TRPV5; transient receptor potential cation channel subfamily V member
hsa:2739,1.6049526e-07,0.00013365285582682748,2.218298417567251e-06,3.0944584905456143e-06,0.0,1.4686813e-05,False,GLO1; glyoxalase
hsa:53918,0.0,0.0,2.0434740701380115e-07,5.027348812341146e-07,0.0,2.6874554e-06,False,PELO; pelota mRNA surveillance and ribosome rescue
hsa:27346,9.742659e-08,8.113225267194453e-05,1.3922789688154967e-05,2.7993481642095057e-05,0.0,0.0002074161,False,TMEM97; transmembrane protein
hsa:79671,4.455593e-07,0.00037104069543986645,1.4261913440292399e-05,3.0097424381690918e-05,0.0,0.00018835493,False,NLRX1; NLR family member
hsa:79767,2.2050877e-08,1.836292663431996e-05,1.7774920511409365e-05,4.8655733759826724e-05,0.0,0.00039665579,False,ELMO3; engulfment and cell motility
hsa:5222,3.7232805e-06,0.0031005717668505487,3.401358993070175e-05,6.098551747334903e-05,0.0,0.00028111183,False,PGA5; pepsinogen
hsa:23016,1.2064895e-07,0.00010047073489901272,1.1911205907602344e-06,2.0809717458968677e-06,0.0,1.0736464e-05,False,EXOSC7; exosome component
hsa:1553,0.0,0.0,7.880184828070174e-06,9.35216101994941e-05,0.0,0.0012214867,False,CYP2A13; cytochrome P450 family 2 subfamily A member
hsa:219484,0.0,0.0,1.1854972709941522e-06,1.0359102633806217e-05,0.0,0.00010723595,False,OR5M8; olfactory receptor family 5 subfamily M member
hsa:285973,0.0,0.0,8.162411939035088e-06,9.97688604775084e-05,0.0,0.0013041651,False,ATG9B; autophagy related
hsa:5062,6.222957e-06,0.005182184039189363,4.102694830608188e-05,7.558853383061587e-05,0.0,0.0005148549,False,PAK2; p21 (RAC1) activated kinase
hsa:5970,0.0,0.0,0.00030621994340350884,0.0006155030783876462,0.0,0.0028238771,False,RELA; RELA proto-oncogene
hsa:114112,1.7565071e-06,0.0014627359723589273,0.00012875975966590645,0.0004115612321736381,0.0,0.0023802253,False,TXNRD3; thioredoxin reductase
hsa:3556,0.0,0.0,4.792388150502925e-05,0.0001449729383623868,0.0,0.0010165516,False,IL1RAP; interleukin 1 receptor accessory
hsa:51412,0.0,0.0,1.735408660409357e-07,6.108691979833035e-07,0.0,4.237049e-06,False,ACTL6B; actin like
hsa:377,0.0,0.0,8.345763406894734e-07,2.4837366059511313e-06,0.0,2.4006526e-05,False,ARF3; ADP ribosylation factor
hsa:8850,8.29932e-06,0.006911280865370766,0.00011191355146783628,0.00023427380839032163,0.0,0.0015773787,False,KAT2B; lysine acetyltransferase
hsa:4928,0.0,0.0,2.687582382274854e-06,7.407609263109039e-06,0.0,3.514357e-05,False,NUP98; nucleoporin 98 and 96
hsa:115111,2.8183315e-08,2.346973073483332e-05,5.462638875366667e-06,1.7519041020160382e-05,0.0,0.00012204865,False,SLC26A7; solute carrier family 26 member
hsa:1308,0.0,0.0,3.106034955520468e-06,9.839054440712989e-06,0.0,7.127839e-05,False,COL17A1; collagen type XVII alpha 1
hsa:11000,9.533366e-06,0.007938935963232677,6.714180783894147e-05,0.00021117266544148282,0.0,0.00150938,False,SLC27A3; solute carrier family 27 member
hsa:9054,5.600014e-06,0.004663426594468993,9.388890192538012e-05,0.0001655124175493454,0.0,0.00079414196,False,NFS1; NFS1 cysteine
hsa:64208,0.0,0.0,3.3747729362356703e-06,1.19589921618841e-05,0.0,8.578467e-05,False,POPDC3; popeye domain containing
hsa:50506,0.0,0.0,3.4374275082222226e-06,1.034814916171167e-05,0.0,6.844103e-05,False,DUOX2; dual oxidase
hsa:5832,7.66777e-08,6.385355918444403e-05,7.695333729474618e-05,0.0001456581962325973,0.0,0.0010234314,False,ALDH18A1; aldehyde dehydrogenase 18 family member
hsa:29108,8.938011e-08,7.443152499093109e-05,4.540315829046784e-05,7.231318601463582e-05,0.0,0.00040756058,False,PYCARD; PYD and CARD domain
hsa:58492,7.403447e-09,6.165240235210427e-06,3.980159406959066e-08,6.869657405929915e-08,0.0,4.655922e-07,False,ZNF77; zinc finger protein
hsa:1478,0.0,0.0,1.3705402341812858e-07,3.6571348391461293e-07,0.0,1.942078e-06,False,CSTF2; cleavage stimulation factor subunit
hsa:2889,3.7665682e-06,0.0031366197144795,6.256213691649125e-06,7.572045850770134e-06,0.0,3.337737e-05,False,RAPGEF1; Rap guanine nucleotide exchange factor
hsa:5166,5.81571e-09,4.843048013758407e-06,4.937854341260234e-07,1.3816300666219835e-06,0.0,1.0064803e-05,False,PDK4; pyruvate dehydrogenase kinase
hsa:80237,1.057438e-06,0.0008805843148253028,2.045063498830993e-05,5.437789986378569e-05,0.0,0.00038953032,False,ELL3; elongation factor for RNA polymerase II
hsa:6497,5.894901e-08,4.908994530221149e-05,6.16937285775965e-05,0.00014595668522844921,0.0,0.0010425475,False,SKI; SKI
hsa:3423,5.83469e-06,0.0048588536593805465,0.00014750386322649126,0.0003645813282003044,0.0,0.0022493973,False,IDS; iduronate
hsa:51274,1.492466e-07,0.0001242855042101816,9.460737777054972e-06,2.6872987149079665e-05,0.0,0.00021896623,False,KLF3; KLF transcription factor
hsa:406,0.0,0.0,1.5822757818713455e-06,4.659778832544539e-06,0.0,3.510976e-05,False,BMAL1; basic helix-loop-helix ARNT like
hsa:121130,0.0,0.0,8.326620409356725e-08,6.627547296271067e-07,0.0,7.674713e-06,False,OR10P1; olfactory receptor family 10 subfamily P member
hsa:10992,0.0,0.0,1.5573880669005847e-07,2.6896959703678646e-07,0.0,1.3384863e-06,False,SF3B2; splicing factor 3b subunit
hsa:10458,1.5162777e-06,0.0012626842987857312,5.175937075423393e-05,0.00015759408913150176,0.0,0.0010551182,False,BAIAP2; BAR/IMD domain containing adaptor protein
hsa:339221,0.0,0.0,3.7797838977567247e-07,1.8971236822519806e-06,0.0,1.58885e-05,False,ENPP7; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:4293,1.8960329e-10,1.5789264544424655e-07,3.6396632878304094e-08,7.028233270053154e-08,0.0,4.6537272e-07,False,MAP3K9; mitogen-activated protein kinase kinase kinase
hsa:29958,8.7991154e-08,7.327486817740397e-05,3.0402138383554994e-06,6.381898521666333e-06,0.0,3.2687e-05,False,DMGDH; dimethylglycine
hsa:3597,0.0,0.0,8.236787810818714e-07,2.5728956586617696e-06,0.0,2.4498882e-05,False,IL13RA1; interleukin 13 receptor subunit alpha
hsa:349565,0.0,0.0,3.3371783511316146e-05,7.477492848987339e-05,0.0,0.000597821,False,NMNAT3; nicotinamide nucleotide adenylyltransferase
hsa:5723,0.0,0.0,7.647270058054328e-05,0.0001459674050438512,0.0,0.00068032264,False,PSPH; phosphoserine
hsa:26834,0.0,0.0,7.431481445614033e-08,1.3979824743006683e-07,0.0,5.619156e-07,False,RNU4-2; RNA
hsa:158835,0.0,0.0,8.679003702807016e-07,4.226114963333364e-06,0.0,4.0343824e-05,False,AWAT2; acyl-CoA wax alcohol acyltransferase
hsa:2917,3.5510332e-08,2.957132368369495e-05,4.6334405046257294e-06,1.5796769111997776e-05,0.0,0.0001799764,False,GRM7; glutamate metabotropic receptor
hsa:285242,0.0,0.0,1.5250363764385962e-05,0.00010294944268873756,0.0,0.0012865416,False,HTR3E; 5-hydroxytryptamine receptor
hsa:773,0.0,0.0,3.432990280701754e-07,2.9098050764888476e-06,0.0,3.0144125e-05,False,CACNA1A; calcium voltage-gated channel subunit alpha1
hsa:122042,0.0,0.0,3.922096900584796e-11,4.3041361617318875e-10,0.0,5.5058402e-09,False,RXFP2; relaxin family peptide receptor
hsa:832,0.0,0.0,2.1240076294561403e-06,6.510389472577468e-06,0.0,2.9856328e-05,False,CAPZB; capping actin protein of muscle Z-line subunit
hsa:3456,0.0,0.0,8.299235322807019e-07,6.35527424160452e-06,0.0,8.1112776e-05,False,IFNB1; interferon beta
hsa:5557,0.0,0.0,5.827822766701756e-06,2.458239744060773e-05,0.0,0.0002464381,False,PRIM1; DNA primase subunit
hsa:134860,0.0,0.0,5.7499521241520475e-09,7.516732974730798e-08,0.0,9.829421e-07,False,TAAR9; trace amine associated receptor
hsa:215,0.0,0.0,0.00021102510807602352,0.0004453178842052013,0.0,0.002223368,False,ABCD1; ATP binding cassette subfamily D member
hsa:79001,0.0,0.0,4.993088203929825e-05,0.00016432934778423867,0.0,0.0007311076,False,VKORC1; vitamin K epoxide reductase complex subunit
hsa:10538,0.0,0.0,8.622194724444446e-07,1.524161082070716e-06,0.0,9.609284e-06,False,BATF; basic leucine zipper ATF-like transcription
hsa:23275,3.949948e-06,0.0032893297320273854,0.00014730226424900588,0.00036269344765757543,0.0,0.0020296508,False,POFUT2; protein O-fucosyltransferase
hsa:4478,2.4836204e-06,0.0020682415122400977,2.1603844390491244e-05,4.089937465291589e-05,0.0,0.00024836423,False,MSN;
hsa:4163,0.0,0.0,1.6168017176374271e-06,4.674885888835851e-06,0.0,2.6412832e-05,False,MCC; MCC regulator of WNT signaling
hsa:7644,0.0,0.0,6.505180035582456e-08,1.1722503286795118e-07,0.0,7.0251775e-07,False,ZNF91; zinc finger protein
hsa:4091,0.0,0.0,1.3926657552339182e-07,4.0794412076032393e-07,0.0,2.7443741e-06,False,SMAD6; SMAD family member
hsa:374659,2.2368294e-08,1.8627256487662567e-05,2.0259640704877187e-06,4.763351489716647e-06,0.0,2.9851328e-05,False,HDDC3; HD domain containing
hsa:5577,2.812703e-07,0.00023422859250963875,7.592972646381286e-06,2.0971839769148398e-05,0.0,0.00013923233,False,PRKAR2B; protein kinase cAMP-dependent type II regulatory subunit
hsa:5862,0.0,0.0,4.298238745597662e-06,9.091783284696405e-06,0.0,7.5250435e-05,False,RAB2A; RAB2A
hsa:2305,1.4575659e-07,0.00012137918907436896,2.115070239619883e-06,6.224919119868804e-06,0.0,4.5241068e-05,False,FOXM1; forkhead box
hsa:51060,3.4241955e-06,0.0028515079354017774,0.00011791616823491218,0.0003528141255146265,0.0,0.0021615867,False,TXNDC12; thioredoxin domain containing
hsa:1025,7.307904e-06,0.006085676547134763,2.0054221904526318e-05,4.924486207048583e-05,0.0,0.0004533854,False,CDK9; cyclin dependent kinase
hsa:441531,0.0,0.0,9.574187835592327e-06,2.4523064859349935e-05,0.0,0.00019417236,False,PGAM4; phosphoglycerate mutase family member
hsa:4967,0.0,0.0,4.954970216573099e-05,0.00011663067284826712,0.0,0.00061377144,False,OGDH; oxoglutarate
hsa:6756,0.0,0.0,5.783199866659286e-06,2.5653323896392823e-05,0.0,0.00017368741,False,SSX1; SSX family member
hsa:51699,8.1782915e-08,6.810494059196942e-05,2.1899728802507024e-06,5.905546122654215e-06,0.0,3.3638815e-05,False,VPS29; VPS29 retromer complex
hsa:1431,0.0,0.0,2.8554807962222234e-05,6.720150393402355e-05,0.0,0.00036820126,False,CS; citrate
hsa:7058,0.0,0.0,3.6831037195906433e-06,1.2083075891151378e-05,0.0,0.00013053934,False,THBS2; thrombospondin
hsa:23396,8.588602e-07,0.0007152181222423655,1.0983615371421056e-05,1.925880914186108e-05,0.0,0.000116527284,False,PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:147657,0.0,0.0,6.929341919883039e-08,1.4232226241349548e-07,0.0,6.036605e-07,False,ZNF480; zinc finger protein
hsa:913,0.0,0.0,4.341086273554388e-06,1.3688358028781993e-05,0.0,0.00010787966,False,CD1E; CD1e
hsa:2847,0.0,0.0,3.2547096390643265e-06,1.1232659275556326e-05,0.0,0.000114878836,False,MCHR1; melanin concentrating hormone receptor
hsa:84992,0.0,0.0,5.711173375906434e-06,1.2749952679466605e-05,0.0,8.934401e-05,False,PIGY; phosphatidylinositol glycan anchor biosynthesis class
hsa:729230,0.0,0.0,3.4375369110526315e-06,1.364604120212423e-05,0.0,0.00011366967,False,CCR2; C-C motif chemokine receptor
hsa:30061,0.0,0.0,4.5402784096491244e-05,0.00014496303270774947,0.0,0.0011541835,False,SLC40A1; solute carrier family 40 member
hsa:152831,0.0,0.0,2.9586526599473675e-08,5.906482474775909e-08,0.0,3.25614e-07,False,KLB; klotho
hsa:2885,0.0002744367,0.22853789388353468,0.000863484860378398,0.0016485674599900375,0.0,0.01147511,False,GRB2; growth factor receptor bound protein
hsa:7263,0.0,0.0,5.4129780133333343e-05,0.00012778833144926055,0.0,0.0008199285,False,TST; thiosulfate
hsa:407034,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30E; microRNA
hsa:4711,5.273101e-06,0.0043911889217993095,7.703502492982454e-06,8.31839415214172e-06,0.0,4.4942743e-05,False,NDUFB5; NADH:ubiquinone oxidoreductase subunit
hsa:146664,8.8095254e-07,0.0007336155773005227,0.00012663249887216377,0.00033845194393334146,0.0,0.0024591705,False,MGAT5B; alpha-1
hsa:1540,0.0,0.0,3.3156341145614036e-05,7.267147340563264e-05,0.0,0.00038665492,False,CYLD; CYLD lysine 63
hsa:170958,1.6932816e-09,1.4100847686032584e-06,8.711320070389476e-08,1.9304463139451113e-07,0.0,1.2399043e-06,False,ZNF525; zinc finger protein
hsa:574455,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR193B; microRNA
hsa:7520,1.0904341e-06,0.0009080619051052125,9.336828221923974e-05,0.00016194264565898037,0.0,0.00096429157,False,XRCC5; X-ray repair cross complementing
hsa:27180,0.0,0.0,1.3010580286783626e-06,7.573567932902138e-06,0.0,9.728506e-05,False,SIGLEC9; sialic acid binding Ig like lectin
hsa:54658,0.0,0.0,2.5852790082456144e-05,0.0001252701283670145,0.0,0.0013447709,False,UGT1A1; UDP glucuronosyltransferase family 1 member
hsa:10257,3.2963482e-05,0.027450427553413252,0.00017024217711403505,0.00031877575265344655,0.0,0.0021732594,False,ABCC4; ATP binding cassette subfamily C member
hsa:55737,0.0,0.0,6.766688339122807e-07,1.8765877437485872e-06,0.0,1.7644667e-05,False,VPS35; VPS35 retromer complex
hsa:5700,0.0,0.0,9.758866816994153e-06,2.8927293637725628e-05,0.0,0.00029083894,False,PSMC1; proteasome 26S subunit
hsa:23047,1.5537941e-07,0.00012939261809468715,3.1621916791380117e-06,6.030381741257373e-06,0.0,3.0060042e-05,False,PDS5B; PDS5 cohesin associated factor
hsa:6829,0.0,0.0,7.149055349274859e-05,0.00021956176053505093,0.0,0.0016233391,False,SUPT5H; SPT5 homolog
hsa:10005,1.07364185e-05,0.008940781141305879,0.00045964335004736846,0.0008400677550721115,0.0,0.0036498494,False,ACOT8; acyl-CoA thioesterase
hsa:348980,0.0,0.0,9.331369968005849e-07,4.60030911504619e-06,0.0,5.242086e-05,False,HCN1; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:4249,6.063588e-08,5.049469079381419e-05,7.195089812797508e-05,0.00019019229435730592,0.0,0.0014321695,False,MGAT5; alpha-1
hsa:1824,0.0,0.0,4.642298411900584e-06,1.9625255796129056e-05,0.0,0.00017022288,False,DSC2; desmocollin
hsa:5837,0.0,0.0,9.74915486319298e-05,0.0002391010261115763,0.0,0.0013689395,False,PYGM; glycogen phosphorylase
hsa:390195,0.0,0.0,2.9410934122807016e-07,2.584720822228347e-06,0.0,2.9029572e-05,False,OR5AN1; olfactory receptor family 5 subfamily AN member
hsa:4350,0.0,0.0,2.3764760388538013e-06,6.352882120929733e-06,0.0,4.7805144e-05,False,MPG; N-methylpurine DNA
hsa:27175,1.1221582e-08,9.344802339925319e-06,3.63614846963158e-07,8.521426051292836e-07,0.0,4.3812793e-06,False,TUBG2; tubulin gamma
hsa:346528,0.0,0.0,1.1066747689064325e-06,2.799945251746482e-06,0.0,1.6033524e-05,False,OR2A1; olfactory receptor family 2 subfamily A member
hsa:6385,0.0,0.0,5.637800969005847e-07,4.474642044779752e-06,0.0,5.75936e-05,False,SDC4; syndecan
hsa:84002,0.0,0.0,9.183454332941521e-06,2.438587577662809e-05,0.0,0.00018421038,False,B3GNT5; UDP-GlcNAc:betaGal beta-1
hsa:403244,0.0,0.0,7.596102923976609e-07,9.933193503104337e-06,0.0,0.00012989336,False,OR2T35; olfactory receptor family 2 subfamily T member
hsa:10683,7.0121623e-06,0.005839396857678009,0.0001732732213089684,0.0003953026298719264,0.0,0.0022323707,False,DLL3; delta like canonical Notch ligand
hsa:8626,0.0,0.0,5.9200682743274865e-09,1.5778092535482914e-08,0.0,1.0262863e-07,False,TP63; tumor protein
hsa:393046,0.0,0.0,3.480469260233918e-08,2.1214883166466874e-07,0.0,1.6648746e-06,False,OR2A5; olfactory receptor family 2 subfamily A member
hsa:127385,0.0,0.0,6.024005847953217e-08,7.877409817957817e-07,0.0,1.030105e-05,False,OR10J5; olfactory receptor family 10 subfamily J member
hsa:9928,4.1844967e-09,3.4846507875244135e-06,1.4168430149960234e-06,4.9727151019830346e-06,0.0,3.0311216e-05,False,KIF14; kinesin family member
hsa:8553,0.0,0.0,7.152655738011695e-06,1.65577364769007e-05,0.0,0.00011732207,False,BHLHE40; basic helix-loop-helix family member
hsa:5428,0.0,0.0,2.0858575960970756e-05,7.29368954047501e-05,0.0,0.0005068164,False,POLG; DNA polymerase gamma
hsa:8509,1.1464547e-06,0.0009547132091694718,0.0002822892328504677,0.00086968274736919,0.0,0.005098628,False,NDST2; N-deacetylase and N-sulfotransferase
hsa:9706,0.0,0.0,0.0006603345507331872,0.0020451464819046298,0.0,0.011077503,False,ULK2; unc-51 like autophagy activating kinase
hsa:11164,0.0,0.0,1.6701774993391816e-06,4.443128544349979e-06,0.0,3.1909225e-05,False,NUDT5; nudix hydrolase
hsa:594,8.895814e-06,0.007408012834798198,6.552011243371347e-05,0.00019767971380376547,0.0,0.0021158813,False,BCKDHB; branched chain keto acid dehydrogenase E1 subunit
hsa:2034,0.0,0.0,1.0618563205614036e-06,2.453644116258011e-06,0.0,1.533655e-05,False,EPAS1; endothelial PAS domain protein
hsa:9630,0.0,0.0,1.2308913602210524e-05,4.73329649504624e-05,0.0,0.0004083869,False,GNA14; G protein subunit alpha
hsa:29796,5.539785e-07,0.0004613270734080381,0.00020714409640590657,0.0005503865642391251,0.0,0.0030270815,False,UQCR10; ubiquinol-cytochrome c reductase
hsa:10814,0.0,0.0,3.901856445676609e-05,0.00013750585513476352,0.0,0.0009201936,False,CPLX2; complexin
hsa:549,1.0621985e-07,8.845486338971782e-05,1.8255141828918117e-06,3.470816196274736e-06,0.0,2.028464e-05,False,AUH; AU RNA binding methylglutaconyl-CoA
hsa:2121,0.0,0.0,9.485367859649122e-08,3.198133381148576e-07,0.0,2.1681878e-06,False,EVC; EvC ciliary complex subunit
hsa:8677,1.8568112e-08,1.5462644791580672e-05,4.3652788566959083e-07,8.580365636037814e-07,0.0,4.946093e-06,False,STX10; syntaxin
hsa:79586,0.0,0.0,0.00039280828655280706,0.0013874223674538303,0.0,0.008343099,False,CHPF; chondroitin polymerizing
hsa:2642,0.0,0.0,1.8387803251491236e-05,5.191980982615979e-05,0.0,0.00043622206,False,GCGR; glucagon
hsa:5427,8.611784e-07,0.0007171486094753078,8.708419762279536e-05,0.0002582190285928214,0.0,0.0012547331,False,POLE2; DNA polymerase epsilon 2
hsa:1139,8.278888e-06,0.006894266062875952,0.0006957689102538014,0.0014272536488100888,0.0,0.009513499,False,CHRNA7; cholinergic receptor nicotinic alpha 7
hsa:341,0.0,0.0,0.00010597248549824558,0.0002682716395992789,0.0,0.0015360622,False,APOC1; apolipoprotein
hsa:527,0.0,0.0,2.7608903985847946e-05,7.024227521002279e-05,0.0,0.00043206816,False,ATP6V0C; ATPase H+ transporting V0 subunit
hsa:10057,0.00014555015,0.12120727561376653,0.001076022293918947,0.0015571831787680307,0.0,0.008093039,False,ABCC5; ATP binding cassette subfamily C member
hsa:100169851,0.0,0.0,2.686654524065322e-07,1.385934700031537e-06,0.0,1.3766902e-05,False,PATE3; prostate and testis expressed
hsa:23171,1.2750771e-08,1.0618238558222173e-05,6.584309540584793e-07,1.3852156029247454e-06,0.0,9.996885e-06,False,GPD1L; glycerol-3-phosphate dehydrogenase 1
hsa:8871,0.0,0.0,4.883648340216373e-07,1.2474901620169324e-06,0.0,6.7581873e-06,False,SYNJ2; synaptojanin
hsa:6210,0.0,0.0,2.1525257912280703e-07,3.798499148692655e-07,0.0,1.8174202e-06,False,RPS15A; ribosomal protein
hsa:3586,0.0,0.0,5.618438819883042e-06,3.261426044240191e-05,0.0,0.00038925835,False,IL10; interleukin
hsa:8741,0.0,0.0,1.4430849261169592e-05,3.465476073867385e-05,0.0,0.00018222361,False,TNFSF13; TNF superfamily member
hsa:79587,0.0,0.0,1.5909073236140354e-06,3.5676295927547065e-06,0.0,1.8385652e-05,False,CARS2; cysteinyl-tRNA synthetase 2
hsa:143187,1.904041e-08,1.5855952210761144e-05,3.607747914590642e-06,1.5281987299104662e-05,0.0,0.00017082511,False,VTI1A; vesicle transport through interaction with t-SNAREs
hsa:1069,0.0,0.0,2.111748704032164e-06,5.14992012147396e-06,0.0,2.8438018e-05,False,CETN2; centrin
hsa:22987,3.2478468e-07,0.00027046530851317546,4.1530998593900573e-05,0.00010555399646700683,0.0,0.0006254189,False,SV2C; synaptic vesicle glycoprotein
hsa:117178,1.5473573e-07,0.0001288565918579085,2.7613763395742682e-05,6.468852278214779e-05,0.0,0.00032572044,False,SSX2IP; SSX family member 2 interacting
hsa:85477,0.0,0.0,1.9168720812456142e-06,6.889658809687246e-06,0.0,4.6320918e-05,False,SCIN;
hsa:84976,0.0,0.0,6.679543021356727e-05,0.0001480996712045901,0.0,0.0010358003,False,DISP1; dispatched RND transporter family member
hsa:6144,1.4864284e-07,0.0001237827214598748,9.489375434093568e-07,1.8052995355204082e-06,0.0,9.769655e-06,False,RPL21; ribosomal protein
hsa:5501,0.00015461768,0.12875828540555373,0.00041616877202046786,0.0006140413236523537,0.0,0.003784942,False,PPP1CC; protein phosphatase 1 catalytic subunit
hsa:8876,2.7873605e-07,0.00023211818906296284,4.1159229590994135e-06,8.259350236057241e-06,0.0,5.1956253e-05,False,VNN1; vanin
hsa:83998,0.0,0.0,1.1442662375029238e-07,6.340973407633553e-07,0.0,5.604856e-06,False,REG4; regenerating family member
hsa:90865,0.0,0.0,4.8041974884795315e-06,1.0428558687296852e-05,0.0,5.0633636e-05,False,IL33; interleukin
hsa:545,0.0,0.0,8.822842902923976e-05,0.0001961849077408468,0.0,0.0011053593,False,ATR; ATR serine/threonine
hsa:6375,4.788413e-05,0.039875636970730884,0.00016064369491478357,0.0003442306617640942,0.0,0.0031699794,False,XCL1; X-C motif chemokine ligand
hsa:1564,7.087038e-06,0.005901749796556284,8.049089664058483e-05,0.0001424913001758787,0.0,0.0009217142,False,CYP2D7; cytochrome P450 family 2 subfamily D member 7
hsa:6677,0.0,0.0,2.0793444042690058e-07,1.3984561911442049e-06,0.0,1.5332345e-05,False,SPAM1; sperm adhesion molecule
hsa:55659,0.0,0.0,6.408689676842106e-09,1.2031713403418831e-08,0.0,4.8347747e-08,False,ZNF416; zinc finger protein
hsa:23335,3.7454114e-07,0.0003119001332851551,2.242647089136257e-06,4.506556811519773e-06,0.0,3.979997e-05,False,WDR7; WD repeat domain
hsa:84812,1.7089647e-05,0.01423144911957135,0.00020769267700011676,0.0005211494180324382,0.0,0.0028252464,False,PLCD4; phospholipase C delta
hsa:3706,0.0,0.0,1.5768350156900574e-06,6.482685190836342e-06,0.0,7.188919e-05,False,ITPKA; inositol-trisphosphate 3-kinase
hsa:2178,1.195942e-05,0.009959238902335667,0.0001475475256859941,0.0002383684119790679,0.0,0.0012165612,False,FANCE; FA complementation group
hsa:83734,1.5369287e-06,0.001279881474114646,0.00022963625867683974,0.000641708308518681,0.0,0.003430012,False,ATG10; autophagy related
hsa:200959,0.0,0.0,1.6578381929824562e-08,1.2498847641470756e-07,0.0,1.5403328e-06,False,GABRR3; gamma-aminobutyric acid type A receptor subunit
hsa:5395,6.8658283e-06,0.005717536828886113,0.0003248084001311697,0.0007038780493171319,0.0,0.0038611644,False,PMS2; PMS1 homolog 2
hsa:1642,0.0,0.0,1.7489271546783628e-06,2.8014348698450286e-06,0.0,1.3485839e-05,False,DDB1; damage specific DNA binding protein
hsa:80331,0.0,0.0,6.872680377906433e-07,1.5901352399054112e-06,0.0,9.937724e-06,False,DNAJC5; DnaJ heat shock protein family (Hsp40) member
hsa:8817,0.0,0.0,3.8888854971228075e-06,1.41330461044093e-05,0.0,9.733269e-05,False,FGF18; fibroblast growth factor
hsa:983,2.3256109e-05,0.01936658679683117,0.0004327620408970762,0.0007869521384417047,0.0,0.0057328674,False,CDK1; cyclin dependent kinase
hsa:259285,-0.0,0.0,2.1143807409356728e-07,2.0079932550126084e-06,0.0,2.4288993e-05,False,TAS2R39; taste 2 receptor member
hsa:9519,0.0,0.0,7.820122414385964e-07,1.766298288930626e-06,0.0,1.43646685e-05,False,TBPL1; TATA-box binding protein like
hsa:5000,2.9511325e-08,2.45756346043095e-05,1.1900972601052632e-06,3.0621882458010248e-06,0.0,1.6225165e-05,False,ORC4; origin recognition complex subunit
hsa:382,1.8329007e-06,0.0015263529465106397,1.8620868883029234e-05,4.426660215509681e-05,0.0,0.00029576008,False,ARF6; ADP ribosylation factor
hsa:127602,1.8554127e-08,1.5450998745530847e-05,3.6406244650116957e-07,1.0489315622962042e-06,0.0,6.732901e-06,False,DNAH14; dynein axonemal heavy chain
hsa:84295,0.0,0.0,1.2751978301040936e-06,3.770626975159401e-06,0.0,2.1556456e-05,False,PHF6; PHD finger protein
hsa:25885,0.0,0.0,0.00010263661437926897,0.00036994323360482496,0.0,0.0026170297,False,POLR1A; RNA polymerase I subunit
hsa:3106,0.0,0.0,0.0001052305697380117,0.0002931470119716373,0.0,0.001922082,False,HLA-B; major histocompatibility complex
hsa:4046,0.0,0.0,3.5408805721637426e-06,1.8346619829158272e-05,0.0,0.00019378404,False,LSP1; lymphocyte specific protein
hsa:79296,-0.0,0.0,2.38469783625731e-08,2.586671755732743e-07,0.0,3.2953724e-06,False,OR52E1; olfactory receptor family 52 subfamily E member 1
hsa:50831,1.3504188e-05,0.011245648574433751,9.169786846432748e-05,0.00019672282715809994,0.0,0.0012591046,False,TAS2R3; taste 2 receptor member
hsa:7314,1.1405493e-06,0.0009497954715689986,8.4419581152807e-06,1.9599528820143362e-05,0.0,0.00017901816,False,UBB; ubiquitin
hsa:27086,0.0,0.0,1.6574334529824569e-07,2.8834583151581917e-07,0.0,1.6330972e-06,False,FOXP1; forkhead box
hsa:11181,-0.0,0.0,4.664599419298246e-07,2.6597127274360426e-06,0.0,2.6182624e-05,False,TREH;
hsa:3205,0.0,0.0,8.450742608169592e-08,3.1348611115171965e-07,0.0,2.3585994e-06,False,HOXA9; homeobox
hsa:116984,2.0413653e-10,1.6999523981629643e-07,6.389861345678361e-08,1.4856752820279286e-07,0.0,1.103572e-06,False,ARAP2; ArfGAP with RhoGAP domain
hsa:51561,2.9346897e-05,0.02443870674875854,6.22434528146199e-05,9.164754583053608e-05,0.0,0.000481671,False,IL23A; interleukin 23 subunit
hsa:22823,0.0,0.0,7.434546534641226e-05,0.0002715199640854245,0.0,0.0016670902,False,MTF2; metal response element binding transcription factor
hsa:939,0.0,0.0,1.2624524062432747e-05,4.831014490280565e-05,0.0,0.00036884224,False,CD27; CD27
hsa:2902,5.2908938e-05,0.04406005923455032,0.0006213124975126314,0.0012190598934497267,0.0,0.0074226786,False,GRIN1; glutamate ionotropic receptor NMDA type subunit
hsa:10915,0.0,0.0,8.494366292982456e-08,2.5674614080544166e-07,0.0,1.4148796e-06,False,TCERG1; transcription elongation regulator
hsa:64901,1.7787978e-09,1.4812986122361369e-06,2.1821891276099423e-07,6.05719626752666e-07,0.0,3.5200624e-06,False,RANBP17; RAN binding protein
hsa:9790,8.8739725e-08,7.389824267419063e-05,2.593383476975965e-06,4.850746350012881e-06,0.0,2.4387975e-05,False,BMS1; BMS1 ribosome biogenesis
hsa:55252,1.14620704e-07,9.545069696439302e-05,3.670143038242259e-05,0.0001218247827842596,0.0,0.000632773,False,ASXL2; ASXL transcriptional regulator
hsa:2207,0.0,0.0,0.00024846888665573094,0.0008277947461968225,0.0,0.004730145,False,FCER1G; Fc epsilon receptor
hsa:136051,1.7522455e-09,1.4591871135926837e-06,1.939655851345029e-08,4.144892422522781e-08,0.0,2.2547692e-07,False,ZNF786; zinc finger protein
hsa:51761,8.1123845e-09,6.7556098291643635e-06,7.504032821411463e-05,0.0002511919318426522,0.0,0.0019231135,False,ATP8A2; ATPase phospholipid transporting
hsa:7326,0.0,0.0,7.036170689795323e-07,1.367484373058849e-06,0.0,8.425502e-06,False,UBE2G1; ubiquitin conjugating enzyme E2
hsa:51206,0.0,0.0,2.4438792832105274e-06,8.920785017892714e-06,0.0,7.6276054e-05,False,GP6; glycoprotein VI
hsa:390067,0.0,0.0,3.3700003099415205e-07,1.988353937108463e-06,0.0,2.3931134e-05,False,OR52H1; olfactory receptor family 52 subfamily H member
hsa:79168,0.0,0.0,1.5563387781444447e-05,5.630757561866023e-05,0.0,0.0004105301,False,LILRA6; leukocyte immunoglobulin like receptor
hsa:2931,0.0,0.0,9.550155656315792e-06,2.4207846201417013e-05,0.0,0.00019914877,False,GSK3A; glycogen synthase kinase 3
hsa:7535,0.0,0.0,6.879743750994151e-05,0.0001793772153527258,0.0,0.0011712837,False,ZAP70; zeta chain of T cell receptor associated protein kinase
hsa:79017,0.0,0.0,8.80546293820468e-05,0.00027735998244967947,0.0,0.0019594561,False,GGCT;
hsa:5329,2.7240964e-07,0.00022684985426210086,4.073665589321636e-06,1.2317219227099443e-05,0.0,9.5877054e-05,False,PLAUR; plasminogen activator
hsa:3694,2.5850022e-07,0.0002152667476588604,8.64692364899415e-05,0.00025963839842705895,0.0,0.0017622969,False,ITGB6; integrin subunit beta
hsa:796,0.0,0.0,1.8671399286549709e-07,1.636625948098051e-06,0.0,2.0932512e-05,False,CALCA; calcitonin related polypeptide
hsa:401992,0.0,0.0,2.0659749237426902e-07,1.48231734991493e-06,0.0,1.6216485e-05,False,OR2T2; olfactory receptor family 2 subfamily T member
hsa:84643,0.0,0.0,3.228605005847953e-11,2.471426205625382e-10,0.0,3.0771634e-09,False,KIF2B; kinesin family member
hsa:5601,0.0004512639,0.37579121630478,0.0006857280541286554,0.000738050085788251,0.0,0.0030970327,False,MAPK9; mitogen-activated protein kinase
hsa:2131,0.0,0.0,1.6543741190409355e-05,3.080581133660974e-05,0.0,0.00017902865,False,EXT1; exostosin glycosyltransferase
hsa:9365,0.0,0.0,1.7930654242690062e-05,3.475681311545634e-05,0.0,0.00021251102,False,KL;
hsa:162466,0.0,0.0,2.6976697811309955e-07,5.613724501712785e-07,0.0,3.025533e-06,False,PHOSPHO1; phosphoethanolamine/phosphocholine phosphatase
hsa:338376,0.0,0.0,2.201757556134502e-06,8.728733175105424e-06,0.0,6.9074486e-05,False,IFNE; interferon
hsa:548593,0.0,0.0,4.117540341690058e-06,1.2824974619506125e-05,0.0,8.7527e-05,False,SLX1A; SLX1 homolog A
hsa:55870,2.5587176e-06,0.0021307789058341415,2.155197970900585e-05,5.735328530351791e-05,0.0,0.00034392127,False,ASH1L; ASH1 like histone lysine
hsa:3769,0.0,0.0,3.1964150180545024e-06,8.488083857238825e-06,0.0,7.66997e-05,False,KCNJ13; potassium inwardly rectifying channel subfamily J member
hsa:3814,0.0,0.0,4.031850349349123e-06,1.3187799892279902e-05,0.0,0.000118019016,False,KISS1; KiSS-1 metastasis
hsa:51013,4.1276613e-07,0.00034373209565869756,3.397072611897659e-05,0.0001261148381268218,0.0,0.0010900188,False,EXOSC1; exosome component
hsa:7419,1.3478529e-05,0.011224280973747844,0.0001902412166333333,0.0002915281291533416,0.0,0.0013464647,False,VDAC3; voltage dependent anion channel
hsa:648,0.0,0.0,6.390796664976259e-05,0.00014073695912880698,0.0,0.00082748913,False,BMI1; BMI1 proto-oncogene
hsa:967,3.3119834e-06,0.002758063009842446,6.00367423105263e-06,1.1880849746788611e-05,0.0,0.00012693765,False,CD63; CD63
hsa:246213,9.793965e-07,0.0008155950475534258,5.372395803707604e-05,0.00018025901750002557,0.0,0.001136748,False,SLC17A8; solute carrier family 17 member
hsa:9187,0.0,0.0,2.015065884327485e-05,3.3236934845516867e-05,0.0,0.00019534877,False,SLC24A1; solute carrier family 24 member
hsa:8787,0.0,0.0,0.00024916431183684195,0.00042698467600696524,0.0,0.002512284,False,RGS9; regulator of G protein signaling
hsa:4221,1.0952956e-06,0.0009121103321964682,2.125459740620818e-05,5.336125378495101e-05,0.0,0.00043854865,False,MEN1; menin
hsa:55851,1.6361468e-05,0.013625056115172823,0.0003326123009566782,0.0007620333574584683,0.0,0.0049185483,False,PSENEN; presenilin enhancer
hsa:55207,8.5677485e-08,7.134815414679646e-05,2.3390911197660822e-07,3.845103996773902e-07,0.0,1.7192912e-06,False,ARL8B; ADP ribosylation factor like GTPase
hsa:94160,0.0,0.0,7.502899032625731e-07,2.801472167530414e-06,-0.0,2.1087302e-05,False,ABCC12; ATP binding cassette subfamily C member
hsa:6602,0.0,0.0,1.8285592334385958e-06,4.186933488363116e-06,0.0,2.5473866e-05,False,SMARCD1; SWI/SNF related
hsa:6789,0.0,0.0,1.7949785703883044e-06,4.249420756710027e-06,0.0,2.8884459e-05,False,STK4; serine/threonine kinase
hsa:24146,4.364175e-06,0.003634278371074914,4.7991272094736826e-05,0.00011225868530216061,0.0,0.00081252016,False,CLDN15; claudin
hsa:5579,0.001443316,1.2019252485123446,0.0024101370423625728,0.002521979776411598,0.0,0.012138994,True,PRKCB; protein kinase C
hsa:55247,1.06773065e-07,8.891555465646451e-05,6.521402161047311e-05,0.0001940120792818428,0.0,0.0014364043,False,NEIL3; nei like DNA glycosylase
hsa:64963,6.273052e-10,5.223900784049272e-07,5.217786941578947e-08,9.388389527406608e-08,0.0,6.142801e-07,False,MRPS11; mitochondrial ribosomal protein
hsa:6442,0.0,0.0,8.198960036842104e-07,4.686023217733134e-06,0.0,5.6122288e-05,False,SGCA; sarcoglycan
hsa:219858,0.0,0.0,1.2744254319239764e-06,7.628949856676609e-06,0.0,7.2648094e-05,False,OR8B12; olfactory receptor family 8 subfamily B member
hsa:54961,4.2452191e-07,0.00035352175280789873,1.2358285375707595e-05,3.1527884773599375e-05,0.0,0.00017865191,False,SSH3; slingshot protein phosphatase
hsa:6716,1.04403235e-07,8.694207240331827e-05,4.1518051863566066e-06,9.319409069911173e-06,0.0,5.887655e-05,False,SRD5A2; steroid 5 alpha-reductase
hsa:2593,0.0,0.0,0.00016421982495023395,0.0003599478632498189,0.0,0.0021022777,False,GAMT; guanidinoacetate
hsa:56950,0.0,0.0,1.0545125512066669e-05,3.177266584638035e-05,0.0,0.00018877993,False,SMYD2; SET and MYND domain containing
hsa:5335,0.0002639158,0.21977658634791977,0.0003822943734619883,0.00045825465906536934,0.0,0.0019449831,False,PLCG1; phospholipase C gamma
hsa:340267,0.0,0.0,1.8377075146783624e-06,6.77485241025299e-06,0.0,5.4005723e-05,False,COL28A1; collagen type XXVIII alpha 1
hsa:54659,0.0,0.0,4.168106567251462e-06,2.9072772893133543e-05,0.0,0.00025852912,False,UGT1A3; UDP glucuronosyltransferase family 1 member
hsa:84134,1.655406e-08,1.3785437616840847e-05,6.493192184786548e-08,9.45009594753341e-08,0.0,4.1407174e-07,False,TOMM40L; translocase of outer mitochondrial membrane 40
hsa:606495,2.843985e-06,0.0023683360940295684,3.219364563805261e-05,5.665797228041168e-05,0.0,0.000290423,False,CYB5RL; cytochrome b5 reductase
hsa:972,1.7047711e-06,0.001419652680372256,2.4545614934491236e-05,7.761902329232975e-05,0.0,0.00052729197,False,CD74; CD74
hsa:8674,0.0,0.0,3.632246998700585e-05,0.0001036449465665534,0.0,0.00078763,False,VAMP4; vesicle associated membrane protein
hsa:6201,3.886871e-07,0.00032368021920427855,8.885602798421046e-07,1.5915078800774139e-06,0.0,9.175502e-06,False,RPS7; ribosomal protein
hsa:8775,0.0,0.0,5.018547226403509e-06,1.5165428203768655e-05,0.0,0.00015392616,False,NAPA; NSF attachment protein
hsa:27289,0.0,0.0,2.3468696260000003e-07,6.092530862122178e-07,0.0,3.6536148e-06,False,RND1; Rho family GTPase
hsa:29925,6.5530656e-07,0.0005457082856282128,5.60247308144444e-05,0.00016515928746386216,0.0,0.0011398572,False,GMPPB; GDP-mannose pyrophosphorylase
hsa:100169751,0.0,0.0,1.1858577237309938e-08,1.0985664073268828e-07,0.0,1.3201592e-06,False,RNA5S1; RNA
hsa:3581,8.05658e-06,0.006709138482951471,3.585857921817133e-05,7.103983065419744e-05,0.0,0.0004981987,False,IL9R; interleukin 9
hsa:4843,0.0,0.0,2.9410216816257305e-05,0.00014468640445080658,0.0,0.001836286,False,NOS2; nitric oxide synthase
hsa:7692,5.505316e-09,4.5845665823970545e-06,1.801595624188305e-07,4.357440522748423e-07,0.0,2.2604027e-06,False,ZNF133; zinc finger protein
hsa:1101,4.4557552e-07,0.0003710542026881273,9.081374297818719e-06,5.164722488752958e-05,0.0,0.0006008062,False,CHAD;
hsa:54209,0.0,0.0,1.70506607854386e-05,6.310420535838721e-05,0.0,0.0004902108,False,TREM2; triggering receptor expressed on myeloid cells
hsa:2876,0.0,0.0,8.752164391812864e-06,2.40846497976927e-05,0.0,0.0002329723,False,GPX1; glutathione peroxidase
hsa:2904,0.0,0.0,4.98732102251462e-07,1.8853729170249948e-06,0.0,1.41284845e-05,False,GRIN2B; glutamate ionotropic receptor NMDA type subunit
hsa:476,0.0,0.0,0.00040481988392105273,0.0007586204156589824,0.0,0.0037287935,False,ATP1A1; ATPase Na+/K+ transporting subunit alpha
hsa:83594,0.0,0.0,0.00014228570601625728,0.00031034760256920925,0.0,0.0016367699,False,NUDT12; nudix hydrolase
hsa:1668,0.0,0.0,1.76962060122807e-06,7.028613308254567e-06,0.0,7.160142e-05,False,DEFA3; defensin alpha
hsa:2099,0.0,0.0,3.7001751639795313e-06,1.2650802050963214e-05,0.0,0.00011826368,False,ESR1; estrogen receptor
hsa:914,3.1951704e-06,0.0026607866725369134,2.674067417890059e-05,5.627219891348239e-05,0.0,0.00047146587,False,CD2; CD2
hsa:8277,0.0,0.0,2.0761634143398535e-06,7.084303314116889e-06,0.0,6.198373e-05,False,TKTL1; transketolase like
hsa:732,0.0,0.0,1.2732062333011698e-06,1.4733998743143905e-05,0.0,0.00019258472,False,C8B; complement C8 beta
hsa:146434,0.0,0.0,1.637871247342105e-08,3.461372856170206e-08,0.0,2.106478e-07,False,ZNF597; zinc finger protein
hsa:23446,4.225843e-07,0.0003519082029125397,3.3968952474543254e-06,7.227157807935754e-06,0.0,3.7123526e-05,False,SLC44A1; solute carrier family 44 member
hsa:2913,4.151414e-09,3.4571010808635298e-06,1.9831235723508774e-05,4.294777248433377e-05,0.0,0.00031740539,False,GRM3; glutamate metabotropic receptor
hsa:1128,0.0,0.0,5.5102546508362574e-05,0.00011903879033570593,0.0,0.0007142625,False,CHRM1; cholinergic receptor muscarinic
hsa:10769,0.0,0.0,4.463231157309941e-07,8.348761934705468e-07,0.0,4.590735e-06,False,PLK2; polo like kinase
hsa:8767,0.0,0.0,6.777850504093569e-07,1.9703116464415863e-06,0.0,1.4192156e-05,False,RIPK2; receptor interacting serine/threonine kinase
hsa:90701,2.284455e-06,0.0019023859941899542,0.0001213898390583041,0.00029823565257903453,0.0,0.0019804034,False,SEC11C; SEC11 homolog C
hsa:284340,0.0,0.0,1.1005111452514616e-06,4.257309173782817e-06,0.0,3.1652886e-05,False,CXCL17; C-X-C motif chemokine ligand
hsa:10112,1.4841373e-08,1.2359192949630851e-05,1.4193437754250877e-06,4.534865663876314e-06,0.0,2.376598e-05,False,KIF20A; kinesin family member
hsa:8322,0.0,0.0,1.7841865475614035e-05,4.347583689473528e-05,0.0,0.00033752524,False,FZD4; frizzled class receptor
hsa:441234,0.0,0.0,9.346966679999998e-10,5.4576293815576535e-09,0.0,5.4034945e-08,False,ZNF716; zinc finger protein
hsa:64577,2.2457976e-05,0.018701939412356178,7.1564328202924e-05,0.00010744953280928184,0.0,0.0006116217,False,ALDH8A1; aldehyde dehydrogenase 8 family member
hsa:8504,3.9549917e-07,0.00032935298866545933,6.602782864185085e-05,0.0002278384760833731,0.0,0.001394605,False,PEX3; peroxisomal biogenesis factor
hsa:242,0.0,0.0,1.4471452057728067e-05,3.2598085187311674e-05,0.0,0.00017994546,False,ALOX12B; arachidonate 12-lipoxygenase
hsa:859,0.0,0.0,1.5815718195146195e-06,8.219927600119783e-06,0.0,9.010318e-05,False,CAV3; caveolin
hsa:25909,0.0,0.0,7.647618263888888e-08,1.8012669991971542e-07,0.0,7.896246e-07,False,AHCTF1; AT-hook containing transcription factor
hsa:2941,0.0011551996,0.9619955479682627,0.0014610888076374271,0.0014163362763926545,0.0,0.008019,True,GSTA4; glutathione S-transferase alpha
hsa:135112,1.3478609e-06,0.0011224347593961216,3.773063559157895e-06,8.601397620598922e-06,0.0,9.021699e-05,False,NCOA7; nuclear receptor coactivator
hsa:340156,3.8540406e-07,0.000320946258887982,1.2583518429593566e-05,2.3670057065996936e-05,0.0,0.000113608156,False,MYLK4; myosin light chain kinase family member
hsa:9727,4.727458e-08,3.93680325824814e-05,4.999510289649124e-07,8.118097763072814e-07,0.0,3.7607163e-06,False,RAB11FIP3; RAB11 family interacting protein
hsa:80230,0.0,0.0,3.5591797670116963e-07,6.261637405015812e-07,0.0,2.5559798e-06,False,RUFY1; RUN and FYVE domain containing
hsa:654364,0.0,0.0,0.00015793286914257313,0.0005075019874276363,0.0,0.0027604285,False,NME1-NME2; NME1-NME2
hsa:11315,1.4106872e-08,1.1747535282870722e-05,1.9654099271736844e-07,4.254910886539578e-07,0.0,1.9261472e-06,False,PARK7; Parkinsonism associated
hsa:81050,0.0,0.0,2.387144409356725e-07,3.0087034800821457e-06,0.0,3.9324255e-05,False,OR5AC2; olfactory receptor family 5 subfamily AC member
hsa:8427,0.0,0.0,1.3312120770760233e-07,2.4191457819112066e-07,0.0,1.3041085e-06,False,ZNF282; zinc finger protein
hsa:102157402,5.4861795e-07,0.00045686306109825087,3.2842624977573096e-06,4.959047820422923e-06,0.0,3.056366e-05,False,AK6; adenylate kinase
hsa:132884,0.0,0.0,4.035799332222223e-07,1.341126239038964e-06,0.0,7.450007e-06,False,EVC2; EvC ciliary complex subunit
hsa:59285,0.0,0.0,2.141165982192982e-05,0.00015494786707107329,0.0,0.0014800025,False,CACNG6; calcium voltage-gated channel auxiliary subunit gamma
hsa:285613,2.0539547e-08,1.7104362545905387e-05,3.0829763172106835e-05,8.344472737136696e-05,0.0,0.0006747099,False,RELL2; RELT like
hsa:84759,1.2529458e-07,0.00010433939567201488,0.0001423048634696491,0.0003631503121771605,0.0,0.001954428,False,PCGF1; polycomb group ring finger
hsa:445,0.0,0.0,6.577059295497076e-05,0.00012860857576260632,0.0,0.00084037613,False,ASS1; argininosuccinate synthase
hsa:169355,0.0,0.0,2.9365033892222234e-05,8.588771149134202e-05,0.0,0.00068341836,False,IDO2; indoleamine 2
hsa:23373,0.0,0.0,3.150396901754386e-08,5.97727294706749e-08,0.0,3.1269724e-07,False,CRTC1; CREB regulated transcription coactivator
hsa:8313,0.0,0.0,5.1743750742865514e-05,0.00010439705198591961,0.0,0.0005801443,False,AXIN2; axin
hsa:79813,0.0,0.0,4.779408917192981e-06,8.112278980075393e-06,0.0,3.498879e-05,False,EHMT1; euchromatic histone lysine methyltransferase
hsa:1211,3.894157e-05,0.03242869627975499,0.00015662313716397662,0.0002819677687331587,0.0,0.0016339287,False,CLTA; clathrin light chain
hsa:50937,2.5565405e-05,0.021289659200025318,0.00015312831037978954,0.00024475787083470406,0.0,0.0013391308,False,CDON; cell adhesion associated
hsa:53354,0.0,0.0,4.5911177688830394e-05,0.000126228786219476,0.0,0.0005277947,False,PANK1; pantothenate kinase
hsa:10939,0.0,0.0,1.6635691238011692e-07,3.175222686087655e-07,0.0,1.2338162e-06,False,AFG3L2; AFG3 like matrix AAA peptidase subunit
hsa:23432,2.7758193e-05,0.0231157092554774,7.990450917810526e-05,0.00014609571747778506,0.0,0.0010046157,False,GPR161; G protein-coupled receptor
hsa:11151,1.356565e-06,0.0011296831218860933,2.7950684768654984e-06,3.892330321909518e-06,0.0,1.7501257e-05,False,CORO1A; coronin
hsa:6135,7.4456676e-07,0.0006200399552468283,1.9125882890175445e-06,2.868514921332579e-06,0.0,1.3461336e-05,False,RPL11; ribosomal protein
hsa:7329,0.0,0.0,2.5452631596491227e-06,5.234560140240367e-06,0.0,2.519047e-05,False,UBE2I; ubiquitin conjugating enzyme E2
hsa:253430,8.152222e-08,6.788784613541181e-05,9.012863969602332e-06,2.713785931147849e-05,0.0,0.00020546741,False,IPMK; inositol polyphosphate
hsa:270,0.0,0.0,2.137637809730994e-09,9.329340162266953e-09,0.0,9.495507e-08,False,AMPD1; adenosine monophosphate deaminase
hsa:255189,0.0,0.0,3.929288340292397e-06,1.702685358699384e-05,0.0,0.00017126535,False,PLA2G4F; phospholipase A2 group
hsa:9474,2.8693856e-05,0.02389488511426287,0.0002496016185076024,0.00045924615926593726,0.0,0.003312968,False,ATG5; autophagy related
hsa:3098,0.0005413486,0.4508094904974447,0.0008461171593918126,0.0009809401835946883,0.0,0.005391193,True,HK1; hexokinase
hsa:2327,0.0,0.0,1.4893648817298247e-05,6.320793866150586e-05,0.0,0.0006891351,False,FMO2; flavin containing dimethylaniline monoxygenase
hsa:59350,3.3404103e-08,2.7817355866357027e-05,1.242612093744444e-06,3.951109242871664e-06,0.0,3.051318e-05,False,RXFP1; relaxin family peptide receptor
hsa:8784,0.0,0.0,2.531681583567252e-07,1.0261555767537634e-06,0.0,1.1577854e-05,False,TNFRSF18; TNF receptor superfamily member
hsa:56261,3.1799527e-08,2.6481140922743194e-05,3.2000176618128656e-05,6.96518451331184e-05,0.0,0.00037954602,False,GPCPD1; glycerophosphocholine phosphodiesterase
hsa:326625,0.0,0.0,5.7724203420526326e-05,0.00013310209151494044,0.0,0.000911749,False,MMAB; metabolism of cobalamin associated
hsa:6615,3.4605162e-07,0.000288175409519883,1.3591058541520467e-06,2.3853323651146834e-06,0.0,1.4024886e-05,False,SNAI1; snail family transcriptional repressor
hsa:337876,0.0,0.0,4.178143578766082e-06,1.532865674869584e-05,0.0,0.00012620409,False,CHSY3; chondroitin sulfate synthase
hsa:108,0.00033718074,0.28078816054008704,0.0006307044935982456,0.0008675334065760719,0.0,0.0057113324,False,ADCY2; adenylate cyclase
hsa:4651,0.0,0.0,1.4079740910526318e-07,3.4828572206160333e-07,0.0,2.6183022e-06,False,MYO10; myosin
hsa:948,0.0,0.0,5.6459571674853787e-05,0.00016404973521653169,0.0,0.001019062,False,CD36; CD36
hsa:93978,0.0,0.0,1.2936627174551466e-06,5.443077134440081e-06,0.0,4.6757592e-05,False,CLEC6A; C-type lectin domain containing
hsa:6869,0.0,0.0,3.1701443887719314e-08,1.2059561812075232e-07,0.0,7.6922726e-07,False,TACR1; tachykinin receptor
hsa:407010,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR23A; microRNA
hsa:4297,0.0,0.0,5.049859646017545e-05,0.0001751113896229051,0.0,0.0011653658,False,KMT2A; lysine methyltransferase
hsa:203859,1.1784321e-06,0.0009813424743073756,9.981579901632226e-05,0.00017302735901656734,0.0,0.0012323338,False,ANO5; anoctamin
hsa:8763,3.9420103e-09,3.2827195911815026e-06,1.9965198563970762e-06,5.392235880228727e-06,0.0,2.4712426e-05,False,CD164; CD164
hsa:47,1.5178908e-07,0.00012640276121130798,3.1859025965766065e-05,0.00010317595008772964,0.0,0.0006516642,False,ACLY; ATP citrate
hsa:132660,0.0,0.0,4.3936724759356726e-06,1.4518641561205539e-05,0.0,0.00010093754,False,LIN54; lin-54 DREAM MuvB core complex
hsa:116986,6.886218e-07,0.0005734516405943107,2.2322640335280704e-05,7.156699305906087e-05,0.0,0.0006147586,False,AGAP2; ArfGAP with GTPase domain
hsa:8630,4.3628992e-05,0.036332159452221895,0.00014866048127830413,0.0002396902510734802,0.0,0.0018781831,False,HSD17B6; hydroxysteroid 17-beta dehydrogenase
hsa:728340,7.717395e-07,0.0006426681269550761,3.2297350152514615e-06,5.584171260791664e-06,0.0,2.8699453e-05,False,GTF2H2C; GTF2H2 family member
hsa:3141,0.0,0.0,6.278191135321637e-05,0.00013896001370577706,0.0,0.0009202537,False,HLCS; holocarboxylase
hsa:3290,0.0,0.0,4.580430085497075e-06,3.0395990511820466e-05,0.0,0.00036933296,False,HSD11B1; hydroxysteroid 11-beta dehydrogenase
hsa:10154,4.850782e-08,4.03950164816936e-05,2.900691812692983e-06,7.78653962045785e-06,0.0,5.021853e-05,False,PLXNC1; plexin
hsa:1443,0.0,0.0,1.8736064166023397e-05,5.878476810373654e-05,0.0,0.00053782563,False,CSH2; chorionic somatomammotropin hormone
hsa:8820,0.0,0.0,1.4866834554970765e-07,4.1856179500593035e-07,0.0,4.5461265e-06,False,HESX1; HESX homeobox
hsa:1305,1.1523512e-05,0.009596235352712076,3.3971156598888896e-05,5.4821323158190585e-05,0.0,0.00032535146,False,COL13A1; collagen type XIII alpha 1
hsa:440275,0.0,0.0,1.2475139913450295e-06,2.67214136686812e-06,0.0,1.2907109e-05,False,EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase
hsa:1794,5.306786e-08,4.4192401953916054e-05,7.183270786719302e-07,1.559953845336316e-06,0.0,9.402838e-06,False,DOCK2; dedicator of cytokinesis
hsa:5087,5.5199103e-05,0.045967200246469594,0.00018898500520877205,0.00031407659014689077,0.0,0.0018194321,False,PBX1; PBX homeobox
hsa:2780,0.0,0.0,5.11934976805263e-06,1.638285612362882e-05,0.0,0.00015645438,False,GNAT2; G protein subunit alpha transducin
hsa:2053,0.0,0.0,9.930750167136842e-05,0.000293149715220053,0.0,0.0016266762,False,EPHX2; epoxide hydrolase
hsa:1603,0.0,0.0,5.887510106821638e-05,0.0001976051558643473,0.0,0.0013825326,False,DAD1; defender against cell death
hsa:2193,0.0,0.0,4.0323195004678367e-07,1.2542427487756809e-06,0.0,6.296558e-06,False,FARSA; phenylalanyl-tRNA synthetase subunit
hsa:51362,0.0,0.0,7.385949105760232e-08,1.5520594435306994e-07,0.0,9.344786e-07,False,CDC40; cell division cycle
hsa:347688,3.447558e-08,2.8709631195876178e-05,2.179402835076082e-05,6.335434850694782e-05,0.0,0.00036231847,False,TUBB8; tubulin beta 8 class
hsa:7547,0.0,0.0,3.9377678236666664e-08,2.859621572422739e-07,-0.0,3.0877566e-06,False,ZIC3; Zic family member
hsa:6511,0.0,0.0,6.042160623647952e-06,3.015358728750127e-05,0.0,0.00025992442,False,SLC1A6; solute carrier family 1 member
hsa:23640,8.87008e-08,7.386582777662257e-05,1.3970487399181285e-06,2.9414697178119157e-06,0.0,1.29840055e-05,False,HSPBP1; HSPA (Hsp70) binding protein
hsa:51534,4.48919e-09,3.7383849457562534e-06,4.203710493871346e-07,1.0144031667755315e-06,0.0,9.466192e-06,False,VTA1; vesicle trafficking
hsa:390260,0.0,0.0,1.7811711244444444e-06,9.964500101423042e-06,0.0,9.922335e-05,False,OR6X1; olfactory receptor family 6 subfamily X member
hsa:11200,3.6132367e-06,0.003008932498899357,0.00011908419235386713,0.00023808185420484744,0.0,0.0012601025,False,CHEK2; checkpoint kinase
hsa:65264,0.0,0.0,1.699253023777778e-07,3.8665686663941735e-07,0.0,2.4954134e-06,False,UBE2Z; ubiquitin conjugating enzyme E2
hsa:7515,4.9116334e-08,4.090175813817994e-05,5.1210882734988336e-05,0.00015971179608248353,0.0,0.0008494632,False,XRCC1; X-ray repair cross complementing
hsa:7283,1.1389152e-07,9.484346704356403e-05,1.3770114363308186e-06,2.9854752549095184e-06,0.0,1.5424946e-05,False,TUBG1; tubulin gamma
hsa:10857,0.0,0.0,1.4505236238797664e-05,4.3838796477323984e-05,0.0,0.00032326108,False,PGRMC1; progesterone receptor membrane component
hsa:5476,0.0,0.0,0.0001059425225294737,0.00025658920031144874,0.0,0.0014512308,False,CTSA; cathepsin
hsa:1179,0.0,0.0,4.31657523445614e-07,1.3288099386291226e-06,0.0,9.318711e-06,False,CLCA1; chloride channel accessory
hsa:6191,2.838125e-07,0.00023634561634001828,1.5073720444035085e-06,2.50086449912151e-06,0.0,1.1231689e-05,False,RPS4X; ribosomal protein S4
hsa:102,0.0,0.0,1.1903166042105261e-05,7.433428724548813e-05,0.0,0.00095956825,False,ADAM10; ADAM metallopeptidase domain
hsa:9585,0.0,0.0,5.99572226368421e-08,1.5877131659243045e-07,0.0,1.1414494e-06,False,KIF20B; kinesin family member
hsa:1359,0.0,0.0,0.0,0.0,0.0,0.0,False,CPA3; carboxypeptidase
hsa:10505,5.5037486e-07,0.00045832613258665943,6.874185237161411e-06,2.142662913116166e-05,0.0,0.00015184985,False,SEMA4F; ssemaphorin
hsa:50487,1.7468868e-06,0.0014547246418753304,1.4212191256666663e-05,6.916978539507751e-05,0.0,0.00083000236,False,PLA2G3; phospholipase A2 group
hsa:5081,0.0,0.0,3.3719232721238184e-06,9.863095952184195e-06,0.0,6.727851e-05,False,PAX7; paired box
hsa:5136,0.0,0.0,8.09988370760234e-06,2.8210565674633114e-05,0.0,0.00018565908,False,PDE1A; phosphodiesterase
hsa:644,6.839895e-06,0.005695940804143613,0.000402966372476082,0.0007617764083975442,0.0,0.0049818223,False,BLVRA; biliverdin reductase
hsa:994,0.0,0.0,1.2678797454245607e-05,3.7740486288895905e-05,0.0,0.00018158743,False,CDC25B; cell division cycle
hsa:79178,6.2172676e-06,0.005177446176164989,0.00011205700232581879,0.0003014287634094509,0.0,0.0015315495,False,THTPA; thiamine
hsa:10267,4.8942534e-09,4.075702572463264e-06,0.00018108569639658828,0.00044875522865326777,0.0,0.0031047715,False,RAMP1; receptor activity modifying protein
hsa:2937,0.0,0.0,1.1308418685181284e-05,3.6793623709615115e-05,0.0,0.00038872167,False,GSS; glutathione
hsa:204,1.3488997e-06,0.001123299822866737,2.429316759707602e-05,4.438574541181411e-05,0.0,0.00021582296,False,AK2; adenylate kinase
hsa:8515,0.0,0.0,1.9296972902046784e-05,5.8077555659761306e-05,0.0,0.0004494832,False,ITGA10; integrin subunit alpha
hsa:3872,4.7113767e-06,0.003923411512782212,1.8543241441461993e-05,3.6214054141213976e-05,0.0,0.00031403455,False,KRT17; keratin
hsa:727837,-0.0,0.0,1.259730272522339e-06,6.025778952504256e-06,0.0,5.8917627e-05,False,SSX2B; SSX family member
hsa:6757,0.0,0.0,7.881017700181286e-07,6.035670472284966e-06,0.0,7.309719e-05,False,SSX2; SSX family member
hsa:396,2.1174828e-06,0.0017633394493032817,0.0003365371398754386,0.0008535976080238447,0.0,0.0055361716,False,ARHGDIA; Rho GDP dissociation inhibitor
hsa:139065,0.0,0.0,3.355060428052631e-07,1.748847818115682e-06,0.0,2.0266742e-05,False,SLITRK4; SLIT and NTRK like family member
hsa:29986,0.0,0.0,1.9362656502222223e-09,7.597145826051789e-09,0.0,5.470822e-08,False,SLC39A2; solute carrier family 39 member
hsa:57677,8.490273e-09,7.070297485417365e-06,4.589707878011694e-08,9.657332095284839e-08,0.0,6.9613156e-07,False,ZFP14; ZFP14 zinc finger
hsa:80834,0.0,0.0,1.7188019513450292e-07,8.913750652857162e-07,0.0,7.9782285e-06,False,TAS1R2; taste 1 receptor member
hsa:23380,8.0100826e-08,6.67041764908683e-05,4.939734396688304e-06,1.5132112744555921e-05,0.0,0.00011430113,False,SRGAP2; SLIT-ROBO Rho GTPase activating protein
hsa:53829,0.0,0.0,9.478797643625731e-07,3.2142554395616414e-06,0.0,2.8378094e-05,False,P2RY13; purinergic receptor
hsa:25865,3.6076895e-07,0.00030043130533042494,3.3985401611111117e-06,6.575223897571099e-06,0.0,3.104189e-05,False,PRKD2; protein kinase
hsa:26290,1.7106377e-05,0.014245381071692447,0.00017064308233046197,0.0003993409279678961,0.0,0.0027406178,False,GALNT8; polypeptide N-acetylgalactosaminyltransferase
hsa:1147,0.00012325478,0.10264074678160179,0.0002985150670643275,0.0004285778820144439,0.0,0.0020714113,False,CHUK; component of inhibitor of nuclear factor kappa B kinase
hsa:6520,0.0,0.0,8.680799234152046e-05,0.0001882541986401033,0.0,0.0010897544,False,SLC3A2; solute carrier family 3 member
hsa:100861540,0.0,0.0,5.221588052631579e-06,1.8835005595817356e-05,0.0,0.00017517142,False,CYP3A7-CYP3A51P; CYP3A7-CYP3A51P
hsa:389898,0.0,0.0,4.808792687134503e-10,2.567629155221632e-09,0.0,2.1254397e-08,False,UBE2NL; ubiquitin conjugating enzyme E2 N like
hsa:7068,0.0,0.0,5.9278615891228047e-08,2.5420696726579656e-07,0.0,2.4596618e-06,False,THRB; thyroid hormone receptor
hsa:57459,0.0,0.0,7.440592844298251e-07,2.116973177672666e-06,0.0,1.1433929e-05,False,GATAD2B; GATA zinc finger domain containing
hsa:2248,0.0,0.0,3.6639323141812865e-06,2.3704521168895077e-05,0.0,0.000294745,False,FGF3; fibroblast growth factor
hsa:348995,0.0,0.0,1.1929253539766078e-07,3.272336873852202e-07,0.0,1.7097581e-06,False,NUP43; nucleoporin
hsa:3569,0.0,0.0,1.8523744783625732e-05,0.0001444843606638613,0.0,0.0017474066,False,IL6; interleukin
hsa:2186,2.2439627e-08,1.8686659233667e-05,3.158957354327486e-07,6.171080010493067e-07,0.0,2.7830165e-06,False,BPTF; bromodomain PHD finger transcription
hsa:51074,5.354928e-07,0.00044593305742926103,2.1394853197959063e-05,5.26222067544054e-05,0.0,0.00038751384,False,APIP; APAF1 interacting
hsa:2719,7.093134e-08,5.9068262568151125e-05,3.561167578158363e-07,6.737259673434979e-07,0.0,3.0843878e-06,False,GPC3; glypican
hsa:4205,5.941251e-07,0.0004947592616342655,1.3874780719590645e-05,3.526828125738873e-05,0.0,0.00030006512,False,MEF2A; myocyte enhancer factor
hsa:10850,0.00017466185,0.1454501214334739,0.00037867015523311993,0.0006075177669687694,0.0,0.0038226806,False,CCL27; C-C motif chemokine ligand
hsa:80329,5.628885e-08,4.687468996721722e-05,2.0490027764593923e-05,0.00010726555932354581,0.0,0.0012299324,False,ULBP1; UL16 binding protein
hsa:608,1.4081722e-06,0.0011726591553292386,2.694186527991871e-05,5.532303747064385e-05,0.0,0.00029836435,False,TNFRSF17; TNF receptor superfamily member
hsa:8692,0.0,0.0,7.119622477192982e-06,1.4988723937478311e-05,0.0,8.114312e-05,False,HYAL2; hyaluronidase
hsa:6540,2.2981549e-06,0.0019137946224543777,1.4936927015204677e-05,3.0962748019824324e-05,0.0,0.0002467549,False,SLC6A13; solute carrier family 6 member
hsa:100529215,0.0,0.0,2.2596442702923967e-08,5.2010349149136247e-08,0.0,2.584662e-07,False,ZNF559-ZNF177; ZNF559-ZNF177
hsa:22872,0.0,0.0,5.275131295807017e-07,1.98741471012145e-06,0.0,1.4237678e-05,False,SEC31A; SEC31 homolog A
hsa:7433,0.0,0.0,2.0378310562195905e-06,4.603066216422665e-06,0.0,2.870554e-05,False,VIPR1; vasoactive intestinal peptide receptor
hsa:405,0.0,0.0,3.057774878391813e-05,7.00863766508806e-05,0.0,0.00057935907,False,ARNT; aryl hydrocarbon receptor nuclear
hsa:26648,0.0,0.0,3.691636989842105e-06,1.9347108830149533e-05,0.0,0.00021296868,False,OR7E24; olfactory receptor family 7 subfamily E member
hsa:81318,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4A5; olfactory receptor family 4 subfamily A member
hsa:6659,0.0,0.0,2.171315506713451e-07,5.603038264989727e-07,0.0,3.0023705e-06,False,SOX4; SRY-box transcription factor
hsa:23365,2.1496799e-06,0.0017901516702021538,2.952781674263156e-05,8.130194217865003e-05,0.0,0.0007560249,False,ARHGEF12; Rho guanine nucleotide exchange factor
hsa:10947,1.11389106e-07,9.275957511079896e-05,2.279178504011696e-06,5.781302218409706e-06,0.0,5.202202e-05,False,AP3M2; adaptor related protein complex 3 subunit mu
hsa:342926,1.750506e-08,1.4577385403282096e-05,1.277499569122807e-07,2.239729001151048e-07,0.0,1.1052301e-06,False,ZNF677; zinc finger protein
hsa:51626,0.0,0.0,9.293118710249708e-05,0.00019354713412386243,0.0,0.0010010448,False,DYNC2LI1; dynein cytoplasmic 2 light intermediate chain
hsa:5333,0.0,0.0,4.274063314152047e-06,6.5681079453748224e-06,0.0,4.3382148e-05,False,PLCD1; phospholipase C delta
hsa:3934,2.5356215e-07,0.00021115455669588255,1.6368068411549703e-05,6.989139187410988e-05,0.0,0.00053549197,False,LCN2; lipocalin
hsa:11036,2.4764054e-08,2.06223320174675e-05,1.2744964711345025e-07,5.494282200796308e-07,0.0,6.882915e-06,False,GTF2A1L; general transcription factor IIA subunit 1
hsa:8521,0.0,0.0,1.443739193816959e-07,4.569601145381002e-07,0.0,2.8548084e-06,False,GCM1; glial cells missing transcription factor
hsa:51619,0.0,0.0,6.669591357134502e-05,0.00023179685652884095,0.0,0.001551278,False,UBE2D4; ubiquitin conjugating enzyme E2 D4
hsa:343169,0.0,0.0,7.046522259824561e-07,4.539186304444003e-06,0.0,3.4799035e-05,False,OR6F1; olfactory receptor family 6 subfamily F member
hsa:26227,2.0327177e-06,0.001692751086198685,2.6839961268421062e-05,5.7835152431563666e-05,0.0,0.00045457762,False,PHGDH; phosphoglycerate
hsa:60401,1.5726605e-06,0.0013096372258660253,2.5881197400826898e-05,4.7038329229458365e-05,0.0,0.00022994299,False,EDA2R; ectodysplasin A2
hsa:3574,0.00038800843,0.323115054951677,0.000527171424783626,0.0005662289074650217,0.0,0.003098415,False,IL7; interleukin
hsa:84109,0.0,0.0,8.036131346069596e-07,6.083926344600551e-06,0.0,7.7213124e-05,False,QRFPR; pyroglutamylated RFamide peptide
hsa:4225,6.632607e-07,0.0005523321169279435,4.079944433908772e-06,8.650794926104534e-06,0.0,6.5284745e-05,False,MEP1B; meprin A subunit
hsa:344807,0.0,0.0,2.684431514619883e-11,2.0920607128957924e-10,0.0,2.2457003e-09,False,CD200R1L; CD200 receptor 1
hsa:133,0.0,0.0,1.3446111716432745e-05,5.1279070941507275e-05,0.0,0.0004721969,False,ADM;
hsa:1813,0.00016648317,0.1386393038498658,0.000627988127325731,0.001249784458952581,0.0,0.007959142,False,DRD2; dopamine receptor
hsa:3758,0.0,0.0,5.535373467859648e-07,2.1047674684098368e-06,0.0,1.8041792e-05,False,KCNJ1; potassium inwardly rectifying channel subfamily J member
hsa:2565,0.0,0.0,4.837930649122806e-05,0.00018996050640760886,0.0,0.0017108251,False,GABRG1; gamma-aminobutyric acid type A receptor subunit
hsa:5053,2.247997e-06,0.0018720254974517053,2.4166530859473685e-05,6.0341564446221795e-05,0.0,0.00042218092,False,PAH; phenylalanine
hsa:30835,0.0,0.0,3.753526292105263e-05,0.00010794111166172671,0.0,0.00097528496,False,CD209; CD209
hsa:124538,0.0,0.0,3.839507159649123e-07,2.501399509149428e-06,0.0,2.1750195e-05,False,OR4D2; olfactory receptor family 4 subfamily D member
hsa:11222,1.6959023e-08,1.4122671635180077e-05,3.4049245451660826e-07,6.860977865676216e-07,0.0,3.4376524e-06,False,MRPL3; mitochondrial ribosomal protein
hsa:2175,0.0,0.0,9.237794171426905e-06,3.085229631869227e-05,0.0,0.00019958535,False,FANCA; FA complementation group
hsa:6583,0.0,0.0,3.8647780396023385e-07,1.1043511639703816e-06,0.0,5.624924e-06,False,SLC22A4; solute carrier family 22 member
hsa:10000,0.0010704851,0.8914493221486232,0.001267479936491228,0.0011778300090809109,0.0,0.0046756025,True,AKT3; AKT serine/threonine kinase
hsa:91975,8.50935e-09,7.086183908048216e-06,1.0098948713099413e-07,1.8201859745304765e-07,0.0,1.0436781e-06,False,ZNF300; zinc finger protein
hsa:4598,1.2485305e-06,0.001039717103868967,0.0002853062744591814,0.0008252453722436171,0.0,0.00433107,False,MVK; mevalonate
hsa:1435,0.0,0.0,3.566621914619883e-06,1.3915155889781642e-05,0.0,8.728986e-05,False,CSF1; colony stimulating factor
hsa:7405,0.0,0.0,1.62935945545614e-07,4.854607563622193e-07,0.0,2.6920527e-06,False,UVRAG; UV radiation resistance
hsa:6688,0.0,0.0,2.258310553450292e-05,7.410081018265267e-05,0.0,0.00062492426,False,SPI1; Spi-1
hsa:23435,0.0,0.0,1.2017771267415207e-06,3.689811120984689e-06,0.0,1.7617122e-05,False,TARDBP; TAR DNA binding
hsa:2741,0.0,0.0,2.343158289241035e-06,1.0161572439345174e-05,0.0,8.016676e-05,False,GLRA1; glycine receptor alpha
hsa:664,0.0,0.0,5.982605530377192e-05,0.00010425059606356995,0.0,0.0006463627,False,BNIP3; BCL2 interacting protein
hsa:6452,2.1074225e-09,1.7549617076461475e-06,4.941247631621287e-05,0.00016498096828520945,0.0,0.0009603069,False,SH3BP2; SH3 domain binding protein
hsa:55276,0.0,0.0,3.279076335467836e-05,8.616433471499027e-05,0.0,0.00038270862,False,PGM2; phosphoglucomutase
hsa:286075,2.1106992e-08,1.757690388310534e-05,1.849178611795321e-07,3.8414325934598656e-07,0.0,1.951956e-06,False,ZNF707; zinc finger protein
hsa:3712,4.7729634e-07,0.0003974698001466987,2.637638255023393e-06,5.128321798284069e-06,0.0,3.3032193e-05,False,IVD; isovaleryl-CoA
hsa:1000,1.3304756e-05,0.011079571044522549,6.510537456656142e-05,0.00012305173625794466,0.0,0.0007430064,False,CDH2; cadherin
hsa:55052,4.4038504e-08,3.66731816624439e-05,1.3464627486081874e-07,1.876559770961089e-07,0.0,8.2783964e-07,False,MRPL20; mitochondrial ribosomal protein
hsa:5297,0.0,0.0,4.60688068364503e-05,0.00014128132324095998,0.0,0.0010223242,False,PI4KA; phosphatidylinositol 4-kinase
hsa:10564,0.0,0.0,1.0713914286578944e-06,2.5424211712702804e-06,0.0,1.2892725e-05,False,ARFGEF2; ADP ribosylation factor guanine nucleotide exchange factor
hsa:1201,0.0,0.0,1.6146353942047368e-06,4.028113234230793e-06,0.0,1.8906352e-05,False,CLN3; CLN3 lysosomal/endosomal transmembrane protein
hsa:8140,0.0,0.0,2.087263910350877e-06,5.009909071990469e-06,0.0,3.2950422e-05,False,SLC7A5; solute carrier family 7 member
hsa:10813,8.413514e-08,7.006376223441083e-05,1.1814494068577076e-06,2.375307487961631e-06,0.0,1.2062352e-05,False,UTP14A; UTP14A small subunit processome
hsa:10313,0.0,0.0,2.38782246994152e-09,7.764275548434797e-09,0.0,4.5730285e-08,False,RTN3; reticulon
hsa:127623,0.0,0.0,2.6209300967836264e-07,1.2839920259245147e-06,0.0,1.1494628e-05,False,OR2B11; olfactory receptor family 2 subfamily B member
hsa:9135,0.0,0.0,4.6019947840818715e-07,1.1010639760883937e-06,0.0,5.7821603e-06,False,RABEP1; rabaptin
hsa:256471,0.0,0.0,6.805947149730996e-07,1.3893268386554198e-06,0.0,6.8778577e-06,False,MFSD8; major facilitator superfamily domain containing
hsa:140,0.0,0.0,9.637267819883038e-08,3.2646299982860866e-07,0.0,2.9760247e-06,False,ADORA3; adenosine A3
hsa:3553,0.0,0.0,1.8439771426900584e-05,7.098284619422838e-05,0.0,0.0004942938,False,IL1B; interleukin 1
hsa:5321,0.0,0.0,5.79285521871345e-05,0.00020589568441968102,0.0,0.0015882235,False,PLA2G4A; phospholipase A2 group
hsa:10910,0.0,0.0,5.038186809298245e-07,9.571704860858184e-07,0.0,4.3214036e-06,False,SUGT1; SGT1 homolog
hsa:79077,0.0,0.0,9.911033903707893e-05,0.000303659956096671,0.0,0.0018431465,False,DCTPP1; dCTP pyrophosphatase
hsa:2118,0.0,0.0,5.228349203833917e-07,1.8377736399711578e-06,0.0,1.4495051e-05,False,ETV4; ETS variant transcription factor
hsa:403274,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5H15; olfactory receptor family 5 subfamily H member
hsa:6993,1.05559025e-07,8.79045596084612e-05,2.4793822419883045e-07,4.6911612362179283e-07,0.0,2.8420661e-06,False,DYNLT1; dynein light chain Tctex-type
hsa:1763,7.0149156e-08,5.84168967559642e-05,3.153628331968304e-06,1.5201295229068794e-05,0.0,0.00018884795,False,DNA2; DNA replication helicase/nuclease
hsa:2696,0.0,0.0,4.5746759562941524e-07,1.3675685160142858e-06,0.0,8.413525e-06,False,GIPR; gastric inhibitory polypeptide
hsa:406982,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR20A; microRNA
hsa:81858,0.0,0.0,1.1768960781637426e-06,2.5246340647187738e-06,0.0,1.8204462e-05,False,SHARPIN; SHANK associated RH domain
hsa:2832,0.0,0.0,1.1702926915587426e-06,3.3598133878897424e-06,0.0,2.233329e-05,False,NPBWR2; neuropeptides B and W receptor
hsa:778,0.00019038396,0.15854275046889543,0.0003157286121304094,0.0003393776157234272,0.0,0.0015556378,False,CACNA1F; calcium voltage-gated channel subunit alpha1
hsa:7253,1.735264e-05,0.014450457241758042,5.908583949818713e-05,0.00012696946025860743,0.0,0.001066202,False,TSHR; thyroid stimulating hormone
hsa:5962,0.0,0.0,1.7646890088596492e-06,5.891080250071821e-06,0.0,5.0444025e-05,False,RDX;
hsa:81099,-0.0,0.0,2.9297676988304095e-07,3.403062542267563e-06,0.0,4.421392e-05,False,OR4F17; olfactory receptor family 4 subfamily F member
hsa:8900,3.3186084e-06,0.002763579996262187,4.344591357403508e-05,7.828966299862836e-05,0.0,0.0003629337,False,CCNA1; cyclin
hsa:113026,0.0,0.0,1.2589302453216375e-06,3.38697032680541e-06,0.0,1.9973744e-05,False,PLCD3; phospholipase C delta
hsa:118429,0.0,0.0,3.3399370446959076e-07,7.933095859638026e-07,0.0,4.6112855e-06,False,ANTXR2; ANTXR cell adhesion molecule
hsa:403257,0.0,0.0,2.5998730994152046e-09,3.399775231914233e-08,0.0,4.445783e-07,False,OR4C45; olfactory receptor family 4 subfamily C member 45
hsa:26524,0.0,0.0,3.6930940368421056e-06,1.1879326645418133e-05,0.0,8.844473e-05,False,LATS2; large tumor suppressor kinase
hsa:54738,1.343762e-07,0.00011190213894888196,2.1444865230862577e-05,6.531696712799928e-05,0.0,0.0006746133,False,FEV; FEV transcription factor
hsa:51172,7.243869e-08,6.032351230095052e-05,1.6886263536900591e-06,2.962606523259857e-06,0.0,1.5629508e-05,False,NAGPA; N-acetylglucosamine-1-phosphodiester
hsa:3419,0.0,0.0,1.29832450251462e-06,3.411959929073759e-06,0.0,3.066472e-05,False,IDH3A; isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit
hsa:155,1.4200059e-06,0.0011825137005662622,9.08768161283041e-06,3.596811011555802e-05,0.0,0.00034254135,False,ADRB3; adrenoceptor beta
hsa:341640,0.0,0.0,1.9540175250292397e-08,7.493619073496789e-08,0.0,7.119774e-07,False,FREM2; FRAS1 related extracellular matrix
hsa:2194,0.0,0.0,4.074788676935672e-05,0.0001799542524330321,0.0,0.0022414126,False,FASN; fatty acid
hsa:6237,0.0,0.0,4.795532415789473e-06,1.0338467409187015e-05,0.0,6.0670292e-05,False,RRAS; RAS
hsa:730051,0.0,0.0,7.939444364210527e-08,1.8866781393990163e-07,0.0,9.649249e-07,False,ZNF814; zinc finger protein
hsa:56896,1.2626022e-07,0.00010514353495750293,1.8923041698163163e-05,6.870918719071664e-05,0.0,0.0005955588,False,DPYSL5; dihydropyrimidinase like
hsa:9092,0.0,0.0,1.2655811862035086e-07,3.3819621319683725e-07,0.0,2.1938495e-06,False,SART1; spliceosome associated factor 1
hsa:26050,2.753827e-07,0.00022932567790664033,4.82751732743158e-06,1.1972114912965799e-05,0.0,8.812025e-05,False,SLITRK5; SLIT and NTRK like family member
hsa:2998,4.960974e-06,0.004131264330065821,2.8386478634701753e-05,0.00010988315215115728,0.0,0.0013698048,False,GYS2; glycogen synthase
hsa:55072,0.0,0.0,3.504808893099416e-07,6.178157889784969e-07,0.0,2.5350496e-06,False,RNF31; ring finger protein
hsa:5023,0.0,0.0,7.177480419836257e-07,2.253632632911547e-06,0.0,1.6465336e-05,False,P2RX1; purinergic receptor P2X
hsa:9378,0.0,0.0,6.7862395614885984e-06,1.4880346833472942e-05,0.0,7.215411e-05,False,NRXN1; neurexin
hsa:3211,0.0,0.0,2.342142475196492e-07,1.910476950887167e-06,0.0,2.376045e-05,False,HOXB1; homeobox
hsa:10424,0.0,0.0,2.035726543532164e-05,4.1595727768096286e-05,0.0,0.0003009494,False,PGRMC2; progesterone receptor membrane component
hsa:8773,4.3112135e-07,0.00035901745406946746,2.519949136438012e-05,4.758055789499284e-05,0.0,0.0002977051,False,SNAP23; synaptosome associated protein
hsa:3768,8.4942525e-07,0.0007073611424656211,1.0412224389304092e-05,3.076474432027e-05,0.0,0.00016199092,False,KCNJ12; potassium inwardly rectifying channel subfamily J member
hsa:9343,0.0,0.0,1.3427735019105268e-07,2.66145776597517e-07,0.0,1.6103221e-06,False,EFTUD2; elongation factor Tu GTP binding domain containing
hsa:8675,4.7842796e-08,3.984121597198771e-05,1.0451704037736839e-05,3.388398069476889e-05,0.0,0.00033408424,False,STX16; syntaxin
hsa:9564,0.0,0.0,5.84959508374269e-05,0.0001345514956726486,0.0,0.0012014282,False,BCAR1; BCAR1 scaffold protein
hsa:6416,1.42615845e-05,0.011876372529884171,0.00020218043305672526,0.0003817470914188868,0.0,0.0017100021,False,MAP2K4; mitogen-activated protein kinase kinase
hsa:148103,0.0,0.0,9.008709179964913e-08,1.741652167559965e-07,0.0,7.7436664e-07,False,ZNF599; zinc finger protein
hsa:7494,0.0,0.0,1.6258163502339187e-06,2.971691481684059e-06,0.0,1.9599005e-05,False,XBP1; X-box binding protein
hsa:493869,0.0,0.0,9.526418085380115e-07,3.635815771166769e-06,0.0,3.17486e-05,False,GPX8; glutathione peroxidase 8
hsa:8701,0.0,0.0,3.3567358071812856e-09,1.0249487853195474e-08,0.0,7.406495e-08,False,DNAH11; dynein axonemal heavy chain
hsa:23299,6.482413e-07,0.0005398246715192413,1.8483429309497076e-05,4.936567615499692e-05,0.0,0.0003153226,False,BICD2; BICD cargo adaptor
hsa:9716,3.8635367e-08,3.217370491482159e-05,2.5346646701578933e-07,4.5591891022417424e-07,0.0,3.348595e-06,False,AQR; aquarius intron-binding spliceosomal
hsa:388558,1.7904778e-08,1.4910251633882225e-05,7.441816668654968e-08,1.5404850891209905e-07,0.0,8.1551224e-07,False,ZNF808; zinc finger protein
hsa:90639,0.0,0.0,7.586523437660818e-07,2.1756092846745937e-06,0.0,1.0279406e-05,False,COX19; cytochrome c oxidase assembly factor
hsa:7920,7.1576274e-06,0.005960533307677437,0.00010136110936549708,0.00020296866913225965,0.0,0.0013334863,False,ABHD16A; abhydrolase domain containing 16A
hsa:4214,1.0069339e-05,0.008385268908492696,0.00012527463621526315,0.0002569071407405786,0.0,0.0016123863,False,MAP3K1; mitogen-activated protein kinase kinase kinase
hsa:8705,0.0,0.0,1.4952613917836257e-05,5.250498675534793e-05,0.0,0.00055405597,False,B3GALT4; beta-1
hsa:9582,0.0,0.0,3.842957430721637e-06,2.366184630250344e-05,0.0,0.0002975926,False,APOBEC3B; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:51009,0.0,0.0,6.234570378187135e-08,1.2297362895989437e-07,0.0,5.904989e-07,False,DERL2; derlin
hsa:2901,3.6624456e-08,3.049911341620922e-05,5.669660528611697e-05,0.00011976224594052158,0.0,0.00056416617,False,GRIK5; glutamate ionotropic receptor kainate type subunit
hsa:6445,3.5068184e-05,0.029203123757428468,8.838870007612283e-05,0.00014540035396487684,0.0,0.0011705124,False,SGCG; sarcoglycan
hsa:2747,0.0,0.0,7.237464164187134e-05,0.00021697480065651368,0.0,0.0024476126,False,GLUD2; glutamate dehydrogenase
hsa:2946,0.0004925559,0.41017723943593887,0.0007962087572339177,0.0009515752827954554,0.0,0.0045147403,False,GSTM2; glutathione S-transferase mu
hsa:7168,0.0,0.0,0.0004306350104385964,0.0008694069791608174,0.0,0.0050382605,False,TPM1; tropomyosin
hsa:79065,0.0,0.0,5.52506075409357e-05,0.0001330306476872691,0.0,0.0006706431,False,ATG9A; autophagy related
hsa:9610,0.0,0.0,6.196005104795323e-07,1.3125767805784161e-06,0.0,7.45893e-06,False,RIN1; Ras and Rab interactor
hsa:5170,0.0003839307,0.31971931441833834,0.0007310937566900585,0.0008837269678600097,0.0,0.0064333864,False,PDPK1; 3-phosphoinositide dependent protein kinase
hsa:23708,0.0,0.0,4.262801605789474e-09,3.144515324534841e-08,0.0,3.911209e-07,False,GSPT2; G1 to S phase transition
hsa:55593,0.0,0.0,1.6699904277192985e-06,6.246715632356581e-06,0.0,5.4759104e-05,False,OTUD5; OTU deubiquitinase
hsa:6441,0.0,0.0,4.115543598847953e-08,9.680172767048375e-08,0.0,4.699759e-07,False,SFTPD; surfactant protein
hsa:10569,0.0,0.0,3.912288549923977e-07,9.396599599226316e-07,0.0,5.3353892e-06,False,SLU7; SLU7 homolog
hsa:10411,0.0,0.0,4.053063864286549e-05,0.00014789361605422265,0.0,0.0010230729,False,RAPGEF3; Rap guanine nucleotide exchange factor
hsa:168620,3.7038153e-05,0.030843620696343173,0.00011670032428421053,0.00017142412945038462,0.0,0.0010668735,False,BHLHA15; basic helix-loop-helix family member
hsa:341947,0.0,0.0,1.7885197320507602e-05,3.980744269758637e-05,0.0,0.00019624284,False,COX8C; cytochrome c oxidase subunit
hsa:6337,0.0,0.0,3.2590106448538013e-07,1.7927081431427536e-06,0.0,1.9851006e-05,False,SCNN1A; sodium channel epithelial 1 subunit
hsa:6480,0.0,0.0,8.601829088128653e-05,0.0002411409949543204,0.0,0.0023706004,False,ST6GAL1; ST6 beta-galactoside alpha-2
hsa:57461,8.3190855e-08,6.927740638212936e-05,2.855280937426901e-07,4.131175122286493e-07,0.0,1.7971714e-06,False,ISY1; ISY1 splicing factor
hsa:10347,7.148743e-05,0.05953134799881581,0.00036778571317356727,0.0007849889390655055,0.0,0.0059468024,False,ABCA7; ATP binding cassette subfamily A member
hsa:64965,1.7555138e-07,0.00014619087991346667,3.796264541964912e-07,5.009130140243619e-07,0.0,2.113463e-06,False,MRPS9; mitochondrial ribosomal protein
hsa:390892,0.0,0.0,4.34246081871345e-08,5.678504362517044e-07,0.0,7.425608e-06,False,OR7A10; olfactory receptor family 7 subfamily A member
hsa:26471,0.0,0.0,4.6818173516432746e-07,1.3758075892739109e-06,0.0,9.695236e-06,False,NUPR1; nuclear protein 1
hsa:4137,1.1576875e-08,9.64067353328817e-06,5.928232427614032e-07,1.6561781999154757e-06,0.0,1.2427353e-05,False,MAPT; microtubule associated protein
hsa:5499,0.0,0.0,0.000264867252877193,0.000678739748460763,0.0,0.0038278757,False,PPP1CA; protein phosphatase 1 catalytic subunit
hsa:79861,0.0,0.0,2.1968741799415207e-08,7.474539870437313e-08,0.0,5.546444e-07,False,TUBAL3; tubulin alpha like
hsa:390063,-0.0,0.0,2.6400675093567257e-07,2.050933503565737e-06,0.0,2.5050416e-05,False,OR51I1; olfactory receptor family 51 subfamily I member
hsa:27141,0.0,0.0,4.183259498070175e-06,1.1032135849857748e-05,0.0,9.725664e-05,False,CIDEB; cell death inducing DFFA like effector
hsa:1454,0.0006095694,0.5076205436512315,0.0021611291160426897,0.0028768758086202178,0.0,0.01297749,True,CSNK1E; casein kinase 1
hsa:10617,3.002737e-07,0.0002500537245441894,1.9901266690694735e-06,4.6582120052348475e-06,0.0,2.7767073e-05,False,STAMBP; STAM binding
hsa:4215,2.2199613e-06,0.0018486786935018305,5.069368280350877e-05,0.00013025003454061553,0.0,0.0012194429,False,MAP3K3; mitogen-activated protein kinase kinase kinase
hsa:9252,3.440377e-05,0.028649831226849522,0.00011083133005403508,0.0001818445182228949,0.0,0.0009465651,False,RPS6KA5; ribosomal protein S6 kinase
hsa:6340,0.0,0.0,5.109603826666665e-06,2.7162722596513233e-05,0.0,0.0003047767,False,SCNN1G; sodium channel epithelial 1 subunit
hsa:8405,3.6030466e-05,0.03000446665946029,0.00027877491109638597,0.0005762038090601624,0.0,0.0040607443,False,SPOP; speckle type BTB/POZ
hsa:1326,0.0,0.0,9.946420944673686e-06,3.1852673637450535e-05,0.0,0.00017395407,False,MAP3K8; mitogen-activated protein kinase kinase kinase
hsa:3101,0.00022678378,0.18885479765697108,0.0004611719863596491,0.0005748426833480048,0.0,0.0025915601,False,HK3; hexokinase
hsa:3613,0.0,0.0,6.804822768829828e-05,0.0002350146875878867,0.0,0.0013433909,False,IMPA2; inositol monophosphatase
hsa:5322,0.0,0.0,3.978516526315788e-06,1.7808262843347645e-05,0.0,0.00014489894,False,PLA2G5; phospholipase A2 group
hsa:50944,0.0,0.0,2.1689585086520477e-05,4.3599519889384446e-05,0.0,0.00023162887,False,SHANK1; SH3 and multiple ankyrin repeat domains
hsa:5923,1.3276868e-08,1.1056347238141609e-05,1.3140902989122806e-07,5.799841147397236e-07,0.0,7.2325033e-06,False,RASGRF1; Ras protein specific guanine nucleotide releasing factor
hsa:2203,0.0,0.0,0.00013050522718362578,0.00038249991673329253,0.0,0.0023242075,False,FBP1; fructose-bisphosphatase
hsa:3291,0.00010840726,0.09027643490132609,0.00031569659479821043,0.0004584832839560813,0.0,0.0026114455,False,HSD11B2; hydroxysteroid 11-beta dehydrogenase
hsa:6402,0.0,0.0,3.2239346078707605e-06,1.0143686388921375e-05,0.0,5.331128e-05,False,SELL; selectin
hsa:84539,0.0,0.0,2.9218972320836256e-07,1.6795236918379894e-06,-0.0,1.8717272e-05,False,MCHR2; melanin concentrating hormone receptor
hsa:482,0.0,0.0,0.0,0.0,0.0,0.0,False,ATP1B2; ATPase Na+/K+ transporting subunit beta
hsa:392392,0.0,0.0,1.1699380245847949e-05,3.0566852433679374e-05,0.0,0.00020026373,False,OR1K1; olfactory receptor family 1 subfamily K member
hsa:8714,0.0,0.0,6.415856306900585e-05,0.00015986328653343394,0.0,0.0014762337,False,ABCC3; ATP binding cassette subfamily C member
hsa:2737,0.0,0.0,9.487608877192984e-07,4.343094130125532e-06,0.0,4.847224e-05,False,GLI3; GLI family zinc finger
hsa:926,3.2560092e-05,0.027114503455019413,7.576990740350879e-05,0.00010502252670050537,0.0,0.0005859996,False,CD8B; CD8 subunit
hsa:2650,0.0,0.0,1.3693047443485381e-05,4.264663261606638e-05,0.0,0.0003427568,False,GCNT1; glucosaminyl (N-acetyl) transferase
hsa:407035,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR31; microRNA
hsa:7097,0.0,0.0,1.072461335614035e-05,2.8930025386078567e-05,0.0,0.00018213136,False,TLR2; toll like receptor
hsa:55844,2.4107392e-05,0.020075494985564154,5.8885772638888845e-05,0.00011544162669038913,0.0,0.00077072834,False,PPP2R2D; protein phosphatase 2 regulatory subunit
hsa:6168,0.0,0.0,4.753455663918126e-07,8.162241602711404e-07,0.0,5.401086e-06,False,RPL37A; ribosomal protein
hsa:533,6.1405253e-06,0.005113538821158249,0.00017155990479216372,0.000426647423594772,0.0,0.0021622472,False,ATP6V0B; ATPase H+ transporting V0 subunit
hsa:135946,0.0,0.0,8.028599469005849e-07,4.250827548520418e-06,0.0,3.6991336e-05,False,OR6B1; olfactory receptor family 6 subfamily B member
hsa:51447,0.0,0.0,5.466199639937135e-05,0.0001744422083044032,0.0,0.00087393663,False,IP6K2; inositol hexakisphosphate kinase
hsa:8424,0.0,0.0,1.3804338199357605e-07,7.12227469961662e-07,0.0,7.805184e-06,False,BBOX1; gamma-butyrobetaine hydroxylase
hsa:1616,1.4370918e-06,0.00119674202936159,3.284251231736841e-06,5.569795916696551e-06,0.0,3.5179793e-05,False,DAXX; death domain associated
hsa:84957,0.0,0.0,1.1099350610526312e-06,3.1479402889615382e-06,0.0,3.136421e-05,False,RELT; RELT TNF
hsa:6370,1.6940587e-05,0.014107319007008857,6.037782573584795e-05,0.00010407240959831707,0.0,0.00057876704,False,CCL25; C-C motif chemokine ligand
hsa:51378,0.0,0.0,9.423652173216376e-08,2.720171672291017e-07,0.0,2.4913152e-06,False,ANGPT4; angiopoietin
hsa:200909,0.0,0.0,1.1749902555555557e-07,1.1242361658177141e-06,0.0,1.4316775e-05,False,HTR3D; 5-hydroxytryptamine receptor
hsa:4713,1.8754137e-06,0.001561755760648365,3.8073489505847952e-06,5.528436199005628e-06,0.0,2.9234405e-05,False,NDUFB7; NADH:ubiquinone oxidoreductase subunit
hsa:79947,0.0,0.0,0.00011581926535548063,0.0004111566124190514,0.0,0.0025140005,False,DHDDS; dehydrodolichyl diphosphate synthase
hsa:3897,3.5995042e-06,0.002997496722897985,3.874919971087719e-05,6.765174917793034e-05,0.0,0.00046983303,False,L1CAM; L1 cell adhesion
hsa:4916,1.39400245e-05,0.01160859258224164,5.398270267456136e-05,0.00012282528727162385,0.0,0.0010189413,False,NTRK3; neurotrophic receptor tyrosine kinase
hsa:3912,0.0,0.0,5.00821396140351e-06,2.332151005915106e-05,0.0,0.00026282558,False,LAMB1; laminin subunit beta
hsa:23553,0.0,0.0,1.0714986648613451e-06,4.428608515028915e-06,0.0,3.7691636e-05,False,HYAL4; hyaluronidase
hsa:604,0.0,0.0,1.8925093812573101e-06,4.729285513154887e-06,0.0,4.4313703e-05,False,BCL6; BCL6 transcription
hsa:26246,-0.0,0.0,8.476007477134505e-05,0.00022044346723444093,0.0,0.0012938192,False,OR2L2; olfactory receptor family 2 subfamily L member
hsa:2321,0.0,0.0,3.684802003309941e-06,1.1398310993768566e-05,0.0,7.6864904e-05,False,FLT1; fms related receptor tyrosine kinase
hsa:6263,0.0,0.0,1.771658489953216e-05,4.8281009639696573e-05,0.0,0.0003934445,False,RYR3; ryanodine receptor
hsa:79643,0.0,0.0,7.802882621342108e-05,0.00018803270365393674,0.0,0.0010283177,False,CHMP6; charged multivesicular body protein
hsa:80174,0.0,0.0,3.1562655535929817e-07,9.543138710939437e-07,0.0,4.3906684e-06,False,DBF4B; DBF4 zinc finger
hsa:1657,1.7289512e-08,1.439788723138742e-05,1.217276233205848e-06,2.1724755044436407e-06,0.0,1.0210821e-05,False,DMXL1; Dmx like
hsa:7306,0.0,0.0,1.3991697000222223e-05,6.398250367360617e-05,0.0,0.0007594574,False,TYRP1; tyrosinase related protein
hsa:2905,0.0,0.0,5.914106030760233e-06,1.9197841025582865e-05,0.0,0.00016773446,False,GRIN2C; glutamate ionotropic receptor NMDA type subunit
hsa:3029,1.5862884e-08,1.3209858959384153e-05,3.275433329397659e-06,6.594891704910491e-06,0.0,3.390311e-05,False,HAGH; hydroxyacylglutathione
hsa:51102,0.0,0.0,9.39369222866959e-05,0.00018590020898837136,0.0,0.00096013217,False,MECR; mitochondrial trans-2-enoyl-CoA
hsa:2911,4.9736565e-05,0.04141825715766705,0.00021264757124268998,0.000514851751408109,0.0,0.0046701604,False,GRM1; glutamate metabotropic receptor
hsa:4018,0.0,0.0,1.5626315453567254e-06,6.870778190457233e-06,0.0,4.5784764e-05,False,LPA;
hsa:392391,0.0,0.0,2.970148545847953e-07,1.3367059272778463e-06,0.0,1.0128419e-05,False,OR5C1; olfactory receptor family 5 subfamily C member
hsa:820,9.0914654e-08,7.570942059976044e-05,1.8502171134461986e-05,5.690215539540714e-05,0.0,0.00049108407,False,CAMP; cathelicidin antimicrobial
hsa:192111,2.5669829e-06,0.0021376618564537767,0.0001825278833078539,0.0006182472880011803,0.0,0.004313317,False,PGAM5; PGAM family member 5
hsa:3481,0.0,0.0,8.467855512748537e-07,2.6174814684158687e-06,0.0,1.8896511e-05,False,IGF2; insulin like growth factor
hsa:255725,0.0,0.0,1.0973652139064328e-06,6.31241882563611e-06,0.0,6.620162e-05,False,OR52B2; olfactory receptor family 52 subfamily B member
hsa:131890,0.0,0.0,6.666455588025733e-06,1.3982143904660853e-05,0.0,9.5401054e-05,False,GRK7; G protein-coupled receptor kinase
hsa:23429,0.0,0.0,1.5950703599081855e-06,5.757840148241543e-06,0.0,3.807197e-05,False,RYBP; RING1 and YY1 binding
hsa:3841,0.0,0.0,1.3438076496477778e-05,4.119686584237246e-05,0.0,0.00020420297,False,KPNA5; karyopherin subunit alpha
hsa:10332,0.0,0.0,0.00012530050736666673,0.00041608458661823635,0.0,0.0036686326,False,CLEC4M; C-type lectin domain family 4 member
hsa:54938,1.194588e-06,0.0009947963431222717,3.6278095009064315e-06,6.9442054892185525e-06,0.0,5.8326485e-05,False,SARS2; seryl-tRNA synthetase 2
hsa:9162,0.000108817614,0.09061815828929382,0.00033800873183502926,0.0005534733537504246,0.0,0.0031704355,False,DGKI; diacylglycerol kinase
hsa:224,2.09339e-05,0.017432761058446364,0.0004449437241159065,0.0007387857504207439,0.0,0.0043057553,False,ALDH3A2; aldehyde dehydrogenase 3 family member
hsa:988,5.7829017e-09,4.815726814429383e-06,1.0850808633450286e-07,1.9397482506313838e-07,0.0,1.159592e-06,False,CDC5L; cell division cycle 5
hsa:9200,1.2666488e-06,0.0010548051665178403,8.430581723099411e-06,1.7883789928218422e-05,0.0,0.00015991447,False,HACD1; 3-hydroxyacyl-CoA dehydratase
hsa:10970,2.3428578e-07,0.00019510210816578525,4.861384625444447e-07,6.176289692327907e-07,0.0,2.4971093e-06,False,CKAP4; cytoskeleton associated protein
hsa:3127,0.0002667025,0.2220972182054128,0.0004132091401263159,0.0005368982727145633,0.0,0.003712791,False,HLA-DRB5; major histocompatibility complex
hsa:6281,0.0,0.0,1.4647421580116958e-07,2.645831527566847e-07,0.0,1.12809e-06,False,S100A10; S100 calcium binding protein
hsa:81579,2.6306677e-06,0.0021906955435094587,0.00011329873225380106,0.00019468483505963058,0.0,0.0011614269,False,PLA2G12A; phospholipase A2 group
hsa:2859,0.0,0.0,3.672172193227485e-06,1.1152867119817228e-05,0.0,6.645734e-05,False,GPR35; G protein-coupled receptor
hsa:100169753,0.0,0.0,1.3761318330888886e-07,1.0430187291444141e-06,0.0,1.2931051e-05,False,RNA5S2; RNA
hsa:729359,4.624721e-08,3.851248747485137e-05,6.892066984794737e-06,2.742066153481708e-05,0.0,0.00025075063,False,PLIN4; perilipin
hsa:6750,2.1410808e-06,0.0017829907467422307,4.8035568067017556e-05,0.00011953751158623158,0.0,0.00083744485,False,SST;
hsa:51168,3.7290206e-09,3.1053518504351454e-06,1.9537396533742693e-08,2.9081787050782904e-08,0.0,1.4969649e-07,False,MYO15A; myosin
hsa:9482,8.129717e-07,0.0006770043514767405,4.467216621021637e-05,0.00011664908821878261,0.0,0.00078635255,False,STX8; syntaxin
hsa:100169755,0.0,0.0,3.712957777637427e-08,2.7795920636160987e-07,0.0,2.6947173e-06,False,RNA5S4; RNA
hsa:57599,2.547612e-05,0.021215306878140553,0.00023696517633853807,0.0004546884382698596,0.0,0.0032894025,False,WDR48; WD repeat domain
hsa:25978,0.0,0.0,4.366356883040935e-08,1.8949392581273593e-07,0.0,1.8947333e-06,False,CHMP2B; charged multivesicular body protein
hsa:3921,8.107444e-08,6.751495614612405e-05,8.172052493684211e-07,1.3094783641791036e-06,0.0,7.1115223e-06,False,RPSA; ribosomal protein
hsa:3383,0.0,0.0,2.2046301159064326e-05,7.85888234597717e-05,0.0,0.00050448254,False,ICAM1; intercellular adhesion molecule
hsa:3547,0.0,0.0,1.4033987218859068e-06,3.957392167810546e-06,0.0,3.1525407e-05,False,IGSF1; immunoglobulin superfamily member
hsa:390432,0.0,0.0,3.1313217543859647e-07,2.8516726976801083e-06,0.0,2.9847848e-05,False,OR4Q2; olfactory receptor family 4 subfamily Q member 2
hsa:57761,8.3658097e-07,0.0006966650340382482,1.3232145344853806e-05,3.444142011557847e-05,0.0,0.00021584985,False,TRIB3; tribbles pseudokinase
hsa:55907,8.0165355e-06,0.006675791318772557,0.0002742648298818069,0.0007014813873919388,0.0,0.004446134,False,CMAS; cytidine monophosphate N-acetylneuraminic acid
hsa:3337,1.12100324e-07,9.335184379721028e-05,1.576499013076023e-05,3.302748945750105e-05,0.0,0.00016165742,False,DNAJB1; DnaJ heat shock protein family (Hsp40) member
hsa:56001,0.0,0.0,3.0107675059649122e-05,0.00011280364707073836,0.0,0.0007206806,False,NXF2; nuclear RNA export factor
hsa:9469,0.0,0.0,1.3336267355380114e-05,4.004106177069591e-05,0.0,0.00030461754,False,CHST3; carbohydrate sulfotransferase
hsa:780852,0.0,0.0,3.646786602001466e-07,1.0603764881499501e-06,0.0,7.3872734e-06,False,SNORD3B-2; small nucleolar RNA
hsa:574473,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520B; microRNA
hsa:55226,2.3162626e-08,1.9288738579249794e-05,2.9524616371169593e-06,6.995991712181358e-06,0.0,3.7099682e-05,False,NAT10; N-acetyltransferase
hsa:26154,7.469487e-07,0.0006220235221347735,0.0001121137485895637,0.0003715466619240688,0.0,0.0033372974,False,ABCA12; ATP binding cassette subfamily A member
hsa:5694,1.2938993e-06,0.0010774980930734841,9.053114410023391e-06,2.176061706416346e-05,0.0,0.00020221564,False,PSMB6; proteasome 20S subunit beta
hsa:114805,5.4251814e-06,0.004517834280517607,0.00012538122995093566,0.00030710715663818673,0.0,0.0025873757,False,GALNT13; polypeptide N-acetylgalactosaminyltransferase
hsa:930,8.088196e-06,0.006735466791275475,9.095795833947367e-05,0.0002523501274505776,0.0,0.0018485708,False,CD19; CD19
hsa:8480,7.887031e-08,6.567946100992136e-05,2.241309638504386e-05,6.587060741215655e-05,0.0,0.00034820513,False,RAE1; ribonucleic acid export
hsa:10013,4.098255e-06,0.0034128327818315316,5.290339589128654e-05,0.0001717263573203098,0.0,0.0018936786,False,HDAC6; histone deacetylase
hsa:284433,0.0,0.0,1.31712987674269e-06,7.434277096541383e-06,0.0,6.9425e-05,False,OR10H5; olfactory receptor family 10 subfamily H member
hsa:6625,0.0,0.0,2.6900651218421055e-07,4.80986053657724e-07,0.0,2.0053003e-06,False,SNRNP70; small nuclear ribonucleoprotein U1 subunit
hsa:6538,8.8330967e-07,0.0007355784835947963,5.389590384928768e-05,0.0001412804998567002,0.0,0.0010574298,False,SLC6A11; solute carrier family 6 member
hsa:1816,0.0,0.0,1.160144104339181e-06,3.7891441841264574e-06,0.0,2.610739e-05,False,DRD5; dopamine receptor
hsa:80267,0.0,0.0,1.8278717928596486e-07,4.4075855359157763e-07,0.0,2.2912445e-06,False,EDEM3; ER degradation enhancing alpha-mannosidase like protein
hsa:5163,1.8454614e-06,0.0015368129029366675,8.453592129223802e-05,0.00018343101010933854,0.0,0.0012339514,False,PDK1; pyruvate dehydrogenase kinase
hsa:2936,9.9539675e-06,0.008289192984156831,3.797116736491231e-05,7.277612569618898e-05,0.0,0.0005059858,False,GSR; glutathione-disulfide
hsa:4995,-0.0,0.0,1.2943826856491229e-06,4.087514405972957e-06,0.0,2.9499239e-05,False,OR3A2; olfactory receptor family 3 subfamily A member
hsa:84911,1.1298366e-08,9.40874442071828e-06,5.5527186811111105e-08,8.298508619470207e-08,0.0,3.5070929e-07,False,ZNF382; zinc finger protein
hsa:10682,0.0,0.0,8.805868849590642e-06,1.855904599703999e-05,0.0,9.543459e-05,False,EBP; EBP cholestenol
hsa:875,1.4088277e-05,0.011732050247025425,0.00030770956301535084,0.0007468213530239064,0.0,0.0043000234,False,CBS; cystathionine
hsa:4088,0.0,0.0,5.877001157894737e-07,7.578317901120665e-06,0.0,9.909772e-05,False,SMAD3; SMAD family member
hsa:29895,0.0,0.0,9.835526328187134e-07,5.61685540366986e-06,0.0,6.183511e-05,False,MYL11; myosin light chain
hsa:5580,0.0,0.0,2.5655336233918126e-05,6.526884172829641e-05,0.0,0.00041564638,False,PRKCD; protein kinase C
hsa:10787,2.5520407e-07,0.0002125218699550977,1.6642393491350876e-05,4.71011680715142e-05,0.0,0.00023381546,False,NCKAP1; NCK associated protein
hsa:6732,0.0,0.0,1.715250993707603e-07,3.418142380535944e-07,0.0,1.5854961e-06,False,SRPK1; SRSF protein kinase
hsa:2938,0.0,0.0,8.844034395906432e-06,6.244859419635028e-05,0.0,0.0007312777,False,GSTA1; glutathione S-transferase alpha
hsa:4173,4.3750396e-07,0.00036433258957022227,9.373411087847953e-06,2.087405429262611e-05,0.0,0.00014867328,False,MCM4; minichromosome maintenance complex component
hsa:410,9.103281e-07,0.0007580781532389792,3.7191177418128674e-05,0.00011042161454253335,0.0,0.00084120705,False,ARSA; arylsulfatase
hsa:23621,0.0,0.0,9.97137867590643e-09,1.6999130467329005e-08,0.0,8.2195e-08,False,BACE1; beta-secretase
hsa:260293,0.0,0.0,3.5954129926426885e-05,9.957219832311515e-05,0.0,0.000706791,False,CYP4X1; cytochrome P450 family 4 subfamily X member
hsa:9935,0.0,0.0,1.0503186023450293e-05,4.3863051051577553e-05,0.0,0.0004019773,False,MAFB; MAF bZIP transcription factor
hsa:284371,0.0,0.0,7.738277713450293e-08,1.3940350741451665e-07,0.0,6.495303e-07,False,ZNF841; zinc finger protein
hsa:175,0.0,0.0,1.2905236505146196e-05,3.949088177728604e-05,0.0,0.0002148499,False,AGA;
hsa:30814,0.0,0.0,1.1776919298245615e-07,1.5400320326186e-06,0.0,2.0138532e-05,False,PLA2G2E; phospholipase A2 group
hsa:57379,0.0,0.0,3.592546161345029e-06,2.1162551958505745e-05,0.0,0.00026243454,False,AICDA; activation induced cytidine
hsa:9562,0.0,0.0,2.7808202515639202e-05,5.9992940011988066e-05,0.0,0.0002740032,False,MINPP1; multiple inositol-polyphosphate phosphatase
hsa:3990,0.0,0.0,2.8977878690877204e-06,1.0245261529567552e-05,0.0,0.00010443188,False,LIPC; lipase C
hsa:80179,1.9440876e-08,1.6189441340356287e-05,1.6759360519005848e-07,3.909192277058298e-07,0.0,2.0814878e-06,False,MYO19; myosin
hsa:51004,0.0,0.0,0.00021783398700725147,0.000425783704230561,0.0,0.0020278317,False,COQ6; coenzyme Q6
hsa:1674,0.0,0.0,3.4246343714754396e-05,0.00015283821290537356,0.0,0.0017153608,False,DES;
hsa:5588,1.5677497e-05,0.0130554774406828,5.871818344294738e-05,0.0001048713639170045,0.0,0.0006256083,False,PRKCQ; protein kinase C
hsa:2263,0.0,0.0,4.5884237520116956e-06,1.7416187509686635e-05,0.0,0.00012787443,False,FGFR2; fibroblast growth factor receptor
hsa:146956,8.383942e-06,0.0069817500615686956,0.00040275860227350876,0.0009324017103995656,0.0,0.0044133225,False,EME1; essential meiotic structure-specific endonuclease
hsa:5824,2.8625885e-07,0.00023838282082725332,6.223019043984092e-05,0.00021273445932490156,0.0,0.0013338276,False,PEX19; peroxisomal biogenesis factor
hsa:6257,3.187312e-05,0.02654242568977534,0.00015789049151695905,0.0002887850973393197,0.0,0.0025159244,False,RXRB; retinoid X receptor
hsa:636,0.0,0.0,5.500035522942688e-05,0.00016493874947582182,0.0,0.001214337,False,BICD1; BICD cargo adaptor
hsa:147658,1.5697746e-09,1.307233984943953e-06,1.6592096775380125e-08,3.953465565503929e-08,0.0,2.9506762e-07,False,ZNF534; zinc finger protein
hsa:143502,0.0,0.0,3.51164350021345e-07,1.8770669805871603e-06,0.0,1.4269708e-05,False,OR52I2; olfactory receptor family 52 subfamily I member
hsa:8546,5.09025e-07,0.0004238919263861803,1.1479398764830403e-06,1.7556523604961527e-06,0.0,1.0868677e-05,False,AP3B1; adaptor related protein complex 3 subunit beta
hsa:27010,0.0,0.0,3.235629269502924e-05,6.848482431673307e-05,0.0,0.00034854238,False,TPK1; thiamin pyrophosphokinase
hsa:55437,4.450138e-07,0.0003705864288599467,2.566245803970761e-06,5.373725193064984e-06,0.0,3.271549e-05,False,STRADB; STE20 related adaptor
hsa:1600,5.791252e-09,4.8226805490257245e-06,3.7766876495087724e-08,8.046606316684615e-08,0.0,6.853438e-07,False,DAB1; DAB adaptor protein
hsa:23013,7.5467557e-07,0.0006284580937358453,0.00010111820648215908,0.0001957309195619551,0.0,0.0014313454,False,SPEN; spen family transcriptional
hsa:6060,0.0,0.0,9.179193482631578e-08,2.3440894176998057e-07,0.0,1.8714295e-06,False,RNU1-4; RNA
hsa:3563,3.3314477e-06,0.002774271957581277,3.9903089402807e-05,6.36027740693893e-05,0.0,0.0004074399,False,IL3RA; interleukin 3 receptor subunit
hsa:80025,0.0,0.0,2.6833078436081878e-05,6.150169117033121e-05,0.0,0.0003740101,False,PANK2; pantothenate kinase
hsa:1902,1.2294571e-06,0.0010238336791477173,6.733242857754388e-05,0.00011949437563324711,0.0,0.0005661319,False,LPAR1; lysophosphatidic acid receptor
hsa:9340,0.0,0.0,6.582130179571931e-07,2.4194451688729263e-06,0.0,1.8687735e-05,False,GLP2R; glucagon like peptide 2
hsa:407032,-0.0,0.0,2.3002473684210527e-10,3.007963747227823e-09,0.0,3.933423e-08,False,MIR30C2; microRNA
hsa:55040,-0.0,0.0,6.00005294677427e-09,1.8175634304623934e-08,0.0,1.3729074e-07,False,EPN3; epsin
hsa:10800,1.6827887e-07,0.00014013467781423232,3.5434841494678354e-06,8.000569481785523e-06,0.0,4.3925927e-05,False,CYSLTR1; cysteinyl leukotriene receptor
hsa:56963,8.4630426e-07,0.0007047621297190331,2.8267553027935667e-05,9.738905008069806e-05,0.0,0.0009210385,False,RGMA; repulsive guidance molecule BMP co-receptor
hsa:5106,0.0,0.0,0.00014627272308771928,0.0003596121479968101,0.0,0.0017798387,False,PCK2; phosphoenolpyruvate carboxykinase 2
hsa:2566,0.0,0.0,0.00014026519357719294,0.00031274756165846,0.0,0.0018582551,False,GABRG2; gamma-aminobutyric acid type A receptor subunit
hsa:6582,0.0,0.0,1.3276028605292401e-08,5.598350037312009e-08,0.0,6.2639003e-07,False,SLC22A2; solute carrier family 22 member
hsa:57134,0.0,0.0,7.49399967250877e-07,8.181535893862809e-06,0.0,0.0001061556,False,MAN1C1; mannosidase alpha class 1C member
hsa:442900,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR326; microRNA
hsa:354,0.0,0.0,7.371058231227485e-06,8.319742197738985e-05,0.0,0.0010843445,False,KLK3; kallikrein related peptidase
hsa:9693,6.6936093e-07,0.000557412099730554,2.4796538379567247e-05,7.643668192818391e-05,0.0,0.00047519305,False,RAPGEF2; Rap guanine nucleotide exchange factor
hsa:3991,0.0,0.0,0.00011361818732982454,0.00033644460066626817,0.0,0.0017820586,False,LIPE; lipase E
hsa:3326,0.0,0.0,9.962527449239765e-05,0.00028434489441894127,0.0,0.0016041781,False,HSP90AB1; heat shock protein 90 alpha family class B member
hsa:4862,0.0,0.0,6.696962778830411e-06,1.3162353680717197e-05,0.0,6.0503236e-05,False,NPAS2; neuronal PAS domain protein
hsa:10846,0.0,0.0,2.0838826933099415e-05,0.00011328487382027903,0.0,0.0013251553,False,PDE10A; phosphodiesterase
hsa:1439,1.6696042e-06,0.0013903673506025392,8.624515831421052e-06,1.557545174308381e-05,0.0,0.00010156887,False,CSF2RB; colony stimulating factor 2 receptor subunit
hsa:5525,0.0,0.0,5.245689846198832e-06,7.79369565585868e-06,0.0,4.0509814e-05,False,PPP2R5A; protein phosphatase 2 regulatory subunit
hsa:27134,0.0,0.0,2.827810694596491e-06,1.6456777316920987e-05,0.0,0.00019568256,False,TJP3; tight junction protein
hsa:2208,1.2843293e-06,0.0010695286500490436,1.1164488094929825e-05,2.059460910846002e-05,0.0,0.00010094628,False,FCER2; Fc epsilon receptor
hsa:54361,3.0471638e-05,0.025375337816339737,0.00010679298801157893,0.00015274913103030844,0.0,0.0007843055,False,WNT4; Wnt family member
hsa:442191,0.0,0.0,5.682038175438596e-07,7.3527718225036295e-06,0.0,9.6150594e-05,False,OR14J1; olfactory receptor family 14 subfamily J member
hsa:10587,3.8388345e-05,0.03196799668548164,0.0001656679519922223,0.00027774972456106884,0.0,0.0012866629,False,TXNRD2; thioredoxin reductase
hsa:170960,0.0,0.0,8.55148068473684e-08,2.391547375227845e-07,0.0,1.2390906e-06,False,ZNF721; zinc finger protein
hsa:83657,0.0,0.0,3.850838826842106e-08,1.1008736618825106e-07,0.0,9.4139295e-07,False,DYNLRB2; dynein light chain roadblock-type
hsa:11065,0.0,0.0,7.889426142105265e-07,1.9033244504568854e-06,0.0,1.0647241e-05,False,UBE2C; ubiquitin conjugating enzyme E2
hsa:55161,1.1021742e-09,9.178385046925932e-07,3.6707407960029224e-07,7.219550339973305e-07,0.0,3.4397337e-06,False,TMEM33; transmembrane protein
hsa:486,0.00015023013,0.12510454144088462,0.00030064524665789484,0.0003805823890057699,0.0,0.0017526967,False,FXYD2; FXYD domain containing ion transport regulator
hsa:9957,0.0,0.0,4.242642469064325e-06,1.0912072608146852e-05,0.0,9.928377e-05,False,HS3ST1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:54941,0.0,0.0,2.0649350355070175e-06,6.1553557843895836e-06,0.0,3.438364e-05,False,RNF125; ring finger protein
hsa:2746,0.0,0.0,0.0005465682259356726,0.0012405150663325492,0.0,0.008825417,False,GLUD1; glutamate dehydrogenase
hsa:10241,0.0,0.0,8.495585216959068e-07,2.477728377060754e-06,0.0,1.9148087e-05,False,CALCOCO2; calcium binding and coiled-coil domain
hsa:4985,7.584588e-08,6.31608588608714e-05,4.991940447064327e-05,0.00021428231632744568,0.0,0.0022187047,False,OPRD1; opioid receptor delta
hsa:3320,0.0,0.0,0.00036362834150760237,0.001112652921598656,0.0,0.007371571,False,HSP90AA1; heat shock protein 90 alpha family class A member
hsa:4648,0.0,0.0,2.2482930493567257e-09,6.132731120534084e-09,0.0,4.2539334e-08,False,MYO7B; myosin
hsa:54898,0.0,0.0,0.0001889460262690644,0.0006303284152170477,0.0,0.003760366,False,ELOVL2; ELOVL fatty acid elongase
hsa:4976,4.6459043e-08,3.868889197058766e-05,3.1307248107690057e-07,4.5178973304805476e-07,0.0,1.8831311e-06,False,OPA1; OPA1 mitochondrial dynamin like
hsa:8732,2.5482738e-09,2.1220818035291624e-06,1.1584376469076024e-07,3.2503857553920865e-07,0.0,2.0019465e-06,False,RNGTT; RNA guanylyltransferase and
hsa:7076,0.0,0.0,1.1587148919532163e-06,3.4071809496047163e-06,0.0,2.1315249e-05,False,TIMP1; TIMP metallopeptidase inhibitor
hsa:11052,0.0,0.0,3.3671531832397648e-06,1.0460854191578049e-05,0.0,6.811093e-05,False,CPSF6; cleavage and polyadenylation specific factor
hsa:35,0.0,0.0,0.0005317583452777775,0.001104626832526532,0.0,0.005734341,False,ACADS; acyl-CoA dehydrogenase short
hsa:1743,8.67307e-06,0.007222522174710846,7.659207918304088e-05,0.00014142053642390254,0.0,0.0009013009,False,DLST; dihydrolipoamide
hsa:9638,1.2011566e-06,0.0010002663622915861,7.021309964871349e-06,1.2388952420607024e-05,0.0,6.513143e-05,False,FEZ1; fasciculation and elongation protein zeta
hsa:2023,0.0,0.0,7.958369622836256e-05,0.00020838192397781293,0.0,0.00107499,False,ENO1; enolase
hsa:9757,4.1154094e-06,0.0034271181541845573,5.566015081883043e-05,0.00018072682134121168,0.0,0.0010574177,False,KMT2B; lysine methyltransferase
hsa:10449,0.0,0.0,6.435634060223978e-05,0.0001692509858285135,0.0,0.0013906904,False,ACAA2; acetyl-CoA acyltransferase
hsa:1212,4.704218e-06,0.003917450086264023,9.47792927157895e-05,0.00020381557804781525,0.0,0.0012930781,False,CLTB; clathrin light chain
hsa:7299,0.0,0.0,7.39656544502924e-08,4.2027009572530713e-07,0.0,4.206161e-06,False,TYR;
hsa:146542,0.0,0.0,1.0394959999397662e-07,2.0383450824298192e-07,0.0,1.2383285e-06,False,ZNF688; zinc finger protein
hsa:116987,0.0,0.0,1.8507461384766083e-06,5.360733379105538e-06,0.0,2.735349e-05,False,AGAP1; ArfGAP with GTPase domain
hsa:3067,0.0,0.0,1.2718859279064325e-06,4.84262591239785e-06,0.0,3.848585e-05,False,HDC; histidine
hsa:100169764,-0.0,0.0,1.3874304237192984e-07,1.1897457890768953e-06,0.0,1.504233e-05,False,RNA5S13; RNA
hsa:2956,2.4926736e-05,0.02075780588686165,0.0002101039600588305,0.00048705419179857957,0.0,0.0028237395,False,MSH6; mutS homolog
hsa:2689,0.0,0.0,5.488449964912281e-08,5.584438623733447e-07,0.0,7.1119166e-06,False,GH2; growth hormone
hsa:6548,0.0,0.0,1.1549251567836257e-05,6.623757726597796e-05,0.0,0.0005884102,False,SLC9A1; solute carrier family 9 member
hsa:57412,2.0819766e-07,0.00017337715665536075,5.507805472163742e-07,1.070225333651744e-06,0.0,7.3352276e-06,False,AS3MT; arsenite
hsa:6309,5.2770433e-06,0.00439447188263894,2.837522123064912e-05,7.361183312139708e-05,0.0,0.0004337361,False,SC5D;
hsa:860,0.0,0.0,5.138724965005846e-07,4.10450774706318e-06,0.0,4.8139358e-05,False,RUNX2; RUNX family transcription factor
hsa:6137,0.0,0.0,6.949088173736843e-07,1.5852418401279433e-06,0.0,7.335088e-06,False,RPL13; ribosomal protein
hsa:78989,0.0,0.0,6.34896274608187e-07,9.821308818220965e-07,0.0,4.800711e-06,False,COLEC11; collectin subfamily member
hsa:9723,8.673952e-09,7.223256662563256e-06,2.3420558462064335e-07,7.59781102669924e-07,0.0,5.738999e-06,False,SEMA3E; semaphorin
hsa:100529261,0.0,0.0,4.1647776587564915e-06,1.9030005796430938e-05,0.0,0.00022705561,False,CHURC1-FNTB; CHURC1-FNTB
hsa:844,5.621795e-08,4.681564780311765e-05,1.6805071435188886e-06,5.710627498418366e-06,0.0,3.349681e-05,False,CASQ1; calsequestrin
hsa:1071,0.0,0.0,0.0001327725448481287,0.0002553234536664328,0.0,0.0014349124,False,CETP; cholesteryl ester transfer
hsa:81620,1.5983742e-08,1.3310503781228229e-05,5.024751290730996e-07,8.604900203209378e-07,0.0,4.815354e-06,False,CDT1; chromatin licensing and DNA replication factor
hsa:9542,4.665022e-06,0.0038848095127231707,1.7793407744567247e-05,3.3237638620704645e-05,0.0,0.0002700509,False,NRG2; neuregulin
hsa:81631,0.0,0.0,4.60998736e-06,9.322436918503117e-06,0.0,5.4857337e-05,False,MAP1LC3B; microtubule associated protein 1 light chain 3
hsa:101954271,0.0,0.0,3.127737625146199e-08,3.684331519548909e-07,0.0,4.8131033e-06,False,RNU6-9; RNA
hsa:3570,0.0,0.0,2.0067193709941516e-05,7.368798907481348e-05,0.0,0.00046942107,False,IL6R; interleukin 6
hsa:6510,0.0,0.0,3.139664341988304e-05,5.5298134484014357e-05,0.0,0.00035905617,False,SLC1A5; solute carrier family 1 member
hsa:10454,1.4389864e-05,0.011983197625647358,7.097186475599998e-05,0.00010640752665090027,0.0,0.0005527083,False,TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:119548,0.0,0.0,1.7350817167251458e-06,1.8888369127916787e-05,0.0,0.00024620263,False,PNLIPRP3; pancreatic lipase related protein
hsa:6626,0.0,0.0,1.38418413848538e-07,2.769115006837698e-07,0.0,1.4327752e-06,False,SNRPA; small nuclear ribonucleoprotein polypeptide
hsa:7086,4.1315405e-07,0.0003440551370733309,7.321415533226319e-05,0.00021620733135827252,0.0,0.0012129013,False,TKT;
hsa:55326,1.2074114e-05,0.01005475063673955,0.00015131543884444444,0.0002905540751625825,0.0,0.0012421266,False,AGPAT5; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:79888,0.0,0.0,1.751963511663743e-05,5.412379998581569e-05,0.0,0.00042667915,False,LPCAT1; lysophosphatidylcholine acyltransferase
hsa:7483,0.0,0.0,7.001106662573099e-06,3.049493203063105e-05,0.0,0.00030482793,False,WNT9A; Wnt family member
hsa:24145,0.0,0.0,9.656472289473688e-08,2.2176899403177867e-07,0.0,1.3843015e-06,False,PANX1; pannexin
hsa:81469,0.0,0.0,1.830140192982456e-08,1.943490118239084e-07,0.0,2.4539906e-06,False,OR2G3; olfactory receptor family 2 subfamily G member
hsa:9971,0.0,0.0,6.237301143707604e-07,2.437936218012272e-06,0.0,2.0594567e-05,False,NR1H4; nuclear receptor subfamily 1 group H member
hsa:7551,1.5346606e-08,1.2779927077903272e-05,2.667139625387719e-07,6.0526942534276e-07,0.0,3.0035465e-06,False,ZNF3; zinc finger protein
hsa:407045,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR7-3; microRNA
hsa:9632,3.156973e-07,0.0002628977685809457,8.004391078947367e-07,1.3431938582348152e-06,0.0,8.626474e-06,False,SEC24C; SEC24 homolog C
hsa:390439,0.0,0.0,1.3150187194152047e-07,1.6231989423130667e-06,0.0,2.1195092e-05,False,OR11G2; olfactory receptor family 11 subfamily G member
hsa:344838,0.0,0.0,2.104456343460926e-06,1.4772533979701171e-05,0.0,0.0001788724,False,PAQR9; progestin and adipoQ receptor family member
hsa:8050,2.1332812e-06,0.0017764956090396786,0.00018227739573692983,0.0004491039689990365,0.0,0.0026105952,False,PDHX; pyruvate dehydrogenase complex component
hsa:3576,0.0,0.0,7.557687138011696e-06,3.280259659402345e-05,0.0,0.00027902334,False,CXCL8; C-X-C motif chemokine ligand
hsa:22943,0.0,0.0,1.6431174766494145e-06,8.42733203318854e-06,0.0,9.103033e-05,False,DKK1; dickkopf WNT signaling pathway inhibitor
hsa:84219,1.6314317e-07,0.00013585790994164942,5.820962356707605e-07,9.89234623437651e-07,0.0,7.0375377e-06,False,WDR24; WD repeat domain
hsa:55777,9.273965e-08,7.72291908862632e-05,2.475617075275532e-05,8.388868979734996e-05,0.0,0.00052803004,False,MBD5; methyl-CpG binding domain protein
hsa:9455,5.5768883e-06,0.004644168606114729,2.965376236959066e-05,6.099394530777743e-05,0.0,0.00036957365,False,HOMER2; homer scaffold protein
hsa:7090,0.0,0.0,7.906515067555557e-06,2.2217782786777256e-05,0.0,0.00013678502,False,TLE3; TLE family member 3
hsa:7517,0.0,0.0,5.750096969374267e-06,1.8613796314700916e-05,0.0,0.00011684395,False,XRCC3; X-ray repair cross complementing
hsa:84152,0.0,0.0,1.0457452432923975e-05,4.282862909899588e-05,0.0,0.00035357545,False,PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit
hsa:83593,3.0130423e-07,0.00025091190115024756,1.9959518520175435e-05,6.081670003879332e-05,0.0,0.00045777304,False,RASSF5; Ras association domain family member
hsa:6229,0.0,0.0,6.430837443040936e-07,1.0788369039778437e-06,0.0,4.5102356e-06,False,RPS24; ribosomal protein
hsa:79891,0.0,0.0,1.0004903021461987e-07,1.9487163755571458e-07,0.0,1.1768675e-06,False,ZNF671; zinc finger protein
hsa:1769,0.0,0.0,2.082153898771111e-08,1.2937812636922207e-07,0.0,1.1926807e-06,False,DNAH8; dynein axonemal heavy chain
hsa:26121,1.3148065e-08,1.094908619635718e-05,1.7783250721637426e-07,3.132062798683606e-07,0.0,1.8769141e-06,False,PRPF31; pre-mRNA processing factor
hsa:65108,5.3561203e-06,0.00446032346529763,0.00010726465377637431,0.0002904086466860461,0.0,0.0017595378,False,MARCKSL1; MARCKS like
hsa:100526760,0.0,0.0,8.945312232914033e-06,2.3881346662545807e-05,0.0,0.00013727557,False,ABHD14A-ACY1; ABHD14A-ACY1
hsa:54474,0.0,0.0,2.145596852949708e-06,6.005641787645774e-06,0.0,4.4157652e-05,False,KRT20; keratin
hsa:645745,0.0,0.0,2.867176052748538e-07,2.618050110582796e-06,0.0,3.261156e-05,False,MT1HL1; metallothionein 1H like
hsa:64499,5.6709184e-09,4.722472422680291e-06,1.9151045218142696e-06,9.100174785066407e-06,0.0,9.825343e-05,False,TPSB2; tryptase beta
hsa:178,0.0,0.0,0.00013734559475438594,0.00025583094069314086,0.0,0.0014692949,False,AGL; amylo-alpha-1
hsa:5241,0.0,0.0,1.205271469321637e-07,4.6774334039594457e-07,0.0,5.0374424e-06,False,PGR; progesterone
hsa:729747,0.0,0.0,1.2626899545415206e-08,4.109403636616883e-08,0.0,3.4467786e-07,False,ZNF878; zinc finger protein
hsa:2774,1.478127e-05,0.012309142016078295,0.00011305720463135991,0.0003082252340602099,0.0,0.0019784428,False,GNAL; G protein subunit alpha
hsa:84456,4.961019e-08,4.131301803935842e-05,2.2084204269788303e-05,5.947467424917801e-05,0.0,0.00031176963,False,L3MBTL3; L3MBTL histone methyl-lysine binding protein
hsa:2903,0.0,0.0,0.00016749745109907607,0.0006855844867357425,0.0,0.0050496426,False,GRIN2A; glutamate ionotropic receptor NMDA type subunit
hsa:9223,0.0,0.0,2.173150750175438e-06,4.64451001795801e-06,0.0,3.1371528e-05,False,MAGI1; membrane associated guanylate kinase
hsa:7416,0.00011323859,0.09429973784461441,0.00025652356349883053,0.0004592569629689357,0.0,0.0026035297,False,VDAC1; voltage dependent anion channel
hsa:10025,1.977806e-07,0.0001647023221567007,1.3381675740786543e-05,3.760150309411506e-05,0.0,0.00032006792,False,MED16; mediator complex subunit
hsa:79109,6.252708e-08,5.206959263789167e-05,1.5206067444970766e-06,3.219211809958666e-06,0.0,1.8711276e-05,False,MAPKAP1; MAPK associated protein
hsa:5111,0.0,0.0,5.756028986842106e-05,0.0001904374324933475,0.0,0.0018117501,False,PCNA; proliferating cell nuclear
hsa:254531,3.2808578e-06,0.0027321430834264045,2.3039084511111113e-05,4.16218068719953e-05,0.0,0.0002610385,False,LPCAT4; lysophosphatidylcholine acyltransferase
hsa:9527,0.0,0.0,5.100341046104679e-05,0.00013484166812761844,0.0,0.001072542,False,GOSR1; golgi SNAP receptor complex member
hsa:146,0.0,0.0,4.68982431763158e-07,1.5592721424011916e-06,0.0,1.1766067e-05,False,ADRA1D; adrenoceptor alpha
hsa:4494,1.05172205e-07,8.758243422176173e-05,1.677423794880117e-05,4.386619743581867e-05,0.0,0.00036688446,False,MT1F; metallothionein
hsa:1906,0.0,0.0,7.132839102923975e-06,2.7338452489119624e-05,0.0,0.00022291401,False,EDN1; endothelin
hsa:2188,4.3529474e-07,0.00036249285572294385,0.0001153645589091813,0.00024058014223853936,0.0,0.0012403004,False,FANCF; FA complementation group
hsa:100169766,0.0,0.0,3.877478754345029e-08,1.769055709456475e-07,0.0,1.3925066e-06,False,RNA5S15; RNA
hsa:8453,6.1039805e-06,0.005083106041488493,3.64602910079766e-05,5.7599602266695874e-05,0.0,0.00031470472,False,CUL2; cullin
hsa:954,0.0,0.0,1.4453220515122807e-06,5.398814202616537e-06,0.0,4.6149802e-05,False,ENTPD2; ectonucleoside triphosphate diphosphohydrolase
hsa:5902,0.0,0.0,3.08791705319766e-05,0.0001228790493575534,0.0,0.0008505036,False,RANBP1; RAN binding protein
hsa:7703,0.0,0.0,9.354394213602338e-06,2.091604458220267e-05,0.0,0.00013050584,False,PCGF2; polycomb group ring finger
hsa:1388,0.00021316348,0.17751245650485145,0.0003314036978684211,0.0004587659896767284,0.0,0.0022820523,False,ATF6B; activating transcription factor 6
hsa:9369,2.9912695e-08,2.4909876542315732e-05,4.952860169590641e-07,1.1701376557730795e-06,0.0,8.6139235e-06,False,NRXN3; neurexin
hsa:3832,3.5106356e-09,2.9234911592238177e-06,2.9754574969005848e-08,4.486575005416995e-08,0.0,2.0172762e-07,False,KIF11; kinesin family member
hsa:56300,0.0,0.0,1.6052401624578955e-06,6.607067361013655e-06,0.0,6.372176e-05,False,IL36G; interleukin 36
hsa:4605,1.4465951e-08,1.2046559277831327e-05,1.1995223528938016e-05,4.1926628623476615e-05,0.0,0.00029891782,False,MYBL2; MYB proto-oncogene like
hsa:406896,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR103A2; microRNA
hsa:2568,0.000153854,0.12812232884871938,0.0006710605069031582,0.0014858090492525717,0.0,0.014507077,False,GABRP; gamma-aminobutyric acid type A receptor subunit
hsa:4697,0.0,0.0,3.175300439356727e-06,4.681462699113985e-06,0.0,2.1131935e-05,False,NDUFA4; NDUFA4 mitochondrial complex
hsa:4801,4.2230408e-07,0.00035167484896015636,1.152302425730994e-06,1.9155335216246136e-06,0.0,1.3504129e-05,False,NFYB; nuclear transcription factor Y subunit
hsa:1453,0.0,0.0,9.184352230116958e-05,0.000323860955646921,0.0,0.0034803213,False,CSNK1D; casein kinase 1
hsa:146754,0.0,0.0,9.3209264451462e-09,3.545793935864122e-08,0.0,3.4701745e-07,False,DNAH2; dynein axonemal heavy chain
hsa:27153,5.2393516e-09,4.3630840189352515e-06,1.2317118744000003e-07,2.765305857895336e-07,0.0,1.3596406e-06,False,ZNF777; zinc finger protein
hsa:118813,0.0,0.0,7.837865894251463e-07,1.8995994587019916e-06,0.0,9.6772565e-06,False,ZFYVE27; zinc finger FYVE-type containing
hsa:8991,0.0,0.0,2.3471388891157903e-05,7.97502268316164e-05,0.0,0.0008547328,False,SELENBP1; selenium binding protein
hsa:7167,2.5976064e-05,0.02163163657755652,0.0003771292232359065,0.0006758935982052249,0.0,0.0037307637,False,TPI1; triosephosphate isomerase
hsa:79778,0.0,0.0,1.7345971437444448e-06,5.742301549289156e-06,0.0,4.6709265e-05,False,MICALL2; MICAL like
hsa:5538,0.0,0.0,1.9263480518812865e-05,6.304237007876712e-05,0.0,0.00030964203,False,PPT1; palmitoyl-protein thioesterase
hsa:286826,0.0,0.0,4.25326738960807e-06,1.568244571123884e-05,0.0,0.00011440406,False,LIN9; lin-9 DREAM MuvB core complex
hsa:9815,7.225131e-07,0.0006016747110618357,7.866444377040936e-06,2.6179742184112065e-05,0.0,0.00026241486,False,GIT2; GIT ArfGAP
hsa:100533105,0.0,0.0,2.3800974668807023e-06,1.1726840818491625e-05,0.0,0.00014223374,False,C8orf44-SGK3; C8orf44-SGK3
hsa:403239,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR2T27; olfactory receptor family 2 subfamily T member
hsa:5224,1.2750733e-05,0.010618206913620825,0.0002683876474783626,0.00039540297358373955,0.0,0.0017560691,False,PGAM2; phosphoglycerate mutase
hsa:51703,0.0,0.0,9.11053584614035e-06,2.0722082891675724e-05,0.0,0.00010973667,False,ACSL5; acyl-CoA synthetase long chain family member
hsa:7576,4.94683e-10,4.119485876341925e-07,4.426043493491229e-08,8.991459014186266e-08,0.0,4.4148487e-07,False,ZNF28; zinc finger protein
hsa:11326,0.0,0.0,4.896505529298245e-07,1.1049129661191498e-06,0.0,7.887756e-06,False,VSIG4; V-set and immunoglobulin domain containing
hsa:25800,0.0,0.0,1.2400525620233917e-08,2.2798499945905396e-08,0.0,1.0728157e-07,False,SLC39A6; solute carrier family 39 member
hsa:255027,1.7364077e-07,0.00014459981434012016,5.708527329078835e-05,0.0002131067036773961,0.0,0.0015196451,False,MPV17L; MPV17 mitochondrial inner membrane protein
hsa:79660,0.0,0.0,2.048721786666667e-06,6.61175818984787e-06,0.0,5.1543386e-05,False,PPP1R3B; protein phosphatase 1 regulatory subunit
hsa:151903,1.0173307e-07,8.471848537788937e-05,4.914168591491228e-07,9.892423478544464e-07,0.0,6.1072615e-06,False,CCDC12; coiled-coil domain containing
hsa:25847,0.0,0.0,2.2785927029239762e-06,9.46701688838688e-06,0.0,0.00010903106,False,ANAPC13; anaphase promoting complex subunit
hsa:5617,1.8976597e-07,0.00015802811764813537,1.778473261933918e-05,7.6773480555649e-05,0.0,0.0008750824,False,PRL;
hsa:54910,8.0521454e-07,0.0006705445557973813,2.1024985029795328e-05,7.463545377392134e-05,0.0,0.00072202826,False,SEMA4C; semaphorin
hsa:9,0.0,0.0,5.321028076608187e-05,0.00011773903974651609,0.0,0.0006754232,False,NAT1; N-acetyltransferase
hsa:7869,0.0,0.0,1.0557477000134509e-07,1.9882337741642485e-07,0.0,1.0640252e-06,False,SEMA3B; semaphorin
hsa:1181,7.892159e-06,0.006572216456669182,3.181833435309941e-05,5.0096849243558095e-05,0.0,0.00026907225,False,CLCN2; chloride voltage-gated channel
hsa:9798,0.0,0.0,3.326410596058478e-07,7.300379434965055e-07,0.0,3.731113e-06,False,IST1; IST1 factor associated with
hsa:406888,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7F1; microRNA
hsa:401427,0.0,0.0,4.210115679532163e-06,1.1740981777858868e-05,0.0,8.2519226e-05,False,OR2A7; olfactory receptor family 2 subfamily A member
hsa:407051,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-3; microRNA
hsa:8379,0.0,0.0,2.9706177554736857e-05,7.842679835171782e-05,0.0,0.0004484711,False,MAD1L1; mitotic arrest deficient 1 like
hsa:5292,0.0,0.0,1.4333935067339178e-05,7.025004220826599e-05,0.0,0.00069252856,False,PIM1; Pim-1 proto-oncogene
hsa:10228,0.0,0.0,8.797571208538015e-06,3.409587634534339e-05,0.0,0.00024736955,False,STX6; syntaxin
hsa:117248,0.0,0.0,3.013548400911697e-05,0.0001146565537365854,0.0,0.0011699912,False,GALNT15; polypeptide N-acetylgalactosaminyltransferase
hsa:256148,0.0,0.0,2.9337407017543856e-07,2.8069707317234574e-06,0.0,3.200446e-05,False,OR4S1; olfactory receptor family 4 subfamily S member
hsa:5435,0.0,0.0,0.00023372986362788891,0.0006690559195276261,0.0,0.0034887083,False,POLR2F; RNA polymerase II
hsa:256051,7.150881e-09,5.954915225083906e-06,9.322566666549712e-08,1.6079135339481416e-07,0.0,8.314113e-07,False,ZNF549; zinc finger protein
hsa:59082,0.0,0.0,3.5848970257309946e-09,2.1886259978407885e-08,0.0,2.3826702e-07,False,CARD18; caspase recruitment domain family member
hsa:6498,0.0,0.0,1.8299717178947373e-06,4.286368663441284e-06,0.0,2.6727264e-05,False,SKIL; SKI like
hsa:79788,0.0,0.0,4.677770227695906e-08,1.2380551583298962e-07,0.0,8.395349e-07,False,ZNF665; zinc finger protein
hsa:6188,1.178491e-08,9.813915234394696e-06,2.45429547197076e-06,4.761287708809438e-06,0.0,3.4299548e-05,False,RPS3; ribosomal protein
hsa:389434,0.0,0.0,8.926331622976609e-07,4.5582397514213605e-06,0.0,4.2216572e-05,False,IYD; iodotyrosine
hsa:6672,0.0,0.0,1.1335232730994152e-07,2.107309400916932e-07,0.0,1.347425e-06,False,SP100; SP100 nuclear
hsa:4548,7.2391185e-06,0.006028395238549846,0.0002121438327190643,0.0003894081028231587,0.0,0.0021715418,False,MTR; 5-methyltetrahydrofolate-homocysteine
hsa:154064,0.0,0.0,1.5254281177406198e-07,1.356790348440978e-06,0.0,1.624593e-05,False,RAET1L; retinoic acid early transcript
hsa:3269,3.983003e-07,0.000331685637143939,4.870980692748537e-05,0.00011614314913446493,0.0,0.00072691304,False,HRH1; histamine receptor
hsa:342909,7.0215567e-10,5.847220069334102e-07,3.1948548763391804e-08,5.515486989760662e-08,0.0,2.1020522e-07,False,ZNF284; zinc finger protein
hsa:2678,8.860487e-05,0.07378594181326473,0.000245591359625731,0.0003508859511108336,0.0,0.0019940662,False,GGT1; gamma-glutamyltransferase
hsa:55748,4.9234786e-05,0.041000399357106906,0.0005304054532935671,0.0014282230924901338,0.0,0.014443793,False,CNDP2; carnosine dipeptidase
hsa:5533,0.0,0.0,0.00010124224356549705,0.00024330092797523694,0.0,0.0016508964,False,PPP3CC; protein phosphatase 3 catalytic subunit
hsa:8482,0.0,0.0,2.674165583625731e-07,5.989848446971695e-07,0.0,3.5183866e-06,False,SEMA7A; semaphorin 7A (John Milton Hagen blood
hsa:140886,0.0,0.0,3.050031751619883e-07,9.508641804761164e-07,0.0,6.453682e-06,False,PABPC5; poly(A) binding protein cytoplasmic
hsa:847,0.0,0.0,0.00012927709333274845,0.00025146379308461355,0.0,0.0023882398,False,CAT;
hsa:5160,2.5806617e-05,0.021490529136369237,0.00013666594348830407,0.00023243952873902435,0.0,0.0011195792,False,PDHA1; pyruvate dehydrogenase E1 subunit alpha
hsa:1442,0.0,0.0,3.191379611163743e-06,1.2539335936747583e-05,0.0,8.2292645e-05,False,CSH1; chorionic somatomammotropin hormone
hsa:114785,4.5592977e-08,3.796767319917648e-05,1.0411040848350876e-05,6.979610220675682e-05,0.0,0.00062434014,False,MBD6; methyl-CpG binding domain protein
hsa:5009,9.871826e-08,8.220789430949719e-05,4.801875584639182e-06,1.3272124551486804e-05,0.0,0.00012428724,False,OTC; ornithine
hsa:275,1.5072293e-05,0.012551492195524662,3.6951506404678335e-05,5.550486897879129e-05,0.0,0.00038375577,False,AMT;
hsa:8542,1.4663085e-06,0.001221072314211346,0.00013373956685099416,0.0003248549787014322,0.0,0.0018613111,False,APOL1; apolipoprotein
hsa:5966,0.0,0.0,1.1786099992637078e-06,4.796968049594144e-06,0.0,5.1302217e-05,False,REL; REL proto-oncogene
hsa:1718,0.0,0.0,4.2922347330877194e-05,0.0001364931773685987,0.0,0.00079541944,False,DHCR24; 24-dehydrocholesterol
hsa:6278,0.0,0.0,3.508060258644444e-06,1.3888551620672097e-05,0.0,0.00010496007,False,S100A7; S100 calcium binding protein
hsa:2729,1.0176761e-05,0.008474724865501205,4.467304176678362e-05,0.00010485367798105093,0.0,0.00093137723,False,GCLC; glutamate-cysteine ligase catalytic
hsa:9976,1.2937595e-08,1.0773816742506192e-05,2.8465788988128667e-07,5.412962433715632e-07,0.0,2.2769443e-06,False,CLEC2B; C-type lectin domain family 2 member
hsa:7474,0.0,0.0,2.1064139580701753e-06,9.088893199186043e-06,0.0,9.170014e-05,False,WNT5A; Wnt family member
hsa:729597,0.0,0.0,2.4967534676140343e-06,6.044150971352371e-06,0.0,3.2310327e-05,False,SPDYE6; speedy/RINGO cell cycle regulator family member
hsa:2987,1.21887584e-08,1.0150221066611143e-05,5.357880105606433e-06,1.7132732128085104e-05,0.0,0.000119598626,False,GUK1; guanylate kinase
hsa:221357,0.0,0.0,3.869098245614035e-09,5.0595024765786406e-08,0.0,6.616158e-07,False,GSTA5; glutathione S-transferase alpha
hsa:390271,0.0,0.0,6.105529177777779e-07,7.142477998089118e-06,0.0,9.313469e-05,False,OR8B3; olfactory receptor family 8 subfamily B member
hsa:6134,9.9709126e-08,8.303304061376627e-05,2.8265097686432756e-07,3.610727119900169e-07,0.0,1.5160799e-06,False,RPL10; ribosomal protein
hsa:9516,3.0355548e-07,0.00025278663559212544,1.7106095009590642e-06,4.101047191873387e-06,0.0,3.6479792e-05,False,LITAF; lipopolysaccharide induced TNF
hsa:10478,5.1702256e-07,0.0004305519158067177,4.508741759497076e-06,6.544414322702265e-06,0.0,2.6826981e-05,False,SLC25A17; solute carrier family 25 member
hsa:7083,0.0,0.0,3.288198644781402e-05,7.132268783645537e-05,0.0,0.000332704,False,TK1; thymidine kinase
hsa:666,4.0193795e-06,0.003347148998835268,0.0003021639676953296,0.0005946401680871697,0.0,0.003103265,False,BOK; BCL2 family apoptosis regulator
hsa:9146,2.1413862e-07,0.00017832450694067726,3.3316577708499424e-05,7.857182420051216e-05,0.0,0.0004309634,False,HGS; hepatocyte growth factor-regulated tyrosine kinase
hsa:259287,-0.0,0.0,2.1735543900584798e-06,2.75806718333959e-05,0.0,0.00036062006,False,TAS2R41; taste 2 receptor member
hsa:10134,1.9966846e-07,0.00016627444260687,8.088267219649123e-07,1.32322285705081e-06,0.0,5.3444924e-06,False,BCAP31; B cell receptor associated protein
hsa:192666,0.0,0.0,1.842110873274854e-08,1.9317291294626712e-07,0.0,2.431421e-06,False,KRT24; keratin
hsa:134083,0.0,0.0,4.316088140350877e-08,5.330500768589494e-07,0.0,6.9603307e-06,False,OR2Y1; olfactory receptor family 2 subfamily Y member
hsa:7850,0.0,0.0,4.704914767836257e-07,2.1802316877395285e-06,0.0,1.8366949e-05,False,IL1R2; interleukin 1 receptor type
hsa:84720,0.0,0.0,2.035864895976608e-05,5.166246997145733e-05,0.0,0.0003976031,False,PIGO; phosphatidylinositol glycan anchor biosynthesis class
hsa:27190,0.0,0.0,1.2850366367836262e-05,3.4399019014622824e-05,0.0,0.00025018599,False,IL17B; interleukin
hsa:137492,0.0,0.0,2.649308037602339e-07,5.134254280421726e-07,0.0,2.3844427e-06,False,VPS37A; VPS37A subunit of
hsa:55744,0.0,0.0,9.982006320268999e-07,2.939223928603452e-06,0.0,1.4199804e-05,False,COA1; cytochrome c oxidase assembly factor
hsa:291,0.0,0.0,4.0967667598245615e-05,0.00014994224372785536,0.0,0.0012100273,False,SLC25A4; solute carrier family 25 member
hsa:283365,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6C6; olfactory receptor family 6 subfamily C member
hsa:10060,0.0,0.0,2.7543358774853803e-05,8.537321446762549e-05,0.0,0.0006393477,False,ABCC9; ATP binding cassette subfamily C member
hsa:57142,4.0874255e-09,3.40381448682284e-06,4.735196723695907e-08,9.854653671505246e-08,0.0,8.9596364e-07,False,RTN4; reticulon
hsa:7166,2.3965106e-07,0.00019957005939568798,1.7100695160526316e-05,3.814149082051984e-05,0.0,0.00034042858,False,TPH1; tryptophan hydroxylase
hsa:435,0.0,0.0,7.355193271403505e-05,0.00014920694811455774,0.0,0.0007858613,False,ASL; argininosuccinate
hsa:5426,4.5212346e-06,0.003765070171873388,3.8434882977982436e-05,9.942291889824173e-05,0.0,0.00066333683,False,POLE; DNA polymerase epsilon
hsa:5080,0.00022471459,0.187131674165671,0.000839179662602339,0.0017820005448379586,0.0,0.013158263,False,PAX6; paired box
hsa:3739,6.129696e-07,0.0005104520692700091,2.0300337017491228e-05,6.336075978830277e-05,0.0,0.0006785136,False,KCNA4; potassium voltage-gated channel subfamily A member
hsa:138883,0.0,0.0,1.1112100011111114e-07,6.532760261155843e-07,0.0,6.1301516e-06,False,OR1N1; olfactory receptor family 1 subfamily N member
hsa:11154,1.0183595e-07,8.480415897228375e-05,1.2714460589999997e-06,3.6052266153245905e-06,0.0,3.526584e-05,False,AP4S1; adaptor related protein complex 4 subunit sigma
hsa:4160,0.0,0.0,9.814311001286547e-06,2.4185564959102863e-05,0.0,0.00018830526,False,MC4R; melanocortin 4
hsa:6256,0.0,0.0,4.0717897660818714e-07,3.1442230340045628e-06,0.0,3.0370858e-05,False,RXRA; retinoid X receptor
hsa:5521,0.0,0.0,1.5175132983801171e-05,3.868854691749377e-05,0.0,0.00024635627,False,PPP2R2B; protein phosphatase 2 regulatory subunit
hsa:3361,0.0,0.0,9.369919164070177e-06,7.54847969958679e-05,0.0,0.0009779833,False,HTR5A; 5-hydroxytryptamine receptor
hsa:9379,2.6226476e-06,0.002184016783843804,3.599317165089474e-05,6.732358383208513e-05,0.0,0.00046740068,False,NRXN2; neurexin
hsa:9978,0.0,0.0,0.0014258412966374268,0.0032961438776173196,0.0,0.01635087,False,RBX1; ring-box
hsa:10891,4.4552307e-06,0.0037101052481073636,3.062280108083331e-05,8.717101389818472e-05,0.0,0.00066592934,False,PPARGC1A; PPARG coactivator 1
hsa:434,0.0,0.0,5.336267493976609e-07,3.340519152708537e-06,0.0,4.0892995e-05,False,ASIP; agouti signaling
hsa:2495,0.0,0.0,0.0004137086096649125,0.001114370615097098,0.0,0.007261085,False,FTH1; ferritin heavy chain
hsa:91807,4.0592724e-07,0.0003380369917709844,2.5841244479473675e-05,8.688425569398961e-05,0.0,0.000664694,False,MYLK3; myosin light chain kinase
hsa:340419,0.0,0.0,2.8871762032748536e-08,1.1314635296339081e-07,0.0,1.0357388e-06,False,RSPO2; R-spondin
hsa:763,-0.0,0.0,6.222455525777779e-06,3.7106135386021106e-05,0.0,0.0004495061,False,CA5A; carbonic anhydrase
hsa:6783,0.0,0.0,2.5615468561878068e-06,1.1259426522371858e-05,0.0,9.830663e-05,False,SULT1E1; sulfotransferase family 1E member
hsa:1215,0.0,0.0,2.5431635209941523e-06,1.2275117036028902e-05,0.0,0.000113820155,False,CMA1; chymase
hsa:57176,0.0,0.0,1.3984985383684208e-06,2.761263593955347e-06,0.0,1.2190652e-05,False,VARS2; valyl-tRNA synthetase 2
hsa:84628,7.77728e-07,0.000647655066302188,1.589771153877194e-05,4.6692333996669236e-05,0.0,0.00028544106,False,NTNG2; netrin
hsa:9051,0.0,0.0,2.6488052356725145e-08,6.712958800019306e-08,0.0,5.189535e-07,False,PSTPIP1; proline-serine-threonine phosphatase interacting protein
hsa:55366,1.6531236e-07,0.00013766430869966255,2.8329639176157884e-06,8.881573294253033e-06,0.0,8.1256134e-05,False,LGR4; leucine rich repeat containing G protein-coupled receptor
hsa:219981,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5A2; olfactory receptor family 5 subfamily A member
hsa:368,2.0040288e-05,0.016688603282066405,8.415927340596488e-05,0.00014543206059220015,0.0,0.000804514,False,ABCC6; ATP binding cassette subfamily C member
hsa:219464,0.0,0.0,1.4680323070175437e-08,1.886363714924174e-07,0.0,2.4666103e-06,False,OR5T2; olfactory receptor family 5 subfamily T member
hsa:4968,0.0,0.0,8.734313116777777e-06,2.5520006727212076e-05,0.0,0.00018906637,False,OGG1; 8-oxoguanine DNA
hsa:5994,2.0620919e-05,0.017172125295935144,0.0002026234251590643,0.000378264624892081,0.0,0.0016903582,False,RFXAP; regulatory factor X associated
hsa:5746,0.0,0.0,4.41519627483069e-06,1.4854350258294665e-05,0.0,9.1535236e-05,False,PTH2R; parathyroid hormone 2
hsa:6455,0.0,0.0,1.639839357245614e-07,4.092926298855493e-07,0.0,2.4360495e-06,False,SH3GL1; SH3 domain containing GRB2 like 1
hsa:406902,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR10A; microRNA
hsa:11231,1.3652057e-06,0.001136878687856969,0.00020117760644664914,0.0005287784918070406,0.0,0.0034720113,False,SEC63; SEC63 homolog
hsa:6045,9.3508234e-08,7.786923126217714e-05,7.770333026433918e-05,0.0002702826730380557,0.0,0.0016844556,False,RNF2; ring finger protein
hsa:5641,7.5873334e-07,0.000631837212525948,6.404024910526316e-06,1.3906442639638414e-05,0.0,8.8562985e-05,False,LGMN;
hsa:387129,0.0,0.0,8.336605881581169e-07,3.365654904530087e-06,0.0,3.773775e-05,False,NPSR1; neuropeptide S receptor
hsa:23401,0.0,0.0,5.083502099415204e-07,1.6395222581567157e-06,0.0,1.5419702e-05,False,FRAT2; FRAT regulator of WNT signaling pathway
hsa:8550,0.0,0.0,2.5729273343157897e-07,4.93390158494983e-07,0.0,3.7734412e-06,False,MAPKAPK5; MAPK activated protein kinase
hsa:3866,4.0893042e-08,3.405378979258579e-05,6.79702778986199e-06,1.920010857945055e-05,0.0,0.00016625316,False,KRT15; keratin
hsa:10861,2.8149099e-08,2.344123726957478e-05,8.007881118365496e-08,1.3871333545695832e-07,0.0,8.3561605e-07,False,SLC26A1; solute carrier family 26 member
hsa:8735,0.0,0.0,1.2900746183122223e-09,1.341699382456384e-08,0.0,1.7114435e-07,False,MYH13; myosin heavy chain
hsa:119682,0.0,0.0,7.430975438596491e-08,9.717261296632498e-07,0.0,1.2706968e-05,False,OR51L1; olfactory receptor family 51 subfamily L member
hsa:673,0.0006330391,0.5271649989229877,0.0008434008594444441,0.0008390745903873538,0.0,0.004972608,True,BRAF; B-Raf proto-oncogene
hsa:5507,0.0,0.0,5.236629982456141e-07,1.4752862561254172e-06,0.0,1.0521383e-05,False,PPP1R3C; protein phosphatase 1 regulatory subunit
hsa:6464,1.849128e-05,0.015398662738659688,0.0001599912840526316,0.00026256603387032055,0.0,0.0014789157,False,SHC1; SHC adaptor protein
hsa:55127,0.0,0.0,5.378462302327485e-07,1.4892684870539818e-06,0.0,7.1027926e-06,False,HEATR1; HEAT repeat containing
hsa:26248,1.2409155e-05,0.01033375692308767,0.00017041186080307016,0.000415748285049826,0.0,0.0026096236,False,OR2K2; olfactory receptor family 2 subfamily K member
hsa:481,0.0020098402,1.6736997870564034,0.0025751773827549706,0.0028909398947138225,0.0,0.026028756,True,ATP1B1; ATPase Na+/K+ transporting subunit beta
hsa:6495,0.0,0.0,4.280688611929825e-09,1.6450496407425866e-08,0.0,1.276654e-07,False,SIX1; SIX homeobox
hsa:1908,1.8058445e-08,1.5038218237982194e-05,7.355139273625148e-06,4.0706904720173174e-05,0.0,0.00039233107,False,EDN3; endothelin
hsa:1236,3.854423e-05,0.032097810334997305,0.00021911035097561392,0.00044656449303967077,0.0,0.002581562,False,CCR7; C-C motif chemokine receptor
hsa:7349,4.4702116e-08,3.7225806325383805e-05,6.646207923345027e-06,1.501210787179724e-05,0.0,8.776664e-05,False,UCN;
hsa:5371,0.0,0.0,5.400882365672514e-06,2.0494342277972272e-05,0.0,0.00020786174,False,PML; PML nuclear body
hsa:4716,0.0,0.0,1.7864103088888896e-06,3.218382592176931e-06,0.0,1.5029018e-05,False,NDUFB10; NADH:ubiquinone oxidoreductase subunit
hsa:27338,0.0,0.0,4.4193694935087725e-07,1.3686585527765688e-06,0.0,7.842416e-06,False,UBE2S; ubiquitin conjugating enzyme E2
hsa:22,0.0,0.0,0.00014541703664912282,0.0003305872419940818,0.0,0.0018492452,False,ABCB7; ATP binding cassette subfamily B member
hsa:6934,6.5205622e-06,0.005430015563241314,3.8485979660818717e-05,9.998727557497494e-05,0.0,0.0010500606,False,TCF7L2; transcription factor 7 like
hsa:5693,0.0,0.0,3.1302025314619875e-06,1.4949469084997429e-05,0.0,0.00016685194,False,PSMB5; proteasome 20S subunit beta
hsa:1890,0.0,0.0,5.694845627017546e-05,0.00017851304722226095,0.0,0.0010595797,False,TYMP; thymidine
hsa:1329,0.0,0.0,0.0004428768577211695,0.0012893715588996025,0.0,0.0075362213,False,COX5B; cytochrome c oxidase subunit
hsa:3655,0.0,0.0,8.746325369883038e-05,0.00021898048864714677,0.0,0.0012620486,False,ITGA6; integrin subunit alpha
hsa:694,4.2171334e-07,0.00035118290864957557,1.4546273615730992e-06,3.263233465206533e-06,0.0,1.9035684e-05,False,BTG1; BTG anti-proliferation factor
hsa:25834,0.0,0.0,8.6321760928924e-05,0.0002707332574338194,0.0,0.0019474176,False,MGAT4C; MGAT4 family member
hsa:6512,0.0,0.0,9.738439907333333e-06,3.389982886676127e-05,0.0,0.0002771166,False,SLC1A7; solute carrier family 1 member
hsa:29086,0.0,0.0,1.4166871019730992e-06,3.987258837117031e-06,0.0,3.0205574e-05,False,BABAM1; BRISC and BRCA1 A complex member
hsa:409,0.0,0.0,0.0002284802660754386,0.00046766283961714765,0.0,0.002180194,False,ARRB2; arrestin beta
hsa:6193,4.863479e-09,4.050075108783918e-06,1.4289591992105261e-06,2.537392025229371e-06,0.0,1.1953561e-05,False,RPS5; ribosomal protein
hsa:9179,0.0,0.0,2.673150721695906e-06,4.476919307991369e-06,0.0,2.13657e-05,False,AP4M1; adaptor related protein complex 4 subunit mu
hsa:101954272,0.0,0.0,2.1096533017543862e-08,8.850569565495089e-08,0.0,8.167239e-07,False,RNVU1-3; RNA
hsa:3689,0.0,0.0,7.912166025672515e-05,0.0001361178846149178,0.0,0.00069163344,False,ITGB2; integrin subunit beta
hsa:83547,2.6734645e-08,2.226334692854116e-05,4.283742907508772e-07,6.657308170329924e-07,0.0,2.802391e-06,False,RILP; Rab interacting lysosomal
hsa:133121,0.0,0.0,9.765889958713448e-07,4.029961181439034e-06,0.0,4.0724135e-05,False,ENPP6; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:7390,2.7983993e-05,0.023303744807715503,0.0002643191782553216,0.0004518987510696134,0.0,0.0024620402,False,UROS; uroporphyrinogen III
hsa:2167,0.0,0.0,9.177430135497076e-06,3.9458241185089526e-05,0.0,0.000304787,False,FABP4; fatty acid binding protein
hsa:2688,0.0,0.0,1.9214967226473686e-06,8.370377233692928e-06,0.0,0.00010037363,False,GH1; growth hormone
hsa:886,0.0,0.0,4.340541493941521e-06,2.6689607016792674e-05,0.0,0.00033260076,False,CCKAR; cholecystokinin A
hsa:140803,0.0,0.0,3.350447315068305e-07,9.100455009914582e-07,0.0,5.4760926e-06,False,TRPM6; transient receptor potential cation channel subfamily M member
hsa:26494,0.0,0.0,1.0815564678362573e-07,8.69936339102658e-07,0.0,8.333849e-06,False,OR8G1; olfactory receptor family 8 subfamily G member
hsa:7153,1.5224905e-06,0.0012678580245560807,1.3062355258415204e-05,2.7189339538136454e-05,0.0,0.00016381587,False,TOP2A; DNA topoisomerase II
hsa:2060,0.0,0.0,4.4770168450116963e-07,1.165562900961154e-06,0.0,1.150805e-05,False,EPS15; epidermal growth factor receptor pathway substrate
hsa:9985,4.2746557e-08,3.559730935240246e-05,1.3010043603801173e-06,2.396860019165754e-06,0.0,1.2915054e-05,False,REC8; REC8 meiotic recombination
hsa:346517,-0.0,0.0,1.2893639937251462e-06,6.900772297471513e-06,0.0,6.7150366e-05,False,OR6V1; olfactory receptor family 6 subfamily V member
hsa:22794,0.0,0.0,2.988776987994153e-07,7.041930697757528e-07,0.0,2.6335404e-06,False,CASC3; CASC3 exon junction complex
hsa:401665,0.0,0.0,1.3162195029239766e-08,1.612517365976702e-07,0.0,2.1044184e-06,False,OR51T1; olfactory receptor family 51 subfamily T member
hsa:54947,3.623474e-06,0.0030174576377785733,2.8103879349923977e-05,5.784652628152343e-05,0.0,0.0002761943,False,LPCAT2; lysophosphatidylcholine acyltransferase
hsa:79718,3.1805902e-07,0.00026486449720996153,7.40131573851462e-06,2.2420488150083796e-05,0.0,0.0001381641,False,TBL1XR1; TBL1X/Y related
hsa:3683,5.3364813e-05,0.04443969035667851,0.0001382658137415205,0.0002627164893436816,0.0,0.0022155656,False,ITGAL; integrin subunit alpha
hsa:4706,2.3684613e-06,0.001972342464570732,0.0001815973553100058,0.0005526868053089261,0.0,0.003032501,False,NDUFAB1; NADH:ubiquinone oxidoreductase subunit
hsa:390436,0.0,0.0,4.264703918128655e-08,5.576824020973422e-07,0.0,7.2926437e-06,False,OR4K17; olfactory receptor family 4 subfamily K member
hsa:140465,9.05245e-06,0.007538451881566874,0.00025913218779742683,0.0005687895093583021,0.0,0.0042685815,False,MYL6B; myosin light chain
hsa:162963,0.0,0.0,5.7010788621637426e-08,1.1560003027221468e-07,0.0,5.07247e-07,False,ZNF610; zinc finger protein
hsa:7633,0.0,0.0,5.2530597661988306e-08,9.109552906595177e-08,0.0,3.5582914e-07,False,ZNF79; zinc finger protein
hsa:654,0.0,0.0,9.922664877719296e-06,4.7726441905339344e-05,0.0,0.00037269038,False,BMP6; bone morphogenetic protein
hsa:3156,1.2083185e-05,0.01006230453618309,0.00025775896284345044,0.0007810409917128826,0.0,0.0051617636,False,HMGCR; 3-hydroxy-3-methylglutaryl-CoA
hsa:10022,2.658799e-08,2.2141219586143113e-05,7.88639050935497e-06,2.3668399217006655e-05,0.0,0.00018048288,False,INSL5; insulin like
hsa:4012,6.453463e-05,0.05374138525478982,0.00023353327333333314,0.00038274462689154423,0.0,0.0018419685,False,LNPEP; leucyl and cystinyl
hsa:80336,5.040202e-07,0.00041972416583772475,4.672326024236373e-05,0.00017279781745157809,0.0,0.0013153398,False,PABPC1L; poly(A) binding protein cytoplasmic 1
hsa:56681,0.0,0.0,1.3997977376959058e-05,3.286331710054687e-05,0.0,0.00019616882,False,SAR1A; secretion associated Ras related GTPase
hsa:8600,2.236629e-06,0.0018625587651317638,1.854483277911111e-05,5.015179738127023e-05,0.0,0.00036805603,False,TNFSF11; TNF superfamily member
hsa:6392,0.0,0.0,2.110043980642105e-06,4.103786884077253e-06,0.0,2.2294491e-05,False,SDHD; succinate dehydrogenase complex subunit
hsa:9879,0.0,0.0,1.705910793333334e-07,3.0289466653065504e-07,0.0,1.3399952e-06,False,DDX46; DEAD-box helicase
hsa:5155,0.0,0.0,9.946404988888888e-06,3.3165508114206186e-05,0.0,0.00033527156,False,PDGFB; platelet derived growth factor subunit
hsa:125965,2.733091e-07,0.0002275988819760782,5.4145218342508804e-05,0.0001535991751389871,0.0,0.0013117231,False,COX6B2; cytochrome c oxidase subunit
hsa:5187,0.0,0.0,7.283354087134504e-05,0.00018911142848315027,0.0,0.0009736219,False,PER1; period circadian regulator
hsa:358,0.0,0.0,0.00014558517521380117,0.00038231222334213417,0.0,0.0021238425,False,AQP1; aquaporin 1 (Colton blood
hsa:5692,0.0,0.0,5.901090849122809e-06,1.54207722389582e-05,0.0,9.2432e-05,False,PSMB4; proteasome 20S subunit beta
hsa:51179,0.0,0.0,7.04634222388889e-07,4.562745462940864e-06,0.0,5.792571e-05,False,HAO2; hydroxyacid oxidase
hsa:717,8.57631e-06,0.007141945026639286,4.888786335666665e-05,9.857701196760952e-05,0.0,0.00064137625,False,C2; complement
hsa:5707,4.273302e-07,0.0003558603637954751,9.134950973099412e-06,2.2865108402355335e-05,0.0,0.00015133304,False,PSMD1; proteasome 26S subunit
hsa:4041,1.2913079e-05,0.010753400978118817,3.129185430906432e-05,7.328461516004593e-05,0.0,0.0006619787,False,LRP5; LDL receptor related protein
hsa:6845,0.0,0.0,4.116706583827484e-06,9.738774767317858e-06,0.0,6.093303e-05,False,VAMP7; vesicle associated membrane protein
hsa:55813,4.402201e-07,0.00036659446239952246,2.0003872722928662e-06,3.474491603932399e-06,0.0,2.3297778e-05,False,UTP6; UTP6 small subunit processome
hsa:54434,9.559604e-08,7.960785727712853e-05,6.324361605625732e-06,1.8009618806707132e-05,0.0,0.00010925272,False,SSH1; slingshot protein phosphatase
hsa:6817,0.0,0.0,6.765528709356726e-06,1.7549252130247823e-05,0.0,0.00011059796,False,SULT1A1; sulfotransferase family 1A member
hsa:29079,0.0,0.0,4.275334560526315e-06,9.870815169925675e-06,0.0,7.120244e-05,False,MED4; mediator complex subunit
hsa:22829,0.0,0.0,1.551524689661404e-06,7.933799701046848e-06,0.0,8.326154e-05,False,NLGN4Y; neuroligin 4
hsa:113878,0.0,0.0,5.3728131650877186e-06,2.4920578650223785e-05,0.0,0.00022380114,False,DTX2; deltex E3 ubiquitin ligase
hsa:3091,0.0,0.0,4.8842739130409354e-05,0.0002031429031462601,0.0,0.0024825786,False,HIF1A; hypoxia inducible factor 1 subunit
hsa:2001,0.0,0.0,1.5919264198824565e-06,1.4096030603386218e-05,0.0,0.00017948085,False,ELF5; E74 like ETS transcription factor
hsa:79473,0.0,0.0,6.953678818713451e-08,3.0909956967296625e-07,-0.0,2.9965815e-06,False,OR52N1; olfactory receptor family 52 subfamily N member
hsa:388566,0.0,0.0,1.805553694912281e-08,3.682791432641913e-08,0.0,1.7937207e-07,False,ZNF470; zinc finger protein
hsa:60490,0.0,0.0,3.46458833175731e-05,8.782627863858838e-05,0.0,0.00047518616,False,PPCDC; phosphopantothenoylcysteine
hsa:116519,0.0,0.0,1.5954391728830416e-06,5.635016136257508e-06,0.0,4.0500337e-05,False,APOA5; apolipoprotein
hsa:148581,0.0,0.0,1.394752169766082e-09,7.10571560332503e-09,0.0,5.961238e-08,False,UBE2U; ubiquitin conjugating enzyme E2
hsa:6203,0.0,0.0,3.2636061248538023e-07,6.937634443821375e-07,0.0,3.2191674e-06,False,RPS9; ribosomal protein
hsa:9023,0.0,0.0,1.3816228422807013e-06,6.388445491936432e-06,0.0,7.089405e-05,False,CH25H; cholesterol
hsa:5624,0.0,0.0,1.2716522270000003e-06,5.372826010288158e-06,0.0,6.413595e-05,False,PROC; protein C
hsa:120775,0.0,0.0,4.073334417251462e-07,3.007825877504041e-06,0.0,3.5708526e-05,False,OR2D3; olfactory receptor family 2 subfamily D member
hsa:4707,2.0566574e-06,0.001712686935223993,3.350334033567251e-06,4.1605152087769125e-06,0.0,2.1477288e-05,False,NDUFB1; NADH:ubiquinone oxidoreductase subunit
hsa:10594,1.3171432e-08,1.0968545127930022e-05,1.4550159068467832e-06,4.574547519691463e-06,0.0,2.865445e-05,False,PRPF8; pre-mRNA processing factor
hsa:599,0.0,0.0,5.133551665473685e-07,1.39304487340689e-06,0.0,7.0505494e-06,False,BCL2L2; BCL2 like
hsa:7031,0.0,0.0,1.2175489873333333e-07,1.3118098964243775e-06,0.0,1.668335e-05,False,TFF1; trefoil factor
hsa:220074,1.3748571e-05,0.01144915916948514,0.00018545869053567264,0.00032569927115467053,0.0,0.0016156131,False,LRTOMT; leucine rich transmembrane and O-methyltransferase domain
hsa:407006,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR221; microRNA
hsa:219432,0.0,0.0,2.019487281871345e-07,2.264971903720497e-06,-0.0,2.92205e-05,False,OR4C6; olfactory receptor family 4 subfamily C member
hsa:5892,6.0510025e-08,5.038988470689246e-05,1.7259189796052635e-05,3.6641718425397904e-05,0.0,0.00023435883,False,RAD51D; RAD51 paralog
hsa:91445,3.5985476e-08,2.9967001116966077e-05,8.251425202080117e-07,1.6949162661378533e-06,0.0,9.188031e-06,False,RNF185; ring finger protein
hsa:3835,0.0,0.0,4.844671719718123e-05,0.0001582138158693732,0.0,0.0007812998,False,KIF22; kinesin family member
hsa:1158,0.0,0.0,1.3437310526643274e-06,1.2240125070481166e-05,0.0,0.0001575129,False,CKM; creatine kinase
hsa:6161,0.0,0.0,5.391090973625731e-07,1.103130109851864e-06,0.0,5.377237e-06,False,RPL32; ribosomal protein
hsa:5914,8.7712016e-07,0.0007304241526340645,6.639755336438595e-05,0.00014834117780414952,0.0,0.0007404087,False,RARA; retinoic acid receptor
hsa:56616,5.7147736e-07,0.0004758992957447839,0.0009434005062614505,0.0014493507944711962,0.0,0.00708115,False,DIABLO; diablo IAP-binding mitochondrial
hsa:123096,0.0,0.0,2.5306365128070166e-07,4.6872645370078534e-07,0.0,1.7433146e-06,False,SLC25A29; solute carrier family 25 member
hsa:50943,4.9260482e-08,4.102179776964149e-05,9.27890571633918e-06,2.5140749501993692e-05,0.0,0.00020409131,False,FOXP3; forkhead box
hsa:54795,0.0,0.0,1.695600336959064e-06,5.281720259442664e-06,0.0,4.7581394e-05,False,TRPM4; transient receptor potential cation channel subfamily M member
hsa:147495,0.0,0.0,5.069418908945616e-06,1.5104872244061609e-05,0.0,0.00010703236,False,APCDD1; APC down-regulated
hsa:693210,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR625; microRNA
hsa:572,0.00016774054,0.13968638207093587,0.00027033264379356737,0.0003575736185649391,0.0,0.0022962585,False,BAD; BCL2 associated agonist of cell
hsa:623,1.5685391e-05,0.013062051190237128,4.3770399888339174e-05,7.199695922552417e-05,0.0,0.00053169543,False,BDKRB1; bradykinin receptor
hsa:8395,0.0,0.0,5.618078493274853e-07,1.3436006716412687e-06,0.0,1.2423635e-05,False,PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:8372,1.722909e-07,0.0001434757064973405,4.9254555206023395e-05,0.0001033111523777348,0.0,0.00060473674,False,HYAL3; hyaluronidase
hsa:268,7.951308e-05,0.06621472944177294,0.00023030227807491224,0.0003576012157965408,0.0,0.0018882595,False,AMH; anti-Mullerian
hsa:280,0.000336359,0.2801038543633991,0.0007424036638210526,0.001139192533621987,0.0,0.008553291,False,AMY2B; amylase alpha
hsa:23327,4.090192e-07,0.0003406118297076457,0.00012127813964426897,0.0004157782499040616,0.0,0.004247298,False,NEDD4L; NEDD4 like E3 ubiquitin protein
hsa:2147,8.8810447e-07,0.0007395713660831544,1.3246980596976611e-05,6.153393880272312e-05,0.0,0.00060749555,False,F2; coagulation factor II
hsa:55775,0.0,0.0,4.03635812078889e-05,9.955204566255684e-05,0.0,0.00055774685,False,TDP1; tyrosyl-DNA phosphodiesterase
hsa:84634,0.0,0.0,6.739989191099417e-06,2.1191431364231614e-05,0.0,0.00016737453,False,KISS1R; KISS1
hsa:5691,0.0,0.0,2.3630915676608186e-06,7.037031986612459e-06,0.0,7.4045965e-05,False,PSMB3; proteasome 20S subunit beta
hsa:283358,3.6981186e-07,0.0003079618127515474,2.2113693219894736e-05,7.805197229171015e-05,0.0,0.00064088707,False,B4GALNT3; beta-1
hsa:2555,0.0,0.0,1.0756644924725145e-05,4.9885800380816434e-05,0.0,0.00040321646,False,GABRA2; gamma-aminobutyric acid type A receptor subunit
hsa:3857,0.0,0.0,1.2921496341169585e-05,7.60910641623316e-05,0.0,0.0009571121,False,KRT9; keratin
hsa:2138,4.06314e-09,3.3835906719252385e-06,3.1272735160237714e-05,9.056571931390178e-05,0.0,0.00069008383,False,EYA1; EYA transcriptional coactivator and phosphatase
hsa:1472,-0.0,0.0,7.42986949866082e-07,5.074580401287814e-06,0.0,5.670196e-05,False,CST4; cystatin
hsa:338339,0.0,0.0,3.7442062359274844e-07,1.4907587080953426e-06,0.0,1.4947209e-05,False,CLEC4D; C-type lectin domain family 4 member
hsa:51343,0.0,0.0,5.215697279122807e-06,2.7282751117838473e-05,0.0,0.0003490015,False,FZR1; fizzy and cell division cycle 20 related
hsa:8694,0.00011859316,0.0987587702934522,0.0008567214534754388,0.0012456574671059985,0.0,0.00672448,False,DGAT1; diacylglycerol O-acyltransferase
hsa:7175,1.472195e-05,0.012259743127864108,6.108095370666672e-05,0.00014477270474926626,0.0,0.0010598568,False,TPR; translocated promoter region
hsa:55294,0.0,0.0,4.1250589436842107e-07,6.848512708438128e-07,0.0,3.3552992e-06,False,FBXW7; F-box and WD repeat domain containing
hsa:27044,0.0,0.0,8.030551166666668e-08,1.977212635061262e-07,0.0,1.3619597e-06,False,SND1; staphylococcal nuclease and tudor domain containing
hsa:94039,0.0,0.0,4.317648443836257e-08,9.309299260863929e-08,0.0,5.0685196e-07,False,ZNF101; zinc finger protein
hsa:26091,3.9347952e-08,3.276711197412889e-05,3.1561404889064326e-07,5.979109859922379e-07,0.0,3.548238e-06,False,HERC4; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:4502,0.0,0.0,8.083414209356725e-05,0.0001901407101319589,0.0,0.0011159051,False,MT2A; metallothionein
hsa:79720,2.2455373e-08,1.8699771757163637e-05,3.384138760239766e-07,6.650180620243094e-07,0.0,3.3480492e-06,False,VPS37B; VPS37B subunit of
hsa:79868,6.661292e-08,5.5472086795360775e-05,0.00020180856370845032,0.0005879654656971572,0.0,0.0030386546,False,ALG13; ALG13 UDP-N-acetylglucosaminyltransferase
hsa:1850,0.0,0.0,5.4361434015046785e-05,0.00018553271201894635,0.0,0.0020840513,False,DUSP8; dual specificity phosphatase
hsa:2115,0.0,0.0,7.985433337836259e-08,3.377729785654377e-07,0.0,2.7993376e-06,False,ETV1; ETS variant transcription factor
hsa:442903,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR331; microRNA
hsa:10928,1.838067e-06,0.0015306551966148367,1.0484484731403511e-05,1.870955228236766e-05,0.0,0.00011589411,False,RALBP1; ralA binding protein
hsa:1943,2.2629051e-07,0.00018844402574885554,3.24996872812415e-05,0.00011503996965383023,0.0,0.0010701261,False,EFNA2; ephrin
hsa:4486,2.515173e-07,0.00020945170240450046,3.398352509683039e-06,1.1513355882797713e-05,0.0,9.408204e-05,False,MST1R; macrophage stimulating 1
hsa:5430,0.0,0.0,4.106836489304093e-05,0.00010398310188568154,0.0,0.0005910434,False,POLR2A; RNA polymerase II subunit
hsa:8742,0.0,0.0,1.0576739528654968e-05,2.4769840114347023e-05,0.0,0.0001439707,False,TNFSF12; TNF superfamily member
hsa:10758,0.0,0.0,4.323201379643275e-05,0.00011211094311659186,0.0,0.00064875185,False,TRAF3IP2; TRAF3 interacting protein
hsa:4595,0.0,0.0,1.3305281418567246e-06,3.4944262068056684e-06,0.0,1.8575687e-05,False,MUTYH; mutY DNA
hsa:84448,3.7514667e-08,3.1240439000768266e-05,1.049268839119065e-05,3.4779460408414925e-05,0.0,0.0002334234,False,ABLIM2; actin binding LIM protein family member
hsa:57805,0.0,0.0,2.4974791507479528e-05,7.882867907204953e-05,0.0,0.0005589627,False,CCAR2; cell cycle and apoptosis regulator
hsa:147945,0.0,0.0,3.798752988888889e-09,1.83608111916648e-08,0.0,2.0086487e-07,False,NLRP4; NLR family pyrin domain containing
hsa:4920,0.0,0.0,5.528931562502923e-07,1.960038718974133e-06,0.0,1.835558e-05,False,ROR2; receptor tyrosine kinase like orphan receptor
hsa:4709,0.0,0.0,2.145430122339181e-06,4.49522104990085e-06,0.0,2.7759485e-05,False,NDUFB3; NADH:ubiquinone oxidoreductase subunit
hsa:574476,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520C; microRNA
hsa:64895,0.0,0.0,1.1613457242807017e-07,2.0538010792476267e-07,0.0,8.056341e-07,False,PAPOLG; poly(A) polymerase
hsa:80233,0.0,0.0,0.00025976974394842107,0.0007702176229068518,0.0,0.005241603,False,FAAP100; FA core complex associated protein
hsa:7373,0.0,0.0,2.9677581507017543e-06,1.2784297999259476e-05,0.0,0.0001275577,False,COL14A1; collagen type XIV alpha 1
hsa:8647,4.9675523e-06,0.004136742426936006,4.71880901397076e-05,0.0001470577797384548,0.0,0.001459415,False,ABCB11; ATP binding cassette subfamily B member
hsa:5148,2.2014447e-05,0.01833258945465639,0.0001296661112274854,0.00020975558703949015,0.0,0.0011429864,False,PDE6G; phosphodiesterase
hsa:404281,0.0,0.0,1.7661350165181871e-06,1.1719084579844563e-05,0.0,0.00013325855,False,YY2; YY2 transcription
hsa:5393,0.0,0.0,1.9666311275421052e-05,7.748476398773539e-05,0.0,0.00066546886,False,EXOSC9; exosome component
hsa:10020,4.663067e-06,0.0038831814812589297,0.00017197424174566665,0.00038898110924456716,0.0,0.0027570848,False,GNE; glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine
hsa:269,1.061448e-05,0.008839236530204967,7.158110485861987e-05,0.00014031810785994519,0.0,0.00094294245,False,AMHR2; anti-Mullerian hormone receptor type
hsa:10948,0.0,0.0,7.437657576315789e-05,0.00015149537182558752,0.0,0.00092804024,False,STARD3; StAR related lipid transfer domain containing
hsa:7748,8.826682e-09,7.35044297741412e-06,1.8577223644573098e-07,3.218573554185691e-07,0.0,1.4477506e-06,False,ZNF195; zinc finger protein
hsa:6326,0.000596252,0.49653044328198576,0.0012552675933286547,0.0018602060831676955,0.0,0.0109485295,True,SCN2A; sodium voltage-gated channel alpha subunit
hsa:63971,1.7300898e-08,1.4407368953255371e-05,9.984489502953217e-08,1.6005509170849147e-07,0.0,1.0583951e-06,False,KIF13A; kinesin family member
hsa:317,0.0004568209,0.380418822876025,0.0007621065252871348,0.0009335589408503634,0.0,0.004576055,False,APAF1; apoptotic peptidase activating factor
hsa:360,0.0,0.0,2.67193992553041e-05,9.090320146908753e-05,0.0,0.0006318647,False,AQP3; aquaporin 3 (Gill blood
hsa:5058,0.0,0.0,0.0007648541894736842,0.0015815778422918689,0.0,0.013602278,False,PAK1; p21 (RAC1) activated kinase
hsa:65243,1.3663131e-08,1.1378008781605497e-05,8.972643092456141e-08,1.9990584497495613e-07,0.0,1.1733846e-06,False,ZFP69B; ZFP69 zinc finger protein
hsa:127396,2.128905e-08,1.7728513168177813e-05,5.2717705304327494e-08,7.595020859251416e-08,0.0,4.3257853e-07,False,ZNF684; zinc finger protein
hsa:6155,1.912752e-07,0.00015928493295594895,2.1861511347122813e-06,3.8109892964006717e-06,0.0,1.8597479e-05,False,RPL27; ribosomal protein
hsa:53342,0.0,0.0,2.250732115029239e-06,8.748765274613903e-06,0.0,8.642303e-05,False,IL17D; interleukin
hsa:117579,0.0,0.0,4.4395018897076025e-08,3.374196626484576e-07,0.0,3.8168296e-06,False,RLN3; relaxin
hsa:2222,5.5153155e-06,0.004592893692692028,8.900083041812863e-06,1.1120624904041157e-05,0.0,6.792698e-05,False,FDFT1; farnesyl-diphosphate farnesyltransferase
hsa:2990,0.0,0.0,3.444107459298245e-05,0.0001305941528000348,0.0,0.00094442174,False,GUSB; glucuronidase
hsa:3983,0.0,0.0,2.3385491125146213e-07,6.309852358380018e-07,0.0,3.5687035e-06,False,ABLIM1; actin binding LIM protein
hsa:92597,0.00015445886,0.12862602762696004,0.0003508430271280701,0.00058919155391314,0.0,0.0057202717,False,MOB1B; MOB kinase activator
hsa:1142,0.0,0.0,3.926925581780117e-09,1.978866163457757e-08,0.0,1.7733512e-07,False,CHRNB3; cholinergic receptor nicotinic beta 3
hsa:6228,0.0,0.0,7.778925644011695e-07,1.3678377516581127e-06,0.0,6.1150245e-06,False,RPS23; ribosomal protein
hsa:2692,0.0,0.0,1.1769604998596495e-07,3.921133804502094e-07,0.0,3.5295197e-06,False,GHRHR; growth hormone releasing hormone
hsa:57519,0.0,0.0,4.718791697836257e-08,1.4633737523344234e-07,0.0,8.723769e-07,False,STARD9; StAR related lipid transfer domain containing
hsa:3146,0.0,0.0,0.0002651444698450292,0.0008447769032707342,0.0,0.0046654693,False,HMGB1; high mobility group box
hsa:2968,0.0,0.0,2.741701080701754e-06,6.549193350466063e-06,0.0,3.6733574e-05,False,GTF2H4; general transcription factor IIH subunit
hsa:8707,0.0,0.0,2.7313693192222225e-06,8.545623918324776e-06,0.0,6.834883e-05,False,B3GALT2; beta-1
hsa:7431,9.111242e-09,7.587411076372819e-06,3.59366690245614e-07,4.83491941563998e-07,0.0,2.1648368e-06,False,VIM;
hsa:9861,0.0,0.0,2.92090659019883e-06,8.68087579698373e-06,0.0,8.6054824e-05,False,PSMD6; proteasome 26S subunit
hsa:728,0.0,0.0,1.912627694701754e-05,8.293367270986474e-05,0.0,0.00077640504,False,C5AR1; complement C5a receptor
hsa:3915,0.0,0.0,2.604626675438596e-06,9.425434718714694e-06,0.0,7.0700444e-05,False,LAMC1; laminin subunit gamma
hsa:56893,0.0,0.0,3.7812052761111104e-07,1.154827658048852e-06,0.0,8.285999e-06,False,UBQLN4; ubiquilin
hsa:488,6.214322e-05,0.0517499321990869,0.0003224639159239767,0.0004846320412361351,0.0,0.002631483,False,ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:23175,2.8871875e-05,0.024043130911312802,0.00013082635460584798,0.00022554385904137116,0.0,0.0014277741,False,LPIN1; lipin
hsa:374654,6.688932e-05,0.055702259632555685,0.00011803411803192976,0.0001701049570952292,0.0,0.001232074,False,KIF7; kinesin family member
hsa:811,0.0,0.0,7.425017157098245e-05,0.0003490632583689007,0.0,0.0040718312,False,CALR;
hsa:81697,-0.0,0.0,9.442249612865498e-07,5.565302467794869e-06,0.0,5.3585856e-05,False,OR2B2; olfactory receptor family 2 subfamily B member
hsa:56886,9.2751273e-10,7.723886997051327e-07,4.947265020488304e-07,1.5279205694219422e-06,0.0,7.790972e-06,False,UGGT1; UDP-glucose glycoprotein glucosyltransferase
hsa:27350,0.0,0.0,4.2640791582456145e-06,9.65739081448465e-06,0.0,6.5556604e-05,False,APOBEC3C; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:1581,0.0,0.0,1.602930105116959e-06,1.9823288098519995e-05,0.0,0.00025927022,False,CYP7A1; cytochrome P450 family 7 subfamily A member
hsa:3804,0.0,0.0,2.417820309005848e-07,7.862580549395084e-07,0.0,5.1959555e-06,False,KIR2DL3; killer cell immunoglobulin like receptor
hsa:3884,0.0,0.0,1.791541926374269e-07,1.5226457492024598e-06,0.0,1.881279e-05,False,KRT33B; keratin
hsa:25946,0.0,0.0,1.7971280459026894e-05,5.6142235089643206e-05,0.0,0.00047980866,False,ZNF385A; zinc finger protein
hsa:10533,1.2572936e-07,0.00010470145987662995,0.0006521516004684795,0.002110263110937076,0.0,0.013928602,False,ATG7; autophagy related
hsa:11332,1.704053e-05,0.014190546806819896,0.0005218867253380116,0.001502096823743238,0.0,0.007909838,False,ACOT7; acyl-CoA thioesterase
hsa:5298,2.2943166e-07,0.000191059826789213,4.551225114502925e-06,9.0986968020611e-06,0.0,4.689557e-05,False,PI4KB; phosphatidylinositol 4-kinase
hsa:8659,0.0,0.0,1.3636421272777778e-05,2.9066405378642325e-05,0.0,0.0001804871,False,ALDH4A1; aldehyde dehydrogenase 4 family member
hsa:10342,0.0,0.0,1.6054865885584797e-05,2.9121186158220188e-05,0.0,0.0002192637,False,TFG; trafficking from ER to golgi
hsa:5730,6.489434e-06,0.005404093471668338,5.77861302976608e-05,0.00012581967733748644,0.0,0.00080275506,False,PTGDS; prostaglandin D2
hsa:225,7.903278e-05,0.06581475833575007,0.00041079314904444444,0.0007846549595496112,0.0,0.0062978505,False,ABCD2; ATP binding cassette subfamily D member
hsa:885,0.0,0.0,6.00065869766082e-07,5.457318891489534e-06,0.0,6.846945e-05,False,CCK;
hsa:912,3.069865e-06,0.0025564382664810398,1.720659723800234e-05,3.900531777678609e-05,0.0,0.0002745704,False,CD1D; CD1d
hsa:7771,0.0,0.0,2.2222802575730977e-08,3.0317561795956804e-08,0.0,1.6623306e-07,False,ZNF112; zinc finger protein
hsa:2313,0.0,0.0,6.248389403949533e-06,2.596379929191414e-05,0.0,0.00020910705,False,FLI1; Fli-1 proto-oncogene
hsa:1235,1.7625078e-06,0.0014677330712885783,7.086767567487723e-05,0.00016970533641429483,0.0,0.0012052822,False,CCR6; C-C motif chemokine receptor
hsa:10126,6.336743e-08,5.276939634171491e-05,3.6034054817736854e-06,1.0911823474419817e-05,0.0,5.5237193e-05,False,DNAL4; dynein axonemal light chain
hsa:22869,0.0,0.0,7.236354039181285e-08,1.5287885232506382e-07,0.0,7.379647e-07,False,ZNF510; zinc finger protein
hsa:3818,1.2865127e-07,0.0001071346882222457,2.6062158412485376e-06,7.433572782418225e-06,0.0,5.7470086e-05,False,KLKB1; kallikrein
hsa:83464,3.5219398e-07,0.0002932904761923596,0.0001444906098687134,0.0002811635751772098,0.0,0.0012474571,False,APH1B; aph-1 homolog B
hsa:26259,0.0,0.0,1.2243755783801166e-07,3.459267506209488e-07,0.0,2.1194662e-06,False,FBXW8; F-box and WD repeat domain containing
hsa:84449,0.0,0.0,1.4273719370175438e-07,3.6203326218028487e-07,0.0,1.8822067e-06,False,ZNF333; zinc finger protein
hsa:551,0.0,0.0,1.992507840584795e-06,6.674942482935426e-06,0.0,4.4024113e-05,False,AVP; arginine
hsa:249,0.0,0.0,2.2747246585807248e-05,6.053964752987052e-05,0.0,0.00035464685,False,ALPL; alkaline phosphatase
hsa:10125,1.5392669e-07,0.0001281828616400931,5.566609723050293e-06,1.8083742944180853e-05,0.0,0.00015104176,False,RASGRP1; RAS guanyl releasing protein
hsa:4725,1.4302052e-06,0.0011910071948441282,9.114328914192982e-06,1.2244267920332296e-05,0.0,5.6156707e-05,False,NDUFS5; NADH:ubiquinone oxidoreductase subunit
hsa:4123,4.4186272e-05,0.03679623585856046,0.0001817166421908187,0.0002727745589087961,0.0,0.0013255606,False,MAN2C1; mannosidase alpha class 2C member
hsa:26871,0.0,0.0,2.614553921360059e-07,7.908801092433101e-07,0.0,6.3702387e-06,False,RNU1-1; RNA
hsa:1536,0.0,0.0,1.2661462447076021e-05,3.780761035279327e-05,0.0,0.0002912906,False,CYBB; cytochrome b-245 beta
hsa:4893,0.00034875286,0.29042487433444303,0.0005949217781871348,0.0007918134942623575,0.0,0.0037999835,False,NRAS; NRAS proto-oncogene
hsa:55651,2.1243054e-08,1.769020987650047e-05,3.1449529897171345e-06,5.132393059056399e-06,0.0,2.5490015e-05,False,NHP2; NHP2
hsa:6804,8.1485797e-07,0.0006785751478501691,0.00018779956903228076,0.0003244649076802666,0.0,0.002080822,False,STX1A; syntaxin
hsa:10297,0.00016530247,0.13765607277578465,0.00028309788761093576,0.00028781482223177486,0.0,0.001901351,False,APC2; APC regulator of WNT signaling pathway
hsa:4686,1.6234818e-08,1.3519587989880723e-05,7.849116296081867e-07,1.3495404165482895e-06,0.0,6.9800217e-06,False,NCBP1; nuclear cap binding protein subunit
hsa:4691,3.5416903e-07,0.000294935204347576,1.786853629362573e-06,3.3942641937042027e-06,0.0,2.1672873e-05,False,NCL;
hsa:390113,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4X1; olfactory receptor family 4 subfamily X member
hsa:100129842,2.1173358e-08,1.7632170346612135e-05,1.1732357040684217e-07,2.5360385686770935e-07,0.0,1.3476634e-06,False,ZNF737; zinc finger protein
hsa:2535,0.0,0.0,5.926852348538011e-07,3.3910731883821637e-06,0.0,3.1436084e-05,False,FZD2; frizzled class receptor
hsa:318,0.0,0.0,1.0547820525730995e-06,3.087113501233685e-06,0.0,1.757352e-05,False,NUDT2; nudix hydrolase
hsa:5863,0.0,0.0,2.711327239590643e-06,6.322083975401061e-06,0.0,3.6191657e-05,False,RGL2; ral guanine nucleotide dissociation stimulator like
hsa:2651,3.1084382e-06,0.002588560201660804,9.251722312818715e-05,0.00020179840608893488,0.0,0.0012969765,False,GCNT2; glucosaminyl (N-acetyl) transferase 2 (I blood
hsa:6477,9.4442985e-06,0.007864764765053019,0.00015632622325146192,0.0003216457802690332,0.0,0.0015162434,False,SIAH1; siah E3 ubiquitin protein ligase
hsa:442319,0.0,0.0,2.8464666930783628e-08,6.257929468451951e-08,0.0,3.9845642e-07,False,ZNF727; zinc finger protein
hsa:2309,2.7772229e-08,2.3127397771913248e-05,0.000104774303204614,0.0002610570262425088,0.0,0.002057609,False,FOXO3; forkhead box
hsa:119772,0.0,0.0,2.3928522251461985e-08,3.0736247012708044e-07,0.0,4.0190557e-06,False,OR52M1; olfactory receptor family 52 subfamily M member
hsa:23530,6.7723304e-05,0.05639676203289997,0.00018479202157497076,0.00034173418318054105,0.0,0.0022967737,False,NNT; nicotinamide nucleotide
hsa:246184,4.37214e-06,0.0036409112460686105,3.379470061519885e-05,8.42866273317505e-05,0.0,0.0005337821,False,CDC26; cell division cycle
hsa:406906,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR122; microRNA
hsa:140801,0.0,0.0,1.6922064152046787e-10,8.349335274411595e-10,0.0,7.570468e-09,False,RPL10L; ribosomal protein L10
hsa:60485,0.00013825997,0.11513635877490398,0.0003503895829687135,0.0005938043965979327,0.0,0.0055235373,False,SAV1; salvador family WW domain containing protein
hsa:5277,0.0,0.0,2.2033235832748535e-06,5.1131195218142e-06,0.0,3.6757385e-05,False,PIGA; phosphatidylinositol glycan anchor biosynthesis class
hsa:8912,0.0,0.0,9.206564145865497e-05,0.00020672400235882414,0.0,0.0010475476,False,CACNA1H; calcium voltage-gated channel subunit alpha1
hsa:9350,0.0,0.0,8.958868011171933e-07,5.836362635444225e-06,0.0,6.026627e-05,False,CER1; cerberus 1
hsa:7009,2.7985297e-07,0.0002330483071719344,1.1616222076549708e-06,1.981499541404275e-06,0.0,1.4637105e-05,False,TMBIM6; transmembrane BAX inhibitor motif containing
hsa:4179,0.0,0.0,6.618121902456138e-05,0.00016878628608755342,0.0,0.0012573949,False,CD46; CD46
hsa:6322,6.018129e-08,5.011612975886325e-05,2.0386308589709945e-05,5.561247333186036e-05,0.0,0.00031199268,False,SCML1; Scm polycomb group protein like
hsa:1022,4.517205e-08,3.761714511725918e-05,3.8554214856549685e-06,7.809633252544487e-06,0.0,6.62087e-05,False,CDK7; cyclin dependent kinase
hsa:187,5.682927e-07,0.00047324726163587973,4.8878567252924e-06,1.5011307947589196e-05,0.0,0.00017273732,False,APLNR; apelin
hsa:3780,2.7540309e-05,0.022934265773352308,7.393319535198829e-05,0.0001325389306984265,0.0,0.0009557496,False,KCNN1; potassium calcium-activated channel subfamily N member
hsa:5346,2.8592685e-06,0.00238106346941766,4.824201356290642e-05,9.969884455045361e-05,0.0,0.0005236957,False,PLIN1; perilipin
hsa:5024,0.0005154967,0.4292812518220497,0.0010106679366725148,0.0012302329182330765,0.0,0.0055420166,False,P2RX3; purinergic receptor P2X
hsa:84061,0.0,0.0,9.918525919883045e-07,1.9054638397843557e-06,0.0,9.8024375e-06,False,MAGT1; magnesium transporter
hsa:55353,4.69915e-07,0.0003913229695747005,3.5440535635385265e-06,6.864427938419277e-06,0.0,4.3147535e-05,False,LAPTM4B; lysosomal protein transmembrane 4
hsa:10461,0.0,0.0,2.2090538080368416e-06,7.029029655640519e-06,0.0,4.0181156e-05,False,MERTK; MER proto-oncogene
hsa:1045,-0.0,0.0,8.02466192982456e-11,4.372548794964732e-10,0.0,3.6827434e-09,False,CDX2; caudal type homeobox
hsa:1159,3.110281e-07,0.00025900947982757924,6.65638412767719e-05,0.00013412604695385485,0.0,0.0007732846,False,CKMT1B; creatine kinase
hsa:3611,2.1588692e-06,0.0017978040842862176,0.00013782920047663736,0.00034330406921757287,0.0,0.0029246786,False,ILK; integrin linked
hsa:100131017,0.0,0.0,1.4930475909649124e-07,3.791830797551101e-07,0.0,1.9431552e-06,False,ZNF316; zinc finger protein
hsa:125962,0.0,0.0,6.806450736842105e-08,7.342704650394145e-07,0.0,9.482287e-06,False,OR7G1; olfactory receptor family 7 subfamily G member
hsa:51744,4.70473e-08,3.917876455629594e-05,6.111471590130403e-06,2.8952368257688236e-05,0.0,0.00031562315,False,CD244; CD244
hsa:5687,0.0,0.0,1.6460839930350863e-06,6.8341022499455254e-06,0.0,7.5430515e-05,False,PSMA6; proteasome 20S subunit alpha
hsa:2912,0.0,0.0,7.675667104690058e-05,0.00016063227994603653,0.0,0.0010117893,False,GRM2; glutamate metabotropic receptor
hsa:253558,1.2446745e-05,0.010365060095845112,0.00011776381063684213,0.0003191775154807789,0.0,0.0020777544,False,LCLAT1; lysocardiolipin acyltransferase
hsa:29880,1.11690646e-07,9.301068335004553e-05,0.00015794071024681947,0.00047262966083233744,0.0,0.0027417205,False,ALG5; ALG5 dolichyl-phosphate
hsa:10890,0.0,0.0,5.522228672988304e-06,1.344077712946619e-05,0.0,6.575551e-05,False,RAB10; RAB10
hsa:158431,0.0,0.0,2.8801458892514614e-08,4.815638904847176e-08,0.0,2.0501133e-07,False,ZNF782; zinc finger protein
hsa:10007,0.0,0.0,2.6811451371596496e-05,7.275420791907736e-05,0.0,0.0004249613,False,GNPDA1; glucosamine-6-phosphate deaminase
hsa:51079,0.0,0.0,6.596975591988303e-06,9.6461421029249e-06,0.0,5.3334727e-05,False,NDUFA13; NADH:ubiquinone oxidoreductase subunit
hsa:56954,0.0,0.0,1.888519660467836e-06,5.316140897231443e-06,0.0,3.715333e-05,False,NIT2; nitrilase family member
hsa:11320,0.0,0.0,2.5424859798245615e-06,5.400375391778343e-06,0.0,3.6283724e-05,False,MGAT4A; alpha-1
hsa:1141,0.00029377593,0.24464268924628782,0.0015309416474700004,0.0025719839988882984,0.0,0.020520246,False,CHRNB2; cholinergic receptor nicotinic beta 2
hsa:10735,0.0,0.0,8.287604537052633e-07,1.9034954488649205e-06,0.0,1.1191843e-05,False,STAG2; STAG2 cohesin complex
hsa:1583,0.0,0.0,1.2932550655146199e-06,8.681240804760316e-06,0.0,0.00010216684,False,CYP11A1; cytochrome P450 family 11 subfamily A member
hsa:5236,0.0,0.0,2.468833086959064e-05,6.604187245839813e-05,0.0,0.00040594657,False,PGM1; phosphoglucomutase
hsa:7699,2.0830099e-08,1.7346320498845534e-05,7.391949696467837e-08,1.191013086066282e-07,0.0,7.107891e-07,False,ZNF140; zinc finger protein
hsa:50507,2.4726413e-07,0.00020590986374324034,1.8568461863362574e-05,4.4252604873184535e-05,0.0,0.0002653828,False,NOX4; NADPH oxidase
hsa:2091,0.0,0.0,1.724891938835673e-06,4.070697871695244e-06,0.0,2.0740415e-05,False,FBL;
hsa:119764,-0.0,0.0,2.9488508771929823e-10,3.856122891976636e-09,0.0,5.042535e-08,False,OR4X2; olfactory receptor family 4 subfamily X member
hsa:148266,4.06219e-08,3.382799556891465e-05,9.844477717017541e-08,1.633770330317211e-07,0.0,7.965889e-07,False,ZNF569; zinc finger protein
hsa:29968,3.491729e-05,0.029077466376474456,0.00016196885722654975,0.00035608656705751334,0.0,0.0024284916,False,PSAT1; phosphoserine aminotransferase
hsa:3760,9.233632e-06,0.00768933167530294,0.0001415110096299006,0.00035733571118795983,0.0,0.0023084227,False,KCNJ3; potassium inwardly rectifying channel subfamily J member
hsa:6209,2.6041448e-07,0.0002168608527794419,5.121673966198831e-07,7.390298717723205e-07,0.0,4.306055e-06,False,RPS15; ribosomal protein
hsa:7278,0.0,0.0,9.282851639660815e-05,0.0004769329017958675,0.0,0.0036752843,False,TUBA3C; tubulin alpha
hsa:25804,5.4009057e-08,4.497618626596143e-05,1.4634195611315786e-05,5.235988844331301e-05,0.0,0.00042923383,False,LSM4; LSM4 homolog
hsa:3594,8.012455e-07,0.0006672393271514331,2.4267824330526307e-05,7.025737802397322e-05,0.0,0.000652753,False,IL12RB1; interleukin 12 receptor subunit beta
hsa:2249,0.0,0.0,3.4875318989999995e-07,3.6864347521112585e-06,0.0,4.734817e-05,False,FGF4; fibroblast growth factor
hsa:2923,0.0,0.0,1.0510274790877192e-06,2.1104272111773804e-06,0.0,9.131325e-06,False,PDIA3; protein disulfide isomerase family A member
hsa:406967,0.0,0.0,3.6200555555555553e-09,4.733836901000897e-08,0.0,6.190295e-07,False,MIR192; microRNA
hsa:339983,0.0,0.0,4.339939530549708e-06,1.0038915807781246e-05,0.0,6.277173e-05,False,NAT8L; N-acetyltransferase 8
hsa:889,1.1621726e-06,0.0009678023323161647,2.6469673159087734e-05,5.087389774812843e-05,0.0,0.0002396177,False,KRIT1; KRIT1 ankyrin repeat
hsa:3833,1.6708267e-08,1.3913853907381062e-05,7.087242716725147e-08,1.0254844878049358e-07,0.0,4.7149783e-07,False,KIFC1; kinesin family member
hsa:23509,7.8245144e-08,6.515885235602196e-05,0.00010565947041002334,0.00024492898436507355,0.0,0.0013666719,False,POFUT1; protein O-fucosyltransferase
hsa:1164,1.5521202e-06,0.0012925322362573614,1.1376164068171346e-05,2.045735433680454e-05,0.0,0.00012290884,False,CKS2; CDC28 protein kinase regulatory subunit
hsa:81856,0.0,0.0,3.461446339415205e-08,6.186732304192849e-08,0.0,2.6610655e-07,False,ZNF611; zinc finger protein
hsa:83605,7.918875e-07,0.0006594464276924244,1.2064819142432744e-05,3.1760181358644994e-05,0.0,0.00016519256,False,CCM2; CCM2 scaffold
hsa:3251,1.3376001e-05,0.011138900508292273,5.07805711016959e-05,8.213348557981481e-05,0.0,0.00052967784,False,HPRT1; hypoxanthine phosphoribosyltransferase
hsa:79026,0.0,0.0,1.4950309821549706e-07,4.908064628136877e-07,0.0,2.7320095e-06,False,AHNAK; AHNAK
hsa:2597,3.5335455e-07,0.0002942569439552515,7.701113297327485e-05,0.00017400618347740069,0.0,0.0008514265,False,GAPDH; glyceraldehyde-3-phosphate
hsa:56832,0.0,0.0,7.948283080116959e-07,4.4034439481819704e-06,0.0,4.888405e-05,False,IFNK; interferon
hsa:169841,0.0,0.0,2.0536046025263162e-08,6.809756004735754e-08,0.0,5.1567173e-07,False,ZNF169; zinc finger protein
hsa:6470,0.0,0.0,4.9952842890643274e-05,0.00011237325032442093,0.0,0.0006638389,False,SHMT1; serine hydroxymethyltransferase
hsa:139189,8.198974e-05,0.06827717466234873,0.0002653389451173508,0.00045636969835163464,0.0,0.0023591644,False,DGKK; diacylglycerol kinase
hsa:284958,1.3884673e-05,0.011562498472986956,7.038912769120586e-05,0.00016998954564764938,0.0,0.00147571,False,NT5DC4; 5'-nucleotidase domain containing
hsa:80031,1.6466917e-08,1.371286905116908e-05,8.279570595204678e-07,1.52423068107487e-06,0.0,7.4577524e-06,False,SEMA6D; semaphorin
hsa:10483,1.2721033e-08,1.0593474159407044e-05,4.663113276187134e-07,6.422344044482642e-07,0.0,2.617523e-06,False,SEC23B; SEC23 homolog B
hsa:7673,0.0,0.0,9.43512790374269e-08,2.116852556092024e-07,0.0,1.0373284e-06,False,ZNF222; zinc finger protein
hsa:260434,0.0,0.0,7.622082961403508e-09,5.875265969033221e-08,0.0,6.8514913e-07,False,PYDC1; pyrin domain containing
hsa:3811,0.0,0.0,2.5930221903157894e-06,9.053897569498384e-06,0.0,7.922533e-05,False,KIR3DL1; killer cell immunoglobulin like receptor
hsa:127829,0.0,0.0,3.4138110643567224e-07,7.895877611319143e-07,0.0,4.3635177e-06,False,ARL8A; ADP ribosylation factor like GTPase
hsa:10842,6.4977264e-08,5.410998989885252e-05,2.780341608398285e-05,0.00010702098106452004,0.0,0.00088423904,False,PPP1R17; protein phosphatase 1 regulatory subunit
hsa:27257,0.0,0.0,6.242029118631578e-07,1.4775001729715887e-06,0.0,7.0423216e-06,False,LSM1; LSM1 homolog
hsa:116985,1.4342919e-08,1.194410405168891e-05,4.651545655187134e-07,8.482570763080309e-07,0.0,4.395301e-06,False,ARAP1; ArfGAP with RhoGAP domain
hsa:58505,0.0,0.0,0.0001441363266319299,0.0004733163112466348,0.0,0.0026781939,False,OSTC; oligosaccharyltransferase complex non-catalytic
hsa:4938,3.5745776e-07,0.0002976739030265486,2.0353147061105264e-05,6.378110373835435e-05,0.0,0.00044870397,False,OAS1; 2'-5'-oligoadenylate synthetase
hsa:22978,0.00015859398,0.13206955983586532,0.0005550868983230058,0.0008265246018358673,0.0,0.0039436817,False,NT5C2; 5'-nucleotidase
hsa:1297,1.5027188e-05,0.012513930886473732,6.995485334789475e-05,0.00011163765676466773,0.0,0.00071443815,False,COL9A1; collagen type IX alpha 1
hsa:3824,3.24369e-06,0.0027011914988450255,1.127109333883041e-05,2.1935422449809932e-05,0.0,0.0001867425,False,KLRD1; killer cell lectin like receptor
hsa:595,0.0015216063,1.2671217046478036,0.0018147191634093564,0.0015401448533147249,0.0,0.008350514,True,CCND1; cyclin
hsa:10616,0.0,0.0,2.9398337172573113e-06,6.307527485156741e-06,0.0,3.6334146e-05,False,RBCK1; RANBP2-type and C3HC4-type zinc finger containing
hsa:1537,1.7501255e-06,0.0014574216779383664,0.00019237823547274842,0.00044509881500381866,0.0,0.002633387,False,CYC1; cytochrome
hsa:377841,0.0,0.0,5.450190784568012e-06,1.8282915271643224e-05,0.0,0.00016837977,False,ENTPD8; ectonucleoside triphosphate diphosphohydrolase
hsa:9123,3.0832635e-07,0.000256759590309159,1.0864473204933918e-05,3.055979058651487e-05,0.0,0.0001717217,False,SLC16A3; solute carrier family 16 member
hsa:23369,0.0,0.0,9.321404630701756e-08,2.5252767406893306e-07,0.0,1.8157962e-06,False,PUM2; pumilio RNA binding family member
hsa:6443,8.73482e-05,0.07273944651906165,0.0005035376863157893,0.0007783371509386539,0.0,0.0038800824,False,SGCB; sarcoglycan
hsa:8438,3.007887e-07,0.0002504825921677616,3.278777439852807e-05,7.535162302203716e-05,0.0,0.00040236217,False,RAD54L; RAD54
hsa:80349,3.4597025e-07,0.00028810764843535853,2.9995542487017516e-06,8.399215414682181e-06,0.0,6.164604e-05,False,SKIC8; SKI8 subunit of superkiller
hsa:2977,0.0,0.0,1.175136898187135e-05,2.5839051093415138e-05,0.0,0.00016909008,False,GUCY1A2; guanylate cyclase 1 soluble subunit alpha
hsa:4093,2.3116377e-06,0.0019250224601147668,4.903306533132167e-05,0.00011930064355907921,0.0,0.001018596,False,SMAD9; SMAD family member
hsa:11100,4.8886665e-08,4.0710500665872714e-05,6.166918432222227e-06,1.5844446588907984e-05,0.0,7.95029e-05,False,HNRNPUL1; heterogeneous nuclear ribonucleoprotein U like
hsa:7710,9.315597e-09,7.757588247664303e-06,3.484371916871347e-08,6.25952105224795e-08,0.0,4.7488834e-07,False,ZNF154; zinc finger protein
hsa:57121,2.5547146e-07,0.00021274453969076176,1.2432978411754382e-06,2.1901969744713802e-06,0.0,2.010029e-05,False,LPAR5; lysophosphatidic acid receptor
hsa:6611,0.0,0.0,0.00018014033658812867,0.0003870009021055786,0.0,0.0022204584,False,SMS; spermine
hsa:390538,-0.0,0.0,1.1669968459064327e-06,5.6406515691949125e-06,0.0,5.6985453e-05,False,OR4M2; olfactory receptor family 4 subfamily M member
hsa:1232,0.0,0.0,1.7364492502134505e-06,7.501855687456815e-06,0.0,6.841464e-05,False,CCR3; C-C motif chemokine receptor
hsa:441273,2.5510403e-07,0.00021243856137827797,1.3485658372707611e-05,3.569524905275682e-05,0.0,0.00021007178,False,SPDYE2; speedy/RINGO cell cycle regulator family member
hsa:8013,0.0,0.0,1.442485995223684e-06,7.1959847404966115e-06,0.0,7.717181e-05,False,NR4A3; nuclear receptor subfamily 4 group A member
hsa:79885,0.0,0.0,1.2171677577719306e-05,5.131432187080387e-05,0.0,0.00056870887,False,HDAC11; histone deacetylase
hsa:440279,0.0,0.0,6.605594536888964e-07,3.2236852349238522e-06,0.0,3.4694312e-05,False,UNC13C; unc-13 homolog
hsa:3135,0.0,0.0,3.2730089617304084e-06,1.0051904556731075e-05,0.0,7.0492984e-05,False,HLA-G; major histocompatibility complex
hsa:6880,0.0,0.0,1.3148506011415205e-06,2.8418045237643245e-06,0.0,1.7749871e-05,False,TAF9; TATA-box binding protein associated factor
hsa:64328,1.8148276e-08,1.5113025242823205e-05,2.2650867917777785e-07,4.366827200969869e-07,0.0,2.1266337e-06,False,XPO4; exportin
hsa:2906,3.3269482e-06,0.002770524986955523,7.95529439637427e-05,0.0002070029195307576,0.0,0.0015787344,False,GRIN2D; glutamate ionotropic receptor NMDA type subunit
hsa:84631,0.0,0.0,6.151139631483158e-07,2.241168935596432e-06,0.0,1.6000615e-05,False,SLITRK2; SLIT and NTRK like family member
hsa:1379,6.1077762e-06,0.005086266920787121,1.554992925011695e-05,2.68346134875454e-05,0.0,0.00017516478,False,CR1L; complement C3b/C4b receptor 1
hsa:5045,0.0,0.0,1.3631269983859654e-05,4.506590271591676e-05,0.0,0.00041234682,False,FURIN; furin
hsa:1638,1.3570366e-06,0.0011300758480439124,1.1688763531444444e-05,5.823383249719952e-05,0.0,0.0006727443,False,DCT; dopachrome
hsa:9695,0.0,0.0,3.318951756479531e-07,8.783765696212353e-07,0.0,5.7368084e-06,False,EDEM1; ER degradation enhancing alpha-mannosidase like protein
hsa:3631,0.0,0.0,3.6015170120116954e-06,1.089146966050697e-05,0.0,7.749582e-05,False,INPP4A; inositol polyphosphate-4-phosphatase type I
hsa:3192,0.0,0.0,2.2595755585695905e-07,4.778296611856724e-07,0.0,2.9776782e-06,False,HNRNPU; heterogeneous nuclear ribonucleoprotein
hsa:26291,0.0,0.0,2.790505854736842e-06,1.9747707602020458e-05,0.0,0.00021351011,False,FGF21; fibroblast growth factor
hsa:6675,0.0,0.0,7.937897764561402e-06,3.0059336169659558e-05,0.0,0.00026921503,False,UAP1; UDP-N-acetylglucosamine pyrophosphorylase
hsa:7100,0.0,0.0,5.168776261988303e-06,1.6827710013238436e-05,0.0,0.00014654631,False,TLR5; toll like receptor
hsa:2157,0.0,0.0,1.307851590672514e-06,3.0634512077941363e-06,0.0,3.1012256e-05,False,F8; coagulation factor
hsa:6599,0.0,0.0,7.046044189409354e-06,2.0143050143135297e-05,0.0,0.00012037567,False,SMARCC1; SWI/SNF related
hsa:50614,1.1511103e-06,0.0009585901724865653,0.00012692279994722805,0.00038902844778176184,0.0,0.003900622,False,GALNT9; polypeptide N-acetylgalactosaminyltransferase
hsa:6184,5.8903663e-07,0.0004905218246701512,3.396579971421054e-05,0.00011911934290158558,0.0,0.0011066766,False,RPN1; ribophorin
hsa:1607,9.578259e-08,7.976320728718175e-05,4.161708914719882e-05,0.00013756275538155175,0.0,0.0011074836,False,DGKB; diacylglycerol kinase
hsa:100532731,0.0,0.0,4.177788299228071e-05,7.135476432920067e-05,0.0,0.00047110568,False,COMMD3-BMI1; COMMD3-BMI1
hsa:2134,0.0,0.0,5.094464014473681e-06,1.0968590596955238e-05,0.0,6.960918e-05,False,EXTL1; exostosin like glycosyltransferase
hsa:6484,0.0,0.0,0.00012336519985497074,0.00027339764138834807,0.0,0.0013314993,False,ST3GAL4; ST3 beta-galactoside alpha-2
hsa:4210,1.1298703e-08,9.409025058367103e-06,9.575375865128657e-08,1.9289405248043e-07,0.0,1.4000392e-06,False,MEFV; MEFV innate immunity regulator
hsa:28964,3.950215e-06,0.0032895520769895097,0.0001179097867078889,0.0002583662933362798,0.0,0.0014162646,False,GIT1; GIT ArfGAP
hsa:10902,3.1239678e-09,2.6014925174802764e-06,1.424163230777777e-07,3.9918595552419434e-07,0.0,4.1275657e-06,False,BRD8; bromodomain containing
hsa:91734,0.0,0.0,5.909644496477561e-08,6.03938728802188e-07,0.0,7.860626e-06,False,IDI2; isopentenyl-diphosphate delta isomerase
hsa:9652,3.8891872e-07,0.0003238731013770394,3.895215380724561e-05,0.0001490273413323202,0.0,0.0012687399,False,SKIC3; SKI3 subunit of superkiller
hsa:23466,0.0,0.0,1.4202607401693802e-05,5.4859079205201335e-05,0.0,0.00036982642,False,CBX6; chromobox
hsa:5462,6.2399006e-09,5.196293867280157e-06,1.1939523651317257e-06,4.3215011765671225e-06,0.0,3.626121e-05,False,POU5F1B; POU class 5 homeobox
hsa:148268,0.0,0.0,5.460297507017544e-08,1.0601397047224997e-07,0.0,5.142756e-07,False,ZNF570; zinc finger protein
hsa:6261,0.0,0.0,1.1281000602643277e-05,4.575982386196681e-05,0.0,0.00035304998,False,RYR1; ryanodine receptor
hsa:1962,3.4042314e-05,0.028348827778799147,0.000357870044859649,0.0006127295762559798,0.0,0.003097123,False,EHHADH; enoyl-CoA hydratase and 3-hydroxyacyl CoA
hsa:84775,3.9851935e-09,3.3186805161567398e-06,5.100416803157894e-08,9.379907467002341e-08,0.0,3.905756e-07,False,ZNF607; zinc finger protein
hsa:29929,0.0,0.0,7.241777366852923e-05,0.0002060713738554866,0.0,0.0010947135,False,ALG6; ALG6
hsa:89845,0.00017954932,0.14952017511149499,0.0005874224371286551,0.000996730655675593,0.0,0.0066068894,False,ABCC10; ATP binding cassette subfamily C member
hsa:9922,2.6563553e-08,2.212086960921644e-05,1.2707679668532165e-06,4.041446982381508e-06,0.0,2.3670946e-05,False,IQSEC1; IQ motif and Sec7 domain ArfGEF
hsa:8831,2.640249e-07,0.00021986743966390378,1.8746001936192982e-06,4.373045727715847e-06,0.0,2.4072498e-05,False,SYNGAP1; synaptic Ras GTPase activating protein
hsa:6927,5.514784e-05,0.04592451084649447,0.0002727906235243274,0.0005640049701212092,0.0,0.0036057704,False,HNF1A; HNF1 homeobox
hsa:51602,1.42364485e-08,1.1855440458843175e-05,1.1967858703760235e-06,3.434702938355772e-06,0.0,1.966491e-05,False,NOP58; NOP58
hsa:574484,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520G; microRNA
hsa:1770,0.0,0.0,1.7507687485204685e-08,4.185921881804464e-08,0.0,2.5445246e-07,False,DNAH9; dynein axonemal heavy chain
hsa:3672,0.0,0.0,9.655315675438598e-05,0.0002357468014434024,0.0,0.0015770778,False,ITGA1; integrin subunit alpha
hsa:145226,2.3128757e-06,0.0019260534079166745,3.275362275114035e-05,5.624712169968462e-05,0.0,0.0003614168,False,RDH12; retinol dehydrogenase
hsa:1310,1.2585481e-07,0.0001048059286987215,6.676543079957894e-06,1.6507236176511687e-05,0.0,0.00013201608,False,COL19A1; collagen type XIX alpha 1
hsa:286362,0.0,0.0,2.656610465906432e-06,1.4417619858526277e-05,0.0,0.00015494494,False,OR13C9; olfactory receptor family 13 subfamily C member
hsa:57541,3.7936836e-08,3.1592001361498145e-05,1.1214149797953215e-07,1.6057250682822326e-07,0.0,8.3040885e-07,False,ZNF398; zinc finger protein
hsa:340980,0.0,0.0,1.2533783447076024e-06,7.093287366614223e-06,0.0,6.2336934e-05,False,OR52B6; olfactory receptor family 52 subfamily B member
hsa:6328,0.00029817375,0.24830498558084832,0.001055522523515789,0.0017668971298339154,0.0,0.010917873,False,SCN3A; sodium voltage-gated channel alpha subunit
hsa:3171,4.997685e-06,0.004161835513228854,6.910342474935673e-05,0.00021584497387939683,0.0,0.0017151554,False,FOXA3; forkhead box
hsa:23179,7.883517e-08,6.565019808119839e-05,3.493809408947367e-07,7.042430936372764e-07,0.0,4.1388143e-06,False,RGL1; ral guanine nucleotide dissociation stimulator like
hsa:6932,3.709186e-05,0.030888345343836755,7.644665301052631e-05,0.00011148156547921643,0.0,0.00062312855,False,TCF7; transcription factor
hsa:1051,0.0,0.0,2.4533064393567254e-05,9.554923287387928e-05,0.0,0.0007328778,False,CEBPB; CCAAT enhancer binding protein
hsa:6158,1.472086e-07,0.00012258835427456934,4.376823096608186e-07,5.736448057867885e-07,0.0,2.1589237e-06,False,RPL28; ribosomal protein
hsa:259286,0.0,0.0,2.4062528473684215e-06,8.573413922124175e-06,0.0,6.236962e-05,False,TAS2R40; taste 2 receptor member
hsa:26870,1.8308072e-08,1.5246095788020017e-05,6.363368943032748e-07,2.696532701594918e-06,0.0,2.6723197e-05,False,RNU1-2; RNA
hsa:6877,2.8966357e-07,0.0002412181104880864,9.080721599590641e-07,1.6327034451061819e-06,0.0,9.774462e-06,False,TAF5; TATA-box binding protein associated factor
hsa:5034,0.0,0.0,4.277145573126313e-07,1.7694884729405419e-06,0.0,1.8300341e-05,False,P4HB; prolyl 4-hydroxylase subunit
hsa:1874,0.0,0.0,1.4566608712080706e-05,3.555226848049392e-05,0.0,0.000303455,False,E2F4; E2F transcription factor
hsa:343,2.6371106e-06,0.0021960608856685148,3.1745322691070176e-05,7.359480556324174e-05,0.0,0.0005769678,False,AQP8; aquaporin
hsa:1846,0.0,0.0,1.2530426787368424e-07,5.584243573979539e-07,0.0,5.117482e-06,False,DUSP4; dual specificity phosphatase
hsa:4191,9.342754e-06,0.007780203311845571,4.254864905017543e-05,7.555049397275534e-05,0.0,0.00033487892,False,MDH2; malate dehydrogenase
hsa:566,0.0,0.0,1.9365733795116967e-06,7.346772857088696e-06,0.0,6.798098e-05,False,AZU1; azurocidin
hsa:973,7.6387105e-06,0.006361156542313919,5.9368488475029256e-05,0.0001369776957226849,0.0,0.00092674885,False,CD79A; CD79a
hsa:10371,1.2439297e-07,0.00010358857753980321,4.972702622824564e-06,1.7201591093878695e-05,0.0,0.00011508153,False,SEMA3A; semaphorin
hsa:3633,2.0179086e-06,0.001680418768675881,1.861707301929824e-05,3.798240408330431e-05,0.0,0.0002003956,False,INPP5B; inositol polyphosphate-5-phosphatase
hsa:2893,0.00059584924,0.49619504381777213,0.0012679938757625732,0.0018926693358499848,0.0,0.016316429,True,GRIA4; glutamate ionotropic receptor AMPA type subunit
hsa:120066,0.0,0.0,5.862632385964912e-07,5.611571908905645e-06,0.0,6.787778e-05,False,OR5P3; olfactory receptor family 5 subfamily P member
hsa:6405,0.0,0.0,1.7206087651169583e-07,5.040324271715085e-07,0.0,2.8405348e-06,False,SEMA3F; semaphorin
hsa:8534,2.3747683e-07,0.0001977594635642325,1.3712122209198832e-05,2.7484781475455605e-05,0.0,0.00017070478,False,CHST1; carbohydrate sulfotransferase
hsa:54566,0.0,0.0,1.5491454904160234e-06,3.28317965569733e-06,0.0,2.0261301e-05,False,EPB41L4B; erythrocyte membrane protein band 4.1 like
hsa:64781,3.3409402e-09,2.782176862274015e-06,1.1200248255116957e-05,2.984850328609122e-05,0.0,0.00019749993,False,CERK; ceramide
hsa:140838,1.5975448e-06,0.0013303596930607045,5.0221241158397646e-05,0.00011814517118364879,0.0,0.00077498745,False,NANP; N-acetylneuraminic acid
hsa:80763,0.0,0.0,1.8045724419492396e-07,4.429232686889427e-07,0.0,2.5730178e-06,False,SPX; spexin
hsa:3444,0.0,0.0,2.870120794152047e-06,1.5898410809419667e-05,0.0,0.00016666071,False,IFNA7; interferon alpha
hsa:782,0.00012739513,0.10608863428695618,0.0005709182192292396,0.0009189918358309907,0.0,0.005165783,False,CACNB1; calcium voltage-gated channel auxiliary subunit beta
hsa:5328,0.0,0.0,3.169950084619882e-06,6.2183600820532355e-06,0.0,4.835465e-05,False,PLAU; plasminogen activator
hsa:283694,-0.0,0.0,5.0334750912298246e-05,0.00024150561957135119,0.0,0.0025989579,False,OR4N4; olfactory receptor family 4 subfamily N member
hsa:6423,0.0,0.0,2.8233497952339174e-07,8.10407975938871e-07,0.0,5.844963e-06,False,SFRP2; secreted frizzled related protein
hsa:9001,6.7126854e-07,0.000559000667045899,5.153882332631577e-06,1.4913412132542474e-05,0.0,0.00013026086,False,HAP1; huntingtin associated protein
hsa:57556,0.0,0.0,3.986989508099416e-07,1.233024543231867e-06,0.0,6.945914e-06,False,SEMA6A; semaphorin
hsa:55083,0.0,0.0,4.2479666083625717e-08,8.564704123903985e-08,0.0,4.5562382e-07,False,KIF26B; kinesin family member
hsa:115509,4.9775656e-10,4.1450810292177865e-07,3.105750898614033e-08,6.574538028862739e-08,0.0,3.274878e-07,False,ZNF689; zinc finger protein
hsa:9975,0.0,0.0,0.00019364829640467838,0.0004430321604129881,0.0,0.0040747956,False,NR1D2; nuclear receptor subfamily 1 group D member
hsa:5199,0.0,0.0,2.0690716004678363e-08,4.256885384358213e-08,0.0,1.7896465e-07,False,CFP; complement factor
hsa:59,1.0065129e-06,0.0008381763019764076,9.636298406561405e-05,0.00021048763435895223,0.0,0.0010992924,False,ACTA2; actin alpha 2
hsa:5165,0.0,0.0,8.463044364035088e-08,3.047358922378887e-07,0.0,1.9010251e-06,False,PDK3; pyruvate dehydrogenase kinase
hsa:2339,9.1331464e-07,0.0007605652023894715,0.0001056272146263696,0.00030290457380918647,0.0,0.0016610483,False,FNTA; farnesyltransferase
hsa:2542,8.639166e-07,0.0007194288528284448,7.623851332011696e-05,0.0001729053120157576,0.0,0.0012741352,False,SLC37A4; solute carrier family 37 member
hsa:51181,9.857595e-05,0.08208938527743782,0.000301934052087924,0.0005448870274226865,0.0,0.004293866,False,DCXR; dicarbonyl and L-xylulose
hsa:2662,0.0,0.0,5.919045956473687e-06,2.4364631431154507e-05,0.0,0.00028535622,False,GDF10; growth differentiation factor
hsa:653857,0.0,0.0,3.953715604725146e-06,1.3002290588399513e-05,0.0,8.862569e-05,False,ACTR3C; actin related protein
hsa:6175,1.8381074e-07,0.00015306888398225889,5.068456967128655e-07,6.580129910856866e-07,0.0,2.474864e-06,False,RPLP0; ribosomal protein lateral stalk subunit
hsa:219875,0.0,0.0,2.878057076023392e-09,3.76354798443843e-08,0.0,4.9214776e-07,False,OR4D5; olfactory receptor family 4 subfamily D member
hsa:10898,0.0,0.0,3.289568217629239e-05,0.00010219956823237461,0.0,0.0005010823,False,CPSF4; cleavage and polyadenylation specific factor
hsa:54413,3.8499311e-07,0.0003206040391794246,6.836124679546902e-06,1.1250236473640378e-05,0.0,6.3231426e-05,False,NLGN3; neuroligin
hsa:230,0.0,0.0,1.7192144617777776e-05,4.6391516644041706e-05,0.0,0.00028020976,False,ALDOC; aldolase
hsa:1814,0.0,0.0,2.6946280555555555e-08,1.0633223042439028e-07,0.0,8.235227e-07,False,DRD3; dopamine receptor
hsa:5897,1.7013854e-05,0.014168332296671518,9.469138773208772e-05,0.00018933089308090746,0.0,0.0009699714,False,RAG2; recombination activating
hsa:996,2.1443484e-06,0.0017857118493573472,4.377603580827774e-05,0.00012960480368616597,0.0,0.0009258158,False,CDC27; cell division cycle
hsa:7436,0.0,0.0,2.752177308362573e-07,5.591084510030142e-07,0.0,2.7253664e-06,False,VLDLR; very low density lipoprotein
hsa:163087,0.0,0.0,2.6860074834502925e-08,4.9781120559013945e-08,0.0,2.7626507e-07,False,ZNF383; zinc finger protein
hsa:7994,2.2208306e-07,0.0001849402605395367,1.8458441590803507e-05,5.755039259083985e-05,0.0,0.00043954086,False,KAT6A; lysine acetyltransferase
hsa:4804,0.0,0.0,5.4962171461812874e-05,0.00015990923878003084,0.0,0.0012697404,False,NGFR; nerve growth factor
hsa:90649,0.0,0.0,3.306424617543861e-08,5.3327881887212555e-08,0.0,2.5630519e-07,False,ZNF486; zinc finger protein
hsa:8823,0.0,0.0,6.101828259649122e-08,3.6486144570400556e-07,0.0,3.4232187e-06,False,FGF16; fibroblast growth factor
hsa:54433,0.0,0.0,1.1961307423029828e-06,2.521103744887464e-06,0.0,1.2204486e-05,False,GAR1; GAR1
hsa:5495,0.0,0.0,3.2905241266257306e-07,1.049644000965207e-06,0.0,6.751269e-06,False,PPM1B; protein phosphatase
hsa:6368,0.0,0.0,1.7383080777777776e-07,8.228588181841569e-07,0.0,8.787504e-06,False,CCL23; C-C motif chemokine ligand
hsa:26061,8.577481e-08,7.142920180012495e-05,1.1187424056269005e-06,1.9524752904420727e-06,0.0,1.09219e-05,False,HACL1; 2-hydroxyacyl-CoA lyase
hsa:283093,0.0,0.0,4.3027781771929824e-07,5.219529383339104e-06,0.0,6.808898e-05,False,OR4C12; olfactory receptor family 4 subfamily C member
hsa:10498,0.0,0.0,2.4950357763964914e-05,8.737025794564474e-05,0.0,0.000677999,False,CARM1; coactivator associated arginine methyltransferase
hsa:975,0.0,0.0,0.00010210123816321638,0.0002687676845902562,0.0,0.0015190453,False,CD81; CD81
hsa:390980,0.0,0.0,5.3285354271345045e-09,1.3810790285689922e-08,0.0,7.585092e-08,False,ZNF805; zinc finger protein
hsa:84313,0.0,0.0,6.974211517561404e-07,1.5992310985922997e-06,0.0,1.189272e-05,False,VPS25; vacuolar protein sorting 25
hsa:23001,0.0,0.0,3.6946550764175435e-07,9.663437986048114e-07,0.0,5.8949513e-06,False,WDFY3; WD repeat and FYVE domain containing
hsa:55217,0.0,0.0,2.537198759649123e-06,4.611909885380147e-06,0.0,3.922086e-05,False,TMLHE; trimethyllysine hydroxylase
hsa:1213,0.0,0.0,6.375501729900583e-05,0.00014227741007098664,0.0,0.0008809511,False,CLTC; clathrin heavy
hsa:7367,0.0,0.0,1.6355754925380115e-05,4.2909312982034074e-05,0.0,0.0003014391,False,UGT2B17; UDP glucuronosyltransferase family 2 member
hsa:80818,2.842118e-08,2.3667813448000354e-05,1.4725525956959063e-07,2.2839346852463927e-07,0.0,1.3673384e-06,False,ZNF436; zinc finger protein
hsa:50964,0.0,0.0,3.0670947527953207e-07,1.2139646975231914e-06,0.0,1.25453225e-05,False,SOST;
hsa:2224,0.0,0.0,5.931160314654973e-05,0.00013203723772210456,0.0,0.0007800143,False,FDPS; farnesyl diphosphate
hsa:11269,0.0,0.0,6.988115647259065e-07,1.4509254974649345e-06,0.0,7.571023e-06,False,DDX19B; DEAD-box helicase
hsa:4437,3.79186e-05,0.03157681528386035,0.00018737958164678352,0.0003514697470044424,0.0,0.0025642586,False,MSH3; mutS homolog
hsa:5905,2.2605407e-08,1.8824712970823918e-05,2.825657906270759e-07,5.179429791497204e-07,0.0,2.8442387e-06,False,RANGAP1; Ran GTPase activating protein
hsa:2742,0.0,0.0,4.716012030958165e-06,2.871789378440439e-05,0.0,0.00027827985,False,GLRA2; glycine receptor alpha
hsa:83692,1.8111009e-06,0.001508199104917725,6.139643593526315e-06,1.1730757463457523e-05,0.0,5.5408025e-05,False,CD99L2; CD99 molecule like
hsa:3122,0.00030350225,0.25274230816765403,0.0009629996505847958,0.0012683715979090538,0.0,0.0057217344,False,HLA-DRA; major histocompatibility complex
hsa:157570,0.0,0.0,3.471034179527988e-07,7.881039798913991e-07,0.0,3.620351e-06,False,ESCO2; establishment of sister chromatid cohesion N-acetyltransferase
hsa:7417,1.47189285e-05,0.012257226965680372,0.0002860744920730995,0.0005712054766306193,0.0,0.0035504506,False,VDAC2; voltage dependent anion channel
hsa:9860,2.8320412e-07,0.00023583898627238935,1.2436657662280699e-05,4.047942827901388e-05,0.0,0.00027550908,False,LRIG2; leucine rich repeats and immunoglobulin like domains
hsa:9454,0.0,0.0,3.230030767719298e-06,1.0642532827348587e-05,0.0,8.940288e-05,False,HOMER3; homer scaffold protein
hsa:6546,0.0007477183,0.6226644085873972,0.0011161317474561402,0.0011449055829563875,0.0,0.005781967,True,SLC8A1; solute carrier family 8 member
hsa:9459,0.0,0.0,3.0345305224298263e-06,1.103257545593968e-05,0.0,8.781061e-05,False,ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor
hsa:6400,6.111308e-08,5.089208036656892e-05,2.735794661479532e-07,4.2008123590021594e-07,0.0,1.9568217e-06,False,SEL1L; SEL1L adaptor subunit of SYVN1 ubiquitin
hsa:2921,0.0,0.0,7.830988907309941e-07,5.338236579180497e-06,0.0,5.973889e-05,False,CXCL3; C-X-C motif chemokine ligand
hsa:4842,8.843818e-06,0.00736471302711807,6.166909304017545e-05,0.0001396704382645642,0.0,0.0008174414,False,NOS1; nitric oxide synthase
hsa:94026,0.0,0.0,7.522543052631579e-11,3.817949031536954e-10,0.0,4.098934e-09,False,POM121L2; POM121 transmembrane nucleoporin like
hsa:123745,0.0,0.0,3.5048108082280714e-06,2.142154526580845e-05,0.0,0.0002741488,False,PLA2G4E; phospholipase A2 group
hsa:103625684,0.0,0.0,7.724525054970761e-09,4.9669247044918874e-08,0.0,4.6577225e-07,False,RNU6-2; RNA
hsa:407019,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR27B; microRNA
hsa:154664,0.0,0.0,1.1671473229695907e-05,4.092420128821161e-05,0.0,0.00027988222,False,ABCA13; ATP binding cassette subfamily A member
hsa:3454,0.0,0.0,5.544448334502924e-05,0.00012799447086037194,0.0,0.0009650888,False,IFNAR1; interferon alpha and beta receptor subunit
hsa:55802,7.717292e-08,6.426595496026047e-05,1.7482346799480124e-05,6.636361532634102e-05,0.0,0.00050475885,False,DCP1A; decapping mRNA
hsa:6588,0.0,0.0,4.9428366809356725e-08,2.3703438214946038e-07,-0.0,2.6298947e-06,False,SLN;
hsa:1582,1.3028908e-07,0.00010849857886799895,1.3350205357777776e-05,0.00010374709092446819,0.0,0.0012036432,False,CYP8B1; cytochrome P450 family 8 subfamily B member
hsa:834,0.0,0.0,7.833212573976611e-05,0.0002263663656659045,0.0,0.0015690143,False,CASP1; caspase
hsa:401494,2.7905617e-08,2.323847698467647e-05,1.0099925305085963e-05,2.081021349341049e-05,0.0,0.00012972762,False,HACD4; 3-hydroxyacyl-CoA dehydratase
hsa:11201,0.0,0.0,0.00019707976489947374,0.0005971546299587504,0.0,0.0038968474,False,POLI; DNA polymerase
hsa:84503,3.773387e-09,3.142298088366131e-06,7.135510540467837e-08,1.4119168785534834e-07,0.0,6.8412345e-07,False,ZNF527; zinc finger protein
hsa:11194,0.0,0.0,6.883788480467836e-05,0.0001323172899497036,0.0,0.0007127974,False,ABCB8; ATP binding cassette subfamily B member
hsa:204962,4.1542293e-07,0.00034594455294473025,1.3511946774816483e-05,4.059222133601617e-05,0.0,0.00031671918,False,SLC44A5; solute carrier family 44 member
hsa:6722,0.0,0.0,2.8912727339181283e-07,6.991037563435239e-07,0.0,3.203909e-06,False,SRF; serum response
hsa:390072,-0.0,0.0,1.4745436839766084e-06,4.143268395017491e-06,0.0,2.9099274e-05,False,OR52N4; olfactory receptor family 52 subfamily N member
hsa:10960,0.0,0.0,9.65369850988304e-08,4.2501230689873967e-07,0.0,4.120095e-06,False,LMAN2; lectin
hsa:5829,0.0,0.0,4.268374800736841e-05,8.161533347715457e-05,0.0,0.00046121122,False,PXN;
hsa:6935,6.816676e-08,5.676605119965507e-05,1.3746135723391817e-05,5.280027913718176e-05,0.0,0.00056999887,False,ZEB1; zinc finger E-box binding homeobox
hsa:56992,0.0,0.0,1.4064360457444445e-07,3.4804578932702954e-07,0.0,1.7927046e-06,False,KIF15; kinesin family member
hsa:10901,1.6744549e-06,0.0013944067839649897,0.00010502208046842099,0.00023237237337186351,0.0,0.0014999828,False,DHRS4; dehydrogenase/reductase
hsa:3716,0.0,0.0,3.920228328947368e-05,0.00011795937551949949,0.0,0.000908006,False,JAK1; Janus kinase
hsa:5151,0.0,0.0,9.35085406280702e-05,0.00022118386807458846,0.0,0.0011834035,False,PDE8A; phosphodiesterase
hsa:7277,0.0,0.0,6.211941605976611e-05,0.00015984209640379252,0.0,0.0011179426,False,TUBA4A; tubulin alpha
hsa:642843,0.0,0.0,1.6274344644736843e-06,6.0321081832622236e-06,0.0,3.3277487e-05,False,CPSF4L; cleavage and polyadenylation specific factor 4
hsa:406891,0.0,0.0,6.7093777777777775e-09,8.773649912211292e-08,0.0,1.1473036e-06,False,MIRLET7I; microRNA
hsa:10858,0.0,0.0,3.4337099834210546e-05,6.745597733667167e-05,0.0,0.00047219556,False,CYP46A1; cytochrome P450 family 46 subfamily A member
hsa:6657,0.0,0.0,9.967481946666666e-08,3.037725357633963e-07,0.0,2.2815702e-06,False,SOX2; SRY-box transcription factor
hsa:284323,0.0,0.0,1.7410949211111113e-08,5.0970080851219406e-08,0.0,3.2477234e-07,False,ZNF780A; zinc finger protein
hsa:6584,0.0,0.0,1.35297557191462e-05,3.1083148262168364e-05,0.0,0.0001827458,False,SLC22A5; solute carrier family 22 member
hsa:3394,0.0,0.0,1.678220782762573e-05,4.4966431337728857e-05,0.0,0.00028321883,False,IRF8; interferon regulatory factor
hsa:23239,1.0310425e-07,8.586033918000556e-05,2.758045654187134e-07,3.934948164171088e-07,0.0,2.270795e-06,False,PHLPP1; PH domain and leucine rich repeat protein phosphatase
hsa:1029,2.2269323e-05,0.018544838123443978,0.00011600183521403505,0.00019720991470471513,0.0,0.001037935,False,CDKN2A; cyclin dependent kinase inhibitor
hsa:125893,1.0780165e-10,8.977211155858509e-08,2.5254113191672523e-08,5.0825606696794285e-08,0.0,3.2549463e-07,False,ZNF816; zinc finger protein
hsa:55825,4.1970898e-07,0.0003495137725136856,2.8608166156456715e-05,9.686723374933337e-05,0.0,0.00055801036,False,PECR; peroxisomal trans-2-enoyl-CoA
hsa:245711,0.0,0.0,5.534768965292399e-07,1.638891118530657e-06,0.0,1.0231749e-05,False,SPDYA; speedy/RINGO cell cycle regulator family member
hsa:123720,0.0,0.0,5.572510669824564e-07,1.418769922416406e-06,0.0,8.438498e-06,False,WHAMM; WASP homolog associated with actin
hsa:2629,3.195383e-05,0.026609637157539452,0.00015551511187602332,0.00025116441725475365,0.0,0.0011526204,False,GBA1; glucosylceramidase beta
hsa:51167,0.0,0.0,8.817775542469004e-05,0.00030388297878674924,0.0,0.0018315054,False,CYB5R4; cytochrome b5 reductase
hsa:10572,0.0,0.0,0.00010675387380187129,0.00027012592853104856,0.0,0.0013097599,False,SIVA1; SIVA1 apoptosis inducing
hsa:3620,3.5146618e-06,0.0029268439880122195,0.00012205642912508778,0.00027034510112972174,0.0,0.0013923045,False,IDO1; indoleamine 2
hsa:9422,2.6259899e-09,2.1868000930831547e-06,5.1417631365029215e-08,6.958882164165397e-08,0.0,3.1673974e-07,False,ZNF264; zinc finger protein
hsa:133396,0.0,0.0,2.8826446329064327e-07,1.7347101608536344e-06,0.0,1.9905812e-05,False,IL31RA; interleukin 31 receptor
hsa:84364,0.0,0.0,8.328558549128656e-07,1.8710512981985048e-06,0.0,1.0840007e-05,False,ARFGAP2; ADP ribosylation factor GTPase activating protein
hsa:135941,0.0,0.0,3.412120703508772e-07,3.0621276523087658e-06,0.0,3.7226528e-05,False,OR2A14; olfactory receptor family 2 subfamily A member
hsa:1870,0.0002642623,0.22006513514708062,0.0005030532025555553,0.0006857375694573766,0.0,0.0043357783,False,E2F2; E2F transcription factor
hsa:9709,8.469967e-08,7.05338760975861e-05,7.849561370438592e-07,1.4657805710436338e-06,0.0,8.337368e-06,False,HERPUD1; homocysteine inducible ER protein with ubiquitin like domain
hsa:55781,0.0,0.0,1.5980442842163745e-07,7.473362461054493e-07,0.0,9.350064e-06,False,RIOK2; RIO kinase
hsa:5078,0.0,0.0,6.542192236912281e-05,0.0001711351377524715,0.0,0.0010679633,False,PAX4; paired box
hsa:797,0.0,0.0,4.861532559801169e-06,1.848828099680985e-05,0.0,0.0001334201,False,CALCB; calcitonin related polypeptide
hsa:9394,3.347602e-09,2.787724493991906e-06,0.0005158977796569941,0.001421090309092223,0.0,0.008516989,False,HS6ST1; heparan sulfate 6-O-sulfotransferase
hsa:81624,0.0,0.0,9.84703892074713e-06,3.211128860259778e-05,0.0,0.00016045751,False,DIAPH3; diaphanous related formin
hsa:29785,0.0,0.0,3.991679670467838e-05,0.00021844025998326184,0.0,0.0026165908,False,CYP2S1; cytochrome P450 family 2 subfamily S member
hsa:6863,0.0,0.0,5.90271843871345e-07,2.9039095914246045e-06,0.0,3.0486688e-05,False,TAC1; tachykinin precursor
hsa:1434,2.2070195e-07,0.00018379013750343586,7.721804797017546e-07,1.5868379526296638e-06,0.0,1.0119613e-05,False,CSE1L; chromosome segregation 1
hsa:390093,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR10A6; olfactory receptor family 10 subfamily A member 6
hsa:6156,0.0,0.0,8.890562395614038e-07,2.311283652872906e-06,0.0,1.0680419e-05,False,RPL30; ribosomal protein
hsa:336,0.0,0.0,1.9582455798649115e-05,0.00011596963574930045,0.0,0.0012036934,False,APOA2; apolipoprotein
hsa:4287,1.378741e-07,0.00011481502450323828,4.500334316372515e-07,7.074684727550409e-07,0.0,3.6694262e-06,False,ATXN3; ataxin
hsa:10520,0.0,0.0,4.310289825672515e-08,7.579300980856838e-08,0.0,2.8505153e-07,False,ZNF211; zinc finger protein
hsa:348180,0.0,0.0,0.00010945574751801168,0.00022746832313641813,0.0,0.0010475119,False,CTU2; cytosolic thiouridylase subunit
hsa:23512,0.0,0.0,9.843978029222809e-06,3.415038940063177e-05,0.0,0.00020134421,False,SUZ12; SUZ12 polycomb repressive complex 2
hsa:374900,1.0051476e-08,8.37039344759974e-06,3.203233835789474e-08,5.671794865930869e-08,0.0,3.0570595e-07,False,ZNF568; zinc finger protein
hsa:91937,3.5063724e-07,0.00029199409680533063,7.761351354341273e-05,0.00019318541559185272,0.0,0.0012404391,False,TIMD4; T cell immunoglobulin and mucin domain containing
hsa:7384,0.0,0.0,1.656603758187134e-05,4.932045311797834e-05,0.0,0.00028125528,False,UQCRC1; ubiquinol-cytochrome c reductase core protein
hsa:2078,5.99545e-08,4.9927269781484694e-05,2.889768375257311e-06,1.2203696341933745e-05,0.0,0.00010353257,False,ERG; ETS transcription factor
hsa:378884,1.4903417e-08,1.2410860256110302e-05,1.3577394416514627e-07,3.2850869143755756e-07,0.0,2.345134e-06,False,NHLRC1; NHL repeat containing E3 ubiquitin protein ligase
hsa:10580,0.0,0.0,2.3544920555555555e-06,6.003152754143423e-06,0.0,5.3036576e-05,False,SORBS1; sorbin and SH3 domain containing
hsa:8120,0.0,0.0,2.1443532382292407e-06,4.891489596339157e-06,0.0,2.2735416e-05,False,AP3B2; adaptor related protein complex 3 subunit beta
hsa:5138,4.755988e-05,0.039605616918413765,0.00011765292976315784,0.00022005722471802488,0.0,0.0020910269,False,PDE2A; phosphodiesterase
hsa:5433,0.0,0.0,8.681980304404096e-05,0.00030215199253561274,0.0,0.0018480943,False,POLR2D; RNA polymerase II subunit
hsa:4522,0.0,0.0,2.4046949515204682e-05,7.108626110989445e-05,0.0,0.0003852521,False,MTHFD1; methylenetetrahydrofolate dehydrogenase
hsa:5095,7.5462995e-06,0.006284201035591708,0.0006554302238003744,0.001990659294325331,0.0,0.01026994,False,PCCA; propionyl-CoA carboxylase subunit
hsa:166012,0.0,0.0,2.9060149554982462e-05,0.00013731108339642425,0.0,0.0013735496,False,CHST13; carbohydrate sulfotransferase
hsa:8309,0.0,0.0,2.8035515939181296e-05,9.863103045975345e-05,0.0,0.0010393037,False,ACOX2; acyl-CoA oxidase
hsa:10131,0.0,0.0,1.0556309408771931e-07,2.151949297634068e-07,0.0,1.242015e-06,False,TRAP1; TNF receptor associated protein
hsa:57713,0.0,0.0,4.533938658161404e-06,1.6390878534649574e-05,0.0,0.000108992666,False,SFMBT2; Scm like with four mbt domains
hsa:665,8.463536e-08,7.048032177356293e-05,6.429089266625733e-06,1.836873472646902e-05,0.0,0.0001532906,False,BNIP3L; BCL2 interacting protein 3
hsa:57171,1.8153727e-07,0.00015117564577611734,0.0001729286107884633,0.00041142856928684,0.0,0.0021401348,False,DOLPP1; dolichyldiphosphatase
hsa:115201,3.006633e-09,2.5037816498330348e-06,0.0003646792436796535,0.0011829306752637085,0.0,0.006215372,False,ATG4A; autophagy related 4A cysteine
hsa:84870,0.0,0.0,1.2200284190643275e-08,4.6159667032713776e-08,0.0,3.9751762e-07,False,RSPO3; R-spondin
hsa:163059,0.0,0.0,1.7208757030994154e-08,5.5278448009939837e-08,0.0,3.3517057e-07,False,ZNF433; zinc finger protein
hsa:399694,0.0,0.0,0.0,0.0,0.0,0.0,False,SHC4; SHC adaptor protein
hsa:29964,3.3848406e-07,0.00028187350374621177,4.2994423914210525e-06,1.3474635816912453e-05,0.0,0.000111183144,False,PRICKLE4; prickle planar cell polarity protein
hsa:8435,0.0,0.0,3.7368576168362567e-06,1.2112051423432299e-05,0.0,9.535254e-05,False,SOAT2; sterol O-acyltransferase
hsa:5973,0.0,0.0,2.841691425672514e-06,9.80598696209041e-06,0.0,8.423678e-05,False,RENBP; renin binding
hsa:388561,3.949008e-09,3.288546944520283e-06,2.2095241994152043e-08,3.549770911616936e-08,0.0,2.3833498e-07,False,ZNF761; zinc finger protein
hsa:4695,0.0,0.0,1.862656674766082e-06,5.895667160343151e-06,0.0,3.0310894e-05,False,NDUFA2; NADH:ubiquinone oxidoreductase subunit
hsa:6343,0.0,0.0,7.683650596491228e-08,4.1257263555157486e-07,0.0,3.4511286e-06,False,SCT;
hsa:55119,0.0,0.0,6.479207020842105e-07,1.808954492242963e-06,0.0,1.070396e-05,False,PRPF38B; pre-mRNA processing factor
hsa:3977,6.430921e-07,0.0005355366614856521,4.558005057223949e-05,7.840014001179148e-05,0.0,0.00048597588,False,LIFR; LIF receptor subunit
hsa:157855,0.0,0.0,1.59444039202924e-06,1.0004381036740676e-05,0.0,9.881248e-05,False,KCNU1; potassium calcium-activated channel subfamily U member
hsa:5194,0.0,0.0,2.83611833517076e-06,6.9463496985466865e-06,0.0,3.1239735e-05,False,PEX13; peroxisomal biogenesis factor
hsa:523,0.0,0.0,3.1755523114385966e-05,0.00012193371838825963,0.0,0.0014602311,False,ATP6V1A; ATPase H+ transporting V1 subunit
hsa:9514,3.2549022e-07,0.0002710528488299428,5.435990325820469e-06,1.3523903882618468e-05,0.0,9.024523e-05,False,GAL3ST1; galactose-3-O-sulfotransferase
hsa:4942,0.0,0.0,1.6072406636608193e-05,5.1613972443927184e-05,0.0,0.00033289116,False,OAT; ornithine
hsa:140885,1.4764795e-06,0.001229542241588732,9.5250395218807e-05,0.0002507496409436382,0.0,0.0016125878,False,SIRPA; signal regulatory protein
hsa:219477,0.0,0.0,1.7150167251461988e-08,2.242675377418317e-07,0.0,2.9326786e-06,False,OR8J1; olfactory receptor family 8 subfamily J member
hsa:29107,0.0,0.0,3.0478292598731925e-06,8.414742961691114e-06,0.0,4.1062995e-05,False,NXT1; nuclear transport factor 2 like export factor
hsa:2900,0.0,0.0,1.5107207401052632e-06,6.70654535169078e-06,0.0,6.4856315e-05,False,GRIK4; glutamate ionotropic receptor kainate type subunit
hsa:85301,0.0,0.0,6.201875393567249e-07,1.363881931319393e-06,0.0,9.503022e-06,False,COL27A1; collagen type XXVII alpha 1
hsa:79549,0.0,0.0,1.0344215020467835e-07,7.443489659906867e-07,0.0,8.019666e-06,False,OR6J1; olfactory receptor family 6 subfamily J member
hsa:54753,1.4447731e-08,1.2031386524236207e-05,6.721155903216376e-08,1.1604060769603702e-07,0.0,4.960775e-07,False,ZNF853; zinc finger protein
hsa:51645,0.0,0.0,6.509110184701754e-07,2.322871254215402e-06,0.0,1.7034055e-05,False,PPIL1; peptidylprolyl isomerase like
hsa:1468,0.0,0.0,0.0001947646253918129,0.0003127338813874009,0.0,0.001357137,False,SLC25A10; solute carrier family 25 member
hsa:6532,1.476316e-07,0.00012294060865276562,1.3282882182327484e-05,3.297893835667797e-05,0.0,0.00025023503,False,SLC6A4; solute carrier family 6 member
hsa:9677,1.9140035e-07,0.00015938915195224036,7.06625109988304e-07,1.1149405063372336e-06,0.0,6.5613895e-06,False,PPIP5K1; diphosphoinositol pentakisphosphate kinase
hsa:407007,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR222; microRNA
hsa:80095,1.8797047e-08,1.565329102343023e-05,9.275588433684207e-08,1.8966566373175554e-07,0.0,1.2022358e-06,False,ZNF606; zinc finger protein
hsa:442186,0.0,0.0,9.014634970760235e-08,1.0365276904723511e-06,0.0,1.3488803e-05,False,OR2J3; olfactory receptor family 2 subfamily J member
hsa:10798,0.0,0.0,1.9457587134502927e-09,2.5444096801330613e-08,0.0,3.3272474e-07,False,OR5I1; olfactory receptor family 5 subfamily I member
hsa:406988,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR205; microRNA
hsa:64116,0.0,0.0,8.254051250292397e-07,2.230033872096857e-06,0.0,1.0921111e-05,False,SLC39A8; solute carrier family 39 member
hsa:1146,0.0,0.0,1.659142288325497e-07,7.27903682024168e-07,0.0,6.09371e-06,False,CHRNG; cholinergic receptor nicotinic gamma
hsa:27123,4.344256e-08,3.617690770698339e-05,2.4862864827017544e-07,6.20948591028417e-07,0.0,4.7738436e-06,False,DKK2; dickkopf WNT signaling pathway inhibitor
hsa:25825,0.0,0.0,1.381175692530877e-08,4.606701241760691e-08,0.0,2.5484533e-07,False,BACE2; beta-secretase
hsa:51510,0.0,0.0,2.522673282695906e-06,4.771147172145407e-06,0.0,2.9345529e-05,False,CHMP5; charged multivesicular body protein
hsa:4242,0.0,0.0,3.334038545321637e-05,8.249639336417717e-05,0.0,0.000470564,False,MFNG; MFNG O-fucosylpeptide
hsa:50617,5.88663e-06,0.004902106832911313,3.731879652134503e-05,9.113402466632685e-05,0.0,0.00067463546,False,ATP6V0A4; ATPase H+ transporting V0 subunit
hsa:26149,0.0,0.0,2.8761277697076025e-08,5.349145234129518e-08,0.0,2.8984948e-07,False,ZNF658; zinc finger protein
hsa:23761,0.0,0.0,6.4545522061520454e-06,1.9713390208253038e-05,0.0,0.000106178755,False,PISD; phosphatidylserine
hsa:5578,0.0,0.0,0.0006145277620467838,0.0009147035867140699,0.0,0.0061283503,False,PRKCA; protein kinase C
hsa:7350,2.0673115e-08,1.7215591654148695e-05,6.187951312678948e-06,2.476996727006534e-05,0.0,0.00021410662,False,UCP1; uncoupling protein
hsa:6373,6.856543e-07,0.0005709804470546005,1.6710220365783636e-05,4.26543528846155e-05,0.0,0.0003525451,False,CXCL11; C-X-C motif chemokine ligand
hsa:10893,1.1478729e-06,0.0009558942190019965,9.067816906684211e-06,2.552696476015011e-05,0.0,0.00025631365,False,MMP24; matrix metallopeptidase
hsa:1945,0.0,0.0,6.844588114269005e-07,1.246502073961323e-06,0.0,7.4009663e-06,False,EFNA4; ephrin
hsa:27097,8.195616e-08,6.824921082778648e-05,6.491100725789472e-07,2.676274668464969e-06,0.0,3.081194e-05,False,TAF5L; TATA-box binding protein associated factor 5
hsa:5077,-0.0,0.0,4.065716652187134e-08,2.2087501860311463e-07,0.0,2.6369873e-06,False,PAX3; paired box
hsa:843,4.7048192e-07,0.00039179507371675016,7.90314463825731e-06,1.8662296663450253e-05,0.0,0.00012276082,False,CASP10; caspase
hsa:23205,0.0,0.0,4.174427241754387e-06,1.2518641730530566e-05,0.0,7.563759e-05,False,ACSBG1; acyl-CoA synthetase bubblegum family member
hsa:5599,0.00045259923,0.37690321592377957,0.0013687980060058482,0.0019187426036971708,0.0,0.010819168,False,MAPK8; mitogen-activated protein kinase
hsa:9672,2.877164e-06,0.0023959659947722966,2.0056451049631587e-05,2.7278134538047334e-05,0.0,0.00014671056,False,SDC3; syndecan
hsa:6300,0.00040297044,0.3355747086848125,0.0007046981231988303,0.0008201395190822579,0.0,0.003585362,False,MAPK12; mitogen-activated protein kinase
hsa:8739,2.2951878e-07,0.00019113237620157342,1.9118666788128656e-06,3.1560937076985696e-06,0.0,1.4422366e-05,False,HRK; harakiri
hsa:390442,0.0,0.0,2.017760351859649e-05,7.388678802558969e-05,0.0,0.00049522356,False,OR11H4; olfactory receptor family 11 subfamily H member
hsa:155054,0.0,0.0,2.3349560032163733e-08,5.471432525054157e-08,0.0,3.5497817e-07,False,ZNF425; zinc finger protein
hsa:10840,0.0,0.0,4.0715359299309935e-06,1.185675509931851e-05,0.0,8.4108215e-05,False,ALDH1L1; aldehyde dehydrogenase 1 family member
hsa:60496,2.7144529e-06,0.002260467892275534,3.8330484755847965e-05,6.155102721695916e-05,0.0,0.00026335905,False,AASDHPPT; aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl
hsa:9376,-0.0,0.0,1.227861354974854e-06,4.118421541014496e-06,0.0,3.603572e-05,False,SLC22A8; solute carrier family 22 member
hsa:118471,0.0,0.0,6.801745651666081e-08,2.8538413928894825e-07,0.0,2.4997669e-06,False,PRAP1; proline rich acidic protein
hsa:489,0.00011961711,0.09961146738696061,0.0002921710496222222,0.0004308775061227177,0.0,0.0023107466,False,ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:84867,1.8999351e-08,1.5821760219001428e-05,3.4768953155964907e-07,8.189552149899092e-07,0.0,5.2099085e-06,False,PTPN5; protein tyrosine phosphatase non-receptor type
hsa:4908,3.0788726e-08,2.5639393694054858e-05,7.108265606783624e-07,1.5547436310252665e-06,0.0,8.221471e-06,False,NTF3; neurotrophin
hsa:57502,8.963386e-08,7.46428359802155e-05,5.219072649912281e-06,1.4371395582284044e-05,0.0,7.7359364e-05,False,NLGN4X; neuroligin 4
hsa:84869,3.3643628e-05,0.028016820948951495,0.0004938580713140349,0.0011696813977639551,0.0,0.005702142,False,CBR4; carbonyl reductase
hsa:254879,0.0,0.0,7.63136483625731e-07,8.403525405500291e-06,0.0,0.000109471635,False,OR2T6; olfactory receptor family 2 subfamily T member
hsa:6143,0.0,0.0,1.4732898152631578e-06,2.9490709676511474e-06,0.0,1.2646963e-05,False,RPL19; ribosomal protein
hsa:746,2.2306315e-06,0.001857564331010648,0.00011061498734187134,0.0002783794263626029,0.0,0.0020122386,False,TMEM258; transmembrane protein
hsa:9616,6.5902185e-08,5.488022032848766e-05,1.0074701543491229e-06,2.0471538197273094e-06,0.0,1.5861035e-05,False,RNF7; ring finger protein
hsa:2621,0.0,0.0,1.0286820830567253e-05,3.0530992729383196e-05,0.0,0.00016319078,False,GAS6; growth arrest specific
hsa:55509,2.165375e-07,0.00018032218065880363,1.839910469064328e-06,3.1541477856831935e-06,0.0,1.7701472e-05,False,BATF3; basic leucine zipper ATF-like transcription factor
hsa:84883,0.0,0.0,4.832695953532163e-06,1.3352364352517656e-05,0.0,8.011451e-05,False,AIFM2; apoptosis inducing factor mitochondria associated
hsa:29985,0.0,0.0,7.16854044111111e-08,1.9017606061350184e-07,0.0,1.070654e-06,False,SLC39A3; solute carrier family 39 member
hsa:9334,2.747498e-06,0.002287986287436133,0.0002791578554297076,0.0007175194720627954,0.0,0.0057685445,False,B4GALT5; beta-1
hsa:162967,6.971035e-08,5.8051479889111275e-05,1.1828284112187136e-07,1.378437351561967e-07,0.0,5.9603985e-07,False,ZNF320; zinc finger protein
hsa:11024,6.848446e-08,5.7030616722002474e-05,1.5662152323169586e-06,4.8399469416839215e-06,0.0,4.4825338e-05,False,LILRA1; leukocyte immunoglobulin like receptor
hsa:57343,0.0,0.0,7.710783627368423e-08,1.308693844553424e-07,0.0,4.97783e-07,False,ZNF304; zinc finger protein
hsa:11337,0.0,0.0,0.00027705703456935675,0.0008841827486145127,0.0,0.009873457,False,GABARAP; GABA type A receptor-associated
hsa:64005,8.47317e-08,7.056054916551431e-05,2.46158510728655e-07,4.372787753170615e-07,0.0,3.0810609e-06,False,MYO1G; myosin
hsa:3359,0.00010457442,0.08708462716864103,0.00033239119675555545,0.0007769083640867513,0.0,0.008362609,False,HTR3A; 5-hydroxytryptamine receptor
hsa:3053,0.0,0.0,8.252322940526318e-08,3.4107030195410067e-07,0.0,3.8271337e-06,False,SERPIND1; serpin family D member
hsa:64065,7.343629e-07,0.0006115426636168005,6.178034341812866e-06,1.292295127076936e-05,0.0,8.992362e-05,False,PERP; p53 apoptosis effector related to
hsa:2150,0.0,0.0,1.2207687079011697e-05,4.077068280693349e-05,0.0,0.000325765,False,F2RL1; F2R like trypsin receptor
hsa:79184,2.2142644e-06,0.001843934584832454,1.8058537109198825e-05,2.9048574249973725e-05,0.0,0.00014191076,False,BRCC3; BRCA1/BRCA2-containing complex subunit
hsa:8324,0.0,0.0,2.7678315789473686e-06,1.190746517464527e-05,0.0,9.534684e-05,False,FZD7; frizzled class receptor
hsa:10063,0.0,0.0,1.5559430902736842e-06,3.6010625397849936e-06,0.0,2.6258558e-05,False,COX17; cytochrome c oxidase copper chaperone
hsa:27030,0.0,0.0,0.0001390874053329205,0.00041802493569012095,0.0,0.0023681617,False,MLH3; mutL homolog
hsa:254973,0.0,0.0,5.97442056356725e-06,3.786088948213787e-05,0.0,0.00036461288,False,OR1L4; olfactory receptor family 1 subfamily L member
hsa:388,0.0,0.0,6.333459393523392e-08,1.1117833837752661e-07,0.0,4.8078306e-07,False,RHOB; ras homolog family member
hsa:51710,0.0,0.0,1.2189951673099416e-07,3.273236831914431e-07,0.0,1.9438248e-06,False,ZNF44; zinc finger protein
hsa:259230,4.735525e-07,0.00039435210740138823,1.1198206100058483e-05,3.711437669375185e-05,0.0,0.00028934563,False,SGMS1; sphingomyelin synthase
hsa:26003,0.0,0.0,1.7109642128660813e-07,3.6035971440465024e-07,0.0,2.125344e-06,False,GORASP2; golgi reassembly stacking protein
hsa:701,0.0,0.0,2.120460148815205e-06,6.246530704335281e-06,0.0,5.646598e-05,False,BUB1B; BUB1 mitotic checkpoint serine/threonine kinase
hsa:57679,1.6914274e-08,1.4085406786078646e-05,4.6813339498444435e-08,7.587232288913702e-08,0.0,4.1078e-07,False,ALS2; alsin Rho guanine nucleotide exchange factor
hsa:403278,0.0,0.0,1.0236599415204679e-08,1.3386090712915375e-07,0.0,1.7504585e-06,False,OR5K4; olfactory receptor family 5 subfamily K member
hsa:8086,0.0,0.0,1.2585061357719298e-07,2.8694372326376056e-07,0.0,1.4616579e-06,False,AAAS; aladin WD repeat
hsa:5708,0.0,0.0,7.96275895605848e-06,2.452531653366468e-05,0.0,0.0001704155,False,PSMD2; proteasome 26S subunit ubiquitin receptor
hsa:6811,0.0,0.0,1.3399935099625733e-05,4.815888671000133e-05,0.0,0.0004205502,False,STX5; syntaxin
hsa:79023,5.124984e-08,4.2678440950019195e-05,9.238212494327488e-08,1.4371718742230514e-07,0.0,7.491472e-07,False,NUP37; nucleoporin
hsa:283160,0.0,0.0,1.5744533519298243e-06,1.2952208448086124e-05,0.0,0.00013484684,False,OR8D2; olfactory receptor family 8 subfamily D member
hsa:8861,2.7120043e-08,2.258428814094798e-05,3.025940660459064e-06,8.20009828664355e-06,0.0,7.273237e-05,False,LDB1; LIM domain binding
hsa:3720,8.4036856e-07,0.0006998191597127457,4.214186401794736e-05,0.00011573335409031508,0.0,0.00077379815,False,JARID2; jumonji and AT-rich interaction domain containing
hsa:51728,0.0,0.0,5.8651773917368435e-05,0.00019286725944957534,0.0,0.0011324317,False,POLR3K; RNA polymerase III subunit
hsa:412,0.0,0.0,1.5750351059649122e-07,3.76030306769092e-07,0.0,2.6808166e-06,False,STS; steroid
hsa:1571,0.00025249875,0.21026900750965583,0.00047308259089567245,0.0006973858569639533,0.0,0.003813252,False,CYP2E1; cytochrome P450 family 2 subfamily E member
hsa:1447,0.0,0.0,4.141385913274854e-08,3.876872456111912e-07,0.0,4.6203522e-06,False,CSN2; casein
hsa:53371,1.9861898e-07,0.00016540048533776968,2.955511195321637e-07,3.1851487976714146e-07,0.0,1.1836654e-06,False,NUP54; nucleoporin
hsa:28956,0.0,0.0,6.815132365789472e-07,1.612310883356498e-06,0.0,1.2997337e-05,False,LAMTOR2; late endosomal/lysosomal adaptor
hsa:390429,0.0,0.0,3.492872366081871e-06,1.763487591305465e-05,0.0,0.00015563793,False,OR4N2; olfactory receptor family 4 subfamily N member
hsa:66004,2.789313e-09,2.3228078402122013e-06,8.409408974988304e-06,2.3775174974638604e-05,0.0,0.00019257657,False,LYNX1; Ly6/neurotoxin
hsa:58508,9.546255e-07,0.0007949669312359325,4.0093367301335685e-05,0.00013697930342026398,0.0,0.00096074905,False,KMT2C; lysine methyltransferase
hsa:7132,0.0,0.0,0.0001892445451988304,0.000538620519103004,0.0,0.0029094703,False,TNFRSF1A; TNF receptor superfamily member
hsa:7936,0.0,0.0,3.912320561792983e-05,0.00010488630526544543,0.0,0.00071382115,False,NELFE; negative elongation factor complex member
hsa:5360,0.0,0.0,2.939690400350877e-05,7.37124830198317e-05,0.0,0.00050172454,False,PLTP; phospholipid transfer
hsa:5188,0.0,0.0,3.421647611327486e-07,8.227709345453858e-07,0.0,4.480345e-06,False,GATB; glutamyl-tRNA amidotransferase subunit
hsa:57486,0.0002459751,0.20483642057272888,0.00042620583250961406,0.0005039672096992823,0.0,0.0025267403,False,NLN;
hsa:6571,2.0406599e-06,0.0016993649744315705,0.0006363209614281285,0.0013475362000506166,0.0,0.006811979,False,SLC18A2; solute carrier family 18 member
hsa:57449,4.7871172e-08,3.98648461616702e-05,1.0509063306298242e-07,1.8058046800814125e-07,0.0,9.703784e-07,False,PLEKHG5; pleckstrin homology and RhoGEF domain containing
hsa:4991,0.0,0.0,1.0460850099763744e-05,5.917224447118169e-05,0.0,0.0006277232,False,OR1D2; olfactory receptor family 1 subfamily D member
hsa:29894,0.0,0.0,5.39816618460234e-07,9.351406608472941e-07,0.0,4.2187266e-06,False,CPSF1; cleavage and polyadenylation specific factor
hsa:81027,1.3420228e-07,0.0001117573066050146,9.995585274863157e-05,0.00037570210501071654,0.0,0.0028440284,False,TUBB1; tubulin beta 1 class
hsa:8994,0.0,0.0,0.00016871752924701755,0.0005084349369834254,0.0,0.0041567204,False,LIMD1; LIM domain containing
hsa:23586,0.0,0.0,1.037976642857895e-05,3.1203956516181486e-05,0.0,0.00018972157,False,RIGI; RNA sensor
hsa:1053,0.0,0.0,8.980892025730993e-09,3.871440921788863e-08,0.0,3.7945657e-07,False,CEBPE; CCAAT enhancer binding protein
hsa:340485,4.3053316e-07,0.0003585276372781879,4.059317717660819e-06,7.840388908097527e-06,0.0,3.7946305e-05,False,ACER2; alkaline ceramidase
hsa:3908,0.0,0.0,4.390262325730994e-06,2.5115172907503683e-05,0.0,0.0002535132,False,LAMA2; laminin subunit alpha
hsa:92552,0.0,0.0,8.728942959064327e-10,8.041158885906134e-09,0.0,1.00113695e-07,False,ATXN3L; ataxin 3
hsa:845,0.0,0.0,2.8433449221309937e-06,1.7215624578957323e-05,0.0,0.0002069739,False,CASQ2; calsequestrin
hsa:2773,0.0003216758,0.2678763804013863,0.00041364411023391803,0.0004280142078957292,0.0,0.0021887822,False,GNAI3; G protein subunit alpha
hsa:30837,1.4352329e-05,0.011951940254286609,0.00018324468801114152,0.00032391176186732354,0.0,0.0020699634,False,SOCS7; suppressor of cytokine signaling
hsa:2958,0.0,0.0,1.2479157243040937e-06,3.6945041179187757e-06,0.0,3.4619316e-05,False,GTF2A2; general transcription factor IIA subunit
hsa:4124,2.432792e-07,0.00020259140265741141,2.0917981780268997e-05,5.5061712871746226e-05,0.0,0.00042271073,False,MAN2A1; mannosidase alpha class 2A member
hsa:3339,7.3292886e-06,0.006103484629820285,4.737777289005847e-05,0.00011937105772369008,0.0,0.0006988681,False,HSPG2; heparan sulfate proteoglycan
hsa:164091,0.0,0.0,8.606768040947369e-07,2.778835171816988e-06,0.0,1.7920434e-05,False,PAQR7; progestin and adipoQ receptor family member
hsa:7276,0.0,0.0,3.705873142690058e-06,1.1960846838367432e-05,0.0,8.670745e-05,False,TTR;
hsa:5575,0.0,0.0,2.5557964108011697e-07,5.239905101207651e-07,0.0,3.6272706e-06,False,PRKAR1B; protein kinase cAMP-dependent type I regulatory subunit
hsa:387787,0.0,0.0,4.7065846447508775e-06,1.3242740827201143e-05,0.0,8.698442e-05,False,LIPT2; lipoyl(octanoyl) transferase
hsa:285676,7.0643197e-10,5.88283107163861e-07,5.911856520365494e-08,1.4181533835977149e-07,0.0,9.681575e-07,False,ZNF454; zinc finger protein
hsa:153129,8.779432e-08,7.311095413892196e-05,5.753833607894737e-07,1.5167349512321737e-06,0.0,1.482726e-05,False,SLC38A9; solute carrier family 38 member
hsa:5928,2.4857165e-06,0.00206998704510567,1.8030794631578954e-05,3.7692680828171974e-05,0.0,0.00024166478,False,RBBP4; RB binding protein 4
hsa:3249,5.2148175e-09,4.3426531817246005e-06,2.8675874070584805e-08,1.387278116228716e-07,0.0,1.7289356e-06,False,HPN;
hsa:2255,5.0649568e-08,4.217856284101534e-05,1.2323536521323392e-05,4.7623876248361354e-05,0.0,0.0005360523,False,FGF10; fibroblast growth factor
hsa:51276,1.2301913e-08,1.0244450861559245e-05,4.9122003203421056e-08,1.0141238460845677e-07,0.0,9.0805014e-07,False,ZNF571; zinc finger protein
hsa:9611,0.0,0.0,0.00010217871859432746,0.00030383883082149565,0.0,0.0023776926,False,NCOR1; nuclear receptor corepressor
hsa:462,0.0,0.0,3.2368564537181293e-07,1.4861207398977702e-06,0.0,1.352737e-05,False,SERPINC1; serpin family C member
hsa:1477,1.4111778e-08,1.1751620767455661e-05,5.538049263887134e-07,9.423184936581435e-07,0.0,3.994932e-06,False,CSTF1; cleavage stimulation factor subunit
hsa:121536,0.0,0.0,1.181085538201317e-05,4.1600030514704677e-05,0.0,0.0002346243,False,AEBP2; AE binding protein
hsa:4987,0.0,0.0,1.4412405727356545e-05,3.2179106328734566e-05,0.0,0.00023153011,False,OPRL1; opioid related nociceptin receptor
hsa:92285,5.4247407e-09,4.5174672864172015e-06,1.1025518349918126e-07,1.7346151372901114e-07,0.0,6.316181e-07,False,ZNF585B; zinc finger protein
hsa:4363,0.0,0.0,0.0002563198071988303,0.0004970020722108179,0.0,0.0031412796,False,ABCC1; ATP binding cassette subfamily C member
hsa:65258,3.3749185e-07,0.00028104723822235805,2.558693245140351e-05,6.0234227896041454e-05,0.0,0.00038764128,False,MPPE1; metallophosphoesterase
hsa:2668,5.1078257e-09,4.2535554749134914e-06,5.452646422046785e-08,1.6526279514323786e-07,0.0,1.7816875e-06,False,GDNF; glial cell derived neurotrophic
hsa:23516,0.0,0.0,2.1146345257309935e-06,5.234110962105747e-06,0.0,2.329277e-05,False,SLC39A14; solute carrier family 39 member
hsa:4126,8.053913e-06,0.006706917531588234,7.837255704488303e-05,0.0001394949559883449,0.0,0.0006464972,False,MANBA; mannosidase
hsa:29924,1.6024472e-07,0.00013344421797360458,1.937632019953217e-06,4.396643968782577e-06,0.0,2.4974139e-05,False,EPN1; epsin
hsa:8578,1.0926938e-07,9.099436763071275e-05,2.2296436782760234e-05,7.259427365921802e-05,0.0,0.00047796828,False,SCARF1; scavenger receptor class F member
hsa:148203,0.0,0.0,1.9994899951461998e-07,3.987462926966132e-07,0.0,1.9570111e-06,False,ZNF738; zinc finger protein
hsa:51363,7.670702e-09,6.3877975492644305e-06,0.0004975204980469126,0.0011456829320154994,0.0,0.005707249,False,CHST15; carbohydrate sulfotransferase
hsa:874,0.0,0.0,2.1217829947708774e-05,8.252675433479519e-05,0.0,0.0005760213,False,CBR3; carbonyl reductase
hsa:57030,0.0,0.0,2.669259486374269e-06,1.37853049966177e-05,0.0,0.00015288578,False,SLC17A7; solute carrier family 17 member
hsa:3399,0.0,0.0,6.728749869766081e-06,2.2475306947964873e-05,0.0,0.00016558761,False,ID3; inhibitor of DNA binding
hsa:50814,0.0,0.0,5.0076922614619875e-05,0.0001431416669053446,0.0,0.0008251931,False,NSDHL; NAD(P) dependent steroid
hsa:6182,4.5557403e-08,3.7938048855795984e-05,3.140955729988304e-07,7.153550225860758e-07,0.0,3.8061041e-06,False,MRPL12; mitochondrial ribosomal protein
hsa:7171,0.0,0.0,0.0003764290175663917,0.0008146155582060238,0.0,0.004619291,False,TPM4; tropomyosin
hsa:23436,0.0,0.0,2.5564773047953215e-07,1.7479641052034962e-06,0.0,1.8133993e-05,False,CELA3B; chymotrypsin like elastase
hsa:374378,0.0,0.0,0.00010822196225183627,0.00032736956653647067,0.0,0.0024985184,False,GALNT18; polypeptide N-acetylgalactosaminyltransferase
hsa:22999,8.5350644e-07,0.0007107597643231881,2.1051885803036846e-05,5.1556555194342674e-05,0.0,0.0002485522,False,RIMS1; regulating synaptic membrane exocytosis
hsa:7114,0.0,0.0,2.1841590144730995e-05,6.728920229216082e-05,0.0,0.0003548453,False,TMSB4X; thymosin beta 4
hsa:1871,6.2469146e-05,0.05202134794487412,0.00014125376990514627,0.00021885604112824433,0.0,0.0011330132,False,E2F3; E2F transcription factor
hsa:5319,2.9760793e-05,0.02478337974667325,5.394088194146203e-05,6.226315406370365e-05,0.0,0.00038608254,False,PLA2G1B; phospholipase A2 group
hsa:1738,5.8911566e-05,0.04905876371134346,0.0002712461752877192,0.00041013609750717146,0.0,0.0023389328,False,DLD; dihydrolipoamide
hsa:1026,0.0,0.0,0.00013433767945614036,0.0003456788379908963,0.0,0.0019146284,False,CDKN1A; cyclin dependent kinase inhibitor
hsa:390191,0.0,0.0,6.012185277777778e-07,2.966012556527477e-06,-0.0,2.7241915e-05,False,OR5B12; olfactory receptor family 5 subfamily B member
hsa:4617,0.0,0.0,2.4422612830409357e-09,1.521983215350852e-08,0.0,1.7901968e-07,False,MYF5; myogenic factor
hsa:339318,0.0,0.0,1.827924619064327e-08,4.1808886503568086e-08,0.0,2.1882552e-07,False,ZNF181; zinc finger protein
hsa:54,0.0,0.0,8.947393085549707e-06,2.660630299094414e-05,0.0,0.00018040562,False,ACP5; acid phosphatase 5
hsa:83401,0.0,0.0,2.3203017045649124e-06,7.3059828476225965e-06,0.0,6.2579966e-05,False,ELOVL3; ELOVL fatty acid elongase
hsa:210,0.0,0.0,0.00013878526383624568,0.0004538218284637965,0.0,0.0039687348,False,ALAD; aminolevulinate
hsa:4066,0.0,0.0,4.832056832736842e-07,1.015650401015555e-06,0.0,4.7746307e-06,False,LYL1; LYL1 basic helix-loop-helix family
hsa:8879,1.78158e-07,0.00014836154967066276,2.2666872810764912e-05,4.129759498959289e-05,0.0,0.0002780707,False,SGPL1; sphingosine-1-phosphate lyase
hsa:4430,1.48364325e-08,1.2355078735078891e-05,3.251935695739299e-06,6.876568452799785e-06,0.0,2.7426595e-05,False,MYO1B; myosin
hsa:5348,0.0,0.0,5.490842741929825e-08,1.481509633945272e-07,0.0,7.962775e-07,False,FXYD1; FXYD domain containing ion transport regulator
hsa:317749,0.0,0.0,8.157090409391813e-05,0.0001574803832077362,0.0,0.0008127676,False,DHRS4L2; dehydrogenase/reductase 4 like
hsa:5547,0.0,0.0,2.7014261826900593e-05,6.475213862579664e-05,0.0,0.0003499403,False,PRCP;
hsa:89941,0.0,0.0,8.356609407368423e-06,2.6021920194985684e-05,0.0,0.00012216448,False,RHOT2; ras homolog family member
hsa:50700,0.0,0.0,1.5813101123274859e-06,1.2876456603667197e-05,0.0,0.00016508329,False,RDH8; retinol dehydrogenase
hsa:201562,0.0,0.0,4.213832143099416e-06,1.704754016148023e-05,0.0,0.00017526872,False,HACD2; 3-hydroxyacyl-CoA dehydratase
hsa:3703,0.0,0.0,0.00013396777449888874,0.0004352085998159245,0.0,0.0022156823,False,STT3A; STT3 oligosaccharyltransferase complex catalytic subunit
hsa:7345,1.19870025e-08,9.982208302776797e-06,1.7391822710023392e-07,2.7922792670723443e-07,0.0,1.5740442e-06,False,UCHL1; ubiquitin C-terminal hydrolase
hsa:594857,0.0,0.0,9.215357784795323e-08,1.204450886649182e-06,0.0,1.5750284e-05,False,NPS; neuropeptide
hsa:3449,0.0,0.0,1.4636909125146199e-06,1.4134908476152993e-05,0.0,0.00018151378,False,IFNA16; interferon alpha
hsa:126969,6.425411e-08,5.350778147660632e-05,3.3267113831169587e-07,6.316187428342888e-07,0.0,5.0311432e-06,False,SLC44A3; solute carrier family 44 member
hsa:6166,3.910107e-07,0.0003256152033016234,1.5061182636374267e-06,2.662461290589005e-06,0.0,1.3485442e-05,False,RPL36AL; ribosomal protein L36a
hsa:3860,3.4001715e-07,0.0002831501885326631,1.59320013948655e-05,5.927403328810313e-05,0.0,0.00061335316,False,KRT13; keratin
hsa:10955,4.2757563e-07,0.00035606474628256896,1.393216953004037e-05,3.315179611340722e-05,0.0,0.00024494468,False,SERINC3; serine incorporator
hsa:9246,0.0,0.0,3.76673240122807e-07,1.0745540906332985e-06,0.0,6.4351275e-06,False,UBE2L6; ubiquitin conjugating enzyme E2
hsa:2051,0.0,0.0,1.1437521892494563e-05,3.929435217891016e-05,0.0,0.00029875722,False,EPHB6; EPH receptor
hsa:2891,0.002298203,1.9138346778576665,0.0031490077935824555,0.0032251748114737063,0.0,0.01612356,True,GRIA2; glutamate ionotropic receptor AMPA type subunit
hsa:2346,0.0,0.0,2.54009470760234e-05,6.211058839022666e-05,0.0,0.00047579562,False,FOLH1; folate hydrolase
hsa:253782,0.0,0.0,4.474373617543858e-05,9.291729444542088e-05,0.0,0.0005842946,False,CERS6; ceramide synthase
hsa:779,0.0,0.0,2.4796245187368416e-05,0.0002084527161862236,0.0,0.0026561758,False,CACNA1S; calcium voltage-gated channel subunit alpha1
hsa:3066,0.00043556487,0.36271780720091584,0.0008041226626198825,0.0009170791420057564,0.0,0.004346494,False,HDAC2; histone deacetylase
hsa:2710,0.0,0.0,2.4803626213801164e-05,7.856693264723314e-05,0.0,0.00048933196,False,GK; glycerol
hsa:9134,5.594267e-05,0.04658640764890993,0.00027710940630058475,0.00037798913141198293,0.0,0.0015136567,False,CCNE2; cyclin
hsa:22877,0.0,0.0,1.2572293641754388e-05,3.5272699037184505e-05,0.0,0.00024677737,False,MLXIP; MLX interacting
hsa:55215,0.0,0.0,2.9419102342017535e-05,7.679453384609046e-05,0.0,0.0004681244,False,FANCI; FA complementation group
hsa:6195,0.0,0.0,2.6543413301461997e-05,5.161143211397039e-05,0.0,0.0002994528,False,RPS6KA1; ribosomal protein S6 kinase
hsa:92935,1.342978e-05,0.011183685113977894,4.766620604561401e-05,8.423255561641096e-05,0.0,0.0005094855,False,MARS2; methionyl-tRNA synthetase 2
hsa:6892,0.0,0.0,1.7700031810935669e-06,4.081246881802361e-06,0.0,1.8339302e-05,False,TAPBP; TAP binding
hsa:26832,0.0,0.0,1.5980944625730996e-08,7.49876971898932e-08,0.0,7.1414354e-07,False,RNU5B-1; RNA
hsa:102723555,1.2970152e-07,0.00010800928671089965,1.3064851431982468e-05,3.671607106174095e-05,0.0,0.00024685948,False,SPDYE16; speedy/RINGO cell cycle regulator family member
hsa:3110,5.4019683e-06,0.004498503509580236,9.023150763491229e-05,0.0002561308935979276,0.0,0.0016589138,False,MNX1; motor neuron and pancreas homeobox
hsa:643246,5.3197944e-08,4.430072975186708e-05,4.663483779532164e-06,9.587325774473836e-06,0.0,5.7167235e-05,False,MAP1LC3B2; microtubule associated protein 1 light chain 3 beta
hsa:27019,0.0,0.0,1.3523798968421053e-08,4.0042850671113695e-08,0.0,3.0641237e-07,False,DNAI1; dynein axonemal intermediate chain
hsa:6731,0.0,0.0,3.0911186353216373e-06,5.95330929459939e-06,0.0,4.8446724e-05,False,SRP72; signal recognition particle
hsa:2949,0.0,0.0,2.9526586580701753e-06,1.4559788110061868e-05,0.0,0.00011519368,False,GSTM5; glutathione S-transferase mu
hsa:23633,1.7999633e-07,0.00014989242388122905,1.4302657098836258e-05,4.2751409797109926e-05,0.0,0.00021405336,False,KPNA6; karyopherin subunit alpha
hsa:58528,2.2627616e-07,0.00018843207574808225,2.602870338264854e-06,5.995120025815387e-06,0.0,3.2952834e-05,False,RRAGD; Ras related GTP binding
hsa:55821,2.3845825e-10,1.9857674368680786e-07,8.309260050848805e-07,3.244354022931442e-06,0.0,2.747218e-05,False,ALLC;
hsa:5869,1.2061826e-05,0.010044517771965848,0.00024390057622485388,0.0005489728330859504,0.0,0.0036425276,False,RAB5B; RAB5B
hsa:51266,0.0,0.0,5.307015979374269e-08,3.8087581926358546e-07,0.0,4.5523316e-06,False,CLEC1B; C-type lectin domain family 1 member
hsa:1145,0.0,0.0,2.5651475267976606e-07,7.983121677235766e-07,0.0,4.7930835e-06,False,CHRNE; cholinergic receptor nicotinic epsilon
hsa:4649,4.217307e-08,3.5119736523587704e-05,1.4874759146461987e-06,4.370930215270108e-06,0.0,2.0588355e-05,False,MYO9A; myosin
hsa:151,0.0,0.0,4.858191811111111e-09,1.697183768040961e-08,0.0,1.2012138e-07,False,ADRA2B; adrenoceptor alpha
hsa:6230,0.0,0.0,5.756500581877193e-07,1.0612824420120825e-06,0.0,5.346825e-06,False,RPS25; ribosomal protein
hsa:254122,1.2738154e-09,1.0607731717820988e-06,7.054526403953216e-07,2.0391810757569387e-06,0.0,1.4135402e-05,False,SNX32; sorting nexin
hsa:6609,0.0,0.0,8.847987118947365e-06,2.0142299021975937e-05,0.0,0.000119019714,False,SMPD1; sphingomyelin phosphodiesterase
hsa:790,6.4882233e-06,0.005403085258014243,0.000201311512791579,0.0006058956136604772,0.0,0.003179467,False,CAD; carbamoyl-phosphate synthetase 2
hsa:283748,0.00015554993,0.12953461907948627,0.00027571242160584784,0.00037238790510129313,0.0,0.0026102534,False,PLA2G4D; phospholipase A2 group
hsa:3776,0.0,0.0,2.6238978134643267e-05,6.552866237038773e-05,0.0,0.0003494166,False,KCNK2; potassium two pore domain channel subfamily K member
hsa:57038,9.073681e-08,7.556132053442725e-05,4.757822336000001e-06,1.0940624637213439e-05,0.0,6.242332e-05,False,RARS2; arginyl-tRNA synthetase 2
hsa:5881,0.0003149648,0.2622877772522725,0.0006798931994368426,0.0008669597497394277,0.0,0.0047409073,False,RAC3; Rac family small GTPase
hsa:23352,1.4904195e-08,1.2411508137685334e-05,5.613380452631582e-07,1.1068383234449222e-06,0.0,5.8179517e-06,False,UBR4; ubiquitin protein ligase E3 component n-recognin
hsa:100,0.0,0.0,2.335535688187135e-05,5.070603625593875e-05,0.0,0.00032164276,False,ADA; adenosine
hsa:406949,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR15B; microRNA
hsa:113457,4.1179325e-07,0.0003429219272438995,0.00014052325793378946,0.00046482891213092334,0.0,0.0023875441,False,TUBA3D; tubulin alpha
hsa:7292,0.0,0.0,1.329379549850731e-06,4.897485646454553e-06,0.0,3.904724e-05,False,TNFSF4; TNF superfamily member
hsa:4143,0.0,0.0,5.47121260173041e-06,2.023590762218592e-05,-0.0,0.00016138762,False,MAT1A; methionine adenosyltransferase
hsa:3678,0.0,0.0,0.00016885492245614036,0.0004960272778887239,0.0,0.0039031277,False,ITGA5; integrin subunit alpha
hsa:112744,0.0,0.0,2.889579697164912e-06,8.620707312292485e-06,0.0,6.320425e-05,False,IL17F; interleukin
hsa:4099,0.0,0.0,6.95308766723392e-08,3.096613272740683e-07,0.0,2.8672941e-06,False,MAG; myelin associated
hsa:3785,0.0,0.0,7.057016554649124e-05,0.00018574979944319556,0.0,0.0015144001,False,KCNQ2; potassium voltage-gated channel subfamily Q member
hsa:54106,1.05167655e-05,0.008757864519712628,6.926933937473684e-05,0.000148467433376166,0.0,0.0010366355,False,TLR9; toll like receptor
hsa:84649,0.00033340428,0.2776433034027748,0.000428684701245029,0.000443446411790635,0.0,0.0028047503,False,DGAT2; diacylglycerol O-acyltransferase
hsa:1829,7.636303e-08,6.3591516902678e-05,8.142439812553799e-06,1.9002582836679732e-05,0.0,0.00011734876,False,DSG2; desmoglein
hsa:10795,0.0,0.0,7.488232512140352e-08,2.2314250727977166e-07,0.0,1.1920082e-06,False,ZNF268; zinc finger protein
hsa:4780,0.0,0.0,3.0432471824561417e-07,8.107034485532171e-07,0.0,4.136892e-06,False,NFE2L2; NFE2 like bZIP transcription factor
hsa:283464,1.3652898e-06,0.0011369487223562749,5.505289484138596e-05,0.00013586143011633372,0.0,0.0008047712,False,GXYLT1; glucoside xylosyltransferase
hsa:2205,0.0,0.0,1.3349572514619884e-07,7.736170235568788e-07,0.0,9.293294e-06,False,FCER1A; Fc epsilon receptor
hsa:1109,0.0,0.0,1.9642133777719302e-06,6.306608519305829e-06,0.0,6.4740794e-05,False,AKR1C4; aldo-keto reductase family 1 member
hsa:731,0.0,0.0,2.743899205617777e-06,2.2575818469901293e-05,0.0,0.00027176863,False,C8A; complement C8 alpha
hsa:51170,9.968146e-06,0.008301000167847744,8.66333282819766e-05,0.0001685852300287714,0.0,0.0011074484,False,HSD17B11; hydroxysteroid 17-beta dehydrogenase
hsa:387712,1.0045659e-06,0.0008365549325335042,1.5486785163339182e-05,3.6871987806816514e-05,0.0,0.00024665726,False,ENO4; enolase
hsa:119504,0.0,0.0,1.0506578573684207e-05,2.091098035526392e-05,0.0,0.00017992349,False,ANAPC16; anaphase promoting complex subunit
hsa:65010,0.0,0.0,3.969602843567251e-06,6.703146065307424e-06,0.0,2.9034163e-05,False,SLC26A6; solute carrier family 26 member
hsa:79726,1.0797268e-07,8.991453724724445e-05,4.890535108614035e-07,7.239284405525176e-07,0.0,3.0458468e-06,False,WDR59; WD repeat domain
hsa:117581,0.0,0.0,1.8914007757134504e-08,5.084465229095864e-08,0.0,3.8825627e-07,False,TWIST2; twist family bHLH transcription factor
hsa:162972,0.0,0.0,2.4914096814619886e-08,6.712493244258735e-08,0.0,3.6567533e-07,False,ZNF550; zinc finger protein
hsa:4298,5.15921e-07,0.00042963458877871326,0.00010752386714023385,0.00029924907383711494,0.0,0.0017186017,False,MLLT1; MLLT1 super elongation complex
hsa:50604,0.0,0.0,1.0649245993435675e-06,4.4533016847462885e-06,0.0,4.7493224e-05,False,IL20; interleukin
hsa:5094,2.4661338e-07,0.00020536794994510508,1.600707291309942e-05,2.8462395513423644e-05,0.0,0.0001326272,False,PCBP2; poly(rC) binding protein
hsa:6776,0.0,0.0,1.8191070284210525e-05,4.7370450324864084e-05,0.0,0.000318317,False,STAT5A; signal transducer and activator of transcription
hsa:4708,0.0,0.0,4.310351043251461e-06,7.297338665623101e-06,0.0,3.2291337e-05,False,NDUFB2; NADH:ubiquinone oxidoreductase subunit
hsa:4800,6.979083e-07,0.0005811849982376194,3.1479777115204678e-06,7.027353385224877e-06,0.0,5.5383243e-05,False,NFYA; nuclear transcription factor Y subunit
hsa:6727,0.0,0.0,7.249096118596493e-05,0.00023459331810907143,0.0,0.0015183195,False,SRP14; signal recognition particle
hsa:540,4.4097536e-07,0.0003672234071788996,2.2631991812514625e-05,4.0026612615070515e-05,0.0,0.0002836648,False,ATP7B; ATPase copper transporting
hsa:3001,0.0,0.0,1.7208326986526318e-06,4.178838880811428e-06,0.0,1.9619134e-05,False,GZMA; granzyme
hsa:92335,6.655653e-08,5.5425127872461276e-05,3.885806825725146e-06,9.892742799238362e-06,0.0,8.0525686e-05,False,STRADA; STE20 related adaptor
hsa:9869,2.2634158e-06,0.0018848655442756592,0.00015796690819877196,0.00028215853449002577,0.0,0.0013853776,False,SETDB1; SET domain bifurcated histone lysine methyltransferase
hsa:81605,0.0,0.0,0.00011932997653918126,0.00031542774926797906,0.0,0.0015337107,False,URM1; ubiquitin related modifier
hsa:8202,0.0,0.0,8.275301308573098e-06,2.7365172567624598e-05,0.0,0.00019995405,False,NCOA3; nuclear receptor coactivator
hsa:6648,0.0,0.0,6.542038870736842e-05,0.0001363623147432041,0.0,0.00067215774,False,SOD2; superoxide dismutase
hsa:4700,3.8751186e-06,0.0032270153495975993,8.82797883836257e-06,1.5861689175197287e-05,0.0,0.00010567446,False,NDUFA6; NADH:ubiquinone oxidoreductase subunit
hsa:774,0.00059402717,0.49467771016557344,0.0014640649146432751,0.0019993360888758095,0.0,0.009347117,True,CACNA1B; calcium voltage-gated channel subunit alpha1
hsa:55048,0.0,0.0,5.0740446198245606e-08,1.1300541487580503e-07,0.0,6.882928e-07,False,VPS37C; VPS37C subunit of
hsa:9409,5.361118e-07,0.0004464485313302148,1.7961454511169577e-06,2.839299204388197e-06,0.0,1.8012292e-05,False,PEX16; peroxisomal biogenesis factor
hsa:3078,0.0,0.0,2.522859311035088e-07,9.240403200676817e-07,0.0,6.4409273e-06,False,CFHR1; complement factor H related
hsa:183,0.0,0.0,3.45970375637427e-06,1.5977176653402992e-05,0.0,0.00017118579,False,AGT;
hsa:442890,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133B; microRNA
hsa:5825,0.0,0.0,0.000795663966573099,0.00181657911770076,0.0,0.010152932,False,ABCD3; ATP binding cassette subfamily D member
hsa:54872,2.4709536e-06,0.002057693200756087,2.9589009298245615e-05,5.183600521378798e-05,0.0,0.00022647333,False,PIGG; phosphatidylinositol glycan anchor biosynthesis class
hsa:339745,2.8487217e-05,0.02372280593587966,0.00011310082611403507,0.0002219295406394714,0.0,0.0014968483,False,SPOPL; speckle type BTB/POZ protein
hsa:100169754,0.0,0.0,1.1770806619887133e-07,6.801837090175258e-07,0.0,7.670449e-06,False,RNA5S3; RNA
hsa:8131,0.0,0.0,3.523164300584795e-07,5.559007511495642e-07,0.0,3.1316602e-06,False,NPRL3; NPR3 like
hsa:6383,2.2450447e-06,0.0018695669617525353,2.307808643812866e-05,4.288842337885336e-05,0.0,0.00030581278,False,SDC2; syndecan
hsa:3590,0.00014054764,0.11704142206891875,0.0002504251041283624,0.0003062577598643316,0.0,0.0015897239,False,IL11RA; interleukin 11 receptor subunit
hsa:201266,1.6834857e-08,1.4019272067513132e-05,3.553864620163743e-08,6.228847023914921e-08,0.0,3.9227416e-07,False,SLC39A11; solute carrier family 39 member
hsa:1398,7.9719386e-05,0.06638653131351799,0.00013757267328070178,0.00026425904243723887,0.0,0.0028512795,False,CRK; CRK proto-oncogene
hsa:7169,0.0,0.0,1.4621687429415206e-05,4.875939804735802e-05,0.0,0.0003120739,False,TPM2; tropomyosin
hsa:406992,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR210; microRNA
hsa:5733,2.7413516e-06,0.002282867856442881,3.229293061666667e-05,7.410575405253937e-05,0.0,0.000447342,False,PTGER3; prostaglandin E receptor
hsa:170506,0.0,0.0,1.1273280070035087e-06,2.604907861761399e-06,0.0,1.4442882e-05,False,DHX36; DEAH-box helicase
hsa:8560,0.0,0.0,3.0139223314486556e-05,8.501247303924623e-05,0.0,0.00067037164,False,DEGS1; delta 4-desaturase
hsa:255022,8.746568e-06,0.007283727830239615,5.004381657024562e-05,0.00011778306190098042,0.0,0.00081619056,False,CALHM1; calcium homeostasis modulator
hsa:26740,-0.0,0.0,1.7261546823391817e-06,8.524913757795498e-06,0.0,7.237874e-05,False,OR1J2; olfactory receptor family 1 subfamily J member
hsa:51807,1.2989701e-06,0.00108172081529797,6.337568913543858e-06,1.3967369364799045e-05,0.0,9.812686e-05,False,TUBA8; tubulin alpha
hsa:3442,0.0,0.0,5.13377513883041e-06,1.036966719837071e-05,0.0,5.621057e-05,False,IFNA5; interferon alpha
hsa:4621,1.8189183e-08,1.514709065617752e-05,8.521460355130412e-07,2.7528477789454535e-06,0.0,1.6142034e-05,False,MYH3; myosin heavy chain
hsa:3692,1.3834325e-08,1.1520571041702261e-05,3.357373556436666e-06,6.50690312974626e-06,0.0,3.739694e-05,False,EIF6; eukaryotic translation initiation factor
hsa:221823,0.0,0.0,1.6794322090350878e-07,2.0004415585211422e-06,0.0,2.6143893e-05,False,PRPS1L1; phosphoribosyl pyrophosphate synthetase 1 like
hsa:158067,0.0,0.0,4.579218793304094e-06,1.1680700532491587e-05,0.0,7.4896154e-05,False,AK8; adenylate kinase
hsa:81035,0.0,0.0,1.8665296715029235e-07,6.852856021364423e-07,0.0,5.45364e-06,False,COLEC12; collectin subfamily member
hsa:2563,0.0,0.0,1.1274117822426902e-05,5.1647315889430846e-05,0.0,0.00050205615,False,GABRD; gamma-aminobutyric acid type A receptor subunit
hsa:9129,2.7410685e-08,2.2826321041628162e-05,3.9413385372842144e-07,9.990800138781929e-07,0.0,6.0056886e-06,False,PRPF3; pre-mRNA processing factor
hsa:27429,0.0,0.0,0.00022105022951116962,0.00048144012284287284,0.0,0.0018799999,False,HTRA2; HtrA serine peptidase
hsa:126129,0.00025963827,0.2162144618316884,0.00042779605954210544,0.0005634170788803645,0.0,0.0033246796,False,CPT1C; carnitine palmitoyltransferase
hsa:9373,0.0,0.0,1.8980467502801173e-07,5.273480004571325e-07,0.0,2.6677549e-06,False,PLAA; phospholipase A2 activating
hsa:25920,0.0,0.0,3.840541350107017e-06,1.0269880800442078e-05,0.0,5.8004392e-05,False,NELFB; negative elongation factor complex member
hsa:7088,0.0,0.0,1.001590596263158e-05,3.4459383346373244e-05,0.0,0.0002937634,False,TLE1; TLE family member 1
hsa:921,6.228655e-07,0.0005186929063886673,1.702689793987515e-05,2.850851291728153e-05,0.0,0.00013521989,False,CD5; CD5
hsa:7706,9.0446486e-07,0.000753195524490952,4.940246424444443e-05,0.00014901468886848699,0.0,0.0013717144,False,TRIM25; tripartite motif containing
hsa:199746,0.0,0.0,2.2042722983918133e-07,4.6389456974018325e-07,0.0,2.599586e-06,False,U2AF1L4; U2 small nuclear RNA auxiliary factor 1 like
hsa:9407,0.0,0.0,5.562377310823975e-07,2.2021705491038548e-06,0.0,1.6539345e-05,False,TMPRSS11D; transmembrane serine protease
hsa:10197,0.0,0.0,3.961475204766082e-06,1.809228418337105e-05,0.0,0.00020925284,False,PSME3; proteasome activator subunit
hsa:9789,0.0,0.0,1.7976061858479529e-06,5.990212687485648e-06,0.0,4.9335955e-05,False,SPCS2; signal peptidase complex subunit
hsa:343563,0.0,0.0,3.5506416771929824e-07,1.7208232950876582e-06,0.0,1.23653945e-05,False,OR2T29; olfactory receptor family 2 subfamily T member
hsa:8697,0.0,0.0,4.2053914739064306e-05,0.0001226202149125019,0.0,0.0008367215,False,CDC23; cell division cycle
hsa:10749,1.3947354e-08,1.1614696242915373e-05,2.3001944878128657e-07,5.834195354530758e-07,0.0,2.878986e-06,False,KIF1C; kinesin family member
hsa:55811,0.0,0.0,1.207149421787719e-05,2.9507998282310698e-05,0.0,0.00025175264,False,ADCY10; adenylate cyclase
hsa:127,0.0,0.0,2.2441230518888883e-05,0.0001472541184879953,0.0,0.0018506362,False,ADH4; alcohol dehydrogenase 4 (class II)
hsa:9440,2.3163801e-07,0.00019289717063633672,2.364963534842105e-06,5.402497732315963e-06,0.0,5.0258197e-05,False,MED17; mediator complex subunit
hsa:27430,6.025706e-08,5.0179227428451744e-05,0.00017261622685154965,0.0005141900662402126,0.0,0.0031890057,False,MAT2B; methionine adenosyltransferase 2 non-catalytic beta
hsa:1386,0.00043720807,0.36408618638354495,0.0005977229167894735,0.0006592804255418085,0.0,0.003739673,False,ATF2; activating transcription factor
hsa:287,1.8188324e-08,1.5146375321636455e-05,7.448420787077192e-07,1.5049512953324808e-06,0.0,8.583163e-06,False,ANK2; ankyrin
hsa:4626,0.0,0.0,1.9676181478888888e-09,2.3422720012795148e-08,0.0,3.0618313e-07,False,MYH8; myosin heavy chain
hsa:3400,4.0620077e-07,0.0003382647746080247,2.8400114040269008e-05,0.00010451485889044448,0.0,0.00083666784,False,ID4; inhibitor of DNA binding
hsa:7280,0.0,0.0,0.0005793421870982456,0.0019032472062617183,0.0,0.012387441,False,TUBB2A; tubulin beta 2A class
hsa:112574,0.0,0.0,9.357600710350878e-08,1.8127839143206503e-07,0.0,9.344911e-07,False,SNX18; sorting nexin
hsa:10263,1.3168199e-07,0.00010965852838557187,5.052876418555556e-06,1.5723935316029795e-05,0.0,0.00010086007,False,CDK2AP2; cyclin dependent kinase 2 associated protein
hsa:93973,2.2142531e-08,1.843925174727315e-05,1.9270589908878945e-06,6.3285916914779226e-06,0.0,3.365279e-05,False,ACTR8; actin related protein
hsa:1497,3.2850568e-07,0.00027356398118756864,1.0364457204385968e-06,1.812748582802767e-06,0.0,7.805075e-06,False,CTNS; cystinosin
hsa:8854,1.4606633e-06,0.0012163712588548602,7.699918070688306e-05,0.0002449088557540347,0.0,0.0017096703,False,ALDH1A2; aldehyde dehydrogenase 1 family member
hsa:2172,3.377128e-07,0.0002812312349241606,0.00017623896257478952,0.0005190280072446445,0.0,0.004448103,False,FABP6; fatty acid binding protein
hsa:9658,0.0,0.0,5.706692836257309e-08,1.8878663303996288e-07,0.0,1.0442091e-06,False,ZNF516; zinc finger protein
hsa:3796,5.8769074e-09,4.894010311829867e-06,4.551816540352047e-06,1.3924155374284837e-05,0.0,6.897549e-05,False,KIF2A; kinesin family member
hsa:2512,0.0,0.0,8.152506130626316e-05,0.00018013885926485292,0.0,0.001096466,False,FTL; ferritin light
hsa:11282,0.0,0.0,4.393094526043274e-05,0.0001313757330138145,0.0,0.0011119591,False,MGAT4B; alpha-1
hsa:50840,0.0003831244,0.3190478659428309,0.0009375394244327481,0.0012230552449195942,0.0,0.007767026,False,TAS2R14; taste 2 receptor member
hsa:91319,1.1013969e-09,9.171912060444323e-07,1.8123155402397663e-07,4.793872701703358e-07,0.0,3.7549949e-06,False,DERL3; derlin
hsa:100288814,0.0,0.0,3.4882597064327483e-09,1.4214600612460727e-08,0.0,1.1646884e-07,False,CLDN34; claudin
hsa:1339,0.0,0.0,2.916754391918129e-06,1.2911421505533268e-05,0.0,0.00012643934,False,COX6A2; cytochrome c oxidase subunit
hsa:8731,0.0,0.0,3.389114255798245e-07,7.028020941874478e-07,0.0,3.5574017e-06,False,RNMT; RNA guanine-7
hsa:26696,0.0,0.0,1.5748980391812866e-06,1.6054192102957344e-05,0.0,0.0002058132,False,OR2T1; olfactory receptor family 2 subfamily T member
hsa:51554,0.0,0.0,2.5755773290175444e-05,6.270237595633754e-05,0.0,0.00042104843,False,ACKR4; atypical chemokine receptor
hsa:10523,0.0,0.0,6.604568954643276e-08,1.488504984975486e-07,0.0,9.30215e-07,False,CHERP; calcium homeostasis endoplasmic reticulum
hsa:377677,2.1646427e-05,0.018026119818098967,0.00012871154578058486,0.000249086539450881,0.0,0.0017914873,False,CA13; carbonic anhydrase
hsa:2548,6.690388e-05,0.0557143845113891,0.00018509422914929826,0.00023815628744993983,0.0,0.0010892773,False,GAA; alpha
hsa:3000,2.1057197e-06,0.0017535436964045573,6.935310834122805e-05,0.0002014902426126533,0.0,0.0020391357,False,GUCY2D; guanylate cyclase 2D
hsa:79008,6.5287127e-06,0.005436802913854763,9.044614343871344e-05,0.000226274567334013,0.0,0.0019761263,False,SLX1B; SLX1 homolog B
hsa:3929,0.0,0.0,2.3692593902352623e-06,1.3503463696946157e-05,0.0,0.0001386707,False,LBP; lipopolysaccharide binding
hsa:1891,0.0,0.0,5.987738988011696e-07,1.2196770322240136e-06,0.0,6.1969135e-06,False,ECH1; enoyl-CoA hydratase
hsa:79679,7.472795e-08,6.222989967170603e-05,2.3240895816116972e-06,5.5265239997172165e-06,0.0,3.8383318e-05,False,VTCN1; V-set domain containing T cell activation inhibitor
hsa:23411,0.0001862185,0.1550739525440694,0.0002990930517718128,0.0003600889829527588,0.0,0.0017825492,False,SIRT1; sirtuin
hsa:5425,9.460215e-06,0.007878019272879405,0.00015927749325251458,0.0003153988254329169,0.0,0.0023327381,False,POLD2; DNA polymerase delta 2
hsa:6157,1.7204742e-07,0.00014327294787794753,1.930764935836258e-06,3.474435496082878e-06,0.0,1.391414e-05,False,RPL27A; ribosomal protein
hsa:219865,-0.0,0.0,7.206498150584797e-06,4.003684924814529e-05,0.0,0.000357226,False,OR8G5; olfactory receptor family 8 subfamily G member
hsa:390199,0.0,0.0,5.499759508771931e-07,7.030722476365668e-06,0.0,9.1938084e-05,False,OR4D9; olfactory receptor family 4 subfamily D member
hsa:4089,0.00012578716,0.1047495929807901,0.00028104521002923993,0.0004471050734356295,0.0,0.0020950632,False,SMAD4; SMAD family member
hsa:5527,0.0,0.0,9.20820841637427e-06,1.8911664879836628e-05,0.0,8.073488e-05,False,PPP2R5C; protein phosphatase 2 regulatory subunit
hsa:1513,0.0,0.0,3.1491893612280705e-06,7.0423676589416735e-06,0.0,2.7267459e-05,False,CTSK; cathepsin
hsa:780854,0.0,0.0,0.0,0.0,0.0,0.0,False,SNORD3D; small nucleolar RNA
hsa:1358,1.6965408e-06,0.0014127988760959706,8.202007008666663e-06,1.7444216764944093e-05,0.0,0.00014665001,False,CPA2; carboxypeptidase
hsa:26188,0.0,0.0,5.132513959561403e-06,2.4367582212582824e-05,0.0,0.0002480315,False,OR1C1; olfactory receptor family 1 subfamily C member
hsa:2619,0.0,0.0,3.950733610526318e-07,1.3880747644214044e-06,0.0,9.477813e-06,False,GAS1; growth arrest specific
hsa:212,0.0,0.0,4.951035809567253e-06,1.3877791885720001e-05,0.0,0.00010192705,False,ALAS2; 5'-aminolevulinate synthase
hsa:4261,0.0,0.0,4.8713521935672505e-06,1.7338259793840048e-05,0.0,0.00014602774,False,CIITA; class II major histocompatibility complex
hsa:388761,0.0,0.0,4.7530742280701757e-08,3.8079667325926754e-07,0.0,4.3827995e-06,False,OR14A2; olfactory receptor family 14 subfamily A member
hsa:7325,0.0,0.0,2.4977424955204674e-07,7.578182327503716e-07,0.0,4.381149e-06,False,UBE2E2; ubiquitin conjugating enzyme E2
hsa:596,0.00043713365,0.3640242129300571,0.0011039069359005849,0.001551067159046214,0.0,0.0068974653,False,BCL2; BCL2 apoptosis
hsa:653166,0.0,0.0,4.215447590175439e-06,2.7536502493235784e-05,0.0,0.00031281373,False,OR1D4; olfactory receptor family 1 subfamily D member
hsa:143503,4.0053726e-07,0.0003335484715502036,5.481973357770174e-05,0.00016454918337253322,0.0,0.0012922283,False,OR51E1; olfactory receptor family 51 subfamily E member
hsa:10073,0.0,0.0,2.9577762186959056e-08,8.212448597497751e-08,0.0,4.3486548e-07,False,SNUPN; snurportin
hsa:80223,3.1422638e-09,2.6167285602780984e-06,1.548130664549708e-07,2.508759093055968e-07,0.0,1.4310924e-06,False,RAB11FIP1; RAB11 family interacting protein
hsa:3612,0.0,0.0,0.00010556491957292393,0.0002955051658686195,0.0,0.0018402061,False,IMPA1; inositol monophosphatase
hsa:11345,1.2632039e-05,0.010519364168548418,0.00041384915445029233,0.0009219687399725607,0.0,0.0056666187,False,GABARAPL2; GABA type A receptor associated protein like
hsa:284370,2.018594e-09,1.6809895373539322e-06,5.124669895502924e-08,1.0897011374581696e-07,0.0,5.1818586e-07,False,ZNF615; zinc finger protein
hsa:81539,4.6100145e-06,0.0038390018703859806,0.00023635939776561385,0.0006062449947390207,0.0,0.0036004633,False,SLC38A1; solute carrier family 38 member
hsa:6870,7.63773e-09,6.360340028323797e-06,5.451536492546784e-07,2.057571472179913e-06,0.0,1.7217011e-05,False,TACR3; tachykinin receptor
hsa:9846,1.03870925e-05,0.008649878983107795,9.096426382502925e-05,0.0001635694936991186,0.0,0.000728304,False,GAB2; GRB2 associated binding protein
hsa:2814,1.2085457e-07,0.00010064196550242813,1.1193151219415198e-06,2.1882823484764723e-06,0.0,1.2804121e-05,False,GP5; glycoprotein V
hsa:6775,5.6391063e-06,0.004695980811558265,0.00021833775366421037,0.0005014532356300198,0.0,0.0031281933,False,STAT4; signal transducer and activator of transcription
hsa:284273,4.030012e-06,0.003356003241568534,0.00016497126880614033,0.0004209588515661258,0.0,0.0023455098,False,PTGR3; prostaglandin reductase
hsa:821,0.0,0.0,3.329973760818713e-05,0.00010275998406267878,0.0,0.00075894635,False,CANX;
hsa:890,2.1519334e-05,0.01792028278337533,6.840424702836257e-05,0.00010154114284564426,0.0,0.00068459345,False,CCNA2; cyclin
hsa:8729,3.6033544e-08,3.0007029872169716e-05,2.8982900846549717e-07,5.717101433257657e-07,0.0,3.1455675e-06,False,GBF1; golgi brefeldin A resistant guanine nucleotide exchange factor
hsa:29761,0.0,0.0,2.0250859541345032e-05,5.732659691351769e-05,0.0,0.00034793545,False,USP25; ubiquitin specific peptidase
hsa:1399,4.957102e-06,0.0041280399117386915,0.00018406720251871336,0.0003660434080689522,0.0,0.001739485,False,CRKL; CRK like proto-oncogene
hsa:55526,0.0,0.0,6.553457487637426e-05,0.00013403838345746102,0.0,0.0011512617,False,DHTKD1; dehydrogenase E1 and transketolase domain containing
hsa:79796,6.2553994e-08,5.2092005343174825e-05,0.00015604696987431575,0.00042841745427789487,0.0,0.0022870288,False,ALG9; ALG9
hsa:8473,0.0,0.0,0.00012942187785614033,0.00022549332495011142,0.0,0.0010058543,False,OGT; O-linked N-acetylglucosamine (GlcNAc)
hsa:6940,1.3563059e-08,1.1294673556700397e-05,1.1396260809649127e-07,2.0011123542114043e-07,0.0,1.073963e-06,False,ZNF354A; zinc finger protein
hsa:7113,0.0,0.0,1.6938283768304095e-06,1.3015578740190064e-05,0.0,0.00016208382,False,TMPRSS2; transmembrane serine protease
hsa:6176,4.0583495e-07,0.00033796013702733495,1.3341878692847956e-06,2.4528490445734566e-06,0.0,1.1457605e-05,False,RPLP1; ribosomal protein lateral stalk subunit
hsa:1072,1.6049323e-06,0.0013365116533891322,8.124136581637429e-06,1.7400768710512195e-05,0.0,0.0001302673,False,CFL1; cofilin
hsa:6622,0.0,0.0,7.696900781052631e-08,1.2816867435115863e-07,0.0,6.991775e-07,False,SNCA; synuclein
hsa:9173,0.0,0.0,2.4036193924736843e-06,1.5907712578513996e-05,0.0,0.00016052923,False,IL1RL1; interleukin 1 receptor like
hsa:635,0.0,0.0,6.149035232467841e-06,2.3958758104555602e-05,0.0,0.0002150982,False,BHMT; betaine--homocysteine
hsa:4851,0.0,0.0,6.826986109064327e-06,2.052807889883563e-05,0.0,0.00017685433,False,NOTCH1; notch receptor
hsa:29896,1.580628e-08,1.3162721827413886e-05,3.3665853250467817e-06,5.281810055402234e-06,0.0,2.6710668e-05,False,TRA2A; transformer 2 alpha
hsa:80201,0.0,0.0,1.4062654140350878e-06,5.97815347501268e-06,0.0,3.8753547e-05,False,HKDC1; hexokinase domain containing
hsa:59284,0.00010039436,0.08360367105487489,0.0004006106544466373,0.0007908675680853125,0.0,0.0052626063,False,CACNG7; calcium voltage-gated channel auxiliary subunit gamma
hsa:383,3.2461517e-06,0.0027032414860857015,2.134786666235088e-05,8.64038065234884e-05,0.0,0.0010961605,False,ARG1; arginase
hsa:148022,0.0,0.0,2.5099750304444447e-05,5.4059580501031174e-05,0.0,0.00039141736,False,TICAM1; TIR domain containing adaptor molecule
hsa:374875,0.0005832873,0.485734054778437,0.000958046326415204,0.001115161218544568,0.0,0.006570707,True,HSD11B1L; hydroxysteroid 11-beta dehydrogenase 1
hsa:678,0.0,0.0,2.804123938187134e-07,4.884044918145266e-07,0.0,2.6897244e-06,False,ZFP36L2; ZFP36 ring finger protein like
hsa:4854,0.0,0.0,0.00011762156928245609,0.00026082458975776747,0.0,0.0014907597,False,NOTCH3; notch receptor
hsa:55163,5.6277117e-06,0.0046864919280173774,6.972291399872514e-05,0.00012584793191046587,0.0,0.000578153,False,PNPO; pyridoxamine 5'-phosphate
hsa:1284,0.0,0.0,4.960255916888889e-05,0.0001590655715685096,0.0,0.00083622383,False,COL4A2; collagen type IV alpha 2
hsa:116512,3.3067565e-07,0.00027537102949266206,1.933583657321345e-05,5.4954104673829774e-05,0.0,0.0004424509,False,MRGPRD; MAS related GPR family member
hsa:8649,2.1415704e-07,0.0001783398462448058,2.2323550333883035e-06,4.388965093084534e-06,0.0,2.4503184e-05,False,LAMTOR3; late endosomal/lysosomal adaptor
hsa:7030,0.0,0.0,3.819754940175439e-06,7.933895185053336e-06,0.0,4.8286027e-05,False,TFE3; transcription factor binding to IGHM enhancer
hsa:6356,0.0,0.0,0.0,0.0,0.0,0.0,False,CCL11; C-C motif chemokine ligand
hsa:11260,8.5698396e-08,7.136556783781882e-05,1.5428852714502926e-07,2.1673569274969648e-07,0.0,9.809627e-07,False,XPOT; exportin for
hsa:6154,1.9158894e-07,0.00015954620077773452,8.425033206491228e-07,1.6277203695219883e-06,0.0,9.781128e-06,False,RPL26; ribosomal protein
hsa:26830,0.0,0.0,1.8063290409356726e-09,1.9487254045896873e-08,0.0,2.5250637e-07,False,RNU5D-1; RNA
hsa:5334,1.004058e-06,0.0008361319774538684,1.655759349807017e-05,3.9508556660048604e-05,0.0,0.00027101455,False,PLCL1; phospholipase C like 1
hsa:407024,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29B1; microRNA
hsa:107,0.003047838,2.538095223482153,0.0038843015875029254,0.002527744419027234,1.5145573e-05,0.012049589,True,ADCY1; adenylate cyclase
hsa:85480,0.0,0.0,1.8780199026900583e-08,7.134694260919851e-08,0.0,5.9469886e-07,False,TSLP; thymic stromal
hsa:30009,2.7146177e-07,0.0002260605129915077,1.4657142167660821e-05,3.977809380630465e-05,0.0,0.00021961147,False,TBX21; T-box transcription factor
hsa:57724,0.0,0.0,1.348999124532164e-07,2.9784013753182085e-07,0.0,1.4310367e-06,False,EPG5; ectopic P-granules 5 autophagy tethering
hsa:5728,0.0,0.0,0.00018076257050292396,0.0003459369712935797,0.0,0.0018852673,False,PTEN; phosphatase and tensin
hsa:3868,0.0,0.0,1.2495479901871345e-07,6.480527127880775e-07,0.0,5.306791e-06,False,KRT16; keratin
hsa:63970,2.7447575e-06,0.0022857041287518616,7.536161742124679e-05,0.00016454533340061575,0.0,0.0012820394,False,TP53AIP1; tumor protein p53 regulated apoptosis inducing protein
hsa:114026,0.0,0.0,2.7864937660818715e-11,2.1535264121132252e-10,0.0,2.367974e-09,False,ZIM3; zinc finger imprinted
hsa:80012,1.4105577e-08,1.1746456868166785e-05,9.205858983306439e-07,3.0911608909343938e-06,0.0,1.644899e-05,False,PHC3; polyhomeotic homolog
hsa:3565,0.0,0.0,4.015981057309941e-05,8.672504194947752e-05,0.0,0.00054426445,False,IL4; interleukin
hsa:6768,1.6424105e-08,1.3677217243983881e-05,1.1101377716491234e-07,1.7167118799586007e-07,0.0,8.4818373e-07,False,ST14; ST14 transmembrane serine protease
hsa:337,0.0,0.0,1.813988293181286e-05,7.960742418375958e-05,0.0,0.00072392967,False,APOA4; apolipoprotein
hsa:1834,0.0,0.0,2.4678836506959064e-07,7.576731343194964e-07,0.0,6.564957e-06,False,DSPP; dentin
hsa:3579,0.0,0.0,1.9582722568359653e-06,5.9246464260758785e-06,0.0,4.8187663e-05,False,CXCR2; C-X-C motif chemokine receptor
hsa:2790,0.0,0.0,0.00012076306777192981,0.0002653919891756676,0.0,0.0021423465,False,GNG10; G protein subunit gamma
hsa:55505,3.558576e-08,2.9634136551871286e-05,7.398961873504095e-07,1.346132037068219e-06,0.0,5.7987163e-06,False,NOP10; NOP10
hsa:55300,2.2261067e-07,0.0001853796291742415,1.267614291783626e-06,2.023298307358367e-06,0.0,9.172871e-06,False,PI4K2B; phosphatidylinositol 4-kinase type 2
hsa:6907,0.0,0.0,3.1344815393567263e-07,5.05209300796815e-07,0.0,3.3591089e-06,False,TBL1X; transducin beta like 1
hsa:1154,3.0822628e-06,0.0025667625674975925,5.1025046858567265e-05,0.00010592911119763042,0.0,0.00061914406,False,CISH; cytokine inducible SH2 containing
hsa:2215,5.980352e-07,0.0004980154078380131,1.2134129519895908e-05,3.580818934411346e-05,0.0,0.0002790769,False,FCGR3B; Fc gamma receptor
hsa:3984,0.0,0.0,4.5603015932116944e-05,0.00012003062220765374,0.0,0.0006995313,False,LIMK1; LIM domain kinase
hsa:221037,0.0,0.0,1.5615171121050288e-05,4.750474632023114e-05,0.0,0.0003700613,False,JMJD1C; jumonji domain containing
hsa:339403,0.0,0.0,2.6095114970760237e-09,1.5149422276592347e-08,0.0,1.6867048e-07,False,RXFP4; relaxin family peptide/INSL5 receptor
hsa:10715,0.0,0.0,2.3153142183450296e-05,6.158026105029716e-05,0.0,0.00045534596,False,CERS1; ceramide synthase
hsa:163050,3.5971304e-08,2.9955199346167503e-05,9.012282405181286e-08,1.5771893359869568e-07,0.0,1.0011038e-06,False,ZNF564; zinc finger protein
hsa:5771,6.0651706e-07,0.0005050786993752419,3.414206935245615e-05,9.511027665797317e-05,0.0,0.00065654266,False,PTPN2; protein tyrosine phosphatase non-receptor type
hsa:3592,0.0,0.0,5.925274195777778e-06,2.113625402926503e-05,0.0,0.00014186188,False,IL12A; interleukin
hsa:534,4.711984e-05,0.03923917243476959,0.00037584243909690064,0.0007596907355182136,0.0,0.004075409,False,ATP6V1G2; ATPase H+ transporting V1 subunit
hsa:6693,2.030207e-08,1.6906602940773203e-05,3.5358148707912283e-06,6.983180313485667e-06,0.0,3.269944e-05,False,SPN;
hsa:90226,0.0,0.0,5.940661491812866e-08,2.470303468943751e-07,0.0,1.870102e-06,False,UCN2; urocortin
hsa:6833,0.00021550417,0.17946167234527752,0.0006394361808859649,0.001001857951924731,0.0,0.005671934,False,ABCC8; ATP binding cassette subfamily C member
hsa:4224,1.5619829e-06,0.001300745425987471,1.833541228321637e-05,6.748520049133535e-05,0.0,0.00070320955,False,MEP1A; meprin A subunit
hsa:22861,0.0,0.0,8.735160415204679e-08,2.0731584131773596e-07,0.0,2.023272e-06,False,NLRP1; NLR family pyrin domain containing
hsa:8498,1.4685952e-08,1.2229765697352736e-05,1.983576404070175e-07,4.0923029396238647e-07,0.0,2.7757508e-06,False,RANBP3; RAN binding protein
hsa:3751,1.8510777e-06,0.0015414898917410734,8.110590442112278e-05,0.00016738798532017746,0.0,0.0009073631,False,KCND2; potassium voltage-gated channel subfamily D member
hsa:1520,1.9360116e-06,0.0016122188234958814,3.5190981530058486e-06,4.9367330191274566e-06,0.0,2.6263291e-05,False,CTSS; cathepsin
hsa:1601,8.713239e-09,7.255973016596819e-06,5.429769582742691e-07,1.0486695163940698e-06,0.0,5.2965333e-06,False,DAB2; DAB adaptor protein
hsa:406887,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7E; microRNA
hsa:6189,3.1493977e-07,0.0002622669334530142,1.2263879206315785e-06,2.0351836268557685e-06,0.0,1.0765492e-05,False,RPS3A; ribosomal protein
hsa:9103,0.0,0.0,2.3655936315871336e-05,0.00012457601368298787,0.0,0.00131815,False,FCGR2C; Fc gamma receptor IIc
hsa:1719,1.706725e-05,0.014212797958085627,0.0002463881012614035,0.00048255208920962306,0.0,0.002988525,False,DHFR; dihydrofolate
hsa:100526794,0.0,0.0,5.675118245614035e-08,3.51320025336103e-07,0.0,3.7603706e-06,False,NT5C1B-RDH14; NT5C1B-RDH14
hsa:30011,0.0,0.0,6.45371862571345e-07,2.237714251292744e-06,0.0,2.5717902e-05,False,SH3KBP1; SH3 domain containing kinase binding protein
hsa:6317,-0.0,0.0,9.059815465672515e-08,1.093274632935158e-06,0.0,1.4257892e-05,False,SERPINB3; serpin family B member
hsa:79132,0.0,0.0,1.9874201087160235e-05,5.883476294906671e-05,0.0,0.0003695712,False,DHX58; DExH-box helicase
hsa:4988,0.0,0.0,6.30509598877193e-06,1.7397076839814377e-05,0.0,0.00013597182,False,OPRM1; opioid receptor mu
hsa:2043,0.0,0.0,1.7990439962807018e-07,4.538481578508891e-07,0.0,3.0454466e-06,False,EPHA4; EPH receptor
hsa:1836,0.0,0.0,1.264210305380117e-07,2.534101863343303e-07,0.0,1.566638e-06,False,SLC26A2; solute carrier family 26 member
hsa:960,0.0,0.0,5.420266139298246e-05,0.0002488162263870696,0.0,0.0030528721,False,CD44; CD44 molecule (Indian blood
hsa:5747,0.00011168116,0.09300278385824512,0.00021590185063157904,0.00027798117746779757,0.0,0.0016959949,False,PTK2; protein tyrosine kinase
hsa:6908,0.0,0.0,2.7915747863099397e-05,0.00011264183075288115,0.0,0.00077724096,False,TBP; TATA-box binding
hsa:10873,5.925369e-06,0.004934366838483286,0.00013106483595730993,0.00044909000735384624,0.0,0.0034387098,False,ME3; malic enzyme
hsa:11112,0.0,0.0,4.5106905153725137e-07,8.185580518094492e-07,0.0,4.0891778e-06,False,HIBADH; 3-hydroxyisobutyrate
hsa:23492,0.0,0.0,9.015655667222805e-06,3.10697118930884e-05,0.0,0.00018510236,False,CBX7; chromobox
hsa:8505,0.0,0.0,1.7261167961777773e-05,5.468243779607445e-05,0.0,0.0003696112,False,PARG; poly(ADP-ribose)
hsa:645,0.0,0.0,6.963887632105264e-05,0.00020380776930040815,0.0,0.0012492243,False,BLVRB; biliverdin reductase
hsa:221937,1.8232713e-08,1.5183340379777717e-05,7.721047572926685e-05,0.0002828418718446115,0.0,0.0017203391,False,FOXK1; forkhead box
hsa:10450,0.0,0.0,8.213288063567254e-08,2.1784525066539405e-07,0.0,1.2825698e-06,False,PPIE; peptidylprolyl isomerase
hsa:1573,0.0,0.0,3.80802997683041e-05,0.00014452121048605049,0.0,0.0013852204,False,CYP2J2; cytochrome P450 family 2 subfamily J member
hsa:10507,1.9100885e-07,0.0001590631292830587,7.424218608654971e-07,1.4850233893057457e-06,0.0,8.951921e-06,False,SEMA4D; semaphorin
hsa:27,0.0,0.0,1.392796071023392e-05,3.448542673118728e-05,0.0,0.00022503249,False,ABL2; ABL proto-oncogene 2
hsa:43,5.1310863e-06,0.00427292580160255,2.6931397332163743e-05,5.934301968711222e-05,0.0,0.0005661699,False,ACHE; acetylcholinesterase (Cartwright blood
hsa:57105,0.0,0.0,8.672357614277778e-07,3.076872642517819e-06,0.0,1.902364e-05,False,CYSLTR2; cysteinyl leukotriene receptor
hsa:10952,0.0,0.0,2.401974321438597e-06,4.224176587812965e-06,0.0,1.896699e-05,False,SEC61B; SEC61 translocon subunit
hsa:4360,7.637495e-08,6.36014433144702e-05,9.347016352456139e-07,2.2640769368234476e-06,0.0,1.4552755e-05,False,MRC1; mannose receptor C-type
hsa:388569,2.4682414e-09,2.0554346089722956e-06,7.195197901637428e-08,1.2125519050134346e-07,0.0,6.8056653e-07,False,ZNF324B; zinc finger protein
hsa:7098,0.0,0.0,1.126126233391813e-06,3.837928504173712e-06,0.0,3.2609427e-05,False,TLR3; toll like receptor
hsa:2762,7.113145e-07,0.0005923490470437064,2.4976457508245616e-05,5.028137786354828e-05,0.0,0.0003180535,False,GMDS; GDP-mannose
hsa:6382,1.3221481e-06,0.0011010223566167245,5.426569329929826e-05,0.00015563465213134925,0.0,0.0009793597,False,SDC1; syndecan
hsa:5162,3.5545487e-05,0.02960059910370793,0.00014536963101804094,0.00021532520431396583,0.0,0.0011763481,False,PDHB; pyruvate dehydrogenase E1 subunit
hsa:81030,0.0,0.0,1.8281623104532166e-06,6.942470694672219e-06,0.0,4.8998012e-05,False,ZBP1; Z-DNA binding protein
hsa:3595,0.0,0.0,6.964776549426901e-06,2.2830229770692998e-05,0.0,0.00022087278,False,IL12RB2; interleukin 12 receptor subunit beta
hsa:3375,0.0,0.0,0.00014865003565228072,0.0007737309408751518,0.0,0.009655888,False,IAPP; islet amyloid
hsa:5568,0.0,0.0,1.2954042982456142e-06,9.23364727639598e-06,0.0,8.922137e-05,False,PRKACG; protein kinase cAMP-activated catalytic subunit
hsa:100169767,0.0,0.0,1.4077671020380115e-07,1.2557402011181267e-06,0.0,1.5985106e-05,False,RNA5S16; RNA
hsa:55916,0.0,0.0,1.3920138969614038e-06,3.857776760828337e-06,0.0,3.5677604e-05,False,NXT2; nuclear transport factor 2 like export factor
hsa:51005,9.540822e-07,0.0007945144967118804,0.00010177708837470176,0.00030757276984621915,0.0,0.00191234,False,AMDHD2; amidohydrolase domain containing
hsa:55860,9.19911e-08,7.660583387728255e-05,6.615059778070174e-06,1.9927678763833667e-05,0.0,9.990062e-05,False,ACTR10; actin related protein
hsa:64689,0.0,0.0,5.967686138269007e-08,1.3035949287436347e-07,0.0,7.383943e-07,False,GORASP1; golgi reassembly stacking protein
hsa:56983,0.0,0.0,2.0710985039415212e-05,5.655210888351636e-05,0.0,0.0003870898,False,POGLUT1; protein O-glucosyltransferase
hsa:1292,2.9693123e-05,0.024727027373688516,6.119857874959066e-05,0.00010051328144127554,0.0,0.0007480772,False,COL6A2; collagen type VI alpha 2
hsa:2683,0.0,0.0,0.00016121987039473685,0.00031901289462524517,0.0,0.0014936697,False,B4GALT1; beta-1
hsa:1741,2.941967e-06,0.002449930865860364,2.2882286688257314e-05,4.191407388264474e-05,0.0,0.00022294949,False,DLG3; discs large MAGUK scaffold protein
hsa:4303,0.0,0.0,3.3639664184738834e-06,7.121684259443604e-06,0.0,3.89667e-05,False,FOXO4; forkhead box
hsa:7643,1.0775429e-08,8.973267239226977e-06,1.6148875308421048e-07,2.777463086145158e-07,0.0,1.3403877e-06,False,ZNF90; zinc finger protein
hsa:171392,0.0,0.0,1.2505445200280702e-07,2.7078733177981057e-07,0.0,1.4643801e-06,False,ZNF675; zinc finger protein
hsa:23529,0.0,0.0,1.7988421614853796e-07,9.351539542259853e-07,0.0,1.1013581e-05,False,CLCF1; cardiotrophin like cytokine factor
hsa:170572,0.0,0.0,1.1595551354970763e-06,5.626315397084432e-06,0.0,5.433861e-05,False,HTR3C; 5-hydroxytryptamine receptor
hsa:151449,0.0,0.0,7.513543179732748e-06,2.6047539176675526e-05,0.0,0.00030123245,False,GDF7; growth differentiation factor
hsa:7044,1.1965244e-07,9.964088853869035e-05,2.3821297295462006e-05,5.772801269770999e-05,0.0,0.00032119258,False,LEFTY2; left-right determination factor
hsa:1839,0.0,0.0,3.874921362573099e-07,3.385754646992245e-06,0.0,3.372862e-05,False,HBEGF; heparin binding EGF like growth
hsa:1500,2.4597332e-06,0.002048349382729814,3.2883665973830394e-05,5.462412939304161e-05,0.0,0.00026276,False,CTNND1; catenin delta
hsa:7294,1.7989255e-07,0.00014980600080943422,1.919612188275789e-06,4.540025104149349e-06,0.0,3.2383166e-05,False,TXK; TXK tyrosine
hsa:79709,0.0,0.0,6.856046089473684e-05,0.0002505009382663894,0.0,0.0024513109,False,COLGALT1; collagen beta(1-O)galactosyltransferase
hsa:1291,0.00012899042,0.10741711628930303,0.000319390760105848,0.0004659470815843677,0.0,0.0025962417,False,COL6A1; collagen type VI alpha 1
hsa:26285,0.0,0.0,9.880244011695907e-09,1.2415720010984623e-07,0.0,1.6231578e-06,False,CLDN17; claudin
hsa:80712,0.0,0.0,2.328268360233919e-08,2.9960925598886906e-07,0.0,3.9181623e-06,False,ESX1; ESX homeobox
hsa:4917,7.4145326e-08,6.17447179817717e-05,9.608473192858485e-06,3.428743656979878e-05,0.0,0.00024530094,False,NTN3; netrin
hsa:3708,0.0,0.0,6.442600542105261e-05,0.00026702740654047406,0.0,0.0017776027,False,ITPR1; inositol 1
hsa:406911,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125B1; microRNA
hsa:286530,0.0,0.0,1.5493731700842106e-07,5.392695845706274e-07,0.0,6.2351605e-06,False,P2RY8; P2Y receptor family member
hsa:57181,4.3072887e-10,3.5869061530267203e-07,5.2297361329736845e-08,1.1258082729516978e-07,0.0,6.0600826e-07,False,SLC39A10; solute carrier family 39 member
hsa:22824,0.0,0.0,1.5587097638362577e-07,4.2877811608736557e-07,0.0,3.6199528e-06,False,HSPA4L; heat shock protein family A (Hsp70) member 4
hsa:9970,0.0,0.0,8.333359077777775e-08,1.4038796829864e-07,0.0,7.74055e-07,False,NR1I3; nuclear receptor subfamily 1 group I member
hsa:131450,0.0,0.0,5.208462649064325e-09,1.4048152883928356e-08,0.0,1.32922e-07,False,CD200R1; CD200 receptor
hsa:1854,0.0,0.0,2.5401363813450292e-05,5.47682028725761e-05,0.0,0.0002498323,False,DUT; deoxyuridine
hsa:23381,0.0,0.0,4.128006837573101e-07,9.093253816572435e-07,0.0,3.5946882e-06,False,SMG5; SMG5 nonsense mediated mRNA decay
hsa:402135,0.0,0.0,1.924727076391813e-06,4.706588555919441e-06,0.0,3.5811147e-05,False,OR5K2; olfactory receptor family 5 subfamily K member
hsa:28960,2.3726855e-08,1.9758601783872255e-05,3.101446243625731e-07,5.693865273768436e-07,0.0,3.834669e-06,False,DCPS; decapping enzyme
hsa:9770,0.0,0.0,9.725684665497077e-05,0.0002488100797620247,0.0,0.0012479142,False,RASSF2; Ras association domain family member
hsa:9219,0.0,0.0,8.651320484783626e-07,2.1635515520073433e-06,0.0,9.487033e-06,False,MTA2; metastasis associated 1 family member
hsa:3705,2.894645e-07,0.0002410523344146407,1.9012683167719295e-05,5.414956575295367e-05,0.0,0.00037328168,False,ITPK1; inositol-tetrakisphosphate
hsa:1288,1.3783871e-07,0.00011478555338634852,3.6471151326549704e-06,1.2777160346553048e-05,0.0,0.000103717975,False,COL4A6; collagen type IV alpha 6
hsa:8458,1.126905e-05,0.009384331443528678,4.07347445878655e-05,6.285128205400777e-05,0.0,0.00033855689,False,TTF2; transcription termination factor
hsa:5799,3.9623083e-05,0.032996228048189205,0.00014216981011855849,0.00021253238979725353,0.0,0.001282173,False,PTPRN2; protein tyrosine phosphatase receptor type
hsa:6330,1.3252324e-07,0.00011035908156679555,1.1931479970877194e-06,2.4337819249579197e-06,0.0,1.5244637e-05,False,SCN4B; sodium voltage-gated channel beta subunit
hsa:56922,0.0,0.0,9.310819646619884e-07,2.1518407401945684e-06,0.0,1.1090585e-05,False,MCCC1; methylcrotonyl-CoA carboxylase subunit
hsa:117608,2.6204402e-08,2.18217856560638e-05,1.1381052330643277e-07,1.5528839877809783e-07,0.0,8.489622e-07,False,ZNF354B; zinc finger protein
hsa:29780,3.2694738e-09,2.722663027063789e-06,2.1035867491403515e-07,3.0716399523778665e-07,0.0,1.2185585e-06,False,PARVB; parvin
hsa:1378,1.227234e-06,0.0010219823866934189,1.3164924762631578e-05,3.893188640857915e-05,0.0,0.00042393443,False,CR1; complement C3b/C4b receptor 1 (Knops blood
hsa:51655,0.0,0.0,1.6949249935672517e-05,4.728347214647822e-05,0.0,0.00030732868,False,RASD1; ras related dexamethasone induced
hsa:2618,0.0,0.0,0.00020378178530467818,0.0005118764507489396,0.0,0.0040476257,False,GART; phosphoribosylglycinamide formyltransferase
hsa:3998,5.6406666e-09,4.697280155544789e-06,2.4618963771146206e-07,5.467572681982327e-07,0.0,2.8154948e-06,False,LMAN1; lectin
hsa:8792,0.0,0.0,5.852638398713453e-06,1.7364190597937625e-05,0.0,0.00011741254,False,TNFRSF11A; TNF receptor superfamily member
hsa:50515,0.0,0.0,5.484716093011695e-06,1.2573597196434302e-05,0.0,5.7863548e-05,False,CHST11; carbohydrate sulfotransferase
hsa:6444,0.0,0.0,5.662934633728655e-06,2.3657613417145703e-05,0.0,0.00017534554,False,SGCD; sarcoglycan
hsa:9091,0.0,0.0,2.051175118479532e-05,3.006749089831303e-05,0.0,0.0001501595,False,PIGQ; phosphatidylinositol glycan anchor biosynthesis class
hsa:9197,2.3846267e-05,0.019858042445359658,6.165009559046783e-05,0.0001294728656509378,0.0,0.00095999124,False,SLC33A1; solute carrier family 33 member
hsa:55703,0.0,0.0,8.125925442491232e-05,0.00025314759409601555,0.0,0.001247853,False,POLR3B; RNA polymerase III subunit
hsa:10243,1.7785454e-05,0.014810884254629527,0.0002174845884664912,0.0006193213140201948,0.0,0.004514134,False,GPHN;
hsa:203068,7.6177565e-07,0.0006343707042926863,8.14888092848538e-05,0.0002390520639715193,0.0,0.001921862,False,TUBB; tubulin beta class
hsa:3032,0.0,0.0,4.605758721871345e-05,0.00011790570342679974,0.0,0.0012814531,False,HADHB; hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
hsa:9807,4.3306068e-07,0.00036063243629941397,6.270047912365792e-05,0.00021198019879988005,0.0,0.0012194308,False,IP6K1; inositol hexakisphosphate kinase
hsa:10062,0.0,0.0,3.124639631836256e-05,8.424469995658238e-05,0.0,0.0005829296,False,NR1H3; nuclear receptor subfamily 1 group H member
hsa:414062,0.0,0.0,6.857680008771929e-05,0.00023353613389062174,0.0,0.0017908828,False,CCL3L3; C-C motif chemokine ligand 3 like
hsa:59067,0.0,0.0,3.6242902392105263e-06,2.1070687019355203e-05,0.0,0.00022389599,False,IL21; interleukin
hsa:5289,3.7460297e-05,0.031195162238256375,0.00011772501924076023,0.0001818271775113643,0.0,0.0008162244,False,PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type
hsa:9871,2.4052605e-07,0.00020029870965190068,1.4488442876374273e-06,1.9886885712040967e-06,0.0,6.990117e-06,False,SEC24D; SEC24 homolog D
hsa:79071,0.0,0.0,5.5139952547602334e-05,0.00016178606267153295,0.0,0.00090987445,False,ELOVL6; ELOVL fatty acid elongase
hsa:5732,0.0,0.0,9.094883903801168e-06,3.426070794292571e-05,0.0,0.00024566986,False,PTGER2; prostaglandin E receptor
hsa:5885,6.222843e-08,5.182089105385311e-05,8.130755860263154e-07,1.4927563058940013e-06,0.0,7.641983e-06,False,RAD21; RAD21 cohesin complex
hsa:196385,0.0,0.0,6.242853639356726e-08,1.0425114724287468e-07,0.0,7.5999634e-07,False,DNAH10; dynein axonemal heavy chain
hsa:5535,0.0,0.0,1.1063979479356726e-05,3.867519904741787e-05,0.0,0.00027262283,False,PPP3R2; protein phosphatase 3 regulatory subunit B
hsa:1543,1.383554e-05,0.011521582836192824,9.383142747140355e-05,0.00018248473492236036,0.0,0.0010076821,False,CYP1A1; cytochrome P450 family 1 subfamily A member
hsa:10600,0.0,0.0,9.85913089497111e-06,3.7136963670761514e-05,0.0,0.00024602158,False,USP16; ubiquitin specific peptidase
hsa:79154,2.5870506e-06,0.0021543732871519543,9.348883121679537e-05,0.00018788635959896148,0.0,0.00089575164,False,DHRS11; dehydrogenase/reductase
hsa:129685,6.837572e-08,5.694006319697869e-05,7.956251789286548e-07,1.471087803621551e-06,0.0,9.507504e-06,False,TAF8; TATA-box binding protein associated factor
hsa:2961,5.811245e-07,0.00048393297730996675,1.7574053490754384e-06,3.4237178015914065e-06,0.0,2.0277594e-05,False,GTF2E2; general transcription factor IIE subunit
hsa:26533,-0.0,0.0,1.971582532163743e-07,2.211240015137871e-06,0.0,2.8466446e-05,False,OR10G3; olfactory receptor family 10 subfamily G member
hsa:3643,0.0,0.0,0.00013404738275731002,0.0004064564405450972,0.0,0.003504367,False,INSR; insulin
hsa:2235,5.148433e-06,0.004287371312293466,0.00024917579164990646,0.0004629117463124993,0.0,0.0031743755,False,FECH;
hsa:1260,0.0,0.0,8.851129965146198e-07,3.143260756465612e-06,0.0,2.3419598e-05,False,CNGA2; cyclic nucleotide gated channel subunit alpha
hsa:100101267,1.2997623e-08,1.0823805219608711e-05,3.4734302062865497e-07,7.355028014629121e-07,0.0,3.7346329e-06,False,POM121C; POM121 transmembrane nucleoporin
hsa:84952,1.4320997e-08,1.192584844772007e-05,4.5854984761812866e-07,1.1057100217320833e-06,0.0,6.2975832e-06,False,CGNL1; cingulin like
hsa:55584,0.0,0.0,4.318247172e-07,2.291698830634955e-06,0.0,1.8701285e-05,False,CHRNA9; cholinergic receptor nicotinic alpha 9
hsa:290,0.0,0.0,6.425006161988304e-06,1.7707299512567165e-05,0.0,0.0001221287,False,ANPEP; alanyl aminopeptidase
hsa:11059,1.381643e-07,0.00011505668932723958,1.451732365798246e-06,3.106821142361436e-06,0.0,1.6881066e-05,False,WWP1; WW domain containing E3 ubiquitin protein ligase
hsa:392376,0.0,0.0,1.5698432206918127e-05,5.00793437246686e-05,0.0,0.0004265473,False,OR13C2; olfactory receptor family 13 subfamily C member
hsa:1677,0.0,0.0,1.552305334501345e-06,2.891078527706142e-06,0.0,1.7843888e-05,False,DFFB; DNA fragmentation factor subunit
hsa:79541,0.0,0.0,2.4226349508771927e-06,1.385980298472137e-05,0.0,0.00015851251,False,OR2A4; olfactory receptor family 2 subfamily A member
hsa:58,1.3301556e-08,1.1076906235987732e-05,4.984899989491229e-08,1.0027538352306414e-07,0.0,5.969546e-07,False,ACTA1; actin alpha 1
hsa:909,1.9255656e-06,0.0016035198891350348,9.512901662663742e-06,1.9011566894265808e-05,0.0,0.0001208742,False,CD1A; CD1a
hsa:282616,0.0,0.0,2.124260090467836e-06,1.9884091709165064e-05,0.0,0.0002518349,False,IFNL2; interferon lambda
hsa:93183,1.8955919e-06,0.0015785592105162609,2.643266762914035e-05,6.645888374813833e-05,0.0,0.00049283763,False,PIGM; phosphatidylinositol glycan anchor biosynthesis class
hsa:2831,0.0,0.0,6.916897772807017e-08,3.804069430477812e-07,0.0,3.752422e-06,False,NPBWR1; neuropeptides B and W receptor
hsa:672,0.0,0.0,3.9966461438421046e-05,0.00011019436265721322,0.0,0.00067990815,False,BRCA1; BRCA1 DNA repair
hsa:5213,6.3081375e-06,0.005253118327751886,0.00016943108687076028,0.00042558572096998323,0.0,0.002508116,False,PFKM; phosphofructokinase
hsa:8681,0.00033070045,0.2753916817588069,0.0004580792565029239,0.0004959350040391768,0.0,0.0036925483,False,JMJD7-PLA2G4B; JMJD7-PLA2G4B
hsa:693200,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR615; microRNA
hsa:9152,0.0,0.0,2.941786932596433e-06,1.808859337115718e-05,0.0,0.00016754834,False,SLC6A5; solute carrier family 6 member
hsa:6778,0.0,0.0,3.3803935379532157e-06,9.303246603365462e-06,0.0,8.490589e-05,False,STAT6; signal transducer and activator of transcription
hsa:6130,0.0,0.0,9.588538245321635e-07,1.935306103755048e-06,0.0,8.579353e-06,False,RPL7A; ribosomal protein
hsa:27173,0.0,0.0,8.180160086549706e-10,4.073715449489445e-09,0.0,3.270985e-08,False,SLC39A1; solute carrier family 39 member
hsa:6843,0.0,0.0,3.524620264859332e-05,7.69898559494925e-05,0.0,0.0003668377,False,VAMP1; vesicle associated membrane protein
hsa:4086,6.784425e-07,0.0005649748013697876,0.0001009031633699064,0.00024388522534137596,0.0,0.0015030681,False,SMAD1; SMAD family member
hsa:2782,1.8809122e-05,0.01566334651188583,0.0011506683429040932,0.002330925942805106,0.0,0.010249967,False,GNB1; G protein subunit beta
hsa:8555,0.0,0.0,3.565993447403508e-07,1.113505604366055e-06,0.0,6.598387e-06,False,CDC14B; cell division cycle
hsa:51109,0.0,0.0,0.00017813018744791933,0.0005020017999085436,0.0,0.0035466508,False,RDH11; retinol dehydrogenase
hsa:6654,0.000299729,0.2496001241664033,0.0005529239631637428,0.0008188498950619969,0.0,0.005383237,False,SOS1; SOS Ras/Rac guanine nucleotide exchange factor
hsa:404672,0.0,0.0,2.4177636625146213e-06,7.1956118612000115e-06,0.0,5.630988e-05,False,GTF2H5; general transcription factor IIH subunit
hsa:3693,0.0,0.0,3.0722976416023395e-05,0.00011859568883870886,0.0,0.0012593702,False,ITGB5; integrin subunit beta
hsa:9958,6.705163e-07,0.0005583742371795766,6.297272359208187e-06,1.1222091433363436e-05,0.0,5.52085e-05,False,USP15; ubiquitin specific peptidase
hsa:8754,0.0,0.0,1.5479149282619888e-05,4.239000885106837e-05,0.0,0.00025084332,False,ADAM9; ADAM metallopeptidase domain
hsa:952,4.267583e-06,0.003553841125451431,6.169916857485379e-05,0.00010797756482827218,0.0,0.0007095806,False,CD38; CD38
hsa:1040,5.0028564e-08,4.166142010371653e-05,1.9621669704316953e-05,6.729302720395085e-05,0.0,0.00052246713,False,CDS1; CDP-diacylglycerol synthase
hsa:8288,1.5306672e-05,0.012746671932894077,0.00013527273859612277,0.00028880035030942825,0.0,0.0017742347,False,EPX; eosinophil
hsa:2153,2.118947e-07,0.00017645587657584943,7.392665859321638e-07,1.7616444571793383e-06,0.0,1.513536e-05,False,F5; coagulation factor
hsa:89849,0.0,0.0,1.0073740855614031e-07,2.1527447057291073e-07,0.0,1.0032229e-06,False,ATG16L2; autophagy related 16 like
hsa:9488,0.0,0.0,2.936691416350878e-06,7.749849159922491e-06,0.0,4.6143417e-05,False,PIGB; phosphatidylinositol glycan anchor biosynthesis class
hsa:768,0.0,0.0,0.00010145786024622223,0.0002727398926069407,0.0,0.0018943106,False,CA9; carbonic anhydrase
hsa:4495,5.603163e-07,0.00046660489326177875,1.23323160481462e-05,3.5925005365743866e-05,0.0,0.00027590198,False,MT1G; metallothionein
hsa:55801,0.0,0.0,1.581981248064328e-06,4.707775009772962e-06,0.0,2.9138193e-05,False,IL26; interleukin
hsa:55904,0.0,0.0,1.7088344900584794e-06,5.8678731059644016e-06,0.0,6.540543e-05,False,KMT2E; lysine methyltransferase 2E
hsa:1633,7.248738e-07,0.000603640590283131,9.099960022502417e-05,0.00019391573363376592,0.0,0.0008218186,False,DCK; deoxycytidine
hsa:10978,5.2352696e-08,4.3596847225480236e-05,4.2302361546491216e-07,8.638498469568652e-07,0.0,4.712321e-06,False,CLP1; cleavage factor polyribonucleotide kinase subunit
hsa:8853,9.774585e-07,0.0008139811728845268,1.6200562480777783e-05,4.975350048403926e-05,0.0,0.00028681997,False,ASAP2; ArfGAP with SH3 domain
hsa:669,0.0,0.0,1.5487463972105266e-05,2.854492548267507e-05,0.0,0.00012363169,False,BPGM; bisphosphoglycerate
hsa:8930,0.0,0.0,3.320076582017544e-07,1.1742980992478782e-06,0.0,8.853653e-06,False,MBD4; methyl-CpG binding domain 4
hsa:84667,0.0,0.0,1.595239566248538e-07,4.872534770052537e-07,0.0,2.7926908e-06,False,HES7; hes family bHLH transcription factor
hsa:767,0.0,0.0,0.0001163122773642105,0.0003429981620335084,0.0,0.0024624867,False,CA8; carbonic anhydrase
hsa:9456,0.0,0.0,1.1067530844567247e-05,3.400694009474502e-05,0.0,0.00020816443,False,HOMER1; homer scaffold protein
hsa:112483,0.0,0.0,3.8976694836900596e-05,7.96813280332734e-05,0.0,0.0004864397,False,SAT2; spermidine/spermine N1-acetyltransferase family member
hsa:10026,0.0,0.0,2.1177204764327487e-05,5.415883326643469e-05,0.0,0.00031080993,False,PIGK; phosphatidylinositol glycan anchor biosynthesis class
hsa:5451,2.1084663e-08,1.7558309348800984e-05,5.640625915350879e-07,8.862843649311338e-07,0.0,4.2892975e-06,False,POU2F1; POU class 2 homeobox
hsa:51455,0.0,0.0,2.75728560525497e-05,0.00010074446622408338,0.0,0.0007970094,False,REV1; REV1 DNA directed
hsa:5498,3.2426392e-06,0.002700316442342405,0.0004409190455832161,0.0008201168657037945,0.0,0.0038803509,False,PPOX; protoporphyrinogen
hsa:5883,0.0,0.0,8.215922843333333e-06,2.6987148528417817e-05,0.0,0.00016809451,False,RAD9A; RAD9 checkpoint clamp component
hsa:80168,0.0,0.0,1.913859203695905e-05,0.00012361177816564114,0.0,0.0015848724,False,MOGAT2; monoacylglycerol O-acyltransferase
hsa:8864,0.0,0.0,4.757796540350878e-06,1.3581509280132107e-05,0.0,7.537374e-05,False,PER2; period circadian regulator
hsa:998,0.0,0.0,0.00015371411220058481,0.0003557106422031028,0.0,0.0018275898,False,CDC42; cell division cycle
hsa:388567,9.4140605e-11,7.839583989904323e-08,9.604512270652044e-08,2.4844817228417475e-07,0.0,1.2035838e-06,False,ZNF749; zinc finger protein
hsa:441639,0.0,0.0,4.9250637426900584e-09,6.440356543464646e-08,0.0,8.421859e-07,False,OR9K2; olfactory receptor family 9 subfamily K member
hsa:7036,2.7735925e-07,0.00023097165519085741,0.00015543044016537425,0.00033866609427581047,0.0,0.0030098313,False,TFR2; transferrin receptor
hsa:8818,4.4793055e-06,0.0037301536020179996,0.00016972023221111115,0.0003864221741497715,0.0,0.0019682294,False,DPM2; dolichyl-phosphate mannosyltransferase subunit 2
hsa:2744,0.0,0.0,0.00029445442269590636,0.0005597438525205003,0.0,0.0027049466,False,GLS;
hsa:26493,0.0,0.0,1.446380465672515e-06,1.4696032347065423e-05,0.0,0.00018845988,False,OR8B8; olfactory receptor family 8 subfamily B member
hsa:7082,0.0,0.0,0.0002769009350336843,0.0005978825731801492,0.0,0.0035194864,False,TJP1; tight junction protein
hsa:9113,0.00024308283,0.20242787501616694,0.0007452653739415204,0.0013808638447887225,0.0,0.011655173,False,LATS1; large tumor suppressor kinase
hsa:84938,0.0,0.0,6.423112636187135e-06,5.158071187640208e-05,0.0,0.00065294834,False,ATG4C; autophagy related 4C cysteine
hsa:441670,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4M1; olfactory receptor family 4 subfamily M member
hsa:64926,0.0,0.0,2.514102475380117e-07,6.631098452320296e-07,0.0,4.0434775e-06,False,RASAL3; RAS protein activator like
hsa:7201,0.0,0.0,9.218444188479531e-07,3.875626915756919e-06,-0.0,3.9761147e-05,False,TRHR; thyrotropin releasing hormone
hsa:2335,0.0,0.0,0.00011407986936257316,0.00023603850412388266,0.0,0.0012344015,False,FN1; fibronectin
hsa:79346,0.0,0.0,7.053893374269006e-08,9.011429665423068e-07,0.0,1.1782296e-05,False,OR4C5; olfactory receptor family 4 subfamily C member
hsa:3207,0.0,0.0,1.422449535497076e-09,6.058789909578907e-09,0.0,4.2662816e-08,False,HOXA11; homeobox
hsa:57492,0.0,0.0,6.816938264561402e-07,1.8537767155085004e-06,0.0,1.1678561e-05,False,ARID1B; AT-rich interaction domain
hsa:414189,0.0,0.0,5.149359155555556e-07,1.0572789163952976e-06,0.0,5.3045546e-06,False,AGAP6; ArfGAP with GTPase domain
hsa:6142,0.0,0.0,1.0840803874824562e-06,3.1054987844608384e-06,0.0,1.460788e-05,False,RPL18A; ribosomal protein
hsa:55471,0.0,0.0,1.878576475438596e-07,4.1771789913964144e-07,0.0,2.2988486e-06,False,NDUFAF7; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:10666,1.7447631e-07,0.00014529561250361452,5.366524461998536e-07,8.479435856657154e-07,0.0,4.101713e-06,False,CD226; CD226
hsa:26281,2.3900876e-07,0.00019903518235759001,6.8941182058304096e-06,1.444675235806611e-05,0.0,8.473622e-05,False,FGF20; fibroblast growth factor
hsa:185,0.0,0.0,5.82859341625731e-06,2.2312240635237294e-05,0.0,0.00015985187,False,AGTR1; angiotensin II receptor type
hsa:3283,0.0,0.0,1.5750294523976609e-06,4.98579151696445e-06,0.0,2.9926005e-05,False,HSD3B1; hydroxy-delta-5-steroid dehydrogenase
hsa:128360,-0.0,0.0,2.171542230327486e-05,0.00015372530502201173,0.0,0.0018854383,False,OR10T2; olfactory receptor family 10 subfamily T member
hsa:55850,5.7744427e-07,0.0004808682559618126,4.7852391578175445e-05,0.00012831201557583194,0.0,0.0009243467,False,USE1; unconventional SNARE in the ER
hsa:54840,0.0,0.0,1.0892784637888884e-06,3.6157552446048027e-06,0.0,3.1661213e-05,False,APTX;
hsa:8794,8.009146e-05,0.06669637692938794,0.0001344494699095089,0.0001692311996111361,0.0,0.00093422213,False,TNFRSF10C; TNF receptor superfamily member
hsa:3578,0.0,0.0,0.0,0.0,0.0,0.0,False,IL9; interleukin
hsa:1591,0.0,0.0,1.1236344921812863e-06,6.741011444463653e-06,0.0,6.610048e-05,False,CYP24A1; cytochrome P450 family 24 subfamily A member
hsa:81876,1.1164195e-06,0.0009297013162616693,3.487223915416375e-05,6.537126340370662e-05,0.0,0.00034014697,False,RAB1B; RAB1B
hsa:401666,-0.0,0.0,3.985183625730994e-09,5.2113038088043394e-08,-0.0,6.814664e-07,False,OR51A4; olfactory receptor family 51 subfamily A member
hsa:254783,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6C74; olfactory receptor family 6 subfamily C member
hsa:5338,9.276938e-06,0.007725394862305699,0.00017092461060994155,0.000325966823680699,0.0,0.0016164598,False,PLD2; phospholipase
hsa:7752,0.0,0.0,7.659654079532163e-08,1.7086353748842236e-07,0.0,8.5546895e-07,False,ZNF200; zinc finger protein
hsa:574537,0.0,0.0,2.1716590643274856e-05,0.00011368387733501097,0.0,0.0012333386,False,UGT2A2; UDP glucuronosyltransferase family 2 member
hsa:37,2.5682941e-06,0.002138753761750918,3.412290690896491e-05,7.721038714579384e-05,0.0,0.00055197213,False,ACADVL; acyl-CoA dehydrogenase very long
hsa:7006,0.0,0.0,7.479326118824563e-06,2.7180206593445785e-05,0.0,0.0001704625,False,TEC; tec protein tyrosine
hsa:3562,0.0,0.0,1.2361501695906434e-06,6.759424014385696e-06,0.0,7.279235e-05,False,IL3; interleukin
hsa:5139,3.1484478e-06,0.0026218783027716344,2.086546087842105e-05,4.6892254835677745e-05,0.0,0.0002955581,False,PDE3A; phosphodiesterase
hsa:84335,0.0,0.0,6.874403275315791e-05,0.00011712290501601632,0.0,0.0005640186,False,AKT1S1; AKT1 substrate
hsa:142,7.4229433e-06,0.006181475831034606,0.0002460216394862573,0.000722883864036277,0.0,0.0043276222,False,PARP1; poly(ADP-ribose) polymerase
hsa:138474,0.0,0.0,5.590193916929826e-09,2.512407761426971e-08,-0.0,1.774388e-07,False,TAF1L; TATA-box binding protein associated factor 1
hsa:2587,0.0,0.0,8.306801506900584e-08,5.221172378210472e-07,0.0,5.3319054e-06,False,GALR1; galanin receptor
hsa:4199,0.0,0.0,7.342476209912279e-05,0.0002725042128791481,0.0,0.002269563,False,ME1; malic enzyme
hsa:200916,1.9711036e-08,1.6414417800908303e-05,2.982368343818713e-07,7.272411355466262e-07,0.0,4.0817195e-06,False,RPL22L1; ribosomal protein L22 like
hsa:112755,1.6539437e-06,0.0013773260274589395,1.9158711260555558e-05,7.687914013446263e-05,0.0,0.0008839295,False,STX1B; syntaxin
hsa:2066,0.0,0.0,4.4406895497076026e-07,1.259351457480986e-06,0.0,7.563001e-06,False,ERBB4; erb-b2 receptor tyrosine kinase
hsa:139341,0.0,0.0,1.802384106865497e-06,5.333169622471981e-06,0.0,2.7954944e-05,False,FUNDC1; FUN14 domain containing
hsa:1200,0.0,0.0,2.4770873533274864e-06,5.9438704513269645e-06,0.0,2.673636e-05,False,TPP1; tripeptidyl peptidase
hsa:5502,0.0,0.0,0.00011139890582789473,0.00034932332877373406,0.0,0.002545087,False,PPP1R1A; protein phosphatase 1 regulatory inhibitor subunit
hsa:390648,0.0,0.0,2.229598177660234e-06,1.7062346986056512e-05,0.0,0.00016200553,False,OR4F6; olfactory receptor family 4 subfamily F member
hsa:160,1.2597855e-05,0.010490897351375225,8.262811175280701e-05,0.0001684409301706715,0.0,0.0009037894,False,AP2A1; adaptor related protein complex 2 subunit alpha
hsa:6351,1.096315e-05,0.009129592402653411,0.0001982134528128655,0.0004316077317366509,0.0,0.0036873687,False,CCL4; C-C motif chemokine ligand
hsa:574493,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520H; microRNA
hsa:23493,0.0,0.0,1.8581697028070179e-06,6.965705363769924e-06,0.0,6.697228e-05,False,HEY2; hes related family bHLH transcription factor with YRPW motif
hsa:5494,0.0,0.0,1.1938557872105264e-07,2.3688210720617902e-07,0.0,1.3049847e-06,False,PPM1A; protein phosphatase
hsa:286204,4.1164787e-09,3.4280086166115205e-06,4.998091424603509e-06,1.3852897275380016e-05,0.0,8.2421466e-05,False,CRB2; crumbs cell polarity complex component
hsa:23160,0.0,0.0,4.003226299408013e-07,1.0277087532975153e-06,0.0,5.664581e-06,False,WDR43; WD repeat domain
hsa:119774,0.0,0.0,8.017051448538013e-07,5.105966305941055e-06,0.0,4.7733756e-05,False,OR52K2; olfactory receptor family 52 subfamily K member
hsa:911,0.0,0.0,5.355126980871346e-06,1.6706251655124022e-05,0.0,0.00012360673,False,CD1C; CD1c
hsa:3119,0.0,0.0,3.3222651532163745e-05,0.00010852330320600992,0.0,0.0005784641,False,HLA-DQB1; major histocompatibility complex
hsa:124540,0.0,0.0,4.327003557426901e-09,1.6333461163307862e-08,0.0,1.236369e-07,False,MSI2; musashi RNA binding protein
hsa:1436,0.0,0.0,0.00019123481967251474,0.0003384157981443309,0.0,0.0016749941,False,CSF1R; colony stimulating factor 1
hsa:10815,0.0,0.0,1.0640662173099413e-06,2.04930382972742e-06,0.0,1.2276039e-05,False,CPLX1; complexin
hsa:53407,2.5699416e-07,0.00021401257217700158,3.2872215635992406e-05,9.237197664009826e-05,0.0,0.0008693032,False,STX18; syntaxin
hsa:10133,0.0,0.0,7.3234666065146196e-06,1.8583317220792482e-05,0.0,0.00017718214,False,OPTN;
hsa:38,0.0,0.0,3.8060556876023394e-05,0.00010397898902332525,0.0,0.0006021929,False,ACAT1; acetyl-CoA acetyltransferase
hsa:90550,0.0,0.0,8.817452530994153e-06,3.569628968272509e-05,0.0,0.0003488598,False,MCU; mitochondrial calcium
hsa:64840,0.0,0.0,2.3785030952339186e-07,5.476584679895912e-07,0.0,2.654142e-06,False,PORCN; porcupine
hsa:7027,6.0731277e-06,0.005057413290000044,0.00011146473238598834,0.0002279462402229223,0.0,0.0010418082,False,TFDP1; transcription factor
hsa:84433,0.0,0.0,1.9765932730467832e-06,4.612876985226244e-06,0.0,4.4742137e-05,False,CARD11; caspase recruitment domain family member
hsa:154796,7.38197e-07,0.0006147355206178462,1.6426628569239764e-05,4.8476387261671795e-05,0.0,0.00044485045,False,AMOT;
hsa:2953,9.8926525e-05,0.08238132754371714,0.0002656073974859647,0.0003752840289616559,0.0,0.0021005343,False,GSTT2; glutathione S-transferase theta 2
hsa:23195,8.266221e-10,6.883717584841408e-07,3.334755622270116e-06,7.80281216277346e-06,0.0,3.7356378e-05,False,MDN1; midasin AAA ATPase
hsa:144715,0.0,0.0,1.2749641377894738e-08,2.6939400886044696e-08,0.0,1.4014952e-07,False,RAD9B; RAD9 checkpoint clamp component
hsa:9550,0.00010718652,0.089259860410453,0.0003281862488017543,0.0005103153720188041,0.0,0.0024875633,False,ATP6V1G1; ATPase H+ transporting V1 subunit
hsa:4828,0.0,0.0,5.07824697877193e-07,1.5938970433043784e-06,0.0,8.198494e-06,False,NMB; neuromedin
hsa:7184,7.119649e-05,0.05928906693784082,0.00032291674891988306,0.0005908001913189056,0.0,0.0029543478,False,HSP90B1; heat shock protein 90 beta family member
hsa:5424,6.012695e-07,0.0005007087797893137,0.00033704123433421057,0.0007370996810234867,0.0,0.0032228515,False,POLD1; DNA polymerase delta 1
hsa:23007,8.7654883e-10,7.299483760527528e-07,2.746913032148404e-07,1.6659250336805387e-06,0.0,2.1174608e-05,False,PLCH1; phospholipase C eta
hsa:54577,0.0,0.0,2.581442946432749e-05,8.518357140035925e-05,0.0,0.0007963661,False,UGT1A7; UDP glucuronosyltransferase family 1 member
hsa:389692,0.0,0.0,1.886647035725147e-05,6.373827287003811e-05,0.0,0.0006500003,False,MAFA; MAF bZIP transcription factor
hsa:10163,3.0296303e-06,0.0025229327127448387,5.53514649348538e-05,0.00011803639394385401,0.0,0.00061024236,False,WASF2; WASP family member
hsa:1278,0.0,0.0,9.41262489491228e-05,0.000276794894916113,0.0,0.0021506094,False,COL1A2; collagen type I alpha 2
hsa:8703,5.830132e-06,0.004855057972723765,0.0005675969515380117,0.000978456109642251,0.0,0.003940264,False,B4GALT3; beta-1
hsa:3626,2.3980956e-06,0.0019970205069342823,2.3330113143487718e-05,0.00011461876580331759,0.0,0.0013976981,False,INHBC; inhibin subunit beta
hsa:23604,0.0,0.0,1.1776211560807017e-05,2.9913703679284583e-05,0.0,0.00022057127,False,DAPK2; death associated protein kinase
hsa:51780,0.0,0.0,1.8161437020467833e-07,3.4748122791843305e-07,0.0,1.4443242e-06,False,KDM3B; lysine demethylase
hsa:5367,0.0,0.0,4.5166979071345013e-07,1.1010639159477858e-06,0.0,6.0892908e-06,False,PMCH; pro-melanin concentrating
hsa:9112,5.4097086e-08,4.5049492650496266e-05,6.179247033080117e-06,1.840439457723218e-05,0.0,9.691964e-05,False,MTA1; metastasis associated
hsa:26301,0.0,0.0,9.239178255479531e-05,0.0002048493655030756,0.0,0.0015704855,False,GBGT1; globoside alpha-1
hsa:9462,2.7521137e-08,2.291830023921808e-05,5.208901783450292e-07,1.1958116169430946e-06,0.0,7.1017585e-06,False,RASAL2; RAS protein activator like
hsa:5295,0.0008451847,0.7038298131430203,0.0013432026266929822,0.001486158717063647,0.0,0.0067936853,True,PIK3R1; phosphoinositide-3-kinase regulatory subunit
hsa:406918,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR129-2; microRNA
hsa:26189,0.0,0.0,5.267561403508771e-10,6.888230351037017e-09,-0.0,9.00753e-08,False,OR1A2; olfactory receptor family 1 subfamily A member
hsa:51144,0.0,0.0,4.836258553017544e-05,9.193009773987973e-05,0.0,0.0006373046,False,HSD17B12; hydroxysteroid 17-beta dehydrogenase
hsa:162993,2.7040967e-09,2.2518437391041954e-06,6.942648700350875e-08,1.630076329475525e-07,0.0,8.1038445e-07,False,ZNF846; zinc finger protein
hsa:9744,7.412953e-09,6.17315638206417e-06,6.795194901140353e-07,2.22708779653734e-06,0.0,1.6175447e-05,False,ACAP1; ArfGAP with coiled-coil
hsa:23163,1.1060438e-06,0.0009210609244133217,4.1954239660302336e-06,7.69353461183245e-06,0.0,4.013656e-05,False,GGA3; golgi associated
hsa:406986,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR203A; microRNA
hsa:4791,0.0,0.0,5.1267988126900584e-05,0.0001486734433311943,0.0,0.0014033534,False,NFKB2; nuclear factor kappa B subunit
hsa:130367,0.0,0.0,1.084845261625731e-05,3.1671184981343884e-05,0.0,0.00018917483,False,SGPP2; sphingosine-1-phosphate phosphatase
hsa:84254,1.7063134e-07,0.00014209370348107717,1.908119500252924e-05,9.569025245156118e-05,0.0,0.0010629944,False,CAMKK1; calcium/calmodulin dependent protein kinase kinase
hsa:4051,6.509884e-08,5.4211232637111594e-05,2.037908024959063e-06,1.3644223470394213e-05,0.0,0.00017199804,False,CYP4F3; cytochrome P450 family 4 subfamily F member
hsa:10308,0.0,0.0,1.576212617368421e-08,2.9510498188452933e-08,0.0,1.312679e-07,False,ZNF267; zinc finger protein
hsa:55738,0.0,0.0,3.2016673843625734e-07,6.299461900709388e-07,0.0,2.7892845e-06,False,ARFGAP1; ADP ribosylation factor GTPase activating protein
hsa:163227,0.0,0.0,5.2384872176023413e-08,9.804569186788114e-08,0.0,4.2615923e-07,False,ZNF100; zinc finger protein
hsa:80343,0.0,0.0,1.6523620392315794e-08,5.1198348627950706e-08,0.0,4.4579093e-07,False,SEL1L2; SEL1L2 adaptor subunit of SYVN1 ubiquitin
hsa:3420,9.538496e-07,0.0007943207984415059,0.0001020065903570234,0.0003481863512805556,0.0,0.002134048,False,IDH3B; isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit
hsa:4325,1.6490976e-06,0.0013732904247587576,1.8094756910611692e-05,4.5151075319434265e-05,0.0,0.00032088955,False,MMP16; matrix metallopeptidase
hsa:9341,2.7841955e-07,0.000231854622843816,2.294886778063742e-05,5.622638982166615e-05,0.0,0.00033460447,False,VAMP3; vesicle associated membrane protein
hsa:26,1.1886215e-05,0.009898277243338366,8.536875571485613e-05,0.00016117533530708432,0.0,0.000777974,False,AOC1; amine oxidase copper containing
hsa:6755,0.0,0.0,4.900229304093568e-08,2.328181865297358e-07,0.0,2.5176616e-06,False,SSTR5; somatostatin receptor
hsa:4886,0.0,0.0,1.9726941414912284e-05,8.300120470261738e-05,0.0,0.00068441767,False,NPY1R; neuropeptide Y receptor
hsa:26872,0.0,0.0,4.888929353514618e-06,1.3690182849280638e-05,0.0,9.358766e-05,False,STEAP1; STEAP family member
hsa:9048,1.2187103e-08,1.0148842527845974e-05,3.0281411016491237e-07,7.076190185171912e-07,0.0,5.0937706e-06,False,ARTN;
hsa:477,0.0,0.0,1.165641370760234e-06,8.92481097201218e-06,0.0,0.00010020235,False,ATP1A2; ATPase Na+/K+ transporting subunit alpha
hsa:10629,0.0,0.0,4.1797960860233905e-07,1.4153302615725259e-06,0.0,1.0344931e-05,False,TAF6L; TATA-box binding protein associated factor 6
hsa:223,0.0,0.0,0.0003981246023643274,0.0008066239439847206,0.0,0.005205084,False,ALDH9A1; aldehyde dehydrogenase 9 family member
hsa:83937,0.0,0.0,0.0006227204822684212,0.0011929239844512111,0.0,0.0103484085,False,RASSF4; Ras association domain family member
hsa:347168,0.0,0.0,1.1301194865672515e-05,4.607006429878077e-05,0.0,0.00044585066,False,OR1J1; olfactory receptor family 1 subfamily J member
hsa:4683,0.0,0.0,1.3788404144401751e-05,3.448564978634073e-05,0.0,0.0003142154,False,NBN;
hsa:795,0.0,0.0,0.0,0.0,0.0,0.0,False,S100G; S100 calcium binding protein
hsa:57016,0.0,0.0,1.3190203614269006e-05,5.9624807757159856e-05,0.0,0.000468402,False,AKR1B10; aldo-keto reductase family 1 member
hsa:5284,0.0,0.0,1.0926575880763744e-05,8.51287133706915e-05,0.0,0.0010910691,False,PIGR; polymeric immunoglobulin
hsa:205,0.0,0.0,1.0669288298929823e-05,2.9715559060873864e-05,0.0,0.00017582596,False,AK4; adenylate kinase
hsa:64106,0.0,0.0,5.504671298225906e-07,1.7439695581210671e-06,0.0,1.189061e-05,False,NPFFR1; neuropeptide FF receptor
hsa:23534,0.0,0.0,6.239815625836434e-05,0.0001712253158034673,0.0,0.0010322798,False,TNPO3; transportin
hsa:9371,0.0,0.0,3.524309341695907e-08,5.6589806656991044e-08,0.0,2.6532322e-07,False,KIF3B; kinesin family member
hsa:4499,0.0,0.0,1.1759980880087718e-06,3.0619032300224997e-06,0.0,2.5909792e-05,False,MT1M; metallothionein
hsa:730087,1.6700122e-08,1.3907071136907285e-05,1.723276563633216e-07,3.8234969167574713e-07,0.0,2.4565504e-06,False,ZNF726; zinc finger protein
hsa:6363,6.983793e-06,0.00581577224743838,0.0002453265028685379,0.0005674852172589845,0.0,0.0045624366,False,CCL19; C-C motif chemokine ligand
hsa:5008,0.0,0.0,1.5679538706432752e-07,8.087016802169456e-07,0.0,1.0114896e-05,False,OSM; oncostatin
hsa:4838,1.8718467e-06,0.0015587853318847099,8.820712197813741e-06,1.812422314787603e-05,0.0,0.00014290676,False,NODAL; nodal growth differentiation
hsa:57711,0.0,0.0,5.0601288763157895e-08,1.1085927626868603e-07,0.0,4.95224e-07,False,ZNF529; zinc finger protein
hsa:245972,1.3737417e-06,0.0011439870646235964,3.163856728488479e-05,8.409977014192007e-05,0.0,0.0007177767,False,ATP6V0D2; ATPase H+ transporting V0 subunit
hsa:55515,8.658896e-06,0.007210718738406937,0.00012947631171239765,0.0002834010101164174,0.0,0.0019428681,False,ASIC4; acid sensing ion channel subunit family member
hsa:1371,5.6488816e-06,0.004704121218705267,0.00011574233220321641,0.0002636262776601055,0.0,0.001669345,False,CPOX; coproporphyrinogen
hsa:83444,0.0,0.0,1.391384795438596e-06,4.948295019559353e-06,0.0,2.4965644e-05,False,INO80B; INO80 complex subunit
hsa:9559,0.0,0.0,1.1964744479105257e-06,3.5841645529230652e-06,0.0,2.109656e-05,False,VPS26A; VPS26 retromer complex component
hsa:693187,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR602; microRNA
hsa:1469,0.0,0.0,4.650098202292398e-06,1.4728211040929307e-05,0.0,0.000109461056,False,CST1; cystatin
hsa:136227,3.0517986e-05,0.02541393423695591,0.00010289345600017548,0.00018817830503074052,0.0,0.0013680246,False,COL26A1; collagen type XXVI alpha 1
hsa:4773,0.0,0.0,3.334061947368421e-06,1.1628724112798146e-05,0.0,8.881599e-05,False,NFATC2; nuclear factor of activated T cells
hsa:65083,0.0,0.0,2.701874420818714e-07,6.634973531479804e-07,0.0,6.7437127e-06,False,NOL6; nucleolar protein
hsa:10231,0.0,0.0,1.0021563570321638e-06,2.576849782596291e-06,0.0,1.6126167e-05,False,RCAN2; regulator of calcineurin
hsa:27068,2.453564e-07,0.0002043211964975752,1.7673000923286553e-06,3.4282723735824198e-06,0.0,1.5829375e-05,False,PPA2; inorganic pyrophosphatase
hsa:51601,2.775254e-07,0.00023111001704650115,1.0071290795438596e-05,2.216186053107926e-05,0.0,0.00014335447,False,LIPT1; lipoyltransferase
hsa:51366,0.0,0.0,8.178803043888886e-07,1.8981627810512771e-06,0.0,1.0331976e-05,False,UBR5; ubiquitin protein ligase E3 component n-recognin
hsa:140612,2.2768214e-09,1.896029093430146e-06,1.0117377582690058e-07,2.426497494066406e-07,0.0,1.1622898e-06,False,ZFP28; ZFP28 zinc finger
hsa:5596,6.3106604e-06,0.0052552192794557894,0.00015803455815087717,0.00039657412565819594,0.0,0.0026056715,False,MAPK4; mitogen-activated protein kinase
hsa:1132,0.0,0.0,5.113337581871345e-07,1.642564928972933e-06,0.0,1.265443e-05,False,CHRM4; cholinergic receptor muscarinic
hsa:1375,0.000376184,0.3132682293318773,0.0005968568766140349,0.0008504675751258853,0.0,0.008692222,False,CPT1B; carnitine palmitoyltransferase
hsa:79723,0.0,0.0,1.1751810995788301e-05,3.321962603877856e-05,0.0,0.00021456354,False,SUV39H2; SUV39H2 histone lysine
hsa:5609,0.00011173943,0.09305130835615884,0.00017209079733333335,0.0002115025428362839,0.0,0.001021931,False,MAP2K7; mitogen-activated protein kinase kinase
hsa:4591,0.0,0.0,5.765513422760236e-07,1.476187538778523e-06,0.0,1.0136615e-05,False,TRIM37; tripartite motif containing
hsa:10479,0.0,0.0,2.4546669896140354e-07,7.19138445388778e-07,0.0,3.8925255e-06,False,SLC9A6; solute carrier family 9 member
hsa:1407,0.0,0.0,0.0003577107197614035,0.0007933007431785713,0.0,0.0038668725,False,CRY1; cryptochrome circadian regulator
hsa:7108,6.03791e-06,0.005028085656394837,3.477615676625732e-05,6.936257086939074e-05,0.0,0.000598086,False,TM7SF2; transmembrane 7 superfamily member
hsa:5209,0.0,0.0,0.000156390599509614,0.0004390855635668109,0.0,0.0023089333,False,PFKFB3; 6-phosphofructo-2-kinase/fructose-2
hsa:83729,2.0200518e-07,0.00016822035241920752,2.5317924249485377e-06,9.87730030222464e-06,0.0,0.000103884624,False,INHBE; inhibin subunit beta
hsa:3690,0.0,0.0,1.9391780312865495e-05,9.347183486940759e-05,0.0,0.00080777,False,ITGB3; integrin subunit beta
hsa:8906,0.0,0.0,1.497213783748538e-06,4.629682838332204e-06,0.0,3.4948793e-05,False,AP1G2; adaptor related protein complex 1 subunit gamma
hsa:9655,0.0,0.0,2.5348762777076028e-05,7.753966776550875e-05,0.0,0.00045206494,False,SOCS5; suppressor of cytokine signaling
hsa:50484,0.0,0.0,9.06131179730994e-05,0.00014094322885403496,0.0,0.00054072053,False,RRM2B; ribonucleotide reductase regulatory TP53 inducible subunit
hsa:378,1.7884929e-09,1.489372232619235e-06,8.255336820081872e-07,2.1395563668914845e-06,0.0,2.1042539e-05,False,ARF4; ADP ribosylation factor
hsa:953,0.0,0.0,9.891235289128654e-06,3.074383254760007e-05,0.0,0.00019413428,False,ENTPD1; ectonucleoside triphosphate diphosphohydrolase
hsa:191,7.882587e-06,0.006564245348139409,0.0003113935069385952,0.0008522888319575349,0.0,0.005038835,False,AHCY;
hsa:55168,0.0,0.0,2.225153928740935e-07,5.914317405106591e-07,0.0,3.1297327e-06,False,MRPS18A; mitochondrial ribosomal protein
hsa:3636,2.6488172e-07,0.00022058095880415468,2.4601055790760233e-05,5.621323593097226e-05,0.0,0.00039684016,False,INPPL1; inositol polyphosphate phosphatase like
hsa:4216,0.0,0.0,4.742480173421053e-06,1.4983487510224808e-05,0.0,0.00015081899,False,MAP3K4; mitogen-activated protein kinase kinase kinase
hsa:1015,2.0139372e-09,1.677111574733638e-06,3.9922987436497075e-07,1.7717662734496645e-06,0.0,1.5794618e-05,False,CDH17; cadherin
hsa:5315,0.0,0.0,6.155185416842107e-05,0.00012022786933250693,0.0,0.0006857529,False,PKM; pyruvate kinase
hsa:4357,0.0,0.0,0.0003313479400093977,0.0009965195381904665,0.0,0.0061508873,False,MPST; mercaptopyruvate
hsa:57504,0.0,0.0,4.525768241282457e-06,1.232087410045887e-05,0.0,8.042426e-05,False,MTA3; metastasis associated 1 family member
hsa:2021,5.2786426e-08,4.395803703979481e-05,4.002275270912281e-06,7.814219640253774e-06,0.0,3.439593e-05,False,ENDOG; endonuclease
hsa:50940,9.713468e-07,0.0008088916384088243,1.1987019268210527e-05,3.0201592696131043e-05,0.0,0.00025827737,False,PDE11A; phosphodiesterase
hsa:57467,6.1382907e-06,0.005111677952048279,2.880350120283041e-05,5.068954591070102e-05,0.0,0.00030516592,False,HHATL; hedgehog acyltransferase
hsa:56904,0.0,0.0,4.3357600972456143e-07,9.769144134210393e-07,0.0,6.4480264e-06,False,SH3GLB2; SH3 domain containing GRB2 like
hsa:80896,4.8565045e-07,0.0004044267075307015,4.124537317072515e-05,0.00010945758811412991,0.0,0.00073454296,False,NPL; N-acetylneuraminate pyruvate
hsa:7991,0.0,0.0,0.00017916880437378362,0.0005014025785927077,0.0,0.0026234563,False,TUSC3; tumor suppressor candidate
hsa:406937,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR145; microRNA
hsa:1013,0.0,0.0,2.7064539093095905e-07,1.1122865644397641e-06,0.0,9.742318e-06,False,CDH15; cadherin
hsa:680,0.0,0.0,1.0063539781853157e-06,3.551240686045398e-06,0.0,3.5465306e-05,False,BRS3; bombesin receptor subtype
hsa:84168,0.0,0.0,5.256829956725146e-08,1.686745153521977e-07,0.0,9.733694e-07,False,ANTXR1; ANTXR cell adhesion molecule
hsa:761,2.3127022e-06,0.0019259089253289272,5.462776316792396e-05,0.00019141991884776696,0.0,0.0013202949,False,CA3; carbonic anhydrase
hsa:8554,1.7234379e-07,0.00014351975078590504,9.476935378631575e-05,0.00027626415282484335,0.0,0.001746523,False,PIAS1; protein inhibitor of activated STAT
hsa:4291,0.0,0.0,1.8988886255456138e-07,4.623891198933089e-07,0.0,2.249907e-06,False,MLF1; myeloid leukemia factor
hsa:10314,0.0,0.0,0.00011762363774640344,0.00032707115795411573,0.0,0.0025267657,False,LANCL1; LanC like glutathione S-transferase
hsa:90990,1.1212496e-07,9.33723594919177e-05,4.7527798685035094e-07,1.064184573789402e-06,0.0,6.0742013e-06,False,KIFC2; kinesin family member
hsa:332,0.0002215231,0.1844739523560502,0.0008976238293647955,0.0016563623617993465,0.0,0.011419313,False,BIRC5; baculoviral IAP repeat containing
hsa:10250,2.5566525e-08,2.1290591883012502e-05,8.173979968423389e-07,1.2242822166646381e-06,0.0,5.744184e-06,False,SRRM1; serine and arginine repetitive matrix
hsa:10157,3.9684346e-07,0.00033047244974835634,3.7264039475672517e-06,1.0639073677647082e-05,0.0,7.7747594e-05,False,AASS; aminoadipate-semialdehyde
hsa:90075,0.0,0.0,2.400100570409356e-08,4.6726881230030694e-08,0.0,2.6136368e-07,False,ZNF30; zinc finger protein
hsa:8824,0.0,0.0,1.913018798227719e-05,5.4116805158964845e-05,0.0,0.00035930218,False,CES2; carboxylesterase
hsa:2166,0.0,0.0,1.3183979864444442e-06,2.8343061327670408e-06,0.0,1.299618e-05,False,FAAH; fatty acid amide
hsa:4756,2.481612e-06,0.0020665690117834326,0.00011469247410046786,0.0002816252537495544,0.0,0.002489193,False,NEO1; neogenin
hsa:2658,0.0,0.0,8.229847193812865e-07,9.030011628427247e-06,0.0,0.00011770639,False,GDF2; growth differentiation factor
hsa:5566,0.0,0.0,0.001047936466438596,0.002191549653530032,0.0,0.011225367,False,PRKACA; protein kinase cAMP-activated catalytic subunit
hsa:150094,0.0,0.0,2.0460533847953228e-07,4.1774415175005827e-07,0.0,2.2291476e-06,False,SIK1; salt inducible kinase
hsa:7565,1.6849343e-09,1.4031335322649187e-06,1.1567673441128661e-07,2.4123942838794315e-07,0.0,1.1176191e-06,False,ZNF17; zinc finger protein
hsa:7324,9.3912014e-08,7.820548013411117e-05,1.0508547102982454e-06,2.033077636119136e-06,0.0,1.1515314e-05,False,UBE2E1; ubiquitin conjugating enzyme E2
hsa:171023,0.0,0.0,4.204514141502923e-06,1.4891073321463532e-05,0.0,9.631418e-05,False,ASXL1; ASXL transcriptional regulator
hsa:10055,0.0,0.0,7.979538000754388e-07,2.5022621080397173e-06,0.0,1.4377318e-05,False,SAE1; SUMO1 activating enzyme subunit
hsa:54490,0.0,0.0,2.550972529239766e-06,1.86241611244856e-05,0.0,0.00022009999,False,UGT2B28; UDP glucuronosyltransferase family 2 member
hsa:51023,0.0,0.0,5.2011010556374284e-08,9.44988826291253e-08,0.0,4.276612e-07,False,MRPS18C; mitochondrial ribosomal protein
hsa:84436,0.0,0.0,5.6447333275438583e-08,1.0479208736313602e-07,0.0,5.3845133e-07,False,ZNF528; zinc finger protein
hsa:10623,1.1677017e-06,0.0009724067050879969,0.00016056554528766077,0.0004669286421747714,0.0,0.002847829,False,POLR3C; RNA polymerase III subunit
hsa:163,3.92582e-06,0.003269237075674858,4.0625579475730995e-05,8.234268232984614e-05,0.0,0.0005691669,False,AP2B1; adaptor related protein complex 2 subunit beta
hsa:140735,2.1198073e-06,0.001765275182878027,0.00016582415138824568,0.0005142433474955778,0.0,0.0028015366,False,DYNLL2; dynein light chain LC8-type
hsa:339559,0.0,0.0,4.115546856140351e-08,7.974830524671412e-08,0.0,3.5747243e-07,False,ZFP69; ZFP69 zinc finger
hsa:223117,1.4904812e-07,0.00012412021946080952,7.791664186257309e-06,3.158592042340235e-05,0.0,0.00030511036,False,SEMA3D; semaphorin
hsa:49861,4.3297115e-07,0.00036055787995312573,5.546920510213449e-06,1.2060804456222778e-05,0.0,6.984035e-05,False,CLDN20; claudin
hsa:4833,0.0,0.0,1.3413300950210523e-05,6.976425571798432e-05,0.0,0.00069428777,False,NME4; NME/NM23 nucleoside diphosphate kinase
hsa:6424,0.0,0.0,2.8950377240643274e-07,6.772448456007328e-07,0.0,6.019791e-06,False,SFRP4; secreted frizzled related protein
hsa:51371,0.0,0.0,3.113119118333333e-06,7.561356052095618e-06,0.0,7.2661074e-05,False,POMP; proteasome maturation
hsa:943,0.0,0.0,2.974596143450293e-07,7.988709416389299e-07,0.0,6.2085237e-06,False,TNFRSF8; TNF receptor superfamily member
hsa:55034,2.0250774e-08,1.686388605996007e-05,9.267322859043861e-07,3.986818979121071e-06,0.0,4.3172247e-05,False,MOCOS; molybdenum cofactor
hsa:442361,0.0,0.0,7.409313776959065e-07,4.658895633814438e-06,0.0,3.949096e-05,False,OR2A2; olfactory receptor family 2 subfamily A member
hsa:3696,0.0,0.0,6.997483182456138e-06,2.34047695600937e-05,0.0,0.0001978414,False,ITGB8; integrin subunit beta
hsa:23026,5.0179705e-10,4.178728317457933e-07,4.3604506153731e-07,1.7290558710162861e-06,0.0,1.1193576e-05,False,MYO16; myosin
hsa:8632,0.0,0.0,9.535574036736841e-07,3.0811355251596344e-06,0.0,1.636539e-05,False,DNAH17; dynein axonemal heavy chain
hsa:6662,0.0,0.0,4.545165891988305e-08,1.0964658369952057e-07,0.0,5.333319e-07,False,SOX9; SRY-box transcription factor
hsa:6358,0.0,0.0,2.50367166e-05,8.206379853472316e-05,0.0,0.0006624169,False,CCL14; C-C motif chemokine ligand
hsa:7412,0.0,0.0,4.023843160602339e-05,7.661164074343809e-05,0.0,0.00039381476,False,VCAM1; vascular cell adhesion molecule
hsa:154,0.0,0.0,6.169425478479535e-05,0.00014776551883767135,0.0,0.0009854385,False,ADRB2; adrenoceptor beta
hsa:1847,0.0,0.0,2.127430744093566e-07,5.158562802806398e-07,0.0,2.3121722e-06,False,DUSP5; dual specificity phosphatase
hsa:55613,6.224532e-08,5.183495624640093e-05,1.2055915505555556e-06,3.7889402321210403e-06,0.0,3.056732e-05,False,MTMR8; myotubularin related protein
hsa:3483,0.0,0.0,7.837016706935676e-08,2.4790446645495235e-07,0.0,2.822978e-06,False,IGFALS; insulin like growth factor binding protein acid labile
hsa:51032,0.0,0.0,3.398699607657894e-05,0.00033344534672787306,0.0,0.0043521086,False,CELA2B; chymotrypsin like elastase
hsa:8878,0.0,0.0,1.5193225475438595e-06,5.069720154885216e-06,0.0,3.0680076e-05,False,SQSTM1; sequestosome
hsa:2176,3.9737088e-06,0.003309116601600544,0.00011029318069919303,0.00024297205674172597,0.0,0.001563286,False,FANCC; FA complementation group
hsa:101954267,0.0,0.0,2.0361411834269004e-07,9.814939914998644e-07,0.0,1.04472165e-05,False,RNVU1-15; RNA
hsa:1649,0.0,0.0,5.158441860935673e-06,1.4330142832462381e-05,0.0,0.00012090226,False,DDIT3; DNA damage inducible transcript
hsa:10940,1.7374376e-08,1.4468557953730796e-05,6.623303058912279e-07,1.6220530948846198e-06,0.0,9.128546e-06,False,POP1; POP1 homolog
hsa:100169768,0.0,0.0,8.105517048380116e-08,7.600447198527339e-07,0.0,9.695978e-06,False,RNA5S17; RNA
hsa:1632,1.761126e-06,0.0014665823736531372,2.2507991877181273e-05,0.00010128668274384394,0.0,0.001169003,False,ECI1; enoyl-CoA delta isomerase
hsa:406984,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR200B; microRNA
hsa:375775,1.8435567e-07,0.0001535226758931584,6.403054787175437e-06,1.4421873049981401e-05,0.0,0.000101529055,False,PNPLA7; patatin like phospholipase domain containing
hsa:100131827,0.0,0.0,3.287392098245614e-08,8.150950378614599e-08,0.0,4.3526865e-07,False,ZNF717; zinc finger protein
hsa:93343,7.818953e-08,6.511253964919216e-05,1.3409994677397664e-06,2.6721951854777382e-06,0.0,1.406436e-05,False,MVB12A; multivesicular body subunit
hsa:3043,3.651428e-06,0.0030407364058355436,0.0001470022459631579,0.0003024552289020022,0.0,0.0020501711,False,HBB; hemoglobin subunit
hsa:81616,1.2478737e-05,0.010391701519171955,5.597410761402924e-05,0.00011868285278861742,0.0,0.0008591891,False,ACSBG2; acyl-CoA synthetase bubblegum family member
hsa:9070,0.0,0.0,4.487242659298244e-06,8.598546212480403e-06,0.0,7.285476e-05,False,ASH2L; ASH2 like
hsa:64324,1.126149e-06,0.000937803583336517,1.8644784536257305e-05,4.309124130666385e-05,0.0,0.00026188607,False,NSD1; nuclear receptor binding SET domain protein
hsa:339302,0.0,0.0,3.905610562100702e-07,1.8325395856554529e-06,0.0,1.4412042e-05,False,CPLX4; complexin
hsa:6746,1.2748265e-07,0.00010616151680038346,9.47439689358947e-07,1.5341855410787972e-06,0.0,7.236299e-06,False,SSR2; signal sequence receptor subunit
hsa:2806,0.0,0.0,0.0002858050478345029,0.0007051002399359578,0.0,0.005047352,False,GOT2; glutamic-oxaloacetic transaminase
hsa:2266,0.0,0.0,1.7326132177192984e-06,1.0812625168175958e-05,0.0,0.000106082014,False,FGG; fibrinogen gamma
hsa:3662,0.0,0.0,3.7127495437216376e-06,1.6505877598377113e-05,0.0,0.00016710657,False,IRF4; interferon regulatory factor
hsa:343172,0.0,0.0,9.334270146783627e-07,5.1603198657710015e-06,0.0,6.0065897e-05,False,OR2T8; olfactory receptor family 2 subfamily T member
hsa:171546,0.0,0.0,3.898226153684212e-06,1.0010460148721758e-05,0.0,5.9837308e-05,False,SPTSSA; serine palmitoyltransferase small subunit
hsa:406909,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR124-3; microRNA
hsa:3155,0.0,0.0,1.1718496045321637e-05,2.6582612193854344e-05,0.0,0.0001477419,False,HMGCL; 3-hydroxy-3-methylglutaryl-CoA
hsa:283455,1.5433486e-08,1.2852276629623581e-05,5.937820240988889e-07,1.3420975768356947e-06,0.0,8.537217e-06,False,KSR2; kinase suppressor of ras
hsa:2169,0.0,0.0,3.1211278507602353e-07,8.011157446761881e-07,0.0,4.7844587e-06,False,FABP2; fatty acid binding protein
hsa:5770,0.0,0.0,4.2541917452865494e-05,0.00011919168882990709,0.0,0.00085855334,False,PTPN1; protein tyrosine phosphatase non-receptor type
hsa:391114,0.0,0.0,1.988205410526316e-06,1.4854272599126215e-05,0.0,0.00015843366,False,OR6K3; olfactory receptor family 6 subfamily K member
hsa:10156,0.0,0.0,2.1378518459064326e-07,5.380653037198691e-07,0.0,3.649042e-06,False,RASA4; RAS p21 protein activator
hsa:273,1.7810956e-07,0.00014832121113146694,2.646082736812865e-06,5.9879508844360765e-06,0.0,3.460582e-05,False,AMPH;
hsa:5305,0.0,0.0,9.243517855847953e-06,3.1706583006325214e-05,0.0,0.00019477098,False,PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:168374,1.153308e-07,9.604203130231183e-05,2.3559217188128658e-07,3.103821004870699e-07,0.0,1.3867971e-06,False,ZNF92; zinc finger protein
hsa:414328,2.7703743e-06,0.002307036587275214,6.955899154965964e-05,0.0002059936473672532,0.0,0.0010909361,False,IDNK; IDNK
hsa:83667,0.0,0.0,1.924404981432164e-05,5.8746981432116426e-05,0.0,0.00038826917,False,SESN2; sestrin
hsa:9231,0.0,0.0,4.511848330116959e-06,7.604711280818469e-06,0.0,4.431916e-05,False,DLG5; discs large MAGUK scaffold protein
hsa:6303,0.0,0.0,2.1922734591900585e-05,5.0763229826646777e-05,0.0,0.00028229307,False,SAT1; spermidine/spermine N1-acetyltransferase
hsa:747,0.0,0.0,7.0599699466257305e-06,2.290130712324569e-05,0.0,0.00012322771,False,DAGLA; diacylglycerol lipase
hsa:26873,0.0,0.0,9.60499413994152e-07,2.6224387684648823e-06,0.0,1.756216e-05,False,OPLAH; 5-oxoprolinase
hsa:7323,1.7826786e-06,0.0014845303587867373,6.831376079465504e-05,0.0002094736656765476,0.0,0.0011037355,False,UBE2D3; ubiquitin conjugating enzyme E2
hsa:1019,0.00041549746,0.3460066180010115,0.0006617055252087718,0.0007995362978093272,0.0,0.0043409634,False,CDK4; cyclin dependent kinase
hsa:51727,0.0,0.0,3.7119840451988306e-05,9.793854740782768e-05,0.0,0.0005641224,False,CMPK1; cytidine/uridine monophosphate kinase
hsa:81490,4.1697232e-09,3.4723481159965583e-06,3.7943202089251466e-06,8.503689241747031e-06,0.0,4.1085008e-05,False,PTDSS2; phosphatidylserine synthase
hsa:283617,0.0,0.0,6.245662573099415e-08,8.167263597478377e-07,0.0,1.0680083e-05,False,OR4K3; olfactory receptor family 4 subfamily K member 3
hsa:100271927,0.0,0.0,2.348172440719298e-06,5.044896628466801e-06,0.0,3.2127027e-05,False,RASA4B; RAS p21 protein activator
hsa:2894,0.0,0.0,1.3941548341384207e-05,2.5669355933749228e-05,0.0,0.00017612451,False,GRID1; glutamate ionotropic receptor delta type subunit
hsa:92912,4.1280295e-08,3.437627576119013e-05,3.9274494816725164e-07,7.097635264333369e-07,0.0,4.0065634e-06,False,UBE2Q2; ubiquitin conjugating enzyme E2
hsa:1462,0.0,0.0,2.781653002146198e-06,7.413193808795174e-06,0.0,5.0395607e-05,False,VCAN;
hsa:98,0.0,0.0,1.1771173737660817e-06,2.2922640645167085e-06,0.0,1.2490308e-05,False,ACYP2; acylphosphatase
hsa:3842,3.5489087e-08,2.955363185328176e-05,1.4893962409257302e-07,2.929217126432019e-07,0.0,1.5118965e-06,False,TNPO1; transportin
hsa:7102,2.8532131e-08,2.3760208189171163e-05,1.6410465629940926e-05,5.716511493453906e-05,0.0,0.0004195275,False,TSPAN7; tetraspanin
hsa:8896,7.5343654e-10,6.274262881986904e-07,1.8573463143181287e-07,3.43922222638253e-07,0.0,1.9121544e-06,False,BUD31; BUD31
hsa:3628,0.0,0.0,6.128842002900584e-06,1.9393197087598343e-05,0.0,0.00012921468,False,INPP1; inositol
hsa:10438,0.0,0.0,1.1112300809684211e-06,3.0362062833243398e-06,0.0,1.913056e-05,False,C1D; C1D nuclear receptor
hsa:7867,0.0,0.0,1.4248231698479531e-05,6.511574102580668e-05,0.0,0.00075336226,False,MAPKAPK3; MAPK activated protein kinase
hsa:6342,8.659208e-05,0.07210978557239082,0.00021150763974947363,0.00027321438477282247,0.0,0.0011130987,False,SCP2; sterol carrier protein
hsa:439996,1.1559442e-09,9.626156156042082e-07,5.804549128614037e-09,1.284380039592433e-08,0.0,1.0713178e-07,False,IFIT1B; interferon induced protein with tetratricopeptide repeats
hsa:10847,0.0,0.0,3.5163502074502935e-07,6.063282402666506e-07,0.0,2.999836e-06,False,SRCAP; Snf2 related CREBBP activator
hsa:6374,0.0,0.0,1.023510154877193e-05,3.433199650350373e-05,0.0,0.00033886312,False,CXCL5; C-X-C motif chemokine ligand
hsa:28234,0.0,0.0,1.1949373213157895e-06,6.721338329024959e-06,0.0,7.681444e-05,False,SLCO1B3; solute carrier organic anion transporter family member
hsa:90381,0.0,0.0,1.0883628390333335e-06,3.254041197167713e-06,0.0,1.6474542e-05,False,TICRR; TOPBP1 interacting checkpoint and replication
hsa:23545,2.0863215e-05,0.017373897936170234,0.00010179033705380118,0.00016315629954128375,0.0,0.0007920034,False,ATP6V0A2; ATPase H+ transporting V0 subunit
hsa:3439,0.0,0.0,3.730837660818713e-08,3.4562769791114446e-07,0.0,3.5024927e-06,False,IFNA1; interferon alpha
hsa:128366,0.0,0.0,2.6026209935672513e-06,2.9992786017714132e-05,0.0,0.00038936242,False,OR6P1; olfactory receptor family 6 subfamily P member
hsa:226,0.0,0.0,0.0004603376910871344,0.0010710582269177174,0.0,0.0051750094,False,ALDOA; aldolase
hsa:1584,0.0,0.0,1.2218255300380118e-05,5.743484558138302e-05,0.0,0.00040173624,False,CYP11B1; cytochrome P450 family 11 subfamily B member
hsa:9899,4.1210383e-06,0.003431805635672569,2.4499309859742682e-05,5.434754567493296e-05,0.0,0.00029981736,False,SV2B; synaptic vesicle glycoprotein
hsa:8434,0.0,0.0,2.214303618128656e-08,5.45669760326563e-08,0.0,2.8416648e-07,False,RECK; reversion inducing cysteine rich protein with kazal
hsa:775,0.0,0.0,0.00020664837908187126,0.0004721916051804071,0.0,0.0033605597,False,CACNA1C; calcium voltage-gated channel subunit alpha1
hsa:90317,0.0,0.0,2.887403389146198e-08,5.8051147878454255e-08,0.0,2.444081e-07,False,ZNF616; zinc finger protein
hsa:80308,7.1834177e-07,0.0005982010248788537,0.0001402179697364912,0.0002876964602399944,0.0,0.001293936,False,FLAD1; flavin adenine dinucleotide synthetase
hsa:7318,0.0,0.0,1.626115343760234e-07,4.2218404956327083e-07,0.0,2.9376574e-06,False,UBA7; ubiquitin like modifier activating enzyme
hsa:10452,0.0,0.0,4.422392484970761e-08,1.359438626247223e-07,0.0,8.383458e-07,False,TOMM40; translocase of outer mitochondrial membrane
hsa:21,0.0001386832,0.11548880468621367,0.0008657793375350872,0.0016295599971383114,0.0,0.010644812,False,ABCA3; ATP binding cassette subfamily A member
hsa:2869,3.0980202e-06,0.002579884584374637,5.953598660175437e-06,8.33669132292994e-06,0.0,4.2418058e-05,False,GRK5; G protein-coupled receptor kinase
hsa:6391,3.846585e-07,0.000320325391809476,0.00014831695816842108,0.00048037431388333734,0.0,0.0031599489,False,SDHC; succinate dehydrogenase complex subunit
hsa:5288,0.0,0.0,9.045073311390056e-07,5.842984913146728e-06,0.0,5.486746e-05,False,PIK3C2G; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:406943,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR152; microRNA
hsa:7295,0.0,0.0,9.634105932982455e-07,2.0800323801280224e-06,0.0,1.3790774e-05,False,TXN;
hsa:7988,0.0,0.0,3.038116091871345e-08,7.245691452740225e-08,0.0,3.7375617e-07,False,ZNF212; zinc finger protein
hsa:54575,0.0,0.0,5.5682852765497065e-05,0.0002260404903292683,0.0,0.0018293821,False,UGT1A10; UDP glucuronosyltransferase family 1 member
hsa:91543,0.0,0.0,2.4603113151929817e-06,6.0856501071385e-06,0.0,4.3396176e-05,False,RSAD2; radical S-adenosyl methionine domain containing
hsa:6569,0.0,0.0,3.152090872280702e-07,9.74079264198115e-07,0.0,8.492931e-06,False,SLC34A1; solute carrier family 34 member
hsa:129521,0.0,0.0,0.0,0.0,-0.0,-0.0,False,NMS; neuromedin
hsa:84465,6.1185676e-07,0.0005095253487919194,5.5298700435028654e-05,0.00012914410428607363,0.0,0.0008451936,False,MEGF11; multiple EGF like domains
hsa:1815,0.0,0.0,2.9993783017251466e-06,7.000476031741203e-06,0.0,3.7959566e-05,False,DRD4; dopamine receptor
hsa:56915,1.2115031e-07,0.00010088824377620534,1.1171762669497072e-05,4.0576012535618925e-05,0.0,0.0002872923,False,EXOSC5; exosome component
hsa:406971,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR195; microRNA
hsa:9883,3.0988636e-09,2.580586927974095e-06,1.9868253015847962e-07,3.8379728855803207e-07,0.0,1.5390572e-06,False,POM121; POM121 transmembrane
hsa:84245,4.038749e-08,3.363279001621255e-05,2.4842117077649127e-05,7.245090788406899e-05,0.0,0.00048694143,False,MRI1; methylthioribose-1-phosphate isomerase
hsa:5581,0.00012072685,0.10053560633178218,0.00033121336750409347,0.00048798309084585156,0.0,0.0027395182,False,PRKCE; protein kinase C
hsa:9175,1.739597e-08,1.4486540414824813e-05,1.8116737113877192e-07,3.072043726088258e-07,0.0,2.2536572e-06,False,MAP3K13; mitogen-activated protein kinase kinase kinase
hsa:4853,0.0,0.0,3.576566795321638e-07,1.1973938817327558e-06,0.0,7.3230544e-06,False,NOTCH2; notch receptor
hsa:128372,0.0,0.0,1.0230678005847952e-06,1.1107583758374204e-05,0.0,0.00014267075,False,OR6N1; olfactory receptor family 6 subfamily N member
hsa:3443,0.0,0.0,1.975003614035088e-07,1.273151374986418e-06,0.0,1.2352792e-05,False,IFNA6; interferon alpha
hsa:54600,0.0,0.0,5.479964659532163e-05,0.00021724213207453577,0.0,0.0020001149,False,UGT1A9; UDP glucuronosyltransferase family 1 member
hsa:9107,1.6107428e-07,0.00013413503627614947,3.692443932462221e-05,0.0001251151416841757,0.0,0.0007942123,False,MTMR6; myotubularin related protein
hsa:353091,0.0,0.0,5.766094596491226e-08,1.1184654619724674e-07,0.0,8.031564e-07,False,RAET1G; retinoic acid early transcript
hsa:64600,0.0,0.0,2.421789529239766e-07,1.4925972331053723e-06,0.0,1.4117727e-05,False,PLA2G2F; phospholipase A2 group
hsa:3992,0.0,0.0,0.0003018805442179684,0.0009216523920044369,0.0,0.004560173,False,FADS1; fatty acid desaturase
hsa:283446,1.1975409e-08,9.972553784730418e-06,2.013659259192983e-07,7.475186940581096e-07,0.0,8.291068e-06,False,MYO1H; myosin
hsa:3178,5.683812e-09,4.733209602469208e-06,5.647380121888889e-07,1.0645177145924718e-06,0.0,5.280109e-06,False,HNRNPA1; heterogeneous nuclear ribonucleoprotein
hsa:8733,1.1726904e-05,0.009765610583185116,2.5754720928225156e-05,3.376141356225352e-05,0.0,0.00019624013,False,GPAA1; glycosylphosphatidylinositol anchor attachment
hsa:92283,0.0,0.0,9.78164558888889e-08,1.960994637143803e-07,0.0,9.4458875e-07,False,ZNF461; zinc finger protein
hsa:9274,5.978727e-09,4.978800855296044e-06,8.171442718484856e-06,1.9800226382045908e-05,0.0,0.00011543385,False,BCL7C; BAF chromatin remodeling complex subunit
hsa:23295,2.9791761e-05,0.02480916843126895,0.00016087425159719298,0.00026019794689577716,0.0,0.001499196,False,MGRN1; mahogunin ring finger
hsa:6774,0.0,0.0,0.00015636644313370764,0.00047010345730337446,0.0,0.002986287,False,STAT3; signal transducer and activator of transcription
hsa:10663,0.0,0.0,2.2377431671175442e-06,8.925970127061871e-06,0.0,9.6417345e-05,False,CXCR6; C-X-C motif chemokine receptor
hsa:2064,0.0,0.0,7.407177557894737e-05,0.00017071266248786085,0.0,0.0013042318,False,ERBB2; erb-b2 receptor tyrosine kinase
hsa:658,6.0072918e-05,0.05002588268682097,0.00030242315741128644,0.0005033163620138946,0.0,0.0023854852,False,BMPR1B; bone morphogenetic protein receptor type
hsa:6262,0.00023755191,0.1978219866344807,0.0005504142105333335,0.0008098056639081318,0.0,0.00606427,False,RYR2; ryanodine receptor
hsa:406981,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19B2; microRNA
hsa:10528,2.9928108e-07,0.00024922711759174215,4.2274870237251456e-06,7.671614297969375e-06,0.0,3.322409e-05,False,NOP56; NOP56
hsa:9453,0.0,0.0,3.818831887619212e-05,0.0001156423431387673,0.0,0.00073327945,False,GGPS1; geranylgeranyl diphosphate synthase
hsa:653247,2.1143169e-08,1.760703037634413e-05,1.2719093656880118e-05,3.340695234191904e-05,0.0,0.00020354173,False,PRB2; proline rich protein BstNI subfamily
hsa:57455,2.0295197e-07,0.00016900879431692013,7.396146373798832e-07,1.1211641039993497e-06,0.0,5.48224e-06,False,REXO1; RNA exonuclease 1
hsa:4440,0.0,0.0,4.1499494695941525e-07,8.644118901046209e-07,0.0,4.3129876e-06,False,MSI1; musashi RNA binding protein
hsa:10349,2.7574795e-05,0.022962984081830975,0.00010825848776918133,0.0001804057488671374,0.0,0.001113418,False,ABCA10; ATP binding cassette subfamily A member
hsa:65008,0.0,0.0,1.3699238969327486e-07,3.232628179229464e-07,0.0,1.520981e-06,False,MRPL1; mitochondrial ribosomal protein
hsa:392133,0.0,0.0,8.357759857894738e-07,2.860030886402638e-06,0.0,2.5549418e-05,False,OR10AC1; olfactory receptor family 10 subfamily AC member 1
hsa:5720,4.1237213e-06,0.0034340399110784807,1.4333920186122813e-05,2.3667922121609196e-05,0.0,0.0001264195,False,PSME1; proteasome activator subunit
hsa:25906,6.8961845e-07,0.0005742816035400064,5.340401490923978e-06,1.1901578007226038e-05,0.0,0.00010949309,False,ANAPC15; anaphase promoting complex subunit
hsa:6572,3.0733784e-06,0.002559364059701737,2.0618449108690048e-05,4.824263865620697e-05,0.0,0.000394858,False,SLC18A3; solute carrier family 18 member
hsa:57369,2.9314036e-09,2.441134166336396e-06,7.951861858146434e-05,0.00024409754071299034,0.0,0.0014970411,False,GJD2; gap junction protein delta
hsa:9002,0.0,0.0,1.259796456081871e-06,4.4241374648655415e-06,0.0,4.11945e-05,False,F2RL3; F2R like thrombin or trypsin receptor
hsa:535,7.141598e-05,0.05947184782074932,0.00016724927590643272,0.0002613018587087808,0.0,0.0013562343,False,ATP6V0A1; ATPase H+ transporting V0 subunit
hsa:1896,0.0,0.0,9.227658199011697e-07,2.1361014009534645e-06,0.0,1.1588229e-05,False,EDA; ectodysplasin
hsa:10389,0.0,0.0,0.00016768458802153584,0.0006317318856755679,0.0,0.0037447647,False,SCML2; Scm polycomb group protein like
hsa:55706,0.0,0.0,1.3046171882456146e-07,4.126603215534307e-07,0.0,2.5718628e-06,False,NDC1; NDC1 transmembrane
hsa:3981,3.2228343e-07,0.0002683823859045149,6.439830062821052e-05,0.0001810524102346488,0.0,0.0014244621,False,LIG4; DNA ligase
hsa:6821,0.0,0.0,0.00016971493142836262,0.0005050062029437703,0.0,0.0031561605,False,SUOX; sulfite
hsa:7317,0.0,0.0,1.9627542117251464e-07,4.6447676542558954e-07,0.0,4.6573628e-06,False,UBA1; ubiquitin like modifier activating enzyme
hsa:138804,0.0,0.0,5.2023121754385963e-08,4.261958302189804e-07,0.0,5.1699794e-06,False,OR13C4; olfactory receptor family 13 subfamily C member
hsa:2264,1.1666041e-06,0.0009714926757605543,2.9964660702264915e-05,6.61652961083552e-05,0.0,0.0003592343,False,FGFR4; fibroblast growth factor receptor
hsa:83544,0.0,0.0,3.1889443714035084e-08,6.33913524831431e-08,0.0,4.912426e-07,False,DNAL1; dynein axonemal light chain
hsa:276,0.0,0.0,8.027074143274853e-07,4.771611299073411e-06,0.0,4.5864137e-05,False,AMY1A; amylase alpha
hsa:65985,7.684978e-06,0.006399685926340387,0.0003630229497334503,0.0010747496803990171,0.0,0.0068289316,False,AACS; acetoacetyl-CoA
hsa:79944,5.7011816e-06,0.0047476741831962,0.0002014498175641228,0.0005350131960934472,0.0,0.0033858195,False,L2HGDH; L-2-hydroxyglutarate
hsa:3248,0.0,0.0,2.3438700715789474e-07,1.282278829753875e-06,0.0,1.1164354e-05,False,HPGD; 15-hydroxyprostaglandin
hsa:57615,0.0,0.0,1.0498273466549708e-08,2.3198198099262918e-08,0.0,1.2354975e-07,False,ZNF492; zinc finger protein
hsa:391191,0.0,0.0,1.2049362092339185e-05,4.911522507085342e-05,0.0,0.00046822458,False,OR2AK2; olfactory receptor family 2 subfamily AK member
hsa:11238,5.6069516e-06,0.004669203899372478,0.00016278522091108007,0.00032241436637959217,0.0,0.0019742867,False,CA5B; carbonic anhydrase
hsa:80142,8.1879216e-07,0.0006818513550656679,2.8924859916725147e-05,5.139252313515795e-05,0.0,0.00026478572,False,PTGES2; prostaglandin E synthase
hsa:259296,0.0,0.0,1.614003163403509e-05,4.076724101808831e-05,0.0,0.00036890985,False,TAS2R50; taste 2 receptor member
hsa:8676,0.0,0.0,3.069313119765381e-05,9.737448926996599e-05,0.0,0.0006622151,False,STX11; syntaxin
hsa:3315,0.0,0.0,1.5305449061403507e-05,2.8952798992355564e-05,0.0,0.00019006769,False,HSPB1; heat shock protein family B (small) member
hsa:5207,0.0,0.0,5.853748152725148e-06,1.704727434788362e-05,0.0,0.00012410017,False,PFKFB1; 6-phosphofructo-2-kinase/fructose-2
hsa:1844,3.6110215e-08,3.007087785191129e-05,5.6832365712126924e-05,0.00017048602447793077,0.0,0.0009713376,False,DUSP2; dual specificity phosphatase
hsa:101954264,0.0,0.0,1.788505945421053e-08,9.531652839653087e-08,0.0,9.776974e-07,False,RNVU1-4; RNA
hsa:4599,0.0,0.0,1.1911187488362573e-05,2.5183702153381298e-05,0.0,0.00011561244,False,MX1; MX dynamin like GTPase
hsa:27329,0.0,0.0,5.578131896280701e-06,1.8263875628504293e-05,0.0,0.00014831094,False,ANGPTL3; angiopoietin like
hsa:8799,3.7338768e-07,0.00031093958639372653,1.4129826688561401e-06,3.1639585209110627e-06,0.0,3.0689116e-05,False,PEX11B; peroxisomal biogenesis factor 11
hsa:59345,0.0,0.0,1.2711532638637427e-05,4.3507464819173354e-05,0.0,0.0003746473,False,GNB4; G protein subunit beta
hsa:6741,3.506199e-08,2.919796568740826e-05,0.00010280034479336844,0.00036577459746744127,0.0,0.002723124,False,SSB; small RNA binding exonuclease protection factor
hsa:248,0.0,0.0,4.868348736155557e-07,2.021044960533816e-06,0.0,1.9856287e-05,False,ALPI; alkaline phosphatase
hsa:6120,0.0,0.0,6.287445293304095e-05,0.00013866667106934648,0.0,0.0010232888,False,RPE;
hsa:284486,1.912886e-08,1.592960918416885e-05,1.1677108533239765e-06,3.076961850380461e-06,0.0,2.1945496e-05,False,THEM5; thioesterase superfamily member
hsa:427,0.0,0.0,6.594054411111109e-06,1.3711431006152158e-05,0.0,9.836264e-05,False,ASAH1; N-acylsphingosine amidohydrolase
hsa:27258,0.0,0.0,5.286684474502924e-07,1.384003161130939e-06,0.0,6.467847e-06,False,LSM3; LSM3 homolog
hsa:84962,0.0,0.0,2.0691047649122805e-06,5.2892159943668825e-06,0.0,3.258794e-05,False,AJUBA; ajuba LIM
hsa:353088,0.0,0.0,4.9549933669590634e-08,9.234401304114002e-08,0.0,4.2843087e-07,False,ZNF429; zinc finger protein
hsa:3980,0.0,0.0,1.4576190193736835e-05,3.964422631341511e-05,0.0,0.00027519593,False,LIG3; DNA ligase
hsa:2639,0.0,0.0,3.457454264576316e-05,0.00010619131426207882,0.0,0.00075009733,False,GCDH; glutaryl-CoA
hsa:3589,0.0,0.0,3.4640407095263157e-06,1.4618738857400512e-05,0.0,0.00011930328,False,IL11; interleukin
hsa:2986,0.0,0.0,1.2807084146783624e-07,8.613776162621089e-07,0.0,8.059233e-06,False,GUCY2F; guanylate cyclase 2F
hsa:9282,1.3673148e-06,0.0011386350465072144,9.492839000684218e-06,2.050313665908799e-05,0.0,0.00014167442,False,MED14; mediator complex subunit
hsa:51135,0.0,0.0,1.90486481721345e-05,5.087146016790269e-05,0.0,0.00042853356,False,IRAK4; interleukin 1 receptor associated kinase
hsa:57494,0.0,0.0,2.2089938944444444e-05,6.978174869476938e-05,0.0,0.00048517794,False,RIMKLB; ribosomal modification protein rimK like family member
hsa:5686,0.0,0.0,2.4688050162339187e-06,8.82370140065565e-06,0.0,9.610159e-05,False,PSMA5; proteasome 20S subunit alpha
hsa:7057,0.0,0.0,3.497613976608187e-07,2.975812399051993e-06,0.0,3.413028e-05,False,THBS1; thrombospondin
hsa:92359,4.252176e-10,3.5410109051089487e-07,2.7818047345633923e-06,2.1027902811329348e-05,0.0,0.00026699173,False,CRB3; crumbs cell polarity complex component
hsa:257202,0.0,0.0,1.3539336873099418e-06,9.690507128576302e-06,0.0,0.00010320208,False,GPX6; glutathione peroxidase
hsa:3231,0.0,0.0,8.984184321847954e-08,3.0005783844080976e-07,0.0,1.844793e-06,False,HOXD1; homeobox
hsa:255631,0.0,0.0,2.0517002230292394e-06,8.332384662453626e-06,0.0,6.484022e-05,False,COL24A1; collagen type XXIV alpha 1
hsa:4607,0.0,0.0,1.8149227064385966e-06,7.004759010182643e-06,0.0,6.277173e-05,False,MYBPC3; myosin binding protein
hsa:197342,5.5634896e-06,0.004633010802953646,6.093093364012279e-05,0.00015044970388295435,0.0,0.00083380466,False,EME2; essential meiotic structure-specific endonuclease subunit
hsa:6745,1.4314354e-08,1.1920316471752322e-05,3.7120321449152046e-07,1.0610050589314925e-06,0.0,1.05002455e-05,False,SSR1; signal sequence receptor subunit
hsa:283297,0.0,0.0,3.9121268128654977e-07,1.7112190998965642e-06,0.0,1.1892118e-05,False,OR10A4; olfactory receptor family 10 subfamily A member
hsa:84639,0.0,0.0,1.0980692982456142e-08,1.4359119312171775e-07,0.0,1.8776985e-06,False,IL1F10; interleukin 1 family member
hsa:5351,0.0,0.0,4.855977488271344e-05,0.0001420880284511357,0.0,0.0009354568,False,PLOD1; procollagen-lysine
hsa:53632,0.0,0.0,1.8001720333345028e-05,0.00010792247255344725,0.0,0.0010778327,False,PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma
hsa:2962,0.0,0.0,1.4181713086444444e-06,6.2453700467260075e-06,0.0,7.4914125e-05,False,GTF2F1; general transcription factor IIF subunit
hsa:274,0.0,0.0,2.2185107128128657e-06,6.14516888064631e-06,0.0,3.5480054e-05,False,BIN1; bridging integrator
hsa:4728,0.0,0.0,1.7552884321520472e-06,3.5853191119407772e-06,0.0,2.1964808e-05,False,NDUFS8; NADH:ubiquinone oxidoreductase core subunit
hsa:124995,1.11009015e-07,9.244305331679658e-05,2.7738327712748533e-07,3.9455941434649603e-07,0.0,1.9921483e-06,False,MRPL10; mitochondrial ribosomal protein
hsa:5449,0.0,0.0,3.374711935824559e-08,7.816145993360779e-08,0.0,6.4945e-07,False,POU1F1; POU class 1 homeobox
hsa:26595,0.0,0.0,9.104571097660818e-07,6.158736897969721e-06,0.0,5.4210548e-05,False,OR8B2; olfactory receptor family 8 subfamily B member
hsa:7479,4.401624e-06,0.0036654641257062902,1.1990580915321637e-05,2.0022587790689032e-05,0.0,0.00012471732,False,WNT8B; Wnt family member
hsa:51719,3.4361616e-07,0.000286147273709193,5.447737143304092e-06,7.842698164595715e-06,0.0,4.3863278e-05,False,CAB39; calcium binding protein
hsa:406989,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR206; microRNA
hsa:5590,2.440937e-05,0.020326967970478928,9.359346824795321e-05,0.00019052304560630072,0.0,0.0010996368,False,PRKCZ; protein kinase C
hsa:5196,1.4319223e-06,0.0011924371144488581,0.0001021260266563685,0.0003701557162499074,0.0,0.0029113938,False,PF4; platelet factor
hsa:1191,0.0,0.0,5.829006067385964e-06,1.8217439332821372e-05,0.0,0.00021049034,False,CLU;
hsa:3759,0.0,0.0,6.936569680409354e-06,2.0352355505367177e-05,0.0,0.00019128332,False,KCNJ2; potassium inwardly rectifying channel subfamily J member
hsa:6598,0.0,0.0,1.8360836906015782e-05,3.538733452611054e-05,0.0,0.00018743752,False,SMARCB1; SWI/SNF related
hsa:3937,0.0,0.0,2.7767890800935678e-05,7.657154769842648e-05,0.0,0.00063997234,False,LCP2; lymphocyte cytosolic protein
hsa:84466,0.0,0.0,1.198695021317812e-05,4.83097721147063e-05,0.0,0.00036426054,False,MEGF10; multiple EGF like domains
hsa:7156,0.0,0.0,0.00032197672461777786,0.000819745174253244,0.0,0.0054468336,False,TOP3A; DNA topoisomerase III
hsa:6023,0.0,0.0,1.3336178962696493e-06,2.834126420251448e-06,0.0,1.45647455e-05,False,RMRP; RNA component of mitochondrial RNA processing
hsa:64087,1.9734973e-07,0.00016434351401501413,1.9606108959064317e-06,3.7401451968788916e-06,0.0,2.1377586e-05,False,MCCC2; methylcrotonyl-CoA carboxylase subunit
hsa:111,0.0004055263,0.33770310791662506,0.0007953819508304092,0.0009315687800058213,0.0,0.0052189687,False,ADCY5; adenylate cyclase
hsa:164668,0.0,0.0,1.805504425846199e-06,1.0808236324406366e-05,0.0,0.00013266619,False,APOBEC3H; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:1347,0.0,0.0,2.673042788339181e-05,7.207536704135697e-05,0.0,0.0004377936,False,COX7A2; cytochrome c oxidase subunit
hsa:4902,0.0,0.0,2.2408660007953216e-08,1.1108448810495334e-07,0.0,1.1533938e-06,False,NRTN;
hsa:56848,0.0,0.0,3.213919907953215e-05,8.098030130347002e-05,0.0,0.00044401985,False,SPHK2; sphingosine kinase
hsa:9349,0.0,0.0,2.5132177397076035e-07,4.0022037406329194e-07,0.0,1.958136e-06,False,RPL23; ribosomal protein
hsa:166336,0.0,0.0,2.2095272561090654e-07,3.9594441476383124e-07,0.0,2.2180363e-06,False,PRICKLE2; prickle planar cell polarity protein
hsa:79087,0.0,0.0,8.169381411812866e-07,2.489029956133864e-06,0.0,2.732658e-05,False,ALG12; ALG12
hsa:6092,0.0,0.0,3.159268097853918e-05,0.00010674863673757417,0.0,0.0007124796,False,ROBO2; roundabout guidance receptor
hsa:64170,0.0,0.0,3.6915005719298263e-07,1.1385193762726198e-06,0.0,9.55376e-06,False,CARD9; caspase recruitment domain family member
hsa:7125,0.0,0.0,9.998499368771933e-08,2.2532840186710105e-07,0.0,2.0104512e-06,False,TNNC2; troponin C2
hsa:127124,0.0,0.0,2.2333276976608185e-06,1.2813390914667746e-05,0.0,0.000100183664,False,ATP6V1G3; ATPase H+ transporting V1 subunit
hsa:2633,0.0,0.0,4.4175498299415194e-07,1.0307681379711998e-06,0.0,5.6039944e-06,False,GBP1; guanylate binding protein
hsa:1521,4.714412e-07,0.0003925939166952753,1.442164042250877e-06,2.111318659668963e-06,0.0,1.0654393e-05,False,CTSW; cathepsin
hsa:51720,3.75085e-07,0.0003123530341507007,7.307775971314034e-05,0.00018066780352016528,0.0,0.001119726,False,UIMC1; ubiquitin interaction motif containing
hsa:5362,0.0,0.0,8.025327872602336e-06,2.629294509264975e-05,0.0,0.00013488487,False,PLXNA2; plexin
hsa:432,2.1585614e-05,0.01797547763015275,0.00010032498798072337,0.0001887300759960659,0.0,0.001074675,False,ASGR1; asialoglycoprotein receptor
hsa:83746,0.0,0.0,5.78115138554339e-06,4.095173263059609e-05,0.0,0.00035540975,False,L3MBTL2; L3MBTL histone methyl-lysine binding protein
hsa:55879,0.0,0.0,2.2773602127719294e-05,5.438388978793991e-05,0.0,0.00036801628,False,GABRQ; gamma-aminobutyric acid type A receptor subunit
hsa:138805,0.0,0.0,1.025764477894737e-06,9.860000322145577e-06,0.0,0.00012518051,False,OR13F1; olfactory receptor family 13 subfamily F member
hsa:3158,0.0,0.0,2.4831059970760234e-06,1.6687035947617558e-05,0.0,0.00015066414,False,HMGCS2; 3-hydroxy-3-methylglutaryl-CoA synthase
hsa:5697,0.0,0.0,2.4711508959181282e-06,1.0771974399469293e-05,0.0,9.723791e-05,False,PYY; peptide
hsa:4067,0.0,0.0,9.082430939766079e-07,3.0218704397952147e-06,0.0,2.1052687e-05,False,LYN; LYN proto-oncogene
hsa:229,1.3905548e-06,0.0011579882184913307,1.4068142152631578e-05,6.765856946124619e-05,0.0,0.0008666781,False,ALDOB; aldolase
hsa:9448,0.0,0.0,2.435243987894737e-07,4.918949344781942e-07,0.0,2.404395e-06,False,MAP4K4; mitogen-activated protein kinase kinase kinase kinase
hsa:84552,0.0,0.0,1.6268543361695906e-05,4.12660937427917e-05,0.0,0.00023326697,False,PARD6G; par-6 family cell polarity regulator
hsa:56246,0.0,0.0,4.905682988894735e-06,2.9130373796999247e-05,0.0,0.00032960475,False,MRAP; melanocortin 2 receptor accessory
hsa:9368,8.3393866e-07,0.0006944646433383623,1.4882722398380123e-05,4.120061042442785e-05,0.0,0.00046048107,False,NHERF1; NHERF family PDZ scaffold protein
hsa:84516,8.687148e-06,0.007234245666758712,0.00010552949085614032,0.00024377384998685894,0.0,0.0014261162,False,DCTN5; dynactin subunit
hsa:5264,2.5633693e-08,2.1346526214158333e-05,1.767009545960467e-05,5.4301840908778795e-05,0.0,0.00036478954,False,PHYH; phytanoyl-CoA
hsa:5787,2.0892122e-07,0.00017397970317518978,4.78009263102339e-06,1.0958586657837336e-05,0.0,4.9840637e-05,False,PTPRB; protein tyrosine phosphatase receptor type
hsa:2820,0.0,0.0,2.5592256390877204e-06,8.643546479006471e-06,0.0,6.933532e-05,False,GPD2; glycerol-3-phosphate dehydrogenase
hsa:1512,0.0,0.0,2.4264521864093566e-06,4.224565650134986e-06,0.0,2.2564454e-05,False,CTSH; cathepsin
hsa:25939,1.4498429e-06,0.0012073605418954397,1.91376425122807e-05,5.106123073434767e-05,0.0,0.00049843,False,SAMHD1; SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase
hsa:10645,2.595483e-05,0.021613953907422667,6.397028789372515e-05,0.00011962684960929261,0.0,0.0012133967,False,CAMKK2; calcium/calmodulin dependent protein kinase kinase
hsa:917,2.173094e-06,0.0018096498244256176,2.683776987432749e-05,5.775682861139829e-05,0.0,0.000378184,False,CD3G; CD3 gamma subunit of T-cell receptor
hsa:390168,0.0,0.0,7.067621052631579e-09,9.242113781898504e-08,0.0,1.2085632e-06,False,OR5M1; olfactory receptor family 5 subfamily M member
hsa:9966,0.0,0.0,8.200092152814621e-06,2.1259902048231897e-05,0.0,0.000116813026,False,TNFSF15; TNF superfamily member
hsa:768211,0.0,0.0,2.641347286549708e-07,7.729360759419321e-07,0.0,7.5870125e-06,False,RELL1; RELT like
hsa:11004,3.180258e-08,2.648368331663594e-05,8.364255598543274e-07,2.1143941572868324e-06,0.0,1.0740525e-05,False,KIF2C; kinesin family member
hsa:5443,0.0,0.0,1.6477825286725144e-05,6.373212629487012e-05,0.0,0.00053017196,False,POMC;
hsa:10558,0.0,0.0,3.729420742789475e-06,1.1689319693843885e-05,0.0,8.637693e-05,False,SPTLC1; serine palmitoyltransferase long chain base subunit
hsa:10603,1.7194522e-07,0.0001431878405553668,5.198513533263157e-06,9.945636770587214e-06,0.0,5.250764e-05,False,SH2B2; SH2B adaptor protein
hsa:347169,0.0,0.0,1.0455496632339181e-05,3.630961640896695e-05,0.0,0.0002242613,False,OR1B1; olfactory receptor family 1 subfamily B member
hsa:781,0.00014920528,0.12425109486997579,0.0003582558237403508,0.0007248466017534854,0.0,0.0040302007,False,CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:150763,0.0,0.0,4.041355164099415e-06,1.2867882569313282e-05,0.0,9.66415e-05,False,GPAT2; glycerol-3-phosphate acyltransferase 2
hsa:5803,4.9148136e-10,4.0928241338500034e-07,6.605471171015206e-07,1.3840855292912569e-06,0.0,9.837623e-06,False,PTPRZ1; protein tyrosine phosphatase receptor type
hsa:1230,0.0,0.0,2.6108581244678353e-05,8.535588153795685e-05,0.0,0.00066460064,False,CCR1; C-C motif chemokine receptor
hsa:2590,4.3137393e-06,0.003592277907381313,5.805835388959066e-05,0.00010586672429557632,0.0,0.00056945224,False,GALNT2; polypeptide N-acetylgalactosaminyltransferase
hsa:5260,2.0230272e-07,0.00016846812964778555,1.772598962459065e-06,3.5765795352056865e-06,0.0,1.8625291e-05,False,PHKG1; phosphorylase kinase catalytic subunit gamma
hsa:23165,2.329576e-08,1.9399606272835563e-05,2.692855489818715e-07,7.191515969154126e-07,0.0,3.8705807e-06,False,NUP205; nucleoporin
hsa:1558,0.0005815588,0.4842946417933016,0.0008066793364672514,0.0008235585407426418,0.0,0.0039597503,True,CYP2C8; cytochrome P450 family 2 subfamily C member
hsa:10110,7.3890794e-07,0.000615327557799016,8.993424123526311e-06,2.4783996634662324e-05,0.0,0.00023629155,False,SGK2; serum/glucocorticoid regulated kinase
hsa:1777,5.224907e-07,0.00043510552397596155,4.136484704181288e-06,9.008262839643704e-06,0.0,7.220985e-05,False,DNASE2; deoxyribonuclease 2
hsa:53343,0.0,0.0,1.1139010556345028e-06,4.014193357821792e-06,0.0,2.9482975e-05,False,NUDT9; nudix hydrolase
hsa:9926,0.0,0.0,8.429255658695909e-07,2.2676842798370864e-06,0.0,2.062475e-05,False,LPGAT1; lysophosphatidylglycerol acyltransferase
hsa:103,6.1999126e-06,0.005162993753626937,0.00011999124251922804,0.00021004629544608817,0.0,0.0010077098,False,ADAR; adenosine deaminase RNA
hsa:1237,2.9628695e-09,2.467337478485062e-06,6.80042243147076e-06,2.5178264625174958e-05,0.0,0.00027673037,False,CCR8; C-C motif chemokine receptor
hsa:1783,0.0,0.0,6.480881038362573e-07,1.415960066550739e-06,0.0,7.4981253e-06,False,DYNC1LI2; dynein cytoplasmic 1 light intermediate chain
hsa:122706,0.0,0.0,1.0146786735252632e-08,5.995696273552035e-08,0.0,5.835235e-07,False,PSMB11; proteasome subunit beta
hsa:5742,0.0,0.0,4.153456033333334e-05,0.00020353699456420753,0.0,0.0024252634,False,PTGS1; prostaglandin-endoperoxide synthase
hsa:947,0.0,0.0,1.1704456284385966e-05,2.6899046782911022e-05,0.0,0.00020403154,False,CD34; CD34
hsa:2966,0.0,0.0,1.6832110175678361e-06,3.926569573946794e-06,0.0,2.192507e-05,False,GTF2H2; general transcription factor IIH subunit
hsa:22928,7.4190946e-05,0.0617827081584462,0.00019017201887426902,0.0002968158666521603,0.0,0.0014199975,False,SEPHS2; selenophosphate synthetase
hsa:6319,0.0,0.0,0.0002715131811292398,0.0008330153184688964,0.0,0.0042844345,False,SCD; stearoyl-CoA
hsa:8995,0.0,0.0,3.337121109766081e-06,8.561701484493299e-06,0.0,6.5496046e-05,False,TNFSF18; TNF superfamily member
hsa:100169765,0.0,0.0,6.093388184327486e-08,4.2751137716196833e-07,0.0,4.3063687e-06,False,RNA5S14; RNA
hsa:55754,1.2122617e-08,1.0095141639353387e-05,2.0773661333450295e-05,7.121650221132612e-05,0.0,0.0005137966,False,TMEM30A; transmembrane protein
hsa:55501,9.278673e-06,0.007726839688183171,0.0007574148368157896,0.0018719966397516142,0.0,0.012062517,False,CHST12; carbohydrate sulfotransferase
hsa:8074,0.0,0.0,4.0987546639941514e-07,3.5448944634900755e-06,0.0,4.5620414e-05,False,FGF23; fibroblast growth factor
hsa:10799,0.0,0.0,2.2641551425276846e-06,5.267820251806076e-06,0.0,3.797564e-05,False,RPP40; ribonuclease P/MRP subunit
hsa:10382,0.0,0.0,1.2782704560409355e-06,3.422397365241695e-06,0.0,3.1783842e-05,False,TUBB4A; tubulin beta 4A class
hsa:1293,0.0,0.0,3.520892683157896e-05,7.735169888391046e-05,0.0,0.00057388115,False,COL6A3; collagen type VI alpha 3
hsa:3157,9.555549e-06,0.007957408915647637,0.00034471336436146197,0.0009815492894408716,0.0,0.0053721555,False,HMGCS1; 3-hydroxy-3-methylglutaryl-CoA synthase
hsa:3630,0.0016885978,1.406184321660952,0.002523903518602338,0.0025326343923902437,0.0,0.014028643,True,INS;
hsa:10280,0.0,0.0,2.7721263303467836e-08,6.879491645963805e-08,0.0,3.1111298e-07,False,SIGMAR1; sigma non-opioid intracellular receptor
hsa:84441,0.0,0.0,7.25498639146199e-06,2.3103642129159783e-05,0.0,0.00013298476,False,MAML2; mastermind like transcriptional coactivator
hsa:1262,4.4277334e-07,0.0003687206798193471,1.7042717222777778e-05,4.223907201943667e-05,0.0,0.00038104286,False,CNGA4; cyclic nucleotide gated channel subunit alpha
hsa:373156,0.0,0.0,0.0002557653894638597,0.00047134672130096593,0.0,0.0028031797,False,GSTK1; glutathione S-transferase kappa
hsa:2130,0.0,0.0,2.046195149804679e-06,4.450270249668933e-06,0.0,2.421753e-05,False,EWSR1; EWS RNA binding protein
hsa:283106,6.0498266e-08,5.038009236827967e-05,4.2828662466666664e-06,1.1830255194913057e-05,0.0,8.949419e-05,False,CSNK2A3; casein kinase 2 alpha
hsa:6354,0.0,0.0,6.843270503508772e-08,6.143334172625622e-07,0.0,7.589509e-06,False,CCL7; C-C motif chemokine ligand
hsa:50835,0.0,0.0,3.249807227602339e-05,8.495806803400483e-05,0.0,0.0005683626,False,TAS2R9; taste 2 receptor member
hsa:286046,2.9507248e-08,2.4572239471685606e-05,3.654312909453633e-05,9.536693781706423e-05,0.0,0.0005660863,False,XKR6; XK related
hsa:55967,0.0,0.0,2.3913180933099422e-06,5.6095960366145275e-06,0.0,3.1584335e-05,False,NDUFA12; NADH:ubiquinone oxidoreductase subunit
hsa:148156,8.057733e-09,6.710098646776672e-06,1.19678796205965e-07,2.514715616383618e-07,0.0,1.2567093e-06,False,ZNF558; zinc finger protein
hsa:6522,0.0,0.0,8.373731532982455e-05,0.00015328944763155558,0.0,0.00077909685,False,SLC4A2; solute carrier family 4 member
hsa:63916,0.0,0.0,9.622271923221057e-05,0.0003167976688250009,0.0,0.0021073464,False,ELMO2; engulfment and cell motility
hsa:5929,0.0,0.0,7.487824597187136e-06,2.2199468717179638e-05,0.0,0.0001273363,False,RBBP5; RB binding protein 5
hsa:805,0.000615776,0.5127891063550445,0.0014702485248245612,0.002077035336120825,0.0,0.010784142,True,CALM2; calmodulin
hsa:7942,7.1792516e-07,0.0005978540917902003,2.2666781547660833e-06,3.3580437490796555e-06,0.0,1.8412278e-05,False,TFEB; transcription factor
hsa:5721,0.0,0.0,8.492209443391811e-06,2.33819862135169e-05,0.0,0.0002467261,False,PSME2; proteasome activator subunit
hsa:271,2.4013296e-08,1.9997136290597824e-05,4.5214616586959065e-06,1.311830705597045e-05,0.0,9.5364645e-05,False,AMPD2; adenosine monophosphate deaminase
hsa:8464,0.0,0.0,4.496179750624563e-06,1.5849139882333473e-05,0.0,0.00013420133,False,SUPT3H; SPT3 homolog
hsa:113146,1.8282197e-08,1.5224548312758011e-05,4.32820242463158e-07,1.0087964707409161e-06,0.0,6.058813e-06,False,AHNAK2; AHNAK nucleoprotein
hsa:4121,0.0,0.0,1.0879914043938593e-05,4.223840735569734e-05,0.0,0.0002875893,False,MAN1A1; mannosidase alpha class 1A member
hsa:4158,0.0,0.0,8.944223680175437e-07,5.678540447099229e-06,0.0,5.7974354e-05,False,MC2R; melanocortin 2
hsa:1506,8.57978e-05,0.07144834678394228,0.00016834995321520464,0.00022779762731317237,4.999088e-07,0.0015322902,False,CTRL; chymotrypsin
hsa:10552,1.7826636e-06,0.0014845178674967304,7.62629151080117e-05,0.00019135871644777603,0.0,0.0011207269,False,ARPC1A; actin related protein 2/3 complex subunit
hsa:25828,0.0,0.0,1.1378724257017543e-06,2.4240754519493658e-06,0.0,1.32355935e-05,False,TXN2; thioredoxin
hsa:5983,0.0,0.0,3.788974261850877e-05,0.00021170902837749336,0.0,0.0017271349,False,RFC3; replication factor C subunit
hsa:7386,2.8396033e-07,0.00023646872216680017,0.00012069890764467837,0.00025921033448939604,0.0,0.002026052,False,UQCRFS1; ubiquinol-cytochrome c reductase
hsa:5587,1.5626759e-08,1.3013225235857924e-05,4.997591225672514e-07,8.947706817125545e-07,0.0,4.9681817e-06,False,PRKD1; protein kinase
hsa:285643,0.0,0.0,5.16886900619883e-10,1.0259804675538555e-09,0.0,6.219038e-09,False,KIF4B; kinesin family member
hsa:2731,0.0,0.0,2.502912237675439e-05,6.778658012847456e-05,0.0,0.00038382894,False,GLDC; glycine
hsa:7993,0.0,0.0,1.4923857358888882e-07,5.295523984611382e-07,0.0,4.8875086e-06,False,UBXN8; UBX domain protein
hsa:26122,0.0,0.0,1.120889005362573e-06,3.2152978589536714e-06,0.0,2.1119775e-05,False,EPC2; enhancer of polycomb homolog
hsa:644150,3.1457684e-08,2.619647025275325e-05,2.712969951143274e-06,1.1931023976397309e-05,0.0,0.0001358244,False,WIPF3; WAS/WASL interacting protein family member
hsa:1032,3.1199485e-07,0.0002598145434685278,1.843187585149123e-05,5.991251227829375e-05,0.0,0.00051902834,False,CDKN2D; cyclin dependent kinase inhibitor
hsa:785,8.042709e-05,0.06697587370705702,0.00018491734532748538,0.00030978280761931293,0.0,0.0016426812,False,CACNB4; calcium voltage-gated channel auxiliary subunit beta
hsa:94235,0.00014577156,0.12139165538179592,0.00046596788127467836,0.0008259037357149534,0.0,0.0050957096,False,GNG8; G protein subunit gamma
hsa:10938,0.0,0.0,1.2845117566959065e-07,2.7299230173955944e-07,0.0,1.4205377e-06,False,EHD1; EH domain containing
hsa:26716,0.0,0.0,8.150357435263158e-07,4.847454383401491e-06,0.0,3.6740403e-05,False,OR2H1; olfactory receptor family 2 subfamily H member
hsa:4952,3.5452817e-07,0.0002952342791404493,0.000124046666703731,0.00033149808043198974,0.0,0.0020431,False,OCRL; OCRL inositol
hsa:1286,0.0,0.0,7.39391281865497e-06,2.5159180343960923e-05,0.0,0.00028692654,False,COL4A4; collagen type IV alpha 4
hsa:3914,0.0,0.0,5.064048860643273e-06,1.3290159214238593e-05,0.0,9.692416e-05,False,LAMB3; laminin subunit beta
hsa:10010,8.372424e-07,0.0006972158416348684,9.264352313573094e-05,0.00019156661674162113,0.0,0.0012718262,False,TANK; TRAF family member associated NFKB
hsa:1346,0.0,0.0,8.982448350233921e-06,4.324948947199722e-05,0.0,0.00048804216,False,COX7A1; cytochrome c oxidase subunit
hsa:6348,0.0,0.0,0.00020376887007660815,0.0006549662111753384,0.0,0.0034876743,False,CCL3; C-C motif chemokine ligand
hsa:7248,2.7329681e-06,0.002275886474457991,3.3430556700292395e-05,5.285195767093199e-05,0.0,0.00021821738,False,TSC1; TSC complex subunit
hsa:23370,7.601637e-08,6.330283486309051e-05,2.523754417748538e-06,8.415462615894172e-06,0.0,6.3361265e-05,False,ARHGEF18; Rho/Rac guanine nucleotide exchange factor
hsa:2628,0.0,0.0,9.216649909649124e-06,2.115378466372683e-05,0.0,0.00010491641,False,GATM; glycine
hsa:84950,3.2625371e-09,2.716886471637704e-06,5.73048466704971e-07,1.8335528793468271e-06,0.0,1.1680596e-05,False,PRPF38A; pre-mRNA processing factor
hsa:1609,0.0,0.0,3.0186877071111124e-05,5.508351535959101e-05,0.0,0.0002754213,False,DGKQ; diacylglycerol kinase
hsa:131870,0.0,0.0,1.9670959590175438e-06,4.583141609365909e-06,0.0,3.001324e-05,False,NUDT16; nudix hydrolase
hsa:127062,0.0,0.0,1.628323336842105e-07,8.101595001813418e-07,0.0,5.920467e-06,False,OR2M3; olfactory receptor family 2 subfamily M member
hsa:11001,1.2174418e-05,0.010138279060263423,9.78691801246843e-05,0.00022086721758829392,0.0,0.0014961321,False,SLC27A2; solute carrier family 27 member
hsa:6396,1.5404959e-07,0.00012828520694288347,2.683605882052632e-06,6.923175125237849e-06,0.0,3.954396e-05,False,SEC13; SEC13 homolog
hsa:6528,2.262695e-08,1.8842652961531914e-05,7.65362215950304e-06,2.3871125826100785e-05,0.0,0.000217082,False,SLC5A5; solute carrier family 5 member
hsa:441308,0.0,0.0,1.8851666539181284e-05,8.841200799004456e-05,0.0,0.0008734745,False,OR4F21; olfactory receptor family 4 subfamily F member
hsa:3885,0.0,0.0,9.455380908362573e-08,7.764018857296159e-07,0.0,9.819588e-06,False,KRT34; keratin
hsa:7003,7.6844386e-05,0.06399236739551736,0.0008926895954549707,0.0018557062291126747,0.0,0.010064696,False,TEAD1; TEA domain transcription factor
hsa:54988,0.0,0.0,1.7970458373216373e-05,5.341368937851565e-05,0.0,0.00027211488,False,ACSM5; acyl-CoA synthetase medium chain family member
hsa:7490,0.0,0.0,5.778186192559649e-07,2.791412363641471e-06,0.0,2.2004133e-05,False,WT1; WT1 transcription
hsa:1729,4.6790383e-06,0.003896481623931473,2.9659888473350872e-05,6.0915634368726605e-05,0.0,0.00049848517,False,DIAPH1; diaphanous related formin
hsa:896,0.0,0.0,1.4731459133333336e-05,3.1885799956941384e-05,0.0,0.00017122868,False,CCND3; cyclin
hsa:55288,2.2314019e-07,0.00018582058836654053,2.9309588350906425e-06,5.59363313396455e-06,0.0,3.1231433e-05,False,RHOT1; ras homolog family member
hsa:120787,0.0,0.0,9.609255569298247e-06,3.1045776094885086e-05,0.0,0.00026783615,False,OR52W1; olfactory receptor family 52 subfamily W member
hsa:3092,1.8110796e-08,1.5081813672859149e-05,5.529888818596493e-08,8.487992311864696e-08,0.0,4.5612467e-07,False,HIP1; huntingtin interacting protein
hsa:5218,0.0,0.0,4.050177358690467e-06,1.7771651251471082e-05,0.0,0.0001999884,False,CDK14; cyclin dependent kinase
hsa:7189,0.0,0.0,9.857717567251464e-05,0.00018991263874310212,0.0,0.0008883616,False,TRAF6; TNF receptor associated factor
hsa:8620,0.0,0.0,3.586128066356723e-05,0.00012990733700756496,0.0,0.0013541903,False,NPFF; neuropeptide FF-amide peptide
hsa:100507436,0.0,0.0,2.8110996916959066e-07,7.170418788977951e-07,0.0,3.8103617e-06,False,MICA; MHC class I polypeptide-related sequence
hsa:55696,1.2261158e-08,1.0210512026610336e-05,1.6152135102473687e-07,3.4564056779774056e-07,0.0,1.980393e-06,False,RBM22; RNA binding motif protein
hsa:8685,2.3757162e-08,1.9783840018954983e-05,2.9350824938654977e-07,9.422876098000958e-07,0.0,1.0113276e-05,False,MARCO; macrophage receptor with collagenous
hsa:26528,0.0,0.0,6.801852497017543e-08,1.2852589631391344e-07,0.0,6.8657806e-07,False,DAZAP1; DAZ associated protein
hsa:55277,0.0,0.0,6.873717767279532e-06,1.32075970008695e-05,0.0,9.033327e-05,False,FGGY; FGGY carbohydrate kinase domain
hsa:2342,5.682546e-08,4.73215533759262e-05,1.4656468156471114e-05,3.353527896741211e-05,0.0,0.00018429721,False,FNTB; farnesyltransferase
hsa:7587,0.0,0.0,3.693255357426901e-08,8.680827302317812e-08,0.0,3.5265748e-07,False,ZNF37A; zinc finger protein
hsa:1911,3.901744e-08,3.24918772246102e-05,0.0001245425749595062,0.000445333930558359,0.0,0.002676571,False,PHC1; polyhomeotic homolog
hsa:23114,8.851188e-08,7.370850414274824e-05,6.143671063391812e-06,1.4380464550360808e-05,0.0,6.0503982e-05,False,NFASC;
hsa:93643,6.109448e-08,5.087659116696029e-05,1.3666303180093577e-05,4.1777999641746296e-05,0.0,0.00026808245,False,TJAP1; tight junction associated protein
hsa:440077,0.0,0.0,9.206912654035087e-10,3.6558803406252165e-09,0.0,4.0273385e-08,False,ZNF705A; zinc finger protein
hsa:9447,1.372478e-07,0.00011429347150781433,1.022869783033918e-05,5.186167667612838e-05,0.0,0.0005633747,False,AIM2; absent in melanoma
hsa:4487,0.0,0.0,2.2169120464736842e-08,5.2255430855813666e-08,0.0,3.1039193e-07,False,MSX1; msh homeobox
hsa:5526,0.0,0.0,7.66943371345029e-06,1.5755976628811738e-05,0.0,8.799e-05,False,PPP2R5B; protein phosphatase 2 regulatory subunit
hsa:1350,0.0,0.0,7.615992223959062e-05,0.0002567337155451046,0.0,0.0014583298,False,COX7C; cytochrome c oxidase subunit
hsa:406997,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR215; microRNA
hsa:51340,0.0,0.0,1.4587849481299998e-07,3.328256644615339e-07,0.0,1.6727618e-06,False,CRNKL1; crooked neck pre-mRNA splicing factor
hsa:6566,2.475661e-06,0.0020616133006613377,6.951685562615439e-05,0.00012573102222548116,0.0,0.0006721434,False,SLC16A1; solute carrier family 16 member
hsa:5925,0.0,0.0,0.00011420696687426904,0.0002512142959909037,0.0,0.0022138515,False,RB1; RB transcriptional corepressor
hsa:2657,0.0,0.0,9.334525718594152e-06,2.599205750189094e-05,0.0,0.0002239419,False,GDF1; growth differentiation factor
hsa:339761,0.0,0.0,2.1469518876012873e-05,7.31365201281354e-05,0.0,0.0005089621,False,CYP27C1; cytochrome P450 family 27 subfamily C member
hsa:151531,3.8894532e-07,0.00032389525259798505,2.3746607057450887e-05,6.636882980453967e-05,0.0,0.0005112693,False,UPP2; uridine phosphorylase
hsa:9651,4.153457e-08,3.458802394562478e-05,1.3373485246254635e-05,4.256755698407312e-05,0.0,0.00026617944,False,PLCH2; phospholipase C eta
hsa:1440,0.0,0.0,8.484331257309942e-07,7.311568017684817e-06,0.0,9.276279e-05,False,CSF3; colony stimulating factor
hsa:22938,9.388263e-05,0.07818101052974019,0.00032310723866660823,0.0005341761754490959,0.0,0.0028519672,False,SNW1; SNW domain containing
hsa:1644,0.0008473281,0.705614735209748,0.0012828739587988297,0.00145560732285702,0.0,0.0062387153,True,DDC; dopa
hsa:3425,2.287978e-05,0.019053197818362556,6.216795213625732e-05,0.00010439026467998422,0.0,0.0005802618,False,IDUA;
hsa:2625,0.00022440497,0.18687383728487403,0.0005770407713197074,0.0009938466767142652,0.0,0.006630627,False,GATA3; GATA binding protein
hsa:978,2.2136851e-07,0.00018434521712123848,1.3351049023117547e-05,2.6010019258076335e-05,0.0,0.00012959335,False,CDA; cytidine
hsa:5190,2.957898e-08,2.463197448600422e-05,2.3326688053540524e-05,6.982093309120247e-05,0.0,0.00038901126,False,PEX6; peroxisomal biogenesis factor
hsa:842,0.0,0.0,0.00014181298293157896,0.00033257832958951956,0.0,0.0020547376,False,CASP9; caspase
hsa:26999,2.7192456e-07,0.0002264459025983291,2.5384781141906427e-05,7.187282214849497e-05,0.0,0.0003573847,False,CYFIP2; cytoplasmic FMR1 interacting protein
hsa:4849,3.8047492e-07,0.0003168415044063216,3.8897904713385964e-05,0.00015034829428725704,0.0,0.0012864445,False,CNOT3; CCR4-NOT transcription complex subunit
hsa:2920,0.0,0.0,5.30788856837427e-05,0.00019139964635116335,0.0,0.0012581181,False,CXCL2; C-X-C motif chemokine ligand
hsa:374,0.0,0.0,5.3499291108187136e-08,1.8988155599806727e-07,0.0,1.7302496e-06,False,AREG;
hsa:55558,0.0,0.0,8.198796728596497e-07,2.688816081510822e-06,0.0,1.8598656e-05,False,PLXNA3; plexin
hsa:10588,1.9207175e-06,0.0015994826209295187,2.7261869072005847e-05,7.498156646504662e-05,0.0,0.0006775359,False,MTHFS; methenyltetrahydrofolate
hsa:112609,0.0,0.0,9.374184235438591e-07,3.538033368920778e-06,0.0,4.1714346e-05,False,MRAP2; melanocortin 2 receptor accessory protein
hsa:259307,0.0,0.0,2.7067405959064335e-05,0.00010921542226019833,0.0,0.000976967,False,IL4I1; interleukin 4 induced
hsa:10344,0.0,0.0,7.626795500058482e-06,2.9634616394580425e-05,0.0,0.00025299744,False,CCL26; C-C motif chemokine ligand
hsa:57216,5.8862774e-08,4.901813204320882e-05,1.6265867709625727e-05,5.245334658376491e-05,0.0,0.00037504328,False,VANGL2; VANGL planar cell polarity protein
hsa:1646,0.0,0.0,0.00017280156604970758,0.00032975044875455215,0.0,0.0014684601,False,AKR1C2; aldo-keto reductase family 1 member
hsa:348158,7.194022e-08,5.99084100789659e-05,1.530638379346959e-05,9.908475193740609e-05,0.0,0.0012462157,False,ACSM2B; acyl-CoA synthetase medium chain family member
hsa:10084,0.0,0.0,5.660936727017546e-08,1.0971676296116072e-07,0.0,4.7345517e-07,False,PQBP1; polyglutamine binding protein
hsa:9181,0.0,0.0,3.0450916222631572e-05,9.944292918750381e-05,0.0,0.0006560559,False,ARHGEF2; Rho/Rac guanine nucleotide exchange factor
hsa:1233,1.1707748e-06,0.000974965837309356,1.7175712195273687e-05,4.176902822701264e-05,0.0,0.0002872895,False,CCR4; C-C motif chemokine receptor
hsa:4923,0.0,0.0,8.06992972362573e-07,7.989468740744581e-06,0.0,0.00010232515,False,NTSR1; neurotensin receptor
hsa:55113,0.0,0.0,1.6486926642077196e-05,6.341762455189533e-05,0.0,0.00057614845,False,XKR8; XK related
hsa:10039,2.7180826e-07,0.0002263490534631418,5.1771803978070175e-06,1.6840198494499308e-05,0.0,0.00018134229,False,PARP3; poly(ADP-ribose) polymerase family member
hsa:3587,0.0,0.0,7.772004432339183e-05,0.0001507199901935908,0.0,0.00091460074,False,IL10RA; interleukin 10 receptor subunit
hsa:23383,5.354979e-08,4.4593730446786334e-05,1.4472592846023393e-06,2.216695921642679e-06,0.0,1.001382e-05,False,MAU2; MAU2 sister chromatid cohesion
hsa:51762,0.0,0.0,1.532533984444444e-06,3.3553480690522853e-06,0.0,2.685025e-05,False,RAB8B; RAB8B
hsa:115209,0.0,0.0,8.101225914502924e-08,2.2450573823889705e-07,0.0,1.0035943e-06,False,OMA1; OMA1 zinc
hsa:10622,0.0,0.0,1.6479512647163743e-05,5.4564376585535455e-05,0.0,0.00028311257,False,POLR3G; RNA polymerase III subunit
hsa:2778,0.0025887308,2.155772478183267,0.004695239174947367,0.005071360102898871,0.0,0.02511599,True,GNAS; GNAS complex
hsa:6601,1.788319e-07,0.0001489227416930421,3.8080128583099417e-06,7.392283467487832e-06,0.0,3.5729645e-05,False,SMARCC2; SWI/SNF related
hsa:29945,1.5786491e-06,0.0013146242484884038,4.9176573775438625e-05,0.00011354808683266028,0.0,0.0006598487,False,ANAPC4; anaphase promoting complex subunit
hsa:27339,0.0,0.0,2.811507401783626e-07,6.877076482830096e-07,0.0,6.1252667e-06,False,PRPF19; pre-mRNA processing factor
hsa:2047,8.586278e-08,7.150245905225244e-05,5.3779184520830425e-06,1.825106596831478e-05,0.0,0.0001322835,False,EPHB1; EPH receptor
hsa:1559,0.0,0.0,2.5160529358304098e-05,9.978834097186098e-05,0.0,0.0010532495,False,CYP2C9; cytochrome P450 family 2 subfamily C member
hsa:406950,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR16-1; microRNA
hsa:5407,0.0,0.0,3.521007516374268e-06,1.2074049534280359e-05,0.0,8.6836706e-05,False,PNLIPRP1; pancreatic lipase related protein
hsa:134526,0.0,0.0,3.8923075215964927e-07,2.070061588288513e-06,0.0,2.0750556e-05,False,ACOT12; acyl-CoA thioesterase
hsa:1030,0.0,0.0,3.002041249122807e-07,1.1072202278188509e-06,0.0,7.719378e-06,False,CDKN2B; cyclin dependent kinase inhibitor
hsa:6643,2.3776161e-08,1.9799661486877797e-05,3.332444820081873e-07,7.894459838163907e-07,0.0,3.6288222e-06,False,SNX2; sorting nexin
hsa:8808,0.0,0.0,2.226863289409357e-08,2.7229754324582093e-07,0.0,3.5606172e-06,False,IL1RL2; interleukin 1 receptor like
hsa:2992,0.0,0.0,1.3651640790678364e-05,4.2025265012674584e-05,0.0,0.0003688307,False,GYG1; glycogenin
hsa:23216,0.0,0.0,5.53155653050193e-06,1.1722072125878318e-05,0.0,7.707143e-05,False,TBC1D1; TBC1 domain family member
hsa:54554,0.0,0.0,6.961057052398832e-05,0.00023198752467783768,0.0,0.0014415714,False,WDR5B; WD repeat domain
hsa:23644,3.3552887e-08,2.7941256139183396e-05,7.176394840467834e-07,1.3053435102261418e-06,0.0,6.8685727e-06,False,EDC4; enhancer of mRNA decapping
hsa:9826,1.0788908e-05,0.008984491912427232,0.00011082242778040935,0.00019626324660959837,0.0,0.0011761433,False,ARHGEF11; Rho guanine nucleotide exchange factor
hsa:3837,6.9043705e-07,0.0005749632948733195,1.1825056010994146e-06,1.2988652629510432e-06,0.0,5.8537603e-06,False,KPNB1; karyopherin subunit beta
hsa:374928,0.0,0.0,2.4969308587678363e-08,5.631005025282638e-08,0.0,2.4763239e-07,False,ZNF773; zinc finger protein
hsa:40,0.0,0.0,0.00014367842327192985,0.00026801282762894794,0.0,0.0015362257,False,ASIC2; acid sensing ion channel subunit
hsa:119016,0.0,0.0,1.4976573224853805e-07,4.1023928973661316e-07,0.0,2.604795e-06,False,AGAP4; ArfGAP with GTPase domain
hsa:64431,2.8311726e-08,2.3576665337572237e-05,6.884999585730993e-07,1.4326221390971998e-06,0.0,9.6892345e-06,False,ACTR6; actin related protein
hsa:25937,0.0,0.0,2.718804300116959e-05,8.875317377037393e-05,0.0,0.0005920535,False,WWTR1; WW domain containing transcription regulator
hsa:10525,1.6366e-07,0.00013628830150260254,4.5137481370187123e-07,7.850349580113534e-07,0.0,3.8021217e-06,False,HYOU1; hypoxia up-regulated
hsa:11177,0.0,0.0,9.17928270859649e-08,6.051619815915206e-07,0.0,7.696968e-06,False,BAZ1A; bromodomain adjacent to zinc finger domain
hsa:1269,4.4073753e-10,3.670253536120759e-07,2.2926001339849018e-06,7.052979720726761e-06,0.0,5.4163058e-05,False,CNR2; cannabinoid receptor
hsa:1503,0.0,0.0,2.459033757613571e-05,7.929775764768137e-05,0.0,0.0004492967,False,CTPS1; CTP synthase
hsa:23085,0.0,0.0,3.488783373491229e-06,8.422473691946065e-06,0.0,4.565352e-05,False,ERC1; ELKS/RAB6-interacting/CAST family member
hsa:8563,0.0,0.0,4.961241790537104e-07,1.268979238435968e-06,0.0,7.874143e-06,False,THOC5; THO complex subunit
hsa:79365,0.0,0.0,1.0350876190467839e-05,3.0661609591963676e-05,0.0,0.00030797103,False,BHLHE41; basic helix-loop-helix family member
hsa:9553,0.0,0.0,1.2293330032707604e-07,2.6855514234059933e-07,0.0,1.3591215e-06,False,MRPL33; mitochondrial ribosomal protein
hsa:9093,0.0,0.0,6.756978394152046e-08,1.1430870305326904e-07,0.0,5.841243e-07,False,DNAJA3; DnaJ heat shock protein family (Hsp40) member
hsa:140609,0.0,0.0,1.561789354152047e-07,2.770677563899932e-07,0.0,1.5043753e-06,False,NEK7; NIMA related kinase
hsa:23431,0.0,0.0,1.5499171810374274e-06,2.8225145497000145e-06,0.0,1.10752935e-05,False,AP4E1; adaptor related protein complex 4 subunit epsilon
hsa:4986,0.0,0.0,4.242042854970761e-07,3.867616106487998e-06,-0.0,4.20107e-05,False,OPRK1; opioid receptor kappa
hsa:6197,0.0,0.0,1.4503661530818705e-05,3.956727967544314e-05,0.0,0.00030372897,False,RPS6KA3; ribosomal protein S6 kinase
hsa:147183,0.0,0.0,6.587941549064328e-08,2.6238360880605197e-07,0.0,1.7554154e-06,False,KRT25; keratin
hsa:6117,0.0,0.0,8.045470481245615e-05,0.0001566401632564946,0.0,0.0011547469,False,RPA1; replication protein
hsa:8893,5.522857e-09,4.5991738969311926e-06,1.4061687148538014e-07,3.0981685405434577e-07,0.0,1.570152e-06,False,EIF2B5; eukaryotic translation initiation factor 2B subunit
hsa:310,1.7034263e-09,1.4185327945854986e-06,1.8737730722807028e-08,3.8565637769491114e-08,0.0,2.7924563e-07,False,ANXA7; annexin
hsa:7372,3.3378066e-05,0.02779567348516294,0.00011320228376858367,0.00017371481375088628,0.0,0.00090207864,False,UMPS; uridine monophosphate
hsa:1188,0.0,0.0,4.273537045707603e-06,1.9849597195047567e-05,0.0,0.0001631788,False,CLCNKB; chloride voltage-gated channel
hsa:655,8.303174e-06,0.0069144902941498864,6.423347616288888e-05,0.00013295779543348138,0.0,0.00077790796,False,BMP7; bone morphogenetic protein
hsa:5901,1.5341907e-06,0.0012776013973120426,7.30988301984795e-05,0.00017676853722326503,0.0,0.0011542401,False,RAN; RAN
hsa:5408,0.0,0.0,2.717149779766082e-07,1.8171318500087372e-06,0.0,2.2427674e-05,False,PNLIPRP2; pancreatic lipase related protein 2
hsa:1294,5.429741e-06,0.004521631299578656,5.749111672356724e-05,0.00012804796098915926,0.0,0.00082280335,False,COL7A1; collagen type VII alpha 1
hsa:346525,0.0,0.0,5.71538830994152e-08,6.835008329150631e-07,0.0,8.914809e-06,False,OR2A12; olfactory receptor family 2 subfamily A member
hsa:554213,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR449A; microRNA
hsa:401152,0.0,0.0,1.7286684411695908e-07,3.2585426648372277e-07,0.0,2.0709551e-06,False,C4orf3; chromosome 4 open reading frame
hsa:4306,0.0,0.0,2.4666291371286552e-05,0.00010167688344411273,0.0,0.00089363893,False,NR3C2; nuclear receptor subfamily 3 group C member
hsa:529,2.642034e-05,0.02200160860149866,9.413019619122808e-05,0.0001889543729213682,0.0,0.0011032393,False,ATP6V1E1; ATPase H+ transporting V1 subunit
hsa:407033,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30D; microRNA
hsa:768239,0.0,0.0,4.83176699325731e-08,2.3771759292460802e-07,0.0,1.9935474e-06,False,PSAPL1; prosaposin like
hsa:407009,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR224; microRNA
hsa:58513,0.0,0.0,1.4887764481637432e-07,2.6135425431234273e-07,0.0,1.3811494e-06,False,EPS15L1; epidermal growth factor receptor pathway substrate 15 like
hsa:130576,0.0,0.0,6.846380518297075e-06,2.8543117844143793e-05,0.0,0.0002924818,False,LYPD6B; LY6/PLAUR domain containing
hsa:6224,0.0,0.0,6.262122219883044e-07,1.4462820307218346e-06,0.0,6.7104847e-06,False,RPS20; ribosomal protein
hsa:1605,0.0,0.0,0.0002351045145757893,0.000614129638750351,0.0,0.0037374056,False,DAG1; dystroglycan
hsa:4633,0.0,0.0,1.4913709064619883e-05,0.00010848123138354453,0.0,0.001377047,False,MYL2; myosin light chain
hsa:2736,0.0,0.0,1.0311280095906434e-07,4.5490155854664914e-07,0.0,4.225766e-06,False,GLI2; GLI family zinc finger
hsa:1298,0.00013936673,0.11605801611677749,0.00030293666231877205,0.00040467159737667173,0.0,0.0024990407,False,COL9A2; collagen type IX alpha 2
hsa:84818,0.0,0.0,2.7466873092397666e-06,9.242115150985798e-06,0.0,4.8834485e-05,False,IL17RC; interleukin 17 receptor
hsa:5719,0.0,0.0,7.429511752456142e-06,1.798448880969344e-05,0.0,0.00016106412,False,PSMD13; proteasome 26S subunit
hsa:4342,0.0,0.0,3.0746473684210526e-10,4.020623149791174e-09,0.0,5.257647e-08,False,MOS; MOS proto-oncogene
hsa:246778,0.0,0.0,1.4266913244561402e-07,1.6921959668089993e-06,0.0,2.212298e-05,False,IL27; interleukin
hsa:10352,0.0,0.0,1.5515331703450288e-06,3.86015571065397e-06,0.0,1.9750005e-05,False,WARS2; tryptophanyl tRNA synthetase 2
hsa:4283,0.00015343384,0.12777243948809774,0.00027720599366140347,0.00038309646368741147,0.0,0.0027593528,False,CXCL9; C-X-C motif chemokine ligand
hsa:53944,1.7360818e-06,0.001445726749306984,0.00010220318338871343,0.00021458316476541113,0.0,0.0010100886,False,CSNK1G1; casein kinase 1 gamma
hsa:9675,0.0,0.0,4.136554069590643e-07,1.266705784116681e-06,0.0,7.3209244e-06,False,TTI1; TELO2 interacting protein
hsa:2957,0.0,0.0,4.594159207894737e-07,1.1712344468534504e-06,0.0,8.182859e-06,False,GTF2A1; general transcription factor IIA subunit
hsa:9075,0.0,0.0,1.247869240897661e-06,1.3794483014217167e-05,0.0,0.00018017387,False,CLDN2; claudin
hsa:80854,0.0,0.0,9.945296481871345e-06,2.8309731333622306e-05,0.0,0.00026071726,False,SETD7; SET domain containing 7
hsa:26153,1.965804e-08,1.6370285240561047e-05,1.4272853178726314e-06,4.149330186343542e-06,0.0,2.030675e-05,False,KIF26A; kinesin family member
hsa:57733,-0.0,0.0,1.6573400151421054e-05,4.9984073561528926e-05,0.0,0.00038350464,False,GBA3; glucosylceramidase beta 3
hsa:330,0.0,0.0,8.671020904818716e-05,0.0003270743342387164,0.0,0.0022346312,False,BIRC3; baculoviral IAP repeat containing
hsa:2013,2.1133643e-07,0.0001759909757443704,5.194431995146199e-07,7.051476848900805e-07,0.0,3.381437e-06,False,EMP2; epithelial membrane protein
hsa:1488,3.0610386e-06,0.0025490880583398778,8.798940639754389e-05,0.00015271355973949492,0.0,0.00069269387,False,CTBP2; C-terminal binding protein
hsa:353376,0.0,0.0,1.4639122610526314e-05,3.7966656979497214e-05,0.0,0.00030558,False,TICAM2; TIR domain containing adaptor molecule
hsa:5350,0.0,0.0,4.983068347707603e-06,2.062206902827462e-05,0.0,0.00018407515,False,PLN;
hsa:956,1.2036245e-08,1.0023215125987977e-05,3.4910332165264936e-06,1.3505531068542868e-05,0.0,9.2886396e-05,False,ENTPD3; ectonucleoside triphosphate diphosphohydrolase
hsa:54431,0.0,0.0,4.266694870736841e-07,1.310219903256208e-06,0.0,9.919568e-06,False,DNAJC10; DnaJ heat shock protein family (Hsp40) member
hsa:80314,2.3739585e-08,1.976920272532483e-05,1.4393063118245616e-06,4.259223315483499e-06,0.0,2.7268825e-05,False,EPC1; enhancer of polycomb homolog
hsa:6773,7.6530545e-05,0.06373101546571242,0.0003574566563859649,0.0005909515182861163,0.0,0.0026520058,False,STAT2; signal transducer and activator of transcription
hsa:132158,2.4430763e-06,0.002034478304828686,0.00011571093667526317,0.0002350435526428739,0.0,0.0014322916,False,GLYCTK; glycerate
hsa:1655,0.0,0.0,4.958070156877194e-06,1.8497476232130546e-05,0.0,0.00018687178,False,DDX5; DEAD-box helicase
hsa:1119,3.6414454e-07,0.00030324233690606447,3.152364979883042e-05,8.203179683062561e-05,0.0,0.00040371346,False,CHKA; choline kinase
hsa:406883,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A3; microRNA
hsa:6751,0.0,0.0,1.6525168711403508e-06,1.0176099880891652e-05,0.0,0.00012312949,False,SSTR1; somatostatin receptor
hsa:3976,0.0,0.0,4.0309366362865505e-06,1.345890555289112e-05,0.0,9.737192e-05,False,LIF; LIF interleukin 6 family
hsa:351,1.1455276e-06,0.0009539411641717751,9.220314201461986e-05,0.0002566781022442809,0.0,0.0017061753,False,APP; amyloid beta precursor
hsa:222236,1.3303806e-07,0.00011078779929488777,4.492303610721753e-06,9.863514427626369e-06,0.0,4.769377e-05,False,NAPEPLD; N-acyl phosphatidylethanolamine phospholipase
hsa:7059,1.0917507e-05,0.009091583072667567,0.00011337926569766083,0.00017178062694683135,0.0,0.00087802496,False,THBS3; thrombospondin
hsa:124454,1.8320367e-06,0.0015256334482062388,0.00023900960743076025,0.0004752134876832007,0.0,0.002818824,False,EARS2; glutamyl-tRNA synthetase 2
hsa:196527,4.5423503e-06,0.0037826543273667182,0.00018974516810615203,0.0004176216348979634,0.0,0.002370167,False,ANO6; anoctamin
hsa:1062,0.0,0.0,3.002126607929824e-08,7.508747411459271e-08,0.0,5.038542e-07,False,CENPE; centromere protein
hsa:1798,5.5812103e-07,0.00046477677631420674,6.8289333766538e-05,0.00017326752374374445,0.0,0.0012523134,False,DPAGT1; dolichyl-phosphate N-acetylglucosaminephosphotransferase
hsa:640,3.6418388e-07,0.0003032750973959894,4.47223454880117e-06,9.340892410490612e-06,0.0,6.4725624e-05,False,BLK; BLK proto-oncogene
hsa:22801,0.0,0.0,6.488799095450293e-05,0.0001270743142574266,0.0,0.0006753223,False,ITGA11; integrin subunit alpha
hsa:5420,2.504817e-08,2.0858930374241992e-05,4.1985702244619864e-07,1.0385515510084979e-06,0.0,5.945288e-06,False,PODXL; podocalyxin
hsa:1050,0.0,0.0,8.684193361146198e-07,3.161736106413119e-06,0.0,3.2985146e-05,False,CEBPA; CCAAT enhancer binding protein
hsa:285220,1.3528022e-08,1.1265496401502141e-05,4.8353854128196496e-06,1.9284014681412905e-05,0.0,0.0001328016,False,EPHA6; EPH receptor
hsa:125981,0.0,0.0,5.197211344678362e-08,1.9567115375348465e-07,0.0,2.0863629e-06,False,ACER1; alkaline ceramidase
hsa:4616,0.0,0.0,7.952081935672515e-06,5.80427892643818e-05,0.0,0.0005910303,False,GADD45B; growth arrest and DNA damage inducible
hsa:8844,2.7669175e-06,0.0023041579278554767,2.105372021780117e-05,5.3919045654255485e-05,0.0,0.00028609938,False,KSR1; kinase suppressor of ras
hsa:152,0.0,0.0,3.345639614620643e-05,0.00011081390528780236,0.0,0.00064742606,False,ADRA2C; adrenoceptor alpha
hsa:390431,0.0,0.0,7.446690409356725e-09,8.332350989874921e-08,0.0,1.0720116e-06,False,OR4K2; olfactory receptor family 4 subfamily K member
hsa:5026,2.823568e-06,0.0023513337828247618,2.5411857170558472e-05,4.878482912666694e-05,0.0,0.0003904954,False,P2RX5; purinergic receptor P2X
hsa:23590,1.1101973e-06,0.0009245197626162489,0.00025110136245705926,0.000845540286972487,0.0,0.0056522326,False,PDSS1; decaprenyl diphosphate synthase subunit
hsa:9927,0.0,0.0,1.942601338479532e-06,5.443934528883773e-06,0.0,2.8403287e-05,False,MFN2; mitofusin
hsa:1473,-0.0,0.0,2.9421310994152044e-08,3.6163799684148995e-07,0.0,4.724926e-06,False,CST5; cystatin
hsa:51360,3.873774e-09,3.2258956303613764e-06,4.775593459304093e-07,1.1002150391308955e-06,0.0,8.544626e-06,False,MBTPS2; membrane bound transcription factor peptidase
hsa:64386,0.0,0.0,3.0026679628918127e-06,1.0628680592033278e-05,0.0,0.000110402514,False,MMP25; matrix metallopeptidase
hsa:57448,2.8420967e-05,0.023667636071682256,0.00033959147390029236,0.0005209379666403995,0.0,0.0029833794,False,BIRC6; baculoviral IAP repeat containing
hsa:10436,7.611011e-09,6.338089709810733e-06,1.782475011791929e-06,3.7593911242354476e-06,0.0,1.6507522e-05,False,EMG1; EMG1 N1-specific pseudouridine
hsa:4602,0.0,0.0,1.6876498713526322e-07,4.656253742505884e-07,0.0,3.5641851e-06,False,MYB; MYB proto-oncogene
hsa:95,1.7941713e-07,0.00014941009353642697,2.7347243026643288e-05,4.5672930223209475e-05,0.0,0.0001884525,False,ACY1; aminoacylase
hsa:1287,0.0,0.0,9.223895866666664e-07,2.9329349376317175e-06,0.0,1.9755103e-05,False,COL4A5; collagen type IV alpha 5
hsa:51287,0.0,0.0,3.8484735843859663e-07,7.030471981989939e-07,0.0,2.8683842e-06,False,COA4; cytochrome c oxidase assembly factor 4
hsa:115361,0.0,0.0,1.0008993174853804e-07,1.8938822140143576e-07,0.0,1.142774e-06,False,GBP4; guanylate binding protein
hsa:90293,1.4687929e-08,1.2231412049375655e-05,1.826684654298246e-07,4.3071696604631575e-07,0.0,2.4817293e-06,False,KLHL13; kelch like family member
hsa:152404,0.0,0.0,1.4831353599518125e-07,4.80515504513044e-07,0.0,2.8968632e-06,False,IGSF11; immunoglobulin superfamily member
hsa:10114,3.7548364e-09,3.126850026739257e-06,6.147144128280702e-07,1.1744922657587115e-06,0.0,5.3356316e-06,False,HIPK3; homeodomain interacting protein kinase
hsa:7442,3.858224e-05,0.03212946326387494,0.00010716631400368424,0.00015080522979041156,0.0,0.00076134474,False,TRPV1; transient receptor potential cation channel subfamily V member
hsa:9261,0.0,0.0,8.271210099415204e-07,2.5860628824791156e-06,0.0,1.7387338e-05,False,MAPKAPK2; MAPK activated protein kinase
hsa:7376,0.0,0.0,2.9026994722982453e-06,1.0079170735437403e-05,0.0,9.3299815e-05,False,NR1H2; nuclear receptor subfamily 1 group H member
hsa:2549,6.2847066e-06,0.005233606183283614,1.2204430386666664e-05,1.9485280987431226e-05,0.0,0.0001697981,False,GAB1; GRB2 associated binding protein
hsa:7712,0.0,0.0,3.1049345711286563e-08,6.213886249943465e-08,0.0,2.8600218e-07,False,ZNF157; zinc finger protein
hsa:2237,0.0,0.0,0.00016288603263748538,0.0004501935269610544,0.0,0.0026367065,False,FEN1; flap structure-specific endonuclease
hsa:8672,1.3955359e-05,0.011621362428015754,0.00010436401483543853,0.00028023557890574955,0.0,0.002519257,False,EIF4G3; eukaryotic translation initiation factor 4 gamma
hsa:5093,1.6575879e-06,0.0013803607447284972,6.23471976411594e-05,0.00016218417442720416,0.0,0.000980445,False,PCBP1; poly(rC) binding protein
hsa:7450,0.0,0.0,6.236518901403509e-06,2.5377333221755498e-05,0.0,0.00022711765,False,VWF; von Willebrand
hsa:6754,0.0,0.0,1.678534611201813e-07,1.633684198005281e-06,0.0,2.1092774e-05,False,SSTR4; somatostatin receptor
hsa:6258,0.0,0.0,2.6285836354444444e-05,0.00012641767698135848,0.0,0.0010645755,False,RXRG; retinoid X receptor
hsa:8516,0.0,0.0,9.197530229805264e-05,0.0002568343777836605,0.0,0.0019164208,False,ITGA8; integrin subunit alpha
hsa:55070,0.0,0.0,1.854126133161813e-07,4.368681761940198e-07,0.0,2.3417688e-06,False,DET1; DET1 partner of COP1 E3 ubiquitin
hsa:2562,0.00040634224,0.3383825841278436,0.0008070828793076023,0.001090364240369134,0.0,0.005266379,False,GABRB3; gamma-aminobutyric acid type A receptor subunit
hsa:7695,3.5183373e-08,2.929904770440258e-05,8.679284458713455e-08,1.3065871187410287e-07,0.0,6.4114596e-07,False,ZNF136; zinc finger protein
hsa:9110,5.214797e-06,0.004342636110294924,0.00021933639448136835,0.0005951820986541355,0.0,0.0037003402,False,MTMR4; myotubularin related protein
hsa:65082,4.6790583e-06,0.0038964982789848157,0.000251858681470156,0.0005096915628758962,0.0,0.0028866725,False,VPS33A; VPS33A core subunit of CORVET and HOPS
hsa:3603,0.0,0.0,2.090556618245614e-05,7.73470037576735e-05,0.0,0.00052277837,False,IL16; interleukin
hsa:90161,1.3056399e-06,0.001087275109037198,0.00043731865407300595,0.0012686363145461782,0.0,0.008472559,False,HS6ST2; heparan sulfate 6-O-sulfotransferase
hsa:924,0.0,0.0,7.746617970877197e-06,2.353671113560119e-05,0.0,0.00014619048,False,CD7; CD7
hsa:170959,0.0,0.0,8.188864444736844e-08,1.9900237041039256e-07,0.0,9.732174e-07,False,ZNF431; zinc finger protein
hsa:119692,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR51S1; olfactory receptor family 51 subfamily S member
hsa:8687,0.0,0.0,1.3082020463040935e-07,9.025698943153267e-07,0.0,9.182591e-06,False,KRT38; keratin
hsa:84618,5.306751e-05,0.044192110490482564,0.00014617436236716375,0.0002291355367795127,0.0,0.0012651075,False,NT5C1A; 5'-nucleotidase
hsa:27436,0.0,0.0,5.614143881520469e-06,1.4657285130574062e-05,0.0,8.5258136e-05,False,EML4; EMAP like
hsa:84700,0.0,0.0,9.314373150467836e-09,2.2700575004742057e-08,0.0,1.7262167e-07,False,MYO18B; myosin
hsa:10524,0.0,0.0,2.6307013755263163e-06,8.28168996038821e-06,0.0,4.0290048e-05,False,KAT5; lysine acetyltransferase
hsa:2785,0.0,0.0,0.00013839369602181283,0.0004247806823979674,0.0,0.0042861975,False,GNG3; G protein subunit gamma
hsa:5347,3.2206906e-06,0.002682038687152621,5.021096717192984e-05,0.00012641185672442108,0.0,0.00076343084,False,PLK1; polo like kinase
hsa:51272,0.0,0.0,1.0720071631260233e-05,4.881228999979227e-05,0.0,0.0005011801,False,BET1L; Bet1 golgi vesicular membrane trafficking protein
hsa:9741,9.615167e-07,0.0008007055964156634,6.128431786888886e-06,1.059216299212546e-05,0.0,6.837819e-05,False,LAPTM4A; lysosomal protein transmembrane 4
hsa:57180,4.5688392e-07,0.0003804713029491076,0.00012383073876325737,0.0002740338487447836,0.0,0.0016550949,False,ACTR3B; actin related protein
hsa:2760,0.0,0.0,4.4629257142339174e-06,1.4883676730196608e-05,0.0,0.00012688739,False,GM2A; ganglioside GM2
hsa:10203,0.0,0.0,5.595447125847953e-06,2.10229384256673e-05,0.0,0.00022221729,False,CALCRL; calcitonin receptor like
hsa:57332,0.0,0.0,0.0001456693862215931,0.0004878497240852184,0.0,0.0025321846,False,CBX8; chromobox
hsa:2184,0.0,0.0,2.0587731511169595e-05,5.374461360184797e-05,0.0,0.0004704469,False,FAH; fumarylacetoacetate
hsa:5422,2.070938e-08,1.7245791429622187e-05,2.497975634539181e-06,1.2412091961141707e-05,0.0,0.00014622307,False,POLA1; DNA polymerase alpha 1
hsa:10211,2.6811261e-07,0.0002232714910688604,1.43279964477193e-06,3.014136264251365e-06,0.0,1.858588e-05,False,FLOT1; flotillin
hsa:3861,0.0,0.0,1.4779364187134502e-07,8.81578215697719e-07,0.0,9.114143e-06,False,KRT14; keratin
hsa:84444,2.220817e-06,0.0018493912799590938,5.551944097964911e-05,0.00020740227744637773,0.0,0.0013891914,False,DOT1L; DOT1 like histone lysine
hsa:219431,0.0,0.0,1.809813e-08,1.6067421843056834e-07,0.0,1.5823149e-06,False,OR4S2; olfactory receptor family 4 subfamily S member
hsa:1917,0.0,0.0,3.568110109649123e-05,7.69684036463098e-05,0.0,0.000412589,False,EEF1A2; eukaryotic translation elongation factor 1 alpha
hsa:23324,0.0,0.0,7.279398590526318e-05,0.00020019821456884146,0.0,0.001232862,False,MAN2B2; mannosidase alpha class 2B member
hsa:102723849,0.0,0.0,2.2375562222222224e-09,1.373493707665881e-08,0.0,1.02767736e-07,False,SPDYE17; speedy/RINGO cell cycle regulator family member
hsa:390054,0.0,0.0,1.0182310877192983e-06,1.1152836613003002e-05,0.0,0.0001425764,False,OR52A5; olfactory receptor family 52 subfamily A member
hsa:1081,0.0,0.0,1.0510344649122807e-08,7.688035126937125e-08,0.0,7.2101045e-07,False,CGA; glycoprotein hormones
hsa:11235,0.0,0.0,1.084138981854386e-05,3.459776293693162e-05,0.0,0.00017193239,False,PDCD10; programmed cell death
hsa:26339,0.0,0.0,1.642797069005848e-06,7.5981152100122126e-06,0.0,6.769219e-05,False,OR5K1; olfactory receptor family 5 subfamily K member
hsa:11128,1.656276e-06,0.0013792682565044883,0.00023201222038444434,0.0006301312078153444,0.0,0.0036959578,False,POLR3A; RNA polymerase III subunit
hsa:394,0.0,0.0,2.761948516005848e-06,8.492633943184262e-06,0.0,4.5369194e-05,False,ARHGAP5; Rho GTPase activating protein
hsa:22798,4.261468e-06,0.0035487488428919264,1.2032829330918131e-05,2.129569430410169e-05,0.0,0.00018772703,False,LAMB4; laminin subunit beta
hsa:6581,5.176124e-09,4.3104310663989806e-06,2.6213039665721754e-06,9.686939086741238e-06,0.0,6.282865e-05,False,SLC22A3; solute carrier family 22 member
hsa:9942,4.0302666e-08,3.356215260397586e-05,6.648940549454038e-05,0.00011306578599432598,0.0,0.0005898786,False,XYLB;
hsa:22953,1.5511654e-05,0.01291737124010785,0.0001074762490614035,0.0002586832635916434,0.0,0.0019741796,False,P2RX2; purinergic receptor P2X
hsa:90673,1.2978712e-06,0.0010808057033920603,4.8557825756140355e-05,0.00010593060815685819,0.0,0.0006303673,False,PPP1R3E; protein phosphatase 1 regulatory subunit
hsa:55503,6.4265696e-06,0.00535174297490077,4.098813889849708e-05,7.399780395900725e-05,0.0,0.00043732836,False,TRPV6; transient receptor potential cation channel subfamily V member
hsa:9554,7.310386e-07,0.0006087743439254582,5.939987208031579e-05,0.00012030775853759985,0.0,0.00084991235,False,SEC22B; SEC22 homolog B
hsa:390084,0.0,0.0,1.6830460337602337e-05,7.370824976632552e-05,0.0,0.0007748274,False,OR56A5; olfactory receptor family 56 subfamily A member
hsa:728927,0.0,0.0,2.4657161475847948e-08,6.079891285897373e-08,0.0,2.766729e-07,False,ZNF736; zinc finger protein
hsa:89790,0.0,0.0,2.932949263647485e-05,7.247961223025817e-05,0.0,0.00040765124,False,SIGLEC10; sialic acid binding Ig like lectin
hsa:144983,0.0,0.0,2.832159230801169e-07,9.556149053245284e-07,0.0,5.9744175e-06,False,HNRNPA1L2; heterogeneous nuclear ribonucleoprotein A1 like
hsa:391189,-0.0,0.0,7.030084064327485e-08,6.416523574971853e-07,-0.0,8.180139e-06,False,OR11L1; olfactory receptor family 11 subfamily L member
hsa:335,0.0,0.0,1.4807976837426898e-05,6.079136150279681e-05,0.0,0.0005544937,False,APOA1; apolipoprotein
hsa:51552,0.0,0.0,0.00010010995618354384,0.0002769270274256514,0.0,0.0013518715,False,RAB14; RAB14
hsa:53947,0.0,0.0,2.800495046748538e-05,6.082567824735421e-05,0.0,0.00058043335,False,A4GALT; alpha 1
hsa:7249,4.4796387e-05,0.03730431075206688,0.0001670483256990059,0.0003423517912290105,0.0,0.0017858907,False,TSC2; TSC complex subunit
hsa:7733,1.7984078e-08,1.4976288920385685e-05,9.352353891228072e-08,1.480587538343497e-07,0.0,6.765072e-07,False,ZNF180; zinc finger protein
hsa:10670,0.0,0.0,9.145416386198832e-07,1.7835687118870881e-06,0.0,8.781675e-06,False,RRAGA; Ras related GTP binding
hsa:8905,6.6293033e-09,5.5205700042930355e-06,2.6824261228175427e-06,5.79436323967421e-06,0.0,2.6894884e-05,False,AP1S2; adaptor related protein complex 1 subunit sigma
hsa:283159,0.0,0.0,1.456122988146199e-06,1.3531693823720245e-05,0.0,0.00017270785,False,OR8D1; olfactory receptor family 8 subfamily D member
hsa:11184,0.0,0.0,4.263210364751683e-07,1.370620019335401e-06,0.0,9.937042e-06,False,MAP4K1; mitogen-activated protein kinase kinase kinase kinase
hsa:406882,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A2; microRNA
hsa:1144,0.0,0.0,4.552631970208397e-06,1.807446497751119e-05,0.0,0.00013549646,False,CHRND; cholinergic receptor nicotinic delta
hsa:602,0.0,0.0,5.663004362573102e-07,1.294296087456734e-06,0.0,1.0057659e-05,False,BCL3; BCL3 transcription
hsa:1301,6.528199e-07,0.0005436375128809657,2.9407544970175437e-05,7.275960921903675e-05,0.0,0.0004739738,False,COL11A1; collagen type XI alpha 1
hsa:284306,1.5626611e-08,1.3013101988463189e-05,4.3814112038523396e-08,6.476474375755121e-08,0.0,2.759193e-07,False,ZNF547; zinc finger protein
hsa:221178,1.555618e-08,1.2954450385364513e-05,7.506130483859063e-06,2.3844656170150534e-05,0.0,0.00014759458,False,SPATA13; spermatogenesis associated
hsa:79973,2.694158e-09,2.243567260171384e-06,1.41891455128655e-08,2.745845261153409e-08,0.0,1.7587e-07,False,ZNF442; zinc finger protein
hsa:3973,9.786596e-07,0.0008149813921130173,9.301198571754384e-06,3.0666598984107215e-05,0.0,0.0003425733,False,LHCGR; luteinizing hormone/choriogonadotropin
hsa:219699,7.375362e-08,6.141852376554062e-05,3.449298241695907e-07,5.805826182260049e-07,0.0,2.7839997e-06,False,UNC5B; unc-5 netrin receptor
hsa:56052,0.0,0.0,4.386776779484443e-05,8.76666306996719e-05,0.0,0.0005298651,False,ALG1; ALG1 chitobiosyldiphosphodolichol
hsa:219428,0.0,0.0,4.6164801169590637e-08,6.03683109140683e-07,0.0,7.894181e-06,False,OR4C16; olfactory receptor family 4 subfamily C member
hsa:5336,0.0,0.0,9.442813054444442e-05,0.000207223304812741,0.0,0.0017620154,False,PLCG2; phospholipase C gamma
hsa:51160,3.0504626e-07,0.00025402808661323037,3.245826467840351e-06,6.634426038539465e-06,0.0,3.4340108e-05,False,VPS28; VPS28 subunit of
hsa:10018,0.0,0.0,0.0003805817093918713,0.0008080350131692161,0.0,0.0037023532,False,BCL2L11; BCL2 like
hsa:166929,0.0,0.0,1.7475893174970753e-06,6.686883965459606e-06,0.0,6.82329e-05,False,SGMS2; sphingomyelin synthase
hsa:1857,0.00023524642,0.19590208368793763,0.0005319989227972515,0.0006960528274981492,0.0,0.0032095788,False,DVL3; dishevelled segment polarity protein
hsa:25949,1.1027816e-08,9.183443186626082e-06,6.799187980438594e-07,1.8544899335767077e-06,0.0,1.3277395e-05,False,SYF2; SYF2 pre-mRNA splicing
hsa:261729,0.0,0.0,6.616928893494619e-06,2.176455964365477e-05,0.0,0.00014756255,False,STEAP2; STEAP2
hsa:150681,-0.0,0.0,8.937333947368421e-08,6.965839670562057e-07,0.0,8.209997e-06,False,OR6B3; olfactory receptor family 6 subfamily B member
hsa:10762,1.32716025e-08,1.1051962378972833e-05,2.6229199149298236e-07,5.321222116237988e-07,0.0,2.7037754e-06,False,NUP50; nucleoporin
hsa:23350,0.0,0.0,1.874892000654971e-07,3.418843139804953e-07,0.0,2.202269e-06,False,U2SURP; U2 snRNP associated SURP domain
hsa:10500,4.0218998e-07,0.0003349247785382237,1.6159125374093566e-05,5.895919176051738e-05,0.0,0.00053145515,False,SEMA6C; semaphorin
hsa:3360,7.18208e-06,0.005980896275545715,3.603801977847952e-05,8.255082585578887e-05,0.0,0.00073499273,False,HTR4; 5-hydroxytryptamine receptor
hsa:216,0.0,0.0,7.854145756584794e-05,0.00022189410088613925,0.0,0.0018719647,False,ALDH1A1; aldehyde dehydrogenase 1 family member
hsa:85358,0.0,0.0,9.979268766707599e-05,0.0002983337348634692,0.0,0.0014752813,False,SHANK3; SH3 and multiple ankyrin repeat domains
hsa:140739,2.0006468e-08,1.666043958686405e-05,6.825251818818715e-07,1.5293210901869156e-06,0.0,7.1672284e-06,False,UBE2F; ubiquitin conjugating enzyme E2 F
hsa:9388,0.0,0.0,4.821760561988303e-06,3.3903760074806314e-05,0.0,0.0004241641,False,LIPG; lipase G
hsa:150084,3.3117626e-08,2.757879138053544e-05,8.830957493080702e-06,2.4510078836189195e-05,0.0,0.00015136859,False,IGSF5; immunoglobulin superfamily member
hsa:390882,0.0,0.0,3.6979709941520466e-08,3.4704998255220414e-07,0.0,3.7599923e-06,False,OR7G2; olfactory receptor family 7 subfamily G member
hsa:135924,0.0,0.0,1.849112128421053e-06,1.3110135617270887e-05,0.0,0.00016867119,False,OR9A2; olfactory receptor family 9 subfamily A member
hsa:23710,0.0,0.0,1.8783903854035094e-05,5.64906432988037e-05,0.0,0.0004274787,False,GABARAPL1; GABA type A receptor associated protein like
hsa:338751,0.0,0.0,7.661810188304093e-07,2.7869166536352007e-06,0.0,3.0189887e-05,False,OR52L1; olfactory receptor family 52 subfamily L member
hsa:4625,1.3534291e-06,0.0011270716927972383,6.0415642417555564e-05,0.00030076376575619154,0.0,0.0038282122,False,MYH7; myosin heavy chain
hsa:79840,0.0,0.0,9.803999129947371e-05,0.0002640084213023117,0.0,0.0015811927,False,NHEJ1; non-homologous end joining factor
hsa:57103,3.086031e-06,0.0025699005460978743,3.537920889520467e-05,7.792634815015794e-05,0.0,0.0006153584,False,TIGAR; TP53 induced glycolysis regulatory
hsa:5597,0.0,0.0,8.168416823801172e-05,0.00026189942516078506,0.0,0.0014531908,False,MAPK6; mitogen-activated protein kinase
hsa:80235,5.879192e-06,0.004895912818573194,3.608989921672516e-05,9.16551497724495e-05,0.0,0.0006042442,False,PIGZ; phosphatidylinositol glycan anchor biosynthesis class
hsa:2113,0.0,0.0,5.409148391812866e-07,1.177080658915002e-06,0.0,7.2756293e-06,False,ETS1; ETS proto-oncogene 1
hsa:9690,2.1064132e-08,1.7541212103792124e-05,1.728917471754386e-07,2.6918480849464665e-07,0.0,1.8972354e-06,False,UBE3C; ubiquitin protein ligase
hsa:5959,3.1543896e-06,0.002626826352569192,0.00016450621444736845,0.0003338195011024892,0.0,0.0015682534,False,RDH5; retinol dehydrogenase
hsa:8737,0.0,0.0,0.0003295528528124562,0.0007831395302994725,0.0,0.004696357,False,RIPK1; receptor interacting serine/threonine kinase
hsa:6605,4.7554888e-08,3.960145981709945e-05,4.588345411540937e-06,1.4360545997871067e-05,0.0,7.806715e-05,False,SMARCE1; SWI/SNF related
hsa:7410,1.7130664e-05,0.01426560613571905,0.00011263217776625728,0.00022430185834242344,0.0,0.001408334,False,VAV2; vav guanine nucleotide exchange factor
hsa:407049,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR92A2; microRNA
hsa:84617,0.0,0.0,3.6196141457426905e-05,0.00011443580833670413,0.0,0.00080306374,False,TUBB6; tubulin beta 6 class
hsa:23743,0.0,0.0,3.718358766843275e-06,1.0618932721474264e-05,0.0,7.068642e-05,False,BHMT2; betaine--homocysteine S-methyltransferase
hsa:23500,0.0,0.0,1.69915167625731e-07,4.19898309162318e-07,0.0,2.4352005e-06,False,DAAM2; dishevelled associated activator of morphogenesis
hsa:9342,2.8544767e-07,0.00023770730851873032,3.313235591046782e-05,9.012574901272445e-05,0.0,0.00068366155,False,SNAP29; synaptosome associated protein
hsa:51585,0.0,0.0,3.7133999930467827e-07,8.201630397007983e-07,0.0,4.4819312e-06,False,PCF11; PCF11 cleavage and polyadenylation factor
hsa:50833,0.0,0.0,4.769454152046783e-10,6.236870599386708e-09,0.0,8.1557666e-08,False,TAS2R16; taste 2 receptor member
hsa:9771,0.0,0.0,3.6561376520877197e-07,8.464073276358379e-07,0.0,4.309998e-06,False,RAPGEF5; Rap guanine nucleotide exchange factor
hsa:1876,0.0,0.0,9.457449468910467e-05,0.00032201678804785435,0.0,0.001721375,False,E2F6; E2F transcription factor
hsa:684,0.0,0.0,1.5783678138596487e-05,4.286525729179945e-05,0.0,0.0003742472,False,BST2; bone marrow stromal cell antigen
hsa:3549,4.185814e-06,0.0034857477726128244,1.4868823877309944e-05,2.528393254435051e-05,0.0,0.00016178851,False,IHH; Indian hedgehog signaling
hsa:116255,0.0,0.0,8.789546599766084e-08,3.8186047174745726e-07,0.0,3.0501378e-06,False,MOGAT1; monoacylglycerol O-acyltransferase
hsa:63035,1.5684503e-07,0.00013061311705868717,5.71560187618912e-05,0.00020055524530990297,0.0,0.0011502358,False,BCORL1; BCL6 corepressor like
hsa:9493,3.5435357e-09,2.950888805247683e-06,1.4489501030994152e-07,2.436843456982118e-07,0.0,1.2695621e-06,False,KIF23; kinesin family member
hsa:137362,0.0,0.0,5.14405730994152e-08,6.726727792145064e-07,0.0,8.796338e-06,False,GOT1L1; glutamic-oxaloacetic transaminase 1 like
hsa:284307,6.902004e-10,5.74766223954643e-07,2.4112495877543865e-08,5.5477991321647774e-08,0.0,3.1779464e-07,False,ZIK1; zinc finger protein interacting with K protein
hsa:22916,2.5477e-07,0.00021216039700487627,7.354468356374265e-07,9.778601901113452e-07,0.0,4.0311015e-06,False,NCBP2; nuclear cap binding protein subunit
hsa:219469,0.0,0.0,5.047006343859648e-07,4.6496481108194296e-06,0.0,5.5140765e-05,False,OR8H1; olfactory receptor family 8 subfamily H member
hsa:3791,7.972641e-07,0.0006639238056825191,6.516274215035089e-06,1.5684024999432884e-05,0.0,0.00013485501,False,KDR; kinase insert domain
hsa:342371,0.0,0.0,4.806379461442982e-05,0.0001458815505071345,0.0,0.00083360076,False,ATXN1L; ataxin 1
hsa:84678,0.0,0.0,3.456789171789471e-06,2.3386806823807684e-05,0.0,0.0002032346,False,KDM2B; lysine demethylase
hsa:50649,0.0,0.0,9.375984608532162e-07,2.921129132506577e-06,0.0,1.6683573e-05,False,ARHGEF4; Rho guanine nucleotide exchange factor
hsa:9612,8.484883e-07,0.0007065808948541531,0.0001391867694101169,0.0003675727624823134,0.0,0.0021163463,False,NCOR2; nuclear receptor corepressor
hsa:7064,0.0005119304,0.4263114059852617,0.0007137561966461987,0.0007486629696041223,0.0,0.002977097,False,THOP1; thimet oligopeptidase
hsa:3685,0.0,0.0,2.599234845614035e-05,7.921966303393983e-05,0.0,0.0004757128,False,ITGAV; integrin subunit alpha
hsa:6315,0.0,0.0,1.870617389507602e-08,9.7348091339956e-08,0.0,1.0860596e-06,False,ATXN8OS; ATXN8 opposite strand
hsa:1827,0.0,0.0,1.1368164131578946e-06,2.607189327221165e-06,0.0,1.3587426e-05,False,RCAN1; regulator of calcineurin
hsa:8724,3.15356e-08,2.6261355009565397e-05,1.4302185660701757e-06,3.886831516021534e-06,0.0,2.2366921e-05,False,SNX3; sorting nexin
hsa:10253,1.3679568e-07,0.00011391696737195123,8.577689942298239e-07,1.8951047067198372e-06,0.0,1.1268724e-05,False,SPRY2; sprouty RTK signaling antagonist
hsa:6121,-0.0,0.0,8.21089753222807e-07,3.9811493573505675e-06,0.0,4.502698e-05,False,RPE65; retinoid isomerohydrolase
hsa:83660,2.4719694e-07,0.00020585391109153586,3.2428892635847944e-05,0.00011724665438984264,0.0,0.000807222,False,TLN2; talin
hsa:2583,0.0,0.0,4.3354142367409364e-05,8.867491013736257e-05,0.0,0.0004826854,False,B4GALNT1; beta-1
hsa:5598,9.745668e-05,0.0811573101996985,0.00037146273699198825,0.000824120705704335,0.0,0.0059600333,False,MAPK7; mitogen-activated protein kinase
hsa:81671,0.0,0.0,4.32676259614035e-08,2.214874930089374e-07,0.0,2.6261043e-06,False,VMP1; vacuole membrane protein
hsa:5745,0.0,0.0,1.785670029725146e-05,5.833581870886453e-05,0.0,0.0005869052,False,PTH1R; parathyroid hormone 1
hsa:23607,6.0052294e-08,5.0008707995814075e-05,2.3184843146766073e-06,7.181918070106011e-06,0.0,5.7171925e-05,False,CD2AP; CD2 associated
hsa:64343,1.4123706e-10,1.1761553841269198e-07,2.9576665217350055e-05,8.791684551044978e-05,0.0,0.0007683436,False,AZI2; 5-azacytidine induced
hsa:3996,2.3193993e-06,0.0019314859532159683,2.7404020518087748e-05,7.29661020738537e-05,0.0,0.0004523493,False,LLGL1; LLGL scribble cell polarity complex component
hsa:407043,0.0,0.0,5.296960643274854e-09,6.926674845584212e-08,0.0,9.0578027e-07,False,MIR7-1; microRNA
hsa:6692,0.0,0.0,1.896938296491228e-08,8.126320614828394e-08,0.0,7.962457e-07,False,SPINT1; serine peptidase inhibitor
hsa:3886,0.0,0.0,3.105847500584795e-08,2.1543600948330104e-07,0.0,2.5029306e-06,False,KRT35; keratin
hsa:22925,3.9225e-08,3.2664723368199844e-05,5.607727161730996e-07,1.570224992688451e-06,0.0,1.0652452e-05,False,PLA2R1; phospholipase A2 receptor
hsa:7532,0.0,0.0,7.858659298596491e-06,1.5199522069735727e-05,0.0,6.196407e-05,False,YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7738,0.0,0.0,1.9531506163625726e-08,5.669636674077251e-08,0.0,3.1390033e-07,False,ZNF184; zinc finger protein
hsa:27092,0.0008200169,0.6828712605672094,0.0012899225945614038,0.001439680084935343,0.0,0.008346786,True,CACNG4; calcium voltage-gated channel auxiliary subunit gamma
hsa:162,7.170926e-07,0.000597160775229654,2.358409662233919e-06,4.383790485014263e-06,0.0,1.9573568e-05,False,AP1B1; adaptor related protein complex 1 subunit beta
hsa:9235,0.0,0.0,4.1300665246198807e-05,0.00013378529030626889,0.0,0.0011736423,False,IL32; interleukin
hsa:79913,0.0,0.0,4.170292779707605e-07,1.2250545351306649e-06,0.0,6.989835e-06,False,ACTR5; actin related protein
hsa:154197,3.907232e-08,3.2537578690982324e-05,1.8602571498895899e-06,7.631995382437423e-06,0.0,7.521612e-05,False,PNLDC1; PARN like ribonuclease domain containing exonuclease
hsa:29760,0.0,0.0,6.058917735672514e-06,2.2513785567459203e-05,0.0,0.00018306653,False,BLNK; B cell
hsa:50674,0.0,0.0,5.651098949929824e-05,0.00045251090224766004,0.0,0.005801951,False,NEUROG3; neurogenin
hsa:63976,0.0,0.0,1.1375995835672512e-06,2.7262115704133276e-06,0.0,1.8229004e-05,False,PRDM16; PR/SET domain
hsa:51056,4.6785085e-06,0.0038960404315684276,8.374566905835672e-05,0.00014437514479693857,0.0,0.0007958431,False,LAP3; leucine aminopeptidase
hsa:5778,0.0,0.0,2.0865209233918127e-08,5.797977742048813e-08,0.0,3.118841e-07,False,PTPN7; protein tyrosine phosphatase non-receptor type
hsa:23678,1.468147e-07,0.00012226033299898658,7.834940691286549e-07,9.611118261416715e-07,0.0,4.595411e-06,False,SGK3; serum/glucocorticoid regulated kinase family member
hsa:80736,0.0,0.0,1.3697848205477777e-06,6.6532215754361755e-06,0.0,8.058401e-05,False,SLC44A4; solute carrier family 44 member
hsa:390064,0.0,0.0,4.5338116809941515e-07,4.2204270582804534e-06,0.0,5.080362e-05,False,OR51I2; olfactory receptor family 51 subfamily I member
hsa:2239,0.0,0.0,2.1811888821637425e-08,5.672599784921593e-08,0.0,4.380644e-07,False,GPC4; glypican
hsa:10229,0.0,0.0,9.53039745954971e-05,0.0002396238432610502,0.0,0.0012284134,False,COQ7; coenzyme Q7
hsa:6579,2.6320346e-05,0.021918338331301596,0.00025569897841559415,0.00056209694751835,0.0,0.0045083235,False,SLCO1A2; solute carrier organic anion transporter family member
hsa:1395,1.0171494e-06,0.0008470338757203428,6.473151632732747e-06,1.4922290678761711e-05,0.0,0.00013436389,False,CRHR2; corticotropin releasing hormone receptor
hsa:55670,5.502842e-07,0.0004582506352298573,0.00010339220994213451,0.0003586933960306744,0.0,0.0020931272,False,PEX26; peroxisomal biogenesis factor
hsa:4909,0.0,0.0,1.5609505008684212e-07,1.2126277906298118e-06,0.0,1.5386982e-05,False,NTF4; neurotrophin
hsa:675,4.435343e-05,0.03693543712889269,0.0001435736637254386,0.00021915129382423483,0.0,0.0010938419,False,BRCA2; BRCA2 DNA repair
hsa:26851,6.7555983e-10,5.6257425023883e-07,5.706265682105265e-07,2.0056845204117235e-06,0.0,1.2755915e-05,False,SNORD3B-1; small nucleolar RNA
hsa:51804,0.0,0.0,2.2607629577192983e-09,9.266829307225135e-09,0.0,7.877724e-08,False,SIX4; SIX homeobox
hsa:79230,0.0,0.0,7.828947786783627e-08,2.0181210600371863e-07,0.0,1.1197712e-06,False,ZNF557; zinc finger protein
hsa:27183,0.0,0.0,0.00010362159825026312,0.0003174863280586739,0.0,0.0022587928,False,VPS4A; vacuolar protein sorting 4 homolog
hsa:4734,0.0,0.0,6.849748316432748e-07,1.454522916241276e-06,0.0,7.0226497e-06,False,NEDD4; NEDD4 E3 ubiquitin protein
hsa:55576,0.0,0.0,1.2117317519118714e-05,7.559775365575289e-05,0.0,0.00085909414,False,STAB2; stabilin
hsa:79310,0.0,0.0,2.706453625730994e-09,3.539147354982201e-08,0.0,4.6280357e-07,False,OR5H2; olfactory receptor family 5 subfamily H member
hsa:92856,3.1459713e-08,2.619815990791486e-05,1.5527578903862749e-06,2.8675977344755403e-06,0.0,1.3358275e-05,False,IMP4; IMP U3 small nucleolar ribonucleoprotein
hsa:5140,0.00021978578,0.1830271944923908,0.00047589178277836273,0.0006996723766089468,0.0,0.00424216,False,PDE3B; phosphodiesterase
hsa:9583,2.9530838e-06,0.002459188410710322,0.00027357075626692967,0.0005788472545126742,0.0,0.0032563459,False,ENTPD4; ectonucleoside triphosphate diphosphohydrolase
hsa:406925,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR135A1; microRNA
hsa:9421,6.216718e-07,0.0005176988495299135,5.084898347686546e-05,0.00012796480962255205,0.0,0.0006353703,False,HAND1; heart and neural crest derivatives expressed
hsa:4055,0.0,0.0,0.00012356936028771933,0.0004157459458000032,0.0,0.0024072004,False,LTBR; lymphotoxin beta
hsa:4496,4.0165034e-08,3.3447539188893336e-05,2.0034064927122403e-05,7.835485794609355e-05,0.0,0.00077022344,False,MT1H; metallothionein
hsa:2165,0.0,0.0,1.5325017043947368e-07,5.646776297748245e-07,0.0,5.1165052e-06,False,F13B; coagulation factor XIII B
hsa:387332,0.0,0.0,1.0111810756608179e-07,7.350778669860944e-07,0.0,8.81758e-06,False,TBPL2; TATA-box binding protein like
hsa:92610,0.0,0.0,5.918266946432751e-08,1.356231085616353e-07,0.0,7.4756963e-07,False,TIFA; TRAF interacting protein with forkhead associated
hsa:3702,3.22908e-07,0.0002689024982378247,9.146550177192978e-06,2.7820348310095154e-05,0.0,0.0002490566,False,ITK; IL2 inducible T cell
hsa:9900,6.795169e-06,0.005658695108353528,0.00018323368254619864,0.0003650877104526792,0.0,0.002188309,False,SV2A; synaptic vesicle glycoprotein
hsa:8718,0.0,0.0,5.697568395789474e-05,0.00014327463103484876,0.0,0.0007213953,False,TNFRSF25; TNF receptor superfamily member
hsa:6586,4.167017e-08,3.47009452072877e-05,8.407295229730996e-07,2.486613735120008e-06,0.0,1.4921645e-05,False,SLIT3; slit guidance ligand
hsa:219968,0.0,0.0,2.19155183883041e-06,9.172563992577277e-06,0.0,7.0823866e-05,False,OR5B21; olfactory receptor family 5 subfamily B member
hsa:9061,0.00012134366,0.10104925650439504,0.0009973331595912282,0.0018948865210166527,0.0,0.01255106,False,PAPSS1; 3'-phosphoadenosine 5'-phosphosulfate synthase
hsa:1548,4.820374e-07,0.0004014179305067251,9.119816005760236e-05,0.0002858402038605864,0.0,0.002272167,False,CYP2A6; cytochrome P450 family 2 subfamily A member
hsa:255403,0.0,0.0,6.913374889327485e-08,1.965283325830641e-07,0.0,1.0125973e-06,False,ZNF718; zinc finger protein
hsa:7549,0.0,0.0,1.3925537571929823e-08,3.6852393723067704e-08,0.0,3.3291417e-07,False,ZNF2; zinc finger protein
hsa:5283,0.0,0.0,1.2188847027485382e-05,2.5799564484555736e-05,0.0,0.0001580452,False,PIGH; phosphatidylinositol glycan anchor biosynthesis class
hsa:2177,2.1092215e-07,0.0001756459829694315,3.893297927211111e-05,0.0001037063080202078,0.0,0.0006074258,False,FANCD2; FA complementation group
hsa:6010,2.879592e-06,0.0023979879182480894,4.8657004415584806e-05,0.00014529474641862216,0.0,0.0011201885,False,RHO;
hsa:79659,0.0,0.0,4.2621967030312276e-05,0.00011750132479654854,0.0,0.0006873521,False,DYNC2H1; dynein cytoplasmic 2 heavy chain
hsa:84376,6.063074e-08,5.049041044510513e-05,1.4192857175087722e-07,2.50705099828226e-07,0.0,1.6279054e-06,False,HOOK3; hook microtubule tethering protein
hsa:4129,0.0,0.0,5.5085491990058474e-05,0.00017402018596286231,0.0,0.001213292,False,MAOB; monoamine oxidase
hsa:4296,3.4979638e-07,0.00029129386839764717,1.2628586716964918e-06,2.042092339459732e-06,0.0,1.3011618e-05,False,MAP3K11; mitogen-activated protein kinase kinase kinase
hsa:79695,0.0,0.0,1.6950787547859654e-06,7.613106152497675e-06,0.0,7.676226e-05,False,GALNT12; polypeptide N-acetylgalactosaminyltransferase
hsa:10172,0.0,0.0,7.429838161286549e-08,1.4546033655040967e-07,0.0,5.586434e-07,False,ZNF256; zinc finger protein
hsa:5145,3.3881366e-05,0.0282147979025298,0.00010955400127233921,0.00017693501070616184,0.0,0.0011663191,False,PDE6A; phosphodiesterase
hsa:89910,4.885732e-09,4.068606353885576e-06,3.307921405918128e-07,8.784026079552547e-07,0.0,5.4706015e-06,False,UBE3B; ubiquitin protein ligase
hsa:3054,1.0788672e-07,8.984295382797789e-05,9.399002498099413e-06,5.6091790886956026e-05,0.0,0.00045245313,False,HCFC1; host cell factor
hsa:2817,0.0,0.0,1.2808781890058478e-06,2.157020976967298e-06,0.0,1.1680127e-05,False,GPC1; glypican
hsa:11025,0.0,0.0,4.838892565473683e-06,1.7402258928119458e-05,0.0,0.00016992136,False,LILRB3; leukocyte immunoglobulin like receptor
hsa:9643,1.794998e-08,1.4947893719941866e-05,2.524002641834503e-07,6.037330011651673e-07,0.0,5.4593297e-06,False,MORF4L2; mortality factor 4 like
hsa:387778,0.0,0.0,1.0144621624678365e-07,5.976897490952751e-07,0.0,6.983168e-06,False,SPDYC; speedy/RINGO cell cycle regulator family member
hsa:407048,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR92A1; microRNA
hsa:54675,4.6165698e-07,0.00038444608139448223,8.055450833391818e-06,2.0954793384184308e-05,0.0,0.00013145094,False,CRLS1; cardiolipin synthase
hsa:5189,3.235792e-07,0.00026946144182800276,0.00024447653973785373,0.0008724755330413946,0.0,0.0053311484,False,PEX1; peroxisomal biogenesis factor
hsa:3635,0.0,0.0,1.5773326981812865e-05,3.902906628532418e-05,0.0,0.00024907556,False,INPP5D; inositol polyphosphate-5-phosphatase
hsa:148254,0.0,0.0,6.767764960153509e-08,1.8054013219173766e-07,0.0,8.678584e-07,False,ZNF555; zinc finger protein
hsa:7366,0.0,0.0,4.1157161043859643e-05,0.0002599557229012221,0.0,0.002224197,False,UGT2B15; UDP glucuronosyltransferase family 2 member
hsa:23513,7.2958383e-06,0.006075628803278965,5.340284596626702e-05,0.00013294918611719692,0.0,0.00089280197,False,SCRIB; scribble planar cell polarity
hsa:79901,0.0,0.0,1.2683403812097074e-05,3.113090977841329e-05,0.0,0.00022126961,False,CYBRD1; cytochrome b reductase
hsa:6564,0.0,0.0,4.473503864567251e-06,3.492317637506725e-05,0.0,0.0004314717,False,SLC15A1; solute carrier family 15 member
hsa:26658,0.0,0.0,1.7027327350877192e-07,2.034652667445135e-06,0.0,2.6575759e-05,False,OR7C2; olfactory receptor family 7 subfamily C member
hsa:64077,6.8961704e-08,5.7428042935874575e-05,8.046318221789472e-07,1.8479663916640242e-06,0.0,1.32175355e-05,False,LHPP; phospholysine phosphohistidine inorganic pyrophosphate
hsa:5001,3.211103e-08,2.6740545876812392e-05,8.872679947444446e-07,1.863264670898335e-06,0.0,9.495929e-06,False,ORC5; origin recognition complex subunit
hsa:55713,3.4662207e-08,2.886504532788477e-05,1.411545229871345e-07,1.9656520928694377e-07,0.0,8.9832093e-07,False,ZNF334; zinc finger protein
hsa:10718,2.6470552e-08,2.2043422778420622e-05,3.1722494839707607e-06,6.648593386327292e-06,0.0,4.6276367e-05,False,NRG3; neuregulin
hsa:6866,2.8322876e-08,2.358595052981074e-05,3.345188692865281e-05,8.793953209081418e-05,0.0,0.00060408417,False,TAC3; tachykinin precursor
hsa:5104,6.7532756e-07,0.0005623808267768357,1.4247632938574285e-05,4.020299754808929e-05,0.0,0.0003846729,False,SERPINA5; serpin family A member
hsa:56474,4.452775e-08,3.7080602573826906e-05,9.309347660612398e-05,0.00020809046976668876,0.0,0.0011903311,False,CTPS2; CTP synthase
hsa:51082,7.253428e-06,0.006040311512840154,0.0001679566399886551,0.00046755780370738955,0.0,0.0030217613,False,POLR1D; RNA polymerase I and III subunit
hsa:100528032,3.0548318e-07,0.00025439193290855317,7.493395229385966e-06,2.715033921906132e-05,0.0,0.00030123955,False,KLRC4-KLRK1; KLRC4-KLRK1
hsa:5777,0.0,0.0,0.00019525897398912275,0.0004208995940333783,0.0,0.002402472,False,PTPN6; protein tyrosine phosphatase non-receptor type
hsa:9540,0.0,0.0,4.761354799104094e-06,1.1105412640697881e-05,0.0,8.0558966e-05,False,TP53I3; tumor protein p53 inducible protein
hsa:22920,1.5302755e-08,1.2743410040696926e-05,3.0355388902163726e-07,6.05065556418794e-07,0.0,4.0052923e-06,False,KIFAP3; kinesin associated protein
hsa:162655,2.0017634e-08,1.666973810314523e-05,8.953861988187135e-08,1.5542809632151138e-07,0.0,7.877205e-07,False,ZNF519; zinc finger protein
hsa:1759,5.7462592e-05,0.047852126748240485,0.00023929661674269013,0.0004572202850927136,0.0,0.0041508125,False,DNM1; dynamin
hsa:10678,1.2754431e-05,0.010621286432983873,0.0001233445777087719,0.00027084749779509497,0.0,0.0015272298,False,B3GNT2; UDP-GlcNAc:betaGal beta-1
hsa:83852,0.0,0.0,3.196001104590642e-05,0.00011288981774420275,0.0,0.0007204574,False,SETDB2; SET domain bifurcated histone lysine methyltransferase
hsa:1912,0.0,0.0,0.0001249334792283474,0.00039562926580997103,0.0,0.0023794696,False,PHC2; polyhomeotic homolog
hsa:23339,1.3674783e-07,0.00011387712015682903,4.754618240479532e-05,0.00019557692189086225,0.0,0.002197616,False,VPS39; VPS39 subunit of HOPS
hsa:9541,3.58327e-07,0.00029839776495492525,0.00013629514344830408,0.0003540648912222989,0.0,0.0026732844,False,CIR1; corepressor interacting with RBPJ
hsa:60495,0.0,0.0,1.3868953880274856e-06,4.57029209304219e-06,0.0,3.9380255e-05,False,HPSE2; heparanase 2
hsa:6310,1.1427494e-06,0.0009516276107119525,0.00015097139600274857,0.0003120741398505207,0.0,0.001726756,False,ATXN1; ataxin
hsa:147741,7.699673e-10,6.411923226783872e-07,2.8608011819409367e-08,6.738647407201231e-08,0.0,3.9297348e-07,False,ZNF560; zinc finger protein
hsa:6307,0.0,0.0,2.058914452748538e-05,5.4651254543002645e-05,0.0,0.0003131407,False,MSMO1; methylsterol monooxygenase
hsa:3242,0.0,0.0,1.301997508011696e-06,6.5389318322142354e-06,0.0,6.402686e-05,False,HPD; 4-hydroxyphenylpyruvate
hsa:1735,0.0,0.0,2.5251087367602347e-07,8.06800347897818e-07,0.0,5.961612e-06,False,DIO3; iodothyronine deiodinase
hsa:55308,0.0,0.0,6.522856229105264e-07,1.0958297059177422e-06,0.0,4.6380674e-06,False,DDX19A; DEAD-box helicase
hsa:27302,0.0,0.0,7.363699729130409e-07,3.6923940424171385e-06,0.0,3.970346e-05,False,BMP10; bone morphogenetic protein
hsa:285704,0.0,0.0,2.2948004944233917e-05,6.881971065314554e-05,0.0,0.0005574486,False,RGMB; repulsive guidance molecule BMP co-receptor
hsa:643834,7.217331e-07,0.0006010251639814738,1.192970315352632e-05,3.9324766157753944e-05,0.0,0.00041358665,False,PGA3; pepsinogen
hsa:7170,0.0,0.0,0.00042721957078596494,0.000882496055062646,0.0,0.006516565,False,TPM3; tropomyosin
hsa:26529,0.0,0.0,2.396062737426901e-07,1.5510716400337963e-06,0.0,1.433466e-05,False,OR12D2; olfactory receptor family 12 subfamily D member
hsa:3607,8.0881115e-08,6.735396423675101e-05,0.00014228848729396157,0.0005127955911021325,0.0,0.0029077136,False,FOXK2; forkhead box
hsa:26060,0.0,0.0,1.2446009107017543e-06,2.517056108659667e-06,0.0,1.1472605e-05,False,APPL1; adaptor protein
hsa:10224,6.861174e-09,5.7136609481474865e-06,3.587470161099416e-08,5.732477829683083e-08,0.0,2.505334e-07,False,ZNF443; zinc finger protein
hsa:64850,0.0,0.0,7.24734245048538e-08,5.111381001201872e-07,-0.0,5.3684457e-06,False,ETNPPL; ethanolamine-phosphate
hsa:26534,0.0,0.0,4.7014946269005845e-06,2.273279887879332e-05,0.0,0.00024023901,False,OR10G2; olfactory receptor family 10 subfamily G member
hsa:57678,2.7276674e-06,0.002271472302395332,0.0001563331993837428,0.0004512056904640877,0.0,0.003025049,False,GPAM; glycerol-3-phosphate acyltransferase
hsa:85479,0.0,0.0,2.7191678645567255e-08,8.864812905583561e-08,0.0,7.5857895e-07,False,DNAJC5B; DnaJ heat shock protein family (Hsp40) member C5
hsa:406995,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181A1; microRNA
hsa:26338,-0.0,0.0,2.7291443859649123e-09,2.5206668146122152e-08,0.0,2.4731958e-07,False,OR5L2; olfactory receptor family 5 subfamily L member
hsa:7556,0.0,0.0,1.4406671312514624e-07,2.854348854011626e-07,0.0,1.479069e-06,False,ZNF10; zinc finger protein
hsa:392309,1.7643252e-06,0.0014692465159858216,7.579893570280527e-05,0.00019931570613317134,0.0,0.0016112197,False,OR13J1; olfactory receptor family 13 subfamily J member
hsa:894,0.0,0.0,3.6303143508771936e-06,1.4329034976845235e-05,0.0,8.634633e-05,False,CCND2; cyclin
hsa:162962,0.0,0.0,2.9651677419573108e-08,5.6669998964451364e-08,0.0,2.6313194e-07,False,ZNF836; zinc finger protein
hsa:7531,0.0,0.0,2.6300020988304077e-05,4.208791189932658e-05,0.0,0.00028382108,False,YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:10780,0.0,0.0,8.538688059181288e-08,1.7864136394377582e-07,0.0,1.1196711e-06,False,ZNF234; zinc finger protein
hsa:4850,2.1284983e-08,1.7725126363080593e-05,3.132977558480702e-05,0.00012611311248044362,0.0,0.0012126717,False,CNOT4; CCR4-NOT transcription complex subunit
hsa:51028,2.9156856e-08,2.4280449599144364e-05,8.60571579391813e-07,2.138503362327099e-06,0.0,1.7929977e-05,False,VPS36; vacuolar protein sorting 36
hsa:10808,1.10241615e-07,9.180399892004053e-05,1.1561492604520467e-06,2.6347909482190757e-06,0.0,1.3668255e-05,False,HSPH1; heat shock protein family H (Hsp110) member
hsa:3765,6.14264e-05,0.05115299843223431,0.0001942454134336842,0.0003805515037709052,0.0,0.0022771794,False,KCNJ9; potassium inwardly rectifying channel subfamily J member
hsa:390174,0.0,0.0,0.0,0.0,0.0,0.0,False,OR9G1; olfactory receptor family 9 subfamily G member
hsa:9688,9.068795e-09,7.552063223911124e-06,2.609032401935672e-07,7.346700824209128e-07,0.0,3.8987073e-06,False,NUP93; nucleoporin
hsa:5985,4.9735327e-06,0.004141722620986515,0.00019279443018830407,0.0004253312721224154,0.0,0.0021805563,False,RFC5; replication factor C subunit
hsa:339896,0.0,0.0,7.982841363742692e-07,3.2812803397783506e-06,0.0,3.4236768e-05,False,GADL1; glutamate decarboxylase like
hsa:388536,2.0487199e-09,1.7060769609286432e-06,6.397895938245616e-08,1.6378784427146943e-07,0.0,8.5073935e-07,False,ZNF790; zinc finger protein
hsa:80222,0.0,0.0,2.315057882070176e-06,6.687594449049592e-06,0.0,3.750189e-05,False,TARS2; threonyl-tRNA synthetase 2
hsa:9166,4.6340372e-07,0.000385900683788266,4.196944138415203e-05,9.522621466218692e-05,0.0,0.00046733816,False,EBAG9; estrogen receptor binding site associated antigen
hsa:5795,2.3871104e-07,0.00019878725523353184,7.259855065105259e-07,1.2679039211936168e-06,0.0,9.878997e-06,False,PTPRJ; protein tyrosine phosphatase receptor type
hsa:4050,6.1818546e-06,0.005147955905963892,3.5988568229064315e-05,6.931492319314241e-05,0.0,0.0003700035,False,LTB; lymphotoxin
hsa:407029,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30A; microRNA
hsa:10908,5.88337e-08,4.899392059216466e-05,1.7540715052690055e-06,3.4399275462659337e-06,0.0,2.6461817e-05,False,PNPLA6; patatin like phospholipase domain containing
hsa:5150,6.920263e-07,0.0005762867470495569,8.452011521695906e-06,2.3251583472050512e-05,0.0,0.0001658839,False,PDE7A; phosphodiesterase
hsa:5834,0.0,0.0,0.00021515070915497077,0.0004354173969331721,0.0,0.0016984727,False,PYGB; glycogen phosphorylase
hsa:130574,1.4772975e-08,1.2302234332704447e-05,9.779099271601114e-06,2.4363889013262034e-05,0.0,0.00016780318,False,LYPD6; LY6/PLAUR domain containing
hsa:5149,0.0,0.0,5.864698575730994e-09,2.525683768462094e-08,0.0,2.3875788e-07,False,PDE6H; phosphodiesterase
hsa:3632,0.0,0.0,5.1787284803216374e-05,0.00018012360700339085,0.0,0.0011687314,False,INPP5A; inositol polyphosphate-5-phosphatase
hsa:165829,0.0,0.0,3.12515501440351e-07,1.0519419984190244e-06,0.0,9.413192e-06,False,GPR156; G protein-coupled receptor
hsa:30833,7.6011415e-06,0.006329870857362488,0.0003249744636678362,0.000611589917663904,0.0,0.0030784325,False,NT5C; 5'
hsa:406901,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR107; microRNA
hsa:8388,0.0,0.0,8.752633436608188e-07,3.440804086629734e-06,0.0,2.3394758e-05,False,OR1E2; olfactory receptor family 1 subfamily E member
hsa:64283,9.59842e-09,7.993109855240194e-06,4.5557912625988315e-06,1.4443505831111472e-05,0.0,0.00014257991,False,ARHGEF28; Rho guanine nucleotide exchange factor
hsa:79816,3.1999196e-05,0.026647415815036504,0.00018116272747407023,0.0003662444784225538,0.0,0.002935136,False,TLE6; TLE family member 6
hsa:79147,1.4041688e-06,0.0011693253133016476,4.09522133522807e-05,7.359268112359589e-05,0.0,0.0005038324,False,FKRP; fukutin related
hsa:537,0.0,0.0,1.5518548192982452e-05,4.060674532192951e-05,0.0,0.00023204801,False,ATP6AP1; ATPase H+ transporting accessory protein
hsa:29940,0.0,0.0,1.535391026320468e-05,3.054005980042508e-05,0.0,0.00016956145,False,DSE; dermatan sulfate
hsa:9491,0.0,0.0,6.868313031672515e-06,2.0149594532875367e-05,0.0,0.00013738479,False,PSMF1; proteasome inhibitor subunit
hsa:5432,0.0,0.0,2.545454113616374e-05,9.053962366770471e-05,0.0,0.00069298455,False,POLR2C; RNA polymerase II subunit
hsa:140032,0.0,0.0,8.917588377192982e-10,5.4560855565260424e-09,0.0,5.7237884e-08,False,RPS4Y2; ribosomal protein S4 Y-linked
hsa:3559,2.0312254e-06,0.0016915083693935262,6.145183733684212e-05,0.00010164048815802765,0.0,0.0005695528,False,IL2RA; interleukin 2 receptor subunit
hsa:5827,7.9438706e-07,0.0006615279429490776,0.0002126258872525244,0.0007465123367026712,0.0,0.0045752292,False,PXMP2; peroxisomal membrane protein
hsa:4798,2.3874566e-08,1.988160851308679e-05,1.4361967937953213e-07,3.369724686052056e-07,0.0,2.049219e-06,False,NFRKB; nuclear factor related to kappaB binding
hsa:5909,0.0,0.0,1.0867394239035092e-06,2.9674665548603512e-06,0.0,1.7741822e-05,False,RAP1GAP; RAP1 GTPase activating
hsa:64147,0.0,0.0,5.9483913855380127e-08,1.4753153653072637e-07,0.0,9.2274263e-07,False,KIF9; kinesin family member
hsa:51382,0.0,0.0,0.00016752845334795316,0.0003853686639760822,0.0,0.0019291741,False,ATP6V1D; ATPase H+ transporting V1 subunit
hsa:27124,3.2543682e-07,0.000271008379837518,2.161978578111111e-05,6.452890745184104e-05,0.0,0.000442526,False,INPP5J; inositol polyphosphate-5-phosphatase
hsa:6926,1.3714867e-08,1.1421092073592169e-05,9.274900959707602e-07,2.0479560221891798e-06,0.0,1.1401865e-05,False,TBX3; T-box transcription factor
hsa:54884,4.0082177e-06,0.0033378539801152893,8.864471756608188e-05,0.00018610889329400492,0.0,0.001155231,False,RETSAT; retinol
hsa:143686,6.3142295e-07,0.0005258191457000045,3.36411735697076e-05,7.022987123052855e-05,0.0,0.0005459662,False,SESN3; sestrin
hsa:5275,0.0,0.0,2.1337542299005848e-08,1.4312880459432854e-07,0.0,1.6073031e-06,False,SERPINB13; serpin family B member
hsa:9253,1.1852367e-06,0.0009870090231061327,0.00014052907494017545,0.00035297336217046275,0.0,0.001930393,False,NUMBL; NUMB like endocytic adaptor
hsa:28996,0.0,0.0,3.858003662769941e-06,1.4022404386866726e-05,0.0,9.5513824e-05,False,HIPK2; homeodomain interacting protein kinase
hsa:399687,0.0,0.0,2.6540616751060825e-06,8.041582580904697e-06,0.0,4.3755037e-05,False,MYO18A; myosin
hsa:9468,3.1906235e-05,0.026570002294347368,0.00036823658147742684,0.0008804970196497899,0.0,0.00584058,False,PCYT1B; phosphate cytidylyltransferase 1B
hsa:10803,5.2861793e-07,0.0004402079911005845,1.9278984823801174e-05,5.7698958948128975e-05,0.0,0.00044277776,False,CCR9; C-C motif chemokine receptor
hsa:225689,0.0,0.0,1.388260047368421e-07,8.285712159386829e-07,0.0,9.582416e-06,False,MAPK15; mitogen-activated protein kinase
hsa:10768,6.9565235e-06,0.00579306349858206,0.00018268006415116957,0.0004992352038475758,0.0,0.0031421662,False,AHCYL1; adenosylhomocysteinase like
hsa:4878,4.9014878e-05,0.04081727038358353,0.00019741537579532172,0.0004442321961670297,0.0,0.003127969,False,NPPA; natriuretic peptide
hsa:1353,2.0896303e-07,0.0001740145205642025,1.0600114732339183e-06,1.344272174095577e-06,0.0,6.3054526e-06,False,COX11; cytochrome c oxidase copper chaperone
hsa:131669,1.2034696e-08,1.0021925192106593e-05,1.7253866980003508e-05,5.454976528790355e-05,0.0,0.0006215056,False,UROC1; urocanate hydratase
hsa:100533467,0.0,0.0,1.1832823164064324e-06,4.434045753492411e-06,0.0,3.2090622e-05,False,BIVM-ERCC5; BIVM-ERCC5
hsa:6631,0.0,0.0,1.267519542873684e-07,2.326211397455888e-07,0.0,1.1520623e-06,False,SNRPC; small nuclear ribonucleoprotein polypeptide
hsa:4353,0.0,0.0,6.338972577956723e-06,2.1630823701412567e-05,0.0,0.00018706638,False,MPO;
hsa:5286,7.6053163e-07,0.0006333347433197224,5.54854678691813e-05,0.00013901408089420268,0.0,0.0007783887,False,PIK3C2A; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:2868,4.0235304e-06,0.0033506056718812603,4.635915589879531e-05,0.00019132544453635426,0.0,0.0020030073,False,GRK4; G protein-coupled receptor kinase
hsa:22909,5.080355e-07,0.0004230679176220545,9.85948793874678e-05,0.000319515119631402,0.0,0.0019366122,False,FAN1; FANCD2 and FANCI associated nuclease
hsa:51806,0.0,0.0,6.3536604415204685e-06,4.561351104445127e-05,0.0,0.0005510111,False,CALML5; calmodulin like
hsa:3752,6.2608696e-10,5.21375585795722e-07,1.1502339732269002e-08,2.9230262933733693e-08,0.0,2.1867086e-07,False,KCND3; potassium voltage-gated channel subfamily D member
hsa:4880,0.0,0.0,2.7874763381871343e-07,1.0253901411777277e-06,0.0,8.382422e-06,False,NPPC; natriuretic peptide
hsa:22854,0.0,0.0,4.395929868426901e-06,8.961032133243094e-06,0.0,5.8884456e-05,False,NTNG1; netrin
hsa:9963,1.9214023e-05,0.016000528899559698,0.00010253262448608188,0.00020815411013278858,0.0,0.0012734146,False,SLC23A1; solute carrier family 23 member
hsa:81392,0.0,0.0,3.784221465497077e-07,1.1648660881105953e-06,0.0,9.956076e-06,False,OR2AE1; olfactory receptor family 2 subfamily AE member
hsa:132,0.0,0.0,2.7998045128298256e-06,6.282412767095177e-06,0.0,4.9896928e-05,False,ADK; adenosine
hsa:6499,0.0,0.0,4.0043667078947335e-07,9.136755631310775e-07,0.0,6.540504e-06,False,SKIC2; SKI2 subunit of superkiller
hsa:3352,0.0,0.0,2.2296876990175438e-05,7.78328833078064e-05,0.0,0.00051292963,False,HTR1D; 5-hydroxytryptamine receptor
hsa:6425,1.6948357e-08,1.4113789495232461e-05,1.3779710231269007e-07,3.9119697577789716e-07,0.0,3.5811727e-06,False,SFRP5; secreted frizzled related protein
hsa:2882,0.00010092617,0.08404653725078164,0.00019674587154736842,0.0002680687141360295,0.0,0.0014315333,False,GPX7; glutathione peroxidase
hsa:388559,0.0,0.0,2.5793233100000002e-09,7.151267447226616e-09,0.0,4.8629914e-08,False,ZNF888; zinc finger protein
hsa:2615,0.0,0.0,1.414805034594737e-07,5.350863004797552e-07,0.0,4.714466e-06,False,LRRC32; leucine rich repeat containing
hsa:4659,0.0,0.0,4.429130338549708e-05,0.00014959469361991863,0.0,0.0015741502,False,PPP1R12A; protein phosphatase 1 regulatory subunit
hsa:10268,0.0,0.0,2.6154361732339177e-06,6.12821389914795e-06,0.0,3.507781e-05,False,RAMP3; receptor activity modifying protein
hsa:9618,1.6541009e-06,0.0013774569361782124,3.845941707783624e-05,7.969809525279981e-05,0.0,0.0004263715,False,TRAF4; TNF receptor associated factor
hsa:578,0.00017927337,0.14929037701300027,0.0004234309285795323,0.0007152985315881293,0.0,0.003768596,False,BAK1; BCL2 antagonist/killer
hsa:5352,0.0,0.0,5.830308041269005e-06,1.6470393043439825e-05,0.0,8.807118e-05,False,PLOD2; procollagen-lysine
hsa:5715,0.0,0.0,2.7429148778128654e-06,7.771691833300686e-06,0.0,4.0773844e-05,False,PSMD9; proteasome 26S subunit
hsa:5717,1.1087167e-06,0.0009232867890172955,8.989727388502919e-06,1.9880980111537014e-05,0.0,0.00013012052,False,PSMD11; proteasome 26S subunit
hsa:1241,0.0,0.0,1.5296083539204678e-06,4.755324291455876e-06,0.0,3.2514024e-05,False,LTB4R; leukotriene B4
hsa:441933,0.0,0.0,1.4404405391812866e-06,5.10253001609645e-06,0.0,3.592954e-05,False,OR13G1; olfactory receptor family 13 subfamily G member
hsa:93,5.4337084e-05,0.045249351625102296,0.0002595758413949707,0.0004545653167097472,0.0,0.0020548678,False,ACVR2B; activin A receptor type
hsa:406895,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR103A1; microRNA
hsa:79139,0.0,0.0,3.226224504846199e-07,6.428573477743434e-07,0.0,4.061753e-06,False,DERL1; derlin
hsa:5255,8.964678e-07,0.0007465359514467482,2.15780633074269e-05,6.536784488892843e-05,0.0,0.0005077335,False,PHKA1; phosphorylase kinase regulatory subunit alpha
hsa:3441,0.0,0.0,3.296932952046784e-06,1.3119678485064499e-05,0.0,9.496521e-05,False,IFNA4; interferon alpha
hsa:6360,0.0,0.0,1.500872781514503e-05,0.00011510695966905915,0.0,0.0014636125,False,CCL16; C-C motif chemokine ligand
hsa:23729,1.3977456e-06,0.001163976376370134,1.6590819972146198e-05,3.4976275244712966e-05,0.0,0.0002115981,False,SHPK;
hsa:4329,4.9970353e-05,0.04161294473821019,0.0003226822851990643,0.0006898135349969268,0.0,0.0050953603,False,ALDH6A1; aldehyde dehydrogenase 6 family member
hsa:7042,0.0,0.0,2.051246499473684e-05,6.802293350521804e-05,0.0,0.00042696405,False,TGFB2; transforming growth factor beta
hsa:407031,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30C1; microRNA
hsa:2915,3.485195e-07,0.0002902305431720414,1.4053317402565793e-05,5.725047165045475e-05,0.0,0.00048135497,False,GRM5; glutamate metabotropic receptor
hsa:8590,0.0,0.0,2.478695273684211e-07,2.6497965196327952e-06,0.0,3.4371988e-05,False,OR6A2; olfactory receptor family 6 subfamily A member
hsa:79339,0.0,0.0,6.271025379315789e-07,2.714491941598202e-06,0.0,2.3337292e-05,False,OR51B4; olfactory receptor family 51 subfamily B member
hsa:148213,2.9057379e-09,2.419760986207621e-06,3.3448912613099417e-08,5.5077740450276675e-08,0.0,2.218284e-07,False,ZNF681; zinc finger protein
hsa:23409,5.150146e-05,0.0428879781761226,0.00012338182025352663,0.00017409666049677096,0.0,0.0009336784,False,SIRT4; sirtuin
hsa:8916,1.05745364e-07,8.805973390770167e-05,3.1459193130175435e-07,4.957284012898931e-07,0.0,2.2756071e-06,False,HERC3; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:92745,2.6263933e-06,0.0021871360255090754,4.99829700603617e-05,0.00017705813769375593,0.0,0.0015335003,False,SLC38A5; solute carrier family 38 member
hsa:54913,0.0,0.0,2.8029987645438597e-07,9.615975804041812e-07,0.0,1.0176579e-05,False,RPP25; ribonuclease P and MRP subunit
hsa:53904,0.0,0.0,2.5027931310409354e-08,1.1550158671073917e-07,0.0,9.954844e-07,False,MYO3A; myosin
hsa:6119,6.164728e-05,0.051336936841350114,0.0004855004750090644,0.0008437418298091178,0.0,0.005062053,False,RPA3; replication protein
hsa:219749,0.0,0.0,4.275609495789473e-08,9.714365577261501e-08,0.0,5.180076e-07,False,ZNF25; zinc finger protein
hsa:3354,1.6343172e-06,0.0013609820072374998,0.000141600925749503,0.00036244354397902773,0.0,0.0026261972,False,HTR1E; 5-hydroxytryptamine receptor
hsa:51174,2.7732565e-08,2.309436747012418e-05,1.4373196579766083e-06,4.3720282372252155e-06,0.0,2.167932e-05,False,TUBD1; tubulin delta
hsa:5465,0.0,0.0,5.7036807591812865e-06,1.7129374543819097e-05,0.0,0.000110990026,False,PPARA; peroxisome proliferator activated receptor
hsa:7766,0.0,0.0,1.1909367328362573e-07,2.0794726995456677e-07,0.0,8.761956e-07,False,ZNF223; zinc finger protein
hsa:5924,4.169357e-08,3.472043161969855e-05,2.398393456883041e-07,4.375887915344166e-07,0.0,2.2860845e-06,False,RASGRF2; Ras protein specific guanine nucleotide releasing factor
hsa:10113,6.42145e-08,5.3474796143461266e-05,7.641153021160237e-07,1.6606473001733143e-06,0.0,8.289861e-06,False,PREB; prolactin regulatory element
hsa:90390,4.1467106e-06,0.0034531843119689474,1.7603360444246492e-05,3.8265916552615956e-05,0.0,0.00031997904,False,MED30; mediator complex subunit
hsa:1161,0.0,0.0,6.8351621189824526e-06,2.0870340341909777e-05,0.0,0.00012910282,False,ERCC8; ERCC excision repair 8
hsa:5879,0.0,0.0,0.00012660433274853803,0.00032910146658810294,0.0,0.0024515681,False,RAC1; Rac family small GTPase
hsa:29979,0.0,0.0,8.711328828415205e-07,1.811102142380294e-06,0.0,9.041902e-06,False,UBQLN1; ubiquilin
hsa:9063,0.0,0.0,3.558408822277779e-05,0.00010311956753476011,0.0,0.0005575664,False,PIAS2; protein inhibitor of activated STAT
hsa:64218,0.0,0.0,1.1591680023356713e-05,3.797064008754521e-05,0.0,0.00021234495,False,SEMA4A; semaphorin
hsa:6570,0.000113509275,0.09452515150031668,0.0007943832394623977,0.0013481939783453948,0.0,0.0066342074,False,SLC18A1; solute carrier family 18 member
hsa:79902,8.2136445e-08,6.839934364238013e-05,3.0203548650292397e-07,5.131831213379384e-07,0.0,2.4667897e-06,False,NUP85; nucleoporin
hsa:56475,5.176467e-07,0.00043107167005638065,0.00011102302477214985,0.00022309076791067676,0.0,0.0012889563,False,RPRM; reprimo
hsa:54498,0.0,0.0,1.3667176177192982e-05,3.530248341562396e-05,0.0,0.0001797228,False,SMOX; spermine
hsa:91133,0.0,0.0,2.9394056325353814e-06,1.2978548233899022e-05,0.0,9.760606e-05,False,L3MBTL4; L3MBTL histone methyl-lysine binding protein
hsa:54891,0.0,0.0,5.6812373610040146e-08,1.4262041326232441e-07,0.0,7.919416e-07,False,INO80D; INO80 complex subunit
hsa:4149,0.0,0.0,8.012206042690058e-06,3.988588494758673e-05,0.0,0.0003804131,False,MAX; MYC associated factor
hsa:56413,5.167254e-07,0.0004303044550241532,1.2492706766671931e-05,2.897888534261735e-05,0.0,0.0001959215,False,LTB4R2; leukotriene B4 receptor
hsa:387082,3.79528e-09,3.160529542507622e-06,2.18757051037427e-08,8.776691293407521e-08,0.0,1.0867387e-06,False,SUMO4; small ubiquitin like modifier
hsa:2244,0.0,0.0,1.3726959342894736e-06,8.25602898660049e-06,0.0,9.3697454e-05,False,FGB; fibrinogen beta
hsa:51513,0.0,0.0,1.682022726888889e-08,4.301139440402048e-08,0.0,3.5799238e-07,False,ETV7; ETS variant transcription factor
hsa:2743,0.0,0.0,1.2326304088782451e-05,3.9718508402896396e-05,0.0,0.0003660643,False,GLRB; glycine receptor
hsa:683,0.0,0.0,5.322195371128655e-05,0.0001635009974831083,0.0,0.0012564595,False,BST1; bone marrow stromal cell antigen
hsa:2712,0.0,0.0,1.2293648136842106e-07,7.960908584537462e-07,0.0,7.171285e-06,False,GK2; glycerol kinase
hsa:51588,0.0,0.0,2.6524318940350875e-07,8.529966475372128e-07,0.0,4.452236e-06,False,PIAS4; protein inhibitor of activated STAT
hsa:81570,0.0,0.0,1.8590187886491223e-05,5.1937489981959365e-05,0.0,0.00047037384,False,CLPB; ClpB family mitochondrial
hsa:27243,2.1500086e-06,0.00179042539600384,3.181888664812865e-05,9.039645486077275e-05,0.0,0.0005450873,False,CHMP2A; charged multivesicular body protein
hsa:1663,1.8954916e-07,0.00015784756854237474,2.27661149364386e-06,4.6223901004938965e-06,0.0,2.101842e-05,False,DDX11; DEAD/H-box helicase
hsa:2635,1.6192067e-07,0.0001348398698060822,5.657627139064328e-07,1.0120122680484603e-06,0.0,4.527058e-06,False,GBP3; guanylate binding protein
hsa:824,8.1519715e-07,0.0006788576008998065,3.4038818446403486e-05,0.00011070551616200507,0.0,0.0006747746,False,CAPN2; calpain
hsa:9862,1.6690826e-08,1.389932986811364e-05,7.195298857181287e-06,2.0686088389290795e-05,0.0,0.00017827972,False,MED24; mediator complex subunit
hsa:81930,2.1854316e-09,1.819923993731609e-06,3.5742592522652624e-07,1.0965487489339186e-06,0.0,5.480982e-06,False,KIF18A; kinesin family member
hsa:26827,0.0,0.0,3.338180760233918e-09,2.4816992404279013e-08,-0.0,2.8294343e-07,False,RNU6-1; RNA
hsa:122011,3.1019733e-06,0.0025831765389430707,8.972844676450292e-06,1.7226887926829987e-05,0.0,0.00011381961,False,CSNK1A1L; casein kinase 1 alpha 1
hsa:5798,3.205976e-05,0.0266978506475686,0.00016628878079239765,0.0002733153473835968,0.0,0.0014009423,False,PTPRN; protein tyrosine phosphatase receptor type
hsa:23521,2.2294222e-08,1.8565572832102867e-05,9.733378924345028e-07,1.7649811092549188e-06,0.0,7.117056e-06,False,RPL13A; ribosomal protein
hsa:7226,0.0,0.0,3.97402841102924e-07,9.860584228764624e-07,0.0,5.046566e-06,False,TRPM2; transient receptor potential cation channel subfamily M member
hsa:60682,0.0,0.0,6.480195956666665e-07,1.7620478194586293e-06,0.0,9.187095e-06,False,SMAP1; small ArfGAP
hsa:7529,2.993581e-06,0.0024929125620216453,1.3561460199999998e-05,2.12950359698221e-05,0.0,0.00015076403,False,YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:10794,0.0,0.0,7.558604357309943e-09,1.4221113138390318e-08,0.0,8.457495e-08,False,ZNF460; zinc finger protein
hsa:6629,0.0,0.0,3.33486731491228e-08,9.53997980979788e-08,0.0,5.6639857e-07,False,SNRPB2; small nuclear ribonucleoprotein polypeptide
hsa:160851,9.211824e-06,0.007671171005138153,0.00010949742461444438,0.00028928792578687256,0.0,0.0017030863,False,DGKH; diacylglycerol kinase
hsa:84765,0.0,0.0,1.2704310146257306e-07,3.5093004176713415e-07,0.0,2.1845742e-06,False,ZNF577; zinc finger protein
hsa:81309,0.0,0.0,2.0367273625730996e-08,2.4972409483500404e-07,0.0,3.2592186e-06,False,OR4C15; olfactory receptor family 4 subfamily C member
hsa:8811,0.0,0.0,1.2022257830409357e-08,5.882770689986576e-08,0.0,6.3428274e-07,False,GALR2; galanin receptor
hsa:1629,8.1447905e-07,0.0006782596012095399,4.161281230795321e-05,0.00016368501975770768,0.0,0.0015012369,False,DBT; dihydrolipoamide branched chain transacylase
hsa:130340,0.0,0.0,2.150262535892982e-07,4.351614687737282e-07,0.0,2.390863e-06,False,AP1S3; adaptor related protein complex 1 subunit sigma
hsa:28,6.986292e-07,0.000581785329635354,1.439508047076024e-05,3.144499363206115e-05,0.0,0.0002007263,False,ABO; ABO
hsa:9039,7.891642e-09,6.571785923540276e-06,6.446327162455938e-07,1.0744992736181884e-06,0.0,5.0812237e-06,False,UBA3; ubiquitin like modifier activating enzyme
hsa:10497,0.0,0.0,3.7816138975947366e-05,0.00012475383082434142,0.0,0.00071146653,False,UNC13B; unc-13 homolog
hsa:928,0.0,0.0,2.3593032274795337e-05,5.319116267509617e-05,0.0,0.00031623399,False,CD9; CD9
hsa:4193,7.9403326e-05,0.06612333150554467,0.0003210810625321638,0.0006046542294735722,0.0,0.0036020288,False,MDM2; MDM2
hsa:7273,5.0549293e-06,0.004209505856731881,3.818045884710438e-05,0.0001766813250474872,0.0,0.002246445,False,TTN;
hsa:3566,0.0,0.0,4.914677043274853e-06,1.6551150191498427e-05,0.0,0.00011393758,False,IL4R; interleukin 4
hsa:93010,2.1196395e-07,0.00017651354469804824,1.9297694052087725e-05,5.644571974484702e-05,0.0,0.00034145976,False,B3GNT7; UDP-GlcNAc:betaGal beta-1
hsa:5529,0.0,0.0,4.319514014619883e-06,1.0570637783971044e-05,0.0,6.479956e-05,False,PPP2R5E; protein phosphatase 2 regulatory subunit
hsa:5130,7.722901e-06,0.006431266405735982,9.591609009725146e-05,0.00018766448873325567,0.0,0.0008506019,False,PCYT1A; phosphate cytidylyltransferase 1A
hsa:54363,0.0,0.0,1.3479579388120464e-07,1.4819897285372564e-06,0.0,1.9356472e-05,False,HAO1; hydroxyacid oxidase
hsa:55315,0.0,0.0,1.3430594024385964e-06,3.4707140388966695e-06,0.0,2.5621242e-05,False,SLC29A3; solute carrier family 29 member
hsa:406912,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125B2; microRNA
hsa:7409,0.0,0.0,2.1577973321480698e-05,6.95087300546968e-05,0.0,0.00048626706,False,VAV1; vav guanine nucleotide exchange factor
hsa:526,3.0883526e-05,0.025718338646898844,0.0002588660134573099,0.00044795089050347263,0.0,0.0024331275,False,ATP6V1B2; ATPase H+ transporting V1 subunit
hsa:5822,2.8839595e-10,2.4016249655217824e-07,4.586594142915203e-07,1.369040005335461e-06,0.0,8.95871e-06,False,PWP2; PWP2 small subunit processome
hsa:199692,0.0,0.0,1.1219205912257311e-07,3.026362125435309e-07,0.0,1.379797e-06,False,ZNF627; zinc finger protein
hsa:83732,1.7872298e-07,0.00014883203827253824,3.5208397121997662e-06,6.670880832301205e-06,0.0,3.7776776e-05,False,RIOK1; RIO kinase
hsa:10200,1.10045974e-07,9.164107835549043e-05,3.523348810678363e-06,1.1446563898942113e-05,0.0,7.5310956e-05,False,MPHOSPH6; M-phase phosphoprotein
hsa:10038,0.0,0.0,6.323097859795326e-06,1.1835617768018072e-05,0.0,6.1030478e-05,False,PARP2; poly(ADP-ribose) polymerase
hsa:55762,7.0878976e-11,5.9024656307489494e-08,3.927227818617543e-08,8.48892456291811e-08,0.0,4.9893526e-07,False,ZNF701; zinc finger protein
hsa:83443,0.0,0.0,2.670133073754385e-07,4.4116601720427404e-07,0.0,2.770964e-06,False,SF3B5; splicing factor 3b subunit
hsa:26286,2.3065645e-08,1.9207977392838797e-05,7.861285736555556e-07,2.147693292430456e-06,0.0,1.2552317e-05,False,ARFGAP3; ADP ribosylation factor GTPase activating protein
hsa:131405,0.0,0.0,4.8912796062578924e-08,3.120686832117981e-07,0.0,2.9347577e-06,False,TRIM71; tripartite motif containing
hsa:4600,0.0,0.0,6.17935524625731e-06,1.8792921439865028e-05,0.0,0.00018421715,False,MX2; MX dynamin like GTPase
hsa:22871,4.184699e-07,0.0003484819253388974,2.012509513035672e-06,4.122736188492881e-06,0.0,3.330711e-05,False,NLGN1; neuroligin
hsa:9392,2.6589655e-07,0.00022142606119333885,7.01272821902105e-05,0.00013324481223284988,0.0,0.00089209067,False,TGFBRAP1; transforming growth factor beta receptor associated protein
hsa:5565,0.00028812164,0.23993406416805765,0.000511826797362573,0.0007114289851397463,0.0,0.0035376952,False,PRKAB2; protein kinase AMP-activated non-catalytic subunit beta
hsa:23235,1.0329843e-07,8.6022043092909e-05,1.1347226659005848e-06,2.756143047365064e-06,0.0,1.8010038e-05,False,SIK2; salt inducible kinase
hsa:23560,8.000254e-08,6.66223285622267e-05,2.3108988662754387e-06,4.646953877592162e-06,0.0,2.2142049e-05,False,GTPBP4; GTP binding protein
hsa:9739,0.0,0.0,1.0171233484678362e-05,3.039699031880913e-05,0.0,0.0001736805,False,SETD1A; SET domain containing 1A
hsa:10325,2.2968761e-07,0.0001912729698343651,3.3280357982900586e-06,6.008056139562316e-06,0.0,3.717881e-05,False,RRAGB; Ras related GTP binding
hsa:8875,2.6552203e-07,0.00022111417866444512,1.4349899170750882e-05,3.929362302883121e-05,0.0,0.0004179099,False,VNN2; vanin
hsa:402317,0.0,0.0,3.456804277228069e-06,1.2688206627873512e-05,0.0,0.000111263435,False,OR2A42; olfactory receptor family 2 subfamily A member
hsa:353164,1.0456006e-06,0.0008707266884034104,1.075537586140351e-05,1.9794775763261467e-05,0.0,0.00012462123,False,TAS2R42; taste 2 receptor member
hsa:9782,0.0,0.0,2.7319811767251458e-08,5.903826928174283e-08,0.0,3.3368133e-07,False,MATR3; matrin
hsa:2539,2.2496182e-05,0.018733755560756574,8.177562400233918e-05,0.00013887851769197424,0.0,0.00089373376,False,G6PD; glucose-6-phosphate
hsa:10402,0.0,0.0,1.1341090510526315e-05,6.552772410426536e-05,0.0,0.00063961954,False,ST3GAL6; ST3 beta-galactoside alpha-2
hsa:4295,0.0,0.0,1.008782844835263e-06,5.504440604406337e-06,0.0,6.3984015e-05,False,MLN;
hsa:6238,0.0,0.0,6.591124639994153e-07,1.6768127677763299e-06,0.0,8.438156e-06,False,RRBP1; ribosome binding protein
hsa:4008,4.259985e-07,0.0003547513870686572,1.3476270694444446e-05,2.7723189127064723e-05,0.0,0.00014380312,False,LMO7; LIM domain
hsa:23464,2.7072338e-06,0.002254456167496251,1.4319610662350888e-05,2.5926227166415143e-05,0.0,0.00014779094,False,GCAT; glycine
hsa:7094,0.0,0.0,2.8840135602210526e-06,8.276144967151105e-06,0.0,4.148115e-05,False,TLN1; talin
hsa:5356,3.0164856e-08,2.511986428761206e-05,1.5812736871812857e-07,2.542011079248352e-07,0.0,1.7750662e-06,False,PLRG1; pleiotropic regulator
hsa:8667,0.0,0.0,3.7404999662638013e-06,1.0829349510500395e-05,0.0,8.891066e-05,False,EIF3H; eukaryotic translation initiation factor 3 subunit
hsa:255043,0.0,0.0,8.278729265672516e-06,1.892497469658399e-05,0.0,0.00017144019,False,TMEM86B; transmembrane protein
hsa:25766,2.7052014e-08,2.252763680975575e-05,9.495006017485381e-08,1.6654067980356317e-07,0.0,1.1384244e-06,False,PRPF40B; pre-mRNA processing factor 40 homolog
hsa:7518,0.0,0.0,0.00010545258622120467,0.00031446756749414355,0.0,0.0022428187,False,XRCC4; X-ray repair cross complementing
hsa:389090,0.0,0.0,1.5675386014035082e-07,5.444750426836789e-07,0.0,3.7766667e-06,False,OR6B2; olfactory receptor family 6 subfamily B member
hsa:7035,8.905344e-08,7.415948967715953e-05,1.2768001785964916e-06,2.2477920161191133e-06,0.0,1.47754245e-05,False,TFPI; tissue factor pathway
hsa:3820,0.0,0.0,2.2815031264912272e-06,6.060377847697898e-06,0.0,4.4731325e-05,False,KLRB1; killer cell lectin like receptor
hsa:392138,0.0,0.0,2.383086482222222e-07,1.4408395312991729e-06,0.0,1.3315026e-05,False,OR2A25; olfactory receptor family 2 subfamily A member
hsa:84701,0.0,0.0,4.179270418487719e-05,0.00012372871226165824,0.0,0.0011399357,False,COX4I2; cytochrome c oxidase subunit
hsa:51652,0.0,0.0,1.4223127600467836e-06,2.6862878508733776e-06,0.0,1.0847335e-05,False,CHMP3; charged multivesicular body protein
hsa:26503,2.3708475e-07,0.00019743295789850394,6.813034696088889e-07,1.0874770447128497e-06,0.0,6.272419e-06,False,SLC17A5; solute carrier family 17 member
hsa:9156,1.197531e-05,0.009972471342216372,0.00026692609767540337,0.0005613655881482216,0.0,0.003256351,False,EXO1; exonuclease
hsa:51194,1.342802e-09,1.1182219469283743e-06,3.829375664546783e-08,7.410312432074929e-08,0.0,3.7354795e-07,False,IPO11; importin
hsa:23062,3.676695e-07,0.0003061777567475934,1.0235895890596488e-06,1.3565611677359527e-06,0.0,5.0493927e-06,False,GGA2; golgi associated
hsa:109,0.0,0.0,0.0003997342033567251,0.0006746135334727162,0.0,0.004007716,False,ADCY3; adenylate cyclase
hsa:119687,0.0,0.0,1.3008469005847953e-07,1.381642168784071e-06,0.0,1.744696e-05,False,OR51A7; olfactory receptor family 51 subfamily A member
hsa:219954,0.0,0.0,9.483298321637427e-08,1.0738687461773428e-06,0.0,1.3918312e-05,False,OR9I1; olfactory receptor family 9 subfamily I member
hsa:55900,0.0,0.0,2.0339114374093576e-07,5.430460871228991e-07,0.0,2.740162e-06,False,ZNF302; zinc finger protein
hsa:10398,0.0,0.0,2.0426065914035083e-06,5.503687570264138e-06,0.0,2.535151e-05,False,MYL9; myosin light chain
hsa:10728,6.8887603e-06,0.0057366335130487525,5.629234079549713e-05,0.0001520426929228116,0.0,0.0015723411,False,PTGES3; prostaglandin E synthase
hsa:80816,1.9741938e-08,1.6440151523827975e-05,1.1237422400047952e-05,7.962975586243295e-05,0.0,0.0007769704,False,ASXL3; ASXL transcriptional regulator
hsa:1327,2.4363464e-06,0.0020288739626541635,2.3455829148947372e-05,4.437751266631393e-05,0.0,0.00026662063,False,COX4I1; cytochrome c oxidase subunit
hsa:2531,1.6829988e-08,1.4015217394776872e-05,1.936643126697777e-05,4.8236011785148084e-05,0.0,0.00037316175,False,KDSR; 3-ketodihydrosphingosine
hsa:3162,0.0,0.0,2.9070631459064313e-05,4.416157628645458e-05,0.0,0.00025873893,False,HMOX1; heme oxygenase
hsa:10838,3.2370902e-08,2.6956954977924966e-05,1.0458561507602336e-07,1.820687281406916e-07,0.0,9.6581e-07,False,ZNF275; zinc finger protein
hsa:256892,-0.0,0.0,7.31446783625731e-09,9.564907837207262e-08,0.0,1.250774e-06,False,OR51F1; olfactory receptor family 51 subfamily F member
hsa:1959,0.0,0.0,3.792787765380117e-07,1.2721238297173344e-06,0.0,1.1518389e-05,False,EGR2; early growth response
hsa:4245,0.0,0.0,7.983896902923978e-06,3.664114901410384e-05,0.0,0.00025705228,False,MGAT1; alpha-1
hsa:9626,0.0,0.0,1.401916881733334e-05,7.00894242123735e-05,0.0,0.000813398,False,GUCA1C; guanylate cyclase activator
hsa:23556,0.0,0.0,6.996313613450292e-06,1.4035710431348172e-05,0.0,0.000114921604,False,PIGN; phosphatidylinositol glycan anchor biosynthesis class
hsa:79054,0.0,0.0,7.753015829352633e-06,2.085422333174085e-05,0.0,0.00019501607,False,TRPM8; transient receptor potential cation channel subfamily M member
hsa:201625,8.888529e-09,7.401946231618149e-06,4.023342949070176e-07,1.6079805365894212e-06,0.0,1.4448397e-05,False,DNAH12; dynein axonemal heavy chain
hsa:3761,1.1788046e-08,9.816526746758818e-06,1.474075230137427e-06,6.465707013986845e-06,0.0,5.8280577e-05,False,KCNJ4; potassium inwardly rectifying channel subfamily J member
hsa:1659,3.4500875e-08,2.8730695674591248e-05,6.470006447520468e-07,1.6648268563914789e-06,0.0,9.454422e-06,False,DHX8; DEAH-box helicase
hsa:115024,1.0925456e-08,9.09820262361859e-06,0.00042966029366296927,0.0009867575837986247,0.0,0.0052632415,False,NT5C3B; 5'-nucleotidase
hsa:10235,1.6039644e-06,0.0013357056320826167,4.333680343274855e-06,5.74248389468616e-06,0.0,2.4098059e-05,False,RASGRP2; RAS guanyl releasing protein
hsa:64319,8.42687e-08,7.01749846806328e-05,8.037055329564914e-06,2.8230362823820154e-05,0.0,0.00016983837,False,FBRS;
hsa:11019,0.0,0.0,1.4574882708362575e-06,5.368042916534415e-06,0.0,5.638098e-05,False,LIAS; lipoic acid
hsa:58478,6.591851e-06,0.005489381501577858,0.000167998141794061,0.0004452570932736158,0.0,0.0028669743,False,ENOPH1; enolase-phosphatase
hsa:29078,0.0,0.0,6.29826463991228e-07,1.896548330911576e-06,0.0,9.825918e-06,False,NDUFAF4; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:81029,4.1092004e-05,0.03421947592874344,9.526022227836258e-05,0.0002055256242263794,0.0,0.0022406308,False,WNT5B; Wnt family member
hsa:23130,0.0,0.0,3.809151711649122e-05,0.00016166621083277217,0.0,0.0019441183,False,ATG2A; autophagy related
hsa:4069,0.0,0.0,2.85345830051462e-05,7.029328730372671e-05,0.0,0.00034414965,False,LYZ;
hsa:3624,0.0,0.0,2.881121103801169e-07,2.34857868873484e-06,0.0,3.032033e-05,False,INHBA; inhibin subunit beta
hsa:2187,0.0,0.0,2.7200304347111105e-05,8.255826772129909e-05,0.0,0.0004697066,False,FANCB; FA complementation group
hsa:387,0.0,0.0,0.00015168725000058478,0.00030786571414637837,0.0,0.001473907,False,RHOA; ras homolog family member
hsa:5021,0.0,0.0,1.162939647362573e-05,3.0465811387764188e-05,0.0,0.00025044318,False,OXTR; oxytocin
hsa:57758,9.116092e-07,0.0007591449926808403,2.330656123722222e-05,4.381171780184244e-05,0.0,0.00030731322,False,SCUBE2; signal peptide
hsa:8321,0.0,0.0,0.0,0.0,0.0,0.0,False,FZD1; frizzled class receptor
hsa:6878,2.579615e-07,0.00021481812714202375,9.684939688304096e-07,1.8198079279230264e-06,0.0,1.3617733e-05,False,TAF6; TATA-box binding protein associated factor
hsa:10266,2.7457733e-07,0.00022865500389111331,4.971716827116962e-06,8.758892221137839e-06,0.0,4.672401e-05,False,RAMP2; receptor activity modifying protein
hsa:784,0.0002323632,0.1935010745430132,0.00036926095251345017,0.000452315705961405,0.0,0.0025631287,False,CACNB3; calcium voltage-gated channel auxiliary subunit beta
hsa:1195,0.0,0.0,1.499519696321637e-05,3.155036094621342e-05,0.0,0.00014742209,False,CLK1; CDC like kinase
hsa:3836,8.1149074e-07,0.0006757710780868266,1.4506634542029238e-05,3.25973413716884e-05,0.0,0.00016169078,False,KPNA1; karyopherin subunit alpha
hsa:80328,3.230621e-08,2.690308254238295e-05,3.312202948251462e-06,1.4905858936835302e-05,0.0,0.00013395806,False,ULBP2; UL16 binding protein
hsa:3250,0.0,0.0,1.8024282927736844e-05,0.0001133264206207756,0.0,0.0013812198,False,HPR; haptoglobin-related
hsa:3554,0.0,0.0,5.2547727280970755e-05,0.00016896167431334425,0.0,0.0017118837,False,IL1R1; interleukin 1 receptor type
hsa:3766,1.10867866e-07,9.232551111058377e-05,4.372921969684211e-06,9.432063425716465e-06,0.0,5.656953e-05,False,KCNJ10; potassium inwardly rectifying channel subfamily J member
hsa:196883,0.0,0.0,1.9470018350877192e-05,8.158835292779904e-05,0.0,0.00063339795,False,ADCY4; adenylate cyclase
hsa:6132,8.4815056e-08,7.062996409683564e-05,4.880127388070173e-07,1.0483599230218992e-06,0.0,5.3100766e-06,False,RPL8; ribosomal protein
hsa:11152,0.0,0.0,1.5740634463596492e-06,5.097268517664772e-06,0.0,3.3178996e-05,False,WDR45; WD repeat domain
hsa:91860,0.0008365803,0.6966644760939613,0.0010397298178450294,0.0011585320395249988,0.0,0.006482732,True,CALML4; calmodulin like
hsa:995,0.0,0.0,2.366845237239181e-05,7.294385584607922e-05,0.0,0.00050924957,False,CDC25C; cell division cycle
hsa:6990,0.0,0.0,2.2974757074093572e-07,4.6618137712216335e-07,0.0,2.6259631e-06,False,DYNLT3; dynein light chain Tctex-type
hsa:10316,0.0,0.0,4.153730231402335e-07,1.7184082111250396e-06,0.0,1.6247448e-05,False,NMUR1; neuromedin U receptor
hsa:118424,0.0,0.0,9.325192892251469e-07,2.1376422721735334e-06,0.0,1.2982733e-05,False,UBE2J2; ubiquitin conjugating enzyme E2
hsa:7205,2.4998312e-07,0.00020817410991764193,5.02976581745813e-07,6.161348477634051e-07,0.0,2.4144388e-06,False,TRIP6; thyroid hormone receptor interactor
hsa:10090,0.0,0.0,3.783891476666667e-06,1.162630809068135e-05,0.0,8.368192e-05,False,UST; uronyl
hsa:406917,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR129-1; microRNA
hsa:90427,0.0,0.0,5.5735123191871364e-08,1.2299906762274302e-07,0.0,5.358486e-07,False,BMF; Bcl2 modifying
hsa:5896,3.4141747e-06,0.002843163087474995,4.295367568561403e-05,9.556964014517076e-05,0.0,0.00064848084,False,RAG1; recombination activating
hsa:403253,0.0,0.0,6.693972664327485e-07,5.408866218323619e-06,0.0,5.9578353e-05,False,OR4A47; olfactory receptor family 4 subfamily A member
hsa:26525,0.0,0.0,5.358403864678363e-08,6.101233414309148e-07,0.0,7.9721e-06,False,IL36RN; interleukin 36 receptor
hsa:4793,0.0,0.0,1.4826143385438597e-05,6.119470594426764e-05,0.0,0.00049763935,False,NFKBIB; NFKB inhibitor
hsa:26289,2.732321e-07,0.00022753476002070915,2.1494441042532165e-05,5.672623464302339e-05,0.0,0.00033772568,False,AK5; adenylate kinase
hsa:729238,3.43637e-09,2.8616462827477596e-06,1.4585174342337428e-06,7.157819868410322e-06,0.0,7.006871e-05,False,SFTPA2; surfactant protein
hsa:2965,0.0,0.0,8.503446414619886e-07,1.7812291058341176e-06,0.0,1.137488e-05,False,GTF2H1; general transcription factor IIH subunit
hsa:55823,0.0,0.0,0.0001285139551461667,0.000311149812222045,0.0,0.0015275213,False,VPS11; VPS11 core subunit of CORVET and HOPS
hsa:2534,4.9035694e-05,0.040834604963102525,0.0005727885171127196,0.0009691507672774663,0.0,0.005576898,False,FYN; FYN proto-oncogene
hsa:2872,7.8254357e-07,0.0006516652450634424,3.3217979433567253e-05,8.771069273064608e-05,0.0,0.0005139952,False,MKNK2; MAPK interacting serine/threonine kinase
hsa:87178,0.0,0.0,2.531737796140351e-07,6.080578199396345e-07,0.0,3.86556e-06,False,PNPT1; polyribonucleotide nucleotidyltransferase
hsa:10672,0.0,0.0,0.00021071332430584781,0.0005366200665168199,0.0,0.003202792,False,GNA13; G protein subunit alpha
hsa:645974,0.0,0.0,4.2093342975321637e-07,1.2581379647789928e-06,0.0,9.260182e-06,False,PABPC1L2B; poly(A) binding protein cytoplasmic 1 like
hsa:4331,0.0,0.0,8.063790454473688e-07,2.538966654495653e-06,0.0,2.597403e-05,False,MNAT1; MNAT1 component of CDK activating
hsa:6790,3.2235607e-06,0.002684428770582553,4.3151597344269013e-05,0.00011877770542993531,0.0,0.00071373716,False,AURKA; aurora kinase
hsa:338,0.0,0.0,1.998235560982456e-05,0.00012100803018166864,0.0,0.0013925633,False,APOB; apolipoprotein
hsa:126370,0.0,0.0,5.5075893099415203e-08,3.9075641410328185e-07,0.0,3.8168073e-06,False,OR1I1; olfactory receptor family 1 subfamily I member
hsa:2775,2.5280493e-05,0.02105239797212779,0.0002302507659064327,0.0003868555067250804,0.0,0.002156324,False,GNAO1; G protein subunit alpha
hsa:7320,0.0,0.0,5.891586341081871e-07,1.4642730193027484e-06,0.0,9.814898e-06,False,UBE2B; ubiquitin conjugating enzyme E2
hsa:1630,2.2352688e-07,0.00018614260549539328,1.5228475246651454e-05,4.637629005776044e-05,0.0,0.00030609776,False,DCC; DCC netrin 1
hsa:7832,1.9295493e-07,0.00016068373259350832,1.0548386600818713e-06,1.7478884490300779e-06,0.0,7.281911e-06,False,BTG2; BTG anti-proliferation factor
hsa:6999,0.0,0.0,4.225306032824561e-06,1.0922195721036488e-05,0.0,8.4274245e-05,False,TDO2; tryptophan
hsa:5473,1.5052925e-06,0.0012535363441867674,0.0001028495612148333,0.00041860430246386634,0.0,0.0036150864,False,PPBP; pro-platelet basic
hsa:119749,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4C46; olfactory receptor family 4 subfamily C member
hsa:3823,0.0,0.0,9.031056678011701e-07,3.770548553048231e-06,0.0,3.3995046e-05,False,KLRC3; killer cell lectin like receptor
hsa:7874,0.0,0.0,2.235060062105263e-05,5.697358644071513e-05,0.0,0.00044935857,False,USP7; ubiquitin specific peptidase
hsa:64768,0.0,0.0,1.6078562302801175e-05,4.212049410553e-05,0.0,0.00028217662,False,IPPK; inositol-pentakisphosphate
hsa:5594,0.0,0.0,0.0008431043729157895,0.0013829707590950779,0.0,0.0060856016,False,MAPK1; mitogen-activated protein kinase
hsa:4776,0.0,0.0,0.00018897741774269,0.00039667199253742353,0.0,0.0021802832,False,NFATC4; nuclear factor of activated T cells
hsa:100169759,0.0,0.0,3.7023591614385965e-08,2.8407459032274613e-07,0.0,2.8402426e-06,False,RNA5S8; RNA
hsa:391,4.967678e-08,4.1368471039462644e-05,3.8136752966374264e-06,8.935602734239077e-06,0.0,4.7903693e-05,False,RHOG; ras homolog family member
hsa:1021,0.00021556977,0.17951630092024126,0.00046103838249707594,0.0005860001913105395,0.0,0.0026489496,False,CDK6; cyclin dependent kinase
hsa:11338,0.0,0.0,1.874074261461988e-07,4.496836868914653e-07,0.0,2.1787212e-06,False,U2AF2; U2 small nuclear RNA auxiliary factor
hsa:100532726,0.0,0.0,4.57189399134503e-07,1.3555360621479997e-06,0.0,1.2307787e-05,False,NDUFC2-KCTD14; NDUFC2-KCTD14
hsa:718,0.0,0.0,8.892534821111109e-05,0.0001936570259681514,0.0,0.001107224,False,C3; complement
hsa:113235,0.00024292542,0.20229679141883392,0.0006851082959187134,0.001042025397794211,0.0,0.0071564694,False,SLC46A1; solute carrier family 46 member
hsa:407036,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR32; microRNA
hsa:50636,3.7232674e-08,3.100560857790609e-05,3.3256038444286558e-06,1.1541836485913825e-05,0.0,8.90066e-05,False,ANO7; anoctamin
hsa:4489,0.0,0.0,1.8941050775935673e-06,9.321645771463036e-06,0.0,8.28884e-05,False,MT1A; metallothionein
hsa:2245,0.0,0.0,2.5658944385964913e-08,5.817966071925619e-08,0.0,3.7892084e-07,False,FGD1; FYVE
hsa:390144,0.0,0.0,2.986149239766082e-07,2.525853703085126e-06,0.0,3.056883e-05,False,OR5D16; olfactory receptor family 5 subfamily D member
hsa:79862,0.0,0.0,5.358597134736842e-08,1.2249075168120558e-07,0.0,5.917999e-07,False,ZNF669; zinc finger protein
hsa:5372,7.138752e-06,0.005944814767984278,6.712664952463156e-05,0.00013724843586334606,0.0,0.0007406329,False,PMM1; phosphomannomutase
hsa:7200,0.0,0.0,6.447854531299531e-06,1.826740025576018e-05,0.0,0.00015914673,False,TRH; thyrotropin releasing
hsa:4802,1.1529293e-06,0.0009601049495880761,8.330597186239766e-06,1.7424757763614465e-05,0.0,0.00010989457,False,NFYC; nuclear transcription factor Y subunit
hsa:442194,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10C1; olfactory receptor family 10 subfamily C member
hsa:1300,0.0,0.0,7.219281467035089e-07,3.986613643995497e-06,0.0,4.9367965e-05,False,COL10A1; collagen type X alpha 1
hsa:57571,0.0,0.0,1.4668880091789465e-05,3.379028461881923e-05,0.0,0.0002077776,False,CARNS1; carnosine synthase
hsa:51256,3.8939947e-07,0.0003242734472217624,2.410497038929825e-06,4.986959444490002e-06,0.0,2.6589636e-05,False,TBC1D7; TBC1 domain family member
hsa:64223,1.016645e-06,0.0008466138352750419,0.0006911812445467836,0.002129477284427122,0.0,0.010891147,False,MLST8; MTOR associated protein
hsa:117157,7.503774e-09,6.248787812045643e-06,2.6712664686988306e-06,9.676691278021565e-06,0.0,7.4653304e-05,False,SH2D1B; SH2 domain containing
hsa:25788,4.779424e-09,3.9800780833482504e-06,6.756340754654387e-06,2.0178828590535227e-05,0.0,0.0001234165,False,RAD54B; RAD54 homolog
hsa:7554,1.1889534e-08,9.901041149440572e-06,9.24415904251462e-08,2.0174977757127944e-07,0.0,9.0187456e-07,False,ZNF8; zinc finger protein
hsa:27034,4.012999e-09,3.3418356204426403e-06,1.1384261615853803e-06,1.9320697678286653e-06,0.0,1.2107783e-05,False,ACAD8; acyl-CoA dehydrogenase family member
hsa:10654,9.932432e-07,0.000827125923909384,9.584422915198835e-05,0.00030287183313688914,0.0,0.002211218,False,PMVK; phosphomevalonate
hsa:8506,2.1268222e-06,0.001771116859562682,7.2866554486458095e-06,1.0108731041106175e-05,0.0,4.4692904e-05,False,CNTNAP1; contactin associated protein
hsa:8829,5.703218e-07,0.0004749370000727545,2.4545668351052636e-05,6.501123324689905e-05,0.0,0.0003990647,False,NRP1; neuropilin
hsa:1258,0.0009943326,0.8280331246649562,0.0013444681313953214,0.0013472359328914774,0.0,0.006442287,True,CNGB1; cyclic nucleotide gated channel subunit beta
hsa:7802,3.796922e-08,3.161896922387051e-05,3.252631942022223e-06,1.0117244440651585e-05,0.0,5.4223525e-05,False,DNALI1; dynein axonemal light intermediate chain
hsa:2797,1.6206393e-06,0.0013495916995317535,3.0473084505789466e-05,5.445463320628496e-05,0.0,0.0002613636,False,GNRH2; gonadotropin releasing hormone
hsa:6217,2.9058485e-08,2.4198530886526056e-05,8.648117182853801e-07,1.6039582984557564e-06,0.0,7.4453733e-06,False,RPS16; ribosomal protein
hsa:9573,0.0,0.0,5.559663711637427e-07,2.6985815622562483e-06,0.0,2.493287e-05,False,GDF3; growth differentiation factor
hsa:11340,4.8794554e-08,4.063379498495064e-05,3.323529671580117e-05,0.00012566135738083958,0.0,0.0010107824,False,EXOSC8; exosome component
hsa:6514,0.0,0.0,5.5562025297543866e-05,0.0003388025059507601,0.0,0.003108815,False,SLC2A2; solute carrier family 2 member
hsa:90665,0.0,0.0,8.898516809140351e-08,5.845888541687106e-07,0.0,6.2936324e-06,False,TBL1Y; transducin beta like 1
hsa:284716,0.0,0.0,2.2699506381871343e-06,6.242046510194171e-06,0.0,5.252596e-05,False,RIMKLA; ribosomal modification protein rimK like family member
hsa:941,7.028348e-05,0.05852875542522386,0.0001709646094577192,0.00025814225431431917,0.0,0.0014246755,False,CD80; CD80
hsa:84620,0.0,0.0,1.72747029336959e-05,5.9424145645494294e-05,0.0,0.00045427625,False,ST6GAL2; ST6 beta-galactoside alpha-2
hsa:9532,7.973033e-10,6.639564495870706e-07,8.344482297426902e-08,1.4043151458436587e-07,0.0,7.5633125e-07,False,BAG2; BAG cochaperone
hsa:4043,0.0,0.0,3.213144023081871e-05,9.505689631450922e-05,0.0,0.00045464057,False,LRPAP1; LDL receptor related protein associated protein
hsa:7625,0.0,0.0,2.4775688113719287e-07,5.475350116862409e-07,0.0,2.4742583e-06,False,ZNF74; zinc finger protein
hsa:403282,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6C65; olfactory receptor family 6 subfamily C member
hsa:8772,0.0,0.0,0.00021765881258888883,0.0005293135523072942,0.0,0.0029931446,False,FADD; Fas associated via death
hsa:5031,0.0,0.0,3.455738871204678e-06,1.174265347826243e-05,0.0,9.062639e-05,False,P2RY6; pyrimidinergic receptor
hsa:6603,0.0,0.0,2.0670877265438585e-06,7.378141677034812e-06,0.0,4.370913e-05,False,SMARCD2; SWI/SNF related
hsa:79345,-0.0,0.0,4.327695210526316e-08,3.422504705569986e-07,0.0,3.8060195e-06,False,OR51B2; olfactory receptor family 51 subfamily B member
hsa:115,0.0,0.0,7.649458692748538e-05,0.00024265002092188907,0.0,0.0016226305,False,ADCY9; adenylate cyclase
hsa:100169762,0.0,0.0,8.398389012812864e-08,5.672151753293848e-07,0.0,5.5731916e-06,False,RNA5S11; RNA
hsa:7581,2.2983698e-08,1.913973581002544e-05,5.9579324429824544e-08,8.342105783005184e-08,0.0,4.6540626e-07,False,ZNF33A; zinc finger protein
hsa:2733,1.8138726e-07,0.00015105072454852107,4.116736445263158e-07,5.059675623828467e-07,0.0,2.070271e-06,False,GLE1; GLE1 RNA export
hsa:5169,0.0,0.0,1.0184875789532166e-05,3.760582428741503e-05,0.0,0.00029392348,False,ENPP3; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:4122,0.0,0.0,8.467728755770176e-05,0.00027885208588645664,0.0,0.0018322412,False,MAN2A2; mannosidase alpha class 2A member
hsa:6865,0.0,0.0,7.599546456140352e-09,2.9601072495497547e-08,0.0,2.3803601e-07,False,TACR2; tachykinin receptor
hsa:3059,5.52095e-07,0.00045975858375949755,4.229763235602339e-06,1.0199603053252986e-05,0.0,4.7986898e-05,False,HCLS1; hematopoietic cell-specific Lyn substrate
hsa:90952,2.4963856e-06,0.0020788717665865537,3.8240338049649125e-05,8.116285089727954e-05,0.0,0.0004885887,False,ESAM; endothelial cell adhesion
hsa:22908,0.0,0.0,1.3480871377111114e-05,4.255893252766735e-05,0.0,0.00029226753,False,SACM1L; SAC1 like phosphatidylinositide
hsa:22803,0.0,0.0,1.4197973941169594e-06,2.6574169777019055e-06,0.0,1.2399003e-05,False,XRN2; 5'-3' exoribonuclease
hsa:25799,9.425622e-09,7.849211859865354e-06,5.546434101421055e-08,8.976796500098043e-08,0.0,4.334919e-07,False,ZNF324; zinc finger protein
hsa:472,0.0,0.0,6.655693009730993e-05,0.00017504437473995596,0.0,0.0009897297,False,ATM; ATM serine/threonine
hsa:4615,0.0,0.0,8.426879524368418e-05,0.0001563840141923158,0.0,0.00097403605,False,MYD88; MYD88 innate immune signal transduction
hsa:3727,1.5499714e-05,0.012907428173262315,4.3789677432163754e-05,8.705080779632747e-05,0.0,0.0008143988,False,JUND; JunD proto-oncogene
hsa:147746,0.0,0.0,4.956786845941521e-08,1.3288216335673605e-07,0.0,8.842814e-07,False,HIPK4; homeodomain interacting protein kinase
hsa:407040,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR34A; microRNA
hsa:50615,1.7892005e-06,0.0014899614884064968,3.718600150434503e-05,7.292657937118945e-05,0.0,0.0005350364,False,IL21R; interleukin 21
hsa:10544,0.0,0.0,2.015133672374854e-06,6.780318039699264e-06,0.0,7.821115e-05,False,PROCR; protein C
hsa:23657,0.0,0.0,9.681812889766078e-07,2.1982693962590355e-06,0.0,1.4748849e-05,False,SLC7A11; solute carrier family 7 member
hsa:710,4.8550723e-06,0.004043074406937151,1.911673511350877e-05,4.236499725220429e-05,0.0,0.0003120501,False,SERPING1; serpin family G member
hsa:64241,8.266952e-05,0.0688432632704108,0.0002712350213539179,0.00048145403213544245,0.0,0.003835646,False,ABCG8; ATP binding cassette subfamily G member
hsa:200931,0.0,0.0,4.1326323009181286e-06,1.2557217498376313e-05,0.0,7.152161e-05,False,SLC51A; solute carrier family 51 member
hsa:7700,7.844775e-09,6.532757304289864e-06,7.136072183274852e-08,1.2208397730741183e-07,0.0,6.9807396e-07,False,ZNF141; zinc finger protein
hsa:219453,0.0,0.0,5.062176590643275e-07,6.468512116177934e-06,0.0,8.45751e-05,False,OR8K5; olfactory receptor family 8 subfamily K member
hsa:2661,0.0,0.0,4.5680563856406414e-05,8.871085123252188e-05,0.0,0.00044593186,False,GDF9; growth differentiation factor
hsa:10467,6.0789944e-08,5.0622988000722994e-05,7.747903683929824e-06,2.202178435778477e-05,0.0,0.00012169902,False,ZNHIT1; zinc finger HIT-type containing
hsa:9266,4.753348e-06,0.003958363224800152,8.545372883157901e-06,1.2671150676988984e-05,0.0,8.798719e-05,False,CYTH2; cytohesin
hsa:5646,8.866571e-05,0.07383660648553295,0.0001999163989157895,0.00028274087382163833,0.0,0.0013183156,False,PRSS3; serine protease
hsa:5555,0.0,0.0,4.222911313430994e-05,0.00010082166044411644,0.0,0.0009007276,False,PRH2; proline rich protein HaeIII subfamily
hsa:57654,8.5295305e-08,7.102989273247247e-05,1.0291678159694153e-06,1.6301978477352943e-06,0.0,7.8003095e-06,False,UVSSA; UV stimulated scaffold protein
hsa:316,0.0,0.0,5.015777144093567e-06,4.6807105045267373e-05,0.0,0.00060973346,False,AOX1; aldehyde oxidase
hsa:923,4.65679e-09,3.877954292767351e-06,4.231034365192401e-06,1.2071517991780657e-05,0.0,8.650554e-05,False,CD6; CD6
hsa:9953,1.959044e-07,0.00016313991160263019,0.00012747998684027487,0.00043853640171581947,0.0,0.0027345147,False,HS3ST3B1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:2114,0.0,0.0,5.219982011070175e-07,1.1045274831825378e-06,0.0,5.972762e-06,False,ETS2; ETS proto-oncogene 2
hsa:1670,0.0,0.0,1.1324051008771927e-05,7.621640780466417e-05,0.0,0.0008178032,False,DEFA5; defensin alpha
hsa:10171,0.0,0.0,7.935480464918244e-07,2.236791092184034e-06,0.0,1.1908607e-05,False,RCL1; RNA terminal phosphate cyclase like
hsa:340529,0.0,0.0,5.168192790343625e-06,2.8283552799207438e-05,0.0,0.00030696433,False,PABPC1L2A; poly(A) binding protein cytoplasmic 1 like
hsa:9138,3.612321e-06,0.0030081699472820655,9.400362753684793e-05,0.00017350854331934785,0.0,0.0012036025,False,ARHGEF1; Rho guanine nucleotide exchange factor
hsa:25904,4.3182615e-07,0.0003596043781492611,8.192804901438596e-07,9.59082201273492e-07,0.0,4.2756883e-06,False,CNOT10; CCR4-NOT transcription complex subunit
hsa:84186,0.0,0.0,1.510062979611111e-05,5.632976265391561e-05,0.0,0.00037901435,False,ZCCHC7; zinc finger CCHC-type containing
hsa:7052,8.1067e-09,6.750876046628059e-06,5.41190289337193e-08,1.0520891284086902e-07,0.0,5.6646246e-07,False,TGM2; transglutaminase
hsa:56477,3.3649276e-06,0.002802152433601545,7.54690108597076e-05,0.000178204637321292,0.0,0.0016576009,False,CCL28; C-C motif chemokine ligand
hsa:81466,0.0,0.0,1.0255716783918126e-05,3.41337121771689e-05,0.0,0.00030206772,False,OR2L5; olfactory receptor family 2 subfamily L member
hsa:6430,0.0,0.0,2.2861723322982446e-07,3.489595287673572e-07,0.0,1.940533e-06,False,SRSF5; serine and arginine rich splicing factor
hsa:6009,8.371627e-06,0.006971494712472982,3.1259550183040945e-05,5.396179206023139e-05,0.0,0.00030109668,False,RHEB; Ras homolog
hsa:944,2.9879526e-08,2.4882254969099673e-05,1.2861923405029244e-06,5.327575902408355e-06,0.0,5.8426962e-05,False,TNFSF8; TNF superfamily member
hsa:9074,1.2550736e-06,0.0010451658878452696,6.493218312456143e-06,1.3152744507356158e-05,0.0,0.0001015212,False,CLDN6; claudin
hsa:7773,0.0,0.0,2.204922299971345e-08,4.122532991693101e-08,0.0,1.958937e-07,False,ZNF230; zinc finger protein
hsa:2185,0.0,0.0,1.981640338211696e-05,7.848707376806098e-05,0.0,0.00059933204,False,PTK2B; protein tyrosine kinase 2
hsa:6708,0.0,0.0,7.654513203298246e-08,2.2051659892179206e-07,0.0,1.2882789e-06,False,SPTA1; spectrin alpha
hsa:8660,3.3587447e-05,0.027970036071359426,0.00014890806895590645,0.00025705511348209477,0.0,0.0013062863,False,IRS2; insulin receptor substrate
hsa:55577,4.4333876e-07,0.0003691915348323962,5.424959784747368e-05,0.00016391221578854507,0.0,0.0010300385,False,NAGK; N-acetylglucosamine
hsa:6772,0.0,0.0,0.0002481693395380116,0.0005480120345822838,0.0,0.0028567866,False,STAT1; signal transducer and activator of transcription
hsa:3800,1.43902e-06,0.0011983477430543513,4.003068322543861e-05,9.723451169080825e-05,0.0,0.0006299553,False,KIF5C; kinesin family member
hsa:829,0.0,0.0,6.580324680233919e-07,1.942310245695971e-06,0.0,1.8196057e-05,False,CAPZA1; capping actin protein of muscle Z-line subunit alpha
hsa:407021,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29A; microRNA
hsa:10926,0.0,0.0,1.205617760988304e-06,3.332364779217951e-06,0.0,1.8518405e-05,False,DBF4; DBF4 zinc
hsa:161,3.88977e-06,0.0032392163420247974,2.1877742057953212e-05,4.788591906535383e-05,0.0,0.00041984973,False,AP2A2; adaptor related protein complex 2 subunit alpha
hsa:79603,0.0,0.0,1.6802778590409358e-05,2.8427552950853397e-05,0.0,0.00015249556,False,CERS4; ceramide synthase
hsa:134430,4.6079638e-08,3.837294144491496e-05,5.749851552349706e-07,9.703918470649929e-07,0.0,4.9355535e-06,False,WDR36; WD repeat domain
hsa:8417,0.0,0.0,5.768298587952807e-05,0.00014049400687320105,0.0,0.0009040371,False,STX7; syntaxin
hsa:971,1.535482e-06,0.0012786767308311084,1.2258631795380115e-05,3.396495683869587e-05,0.0,0.00024715014,False,CD72; CD72
hsa:9785,0.0,0.0,6.886131931461988e-09,3.574486248813198e-08,0.0,3.3999058e-07,False,DHX38; DEAH-box helicase
hsa:7138,2.1566304e-09,1.7959397176150457e-06,9.169954469865495e-08,4.948808827045853e-07,0.0,6.1065803e-06,False,TNNT1; troponin T1
hsa:575,0.0,0.0,0.00015538997319298244,0.0002865612024098983,0.0,0.0012350846,False,ADGRB1; adhesion G protein-coupled receptor
hsa:120065,0.0,0.0,3.4032411695906436e-09,2.938780460365454e-08,0.0,3.4689162e-07,False,OR5P2; olfactory receptor family 5 subfamily P member
hsa:144193,3.8376907e-06,0.0031958471660475,2.3516591474865498e-05,4.3713749389934235e-05,0.0,0.00028144388,False,AMDHD1; amidohydrolase domain containing
hsa:2870,0.0,0.0,2.1107470685426903e-05,0.00010185971267373242,0.0,0.0011177029,False,GRK6; G protein-coupled receptor kinase
hsa:23035,3.2584534e-08,2.7134857595709428e-05,1.0859694902339181e-07,1.8145875227705488e-07,0.0,1.1474355e-06,False,PHLPP2; PH domain and leucine rich repeat protein phosphatase
hsa:873,0.0,0.0,0.00014323446148362573,0.0003449985475147282,0.0,0.0029045718,False,CBR1; carbonyl reductase
hsa:7592,1.1767397e-08,9.799331236935235e-06,4.6749930454970754e-08,8.39097363714759e-08,0.0,4.099833e-07,False,ZNF41; zinc finger protein
hsa:2547,1.4103293e-06,0.001174455486107506,0.0001581679094920761,0.0003257015370691151,0.0,0.0020889472,False,XRCC6; X-ray repair cross complementing
hsa:5013,1.2764719e-09,1.0629853792423313e-06,6.069311792484574e-07,2.361962812692878e-06,0.0,2.1480126e-05,False,OTX1; orthodenticle homeobox
hsa:23498,0.0,0.0,1.3407769793467835e-06,4.431723271184339e-06,0.0,2.6804337e-05,False,HAAO; 3-hydroxyanthranilate
hsa:390151,0.0,0.0,4.83656683625731e-07,6.239768167101108e-06,0.0,8.159453e-05,False,OR8H2; olfactory receptor family 8 subfamily H member
hsa:22992,0.0,0.0,1.3994865719954783e-05,4.762306937460964e-05,0.0,0.00027176292,False,KDM2A; lysine demethylase
hsa:3551,0.0,0.0,0.0001686844747736842,0.00034927196679685694,0.0,0.0016811064,False,IKBKB; inhibitor of nuclear factor kappa B kinase subunit
hsa:5270,0.0,0.0,1.1141229153660818e-05,2.7201895488519104e-05,0.0,0.0001743363,False,SERPINE2; serpin family E member
hsa:338674,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5F1; olfactory receptor family 5 subfamily F member
hsa:8520,0.0,0.0,4.1946686772807034e-05,0.0001355869491692485,0.0,0.0010116035,False,HAT1; histone acetyltransferase
hsa:9842,9.933338e-08,8.27201371301026e-05,3.579590818847954e-07,4.6653124701635717e-07,0.0,1.4589388e-06,False,PLEKHM1; pleckstrin homology and RUN domain containing
hsa:9104,5.0004264e-06,0.004164118421390526,3.506946895608187e-05,6.602590076677671e-05,0.0,0.0004240325,False,RGN;
hsa:128,2.6547152e-06,0.002210721163272283,0.000541708174209357,0.0011262505569330224,0.0,0.007823088,False,ADH5; alcohol dehydrogenase 5 (class III)
hsa:84464,1.442295e-06,0.0012010750080392043,3.288640487970761e-05,6.813641562506593e-05,0.0,0.00031083985,False,SLX4; SLX4 structure-specific endonuclease
hsa:4128,0.0014242327,1.1860335795396901,0.001969116433547953,0.0020809091374267333,0.0,0.010294773,True,MAOA; monoamine oxidase
hsa:147929,1.9199209e-09,1.5988192501548823e-06,1.7193849151959067e-08,3.4636105144101576e-08,0.0,1.851241e-07,False,ZNF565; zinc finger protein
hsa:1840,7.108647e-06,0.005919744748940311,0.0004648272414080116,0.0008796971041720057,0.0,0.005683323,False,DTX1; deltex E3 ubiquitin ligase
hsa:7060,7.246053e-07,0.0006034169961920064,7.2439061553801185e-06,1.3574497902095019e-05,0.0,7.062842e-05,False,THBS4; thrombospondin
hsa:84133,2.0911068e-08,1.7413747649550435e-05,4.363730570146198e-07,8.696724398518574e-07,0.0,5.576503e-06,False,ZNRF3; zinc and ring finger
hsa:7941,0.0,0.0,4.291377649274854e-06,1.2656485538909758e-05,0.0,0.00010579088,False,PLA2G7; phospholipase A2 group
hsa:6138,0.0,0.0,8.545123916198829e-07,1.9703304124346107e-06,0.0,9.216041e-06,False,RPL15; ribosomal protein
hsa:4712,0.0,0.0,1.406524123391813e-06,2.8114161939308893e-06,0.0,1.9619267e-05,False,NDUFB6; NADH:ubiquinone oxidoreductase subunit
hsa:9986,1.099962e-06,0.0009159962892423667,0.0002833971702482256,0.000913234609480917,0.0,0.0051662023,False,RCE1; Ras converting CAAX endopeptidase
hsa:11335,1.385572e-06,0.0011538387785015522,0.0002632482680526667,0.0009522639751464604,0.0,0.00517972,False,CBX3; chromobox
hsa:8698,3.6553612e-07,0.0003044011788625902,1.0055649538662573e-05,1.87006780836917e-05,0.0,9.589486e-05,False,S1PR4; sphingosine-1-phosphate receptor
hsa:4794,9.14284e-06,0.007613724395148813,7.535786693450296e-05,0.00014234725880961713,0.0,0.00073348696,False,NFKBIE; NFKB inhibitor
hsa:116931,5.8812333e-08,4.8976127165926084e-05,2.041595092152047e-06,8.039055514153122e-06,0.0,8.308515e-05,False,MED12L; mediator complex subunit
hsa:64419,0.0,0.0,3.2178620901052635e-05,0.00010872627176884144,0.0,0.00057914713,False,MTMR14; myotubularin related protein
hsa:57644,6.800136e-09,5.662831390851166e-06,1.915730189766082e-08,3.880171837348259e-08,0.0,2.987583e-07,False,MYH7B; myosin heavy chain
hsa:5054,0.0,0.0,6.386639754795322e-05,0.00015855698970275426,0.0,0.0008709676,False,SERPINE1; serpin family E member
hsa:9322,0.0,0.0,2.017105701192983e-07,5.157226760785457e-07,0.0,3.864181e-06,False,TRIP10; thyroid hormone receptor interactor
hsa:1979,2.4871036e-07,0.00020711421563302472,4.32746207055807e-06,8.031401547131983e-06,0.0,3.7110858e-05,False,EIF4EBP2; eukaryotic translation initiation factor 4E binding protein
hsa:51302,0.0,0.0,1.2991629865614039e-06,4.958875025095418e-06,0.0,3.9955376e-05,False,CYP39A1; cytochrome P450 family 39 subfamily A member
hsa:84532,0.0,0.0,4.545482929928656e-05,0.00012037071202558446,0.0,0.0008726252,False,ACSS1; acyl-CoA synthetase short chain family member
hsa:27130,0.0,0.0,7.336810766202928e-06,2.4982530483532223e-05,0.0,0.0001583794,False,INVS;
hsa:101954275,0.0,0.0,7.549534000000002e-09,6.875402637033683e-08,0.0,8.0123255e-07,False,RNU6-7; RNA
hsa:259289,1.7889204e-05,0.014897282343844333,0.00018594552709122805,0.0004337141925258736,0.0,0.003308655,False,TAS2R43; taste 2 receptor member
hsa:9354,0.0,0.0,4.3119639319883044e-08,1.6900338010194724e-07,0.0,1.740322e-06,False,UBE4A; ubiquitination factor
hsa:5522,3.6570937e-06,0.003045454532621706,2.73821479011111e-05,4.4721883794424086e-05,0.0,0.000235267,False,PPP2R2C; protein phosphatase 2 regulatory subunit
hsa:3398,0.0,0.0,5.091069625549705e-05,0.00015393099044962586,0.0,0.0011739006,False,ID2; inhibitor of DNA binding
hsa:257313,0.0,0.0,3.639008931792399e-07,9.245919191320218e-07,0.0,7.464135e-06,False,UTS2B; urotensin
hsa:10437,5.398755e-07,0.00044958276254349446,1.6354097593099403e-05,4.57988816102649e-05,0.0,0.00033995914,False,IFI30; IFI30 lysosomal thiol
hsa:2984,0.0,0.0,2.788096282907778e-09,2.1958312021924135e-08,0.0,2.8399143e-07,False,GUCY2C; guanylate cyclase
hsa:54543,0.0,0.0,2.636726817894737e-06,5.6881743988390765e-06,0.0,2.5011086e-05,False,TOMM7; translocase of outer mitochondrial membrane
hsa:2329,0.0,0.0,1.5237709411111111e-05,4.413104519957743e-05,0.0,0.00031482163,False,FMO4; flavin containing dimethylaniline monoxygenase
hsa:1259,0.0,0.0,9.56732809222222e-07,3.843686546867441e-06,0.0,3.9043127e-05,False,CNGA1; cyclic nucleotide gated channel subunit alpha
hsa:6401,0.0,0.0,1.3854559324561403e-05,4.641639113864254e-05,0.0,0.00035983647,False,SELE; selectin
hsa:7155,8.639596e-07,0.0007194646611931316,1.8751972446719304e-05,4.670275956774369e-05,0.0,0.00035759475,False,TOP2B; DNA topoisomerase II
hsa:81873,0.0,0.0,9.194599869915204e-05,0.00023815114489470602,0.0,0.0013438789,False,ARPC5L; actin related protein 2/3 complex subunit 5
hsa:2103,1.1252812e-09,9.37080920571981e-07,8.862588176584798e-08,1.8280024045489247e-07,0.0,1.3044186e-06,False,ESRRB; estrogen related receptor
hsa:3347,0.0,0.0,1.4099630994122805e-06,6.5517198958851665e-06,0.0,5.6871228e-05,False,HTN3; histatin
hsa:2584,5.16877e-06,0.004304307003284902,0.00017854537687233917,0.00038654949634141754,0.0,0.0024115306,False,GALK1; galactokinase
hsa:9331,1.09094934e-07,9.084909725894249e-05,6.508783549444445e-06,1.731600338181878e-05,0.0,0.00013748008,False,B4GALT6; beta-1
hsa:9126,1.6313561e-07,0.00013585161433148592,4.485193364339181e-06,1.0864358984039365e-05,0.0,5.2565116e-05,False,SMC3; structural maintenance of chromosomes
hsa:7322,5.014228e-07,0.0004175611740601196,1.2488353007721634e-05,3.466321949864323e-05,0.0,0.00024061218,False,UBE2D2; ubiquitin conjugating enzyme E2
hsa:1793,0.0,0.0,7.586364005847957e-08,2.6648700404692873e-07,0.0,1.4066737e-06,False,DOCK1; dedicator of cytokinesis
hsa:837,0.0,0.0,4.436657815152046e-06,8.826486512757803e-06,0.0,3.6599602e-05,False,CASP4; caspase
hsa:11273,2.2443821e-08,1.8690151798352946e-05,1.7065381968304098e-07,3.0319819837792333e-07,0.0,1.9417032e-06,False,ATXN2L; ataxin 2
hsa:100169761,0.0,0.0,4.269985304807017e-08,3.2063832723989006e-07,0.0,3.982646e-06,False,RNA5S10; RNA
hsa:10392,1.0518719e-06,0.0008759491302047868,1.9954072384777784e-05,4.076419005347424e-05,0.0,0.00022552258,False,NOD1; nucleotide binding oligomerization domain containing
hsa:6696,2.9029443e-06,0.002417434608356725,9.315052119245616e-05,0.00021246480125891722,0.0,0.0016949082,False,SPP1; secreted phosphoprotein
hsa:10365,0.0,0.0,2.355445036719298e-06,5.721444560162087e-06,0.0,5.1193863e-05,False,KLF2; KLF transcription factor
hsa:2919,0.0,0.0,3.676241842105263e-07,3.0856040943974698e-06,0.0,3.565119e-05,False,CXCL1; C-X-C motif chemokine ligand
hsa:29851,5.0750396e-06,0.00422625276269368,0.00011454378822964914,0.0003106537926694212,0.0,0.0017663027,False,ICOS; inducible T cell
hsa:259294,0.0002646403,0.22037991565525597,0.00042822058243859675,0.0005302510000633913,0.0,0.0037565017,False,TAS2R19; taste 2 receptor member
hsa:3163,0.0,0.0,4.896289053216374e-05,0.00010950938520818535,0.0,0.00065123936,False,HMOX2; heme oxygenase
hsa:89869,0.0,0.0,2.6799154340350877e-06,1.0978974647334173e-05,0.0,7.736451e-05,False,PLCZ1; phospholipase C zeta
hsa:598,5.4304208e-05,0.045221974048417705,0.00038169581508771925,0.0006424799090800076,0.0,0.003408237,False,BCL2L1; BCL2 like
hsa:23462,0.0,0.0,6.117336135438598e-07,1.816101715328442e-06,0.0,9.5886035e-06,False,HEY1; hes related family bHLH transcription factor with YRPW motif
hsa:933,1.3921041e-07,0.00011592784021985162,6.6618702498011675e-06,1.3765908330582636e-05,0.0,0.000107637556,False,CD22; CD22
hsa:10336,3.3422916e-06,0.0027833022442283755,8.545371025891225e-05,0.0001736292181747753,0.0,0.0009117071,False,PCGF3; polycomb group ring finger
hsa:51384,2.241214e-06,0.0018663769361105579,2.7493308666868424e-05,0.0001699630999324857,0.0,0.002180644,False,WNT16; Wnt family member
hsa:1604,0.0,0.0,8.103149359122805e-05,0.000247025314444866,0.0,0.0017963324,False,CD55; CD55 molecule (Cromer blood
hsa:115752,2.908846e-07,0.00024223492647723293,1.15164775445614e-06,2.2100046727726487e-06,0.0,1.3249912e-05,False,DIS3L; DIS3 like exosome 3'-5'
hsa:390038,0.0,0.0,1.8041388771929825e-08,1.588828678410388e-07,0.0,1.4931425e-06,False,OR51D1; olfactory receptor family 51 subfamily D member
hsa:1848,0.0,0.0,3.2103721756549705e-06,8.535872869508424e-06,0.0,4.0158637e-05,False,DUSP6; dual specificity phosphatase
hsa:733,1.9213905e-06,0.0016000430634744978,4.258254085497077e-05,0.0001266656138506644,0.0,0.0010954799,False,C8G; complement C8 gamma
hsa:11108,0.0,0.0,2.7531143678947367e-06,5.642824333554618e-06,0.0,2.487769e-05,False,PRDM4; PR/SET domain
hsa:4318,0.0,0.0,0.00012124880825730996,0.0002058532227321018,0.0,0.00078624237,False,MMP9; matrix metallopeptidase
hsa:79092,7.591516e-08,6.321855196565022e-05,1.3413239396473681e-06,2.275889066636922e-06,0.0,1.0336053e-05,False,CARD14; caspase recruitment domain family member
hsa:1781,0.0,0.0,0.00015461829771964912,0.00033767242458665204,0.0,0.002706396,False,DYNC1I2; dynein cytoplasmic 1 intermediate chain
hsa:6760,0.0,0.0,2.0877820835029246e-06,6.7047602412671515e-06,0.0,3.521365e-05,False,SS18; SS18 subunit of BAF chromatin remodeling
hsa:91181,0.0,0.0,2.8312581664795316e-09,6.82472551411137e-09,0.0,3.6050253e-08,False,NUP210L; nucleoporin 210
hsa:137682,0.0,0.0,1.3350367365058476e-06,3.046143805002007e-06,0.0,1.725847e-05,False,NDUFAF6; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:7559,0.0,0.0,9.810602161871342e-08,2.438435016255628e-07,0.0,1.2741914e-06,False,ZNF12; zinc finger protein
hsa:9536,0.0,0.0,7.915229967228074e-06,2.33716393370309e-05,0.0,0.00023015535,False,PTGES; prostaglandin E
hsa:407053,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR96; microRNA
hsa:24137,1.793445e-08,1.493496107102133e-05,1.3727040415033334e-06,4.564022626837191e-06,0.0,2.4564606e-05,False,KIF4A; kinesin family member
hsa:6720,0.0,0.0,2.41528146491228e-06,3.583985973876905e-06,0.0,1.781631e-05,False,SREBF1; sterol regulatory element binding transcription factor
hsa:79661,0.0,0.0,2.4603849667192983e-06,1.3706360161894417e-05,0.0,0.00017425173,False,NEIL1; nei like DNA glycosylase
hsa:390148,-0.0,0.0,4.22929567251462e-07,4.006659275595899e-06,0.0,4.782553e-05,False,OR5W2; olfactory receptor family 5 subfamily W member
hsa:501,5.4290842e-05,0.045210843476268844,0.0006888624434766083,0.0013346254362967803,0.0,0.007124566,False,ALDH7A1; aldehyde dehydrogenase 7 family member
hsa:6523,3.7476132e-06,0.0031208348876740387,1.7123888435315783e-05,4.5498964843035e-05,0.0,0.00034583863,False,SLC5A1; solute carrier family 5 member
hsa:100500809,0.0,0.0,2.507162573099415e-09,3.278540487350314e-08,0.0,4.287248e-07,False,MIR23C; microRNA
hsa:81839,1.3960602e-08,1.1625728550249519e-05,9.69504916690994e-08,2.2895058027423357e-07,0.0,1.997344e-06,False,VANGL1; VANGL planar cell polarity protein
hsa:4254,0.0,0.0,5.0508927590643295e-06,1.1294474143372346e-05,0.0,8.067084e-05,False,KITLG; KIT
hsa:27179,-0.0,0.0,5.768707034152046e-07,2.3590097713504927e-06,0.0,1.9668092e-05,False,IL36A; interleukin 36
hsa:57084,1.5540661e-06,0.0012941526896723312,0.0001389115622356726,0.000855156572925369,0.0,0.009970534,False,SLC17A6; solute carrier family 17 member
hsa:442117,5.3569756e-06,0.004461035718653827,0.0001565384044487134,0.00040935370601769943,0.0,0.0029077525,False,GALNTL6; polypeptide N-acetylgalactosaminyltransferase like
hsa:23649,3.8118372e-08,3.1743175949678375e-05,8.551669141056141e-06,2.504665709125091e-05,0.0,0.0002010823,False,POLA2; DNA polymerase alpha 2
hsa:197320,0.0,0.0,8.000202535204679e-08,1.671058054679815e-07,0.0,8.9451567e-07,False,ZNF778; zinc finger protein
hsa:6915,0.0,0.0,8.990868996725146e-07,2.328835428527702e-06,0.0,1.25275365e-05,False,TBXA2R; thromboxane A2
hsa:390441,3.666647e-06,0.003053410068676605,0.00011003954736321637,0.00037850166214072246,0.0,0.004036105,False,OR11H7; olfactory receptor family 11 subfamily H member 7
hsa:3161,7.764345e-06,0.006465779007272544,9.564201254087722e-05,0.00017395894713494867,0.0,0.0009100451,False,HMMR; hyaluronan mediated motility
hsa:54541,0.0,0.0,1.8060068659941515e-06,3.460606151181769e-06,0.0,1.7063658e-05,False,DDIT4; DNA damage inducible transcript
hsa:85315,0.0,0.0,2.148960010760234e-07,3.7176254574671244e-07,0.0,1.5378816e-06,False,PAQR8; progestin and adipoQ receptor family member
hsa:3447,0.0,0.0,1.7344184444444445e-07,1.737488365418016e-06,0.0,2.1982467e-05,False,IFNA13; interferon alpha
hsa:9965,2.8522172e-07,0.00023751914805359212,1.5903489454786553e-05,4.2109919839435895e-05,0.0,0.0002669151,False,FGF19; fibroblast growth factor
hsa:2793,0.0,0.0,4.501892608385966e-05,0.00010235393109121929,0.0,0.00059025333,False,GNGT2; G protein subunit gamma transducin
hsa:2359,0.0,0.0,5.275850661023392e-05,0.000169148383968701,0.0,0.0011773482,False,FPR3; formyl peptide receptor
hsa:3304,0.0,0.0,8.193287920409356e-05,0.0001274341531511371,0.0,0.00057836145,False,HSPA1B; heat shock protein family A (Hsp70) member
hsa:84189,0.0,0.0,5.48546432967899e-06,1.5006424653002436e-05,0.0,0.00010311013,False,SLITRK6; SLIT and NTRK like family member
hsa:388112,1.2058601e-08,1.004183214461435e-05,6.199061884690056e-07,1.962317341299033e-06,0.0,1.4433155e-05,False,NANOGP8; Nanog homeobox retrogene
hsa:63940,0.0,0.0,1.2507656216374272e-07,4.4356512227313004e-07,0.0,2.393103e-06,False,GPSM3; G protein signaling modulator
hsa:135948,0.0,0.0,8.487503854970759e-07,8.567567360355104e-06,0.0,0.00011023175,False,OR2F2; olfactory receptor family 2 subfamily F member
hsa:1244,4.544598e-05,0.03784526105536628,0.00015142544371871347,0.0003222847276827413,0.0,0.0034577032,False,ABCC2; ATP binding cassette subfamily C member
hsa:8819,0.0,0.0,4.865572787719298e-08,1.1619710038634315e-07,0.0,6.368517e-07,False,SAP30; Sin3A associated protein
hsa:84440,0.0,0.0,3.5326090289824553e-07,7.522466397193934e-07,0.0,5.7427683e-06,False,RAB11FIP4; RAB11 family interacting protein
hsa:55740,7.628615e-07,0.0006352749487762902,2.998627138245614e-06,5.310819550601155e-06,0.0,3.312857e-05,False,ENAH; ENAH actin
hsa:2779,0.0,0.0,2.597168564947953e-06,1.4030459078519048e-05,0.0,0.00012463171,False,GNAT1; G protein subunit alpha transducin
hsa:5228,1.515934e-06,0.0012623980816940383,2.061434857485381e-06,2.3188954941740427e-06,0.0,9.018535e-06,False,PGF; placental growth
hsa:112,0.0,0.0,0.0008570862955555558,0.0016956748870443567,0.0,0.00655841,False,ADCY6; adenylate cyclase
hsa:496,0.0,0.0,1.232929595614035e-07,1.007791591551385e-06,0.0,1.2740094e-05,False,ATP4B; ATPase H+/K+ transporting subunit
hsa:204219,0.0,0.0,6.86319504583041e-07,1.922256352161945e-06,0.0,1.3201603e-05,False,CERS3; ceramide synthase
hsa:23550,0.0,0.0,1.8088179666656722e-07,3.3973650111857663e-07,0.0,1.5988469e-06,False,PSD4; pleckstrin and Sec7 domain containing
hsa:11140,6.096032e-07,0.0005076486906913805,1.3450256021111112e-06,1.79416001271194e-06,0.0,1.0433912e-05,False,CDC37; cell division cycle 37
hsa:3351,3.4161698e-05,0.028448245123211875,0.00013065893201052637,0.00021390460726685044,0.0,0.0011951976,False,HTR1B; 5-hydroxytryptamine receptor
hsa:3176,0.0,0.0,5.70834685569883e-05,0.00016664071303074032,0.0,0.0012159044,False,HNMT; histamine
hsa:9663,0.0,0.0,6.049163562339181e-05,0.00011819637482472583,0.0,0.0006068225,False,LPIN2; lipin
hsa:8836,7.675378e-06,0.006391691500735932,6.397298014736845e-05,0.00012577959693160082,0.0,0.0008380114,False,GGH; gamma-glutamyl
hsa:10905,2.5676982e-06,0.002138257524436575,5.7527258480426895e-05,0.00011306411215215916,0.0,0.00078778336,False,MAN1A2; mannosidase alpha class 1A member
hsa:23305,8.775749e-05,0.07308028385819156,0.00035854009448099423,0.0005736075307798827,0.0,0.003467973,False,ACSL6; acyl-CoA synthetase long chain family member
hsa:3074,0.0,0.0,0.0001949063770116959,0.000315318673532713,0.0,0.0016131174,False,HEXB; hexosaminidase subunit
hsa:8881,0.0,0.0,7.426378654818715e-06,1.617117279702252e-05,0.0,0.00013064749,False,CDC16; cell division cycle
hsa:6555,0.0,0.0,3.821243795789473e-07,1.947547826145845e-06,0.0,1.6983671e-05,False,SLC10A2; solute carrier family 10 member
hsa:203,3.0603367e-06,0.002548503549242819,3.192286785111111e-05,8.103791638596408e-05,0.0,0.0007679276,False,AK1; adenylate kinase
hsa:23483,0.0,0.0,4.279360634345027e-06,8.600150489672406e-06,0.0,6.3854735e-05,False,TGDS; TDP-glucose
hsa:2588,0.0,0.0,5.1357596935672514e-06,8.949779871413206e-06,0.0,4.0612736e-05,False,GALNS; galactosamine
hsa:10294,0.0,0.0,2.2422320917198813e-07,6.16117847430045e-07,0.0,4.5392926e-06,False,DNAJA2; DnaJ heat shock protein family (Hsp40) member
hsa:3972,0.0,0.0,2.5234305046783624e-06,8.056200575551318e-06,0.0,6.481859e-05,False,LHB; luteinizing hormone subunit
hsa:145173,0.0,0.0,6.354384302978945e-05,0.00020011882656587754,0.0,0.0013021571,False,B3GLCT; beta
hsa:2214,0.0,0.0,1.6283651850175437e-05,4.278003316239813e-05,0.0,0.00033856838,False,FCGR3A; Fc gamma receptor
hsa:8085,1.2936368e-05,0.010772794954983622,5.252713397246197e-05,0.00010816045843238647,0.0,0.00076377264,False,KMT2D; lysine methyltransferase
hsa:58191,0.0,0.0,2.572086593274854e-06,7.433287635475931e-06,0.0,4.4370798e-05,False,CXCL16; C-X-C motif chemokine ligand
hsa:7293,1.0435604e-07,8.690277064119305e-05,2.1996035237302335e-05,6.385180937353184e-05,0.0,0.0006504187,False,TNFRSF4; TNF receptor superfamily member
hsa:4705,1.7479422e-06,0.0014556035290402202,4.025249609941521e-06,5.3931198708432174e-06,0.0,2.1651247e-05,False,NDUFA10; NADH:ubiquinone oxidoreductase subunit
hsa:115196,0.0,0.0,3.111007600233919e-08,6.455152232435346e-08,0.0,2.8917282e-07,False,ZNF554; zinc finger protein
hsa:9470,1.1269236e-08,9.384486335524765e-06,3.421418622652632e-05,7.035773232746537e-05,0.0,0.00045930987,False,EIF4E2; eukaryotic translation initiation factor 4E family member
hsa:80110,1.3773056e-09,1.1469549118539833e-06,5.170792507251462e-08,7.801933469540357e-08,0.0,3.0080585e-07,False,ZNF614; zinc finger protein
hsa:6737,0.0,0.0,1.0116098433333332e-07,3.5807048120090274e-07,0.0,3.7215682e-06,False,TRIM21; tripartite motif containing
hsa:6500,0.00022054199,0.18365693038680164,0.002027644043754386,0.00443630111249414,0.0,0.021541005,False,SKP1; S-phase kinase associated protein
hsa:138799,0.0,0.0,1.085199793346199e-05,4.22395117316346e-05,0.0,0.00029126686,False,OR13C5; olfactory receptor family 13 subfamily C member
hsa:222,0.0,0.0,5.5708233489064335e-05,0.00033384018676189275,0.0,0.0038968218,False,ALDH3B2; aldehyde dehydrogenase 3 family member
hsa:7272,1.0310031e-08,8.585705813449707e-06,2.6194899971181286e-06,5.777612820270707e-06,0.0,3.1727934e-05,False,TTK; TTK protein
hsa:27232,0.0,0.0,3.692874385766081e-05,0.00010717398020149126,0.0,0.00072932703,False,GNMT; glycine
hsa:552,0.0,0.0,5.663812984157897e-06,2.175774913003931e-05,0.0,0.00015866788,False,AVPR1A; arginine vasopressin receptor
hsa:8760,0.0,0.0,8.741938883859645e-06,2.441361238330212e-05,0.0,0.00014706823,False,CDS2; CDP-diacylglycerol synthase
hsa:55733,0.0,0.0,3.287512036690059e-05,0.00012139214272728319,0.0,0.001010707,False,HHAT; hedgehog
hsa:5296,0.000913392,0.7606296241358007,0.0012741757975555559,0.001479757071990954,0.0,0.009321619,True,PIK3R2; phosphoinositide-3-kinase regulatory subunit
hsa:5042,0.0,0.0,2.803472200913859e-06,1.3131700733753707e-05,0.0,0.00013772344,False,PABPC3; poly(A) binding protein cytoplasmic
hsa:4583,0.0,0.0,4.3684019473684206e-09,1.693158363548318e-08,0.0,1.1909296e-07,False,MUC2; mucin 2
hsa:293,5.228294e-05,0.043538757730431865,0.00047901584263543854,0.0010303831405403334,0.0,0.0056130383,False,SLC25A6; solute carrier family 25 member
hsa:5471,6.7638456e-07,0.0005632610463459927,9.625301899077785e-05,0.00030809824830517257,0.0,0.0017701592,False,PPAT; phosphoribosyl pyrophosphate
hsa:390066,0.0,0.0,2.2029100152046787e-07,1.381652493320991e-06,0.0,1.6961985e-05,False,OR52D1; olfactory receptor family 52 subfamily D member
hsa:338382,0.0,0.0,5.8621062673333305e-06,2.6640647725904843e-05,0.0,0.00030421768,False,RAB7B; RAB7B
hsa:253639,8.0570633e-10,6.709540952315495e-07,2.7279133342748535e-08,4.8535834951059306e-08,0.0,2.4144333e-07,False,ZNF620; zinc finger protein
hsa:114799,9.9205245e-08,8.261343236709981e-05,8.105379992339181e-07,1.9072355465418482e-06,0.0,9.642737e-06,False,ESCO1; establishment of sister chromatid cohesion N-acetyltransferase
hsa:391192,0.0,0.0,8.894765192637426e-06,2.8800822078478098e-05,0.0,0.00017945941,False,OR2L3; olfactory receptor family 2 subfamily L member
hsa:9344,0.0,0.0,1.1528265439181284e-07,3.011529641282076e-07,0.0,2.751458e-06,False,TAOK2; TAO kinase
hsa:390077,0.0,0.0,8.843544684210525e-08,3.956833143525636e-07,0.0,3.119223e-06,False,OR52N2; olfactory receptor family 52 subfamily N member
hsa:6476,0.0,0.0,2.778460842690058e-07,1.2292965704666775e-06,0.0,1.2421762e-05,False,SI;
hsa:3665,0.0,0.0,5.818388982646197e-05,0.00014827983898156518,0.0,0.00093669543,False,IRF7; interferon regulatory factor
hsa:3645,0.0,0.0,0.00012343945419134736,0.0003459475879413442,0.0,0.002803353,False,INSRR; insulin receptor related
hsa:153562,1.598466e-09,1.3311268248176652e-06,8.88959001937427e-08,1.9162465092214592e-07,0.0,1.2568905e-06,False,MARVELD2; MARVEL domain containing
hsa:2162,0.0,0.0,1.597067115906433e-07,3.8759261469775334e-07,0.0,2.5612064e-06,False,F13A1; coagulation factor XIII A
hsa:23220,0.0,0.0,8.651778312584797e-05,0.00027496909974800485,0.0,0.0017205639,False,DTX4; deltex E3 ubiquitin ligase
hsa:147179,3.6687666e-07,0.00030551751712298554,8.112840777836256e-07,1.1511420300881195e-06,0.0,6.684803e-06,False,WIPF2; WAS/WASL interacting protein family member
hsa:4829,0.0,0.0,9.461964856001172e-08,3.5603863562941645e-07,0.0,3.2769476e-06,False,NMBR; neuromedin B
hsa:3988,0.0,0.0,6.903936023005848e-05,0.00020709000187713928,0.0,0.0014450945,False,LIPA; lipase A
hsa:201633,2.9534878e-08,2.4595248427878428e-05,8.441061802970758e-07,1.732663202226893e-06,0.0,9.4157795e-06,False,TIGIT; T cell immunoreceptor with Ig and ITIM
hsa:81488,6.7766985e-07,0.0005643313750215291,8.908475282105266e-06,2.3966568800992788e-05,0.0,0.00014557537,False,POLR2M; RNA polymerase II subunit
hsa:1317,0.0,0.0,6.555085758701757e-05,0.00012031716279275578,0.0,0.00079086813,False,SLC31A1; solute carrier family 31 member
hsa:282775,0.0,0.0,5.664425730994152e-10,7.407197800378522e-09,0.0,9.686168e-08,False,OR5J2; olfactory receptor family 5 subfamily J member
hsa:10501,0.0,0.0,2.188181931906433e-07,4.988166992657209e-07,0.0,2.3357607e-06,False,SEMA6B; semaphorin
hsa:56894,0.0,0.0,2.190841766859649e-05,5.4954215520559775e-05,0.0,0.00040495643,False,AGPAT3; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:3600,9.122421e-06,0.007596720418438672,4.713743783450292e-05,9.295875661039627e-05,0.0,0.0005221345,False,IL15; interleukin
hsa:3560,0.0,0.0,0.00011201135302807018,0.00043196618025927256,0.0,0.0030143238,False,IL2RB; interleukin 2 receptor subunit
hsa:5032,2.2808859e-08,1.8994138166456986e-05,1.6761037035865505e-05,3.600820167466258e-05,0.0,0.00019886522,False,P2RY11; purinergic receptor
hsa:123099,0.0,0.0,3.415126132573098e-06,1.6205874404159117e-05,0.0,0.00019637904,False,DEGS2; delta 4-desaturase
hsa:438,0.0,0.0,1.0342393347894736e-07,5.74664391218525e-07,0.0,6.788435e-06,False,ASMT; acetylserotonin
hsa:8178,3.5782097e-07,0.00029797636712277715,8.092986741122804e-06,2.4475023852877354e-05,0.0,0.00024941962,False,ELL; elongation factor for RNA polymerase
hsa:51208,3.06078e-08,2.548872708500158e-05,1.510110907576609e-06,4.9321869333761046e-06,0.0,4.129892e-05,False,CLDN18; claudin
hsa:6364,9.762845e-07,0.0008130035212533152,2.1078988231000003e-05,7.230018943310032e-05,0.0,0.00070578133,False,CCL20; C-C motif chemokine ligand
hsa:81472,0.0,0.0,2.76567067625731e-07,1.315853595331624e-06,0.0,1.5525748e-05,False,OR2C3; olfactory receptor family 2 subfamily C member
hsa:54108,4.6867865e-09,3.902933958146935e-06,2.4503552513766674e-06,5.8961488196720685e-06,0.0,4.065929e-05,False,CHRAC1; chromatin accessibility complex subunit
hsa:54981,0.0,0.0,0.0001025075032478772,0.00030886962216445204,0.0,0.0026147908,False,NMRK1; nicotinamide riboside kinase
hsa:219,1.9460074e-05,0.01620542852605986,0.0002611814244415203,0.0006144586656313941,0.0,0.0035712132,False,ALDH1B1; aldehyde dehydrogenase 1 family member
hsa:5176,1.532796e-07,0.00012764399571671954,5.20356350014035e-06,1.560966672428802e-05,0.0,0.00011367913,False,SERPINF1; serpin family F member
hsa:5718,0.0,0.0,3.6309252432807012e-06,9.793899833197657e-06,0.0,7.924504e-05,False,PSMD12; proteasome 26S subunit
hsa:4258,0.0,0.0,0.00012572762652807019,0.00023003816613575983,0.0,0.0013567063,False,MGST2; microsomal glutathione S-transferase
hsa:4218,0.0,0.0,5.236944573918129e-05,0.00016933992703820744,0.0,0.0013117602,False,RAB8A; RAB8A
hsa:10138,0.0,0.0,3.425886621017544e-06,8.03193166326998e-06,0.0,3.355516e-05,False,YAF2; YY1 associated factor
hsa:11014,3.3771093e-07,0.00028122967767667305,3.4495253706782234e-05,7.626022791711838e-05,0.0,0.0004068518,False,KDELR2; KDEL endoplasmic reticulum protein retention receptor
hsa:5563,0.00043333336,0.36085951129668714,0.0010099557864223392,0.0017423988380671782,0.0,0.008608774,False,PRKAA2; protein kinase AMP-activated catalytic subunit alpha
hsa:9019,1.7208364e-06,0.00143303110179551,1.3051184261672519e-05,2.883384318590211e-05,0.0,0.00021989841,False,MPZL1; myelin protein zero like
hsa:7767,1.6628078e-08,1.3847076303756524e-05,1.2807610647850292e-07,2.057261183122925e-07,0.0,9.0370685e-07,False,ZNF224; zinc finger protein
hsa:27125,0.0,0.0,5.207829222766082e-06,1.7017063644716477e-05,0.0,0.00012144245,False,AFF4; ALF transcription elongation factor
hsa:55432,0.0,0.0,3.2665981787169597e-07,8.251269047648408e-07,0.0,4.873359e-06,False,YOD1; YOD1
hsa:64805,0.0,0.0,2.3397852337742696e-06,1.122923151597415e-05,0.0,9.099945e-05,False,P2RY12; purinergic receptor
hsa:57468,6.5205313e-07,0.00054299898311839,9.120028847538013e-05,0.00026360411285280633,0.0,0.0019140258,False,SLC12A5; solute carrier family 12 member
hsa:100169758,0.0,0.0,4.213502392397661e-09,4.0112826854320045e-08,0.0,4.6321188e-07,False,RNA5S7; RNA
hsa:2271,0.0,0.0,0.0001166215168005848,0.0003887437927480741,0.0,0.002474554,False,FH; fumarate
hsa:79590,0.0,0.0,8.498717212397663e-08,1.5792346307661123e-07,0.0,8.229714e-07,False,MRPL24; mitochondrial ribosomal protein
hsa:10856,9.767193e-09,8.133656021129836e-06,5.1848442070333314e-06,1.6512095781573777e-05,0.0,9.637008e-05,False,RUVBL2; RuvB like AAA ATPase
hsa:374899,0.0,0.0,8.760039549707601e-10,2.1744241500295e-09,0.0,1.4039435e-08,False,ZNF829; zinc finger protein
hsa:80380,9.886481e-08,8.232993421286519e-05,1.166045773008187e-06,1.922162342945796e-06,0.0,1.1748323e-05,False,PDCD1LG2; programmed cell death 1 ligand
hsa:23451,0.0,0.0,7.423083341067834e-08,1.954126214965775e-07,0.0,1.1489158e-06,False,SF3B1; splicing factor 3b subunit
hsa:174,0.0,0.0,4.5558935546783616e-07,4.5921997132300516e-06,0.0,5.9838516e-05,False,AFP; alpha
hsa:8383,0.0,0.0,1.1560350877192983e-08,1.5117120367666735e-07,0.0,1.97682e-06,False,OR1A1; olfactory receptor family 1 subfamily A member
hsa:51427,0.0,0.0,4.177546356081871e-08,8.89644850419726e-08,0.0,4.0215275e-07,False,ZNF107; zinc finger protein
hsa:54429,9.215777e-05,0.07674462876431323,0.00038491133945380126,0.0005510008758418681,0.0,0.0021201672,False,TAS2R5; taste 2 receptor member
hsa:440073,5.6691565e-08,4.721005195756074e-05,4.6823907943508754e-07,1.1678996967186048e-06,0.0,8.276169e-06,False,IQSEC3; IQ motif and Sec7 domain ArfGEF
hsa:51077,2.5476263e-07,0.00021215425961771954,1.3916291434099412e-06,3.2568216995768573e-06,0.0,1.6509e-05,False,FCF1; FCF1 rRNA-processing
hsa:3627,2.99111e-07,0.00024908548301811657,0.00017101547855771922,0.00035318302700851936,0.0,0.002844329,False,CXCL10; C-X-C motif chemokine ligand
hsa:4493,0.0,0.0,4.92959880305848e-06,1.1527971507680259e-05,0.0,6.018672e-05,False,MT1E; metallothionein
hsa:4240,0.0,0.0,3.112118437953216e-07,7.082914034879307e-07,0.0,3.5663006e-06,False,MFGE8; milk fat globule EGF and factor V/VIII domain
hsa:2488,0.0,0.0,3.9607041253216373e-07,2.2917987174461726e-06,0.0,1.7822967e-05,False,FSHB; follicle stimulating hormone subunit
hsa:392255,3.6920546e-06,0.003074568315341993,3.72309514458359e-05,8.878307519767096e-05,0.0,0.00063530105,False,GDF6; growth differentiation factor
hsa:29933,0.0,0.0,6.576871600962576e-07,3.3763266256810286e-06,0.0,2.8970131e-05,False,GPR132; G protein-coupled receptor
hsa:1667,0.0,0.0,5.4674419250233915e-06,1.6668728672848738e-05,0.0,0.00011288729,False,DEFA1; defensin alpha
hsa:285955,1.3172222e-07,0.00010969203002537056,6.790965815754386e-06,1.9631920971065956e-05,0.0,0.00014525035,False,SPDYE1; speedy/RINGO cell cycle regulator family member
hsa:2979,1.5941556e-05,0.013275373277212652,0.00016875080009432752,0.00035405613544793184,0.0,0.0022460811,False,GUCA1B; guanylate cyclase activator
hsa:56034,0.0,0.0,1.2352136866315791e-05,2.7811006680894192e-05,0.0,0.00013642837,False,PDGFC; platelet derived growth factor
hsa:91653,0.0,0.0,9.674753632748537e-08,5.762142011679048e-07,0.0,4.778319e-06,False,BOC; BOC cell adhesion associated
hsa:9267,0.0,0.0,2.6691907958479528e-06,4.758879182634507e-06,0.0,3.125554e-05,False,CYTH1; cytohesin
hsa:2528,0.0,0.0,1.1356665658526316e-05,7.23320579658359e-05,0.0,0.00092509517,False,FUT6; fucosyltransferase
hsa:53630,3.451199e-06,0.00287399517204864,4.563389563385087e-05,0.00011750303482093198,0.0,0.0011609823,False,BCO1; beta-carotene oxygenase
hsa:125963,0.0,0.0,0.0,0.0,0.0,0.0,False,OR1M1; olfactory receptor family 1 subfamily M member
hsa:5984,2.7054963e-05,0.022530092597371116,0.0006059765067066668,0.0012411344162063184,0.0,0.0057745846,False,RFC4; replication factor C subunit
hsa:9517,0.0,0.0,1.1568389188245618e-05,2.7136121540476992e-05,0.0,0.00016162878,False,SPTLC2; serine palmitoyltransferase long chain base subunit
hsa:5147,5.0680868e-08,4.2204627999496526e-05,2.2891848103304095e-06,7.0421799275201865e-06,0.0,4.929385e-05,False,PDE6D; phosphodiesterase
hsa:4153,0.0,0.0,2.3115271596140342e-07,2.5352995696278963e-06,0.0,3.311009e-05,False,MBL2; mannose binding lectin
hsa:246181,7.538482e-06,0.006277690991616414,0.00010709795223713448,0.00019601592971044962,0.0,0.00127267,False,AKR7L; aldo-keto reductase family 7 like
hsa:2673,4.4516408e-05,0.03707115749307631,0.00023149170473859656,0.00040326729452227887,0.0,0.0023431906,False,GFPT1; glutamine--fructose-6-phosphate transaminase
hsa:1594,1.4894315e-06,0.0012403280541334082,7.92248107210526e-06,1.7020715337871463e-05,0.0,0.0001619133,False,CYP27B1; cytochrome P450 family 27 subfamily B member
hsa:390075,-0.0,0.0,3.718422248538012e-08,3.6551460724761963e-07,0.0,4.705287e-06,False,OR52N5; olfactory receptor family 52 subfamily N member
hsa:5648,7.488202e-07,0.0006235820187513086,1.0551482596329826e-05,2.282864771972225e-05,0.0,0.00013666124,False,MASP1; MBL associated serine protease
hsa:10345,0.0,0.0,1.6432173429187138e-06,9.789306934239305e-06,0.0,0.000114859664,False,TRDN;
hsa:84172,7.3291767e-07,0.0006103391444796833,1.6843375323532173e-05,5.4165610078606314e-05,0.0,0.00039665657,False,POLR1B; RNA polymerase I subunit
hsa:57576,1.2855187e-08,1.070519126071329e-05,3.405217831052634e-08,7.037163909073043e-08,0.0,5.528501e-07,False,KIF17; kinesin family member
hsa:1944,8.774497e-07,0.0007306985779479908,1.733075250879533e-05,5.624530540974691e-05,0.0,0.00049431954,False,EFNA3; ephrin
hsa:5886,3.1204286e-07,0.00025985452392407677,7.314352655596495e-06,1.329430608744497e-05,0.0,6.759561e-05,False,RAD23A; RAD23 homolog A
hsa:4915,0.0,0.0,1.852234989128654e-06,5.5603624477480936e-06,0.0,4.4614648e-05,False,NTRK2; neurotrophic receptor tyrosine kinase
hsa:4799,0.0,0.0,5.428669317076025e-07,1.5770347803827222e-06,0.0,7.396309e-06,False,NFX1; nuclear transcription factor
hsa:121275,3.2282644e-06,0.002688345789302935,6.577399458239768e-05,0.00014190219792745064,0.0,0.0007892582,False,OR10AD1; olfactory receptor family 10 subfamily AD member
hsa:51764,2.1254835e-05,0.017700020535671938,0.00013972936514385965,0.0002937933444878841,0.0,0.0024394796,False,GNG13; G protein subunit gamma
hsa:10096,0.0,0.0,1.1558670092140352e-05,2.8954213853451367e-05,0.0,0.00013165387,False,ACTR3; actin related protein
hsa:83990,2.4786782e-06,0.0020641258820086046,0.0001697195753729211,0.0003440765154926605,0.0,0.0020809516,False,BRIP1; BRCA1 interacting helicase
hsa:64579,0.0,0.0,7.4347183121637405e-06,3.6789333200266765e-05,-0.0,0.00030405645,False,NDST4; N-deacetylase and N-sulfotransferase
hsa:25780,0.0,0.0,1.9838909569005845e-06,3.298819893646794e-06,0.0,1.580348e-05,False,RASGRP3; RAS guanyl releasing protein
hsa:142680,1.1775492e-06,0.000980607236977566,6.864918416320465e-06,1.5963327168162638e-05,0.0,0.00015204959,False,SLC34A3; solute carrier family 34 member
hsa:52,0.0,0.0,0.0001002351243918129,0.0002523506750759882,0.0,0.0016951348,False,ACP1; acid phosphatase
hsa:3925,0.0,0.0,3.3991634745380123e-06,8.288707911050852e-06,0.0,4.5886038e-05,False,STMN1; stathmin
hsa:201514,0.0,0.0,7.385205896830411e-08,1.3991004754531692e-07,0.0,7.225667e-07,False,ZNF584; zinc finger protein
hsa:23583,6.625225e-07,0.0005517173789090676,5.769467923008771e-05,0.00014819476191462136,0.0,0.0010268787,False,SMUG1; single-strand-selective monofunctional uracil-DNA glycosylase
hsa:677,0.0,0.0,4.679208460233918e-07,8.862466969991013e-07,0.0,5.828605e-06,False,ZFP36L1; ZFP36 ring finger protein like
hsa:4025,0.0,0.0,7.5100710445731e-06,2.386793541871323e-05,0.0,0.00021988183,False,LPO;
hsa:259197,2.6930856e-08,2.242674216211153e-05,6.135858738907013e-06,1.8204899985969823e-05,0.0,0.00013595488,False,NCR3; natural cytotoxicity triggering receptor
hsa:64091,1.1035758e-06,0.0009190056908308434,1.3028424182573101e-05,4.007849652976675e-05,0.0,0.0002671511,False,POPDC2; popeye domain containing
hsa:54788,3.3964756e-08,2.828424114744183e-05,3.4384385835421044e-07,6.381185145523619e-07,0.0,2.8779632e-06,False,DNAJB12; DnaJ heat shock protein family (Hsp40) member
hsa:479,0.0,0.0,1.090336112178947e-08,4.2170537942267835e-08,0.0,3.5851633e-07,False,ATP12A; ATPase H+/K+ transporting non-gastric alpha2
hsa:10474,0.0,0.0,6.446258698864091e-07,1.957810826467403e-06,0.0,9.058438e-06,False,TADA3; transcriptional adaptor
hsa:283162,0.0,0.0,2.483868776023392e-07,2.245968134715079e-06,0.0,2.5900657e-05,False,OR8B4; olfactory receptor family 8 subfamily B member
hsa:57187,0.0,0.0,4.6890288507602344e-07,1.0079703485756348e-06,0.0,5.41081e-06,False,THOC2; THO complex subunit
hsa:2784,0.00052625424,0.4382396219488144,0.0012007745234152048,0.0016020713496247355,0.0,0.0070272577,True,GNB3; G protein subunit beta
hsa:6097,4.339876e-05,0.03614043314016307,0.00040267130545366665,0.0011472392113686207,0.0,0.009184506,False,RORC; RAR related orphan receptor
hsa:64332,0.0,0.0,4.6758411479941503e-07,1.7468700586805304e-06,0.0,1.9074112e-05,False,NFKBIZ; NFKB inhibitor
hsa:85007,0.0,0.0,8.257295176519299e-06,1.9769308940530398e-05,0.0,0.00010705139,False,PHYKPL; 5-phosphohydroxy-L-lysine
hsa:145957,1.3564396e-07,0.00011295786947016352,2.6475751769298258e-05,5.0034118362084676e-05,0.0,0.00023067661,False,NRG4; neuregulin
hsa:5273,0.0,0.0,3.747794015438596e-09,2.0455297588661146e-08,0.0,2.4480408e-07,False,SERPINB10; serpin family B member
hsa:5033,0.0,0.0,6.015636521817426e-06,2.374154103029456e-05,0.0,0.0002190297,False,P4HA1; prolyl 4-hydroxylase subunit alpha
hsa:63826,6.437953e-05,0.05361222531611784,0.0004021128462497075,0.0008712305212322749,0.0,0.0044108615,False,SRR; serine
hsa:57573,1.9262899e-08,1.6041230518918377e-05,8.00942101263158e-08,1.0855259230685215e-07,0.0,4.788862e-07,False,ZNF471; zinc finger protein
hsa:27040,3.4304838e-05,0.028567445339984954,0.00018585321942631572,0.00036504857381102965,0.0,0.002015864,False,LAT; linker for activation of T
hsa:4927,0.0,0.0,9.381552726081873e-08,2.3012282942465702e-07,0.0,1.2523896e-06,False,NUP88; nucleoporin
hsa:116442,2.4678815e-08,2.055134901287395e-05,2.1703326319274847e-07,3.4125906974373234e-07,0.0,1.6997128e-06,False,RAB39B; RAB39B
hsa:2878,0.0,0.0,9.803927055497079e-05,0.00027014033802906496,0.0,0.0015955991,False,GPX3; glutathione peroxidase
hsa:84749,0.0,0.0,1.484873089451462e-06,3.342141229761528e-06,0.0,1.9971669e-05,False,USP30; ubiquitin specific peptidase
hsa:51700,0.0,0.0,3.238272508705263e-05,0.00012190534882384391,0.0,0.00082433654,False,CYB5R2; cytochrome b5 reductase
hsa:3978,4.5910634e-05,0.03823220291315921,0.0004161462989338012,0.0007783649640897616,0.0,0.0039287824,False,LIG1; DNA ligase
hsa:406979,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19A; microRNA
hsa:90233,0.0,0.0,2.000360062356725e-08,4.3343268933351275e-08,0.0,2.4213574e-07,False,ZNF551; zinc finger protein
hsa:6037,0.0,0.0,2.1847971187134505e-08,1.1846417749827924e-07,0.0,1.1755302e-06,False,RNASE3; ribonuclease A family member
hsa:3596,0.0,0.0,6.090213199450295e-06,2.0260053426248616e-05,0.0,0.00016747823,False,IL13; interleukin
hsa:3625,0.0,0.0,1.7683701565672519e-06,4.513211726905159e-06,0.0,2.5036774e-05,False,INHBB; inhibin subunit beta
hsa:7596,0.0,0.0,1.1863590077643275e-07,3.06804212363616e-07,0.0,1.3713652e-06,False,ZNF45; zinc finger protein
hsa:390445,-0.0,0.0,2.990662607017544e-08,1.8254524953452628e-07,0.0,1.7828094e-06,False,OR5AU1; olfactory receptor family 5 subfamily AU member
hsa:2331,1.1971848e-07,9.969588352482765e-05,3.874033393011695e-05,0.00013226395090289365,0.0,0.000955754,False,FMOD;
hsa:4650,3.3648735e-08,2.8021073816822526e-05,2.5182041341309943e-06,7.621119098973954e-06,0.0,3.6274625e-05,False,MYO9B; myosin
hsa:23395,4.893782e-07,0.00040753100128559786,1.373730196088889e-06,1.7612668410891677e-06,0.0,7.03267e-06,False,LARS2; leucyl-tRNA synthetase 2
hsa:9210,0.0,0.0,4.5268411543859645e-06,1.4076632535860032e-05,0.0,0.00011104446,False,BMP15; bone morphogenetic protein
hsa:2067,0.0,0.0,2.0967907325672515e-05,5.692433746998202e-05,0.0,0.00040307626,False,ERCC1; ERCC excision repair 1
hsa:6150,1.0633447e-07,8.855031350042433e-05,4.013656286321637e-07,7.376282282710378e-07,0.0,4.4888975e-06,False,MRPL23; mitochondrial ribosomal protein
hsa:11015,0.0,0.0,0.00012000508020085437,0.0004717139876706184,0.0,0.0040408433,False,KDELR3; KDEL endoplasmic reticulum protein retention receptor
hsa:4803,0.0,0.0,7.011246196491228e-06,1.6998692235473833e-05,0.0,0.0001444244,False,NGF; nerve growth
hsa:3949,0.0,0.0,1.8719265168421053e-05,6.134461179083718e-05,0.0,0.0004443564,False,LDLR; low density lipoprotein
hsa:1002,6.4018775e-07,0.0005331180562768713,1.2005991758649125e-05,2.7295505677552195e-05,0.0,0.000169808,False,CDH4; cadherin
hsa:344,1.0116063e-07,8.424178444111708e-05,5.642989649970759e-06,1.97134918911059e-05,0.0,0.00014601745,False,APOC2; apolipoprotein
hsa:7177,0.0,0.0,4.315622383245054e-06,1.8919656884845475e-05,0.0,0.00017841079,False,TPSAB1; tryptase alpha/beta
hsa:1728,0.0,0.0,7.502189308771927e-06,2.014917513865132e-05,0.0,0.0001847944,False,NQO1; NAD(P)H quinone dehydrogenase
hsa:610,0.0,0.0,6.2897637292163715e-06,1.9352591184661677e-05,0.0,0.00012292934,False,HCN2; hyperpolarization activated cyclic nucleotide gated potassium and sodium channel
hsa:3109,0.0,0.0,0.0004282489170023393,0.0011323320681375737,0.0,0.0063377763,False,HLA-DMB; major histocompatibility complex
hsa:252969,0.0,0.0,1.571703717469824e-05,5.6563660076967355e-05,0.0,0.00043410194,False,NEIL2; nei like DNA glycosylase
hsa:6426,9.5363146e-07,0.000794139141774698,0.00010177238679288886,0.0002821503857435843,0.0,0.0015656103,False,SRSF1; serine and arginine rich splicing factor
hsa:4000,0.0,0.0,9.907454912280702e-07,5.486938733727597e-06,0.0,4.1101073e-05,False,LMNA; lamin
hsa:632,5.79017e-07,0.00048217795106398893,2.7807511318321637e-05,8.639950578371741e-05,0.0,0.00085703254,False,BGLAP; bone gamma-carboxyglutamate
hsa:398,0.0,0.0,1.0226095968865497e-05,2.3429629257893803e-05,0.0,0.00020569074,False,ARHGDIG; Rho GDP dissociation inhibitor
hsa:728819,1.2980644e-05,0.0108096659120735,0.0004717767536616375,0.0008779178012802433,0.0,0.0063508535,False,C1GALT1C1L; C1GALT1 specific chaperone 1
hsa:950,1.1177528e-06,0.0009308116253927545,4.5336416203327475e-06,9.583181401279073e-06,0.0,8.933179e-05,False,SCARB2; scavenger receptor class B member
hsa:57817,0.0,0.0,4.0367639468596495e-08,1.5058998935792056e-07,0.0,1.4324804e-06,False,HAMP; hepcidin antimicrobial
hsa:54578,0.0,0.0,2.7281634161403513e-05,0.00010626559269838402,0.0,0.00092393864,False,UGT1A6; UDP glucuronosyltransferase family 1 member
hsa:3452,7.5178114e-06,0.006260477494335223,2.9016995545964915e-05,4.9375873262175226e-05,0.0,0.0002600254,False,IFNA21; interferon alpha
hsa:341208,0.0,0.0,1.7896171703099414e-07,5.881948161119369e-07,0.0,4.833308e-06,False,HEPHL1; hephaestin like
hsa:6839,0.0,0.0,1.7151645021052628e-06,8.453605341620822e-06,0.0,0.000106497006,False,SUV39H1; SUV39H1 histone lysine
hsa:8200,0.0,0.0,5.3270273440760236e-08,2.5383604709295663e-07,0.0,2.1389603e-06,False,GDF5; growth differentiation factor
hsa:1054,5.3761454e-08,4.4769994207321875e-05,1.4303025042339178e-06,3.6946918105788777e-06,0.0,2.373276e-05,False,CEBPG; CCAAT enhancer binding protein
hsa:56288,5.511149e-06,0.004589424028704428,4.342968045555558e-05,8.199627036597901e-05,0.0,0.00043999517,False,PARD3; par-3 family cell polarity
hsa:256144,0.0,0.0,5.975711111111111e-08,7.814256254737928e-07,-0.0,1.0218466e-05,False,OR4C3; olfactory receptor family 4 subfamily C member
hsa:9275,0.0,0.0,6.1615396021467845e-06,2.0292937666443664e-05,0.0,0.00012158795,False,BCL7B; BAF chromatin remodeling complex subunit
hsa:10482,7.863771e-08,6.548576273954678e-05,4.199268871636257e-05,0.00012291350458761303,0.0,0.0005822835,False,NXF1; nuclear RNA export factor
hsa:7841,2.3870882e-06,0.001987854065226108,0.00011090060379085144,0.0002882945135271473,0.0,0.001545929,False,MOGS; mannosyl-oligosaccharide
hsa:9572,0.0,0.0,0.00012181267067660818,0.00037876523348280447,0.0,0.0023911018,False,NR1D1; nuclear receptor subfamily 1 group D member
hsa:7638,0.0,0.0,1.6917891154970757e-08,2.9984345921825017e-08,0.0,1.6208894e-07,False,ZNF221; zinc finger protein
hsa:90594,0.0,0.0,8.006994834619884e-08,1.7189624199330396e-07,0.0,1.0795594e-06,False,ZNF439; zinc finger protein
hsa:6422,0.0,0.0,2.2508305922222217e-07,7.040303484337529e-07,0.0,3.8109235e-06,False,SFRP1; secreted frizzled related protein
hsa:10855,1.653925e-06,0.0013773104549840642,2.5047398884035095e-05,5.306514063313712e-05,0.0,0.00026608043,False,HPSE;
hsa:5645,0.0,0.0,2.0099804276783625e-06,1.91552236915545e-05,0.0,0.00024964343,False,PRSS2; serine protease
hsa:3605,0.0,0.0,6.3522336257309936e-09,5.569979594956654e-08,0.0,6.670192e-07,False,IL17A; interleukin
hsa:475,6.404205e-06,0.00533311879460146,0.00020380852216081877,0.0004484376829635515,0.0,0.0026574654,False,ATOX1; antioxidant 1 copper
hsa:780851,6.220589e-08,5.1802120808735984e-05,2.2437909799731e-06,5.169015064639199e-06,0.0,2.9041454e-05,False,SNORD3A; small nucleolar RNA
hsa:4640,2.0424038e-08,1.7008172118077797e-05,1.1501839957573099e-07,2.872529897551414e-07,0.0,2.1170222e-06,False,MYO1A; myosin
hsa:1592,1.5426885e-08,1.2846779629267854e-05,7.4838992010818695e-06,1.8296828843818797e-05,0.0,0.0001514676,False,CYP26A1; cytochrome P450 family 26 subfamily A member
hsa:5591,2.3529863e-07,0.00019594556170468854,3.453108644438598e-05,0.0001320813085341863,0.0,0.0011013311,False,PRKDC; protein kinase
hsa:10859,0.0,0.0,1.687405133725146e-05,4.8532023061444534e-05,0.0,0.00041657343,False,LILRB1; leukocyte immunoglobulin like receptor
hsa:8519,0.0,0.0,2.0648298748245614e-06,6.426202246742747e-06,0.0,3.611578e-05,False,IFITM1; interferon induced transmembrane protein
hsa:55586,0.0,0.0,5.6664036899251444e-06,1.9483916618519066e-05,0.0,0.00014297698,False,MIOX; myo-inositol
hsa:1514,1.1296618e-06,0.0009407288769056137,1.743894877629239e-05,4.109672408826375e-05,0.0,0.0003848199,False,CTSL; cathepsin
hsa:23595,3.6998458e-08,3.081056457922142e-05,1.5410065346608188e-06,3.7978433141239752e-06,0.0,1.9150842e-05,False,ORC3; origin recognition complex subunit
hsa:9681,2.67105e-07,0.00022243240115393288,1.7924784905029227e-06,3.4700814102041465e-06,0.0,1.8168897e-05,False,DEPDC5; DEP domain containing 5
hsa:10797,1.0173316e-06,0.0008471856032562941,3.381955237222221e-05,7.592004510699193e-05,0.0,0.00059289753,False,MTHFD2; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2
hsa:60482,0.0,0.0,1.7730035266134504e-06,7.898782812004681e-06,0.0,6.578207e-05,False,SLC5A7; solute carrier family 5 member
hsa:786,6.4509572e-06,0.005372051813845685,0.00011574755481134505,0.00031573194107796846,0.0,0.0023775154,False,CACNG1; calcium voltage-gated channel auxiliary subunit gamma
hsa:2899,0.0,0.0,6.565938320859649e-05,0.0002222315123438156,0.0,0.0013842067,False,GRIK3; glutamate ionotropic receptor kainate type subunit
hsa:3615,3.949325e-06,0.0032888109271157636,4.1079635491731e-05,0.00012041305695009152,0.0,0.00068437133,False,IMPDH2; inosine monophosphate dehydrogenase
hsa:9570,0.0,0.0,4.3440151784725147e-05,0.00012455012633866462,0.0,0.0008322954,False,GOSR2; golgi SNAP receptor complex member
hsa:9968,0.0,0.0,3.004039887116959e-06,1.0800834194424032e-05,0.0,0.000101259946,False,MED12; mediator complex subunit
hsa:6536,0.0,0.0,9.03226202397661e-07,2.5445255927575037e-06,0.0,2.2107797e-05,False,SLC6A9; solute carrier family 6 member
hsa:8556,3.3066893e-08,2.7536543339473903e-05,2.2813406252380116e-07,3.945278699752494e-07,0.0,1.993664e-06,False,CDC14A; cell division cycle
hsa:9915,2.7637416e-06,0.0023015131886599365,1.8410384325321633e-05,5.3908961190389454e-05,0.0,0.0004131222,False,ARNT2; aryl hydrocarbon receptor nuclear translocator
hsa:23362,3.1664992e-08,2.6369106542670768e-05,4.624317213691228e-07,9.948649138744028e-07,0.0,4.9377436e-06,False,PSD3; pleckstrin and Sec7 domain containing
hsa:8317,0.0,0.0,3.5978484624444435e-07,7.569249942868889e-07,0.0,2.7958877e-06,False,CDC7; cell division cycle
hsa:6547,0.0006530121,0.5437975679435882,0.0010206517429643277,0.0011151063869583929,0.0,0.0061255116,True,SLC8A3; solute carrier family 8 member
hsa:219983,0.0,0.0,3.680823081871345e-08,4.4778950315072195e-07,0.0,5.8406868e-06,False,OR4D6; olfactory receptor family 4 subfamily D member
hsa:8387,0.0,0.0,6.41308692128655e-07,2.895448051503441e-06,0.0,2.1246593e-05,False,OR1E1; olfactory receptor family 1 subfamily E member
hsa:163081,1.5937707e-10,1.327216801219687e-07,5.098319720552048e-08,7.67155144780264e-08,0.0,4.6872034e-07,False,ZNF567; zinc finger protein
hsa:3080,0.0,0.0,5.493920012923976e-08,3.0888680052582677e-07,0.0,3.197184e-06,False,CFHR2; complement factor H related
hsa:8443,2.5997351e-06,0.002164936338358173,3.187791731311696e-05,9.579416226829198e-05,0.0,0.000594886,False,GNPAT; glyceronephosphate
hsa:84197,0.0,0.0,1.601550806288304e-05,5.537932260099574e-05,0.0,0.00035141062,False,POMK; protein O-mannose
hsa:56479,0.0,0.0,8.575396418128656e-06,1.613214884707737e-05,0.0,7.754969e-05,False,KCNQ5; potassium voltage-gated channel subfamily Q member
hsa:157506,0.0,0.0,2.378285446538012e-05,0.00015029916556956582,0.0,0.0019373732,False,RDH10; retinol dehydrogenase
hsa:5330,0.0,0.0,0.00024050822031461985,0.000497545610554277,0.0,0.0028502648,False,PLCB2; phospholipase C beta
hsa:7582,0.0,0.0,8.439018617309943e-08,1.7773718107340196e-07,0.0,8.819737e-07,False,ZNF33B; zinc finger protein
hsa:1365,2.1246008e-06,0.0017692669827879177,2.788690917830995e-05,7.852494759637926e-05,0.0,0.0007235066,False,CLDN3; claudin
hsa:10164,0.0,0.0,1.4637343198549709e-06,1.2279771625523526e-05,0.0,0.00015591804,False,CHST4; carbohydrate sulfotransferase
hsa:6827,0.0,0.0,5.301435689871347e-06,1.408989038187798e-05,0.0,8.545153e-05,False,SUPT4H1; SPT4 homolog
hsa:3782,0.0,0.0,6.966859389005846e-06,1.8665389914924697e-05,0.0,0.00017879029,False,KCNN3; potassium calcium-activated channel subfamily N member
hsa:219487,0.0,0.0,3.725991047368421e-06,3.061840633428196e-05,0.0,0.00038613062,False,OR5M11; olfactory receptor family 5 subfamily M member
hsa:8110,9.486885e-08,7.900228786511778e-05,4.466804698939768e-06,1.1552522619086728e-05,0.0,7.171664e-05,False,DPF3; double PHD fingers
hsa:3295,0.0,0.0,0.0003274446755912279,0.0006970133701521369,0.0,0.0065767705,False,HSD17B4; hydroxysteroid 17-beta dehydrogenase
hsa:3575,0.0,0.0,4.3166702558538025e-05,8.962025136442081e-05,0.0,0.0007750678,False,IL7R; interleukin 7
hsa:8310,3.090566e-05,0.02573677079443312,0.0007921714407353978,0.0015284225688256565,0.0,0.008100144,False,ACOX3; acyl-CoA oxidase 3
hsa:55236,0.0,0.0,2.2662722554649131e-07,3.7747920676504603e-07,0.0,2.3755126e-06,False,UBA6; ubiquitin like modifier activating enzyme
hsa:3623,0.0,0.0,5.995088435327485e-07,1.4613263261655876e-06,0.0,7.787081e-06,False,INHA; inhibin subunit
hsa:867,2.7849619e-05,0.02319184450082249,5.3232902768163726e-05,7.314894590224063e-05,0.0,0.00040979442,False,CBL; Cbl
hsa:11343,0.0,0.0,2.532385670760234e-06,2.017676412721788e-05,0.0,0.0002545677,False,MGLL; monoglyceride
hsa:51068,0.0,0.0,5.38103113816959e-07,1.2644169497628763e-06,0.0,1.0978107e-05,False,NMD3; NMD3 ribosome export
hsa:196528,3.5632462e-07,0.0002967302776693162,1.2813875532847955e-06,2.0673576579387606e-06,0.0,1.0662948e-05,False,ARID2; AT-rich interaction domain
hsa:319100,0.0,0.0,3.133403929824561e-08,3.2769527729322425e-07,0.0,4.142229e-06,False,TAAR6; trace amine associated receptor
hsa:4161,0.0,0.0,2.4994512069005842e-08,1.282381876333635e-07,0.0,1.3510277e-06,False,MC5R; melanocortin 5
hsa:5025,0.0,0.0,4.553388733450293e-06,1.0055036880002496e-05,0.0,8.0265796e-05,False,P2RX4; purinergic receptor P2X
hsa:51422,0.0,0.0,0.00020847912841169596,0.00040431580427060734,0.0,0.0017401907,False,PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma
hsa:10121,1.4798508e-07,0.00012323497006554296,4.336428974649121e-07,7.859714222139835e-07,0.0,3.8176845e-06,False,ACTR1A; actin related protein
hsa:8174,4.946614e-07,0.00041193060017658245,0.00010582920290123389,0.00029534036302241096,0.0,0.0018263028,False,MADCAM1; mucosal vascular addressin cell adhesion molecule
hsa:27341,0.0,0.0,1.98905296541579e-06,3.4379029530262777e-06,0.0,1.5553791e-05,False,RRP7A; ribosomal RNA processing 7 homolog
hsa:5903,4.5773304e-06,0.003811784098938216,9.411304128235665e-05,0.0002463589968075836,0.0,0.0016392694,False,RANBP2; RAN binding protein
hsa:259293,0.0,0.0,8.33503464409357e-06,2.508551656969286e-05,0.0,0.00019398202,False,TAS2R30; taste 2 receptor member
hsa:9955,7.195175e-07,0.0005991801171721791,4.922343493389472e-05,0.00021626713617569962,0.0,0.0022521724,False,HS3ST3A1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:7157,0.0,0.0,0.000159024321268772,0.0003018379914114394,0.0,0.002008336,False,TP53; tumor protein
hsa:3802,0.0,0.0,4.407480892333333e-06,2.2398743032644982e-05,0.0,0.0002593956,False,KIR2DL1; killer cell immunoglobulin like receptor
hsa:5634,4.1172607e-06,0.0034286598291972162,1.0414998796374269e-05,1.4898878340736014e-05,0.0,6.185556e-05,False,PRPS2; phosphoribosyl pyrophosphate synthetase
hsa:84153,3.4472365e-07,0.00028706953896051347,2.9698283296198853e-05,6.283882713003609e-05,0.0,0.0004282872,False,RNASEH2C; ribonuclease H2 subunit
hsa:6728,0.0,0.0,2.7388720882339176e-06,5.448238054247715e-06,0.0,3.730937e-05,False,SRP19; signal recognition particle
hsa:5621,0.0,0.0,1.7273341901871345e-06,4.423125524310297e-06,0.0,3.875707e-05,False,PRNP; prion
hsa:29082,8.9640525e-06,0.007464838627674191,0.00011545271591598073,0.00035097083425317645,0.0,0.0023731678,False,CHMP4A; charged multivesicular body protein
hsa:171389,0.0,0.0,5.92681587099415e-09,1.5404341150109306e-08,0.0,1.10014184e-07,False,NLRP6; NLR family pyrin domain containing
hsa:3682,0.0,0.0,3.181541394444444e-08,8.013313017124751e-08,0.0,8.390518e-07,False,ITGAE; integrin subunit alpha
hsa:121274,1.6617038e-08,1.3837882714311403e-05,1.125178138011696e-07,2.260361873344218e-07,0.0,1.1304772e-06,False,ZNF641; zinc finger protein
hsa:90333,0.0,0.0,4.4456105502923974e-08,7.192341363780921e-08,0.0,3.3366413e-07,False,ZNF468; zinc finger protein
hsa:2908,0.0,0.0,1.0428389994152047e-06,3.259825229007517e-06,0.0,2.0666286e-05,False,NR3C1; nuclear receptor subfamily 3 group C member
hsa:11346,0.0,0.0,1.970858005964912e-06,4.454545429380584e-06,0.0,2.1551557e-05,False,SYNPO;
hsa:7137,5.2788833e-05,0.0439600414754646,0.00016315805021228065,0.0002796561259236512,0.0,0.0013974227,False,TNNI3; troponin I3
hsa:5553,0.0,0.0,6.413472169970759e-06,3.0526429927075344e-05,0.0,0.00031452862,False,PRG2; proteoglycan 2
hsa:3763,2.7830492e-06,0.002317591644055828,4.2203733125754395e-05,0.00017988395242693976,0.0,0.0019191264,False,KCNJ6; potassium inwardly rectifying channel subfamily J member
hsa:57506,0.0,0.0,4.063275199025614e-05,0.00010668375527017963,0.0,0.0005301788,False,MAVS; mitochondrial antiviral signaling
hsa:2081,0.0,0.0,1.3322145682865496e-06,2.054044196130583e-06,0.0,9.635075e-06,False,ERN1; endoplasmic reticulum to nucleus signaling
hsa:490,0.0,0.0,0.00016402535278245604,0.00030406547768594707,0.0,0.0019154858,False,ATP2B1; ATPase plasma membrane Ca2+ transporting
hsa:8638,0.0,0.0,9.838764764093563e-08,3.725307230939583e-07,0.0,3.1010063e-06,False,OASL; 2'-5'-oligoadenylate synthetase
hsa:10652,1.9529461e-06,0.0016263210735374056,2.955458149701521e-05,6.549596062677686e-05,0.0,0.0005458911,False,YKT6; YKT6 v-SNARE
hsa:8938,2.3699414e-08,1.973575021793352e-05,1.5511500302149702e-05,4.858430669687724e-05,0.0,0.00031355114,False,BAIAP3; BAI1 associated protein
hsa:9825,3.9529706e-07,0.0003291846810239055,1.4475136059211704e-05,4.7750611926552346e-05,0.0,0.00030985803,False,SPATA2; spermatogenesis associated
hsa:5452,0.0,0.0,4.447439541754387e-07,9.741645187189948e-07,0.0,4.2495076e-06,False,POU2F2; POU class 2 homeobox
hsa:831,0.0,0.0,1.0899087764561398e-07,1.81278770836814e-07,0.0,8.9425555e-07,False,CAST;
hsa:84572,5.784957e-09,4.817438370986137e-06,2.5126182370146205e-06,6.641048008681533e-06,0.0,2.833964e-05,False,GNPTG; N-acetylglucosamine-1-phosphate transferase subunit
hsa:3371,2.0402265e-06,0.001699004059425636,4.5558495059356715e-05,9.46967366525989e-05,0.0,0.00051917805,False,TNC; tenascin
hsa:60,0.0,0.0,0.0006895565012748537,0.001109674535678811,0.0,0.009112671,False,ACTB; actin
hsa:3195,0.0,0.0,6.372032344224152e-07,5.854613454350925e-06,0.0,7.1148446e-05,False,TLX1; T cell leukemia homeobox
hsa:10401,6.426819e-07,0.0005351950663415951,8.030653919549707e-06,2.387683712374608e-05,0.0,0.00013488848,False,PIAS3; protein inhibitor of activated STAT
hsa:6448,3.4459626e-06,0.0028696345459824774,0.00013838528084292393,0.000315304325708572,0.0,0.0019077194,False,SGSH; N-sulfoglucosamine
hsa:2251,0.0,0.0,7.722925807017544e-08,4.000905896506908e-07,0.0,2.747283e-06,False,FGF6; fibroblast growth factor
hsa:51512,9.302143e-06,0.007746384393280728,0.0001410022624391544,0.0002869231726208801,0.0,0.0015101152,False,GTSE1; G2 and S-phase expressed
hsa:29978,0.0,0.0,3.5940820328304094e-07,1.1412457631509405e-06,0.0,5.7870575e-06,False,UBQLN2; ubiquilin
hsa:3422,1.6812442e-07,0.00014000605916479397,2.522656309059142e-05,8.26228380459597e-05,0.0,0.0004967658,False,IDI1; isopentenyl-diphosphate delta isomerase
hsa:121601,2.7907896e-09,2.3240374828004863e-06,2.9380856403524383e-05,0.00010627132028300864,0.0,0.0008082142,False,ANO4; anoctamin
hsa:1960,0.0,0.0,8.746144810304094e-07,2.925787773795552e-06,0.0,1.7959886e-05,False,EGR3; early growth response
hsa:400713,1.6093438e-09,1.340185341780179e-06,1.8923892895614034e-07,4.373218908637059e-07,0.0,1.9954477e-06,False,ZNF880; zinc finger protein
hsa:390079,0.0,0.0,6.114945248538012e-07,3.794771624365765e-06,0.0,3.3518125e-05,False,OR52E8; olfactory receptor family 52 subfamily E member
hsa:245973,3.4721538e-06,0.00289144533763783,0.00015837368162549708,0.0005171362293234936,0.0,0.003838215,False,ATP6V1C2; ATPase H+ transporting V1 subunit
hsa:406969,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR194-1; microRNA
hsa:272,1.520036e-08,1.2658140331346081e-05,4.912566357374271e-07,1.4416720323823122e-06,0.0,8.030198e-06,False,AMPD3; adenosine monophosphate deaminase
hsa:4131,0.0,0.0,4.468076757862573e-06,1.1836708302624763e-05,0.0,6.828481e-05,False,MAP1B; microtubule associated protein
hsa:3002,0.0,0.0,2.781188198187135e-06,8.081391596572466e-06,0.0,6.393863e-05,False,GZMB; granzyme
hsa:148789,0.0,0.0,2.545022913350877e-05,4.327889557383086e-05,0.0,0.0002471145,False,B3GALNT2; beta-1
hsa:23636,0.0,0.0,1.7082075610801754e-07,4.6835855877780537e-07,0.0,2.6005168e-06,False,NUP62; nucleoporin
hsa:8693,0.0,0.0,1.383148095712573e-05,5.106505087170182e-05,0.0,0.00052285864,False,GALNT4; polypeptide N-acetylgalactosaminyltransferase
hsa:162514,0.0,0.0,7.807522345327484e-06,2.5553242832664998e-05,0.0,0.0001714787,False,TRPV3; transient receptor potential cation channel subfamily V member
hsa:22865,9.2174455e-09,7.675852324256429e-06,1.8168024515670759e-06,5.08288002652211e-06,0.0,3.8166996e-05,False,SLITRK3; SLIT and NTRK like family member
hsa:50632,8.3733374e-07,0.0006972919052634841,5.599450516330995e-06,9.829182316053032e-06,0.0,6.408314e-05,False,CALY; calcyon neuron specific vesicular
hsa:6949,0.0,0.0,1.2762810734459061e-06,2.6155340132456737e-06,0.0,1.1919966e-05,False,TCOF1; treacle ribosome biogenesis factor
hsa:138050,2.4481771e-05,0.02038726009633186,0.00022389866690877177,0.0004080287980643377,0.0,0.0021562227,False,HGSNAT; heparan-alpha-glucosaminide
hsa:6335,0.0,0.0,0.0006916118991525148,0.0011454175146862183,0.0,0.0042596166,False,SCN9A; sodium voltage-gated channel alpha subunit
hsa:2273,1.8364863e-06,0.0015293388644739031,7.295661192415205e-05,0.00018125221875275402,0.0,0.0008366715,False,FHL1; four and a half LIM domains
hsa:5683,0.0,0.0,3.7889979510116958e-06,1.5148026637509298e-05,0.0,0.00016554694,False,PSMA2; proteasome 20S subunit alpha
hsa:706,0.0,0.0,2.724855506322222e-06,1.5972343535901497e-05,0.0,0.00019701953,False,TSPO; translocator
hsa:56624,0.0,0.0,5.554011340674267e-06,1.1943870420678617e-05,0.0,7.668789e-05,False,ASAH2; N-acylsphingosine amidohydrolase
hsa:266722,1.2653498e-05,0.010537234208032376,0.00019303021639546783,0.00043503581974148114,0.0,0.0031319053,False,HS6ST3; heparan sulfate 6-O-sulfotransferase
hsa:79621,0.0,0.0,1.4690186718915784e-05,4.710783049114806e-05,0.0,0.00031073234,False,RNASEH2B; ribonuclease H2 subunit
hsa:390167,0.0,0.0,4.300692514619883e-08,5.470180430564174e-07,0.0,7.1515096e-06,False,OR5M10; olfactory receptor family 5 subfamily M member
hsa:9817,0.0,0.0,1.4606717830877197e-06,2.5117851924601073e-06,0.0,9.052097e-06,False,KEAP1; kelch like ECH associated protein
hsa:23456,5.514671e-06,0.004592356983598061,0.0003061313370087718,0.0005530471965382572,0.0,0.0028668002,False,ABCB10; ATP binding cassette subfamily B member
hsa:55240,0.0,0.0,0.00014835326532228071,0.0003328400480191065,0.0,0.0019598866,False,STEAP3; STEAP3
hsa:7525,0.0,0.0,3.4386901386023398e-06,1.1757789563941092e-05,0.0,6.7557354e-05,False,YES1; YES proto-oncogene 1
hsa:8887,5.3199545e-07,0.00044302062988887155,9.229274341124561e-06,2.1203749097334584e-05,0.0,0.00017678765,False,TAX1BP1; Tax1 binding protein
hsa:2181,0.0,0.0,0.00011490707813742695,0.00032719319572547346,0.0,0.0018128091,False,ACSL3; acyl-CoA synthetase long chain family member
hsa:10914,0.0,0.0,2.2121569574619878e-07,7.236979057882137e-07,0.0,4.2060633e-06,False,PAPOLA; poly(A) polymerase
hsa:28972,0.0,0.0,4.4716229857877195e-05,0.00015649781414654203,0.0,0.00094458926,False,SPCS1; signal peptidase complex subunit
hsa:1716,2.2370878e-08,1.8629408320554432e-05,4.794471834012866e-06,1.4176768239883228e-05,0.0,9.773745e-05,False,DGUOK; deoxyguanosine
hsa:177,5.8921003e-05,0.04906662239826316,0.00012384302415220465,0.00016719636811144304,0.0,0.0010057691,False,AGER; advanced glycosylation end-product specific
hsa:440567,0.0,0.0,4.324302389483275e-05,0.0001022087121766525,0.0,0.0004987377,False,UQCRHL; ubiquinol-cytochrome c reductase hinge protein
hsa:127074,0.0,0.0,2.0808984355672514e-06,1.555034518016465e-05,0.0,0.00019115896,False,OR2T4; olfactory receptor family 2 subfamily T member
hsa:642517,2.653315e-08,2.209555142987767e-05,7.24948874865497e-07,1.5903689870457956e-06,0.0,7.410684e-06,False,AGAP9; ArfGAP with GTPase domain
hsa:93166,0.0,0.0,6.490656929959065e-07,2.4224619040941244e-06,0.0,2.095946e-05,False,PRDM6; PR/SET domain
hsa:3945,0.00012103135,0.10078917951892347,0.00041001899062204685,0.0006221097520601197,0.0,0.0032566183,False,LDHB; lactate dehydrogenase
hsa:5710,0.0,0.0,1.1316998858830408e-05,3.394103519208839e-05,0.0,0.00022919392,False,PSMD4; proteasome 26S subunit ubiquitin receptor
hsa:2995,0.0,0.0,4.3799624162660815e-06,1.1264817632542073e-05,0.0,5.2140276e-05,False,GYPC; glycophorin C (Gerbich blood
hsa:6872,0.0,0.0,7.256649768900585e-07,2.3032421205202812e-06,0.0,2.280354e-05,False,TAF1; TATA-box binding protein associated factor
hsa:149461,0.0,0.0,7.71771195239766e-08,5.46342694608544e-07,0.0,5.777945e-06,False,CLDN19; claudin
hsa:89780,0.0,0.0,5.387999624795324e-07,1.7847769676189376e-06,0.0,1.520203e-05,False,WNT3A; Wnt family member
hsa:6483,0.00020886608,0.1739337851931242,0.0008254249958,0.001547513803911906,0.0,0.0075792163,False,ST3GAL2; ST3 beta-galactoside alpha-2
hsa:22876,1.9048247e-06,0.0015862478493413445,4.722363158804681e-05,9.128228700445392e-05,0.0,0.0006521041,False,INPP5F; inositol polyphosphate-5-phosphatase
hsa:11284,1.756273e-07,0.0001462541024959552,1.5167920607824557e-05,5.3114605351163693e-05,0.0,0.00032434918,False,PNKP; polynucleotide kinase
hsa:652,0.0,0.0,1.3511553139941518e-05,4.5136283089847106e-05,0.0,0.00028374355,False,BMP4; bone morphogenetic protein
hsa:29071,0.0,0.0,3.122312455695905e-05,9.161613437992541e-05,0.0,0.0006964328,False,C1GALT1C1; C1GALT1 specific chaperone
hsa:64393,0.0,0.0,4.387041055963174e-05,0.00014734971945731674,0.0,0.0009912512,False,ZMAT3; zinc finger matrin-type
hsa:29882,5.6886387e-07,0.00047372290497676463,7.405806943625728e-06,1.4986085877973971e-05,0.0,8.654982e-05,False,ANAPC2; anaphase promoting complex subunit
hsa:257364,0.0,0.0,1.8877222581228076e-07,3.463084606932259e-07,0.0,1.7304874e-06,False,SNX33; sorting nexin
hsa:858,7.708716e-07,0.0006419453809152734,2.0793260710704675e-05,7.20537107813459e-05,0.0,0.00047009025,False,CAV2; caveolin
hsa:23408,0.0,0.0,4.535684489432751e-05,7.638055517649427e-05,0.0,0.00038625655,False,SIRT5; sirtuin
hsa:388646,0.0,0.0,3.285802705847954e-09,1.4288065159668843e-08,0.0,1.3898166e-07,False,GBP7; guanylate binding protein
hsa:3340,0.0,0.0,2.683388175690058e-05,6.253272257452273e-05,0.0,0.00033167392,False,NDST1; N-deacetylase and N-sulfotransferase
hsa:84991,5.445926e-08,4.5351094014961655e-05,6.68342422182456e-07,1.911663218519732e-06,0.0,1.0757368e-05,False,RBM17; RNA binding motif protein
hsa:4790,0.0,0.0,0.00013370680501345022,0.00028305661451516077,0.0,0.0017930439,False,NFKB1; nuclear factor kappa B subunit
hsa:7428,1.9481156e-06,0.0016222984617788308,3.3222888723918135e-05,7.829103126873929e-05,0.0,0.00041007873,False,VHL; von Hippel-Lindau tumor
hsa:10277,0.0,0.0,5.754927995438597e-07,1.2828973454515476e-06,0.0,6.7280453e-06,False,UBE4B; ubiquitination factor
hsa:221264,0.0,0.0,4.583485449845028e-05,0.00011777175678125666,0.0,0.00072284666,False,AK9; adenylate kinase
hsa:970,0.0,0.0,2.8804151402046793e-07,1.7596676223876014e-06,0.0,2.1749105e-05,False,CD70; CD70
hsa:997,1.729004e-09,1.4398326924795665e-06,6.052402119415206e-07,1.400503543742032e-06,0.0,7.3590563e-06,False,CDC34; cell division cycle 34
hsa:10535,0.0,0.0,4.201786655853801e-06,1.4545057662967795e-05,0.0,9.1549344e-05,False,RNASEH2A; ribonuclease H2 subunit
hsa:84868,5.0713607e-09,4.223189148906572e-06,3.8038383905222234e-06,9.40865211792897e-06,0.0,6.60542e-05,False,HAVCR2; hepatitis A virus cellular receptor
hsa:1892,0.0,0.0,0.0005866002298035089,0.0013346985598115286,0.0,0.0068207514,False,ECHS1; enoyl-CoA hydratase
hsa:221074,0.0,0.0,2.053727339883041e-10,7.092890372666372e-10,0.0,5.6872045e-09,False,SLC39A12; solute carrier family 39 member
hsa:433,0.0,0.0,1.4436373057926316e-06,7.573496038857661e-06,0.0,9.052941e-05,False,ASGR2; asialoglycoprotein receptor
hsa:7849,0.0,0.0,1.1170340690058477e-07,8.64202483263196e-07,0.0,8.150212e-06,False,PAX8; paired box
hsa:6822,0.0,0.0,7.990223803742689e-06,4.971827270479644e-05,0.0,0.0004783853,False,SULT2A1; sulfotransferase family 2A member
hsa:29117,4.973639e-07,0.000414181114259503,5.2994373470029245e-06,1.1347237801785331e-05,0.0,5.4865835e-05,False,BRD7; bromodomain containing
hsa:64928,1.6349903e-08,1.3615425330577454e-05,2.0199415920701758e-07,5.714850754478466e-07,0.0,3.2763623e-06,False,MRPL14; mitochondrial ribosomal protein
hsa:92595,0.0,0.0,5.911963521052632e-09,1.2045399821858524e-08,0.0,6.957251e-08,False,ZNF764; zinc finger protein
hsa:3786,2.131575e-08,1.7750747664390202e-05,7.92324497126316e-06,4.2335532027727714e-05,0.0,0.00053574453,False,KCNQ3; potassium voltage-gated channel subfamily Q member
hsa:2993,2.4408564e-06,0.0020326296771829224,2.012685428608773e-05,5.3772684189451926e-05,0.0,0.00045785768,False,GYPA; glycophorin A (MNS blood
hsa:10628,0.0,0.0,5.759708484795322e-08,1.7894686224580877e-07,0.0,1.0321421e-06,False,TXNIP; thioredoxin interacting
hsa:81849,3.1170348e-06,0.0025957190432390597,3.101895506410526e-05,5.2725191702143527e-05,0.0,0.00029799095,False,ST6GALNAC5; ST6 N-acetylgalactosaminide alpha-2
hsa:54798,4.485004e-05,0.03734899043091645,0.00023593202371374278,0.00045470555476937466,0.0,0.0032044284,False,DCHS2; dachsous cadherin-related
hsa:1355,2.16157e-06,0.0018000531826896044,0.00023796945761023392,0.0004909720441786054,0.0,0.0026645625,False,COX15; cytochrome c oxidase assembly homolog
hsa:5836,0.0,0.0,2.398560633941521e-05,8.780437866806997e-05,0.0,0.0007535126,False,PYGL; glycogen phosphorylase
hsa:23198,1.6670431e-07,0.00013882345877467506,2.7963846511871345e-06,6.189179689433156e-06,0.0,4.254538e-05,False,PSME4; proteasome activator subunit
hsa:4543,0.0,0.0,8.706643945543858e-06,3.0276213329145994e-05,0.0,0.00026063237,False,MTNR1A; melatonin receptor
hsa:23312,0.0,0.0,4.223912594269005e-07,1.2100254516464936e-06,0.0,7.1537347e-06,False,DMXL2; Dmx like
hsa:262,2.41522e-06,0.0020112808967072938,0.00021812249826236264,0.0005361009972911953,0.0,0.0030910808,False,AMD1; adenosylmethionine decarboxylase
hsa:8986,0.0,0.0,1.609189824916959e-05,5.7664236264359845e-05,0.0,0.00042299798,False,RPS6KA4; ribosomal protein S6 kinase
hsa:85569,0.0,0.0,8.721189020409357e-08,7.138167910879441e-07,0.0,8.692789e-06,False,GALP; galanin like
hsa:51263,5.3385094e-08,4.445657941352058e-05,2.8030684447543873e-07,5.234209322990855e-07,0.0,3.2221117e-06,False,MRPL30; mitochondrial ribosomal protein
hsa:345,0.0,0.0,8.01939208320468e-06,7.765547247916408e-05,0.0,0.0010031722,False,APOC3; apolipoprotein
hsa:23308,0.0,0.0,1.4680495216491232e-06,4.068898300360871e-06,0.0,3.8515213e-05,False,ICOSLG; inducible T cell costimulator
hsa:10254,0.0,0.0,5.056284016573104e-05,0.00016286434294454373,0.0,0.000949019,False,STAM2; signal transducing adaptor molecule
hsa:79088,1.9554394e-08,1.6283973757623627e-05,1.523992535263158e-07,2.6287710014130166e-07,0.0,1.0199296e-06,False,ZNF426; zinc finger protein
hsa:1991,0.0,0.0,3.243690911988304e-07,1.9644950265139804e-06,0.0,2.3294213e-05,False,ELANE; elastase
hsa:905,7.788282e-06,0.006485712607865651,8.628626571286545e-05,0.00020214864725337053,0.0,0.0013009419,False,CCNT2; cyclin
hsa:64764,0.0,0.0,8.152195516959064e-06,6.569346629435421e-05,0.0,0.00073467154,False,CREB3L2; cAMP responsive element binding protein 3 like
hsa:27121,0.0,0.0,5.635423370343274e-07,2.7918673391474516e-06,0.0,2.6861306e-05,False,DKK4; dickkopf WNT signaling pathway inhibitor
hsa:64506,8.875562e-07,0.0007391147927783467,3.431823112204679e-06,1.4016518725894005e-05,0.0,0.00017416096,False,CPEB1; cytoplasmic polyadenylation element binding protein
hsa:126014,5.4146703e-08,4.50908113395813e-05,1.3999303028380117e-05,5.2730855799146594e-05,0.0,0.00040720045,False,OSCAR; osteoclast associated Ig-like
hsa:128869,0.0,0.0,3.45771471754386e-05,8.181930600894214e-05,0.0,0.00046868474,False,PIGU; phosphatidylinositol glycan anchor biosynthesis class
hsa:10560,0.0,0.0,7.745843575964914e-05,0.00022642065768230983,0.0,0.0012774796,False,SLC19A2; solute carrier family 19 member
hsa:29126,7.330894e-08,6.104821530952096e-05,9.960161376023392e-07,1.8338677533071366e-06,0.0,1.2353881e-05,False,CD274; CD274
hsa:144245,4.0762717e-07,0.0003394526130124198,6.0015424315333345e-05,0.00016474711135795744,0.0,0.000923813,False,ALG10B; ALG10 alpha-1
hsa:2324,0.0,0.0,2.4533292804304094e-06,3.7683251742565972e-06,0.0,1.8215862e-05,False,FLT4; fms related receptor tyrosine kinase
hsa:125958,0.0,0.0,3.1119421052631577e-09,4.069392346497394e-08,0.0,5.321421e-07,False,OR7D4; olfactory receptor family 7 subfamily D member
hsa:64902,0.0,0.0,1.2825158956725147e-06,7.529311703102496e-06,0.0,6.537797e-05,False,AGXT2; alanine--glyoxylate aminotransferase
hsa:780853,0.0,0.0,2.8308924970760236e-08,1.9913336207125578e-07,0.0,2.3119678e-06,False,SNORD3C; small nucleolar RNA
hsa:7769,2.5030754e-08,2.0844427153791243e-05,6.312754749707601e-08,9.36647399270189e-08,0.0,5.317745e-07,False,ZNF226; zinc finger protein
hsa:79317,0.0,0.0,1.6835606432748537e-08,1.5532535710229876e-07,0.0,1.4936757e-06,False,OR4K5; olfactory receptor family 4 subfamily K member
hsa:84693,0.0,0.0,4.125397672222219e-06,9.699525394678264e-06,0.0,8.766555e-05,False,MCEE; methylmalonyl-CoA
hsa:4001,4.4122615e-08,3.674322532202893e-05,4.086230369292398e-06,7.537334162011503e-06,0.0,3.135146e-05,False,LMNB1; lamin
hsa:51529,4.29526e-06,0.0035768892210196056,9.047733370795318e-05,0.00018209062209692368,0.0,0.00091261265,False,ANAPC11; anaphase promoting complex subunit
hsa:399967,2.5634515e-09,2.134721073685071e-06,6.005280903254619e-06,1.5389953782181518e-05,0.0,9.879186e-05,False,PATE2; prostate and testis expressed
hsa:5898,5.7134607e-06,0.004757899636471164,2.6144832206491225e-05,3.5175762444259266e-05,0.0,0.00015241026,False,RALA; RAS like proto-oncogene
hsa:7553,0.0,0.0,1.5232325919005846e-07,4.026576013847782e-07,0.0,1.9898687e-06,False,ZNF7; zinc finger protein
hsa:7004,0.0,0.0,1.4495867511695903e-05,2.8451487345830157e-05,0.0,0.0001433485,False,TEAD4; TEA domain transcription factor
hsa:3294,0.0,0.0,2.779719976859725e-05,0.00016390546610010848,0.0,0.0020688379,False,HSD17B2; hydroxysteroid 17-beta dehydrogenase
hsa:10285,0.0,0.0,8.304267229239767e-08,1.8698720986702242e-07,0.0,1.2786627e-06,False,SMNDC1; survival motor neuron domain containing
hsa:23028,0.0,0.0,4.464804643122807e-08,1.0196629436623342e-07,0.0,7.4617054e-07,False,KDM1A; lysine demethylase
hsa:9416,7.469217e-09,6.2200103781276105e-06,5.45633037603041e-07,1.6255394967815646e-06,0.0,9.104412e-06,False,DDX23; DEAD-box helicase
hsa:10733,1.5335709e-07,0.0001277085257208955,2.590178795990642e-05,7.729443086144454e-05,0.0,0.00067032134,False,PLK4; polo like kinase
hsa:346562,0.0,0.0,4.490474269005848e-06,3.457421590021741e-05,0.0,0.00043631622,False,GNAT3; G protein subunit alpha transducin
hsa:384,4.4666675e-05,0.03719629273810803,0.00013654049357543854,0.00033835354082959856,0.0,0.0040051406,False,ARG2; arginase
hsa:51738,1.8201786e-07,0.0001515758583804137,1.6028621290631582e-05,5.166173811134977e-05,0.0,0.00035305158,False,GHRL; ghrelin and obestatin
hsa:283092,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4C13; olfactory receptor family 4 subfamily C member
hsa:6207,0.0,0.0,1.297564495497076e-07,2.638361535942795e-07,0.0,1.3103349e-06,False,RPS13; ribosomal protein
hsa:5423,7.095433e-08,5.9087407551968456e-05,6.061407086594152e-05,0.0001584058515934902,0.0,0.0009860864,False,POLB; DNA polymerase
hsa:2791,0.0,0.0,0.00014194321684561404,0.0004684274413211398,0.0,0.0030009572,False,GNG11; G protein subunit gamma
hsa:390992,0.0,0.0,1.897348201216374e-08,5.864290494339717e-08,0.0,4.5840085e-07,False,HES3; hes family bHLH transcription factor
hsa:91862,0.0,0.0,1.9034080395438595e-07,4.962239260676437e-07,0.0,3.620884e-06,False,MARVELD3; MARVEL domain containing
hsa:7533,1.0545205e-05,0.008781547589189491,2.4465477885380116e-05,3.571706832672306e-05,0.0,0.00026825618,False,YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:4282,2.9514009e-05,0.02457786971246808,0.00033405319612830404,0.0006901388062889267,0.0,0.0041378387,False,MIF; macrophage migration inhibitory
hsa:8437,6.913171e-09,5.7569615885802795e-06,7.959436837894736e-08,2.566478717178189e-07,0.0,1.9131826e-06,False,RASAL1; RAS protein activator like
hsa:7220,5.7108668e-05,0.047557395593278935,0.00019395435987076026,0.00032519512417092064,0.0,0.0022077041,False,TRPC1; transient receptor potential cation channel subfamily C member
hsa:9372,6.690785e-07,0.0005571769053947762,7.312878864571344e-05,0.00014687587816014164,0.0,0.0008338437,False,ZFYVE9; zinc finger FYVE-type containing
hsa:728343,0.0,0.0,3.236833043021929e-05,0.00011463109734392656,0.0,0.00062013656,False,NXF2B; nuclear RNA export factor
hsa:1134,0.0,0.0,5.401160773450292e-06,1.7960192574602265e-05,0.0,0.00015340898,False,CHRNA1; cholinergic receptor nicotinic alpha 1
hsa:131873,2.427649e-06,0.0020216311796070613,3.2035181534403524e-05,8.359433318667711e-05,0.0,0.0008830783,False,COL6A6; collagen type VI alpha 6
hsa:5268,0.0,0.0,6.981536168840352e-06,3.6455260324861415e-05,-0.0,0.0003852826,False,SERPINB5; serpin family B member
hsa:3845,0.00057672034,0.4802654013234967,0.0006246555931169596,0.0005764127104346185,0.0,0.003059757,True,KRAS; KRAS proto-oncogene
hsa:341392,4.451553e-08,3.7070426336234575e-05,9.225715139169592e-06,3.1299352088586916e-05,0.0,0.00024630857,False,ACSM4; acyl-CoA synthetase medium chain family member
hsa:3606,4.840601e-05,0.040310233932653025,0.00023024095736257313,0.0003874573653996532,0.0,0.0022543212,False,IL18; interleukin
hsa:9648,0.0,0.0,8.050046293859648e-08,2.1591302293048606e-07,0.0,1.3182924e-06,False,GCC2; GRIP and coiled-coil domain containing
hsa:2887,2.244724e-07,0.00018692998979721865,1.5157140258596483e-06,2.8425790563337834e-06,0.0,1.6898699e-05,False,GRB10; growth factor receptor bound protein
hsa:3052,0.0,0.0,5.029649124836258e-05,0.0001288206571935907,0.0,0.00091875374,False,HCCS; holocytochrome c
hsa:2554,7.3037765e-05,0.060822393605011814,0.0005748657414935673,0.001401971477881721,0.0,0.009406986,False,GABRA1; gamma-aminobutyric acid type A receptor subunit
hsa:114,5.8737656e-05,0.04891393969500276,0.0003255931003369007,0.0006298230744924258,0.0,0.0042662593,False,ADCY8; adenylate cyclase
hsa:2641,0.0,0.0,1.9233250028654973e-07,1.094475276862264e-06,0.0,1.0026205e-05,False,GCG;
hsa:945,6.1781216e-06,0.005144847240257493,3.717287831883041e-05,7.144228400090447e-05,0.0,0.0004802155,False,CD33; CD33
hsa:3704,0.0,0.0,2.824513812491229e-05,5.593521709080465e-05,0.0,0.00028118293,False,ITPA; inosine
hsa:407016,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26A2; microRNA
hsa:285,0.0,0.0,3.0258163487719303e-06,6.596450178563066e-06,0.0,5.1523883e-05,False,ANGPT2; angiopoietin
hsa:5589,2.5942165e-07,0.0002160340709489346,1.4942856897391808e-06,3.17363451762203e-06,0.0,1.5598578e-05,False,PRKCSH; protein kinase C substrate
hsa:6093,0.0,0.0,7.346760156257309e-05,0.00021214802024645195,0.0,0.0013209078,False,ROCK1; Rho associated coiled-coil containing protein kinase
hsa:929,0.0,0.0,0.00011127485990058477,0.0002867583687006473,0.0,0.0017538295,False,CD14; CD14
hsa:392390,0.0,0.0,1.774812141017544e-06,1.0072469679310802e-05,0.0,8.847862e-05,False,OR1L6; olfactory receptor family 1 subfamily L member
hsa:79295,0.0,0.0,3.457180704093567e-07,3.886961455542652e-06,0.0,5.0399776e-05,False,OR5H6; olfactory receptor family 5 subfamily H member
hsa:861,0.0,0.0,0.0,0.0,0.0,0.0,False,RUNX1; RUNX family transcription factor
hsa:8517,0.00013238298,0.11024227967770381,0.0004561686971730994,0.0007671356720771235,0.0,0.0037218588,False,IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit
hsa:7084,0.0,0.0,2.20413370272345e-05,5.0489156970000614e-05,0.0,0.00028437018,False,TK2; thymidine kinase
hsa:55862,2.2478916e-06,0.0018719377253205896,0.0003516015087959942,0.0010803010636230917,0.0,0.0061068917,False,ECHDC1; ethylmalonyl-CoA decarboxylase
hsa:1723,1.236866e-07,0.00010300034603832214,0.00013808939897882463,0.0004147983887725905,0.0,0.002380136,False,DHODH; dihydroorotate dehydrogenase
hsa:11047,4.2611902e-07,0.0003548517504200998,9.130445220152045e-06,2.2296563454732255e-05,0.0,0.00014192393,False,ADRM1; ADRM1 26S proteasome ubiquitin
hsa:4668,4.4199205e-06,0.003680700584880447,0.00036766469489835107,0.0009322569402441652,0.0,0.004063047,False,NAGA;
hsa:57547,0.0,0.0,1.0905073192982455e-08,2.6188471569877147e-08,0.0,1.266461e-07,False,ZNF624; zinc finger protein
hsa:1272,1.2415032e-06,0.0010338651010512398,1.4305745963040935e-05,2.8647091452078483e-05,0.0,0.00013062119,False,CNTN1; contactin
hsa:84527,5.031231e-09,4.189771034200419e-06,5.3737001884210524e-08,1.1952070805275377e-07,0.0,7.6345515e-07,False,ZNF559; zinc finger protein
hsa:8803,0.0,0.0,0.0006659418854555204,0.0021432996945562693,0.0,0.011511098,False,SUCLA2; succinate-CoA ligase ADP-forming subunit
hsa:27198,0.0,0.0,2.1562249315146206e-08,1.0442480893354057e-07,0.0,1.199582e-06,False,HCAR1; hydroxycarboxylic acid receptor
hsa:5173,4.9169535e-07,0.0004094606141282396,3.2557337948052626e-05,0.00016717963665154924,0.0,0.0020069992,False,PDYN;
hsa:149233,0.0,0.0,3.2457538936783625e-07,1.1608742049123767e-06,0.0,9.297701e-06,False,IL23R; interleukin 23
hsa:2158,0.0,0.0,1.643819549707602e-08,1.4851580277987136e-07,0.0,1.8493396e-06,False,F9; coagulation factor
hsa:6612,6.4229134e-08,5.3486982645992065e-05,8.010121967040935e-07,1.998270257596005e-06,0.0,1.1240417e-05,False,SUMO3; small ubiquitin like modifier
hsa:3561,0.0002902749,0.2417271971760834,0.0006765835792941521,0.0009446364318448588,0.0,0.0061606113,False,IL2RG; interleukin 2 receptor subunit
hsa:83551,0.0,0.0,3.1028508771929825e-09,4.0575040231682394e-08,0.0,5.305875e-07,False,TAAR8; trace amine associated receptor
hsa:55312,2.814268e-06,0.0023435891830204465,5.2677048880701763e-05,0.00010289376601069658,0.0,0.0005523862,False,RFK; riboflavin
hsa:7091,7.697723e-06,0.006410299359082967,0.0004564646816328069,0.0010840960750298835,0.0,0.0071435347,False,TLE4; TLE family member 4
hsa:643847,4.7213002e-09,3.931675333874483e-06,1.0534226957736843e-06,3.4027586128030877e-06,0.0,1.9485457e-05,False,PGA4; pepsinogen
hsa:25974,5.8156e-06,0.004842956410965021,9.783647552294737e-05,0.00016511173536418088,0.0,0.00087539665,False,MMACHC; metabolism of cobalamin associated
hsa:5688,0.0,0.0,2.8280140058304092e-06,6.174918037903721e-06,0.0,5.500456e-05,False,PSMA7; proteasome 20S subunit alpha
hsa:54874,0.0,0.0,3.459112822725147e-07,7.790293545383323e-07,0.0,4.18949e-06,False,FNBP1L; formin binding protein 1
hsa:6194,9.566338e-07,0.000796639348417331,3.394754516982456e-05,7.312829875142693e-05,0.0,0.0005031466,False,RPS6; ribosomal protein
hsa:56903,0.0,0.0,5.631899318245616e-09,1.245640016200394e-08,0.0,8.0984044e-08,False,PAPOLB; poly(A) polymerase
hsa:8708,4.867013e-06,0.0040530180567095574,0.0004532117179608187,0.0008175867421118004,0.0,0.0047066286,False,B3GALT1; beta-1
hsa:2487,0.0,0.0,1.1897395348654975e-07,2.889670445860587e-07,0.0,1.7950892e-06,False,FRZB; frizzled related
hsa:440387,0.0,0.0,1.0205186895263157e-06,4.155859282891454e-06,0.0,3.1643245e-05,False,CTRB2; chymotrypsinogen
hsa:8218,1.2806716e-05,0.010664826906184798,0.00014985634322865489,0.00022343852368002758,0.0,0.0008635227,False,CLTCL1; clathrin heavy chain like
hsa:1152,1.6150148e-05,0.01344907882155477,0.00018232875787801172,0.00025959981669254736,0.0,0.0011676283,False,CKB; creatine kinase
hsa:910,4.6473534e-07,0.00038700959389487057,1.574905848783362e-05,3.236389621150598e-05,0.0,0.0002460871,False,CD1B; CD1b
hsa:8826,6.578023e-07,0.0005477866197696775,6.364424188865498e-06,1.3180748195947542e-05,0.0,7.797763e-05,False,IQGAP1; IQ motif containing GTPase activating protein
hsa:283871,1.0939875e-06,0.0009110210084325945,9.270087925555562e-06,1.9150028873568122e-05,0.0,0.00011216463,False,PGP; phosphoglycolate
hsa:4597,0.0,0.0,2.3146284308248536e-06,7.94019219915587e-06,0.0,6.783036e-05,False,MVD; mevalonate diphosphate
hsa:246175,0.0,0.0,1.650341961801169e-07,3.5010044618542083e-07,0.0,2.0852492e-06,False,CNOT6L; CCR4-NOT transcription complex subunit 6
hsa:9924,2.4366764e-07,0.00020291487710343164,3.139737167446785e-05,0.00012475879376046818,0.0,0.001131661,False,PAN2; poly(A) specific ribonuclease subunit
hsa:23225,0.0,0.0,1.5903697796005848e-07,4.004233793370528e-07,0.0,2.3881232e-06,False,NUP210; nucleoporin
hsa:64446,0.0,0.0,8.291098203333337e-09,2.6132910581526044e-08,0.0,2.95333e-07,False,DNAI2; dynein axonemal intermediate chain
hsa:6390,3.976304e-07,0.00033112777613222816,7.649377326491227e-06,1.1397971263728884e-05,0.0,4.6702717e-05,False,SDHB; succinate dehydrogenase complex iron sulfur subunit
hsa:81127,0.0,0.0,3.269178187134503e-08,4.275005203844016e-07,0.0,5.5902947e-06,False,OR4K15; olfactory receptor family 4 subfamily K member
hsa:1717,0.0,0.0,2.097437819380117e-05,4.395942332861568e-05,0.0,0.00023936499,False,DHCR7; 7-dehydrocholesterol
hsa:64101,0.0,0.0,4.990799495614035e-06,9.07776002263202e-06,0.0,4.8874015e-05,False,LRRC4; leucine rich repeat containing
hsa:55257,6.282274e-08,5.231580429145552e-05,3.014452096556724e-06,8.317303223667909e-06,0.0,4.4359364e-05,False,MRGBP; MRG domain binding
hsa:9670,0.0,0.0,3.036964441183216e-07,6.180509984552237e-07,0.0,3.2410567e-06,False,IPO13; importin
hsa:4907,0.0,0.0,1.821904853298246e-05,8.657969903975948e-05,0.0,0.00075560785,False,NT5E; 5'-nucleotidase
hsa:4736,0.0,0.0,1.7299075620116967e-07,2.84245121418571e-07,0.0,1.962148e-06,False,RPL10A; ribosomal protein
hsa:55534,0.00018896676,0.15736257338903786,0.000584038301841462,0.00080431605498383,0.0,0.0039550597,False,MAML3; mastermind like transcriptional coactivator
hsa:10877,0.0,0.0,6.438259215263158e-07,2.968290180374173e-06,0.0,3.0552193e-05,False,CFHR4; complement factor H related
hsa:112849,0.0,0.0,2.35409920971462e-05,5.683464628547728e-05,0.0,0.0003396508,False,L3HYPDH; trans-L-3-hydroxyproline
hsa:169270,0.0,0.0,1.2975695340292394e-07,3.2832654086137054e-07,0.0,1.8063217e-06,False,ZNF596; zinc finger protein
hsa:3440,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA2; interferon alpha
hsa:1136,2.4856692e-05,0.02069947655904515,3.911801670280705e-05,5.830373055045734e-05,0.0,0.0005777525,False,CHRNA3; cholinergic receptor nicotinic alpha 3
hsa:7932,1.5834489e-06,0.0013186212947400976,5.265925511283624e-05,0.00018049892678693495,0.0,0.0018936704,False,OR2H2; olfactory receptor family 2 subfamily H member
hsa:5888,3.5586956e-05,0.02963513252406117,8.185659529342688e-05,0.0001163012715664343,0.0,0.0005936825,False,RAD51; RAD51
hsa:8935,5.8927174e-09,4.907176131497203e-06,2.870081260538597e-07,5.987135343732706e-07,0.0,3.179184e-06,False,SKAP2; src kinase associated phosphoprotein
hsa:2042,0.0,0.0,2.2196930278436604e-06,8.357281641647729e-06,0.0,6.006397e-05,False,EPHA3; EPH receptor
hsa:403284,0.0,0.0,3.799128929824561e-07,4.413042317251826e-06,0.0,5.7523102e-05,False,OR6C68; olfactory receptor family 6 subfamily C member
hsa:51421,0.0,0.0,4.4938317871637436e-07,1.297483784164047e-06,0.0,7.589736e-06,False,AMOTL2; angiomotin like
hsa:282618,0.0,0.0,6.331660898947367e-07,4.32079199055377e-06,0.0,5.302156e-05,False,IFNL1; interferon lambda
hsa:25776,3.2732888e-07,0.00027258399784888925,5.5618113053801176e-06,1.5472835547382392e-05,0.0,0.000112435446,False,CBY1; chibby 1
hsa:8822,5.748667e-05,0.04787217776695966,0.00011055419686584794,0.00015126812643431108,0.0,0.0010049783,False,FGF17; fibroblast growth factor
hsa:5631,2.4778408e-06,0.0020634285349251493,7.860362134126318e-05,0.00024589273694092755,0.0,0.0012267916,False,PRPS1; phosphoribosyl pyrophosphate synthetase
hsa:57186,4.6478668e-08,3.8705234741680104e-05,9.128996794619886e-07,2.1809184348981305e-06,0.0,1.1525447e-05,False,RALGAPA2; Ral GTPase activating protein catalytic subunit alpha
hsa:7225,0.0,0.0,1.3060300932163742e-06,4.5427982833692e-06,0.0,3.0421406e-05,False,TRPC6; transient receptor potential cation channel subfamily C member
hsa:1307,0.0,0.0,2.4057656228654973e-05,7.117318003614238e-05,0.0,0.0004698866,False,COL16A1; collagen type XVI alpha 1
hsa:59343,1.322541e-06,0.00110134954513964,8.644808933976606e-06,2.4504446059021125e-05,0.0,0.00013882756,False,SENP2; SUMO specific peptidase
hsa:441478,0.0,0.0,7.931054876842104e-06,2.145048315041707e-05,0.0,0.00015444457,False,NRARP; NOTCH regulated ankyrin repeat
hsa:51099,0.0,0.0,5.150431182105263e-06,1.4965771138587725e-05,0.0,8.937429e-05,False,ABHD5; abhydrolase domain containing 5
hsa:5320,0.0,0.0,7.49930631368421e-06,4.475966982200556e-05,0.0,0.0005572701,False,PLA2G2A; phospholipase A2 group
hsa:27071,2.5075695e-07,0.00020881851891404763,1.5777864315263155e-06,2.529360253062895e-06,0.0,1.3593363e-05,False,DAPP1; dual adaptor of phosphotyrosine and 3-phosphoinositides
hsa:651,0.0,0.0,1.684589848322456e-07,1.0529919457869855e-06,0.0,1.2520651e-05,False,BMP3; bone morphogenetic protein
hsa:1975,1.8995224e-06,0.0015818323448744177,4.019159642339181e-06,5.367407242277792e-06,0.0,2.9864917e-05,False,EIF4B; eukaryotic translation initiation factor
hsa:23414,5.242111e-09,4.365381916644931e-06,5.185209287537426e-07,1.3603569159230878e-06,0.0,8.219919e-06,False,ZFPM2; zinc finger protein
hsa:81285,4.259129e-07,0.00035468010344035086,8.272261282456142e-06,1.890959546789494e-05,0.0,0.00011769753,False,OR51E2; olfactory receptor family 51 subfamily E member
hsa:8314,0.0,0.0,3.77205549018813e-06,1.2252685250877421e-05,0.0,7.589591e-05,False,BAP1; BRCA1 associated protein
hsa:26152,1.8968505e-08,1.5796073130231115e-05,1.9818536044616958e-07,4.3483671279327434e-07,0.0,2.1959097e-06,False,ZNF337; zinc finger protein
hsa:155382,3.5668561e-09,2.9703089305462365e-06,3.7497360346415216e-07,6.0830010098435e-07,0.0,2.8139611e-06,False,VPS37D; VPS37D subunit of
hsa:2571,0.0,0.0,2.0955181563040934e-05,7.743525244136822e-05,0.0,0.00064305664,False,GAD1; glutamate decarboxylase
hsa:3875,0.0,0.0,1.3403522958479533e-05,3.102248091660495e-05,0.0,0.00014505834,False,KRT18; keratin
hsa:406954,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181A2; microRNA
hsa:6346,0.0,0.0,6.57860939169006e-05,0.00044328337445869885,0.0,0.0057048267,False,CCL1; C-C motif chemokine ligand
hsa:955,0.0,0.0,3.59938174869263e-05,8.428424700564155e-05,0.0,0.0005935394,False,ENTPD6; ectonucleoside triphosphate diphosphohydrolase
hsa:2589,0.0,0.0,0.0002031469040216374,0.0004197548841378083,0.0,0.0025689616,False,GALNT1; polypeptide N-acetylgalactosaminyltransferase
hsa:79644,0.0,0.0,7.314494159919882e-05,0.0001857160716585575,0.0,0.0009797587,False,SRD5A3; steroid 5 alpha-reductase
hsa:942,0.0,0.0,7.730723930994153e-05,0.00021078716379393508,0.0,0.0013059473,False,CD86; CD86
hsa:369,0.0,0.0,0.00020282731980701758,0.0004037201986873454,0.0,0.0022969951,False,ARAF; A-Raf proto-oncogene
hsa:5436,0.0,0.0,0.00026300190389269004,0.0008908196958083944,0.0,0.0058688805,False,POLR2G; RNA polymerase II subunit
hsa:118460,9.3839326e-08,7.814494900824277e-05,3.5418833728187134e-06,8.748684630745054e-06,0.0,5.6285906e-05,False,EXOSC6; exosome component
hsa:407041,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR34B; microRNA
hsa:961,7.929104e-05,0.06602982503956324,0.0003059519468834504,0.0004444127223836493,0.0,0.0019181286,False,CD47; CD47
hsa:11136,2.6744141e-05,0.02227125474786823,7.605434461140347e-05,0.00011498990275708669,0.0,0.0005229791,False,SLC7A9; solute carrier family 7 member
hsa:20,7.071591e-05,0.05888886266107116,0.0004201684299863159,0.0007329451278540158,0.0,0.0035932227,False,ABCA2; ATP binding cassette subfamily A member
hsa:1755,0.0,0.0,3.672521815146198e-07,1.2007219748017627e-06,0.0,9.108354e-06,False,DMBT1; deleted in malignant brain tumors
hsa:90249,1.9895398e-07,0.00016567945748125848,2.5181857466150856e-05,8.654348342885519e-05,0.0,0.0005838915,False,UNC5A; unc-5 netrin receptor
hsa:4313,0.0,0.0,2.799745029239766e-06,1.3307208991103208e-05,0.0,0.00013009703,False,MMP2; matrix metallopeptidase
hsa:5997,0.0,0.0,5.321064964912282e-05,0.00010305817291600492,0.0,0.00051592005,False,RGS2; regulator of G protein signaling
hsa:11317,0.0,0.0,1.4710111573391811e-06,1.2939702589172865e-05,0.0,0.00016434646,False,RBPJL; recombination signal binding protein for immunoglobulin kappa J region
hsa:7385,4.6751776e-08,3.8932666157094824e-05,1.3575187371456138e-05,3.333605824066655e-05,0.0,0.00019436167,False,UQCRC2; ubiquinol-cytochrome c reductase core protein
hsa:11267,4.2102024e-09,3.506057277759874e-06,9.79690486805848e-07,2.179377118204774e-06,0.0,1.8769193e-05,False,SNF8; SNF8 subunit of
hsa:79658,0.0,0.0,3.4776621848947354e-07,7.513567991472045e-07,0.0,3.7917425e-06,False,ARHGAP10; Rho GTPase activating protein
hsa:407030,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR30B; microRNA
hsa:113091,0.0,0.0,3.693365333333333e-07,3.136557495312765e-06,0.0,3.9046477e-05,False,PTH2; parathyroid hormone
hsa:7475,0.0,0.0,1.2436075671345032e-05,7.699061313881563e-05,0.0,0.0009832596,False,WNT6; Wnt family member
hsa:120227,1.3176791e-06,0.0010973007849473177,4.549113207029238e-05,0.00010606274730963942,0.0,0.0008543856,False,CYP2R1; cytochrome P450 family 2 subfamily R member
hsa:3316,1.2384857e-07,0.00010313522698781728,3.7210546508257304e-07,5.629625707285571e-07,0.0,2.6741088e-06,False,HSPB2; heat shock protein family B (small) member
hsa:25970,7.237377e-08,6.0269449997800384e-05,2.6587724550877196e-06,5.9314517874352856e-06,0.0,3.854272e-05,False,SH2B1; SH2B adaptor protein
hsa:1758,2.1845356e-08,1.81917784734186e-05,1.0669302712947367e-06,3.64997934086823e-06,0.0,2.7614216e-05,False,DMP1; dentin matrix acidic phosphoprotein
hsa:9038,-0.0,0.0,0.0,0.0,0.0,0.0,False,TAAR5; trace amine associated receptor
hsa:54407,0.0,0.0,0.00025234238530877194,0.0005067401756682019,0.0,0.003362321,False,SLC38A2; solute carrier family 38 member
hsa:2289,1.9877244e-07,0.00016552827956206758,2.1281968926578946e-05,4.6913991573440764e-05,0.0,0.0002557369,False,FKBP5; FKBP prolyl isomerase
hsa:554,0.0,0.0,7.954425019929824e-06,2.9252235772485777e-05,0.0,0.00022833516,False,AVPR2; arginine vasopressin receptor
hsa:407026,0.0,0.0,9.115588304093566e-09,1.1035590391697054e-07,0.0,1.4388016e-06,False,MIR29C; microRNA
hsa:10,0.0,0.0,1.872351325225146e-05,9.780633563460777e-05,0.0,0.0011170302,False,NAT2; N-acetyltransferase
hsa:64240,8.2630606e-05,0.06881085753312209,0.00021315100254619892,0.00028901892583517625,0.0,0.0014540765,False,ABCG5; ATP binding cassette subfamily G member
hsa:573,1.0819458e-07,9.009932506408073e-05,5.950809306397661e-07,1.076838385244213e-06,0.0,7.667351e-06,False,BAG1; BAG cochaperone
hsa:23538,0.0,0.0,1.1724045614035088e-07,1.1080886436269317e-06,0.0,1.3813374e-05,False,OR52A1; olfactory receptor family 52 subfamily A member
hsa:9563,0.0,0.0,4.340111068467835e-06,9.808213782389842e-06,0.0,8.793225e-05,False,H6PD; hexose-6-phosphate dehydrogenase/glucose
hsa:64786,2.2533057e-07,0.00018764463315357015,6.129185755263157e-06,1.2782958837367972e-05,0.0,6.035714e-05,False,TBC1D15; TBC1 domain family member
hsa:1277,0.0,0.0,0.00011405685301695904,0.00027941218150430436,0.0,0.0017792908,False,COL1A1; collagen type I alpha 1
hsa:580,1.6211366e-08,1.3500058274331174e-05,2.8671803029239763e-06,6.184428697768931e-06,0.0,5.1807434e-05,False,BARD1; BRCA1 associated RING domain
hsa:682,0.0,0.0,2.9490128009025733e-05,8.386863232429385e-05,0.0,0.0006777076,False,BSG; basigin (Ok blood
hsa:84844,0.0,0.0,8.97145568994152e-08,1.9069756815193598e-07,0.0,8.736883e-07,False,PHF5A; PHD finger protein
hsa:84188,0.0,0.0,0.00013345704358945617,0.000463324560013472,0.0,0.0026158106,False,FAR1; fatty acyl-CoA reductase
hsa:34,9.9203506e-05,0.08261198421021167,0.00026434929838216374,0.0005885951631900491,0.0,0.0053746183,False,ACADM; acyl-CoA dehydrogenase medium
hsa:345630,9.92863e-09,8.268093113453408e-06,9.92381949546199e-07,2.132823845155219e-06,0.0,1.0372353e-05,False,FBLL1; fibrillarin like
hsa:9027,8.651551e-08,7.204602170066863e-05,2.65077076838339e-05,0.0001018288020607348,0.0,0.0008846972,False,NAT8; N-acetyltransferase 8
hsa:7371,3.6652385e-05,0.030522371365449517,0.0002589144003126782,0.0003516855061436122,0.0,0.0014872772,False,UCK2; uridine-cytidine kinase
hsa:10878,0.0,0.0,4.2042477511959065e-06,2.2967318311607807e-05,0.0,0.00027730013,False,CFHR3; complement factor H related
hsa:3300,3.0026723e-09,2.50048336634433e-06,4.5179793491988327e-07,1.1855872368436738e-06,0.0,8.154417e-06,False,DNAJB2; DnaJ heat shock protein family (Hsp40) member
hsa:57715,6.557695e-08,5.460938001479343e-05,2.226245626613802e-05,7.876757172497831e-05,0.0,0.00067325024,False,SEMA4G; semaphorin
hsa:80335,0.0,0.0,1.7255691681093567e-07,5.247290178680816e-07,0.0,3.0950114e-06,False,WDR82; WD repeat domain
hsa:799,0.0,0.0,2.1883287857116957e-06,8.628860357201799e-06,0.0,7.115572e-05,False,CALCR; calcitonin
hsa:27035,2.7213738e-09,2.2662312902094787e-06,2.164051510683626e-06,6.271808153372983e-06,0.0,3.7186943e-05,False,NOX1; NADPH oxidase
hsa:406903,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR10B; microRNA
hsa:322,0.0,0.0,9.264713932923979e-09,1.5014368478140116e-08,0.0,6.627182e-08,False,APBB1; amyloid beta precursor protein binding family B member
hsa:6818,9.057246e-05,0.07542445763358432,0.00025564427813450286,0.00036251827466232634,0.0,0.0022186951,False,SULT1A3; sulfotransferase family 1A member
hsa:196743,2.948508e-07,0.0002455377901056066,1.3270898275146198e-06,2.0036884732708638e-06,0.0,8.85622e-06,False,PAOX; polyamine
hsa:9724,2.3959632e-10,1.9952447451468925e-07,8.972186143428073e-07,2.395920840171704e-06,0.0,1.296371e-05,False,UTP14C; UTP14C small subunit processome
hsa:4645,0.0,0.0,1.1098557084713451e-07,3.1892506011939854e-07,0.0,2.5237532e-06,False,MYO5B; myosin
hsa:120586,0.0,0.0,5.485773099415205e-08,7.17357917026343e-07,0.0,9.380672e-06,False,OR8I2; olfactory receptor family 8 subfamily I member
hsa:6428,0.0,0.0,2.3041455339766078e-07,3.722529515126873e-07,0.0,2.060289e-06,False,SRSF3; serine and arginine rich splicing factor
hsa:6521,6.6299685e-07,0.000552112395136721,5.1575157075421057e-05,0.00014691731210567867,0.0,0.00104131,False,SLC4A1; solute carrier family 4 member 1 (Diego blood
hsa:22841,1.1144705e-07,9.280782813134317e-05,9.675949314533337e-07,2.7092265469578174e-06,0.0,1.4940737e-05,False,RAB11FIP2; RAB11 family interacting protein
hsa:341568,-0.0,0.0,1.8285789135847952e-07,7.796197238407614e-07,0.0,6.39587e-06,False,OR8S1; olfactory receptor family 8 subfamily S member
hsa:114907,4.432456e-08,3.691139555939263e-05,2.2775837555964907e-07,4.1549775185883283e-07,0.0,2.2327147e-06,False,FBXO32; F-box protein
hsa:7730,0.0,0.0,4.589096936756725e-08,9.283256086474488e-08,0.0,5.009569e-07,False,ZNF177; zinc finger protein
hsa:5727,2.2891409e-05,0.01906288189912862,5.746530199035086e-05,0.00010894777924964409,0.0,0.0011301389,False,PTCH1; patched
hsa:9080,1.7333766e-06,0.001443473986791862,1.1359756194125727e-05,2.7789296306518924e-05,0.0,0.0002030509,False,CLDN9; claudin
hsa:8471,0.0,0.0,8.592344683801168e-06,2.7253625488208433e-05,0.0,0.00021830421,False,IRS4; insulin receptor substrate
hsa:123264,0.0,0.0,1.30298386374269e-07,4.813511279464476e-07,0.0,3.5320504e-06,False,SLC51B; SLC51 subunit
hsa:2783,0.0,0.0,0.00017336296656005848,0.0005138300744103696,0.0,0.0027295947,False,GNB2; G protein subunit beta
hsa:58533,5.206642e-09,4.335845012294474e-06,1.5789211453391815e-07,3.2695312177398344e-07,0.0,2.7455233e-06,False,SNX6; sorting nexin
hsa:8869,0.0,0.0,9.041147475263159e-05,0.00014296279967806083,0.0,0.0006615372,False,ST3GAL5; ST3 beta-galactoside alpha-2
hsa:2734,0.0,0.0,3.926296654192397e-06,7.701617960219941e-06,0.0,4.563979e-05,False,GLG1; golgi glycoprotein
hsa:3198,0.0,0.0,1.2611186390818713e-08,2.483344528487125e-08,0.0,1.3053894e-07,False,HOXA1; homeobox
hsa:7594,4.9148428e-09,4.092848450227883e-06,1.847724129376491e-07,3.4537492768661757e-07,0.0,1.727145e-06,False,ZNF43; zinc finger protein
hsa:3688,0.0,0.0,0.0002437812107467836,0.0004277360033650357,0.0,0.00210121,False,ITGB1; integrin subunit beta
hsa:84108,0.0,0.0,7.246239114672512e-06,2.5989505450230933e-05,0.0,0.0001962182,False,PCGF6; polycomb group ring finger
hsa:347468,0.0,0.0,2.4324620477192983e-06,1.4258059612256076e-05,0.0,0.00014804957,False,OR13H1; olfactory receptor family 13 subfamily H member
hsa:29119,0.0,0.0,2.501284751450293e-06,7.94113943433639e-06,0.0,7.302318e-05,False,CTNNA3; catenin alpha
hsa:26869,0.0,0.0,5.075960864481287e-08,1.4640111213749732e-07,0.0,9.679557e-07,False,RNU1-3; RNA
hsa:4281,2.6402596e-08,2.198683223817309e-05,1.7904567740912276e-07,3.5847663846856756e-07,0.0,2.240657e-06,False,MID1; midline
hsa:9370,0.0,0.0,9.455769441181287e-06,3.964270633959095e-05,0.0,0.0002679385,False,ADIPOQ; adiponectin
hsa:3075,0.0,0.0,7.399058135438593e-06,2.222694988834484e-05,0.0,0.00016336501,False,CFH; complement factor
hsa:51692,0.0,0.0,6.43841564743041e-07,1.7735314165533002e-06,0.0,9.134613e-06,False,CPSF3; cleavage and polyadenylation specific factor
hsa:85414,0.0,0.0,4.061486868245614e-06,1.4789439603960728e-05,0.0,0.00014171541,False,SLC45A3; solute carrier family 45 member
hsa:1131,0.0002909172,0.24226207421418142,0.0006235790078274854,0.0008657097668156556,0.0,0.0060422425,False,CHRM3; cholinergic receptor muscarinic
hsa:10152,0.0,0.0,2.4107726683508772e-05,7.410619092638283e-05,0.0,0.0003617625,False,ABI2; abl interactor
hsa:101954276,0.0,0.0,5.911394432163743e-09,4.528409721151999e-08,0.0,5.68556e-07,False,RNVU1-6; RNA
hsa:347240,8.571736e-09,7.138136015939831e-06,4.3435103040467825e-07,1.479459018228552e-06,0.0,8.318082e-06,False,KIF24; kinesin family member
hsa:10015,0.0,0.0,4.967476908654969e-06,1.2291341998878629e-05,0.0,0.00010153931,False,PDCD6IP; programmed cell death 6 interacting
hsa:7923,0.0,0.0,3.942454276058479e-05,0.0001231295483077633,0.0,0.0012527228,False,HSD17B8; hydroxysteroid 17-beta dehydrogenase
hsa:56913,0.0,0.0,0.00016109968435906426,0.0004426577532564974,0.0,0.0024202638,False,C1GALT1; core 1 synthase
hsa:1756,0.0,0.0,1.0661282416374268e-05,3.860878844145082e-05,0.0,0.0003234477,False,DMD;
hsa:6504,6.787734e-10,5.652503592273411e-07,2.367172837602339e-08,5.626071172456178e-08,0.0,4.5323728e-07,False,SLAMF1; signaling lymphocytic activation molecule family member
hsa:10019,1.4616079e-07,0.00012171578770242317,1.5004161885438592e-06,2.4450241480163814e-06,0.0,1.3880391e-05,False,SH2B3; SH2B adaptor protein
hsa:54811,0.0,0.0,7.221327748888889e-08,1.6802619083242893e-07,0.0,1.0596572e-06,False,ZNF562; zinc finger protein
hsa:64746,0.0,0.0,1.3326315392397657e-07,2.6609945459428447e-07,0.0,1.4886793e-06,False,ACBD3; acyl-CoA binding domain containing
hsa:7037,6.9223504e-05,0.05764605758412938,0.0001889831835216375,0.0002686187555756786,0.0,0.0013413233,False,TFRC; transferrin
hsa:8036,0.0,0.0,4.746114914385965e-07,1.0369484358403331e-06,0.0,4.85502e-06,False,SHOC2; SHOC2 leucine rich repeat scaffold
hsa:1608,1.2844606e-07,0.0001069637990474238,3.1354024591964903e-05,7.270456571320683e-05,0.0,0.00046668717,False,DGKG; diacylglycerol kinase
hsa:7378,0.0,0.0,0.00010539021462263156,0.00030866139425804484,0.0,0.0018336057,False,UPP1; uridine phosphorylase
hsa:2517,0.0,0.0,5.182540678421053e-05,0.00014249380903433745,0.0,0.0009642763,False,FUCA1; alpha-L-fucosidase
hsa:6125,0.0,0.0,5.889781508771929e-07,1.1817454767595197e-06,0.0,8.5873935e-06,False,RPL5; ribosomal protein
hsa:285267,0.0,0.0,2.727217644035086e-08,6.03120782310188e-08,0.0,2.9793532e-07,False,ZNF619; zinc finger protein
hsa:345456,0.0,0.0,3.969081924403508e-07,2.6879332676868973e-06,0.0,3.109004e-05,False,PFN3; profilin
hsa:494324,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR375; microRNA
hsa:4723,0.0,0.0,1.2148127999415203e-05,3.0209344776528387e-05,0.0,0.0001846046,False,NDUFV1; NADH:ubiquinone oxidoreductase core subunit
hsa:6928,4.9925793e-06,0.004157583727936285,2.8299838732631593e-05,6.71296563998693e-05,0.0,0.00040727927,False,HNF1B; HNF1 homeobox
hsa:7465,0.0,0.0,4.315670942836256e-07,7.769131319188359e-07,0.0,4.4751164e-06,False,WEE1; WEE1 G2 checkpoint
hsa:9180,0.0,0.0,2.6075919064327486e-09,2.2517744788649125e-08,0.0,2.6616576e-07,False,OSMR; oncostatin M
hsa:5272,5.12558e-07,0.0004268340415591529,6.912177467444449e-06,2.1154636244744963e-05,0.0,0.00021156228,False,SERPINB9; serpin family B member
hsa:3482,0.00012785253,0.10646953535690175,0.0008110690501637427,0.0013712390293108372,0.0,0.0096810805,False,IGF2R; insulin like growth factor 2
hsa:2132,0.0,0.0,0.00014694644500526317,0.00034513716784740213,0.0,0.001811701,False,EXT2; exostosin glycosyltransferase
hsa:138803,0.0,0.0,2.2181751812865497e-08,1.8603490166580405e-07,0.0,2.3058171e-06,False,OR13C3; olfactory receptor family 13 subfamily C member
hsa:390142,0.0,0.0,7.210625795321638e-08,8.44067211639525e-07,0.0,1.0983578e-05,False,OR5D13; olfactory receptor family 5 subfamily D member
hsa:23191,2.215422e-07,0.0001844898579319924,1.2025057908596488e-06,2.9917878633903907e-06,0.0,1.6577995e-05,False,CYFIP1; cytoplasmic FMR1 interacting protein
hsa:11127,2.5720834e-05,0.021419093114324765,0.00016020789459780113,0.00031031095253356965,0.0,0.0021043445,False,KIF3A; kinesin family member
hsa:221,0.0,0.0,5.220019051929825e-05,0.00016279245404113155,0.0,0.0010842576,False,ALDH3B1; aldehyde dehydrogenase 3 family member
hsa:9863,1.946697e-07,0.00016211171188452395,1.7169479771403511e-06,4.1948823595713054e-06,0.0,2.492709e-05,False,MAGI2; membrane associated guanylate kinase
hsa:5175,0.0,0.0,5.4036734905105265e-05,0.00012878715606095737,0.0,0.0007568557,False,PECAM1; platelet and endothelial cell adhesion molecule
hsa:10008,9.158319e-06,0.0076266145736833294,5.838969645473685e-05,0.0001148568975831608,0.0,0.000686166,False,KCNE3; potassium voltage-gated channel subfamily E regulatory subunit
hsa:222537,3.1509877e-05,0.026239934112708797,0.0005018685452619884,0.0013113050330430273,0.0,0.007771614,False,HS3ST5; heparan sulfate-glucosamine 3-sulfotransferase
hsa:284521,0.0,0.0,2.0729919764035084e-05,7.792221251313569e-05,0.0,0.0008075533,False,OR2L13; olfactory receptor family 2 subfamily L member
hsa:4905,4.454547e-06,0.003709535895108846,0.00015200000071801173,0.00036174477443028677,0.0,0.0026974226,False,NSF; N-ethylmaleimide sensitive factor
hsa:3084,2.2143222e-06,0.0018439827179366139,7.77972495083041e-06,1.6523520965072396e-05,0.0,0.00013366767,False,NRG1; neuregulin
hsa:4194,7.268078e-06,0.006052511339413617,7.115854857888891e-05,0.0001529392825766718,0.0,0.0007612504,False,MDM4; MDM4 regulator of
hsa:64798,0.0,0.0,5.277373532705848e-07,1.5656789556110315e-06,0.0,1.1768692e-05,False,DEPTOR; DEP domain containing MTOR interacting
hsa:55568,0.0,0.0,8.772101019883041e-06,2.505045477943907e-05,0.0,0.0001655518,False,GALNT10; polypeptide N-acetylgalactosaminyltransferase
hsa:7711,8.051535e-09,6.7049372457457975e-06,6.535485690000002e-08,1.815677249650783e-07,0.0,9.325208e-07,False,ZNF155; zinc finger protein
hsa:1577,0.0003902438,0.3249765652812009,0.0009795969913964908,0.0012650562541197362,0.0,0.0056919386,False,CYP3A5; cytochrome P450 family 3 subfamily A member
hsa:9619,1.3374315e-05,0.01113749648729549,0.00015365236735087717,0.0003721172087681933,0.0,0.0023866135,False,ABCG1; ATP binding cassette subfamily G member
hsa:1020,5.56846e-05,0.04637149916810352,0.00024687503263508764,0.0005802479043989697,0.0,0.0037707728,False,CDK5; cyclin dependent kinase
hsa:2068,8.0969204e-07,0.0006742732058644588,3.849986254256138e-06,6.194661502022801e-06,0.0,3.1303098e-05,False,ERCC2; ERCC excision repair 2
hsa:4848,0.0,0.0,7.063336666080114e-07,1.5792161800349514e-06,0.0,7.2572084e-06,False,CNOT2; CCR4-NOT transcription complex subunit
hsa:26735,0.0,0.0,2.2122935597192983e-06,9.681918949482496e-06,0.0,8.537138e-05,False,OR1L3; olfactory receptor family 1 subfamily L member
hsa:54965,6.7206815e-06,0.0055966654440606335,5.0895334769356726e-05,8.216142386169531e-05,0.0,0.0004640175,False,PIGX; phosphatidylinositol glycan anchor biosynthesis class
hsa:3301,0.0,0.0,6.630073213588306e-07,1.6738033916760292e-06,0.0,1.0839977e-05,False,DNAJA1; DnaJ heat shock protein family (Hsp40) member
hsa:9314,3.0402038e-08,2.5317378230707447e-05,3.238146087438595e-06,1.0829622539225988e-05,0.0,7.19691e-05,False,KLF4; KLF transcription factor
hsa:8892,0.0,0.0,5.5573949824561394e-08,9.566199716686274e-08,0.0,4.699404e-07,False,EIF2B2; eukaryotic translation initiation factor 2B subunit
hsa:6530,1.7978804e-06,0.0014971896982819242,2.988191885561403e-05,9.068446833034978e-05,0.0,0.0006982564,False,SLC6A2; solute carrier family 6 member
hsa:142827,0.0,0.0,4.966265464270994e-06,2.0956312696530596e-05,0.0,0.0001488351,False,ACSM6; acyl-CoA synthetase medium chain family member
hsa:51083,0.0,0.0,1.4556091195688542e-06,3.5005551843974876e-06,0.0,1.9062805e-05,False,GAL; galanin and GMAP
hsa:1903,0.0,0.0,5.631475467836258e-07,1.2632714396017666e-06,0.0,5.6777626e-06,False,S1PR3; sphingosine-1-phosphate receptor
hsa:57101,0.0,0.0,9.917598010526313e-06,2.558478456865988e-05,0.0,0.0001644517,False,ANO2; anoctamin
hsa:113130,0.0,0.0,1.3111562781578948e-06,3.7445521884649947e-06,0.0,2.0106896e-05,False,CDCA5; cell division cycle associated
hsa:4352,0.0,0.0,8.091415887526312e-07,2.3628502432490267e-06,0.0,1.6380101e-05,False,MPL; MPL proto-oncogene
hsa:4247,0.0,0.0,2.4119109010953216e-05,9.09048058849065e-05,0.0,0.00060561555,False,MGAT2; alpha-1
hsa:23094,1.4673185e-07,0.00012219133944051482,2.6252583949707605e-07,3.2890041884091024e-07,0.0,1.3648872e-06,False,SIPA1L3; signal induced proliferation associated 1 like
hsa:2595,4.5919887e-06,0.003823990837358817,0.00015870499830350875,0.0004102131307583439,0.0,0.0025478224,False,GANC; glucosidase alpha
hsa:442891,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR135B; microRNA
hsa:8863,0.0,0.0,0.00020571665130423975,0.00043954450184176876,0.0,0.002807521,False,PER3; period circadian regulator
hsa:9241,1.4389124e-07,0.00011982581388673681,3.160276854365205e-05,0.00014181326774242956,0.0,0.0016498639,False,NOG;
hsa:1036,6.465049e-05,0.05383786797880357,0.00024129747290877192,0.0003892859649043544,0.0,0.0027618394,False,CDO1; cysteine dioxygenase type
hsa:390059,0.0,0.0,5.006623356725146e-09,3.9181721879201015e-08,0.0,4.219034e-07,False,OR51M1; olfactory receptor family 51 subfamily M member
hsa:153201,0.0,0.0,1.338732987602339e-06,1.2123045374407032e-05,0.0,0.00015663561,False,SLC36A2; solute carrier family 36 member
hsa:3065,0.00015505598,0.1291232808995571,0.0003589304554152048,0.0005481613945677921,0.0,0.0032844169,False,HDAC1; histone deacetylase
hsa:3799,3.5051232e-07,0.0002918900693421527,2.2392547353783624e-05,6.582543935755453e-05,0.0,0.00057851063,False,KIF5B; kinesin family member
hsa:55502,2.465172e-08,2.0528785579358045e-05,6.221114998245616e-08,7.692423008171628e-08,0.0,3.606946e-07,False,HES6; hes family bHLH transcription factor
hsa:5293,0.00084546505,0.7040632753532503,0.0011189784841871345,0.0011561140414266652,0.0,0.005600705,True,PIK3CD; phosphatidylinositol-4
hsa:57104,6.215629e-06,0.00517608162764463,0.00015293605532725138,0.00045290237308042716,0.0,0.0027006378,False,PNPLA2; patatin like phospholipase domain containing
hsa:9821,0.0,0.0,1.5626766190058482e-06,2.806443944588239e-06,0.0,1.3331264e-05,False,RB1CC1; RB1 inducible coiled-coil
hsa:54807,1.0948501e-08,9.117393408832615e-06,4.515807042730994e-08,9.256005373573864e-08,0.0,6.9188764e-07,False,ZNF586; zinc finger protein
hsa:132789,1.2928753e-07,0.00010766453543423423,1.4644589074691665e-05,3.3506837908915064e-05,0.0,0.00029228037,False,GNPDA2; glucosamine-6-phosphate deaminase
hsa:23385,3.9136083e-07,0.00032590677499296585,0.00011655605705467839,0.00032386936916607934,0.0,0.0017608373,False,NCSTN;
hsa:338755,0.0,0.0,6.8073093405263145e-06,4.959965068713356e-05,0.0,0.00061460305,False,OR2AG2; olfactory receptor family 2 subfamily AG member
hsa:6136,2.556294e-07,0.0002128760646470084,4.25754592131579e-07,5.574656343661177e-07,0.0,3.730242e-06,False,RPL12; ribosomal protein
hsa:6096,1.7067483e-06,0.0014212991989457067,0.0002964689349091778,0.0010171175942848725,0.0,0.007592862,False,RORB; RAR related orphan receptor
hsa:9087,0.0,0.0,3.757610536571457e-06,1.9632881590028597e-05,0.0,0.00015417975,False,TMSB4Y; thymosin beta 4
hsa:391194,0.0,0.0,8.977151403508772e-08,5.334361794139511e-07,0.0,4.7035487e-06,False,OR2M2; olfactory receptor family 2 subfamily M member
hsa:338440,1.0631635e-06,0.0008853522402209593,4.04677435484228e-05,9.078763037068008e-05,0.0,0.0006156105,False,ANO9; anoctamin
hsa:80055,2.1592785e-05,0.017981449299528742,4.1178399630818696e-05,5.555013015303396e-05,0.0,0.00023479799,False,PGAP1; post-GPI attachment to proteins inositol deacylase
hsa:2524,0.000107081665,0.08917254212954102,0.0003826753357204679,0.0005540691792411347,0.0,0.0031397063,False,FUT2; fucosyltransferase
hsa:11040,0.0,0.0,1.849187631324211e-05,6.161391988513347e-05,0.0,0.00043809583,False,PIM2; Pim-2 proto-oncogene
hsa:4931,0.0,0.0,2.9703931042802933e-06,8.818321093533704e-06,0.0,4.255604e-05,False,NVL; nuclear VCP
hsa:51251,5.524384e-08,4.600445510253902e-05,2.2633248037849146e-05,4.52708140383407e-05,0.0,0.00018580667,False,NT5C3A; 5'-nucleotidase
hsa:4724,0.0,0.0,2.628335274649123e-06,7.485974082280267e-06,0.0,4.1984767e-05,False,NDUFS4; NADH:ubiquinone oxidoreductase subunit
hsa:2792,6.475494e-05,0.05392484899488536,0.00044202386945309924,0.0008059403740746624,0.0,0.0045994036,False,GNGT1; G protein subunit gamma transducin
hsa:57600,0.0,0.0,2.113872309000001e-06,4.49849333871441e-06,0.0,2.2323891e-05,False,FNIP2; folliculin interacting protein
hsa:6013,6.281423e-08,5.230871756625823e-05,5.687449799444445e-06,1.4991492509549254e-05,0.0,0.00012694618,False,RLN1; relaxin
hsa:3691,0.0,0.0,4.718415590643275e-07,5.998003197905615e-06,0.0,7.841456e-05,False,ITGB4; integrin subunit beta
hsa:353288,0.0,0.0,8.294100350877193e-08,6.634255737007651e-07,0.0,8.160979e-06,False,KRT26; keratin
hsa:22800,1.0412022e-06,0.0008670639090723028,3.653374763257312e-05,7.525251736797518e-05,0.0,0.00051900867,False,RRAS2; RAS related
hsa:6222,0.0,0.0,7.741600508163746e-07,1.5854653268604803e-06,0.0,7.3577403e-06,False,RPS18; ribosomal protein
hsa:5828,6.306837e-07,0.0005252035332908283,5.7015589983877205e-05,0.00018644045525418885,0.0,0.0011266209,False,PEX2; peroxisomal biogenesis factor
hsa:8639,0.0,0.0,6.036097200584795e-05,0.00014350723000173887,0.0,0.0007376751,False,AOC3; amine oxidase copper containing
hsa:7388,0.0,0.0,0.0005368924304849005,0.0016499305426680101,0.0,0.009815977,False,UQCRH; ubiquinol-cytochrome c reductase hinge
hsa:5243,1.6243663e-05,0.013526953687221493,0.00015535909364795323,0.00028352377670111357,0.0,0.0017668819,False,ABCB1; ATP binding cassette subfamily B member
hsa:1628,4.186149e-05,0.03486026744756313,0.0010825310738415206,0.0021375388173452575,0.0,0.011381367,False,DBP; D-box binding PAR bZIP transcription
hsa:53905,2.8302275e-06,0.002356879499211518,4.918599629306436e-05,8.0461564239598e-05,0.0,0.0003901734,False,DUOX1; dual oxidase
hsa:64321,0.0,0.0,1.8247781824093564e-07,6.380071140749027e-07,0.0,5.7394845e-06,False,SOX17; SRY-box transcription factor
hsa:151636,0.0,0.0,1.47821108128655e-07,8.293186896790837e-07,0.0,1.0287048e-05,False,DTX3L; deltex E3 ubiquitin ligase
hsa:868,2.1117496e-06,0.001758565111712088,3.170423395144444e-05,5.7616722096549884e-05,0.0,0.0003615122,False,CBLB; Cbl proto-oncogene
hsa:100134444,0.0,0.0,5.5542799404210523e-08,3.444948652158552e-07,0.0,3.5067649e-06,False,KCNJ18; potassium inwardly rectifying channel subfamily J member
hsa:406977,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR199A2; microRNA
hsa:5143,0.0,0.0,1.3185212477321633e-05,4.080580745898843e-05,0.0,0.00024525248,False,PDE4C; phosphodiesterase
hsa:9294,0.0,0.0,1.6411954515204678e-06,5.109459911105412e-06,0.0,3.6958438e-05,False,S1PR2; sphingosine-1-phosphate receptor
hsa:3476,3.970058e-05,0.033060763881633835,0.0006161899825997192,0.0012778275553506988,0.0,0.0060865297,False,IGBP1; immunoglobulin binding protein
hsa:83549,0.0,0.0,2.705677245160818e-05,8.555433982674282e-05,0.0,0.0005229968,False,UCK1; uridine-cytidine kinase
hsa:29934,2.8782705e-09,2.3968874355984763e-06,4.7288309485830424e-07,1.169648528312458e-06,0.0,1.0234047e-05,False,SNX12; sorting nexin
hsa:56171,9.247e-09,7.700463912957141e-06,2.1139938583333333e-08,3.51769055659983e-08,0.0,2.8844198e-07,False,DNAH7; dynein axonemal heavy chain
hsa:6635,0.0,0.0,6.165683227719298e-08,1.4345920905136302e-07,0.0,7.9442475e-07,False,SNRPE; small nuclear ribonucleoprotein polypeptide
hsa:2811,2.2757242e-05,0.018951153972037702,6.879051693327484e-05,0.00013704821699880737,0.0,0.0012467917,False,GP1BA; glycoprotein Ib platelet subunit
hsa:55301,0.0,0.0,1.396563768654971e-06,5.075554827017049e-06,0.0,4.8553917e-05,False,OLAH; oleoyl-ACP
hsa:23527,1.8710094e-07,0.00015580880680765214,1.373768693800585e-06,3.4491885507225417e-06,0.0,2.1610844e-05,False,ACAP2; ArfGAP with coiled-coil
hsa:835,2.920531e-07,0.00024320799796877511,1.4370030825906434e-06,2.914620830051592e-06,0.0,1.3881459e-05,False,CASP2; caspase
hsa:7448,9.586313e-06,0.007983027718699246,7.46584282347953e-05,0.0001260385842444928,0.0,0.00091528904,False,VTN;
hsa:3308,0.0,0.0,1.6139842340526316e-05,3.010578559993076e-05,0.0,0.00017834204,False,HSPA4; heat shock protein family A (Hsp70) member
hsa:10864,3.417886e-05,0.02846253682448517,0.00014670748184738604,0.00028666800670953724,0.0,0.0018230282,False,SLC22A7; solute carrier family 22 member
hsa:2017,0.0,0.0,1.0860250243508773e-06,2.4062036914193155e-06,0.0,1.3646885e-05,False,CTTN;
hsa:112714,0.0,0.0,6.12606863686573e-06,3.494251577589101e-05,0.0,0.0004505981,False,TUBA3E; tubulin alpha
hsa:2592,0.00017764884,0.1479375453226665,0.00038243240180058487,0.0005490069654702027,0.0,0.002911217,False,GALT; galactose-1-phosphate
hsa:2050,8.8667875e-08,7.383840939505729e-05,4.046908847374268e-07,8.59324562719273e-07,0.0,4.029777e-06,False,EPHB4; EPH receptor
hsa:7029,9.9260866e-08,8.265975090319829e-05,1.7891212024186367e-06,3.721341699719089e-06,0.0,1.8791028e-05,False,TFDP2; transcription factor
hsa:29072,0.0,0.0,3.0275610647017543e-06,1.2565658738464342e-05,0.0,0.00015772347,False,SETD2; SET domain containing 2
hsa:100506742,0.0,0.0,9.391848009748542e-08,2.417309284271239e-07,0.0,2.170833e-06,False,CASP12; caspase 12
hsa:9131,4.8797432e-08,4.0636191647126644e-05,2.9552189395380123e-06,4.552501449533648e-06,0.0,2.207715e-05,False,AIFM1; apoptosis inducing factor mitochondria associated
hsa:25833,0.0,0.0,1.5377712689181288e-08,8.662985182762252e-08,0.0,1.0567472e-06,False,POU2F3; POU class 2 homeobox
hsa:55556,0.0,0.0,9.329560648660822e-05,0.00027675735507995056,0.0,0.0013213516,False,ENOSF1; enolase superfamily member
hsa:4048,5.088107e-05,0.042371346748961425,0.0001669328958548538,0.00035528260363073324,0.0,0.0021268076,False,LTA4H; leukotriene A4
hsa:55970,0.0,0.0,0.00014601347704695908,0.00046897206645793937,0.0,0.002637555,False,GNG12; G protein subunit gamma
hsa:1555,0.0,0.0,5.344856472514621e-06,2.8384811022254093e-05,0.0,0.00025245946,False,CYP2B6; cytochrome P450 family 2 subfamily B member
hsa:257397,6.8325767e-06,0.0056898464702997515,4.656134776146202e-05,9.250214543322089e-05,0.0,0.00047006228,False,TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:6048,0.0,0.0,1.603232502573099e-07,8.307700687632782e-07,0.0,8.545385e-06,False,RNF5; ring finger protein
hsa:8790,0.0,0.0,3.7931135680174866e-05,0.00011258864800096875,0.0,0.0005162815,False,FPGT; fucose-1-phosphate
hsa:126328,0.0,0.0,2.615072990216375e-06,4.639204133440189e-06,0.0,2.2991928e-05,False,NDUFA11; NADH:ubiquinone oxidoreductase subunit
hsa:8326,0.0,0.0,1.737672640035087e-06,5.57585557847943e-06,0.0,4.755979e-05,False,FZD9; frizzled class receptor
hsa:5592,0.0,0.0,0.0,0.0,0.0,0.0,False,PRKG1; protein kinase cGMP-dependent
hsa:80146,0.0,0.0,4.3201105146198825e-07,1.5787965532847317e-06,0.0,1.0392864e-05,False,UXS1; UDP-glucuronate decarboxylase
hsa:8115,1.519478e-08,1.2653493571463494e-05,1.228126388288889e-07,3.3879241288534043e-07,0.0,2.6638504e-06,False,TCL1A; TCL1 family AKT coactivator
hsa:6507,0.0,0.0,1.6305980253914035e-05,5.042818411482749e-05,0.0,0.00030178227,False,SLC1A3; solute carrier family 1 member
hsa:5079,4.4675823e-09,3.720391075950694e-06,3.4532264816814626e-06,1.2914533108630388e-05,0.0,9.1580434e-05,False,PAX5; paired box
hsa:80228,1.6760328e-08,1.3957207843984554e-05,8.858148682923978e-07,1.4520265213951335e-06,0.0,9.3050385e-06,False,ORAI2; ORAI calcium release-activated calcium modulator
hsa:26683,0.0,0.0,2.416908146783626e-06,8.013785433103037e-06,0.0,6.590236e-05,False,OR4F3; olfactory receptor family 4 subfamily F member
hsa:6614,1.7859409e-07,0.00014872470478127176,1.344421450491228e-06,2.627465445210021e-06,0.0,1.613323e-05,False,SIGLEC1; sialic acid binding Ig like lectin
hsa:56998,0.0,0.0,9.40685322362573e-07,1.9787299279720805e-06,0.0,8.958446e-06,False,CTNNBIP1; catenin beta interacting protein
hsa:4688,0.0,0.0,1.79258200354386e-05,4.5903278210055285e-05,0.0,0.000306501,False,NCF2; neutrophil cytosolic factor
hsa:5226,0.0,0.0,2.7998325455847956e-05,5.8021697400002445e-05,0.0,0.000394037,False,PGD; phosphogluconate
hsa:3948,1.9636883e-07,0.00016352666692382565,1.4574589042263152e-05,4.06544356547805e-05,0.0,0.0003676868,False,LDHC; lactate dehydrogenase
hsa:442898,0.0,0.0,8.434417426900586e-09,9.654043935625047e-08,0.0,1.2486277e-06,False,MIR324; microRNA
hsa:2771,0.0,0.0,4.215227225146198e-05,0.00016790828790745282,0.0,0.0011617534,False,GNAI2; G protein subunit alpha
hsa:51085,0.0,0.0,2.223634174152047e-08,1.0369877881824051e-07,0.0,1.1677392e-06,False,MLXIPL; MLX interacting protein
hsa:406951,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR16-2; microRNA
hsa:79646,1.6149952e-06,0.0013448915602032013,5.559461266321633e-05,0.0001383741180843608,0.0,0.00062485394,False,PANK3; pantothenate kinase
hsa:7799,3.4482053e-08,2.871502160389051e-05,2.7844583623581286e-05,6.199909761735987e-05,0.0,0.00030855782,False,PRDM2; PR/SET domain
hsa:5899,0.0,0.0,5.1928664302163735e-05,0.00012057436133609782,0.0,0.000638125,False,RALB; RAS like proto-oncogene
hsa:79611,0.0,0.0,4.3918541620444446e-05,0.00012165938436569713,0.0,0.00096355524,False,ACSS3; acyl-CoA synthetase short chain family member
hsa:7341,0.0,0.0,8.083119752631578e-07,1.1754872838723708e-06,0.0,5.6871236e-06,False,SUMO1; small ubiquitin like modifier
hsa:898,2.6651855e-05,0.022194403335229415,0.00010829730824935673,0.0002240287204643159,0.0,0.0012492987,False,CCNE1; cyclin
hsa:64399,5.03556e-06,0.004193376020496428,2.8119818711192997e-05,5.4218630360553355e-05,0.0,0.00039164905,False,HHIP; hedgehog interacting
hsa:594855,0.0,0.0,7.1111375864701754e-06,2.3553889712605632e-05,0.0,0.00018652684,False,CPLX3; complexin
hsa:653361,0.0,0.0,4.492875282163743e-06,1.229992454166072e-05,0.0,9.44697e-05,False,NCF1; neutrophil cytosolic factor
hsa:80022,0.0,0.0,1.125442615037427e-06,3.4433116889820743e-06,0.0,1.844535e-05,False,MYO15B; myosin
hsa:55423,9.67601e-07,0.0008057723134682863,5.605845105366082e-05,0.00013883248957819624,0.0,0.0008313966,False,SIRPG; signal regulatory protein
hsa:64581,2.3288422e-07,0.00019393495533764159,4.186746661309942e-06,1.0826846737054362e-05,0.0,0.00011187106,False,CLEC7A; C-type lectin domain containing
hsa:6616,4.8411708e-05,0.04031497895735034,0.00011341789480485981,0.00018494603455703149,0.0,0.0012227434,False,SNAP25; synaptosome associated protein
hsa:56655,0.0,0.0,1.844359365362573e-05,5.8889300275588396e-05,0.0,0.00057923043,False,POLE4; DNA polymerase epsilon 4
hsa:1982,2.8449347e-05,0.023691269592375424,0.00017288418647502937,0.0003553783629558112,0.0,0.0021210846,False,EIF4G2; eukaryotic translation initiation factor 4 gamma
hsa:85417,6.302249e-08,5.2482146636714866e-05,1.7308598255035085e-05,5.9153825850569856e-05,0.0,0.00069096667,False,CCNB3; cyclin
hsa:22808,0.0,0.0,2.259953160638012e-05,5.944286704349067e-05,0.0,0.000357854,False,MRAS; muscle RAS oncogene
hsa:6799,0.0,0.0,1.3146944681871343e-06,4.722894150133318e-06,0.0,3.1089978e-05,False,SULT1A2; sulfotransferase family 1A member
hsa:64374,0.0,0.0,7.358191547859649e-07,2.3621497113252905e-06,0.0,1.378281e-05,False,SIL1; SIL1 nucleotide exchange
hsa:5906,0.0,0.0,4.137205874502923e-06,1.9403606902978465e-05,0.0,0.00017648388,False,RAP1A; RAP1A
hsa:101954278,0.0,0.0,4.329335241520468e-09,3.228844366457249e-08,0.0,3.335706e-07,False,RNU6-8; RNA
hsa:25973,8.161959e-08,6.796893126261032e-05,4.6060746201462e-06,1.4140773286254866e-05,0.0,7.585736e-05,False,PARS2; prolyl-tRNA synthetase 2
hsa:2395,0.0,0.0,9.226619981543858e-05,0.00026787164051314104,0.0,0.0016993992,False,FXN;
hsa:2852,0.0,0.0,1.699534098525146e-05,5.2210094647923406e-05,0.0,0.00040792226,False,GPER1; G protein-coupled estrogen receptor
hsa:7480,5.261203e-07,0.0004381280830565789,2.027584512269006e-05,4.261580460751102e-05,0.0,0.00037139398,False,WNT10B; Wnt family member
hsa:10400,7.366561e-08,6.134523320330645e-05,8.898797708929828e-06,2.004710453338672e-05,0.0,9.672779e-05,False,PEMT; phosphatidylethanolamine
hsa:5536,0.0,0.0,3.5690068713450294e-09,1.3619678399853332e-08,0.0,1.2567945e-07,False,PPP5C; protein phosphatase 5 catalytic
hsa:9060,0.0,0.0,0.00014409231287134503,0.000292701857728167,0.0,0.0015007865,False,PAPSS2; 3'-phosphoadenosine 5'-phosphosulfate synthase
hsa:4322,0.0,0.0,3.2133661611717545e-06,3.4311942591549346e-05,0.0,0.0004479659,False,MMP13; matrix metallopeptidase
hsa:54948,0.0,0.0,9.050509191239767e-08,1.4364301461394908e-07,0.0,5.868702e-07,False,MRPL16; mitochondrial ribosomal protein
hsa:3770,0.0,0.0,2.3629444796955563e-06,9.266727611271236e-06,0.0,9.874949e-05,False,KCNJ14; potassium inwardly rectifying channel subfamily J member
hsa:116983,0.0,0.0,8.998480548830412e-08,2.0219494148874973e-07,0.0,9.455591e-07,False,ACAP3; ArfGAP with coiled-coil
hsa:4722,0.0,0.0,4.011256488011696e-06,6.580895610051271e-06,0.0,2.7941112e-05,False,NDUFS3; NADH:ubiquinone oxidoreductase core subunit
hsa:23221,4.527546e-09,3.770326007056717e-06,4.944846894061402e-07,1.2362474597183255e-06,0.0,7.521402e-06,False,RHOBTB2; Rho related BTB domain containing
hsa:54880,6.749709e-09,5.620838172105769e-06,0.00018729949845819728,0.0006906455212179752,0.0,0.0040857196,False,BCOR; BCL6
hsa:8622,0.0,0.0,3.74393657546959e-05,0.00011574943480090023,0.0,0.0010839333,False,PDE8B; phosphodiesterase
hsa:3421,1.7593841e-09,1.4651318017822625e-06,6.598779074421637e-06,1.6541703418654866e-05,0.0,8.6003136e-05,False,IDH3G; isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit
hsa:51187,5.1457864e-08,4.285167349084638e-05,5.043306140175438e-07,1.1697973087446203e-06,0.0,6.2842237e-06,False,RSL24D1; ribosomal L24 domain containing
hsa:55585,0.0,0.0,2.8229552696666667e-07,6.300988134035129e-07,0.0,2.9026107e-06,False,UBE2Q1; ubiquitin conjugating enzyme E2
hsa:1757,0.0,0.0,3.9301450634913454e-05,9.790008280109151e-05,0.0,0.00067542284,False,SARDH; sarcosine
hsa:10509,6.820238e-07,0.0005679571384965826,1.280323360828537e-05,4.3370580301596394e-05,0.0,0.00036310815,False,SEMA4B; semaphorin
hsa:390261,0.0,0.0,1.9263863567251463e-07,1.6223728917160712e-06,0.0,1.5958522e-05,False,OR6M1; olfactory receptor family 6 subfamily M member
hsa:920,0.0,0.0,0.00034762361426023385,0.0008684534945968946,0.0,0.005100515,False,CD4; CD4
hsa:839,0.0,0.0,3.2187908248538013e-07,6.783491119316829e-07,0.0,5.2448468e-06,False,CASP6; caspase
hsa:10788,0.0,0.0,4.6113735619298236e-08,1.0945726737234962e-07,0.0,9.4471983e-07,False,IQGAP2; IQ motif containing GTPase activating protein
hsa:57693,0.0,0.0,6.485429712865497e-08,1.195842430341117e-07,0.0,7.6745084e-07,False,ZNF317; zinc finger protein
hsa:1969,1.5988284e-07,0.00013314286143842335,9.77683065251462e-07,1.435452662542312e-06,0.0,7.9303745e-06,False,EPHA2; EPH receptor
hsa:91584,3.694198e-07,0.00030763532374087217,1.8755642469470764e-05,6.843661826876857e-05,0.0,0.00046218614,False,PLXNA4; plexin
hsa:8802,1.5658965e-06,0.0013040044868255535,0.0001226109210087134,0.0003979483875372885,0.0,0.0040722704,False,SUCLG1; succinate-CoA ligase GDP/ADP-forming subunit
hsa:55274,1.0564193e-07,8.797359896832968e-05,1.0214101837894737e-06,2.552914599388634e-06,0.0,1.5369847e-05,False,PHF10; PHD finger protein
hsa:5152,0.0,0.0,2.9755007635070175e-06,9.66695390724403e-06,0.0,6.205716e-05,False,PDE9A; phosphodiesterase
hsa:7364,0.0,0.0,1.6154421432748536e-06,1.6433364508372775e-05,0.0,0.00020884322,False,UGT2B7; UDP glucuronosyltransferase family 2 member
hsa:50855,2.8612767e-06,0.002382735803323791,1.4777689353450295e-05,2.478245839613753e-05,0.0,0.00015464806,False,PARD6A; par-6 family cell polarity regulator
hsa:64802,0.0,0.0,9.792398441929826e-06,2.4600697529803708e-05,0.0,0.00018411125,False,NMNAT1; nicotinamide nucleotide adenylyltransferase
hsa:51071,0.0,0.0,3.8045602851462e-06,9.436803644146748e-06,0.0,5.5196146e-05,False,DERA; deoxyribose-phosphate
hsa:7050,0.0,0.0,4.714371685964914e-07,7.882761631068195e-07,0.0,4.127911e-06,False,TGIF1; TGFB induced factor homeobox
hsa:818,0.00119689,0.9967133397620065,0.0016528126620467835,0.0017410138493376365,0.0,0.00787205,True,CAMK2G; calcium/calmodulin dependent protein kinase II
hsa:4056,0.0,0.0,1.2292208053040941e-05,3.2738498209920575e-05,0.0,0.00022816334,False,LTC4S; leukotriene C4
hsa:8193,0.0,0.0,1.2922105737859646e-06,2.3919510515118202e-06,0.0,1.49356465e-05,False,DPF1; double PHD fingers
hsa:163223,0.0,0.0,1.055874336336257e-08,4.431444360637836e-08,0.0,3.2149e-07,False,ZNF676; zinc finger protein
hsa:391107,0.0,0.0,2.30441665497076e-07,1.9559752020411226e-06,0.0,2.3867859e-05,False,OR10K2; olfactory receptor family 10 subfamily K member
hsa:9575,1.7388147e-05,0.01448002579070985,0.00033935815409824556,0.000792895494822604,0.0,0.0040376824,False,CLOCK; clock circadian
hsa:9476,1.6037346e-09,1.33551426551971e-06,5.166030664292282e-07,1.3174163668843549e-06,0.0,6.5550666e-06,False,NAPSA; napsin A aspartic
hsa:4300,9.4741495e-07,0.0007889623264919536,2.7994811399081875e-05,6.176564305500931e-05,0.0,0.00030402667,False,MLLT3; MLLT3 super elongation complex
hsa:55578,0.0,0.0,1.8530576454210524e-07,3.3070587997588583e-07,0.0,1.6577285e-06,False,SUPT20H; SPT20 homolog
hsa:6183,0.0,0.0,5.426267965672517e-08,9.556297367014337e-08,0.0,4.9464234e-07,False,MRPS12; mitochondrial ribosomal protein
hsa:3417,5.893321e-06,0.004907678781007083,7.535247208625733e-05,0.0002085518518751789,0.0,0.0016463982,False,IDH1; isocitrate dehydrogenase (NADP(+))
hsa:10376,0.0,0.0,5.245365495906433e-06,1.5335204952867708e-05,0.0,7.8702804e-05,False,TUBA1B; tubulin alpha
hsa:5411,6.750726e-08,5.6216850815682405e-05,7.930017444935673e-07,1.2671612523842283e-06,0.0,5.2305927e-06,False,PNN; pinin
hsa:10120,8.0412e-08,6.696330746931002e-05,3.964865842777778e-07,7.520037382161871e-07,0.0,4.127132e-06,False,ACTR1B; actin related protein
hsa:3270,0.0,0.0,2.0484140743508764e-06,6.026536789905998e-06,0.0,4.5960078e-05,False,HRC; histidine rich calcium binding
hsa:134,0.0,0.0,5.427441028187134e-06,1.9345125808464942e-05,0.0,0.00017142038,False,ADORA1; adenosine A1
hsa:51084,0.0,0.0,1.3301091725553509e-05,3.943874802044685e-05,0.0,0.00023354543,False,CRYL1; crystallin lambda
hsa:57406,1.0264565e-07,8.547843880685944e-05,5.538949664497075e-07,9.400521475473771e-07,0.0,5.721999e-06,False,ABHD6; abhydrolase domain containing 6
hsa:25956,0.0,0.0,1.632268089596491e-07,4.50520943374772e-07,0.0,3.7744924e-06,False,SEC31B; SEC31 homolog B
hsa:5932,0.0,0.0,2.3517435337076017e-06,8.613514876056854e-06,0.0,5.891333e-05,False,RBBP8; RB binding protein 8
hsa:1441,0.0,0.0,8.403924821602338e-06,1.923291124609103e-05,0.0,9.064134e-05,False,CSF3R; colony stimulating factor 3
hsa:4771,0.00015797537,0.1315544107084516,0.0005208418065643274,0.0008510553372742927,0.0,0.004240041,False,NF2; NF2
hsa:8797,0.0,0.0,5.73971270251462e-06,1.2440912981999398e-05,0.0,7.716335e-05,False,TNFRSF10A; TNF receptor superfamily member
hsa:64221,4.0020123e-07,0.00033326864167146765,2.3416038957309937e-05,8.320388429329673e-05,0.0,0.0007352447,False,ROBO3; roundabout guidance receptor
hsa:6846,3.603436e-07,0.0003000770939834609,0.00010782863423219884,0.00025046116855523823,0.0,0.0014769873,False,XCL2; X-C motif chemokine ligand
hsa:100289635,3.8807815e-09,3.2317311446762938e-06,9.914496277485379e-08,1.7384033201447464e-07,0.0,7.9705114e-07,False,ZNF605; zinc finger protein
hsa:5050,1.015758e-06,0.0008458751836592971,2.5066090228678363e-05,5.7113648191852515e-05,0.0,0.00035571927,False,PAFAH1B3; platelet activating factor acetylhydrolase 1b catalytic subunit
hsa:4208,0.0,0.0,1.8117955772514622e-06,6.769043287364878e-06,0.0,7.4133444e-05,False,MEF2C; myocyte enhancer factor
hsa:57053,1.4258751e-08,1.1874012925201857e-05,1.0138917706575381e-05,1.7669155292590737e-05,0.0,8.370681e-05,False,CHRNA10; cholinergic receptor nicotinic alpha 10
hsa:1535,0.0,0.0,6.147601244497076e-05,0.0002217331619097494,0.0,0.0019214294,False,CYBA; cytochrome b-245 alpha
hsa:1491,0.0,0.0,2.7567597102923968e-05,4.750403862497192e-05,0.0,0.00022863796,False,CTH; cystathionine
hsa:84890,0.00015394614,0.12819905867946882,0.0006641387896732161,0.0011609673637434648,0.0,0.006516472,False,ADO; 2-aminoethanethiol
hsa:4825,2.936658e-05,0.02445509781950567,0.00046404382117192975,0.0011393789980640562,0.0,0.008773443,False,NKX6-1; NK6 homeobox
hsa:3676,0.0,0.0,3.8509340921871354e-05,9.216176304946284e-05,0.0,0.0006403905,False,ITGA4; integrin subunit alpha
hsa:26047,6.383479e-07,0.000531585916282251,6.669499027397662e-06,9.206189607613308e-06,0.0,3.6915844e-05,False,CNTNAP2; contactin associated protein
hsa:7567,0.0,0.0,5.437379887134503e-08,8.755278437343655e-08,0.0,5.015067e-07,False,ZNF19; zinc finger protein
hsa:4994,0.0,0.0,4.829770915789473e-07,1.7958549103528002e-06,0.0,1.24004155e-05,False,OR3A1; olfactory receptor family 3 subfamily A member
hsa:4717,4.0149644e-06,0.0033434723125346194,5.961509047119295e-06,7.822944822680165e-06,0.0,3.743738e-05,False,NDUFC1; NADH:ubiquinone oxidoreductase subunit
hsa:199777,0.0,0.0,2.2160549273684204e-08,3.450349564383035e-08,0.0,1.4924782e-07,False,ZNF626; zinc finger protein
hsa:63982,4.3516186e-09,3.6238219954853556e-06,6.798705566587545e-06,1.8795498474627303e-05,0.0,0.00012969182,False,ANO3; anoctamin
hsa:406996,0.0,0.0,2.1786549005847956e-09,2.0613039235160526e-08,0.0,2.539535e-07,False,MIR214; microRNA
hsa:721,0.0,0.0,4.0267109853274866e-05,0.00012511784166749322,0.0,0.0009001251,False,C4B; complement C4B (Chido blood
hsa:267,7.4799935e-08,6.228984537244942e-05,5.427140973573101e-07,8.945485750939189e-07,0.0,5.686008e-06,False,AMFR; autocrine motility factor
hsa:406881,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A1; microRNA
hsa:57551,0.0,0.0,1.0145344111111112e-07,1.9130503772195258e-07,0.0,1.0253162e-06,False,TAOK1; TAO kinase
hsa:958,0.0,0.0,4.071190654970759e-06,1.688348916707248e-05,0.0,0.00012969853,False,CD40; CD40
hsa:925,0.00015650193,0.13032739961859463,0.0003635506150649122,0.0005318720119416798,0.0,0.0026243892,False,CD8A; CD8 subunit
hsa:57396,2.792733e-06,0.002325655854333788,4.772817129002339e-05,7.827074796576827e-05,0.0,0.00033202834,False,CLK4; CDC like kinase
hsa:624,0.0,0.0,4.6843884283040935e-05,0.00016224563383466424,0.0,0.0010535415,False,BDKRB2; bradykinin receptor
hsa:7514,0.0,0.0,0.00013631057251608188,0.0003033214610928574,0.0,0.0020784605,False,XPO1; exportin
hsa:2014,0.0,0.0,1.5684508326830418e-05,6.79511217950619e-05,0.0,0.000654078,False,EMP3; epithelial membrane protein
hsa:4685,4.511963e-07,0.0003757349222244819,0.00015842259888654964,0.0004000623604168453,0.0,0.0022928724,False,NCAM2; neural cell adhesion molecule
hsa:8021,9.962323e-08,8.296151049067043e-05,5.041296678362577e-07,9.664531190926337e-07,0.0,4.757595e-06,False,NUP214; nucleoporin
hsa:5630,0.0,0.0,3.593155125462574e-08,7.603515273966481e-08,0.0,4.0980967e-07,False,PRPH;
hsa:213,3.7097243e-07,0.00030892828051443924,3.0426128309502915e-05,7.165807931247928e-05,0.0,0.00045762493,False,ALB;
hsa:94,0.0,0.0,3.136897084415204e-05,7.813048695582337e-05,0.0,0.0005460275,False,ACVRL1; activin A receptor like type
hsa:862,1.5929432e-06,0.0013265276983876362,3.6572822817706996e-05,7.584367491710313e-05,0.0,0.000402263,False,RUNX1T1; RUNX1 partner transcriptional co-repressor
hsa:59348,0.0,0.0,1.7943981312573096e-08,3.81553895165242e-08,0.0,2.0853943e-07,False,ZNF350; zinc finger protein
hsa:4696,1.1090511e-06,0.0009235652615091837,7.226458405421055e-06,1.1081073647409048e-05,0.0,5.7249144e-05,False,NDUFA3; NADH:ubiquinone oxidoreductase subunit
hsa:2054,0.0,0.0,3.859547382076023e-05,0.00011064742258725948,0.0,0.0010163354,False,STX2; syntaxin
hsa:9500,2.5513512e-07,0.00021246445165869904,3.4650588481286553e-06,6.113928877558604e-06,0.0,2.7625949e-05,False,MAGED1; MAGE family member
hsa:7187,0.0,0.0,0.00010482021392046782,0.0002166250899308554,0.0,0.0010254815,False,TRAF3; TNF receptor associated factor
hsa:1656,1.3543972e-07,0.00011278778806542875,4.860452197920466e-07,6.74191484592565e-07,0.0,3.4757907e-06,False,DDX6; DEAD-box helicase
hsa:375189,1.0091792e-07,8.40396670412778e-05,5.167775889329825e-06,1.4249307058915436e-05,0.0,8.087017e-05,False,PFN4; profilin family member
hsa:2052,0.0,0.0,0.0001372212684795322,0.00037730300383963933,0.0,0.002259625,False,EPHX1; epoxide hydrolase
hsa:55845,1.8361112e-07,0.00015290264989484628,1.1850314160877193e-06,2.9463020476430886e-06,0.0,1.5500482e-05,False,BRK1; BRICK1 subunit of SCAR/WAVE actin nucleating
hsa:7761,0.0,0.0,1.024843179649123e-08,2.6782983183556282e-08,0.0,1.7672583e-07,False,ZNF214; zinc finger protein
hsa:123688,0.0,0.0,5.2247126593485375e-06,1.4798554204186188e-05,0.0,0.000107507076,False,HYKK; hydroxylysine
hsa:55183,3.8210533e-07,0.0003181992326823381,4.831105751228069e-06,1.3771531222096818e-05,0.0,9.693577e-05,False,RIF1; replication timing regulatory factor
hsa:29982,0.0,0.0,1.3245232448713454e-07,2.4197184024104434e-07,0.0,9.43114e-07,False,NRBF2; nuclear receptor binding factor
hsa:23471,0.0,0.0,1.2520205687134505e-07,5.032835593162332e-07,0.0,5.0925746e-06,False,TRAM1; translocation associated membrane protein
hsa:328,0.0,0.0,7.101643944561402e-07,4.210028681034404e-06,0.0,3.9443952e-05,False,APEX1; apurinic/apyrimidinic endodeoxyribonuclease
hsa:8992,0.0,0.0,1.8307619748538014e-05,3.830815370523369e-05,0.0,0.00025450686,False,ATP6V0E1; ATPase H+ transporting V0 subunit
hsa:8645,0.0,0.0,2.2071324532163743e-07,2.8211599090377335e-06,0.0,3.688914e-05,False,KCNK5; potassium two pore domain channel subfamily K member
hsa:55624,1.7325237e-05,0.014427637320420662,0.00012155492010409356,0.0002581890173340467,0.0,0.0014107304,False,POMGNT1; protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta
hsa:5197,0.0,0.0,2.6206214327485382e-08,1.9814297568734221e-07,0.0,1.9930078e-06,False,PF4V1; platelet factor 4 variant
hsa:949,0.00036247025,0.30184806744301435,0.0008614742046491227,0.001145150122277106,0.0,0.0074388254,False,SCARB1; scavenger receptor class B member
hsa:162605,0.0,0.0,2.960540334836257e-07,9.629931328262942e-07,0.0,7.963907e-06,False,KRT28; keratin
hsa:56603,0.0,0.0,1.9744022087269e-05,4.35147302235361e-05,0.0,0.00027556004,False,CYP26B1; cytochrome P450 family 26 subfamily B member
hsa:3055,0.0,0.0,1.1410522898830407e-06,2.698860339632612e-06,0.0,1.5255811e-05,False,HCK; HCK proto-oncogene
hsa:63923,0.0,0.0,7.02847151245614e-07,2.8502045653553542e-06,0.0,3.430268e-05,False,TNN; tenascin
hsa:4277,0.0,0.0,1.0517614946140348e-07,3.2171713171961555e-07,0.0,2.3292953e-06,False,MICB; MHC class I polypeptide-related sequence
hsa:9722,3.2614597e-07,0.00027159892639141373,2.216953396298246e-05,6.771631594007872e-05,0.0,0.00043431035,False,NOS1AP; nitric oxide synthase 1 adaptor
hsa:51555,0.0,0.0,1.9498794707760245e-06,8.397999422752107e-06,0.0,8.853068e-05,False,PEX5L; peroxisomal biogenesis factor 5
hsa:26229,0.0,0.0,0.0003575469629526316,0.0010066332157171942,0.0,0.0048507294,False,B3GAT3; beta-1
hsa:3834,2.5408866e-08,2.1159300930265348e-05,9.445596950935673e-08,1.7568251947730031e-07,0.0,1.2511196e-06,False,KIF25; kinesin family member
hsa:1585,0.0,0.0,4.914228000175438e-07,4.455935140006496e-06,0.0,5.372099e-05,False,CYP11B2; cytochrome P450 family 11 subfamily B member
hsa:390201,0.0,0.0,7.142361373099415e-07,5.8808866085370015e-06,0.0,6.753277e-05,False,OR10V1; olfactory receptor family 10 subfamily V member
hsa:7415,0.0,0.0,3.3436287654974855e-05,7.256231405978526e-05,0.0,0.00036226248,False,VCP; valosin containing
hsa:148198,1.7116263e-09,1.4253613664559703e-06,3.376697313025147e-08,1.0284762348965408e-07,0.0,6.07639e-07,False,ZNF98; zinc finger protein
hsa:241,1.3554629e-07,0.00011287653451716487,1.6647578370994152e-06,4.365160323139979e-06,0.0,3.837382e-05,False,ALOX5AP; arachidonate 5-lipoxygenase activating
hsa:22914,1.0931859e-06,0.0009103534738946227,3.449668186491229e-05,7.520411770423923e-05,0.0,0.00036600386,False,KLRK1; killer cell lectin like receptor
hsa:1643,9.801135e-05,0.08161921312157586,0.00020224056756725154,0.0002945210149586801,0.0,0.0026535331,False,DDB2; damage specific DNA binding protein
hsa:406980,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19B1; microRNA
hsa:100169756,0.0,0.0,6.281337851894736e-08,3.597263775135949e-07,0.0,2.9426228e-06,False,RNA5S5; RNA
hsa:84987,0.0,0.0,3.959665256725147e-07,9.354250921218643e-07,0.0,5.670419e-06,False,COX14; cytochrome c oxidase assembly factor
hsa:83737,0.0,0.0,2.246987223874854e-05,5.464775731069158e-05,0.0,0.0004400711,False,ITCH; itchy E3 ubiquitin protein
hsa:7852,0.0003693018,0.30753705892615074,0.0008507797639766077,0.0013536793901067707,0.0,0.0077888137,False,CXCR4; C-X-C motif chemokine receptor
hsa:1455,2.0891235e-07,0.00017397231665903235,0.00010909332344342105,0.00027630470819406297,0.0,0.0018794049,False,CSNK1G2; casein kinase 1 gamma
hsa:3093,2.4772675e-07,0.00020629511178210837,9.092856779052633e-07,1.3533211100187558e-06,0.0,5.2469386e-06,False,UBE2K; ubiquitin conjugating enzyme E2
hsa:6355,0.0,0.0,3.3360731625730995e-06,1.0167566817980296e-05,0.0,6.334808e-05,False,CCL8; C-C motif chemokine ligand
hsa:8862,0.0,0.0,2.3763993005847949e-07,6.283549680806005e-07,0.0,4.381815e-06,False,APLN;
hsa:7023,4.0861647e-08,3.402764552260122e-05,4.822378866603504e-07,1.1389486237300044e-06,0.0,7.8107105e-06,False,TFAP4; transcription factor
hsa:471,5.349538e-06,0.004454842037416775,9.990173007777779e-05,0.00016370762712908073,0.0,0.0009667802,False,ATIC; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
hsa:3687,0.0,0.0,1.6187890932748537e-06,7.413984290249775e-06,0.0,8.611851e-05,False,ITGAX; integrin subunit alpha
hsa:1519,3.2441244e-07,0.0002701553246603627,2.9540908476257318e-06,4.632092639179603e-06,0.0,2.0669659e-05,False,CTSO; cathepsin
hsa:51706,1.5278039e-07,0.00012722827725776125,6.901428644437426e-05,0.0001389748776063084,0.0,0.00078351714,False,CYB5R1; cytochrome b5 reductase
hsa:64754,0.0,0.0,5.292233870284794e-06,1.3390986351055491e-05,0.0,9.11258e-05,False,SMYD3; SET and MYND domain containing
hsa:100529063,0.0,0.0,2.6286944775384793e-05,9.238609567158507e-05,0.0,0.0004742149,False,BCL2L2-PABPN1; BCL2L2-PABPN1
hsa:6011,9.392266e-05,0.07821434561900543,0.0003006922392319882,0.0005933405650163691,0.0,0.003948976,False,GRK1; G protein-coupled receptor kinase
hsa:171568,4.4480676e-06,0.00370414015747744,8.654790058865496e-05,0.00022066975128401644,0.0,0.0011138553,False,POLR3H; RNA polymerase III subunit
hsa:2934,0.0,0.0,8.800479247157897e-07,2.079434808600651e-06,0.0,1.17878935e-05,False,GSN;
hsa:340252,1.8908668e-08,1.574624370888802e-05,1.2804969827017543e-07,1.9356391935231033e-07,0.0,9.592487e-07,False,ZNF680; zinc finger protein
hsa:5922,1.7766453e-07,0.0001479506112120138,5.706177666491227e-07,8.390907894324899e-07,0.0,4.6217147e-06,False,RASA2; RAS p21 protein activator
hsa:406991,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR21; microRNA
hsa:5585,0.0,0.0,1.8681943235087718e-06,4.5634626016140605e-06,0.0,2.17945e-05,False,PKN1; protein kinase
hsa:390323,-0.0,0.0,1.026828859649123e-08,7.826221921367447e-08,-0.0,7.3037165e-07,False,OR6C75; olfactory receptor family 6 subfamily C member
hsa:4316,0.0,0.0,1.239159188729415e-06,6.2990851722348665e-06,0.0,6.7895235e-05,False,MMP7; matrix metallopeptidase
hsa:25961,1.1297453e-05,0.00940798411753319,0.00010889918246847954,0.0002172669076307464,0.0,0.0012038966,False,NUDT13; nudix hydrolase
hsa:4036,7.8115585e-07,0.0006505096175322117,1.780582940319298e-05,6.67121025122825e-05,0.0,0.00073268835,False,LRP2; LDL receptor related protein
hsa:1767,0.0,0.0,6.211992253567251e-09,1.939026317283077e-08,0.0,1.5659079e-07,False,DNAH5; dynein axonemal heavy chain
hsa:6311,0.0,0.0,2.3602418745976606e-07,4.0209550536517044e-07,0.0,1.7291212e-06,False,ATXN2; ataxin
hsa:23237,0.0,0.0,1.4607214399949125e-05,4.437453113489433e-05,0.0,0.00027708372,False,ARC; activity regulated cytoskeleton associated
hsa:3356,0.0,0.0,1.2106873204678365e-05,5.276069205204092e-05,0.0,0.00042174556,False,HTR2A; 5-hydroxytryptamine receptor
hsa:7143,7.4809086e-06,0.006229746589210634,8.408983379947372e-05,0.00015368430810961246,0.0,0.0008882022,False,TNR; tenascin
hsa:23214,5.5134347e-08,4.591327451475688e-05,2.999991884894737e-07,3.9973734873967323e-07,0.0,1.6705753e-06,False,XPO6; exportin
hsa:85363,5.0952474e-07,0.0004243080862040522,1.004983422197661e-05,2.8599838025231445e-05,0.0,0.0003000152,False,TRIM5; tripartite motif containing
hsa:8706,0.0002117216,0.17631172708916912,0.0007442294795695906,0.000987357314053965,0.0,0.0043804646,False,B3GALNT1; beta-1
hsa:6697,0.0,0.0,8.464418291052632e-07,2.3747169699306198e-06,0.0,2.2541684e-05,False,SPR; sepiapterin
hsa:91373,1.0634338e-07,8.855773332668848e-05,8.566306349374268e-06,2.0832412699990897e-05,0.0,0.00017867559,False,UAP1L1; UDP-N-acetylglucosamine pyrophosphorylase 1 like
hsa:7569,0.0,0.0,6.162030842824561e-08,1.7633484316381986e-07,0.0,9.552286e-07,False,ZNF182; zinc finger protein
hsa:54107,1.5093796e-06,0.0012569398876125972,3.0677680743157886e-05,6.936649427355007e-05,0.0,0.00044439032,False,POLE3; DNA polymerase epsilon 3
hsa:26508,0.0,0.0,4.149081016561403e-06,1.0639723020541744e-05,0.0,5.8315134e-05,False,HEYL; hes related family bHLH transcription factor with YRPW motif
hsa:7879,0.0,0.0,0.00011016955560116953,0.00042526995320813816,0.0,0.0053365687,False,RAB7A; RAB7A
hsa:10105,2.5893805e-06,0.0021563135175911023,5.158465780994151e-05,0.00012133502040614069,0.0,0.00061779557,False,PPIF; peptidylprolyl isomerase
hsa:100528030,2.4335876e-08,2.0265765645960833e-05,1.5396784575818718e-05,3.7810195214871265e-05,0.0,0.00021616204,False,POC1B-GALNT4; POC1B-GALNT4
hsa:2867,0.0,0.0,6.071828579519299e-06,4.878688819999829e-05,0.0,0.0006265931,False,FFAR2; free fatty acid receptor
hsa:122970,0.0,0.0,2.195691280573099e-06,8.537157682739404e-06,0.0,6.6083114e-05,False,ACOT4; acyl-CoA thioesterase
hsa:4257,0.0,0.0,4.8985043209356726e-05,0.0001937872436452934,0.0,0.0013257698,False,MGST1; microsomal glutathione S-transferase
hsa:8605,0.0,0.0,0.00016078837482456145,0.00031679859170257227,0.0,0.0017360497,False,PLA2G4C; phospholipase A2 group
hsa:10941,0.0,0.0,9.211193964619882e-05,0.00045849550325958657,0.0,0.005470849,False,UGT2A1; UDP glucuronosyltransferase family 2 member A1 complex
hsa:5030,0.0,0.0,9.333533966081873e-06,1.9741296384945354e-05,0.0,0.00015937943,False,P2RY4; pyrimidinergic receptor
hsa:8029,0.0,0.0,1.995462475474854e-05,5.4107628427741643e-05,0.0,0.00029135187,False,CUBN;
hsa:4170,4.07261e-06,0.003391476839682966,8.705290752988304e-05,0.00021691338442401508,0.0,0.0014764885,False,MCL1; MCL1 apoptosis regulator
hsa:5595,0.0,0.0,0.0008312754444093566,0.0015030335337310478,0.0,0.006618802,False,MAPK3; mitogen-activated protein kinase
hsa:5158,6.364221e-05,0.05299822011958907,0.00025283759071356726,0.0005475029997544404,0.0,0.003377294,False,PDE6B; phosphodiesterase
hsa:3798,0.0,0.0,5.216397457157894e-05,0.00018072565786009557,0.0,0.0012798934,False,KIF5A; kinesin family member
hsa:51691,2.3148694e-07,0.00019277136669091329,4.393511901736254e-05,0.00017270449571806358,0.0,0.00163102,False,LSM8; LSM8 homolog
hsa:54881,0.0,0.0,0.00012007433289014677,0.00042687744559823706,0.0,0.0023910028,False,TEX10; testis expressed
hsa:60559,0.0,0.0,1.7395992760526314e-06,5.166482549935044e-06,0.0,4.4659013e-05,False,SPCS3; signal peptidase complex subunit
hsa:163702,4.768479e-07,0.0003970963605406506,1.9934149054659653e-05,5.9494422470090964e-05,0.0,0.00051985146,False,IFNLR1; interferon lambda receptor
hsa:57804,0.0,0.0,8.781474787293568e-05,0.0002794082923821935,0.0,0.002376679,False,POLD4; DNA polymerase delta 4
hsa:388333,0.0,0.0,2.9412109736842104e-08,1.4136898415532315e-07,0.0,1.3055753e-06,False,SPDYE4; speedy/RINGO cell cycle regulator family member
hsa:91750,6.311032e-08,5.255528730346895e-05,1.0926755230116958e-06,1.899377912054963e-06,0.0,9.394756e-06,False,LIN52; lin-52 DREAM MuvB core complex
hsa:6241,1.0098515e-05,0.0084095653003089,0.0003057089322964914,0.0006550237146888881,0.0,0.0035143355,False,RRM2; ribonucleotide reductase regulatory subunit
hsa:3030,0.0,0.0,0.0005235032499824563,0.0013038592655959644,0.0,0.007368253,False,HADHA; hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
hsa:54460,4.3429516e-08,3.616604528119334e-05,4.752282255982452e-07,8.351072971761675e-07,0.0,3.6875495e-06,False,MRPS21; mitochondrial ribosomal protein
hsa:7335,5.422017e-08,4.515199117977738e-05,3.361841825327486e-06,1.0753435315695353e-05,0.0,8.568282e-05,False,UBE2V1; ubiquitin conjugating enzyme E2
hsa:4882,0.0,0.0,1.6536714850877195e-06,5.688880442045553e-06,0.0,5.8903704e-05,False,NPR2; natriuretic peptide receptor
hsa:7473,6.2252684e-06,0.005184108863704169,4.421256612046785e-05,6.892971359504249e-05,0.0,0.0004394293,False,WNT3; Wnt family member
hsa:55616,2.3746882e-08,1.977527932153688e-05,2.907021805442104e-06,5.721425909423332e-06,0.0,2.4106763e-05,False,ASAP3; ArfGAP with SH3 domain
hsa:79490,0.0,0.0,5.835756140350877e-07,7.631241382480924e-06,0.0,9.979143e-05,False,OR10G6; olfactory receptor family 10 subfamily G member
hsa:6171,0.0,0.0,1.0265983939824564e-06,1.8282388488057022e-06,0.0,7.557736e-06,False,RPL41; ribosomal protein
hsa:154807,6.837373e-05,0.056938406019171106,0.0005237515687797311,0.0009956864430980023,0.0,0.004733017,False,VKORC1L1; vitamin K epoxide reductase complex subunit 1 like
hsa:6427,4.6682473e-08,3.887495389900467e-05,3.346105757678362e-07,5.08032000754878e-07,0.0,2.2179527e-06,False,SRSF2; serine and arginine rich splicing factor
hsa:81797,0.0,0.0,2.0946497076023392e-10,2.7391099192666847e-09,0.0,3.581851e-08,False,OR12D3; olfactory receptor family 12 subfamily D member
hsa:1978,6.309998e-05,0.05254667664089081,0.00015948589742807026,0.00018476237026145668,0.0,0.00063531287,False,EIF4EBP1; eukaryotic translation initiation factor 4E binding protein
hsa:284390,0.0,0.0,2.625687334502925e-08,5.1010433381908925e-08,0.0,3.066963e-07,False,ZNF763; zinc finger protein
hsa:55349,0.0,0.0,3.517852394301492e-06,1.3262812160508744e-05,0.0,0.000112206915,False,CHDH; choline
hsa:5210,0.0,0.0,0.00011818261179573101,0.00025666167629285536,0.0,0.0011905786,False,PFKFB4; 6-phosphofructo-2-kinase/fructose-2
hsa:6594,0.0,0.0,2.534819427210526e-07,1.5277346795802694e-06,0.0,1.8874021e-05,False,SMARCA1; SWI/SNF related
hsa:2944,6.4130936e-06,0.005340520799958517,0.0002403559766471929,0.0004293343669429389,0.0,0.0024171977,False,GSTM1; glutathione S-transferase mu
hsa:22901,2.879936e-08,2.3982743851655824e-05,5.140693584457893e-07,1.0751461408349593e-06,0.0,5.9986696e-06,False,ARSG; arylsulfatase
hsa:7048,0.0,0.0,5.977276710116958e-05,0.0001896007554798851,0.0,0.0018914678,False,TGFBR2; transforming growth factor beta receptor
hsa:6223,0.0,0.0,2.736191452631579e-07,5.347732375153444e-07,0.0,2.9240086e-06,False,RPS19; ribosomal protein
hsa:10484,0.0,0.0,1.5253724527941513e-07,3.0439382462946644e-07,0.0,1.571492e-06,False,SEC23A; SEC23 homolog A
hsa:81567,1.7938406e-08,1.4938255440572494e-05,7.707419736156727e-07,1.8061480859749885e-06,0.0,8.736602e-06,False,TXNDC5; thioredoxin domain containing
hsa:1736,1.5696637e-08,1.3071416326731682e-05,1.7112428662128652e-06,3.808656202473968e-06,0.0,1.9442185e-05,False,DKC1; dyskerin pseudouridine synthase
hsa:6794,0.0,0.0,2.971171517807017e-05,7.93801781931885e-05,0.0,0.00048346265,False,STK11; serine/threonine kinase
hsa:2916,4.8991046e-06,0.0040797424222020475,2.2195685036140352e-05,4.932199068879915e-05,0.0,0.0004299039,False,GRM6; glutamate metabotropic receptor
hsa:10767,0.0,0.0,1.2553116115865495e-05,2.9083432305291617e-05,0.0,0.0001749755,False,HBS1L; HBS1 like translational
hsa:2155,0.0,0.0,1.0822156232394736e-06,3.565228830867421e-06,0.0,3.07589e-05,False,F7; coagulation factor
hsa:8688,0.0,0.0,1.0065048314450293e-06,6.313600858213818e-06,0.0,7.5954595e-05,False,KRT37; keratin
hsa:637,0.0,0.0,0.00010674081394736842,0.00021808010414710625,0.0,0.0010713281,False,BID; BH3 interacting domain death
hsa:6996,1.7354975e-07,0.00014452401719235793,1.5241260024463274e-05,4.884061338823204e-05,0.0,0.0003729942,False,TDG; thymine DNA
hsa:153090,1.2002091e-06,0.00099947732913948,3.007813824327486e-06,3.8374729943562055e-06,0.0,1.8911223e-05,False,DAB2IP; DAB2 interacting
hsa:8607,0.0,0.0,2.9930248348830404e-06,8.873662124370805e-06,0.0,4.9156944e-05,False,RUVBL1; RuvB like AAA ATPase
hsa:116228,0.0,0.0,6.691298153216374e-07,1.1379160431599865e-06,0.0,4.117002e-06,False,COX20; cytochrome c oxidase assembly factor
hsa:7066,0.0,0.0,3.633983444473684e-06,1.4134494649568971e-05,0.0,0.00015955186,False,THPO;
hsa:57786,0.0,0.0,1.332895316479532e-07,3.3634481006804473e-07,0.0,1.7076237e-06,False,RBAK; RB associated KRAB zinc
hsa:7381,0.0,0.0,0.0003011553632233333,0.0005921206641894564,0.0,0.0030624464,False,UQCRB; ubiquinol-cytochrome c reductase binding
hsa:10775,2.0341727e-07,0.00016939627413293604,1.8966050144548533e-06,4.746651420536351e-06,0.0,2.3283965e-05,False,POP4; POP4 homolog
hsa:1645,4.7038808e-05,0.03917169282064667,0.000163224936869883,0.00027426999993795676,0.0,0.0015581932,False,AKR1C1; aldo-keto reductase family 1 member
hsa:51128,0.0,0.0,2.038821512161404e-06,9.146837934931392e-06,0.0,6.3811756e-05,False,SAR1B; secretion associated Ras related GTPase
hsa:125,0.0,0.0,7.697443160836257e-05,0.0002481490447525779,0.0,0.0018197601,False,ADH1B; alcohol dehydrogenase 1B (class I)
hsa:101954273,0.0,0.0,3.867006878362573e-09,2.1247962843411687e-08,0.0,2.1720136e-07,False,RNVU1-1; RNA
hsa:4090,6.6904164e-07,0.0005571462101314658,1.3547988325608191e-05,3.5378718942027574e-05,0.0,0.000194231,False,SMAD5; SMAD family member
hsa:3815,0.00013542396,0.11277466388339477,0.00023242847917134504,0.0003220177240532945,0.0,0.0023995647,False,KIT; KIT proto-oncogene
hsa:6646,0.0,0.0,4.5814661035087725e-07,2.282229857975224e-06,0.0,2.0097463e-05,False,SOAT1; sterol O-acyltransferase
hsa:7779,2.962357e-07,0.0002466910692743158,5.585569629590643e-06,9.100182941189122e-06,0.0,4.209583e-05,False,SLC30A1; solute carrier family 30 member
hsa:2316,3.2403562e-07,0.0002698415268003345,1.9997291104912283e-06,3.5096927476035822e-06,0.0,1.984487e-05,False,FLNA; filamin
hsa:1263,0.0,0.0,2.765365775725146e-06,1.3921544177250685e-05,0.0,0.00015914754,False,PLK3; polo like kinase
hsa:3428,0.0,0.0,8.55216776116959e-08,2.254857037665029e-07,0.0,1.4474091e-06,False,IFI16; interferon gamma inducible protein
hsa:81168,0.0,0.0,4.097130467836257e-08,3.8351755125053153e-07,0.0,4.11499e-06,False,OR8J3; olfactory receptor family 8 subfamily J member
hsa:91012,0.0,0.0,2.9499520251169584e-06,9.499430714164692e-06,0.0,5.629397e-05,False,CERS5; ceramide synthase
hsa:4620,0.0,0.0,1.6139343440935675e-09,1.955609317833741e-08,0.0,2.5565967e-07,False,MYH2; myosin heavy chain
hsa:11226,1.5791145e-05,0.013150118115796864,0.00032782303297301184,0.0006220454423377933,0.0,0.003273861,False,GALNT6; polypeptide N-acetylgalactosaminyltransferase
hsa:340665,7.0727433e-09,5.889845847005451e-06,1.2913411886450295e-06,4.104768486573756e-06,0.0,3.625389e-05,False,CYP26C1; cytochrome P450 family 26 subfamily C member
hsa:3455,0.0,0.0,4.613789210274855e-05,0.00011639080779730472,0.0,0.00080155546,False,IFNAR2; interferon alpha and beta receptor subunit
hsa:2634,0.0,0.0,3.224342283538012e-07,5.061309319093056e-07,0.0,2.3197751e-06,False,GBP2; guanylate binding protein
hsa:3809,0.0,0.0,4.166305297509943e-06,3.096982774677564e-05,0.0,0.0003884683,False,KIR2DS4; killer cell immunoglobulin like receptor
hsa:9436,0.0,0.0,1.4635035954280696e-06,6.304815401407973e-06,0.0,4.310583e-05,False,NCR2; natural cytotoxicity triggering receptor
hsa:6636,0.0,0.0,5.706060219730991e-07,1.455780862179644e-06,0.0,8.55394e-06,False,SNRPF; small nuclear ribonucleoprotein polypeptide
hsa:7770,0.0,0.0,6.29965021625731e-08,1.0880153296167538e-07,0.0,4.8168823e-07,False,ZNF227; zinc finger protein
hsa:23547,0.0,0.0,6.9301027478976625e-06,1.6043812871011142e-05,0.0,9.864262e-05,False,LILRA4; leukocyte immunoglobulin like receptor
hsa:7414,0.0,0.0,2.2527221099415204e-06,5.310704786160308e-06,0.0,3.3677272e-05,False,VCL;
hsa:5540,0.0,0.0,2.521186633973684e-07,1.3414958128667839e-06,0.0,1.1873385e-05,False,NPY4R; neuropeptide Y receptor
hsa:55341,3.1708566e-07,0.0002640539290738832,1.8089311768918128e-06,3.4261487395674744e-06,0.0,1.5556765e-05,False,LSG1; large 60S subunit nuclear export GTPase
hsa:4547,1.405429e-06,0.0011703747482127657,1.1263625809584799e-05,3.063050754653404e-05,0.0,0.00029513796,False,MTTP; microsomal triglyceride transfer
hsa:84647,0.0,0.0,9.31551351766082e-06,5.641250044829936e-05,0.0,0.00068178505,False,PLA2G12B; phospholipase A2 group
hsa:2173,0.0,0.0,1.7841429958538015e-07,8.862307850556851e-07,0.0,9.754865e-06,False,FABP7; fatty acid binding protein
hsa:96459,2.511956e-07,0.00020918380587148447,8.120913305263159e-07,1.2024833946901544e-06,0.0,9.829935e-06,False,FNIP1; folliculin interacting protein
hsa:5144,0.0,0.0,2.9866661519298243e-06,1.2513165992579318e-05,0.0,0.00013849427,False,PDE4D; phosphodiesterase
hsa:11264,5.6724593e-07,0.0004723755611265073,4.020563845922806e-05,0.0001444065789647317,0.0,0.00092965184,False,PXMP4; peroxisomal membrane protein
hsa:840,0.0,0.0,0.00030954415252339173,0.000907523522070507,0.0,0.0046009454,False,CASP7; caspase
hsa:6185,0.0,0.0,0.00013484049650878358,0.0003726118900804057,0.0,0.0018248878,False,RPN2; ribophorin
hsa:9442,1.2326761e-07,0.00010265143099832109,1.179418402211696e-06,2.0379772095693053e-06,0.0,1.4987971e-05,False,MED27; mediator complex subunit
hsa:23382,0.0,0.0,0.00013068593086140354,0.00040741444864457547,0.0,0.002581509,False,AHCYL2; adenosylhomocysteinase like
hsa:8642,0.0006325476,0.526755700987093,0.001237897987883041,0.001673394884152772,0.0,0.010636107,True,DCHS1; dachsous cadherin-related
hsa:94033,0.0,0.0,3.209515604678362e-08,2.0035711831937e-07,0.0,1.5177598e-06,False,FTMT; ferritin
hsa:8399,3.587028e-05,0.029871071340723296,9.318906954228068e-05,0.0001259842420672459,0.0,0.00073874055,False,PLA2G10; phospholipase A2 group
hsa:406884,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7B; microRNA
hsa:56953,7.71502e-05,0.06424703481966326,0.0004128646000163742,0.0008167202647545106,0.0,0.0040129772,False,NT5M; 5'
hsa:3670,1.9975424e-08,1.6634587613065645e-05,0.00010371686676757306,0.0002311667499520074,0.0,0.0011354142,False,ISL1; ISL LIM homeobox
hsa:11091,3.2298017e-06,0.002689625979978115,9.904056130354966e-05,0.0002755925296370556,0.0,0.0014915481,False,WDR5; WD repeat domain
hsa:7185,0.0,0.0,1.0469563377076023e-05,2.654546348046579e-05,0.0,0.00017266325,False,TRAF1; TNF receptor associated factor
hsa:5252,0.0,0.0,1.705077977142544e-05,6.516774847844445e-05,0.0,0.0004240902,False,PHF1; PHD finger protein
hsa:56670,1.0487956e-09,8.733873331748927e-07,3.463795114242103e-08,9.431985049383015e-08,0.0,6.9675013e-07,False,SUCNR1; succinate receptor
hsa:10911,0.0,0.0,1.5631970114479531e-06,5.5865905608105644e-06,0.0,4.4380075e-05,False,UTS2; urotensin
hsa:390321,0.0,0.0,8.22390749122807e-07,6.68176751639068e-06,0.0,7.2478346e-05,False,OR6C1; olfactory receptor family 6 subfamily C member
hsa:2049,1.07584945e-07,8.959164989185454e-05,1.0501525539766083e-06,2.4215963688812694e-06,0.0,1.5348489e-05,False,EPHB3; EPH receptor
hsa:1296,0.0,0.0,4.3813750312280694e-07,1.2426643004142695e-06,0.0,1.11038635e-05,False,COL8A2; collagen type VIII alpha 2
hsa:23025,0.0,0.0,3.861859550994152e-06,1.0809881052807598e-05,0.0,6.892923e-05,False,UNC13A; unc-13 homolog
hsa:1852,4.4293934e-08,3.688589167620908e-05,1.3716790941738014e-05,4.877192338493717e-05,0.0,0.0003853446,False,DUSP9; dual specificity phosphatase
hsa:4337,0.0,0.0,5.405588322912866e-06,2.2699994256493208e-05,0.0,0.0002490729,False,MOCS1; molybdenum cofactor synthesis
hsa:7476,1.4444986e-08,1.2029100618164934e-05,3.3835700778450287e-06,1.328459294274364e-05,0.0,0.000143039,False,WNT7A; Wnt family member
hsa:10427,1.4762401e-07,0.0001229342880600221,1.223529833362573e-06,2.3523056264787458e-06,0.0,1.1894049e-05,False,SEC24B; SEC24 homolog B
hsa:219473,0.0,0.0,5.086808066666667e-06,3.2524138246599405e-05,0.0,0.00038615748,False,OR8K3; olfactory receptor family 8 subfamily K member 3
hsa:60412,1.7209377e-08,1.4331154596406905e-05,2.1441369118421044e-07,3.8815984010856427e-07,0.0,2.2655436e-06,False,EXOC4; exocyst complex component
hsa:25,2.1986096e-05,0.018308980083790567,0.00013711872707654972,0.0003287292183579282,0.0,0.0019699847,False,ABL1; ABL proto-oncogene 1
hsa:4860,0.0,0.0,6.725759529005847e-06,2.537649386701611e-05,0.0,0.00023058,False,PNP; purine nucleoside
hsa:292,0.0,0.0,0.00028969799583228073,0.0009736751508273531,0.0,0.0063536703,False,SLC25A5; solute carrier family 25 member
hsa:1356,0.0,0.0,7.3499826766081885e-06,2.0792588562283054e-05,0.0,0.00014018733,False,CP;
hsa:3680,0.0,0.0,3.39451082677193e-05,9.426900158043416e-05,0.0,0.00062473124,False,ITGA9; integrin subunit alpha
hsa:81,1.5448912e-05,0.012865122672266742,8.903808914832162e-05,0.0001999032022547991,0.0,0.0012733256,False,ACTN4; actinin alpha
hsa:9489,7.837724e-08,6.526885565233925e-05,5.175956068099416e-06,1.153860037690274e-05,0.0,8.3862535e-05,False,PGS1; phosphatidylglycerophosphate synthase
hsa:406894,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR101-2; microRNA
hsa:219986,0.0,0.0,6.856129263157894e-08,6.706290595397865e-07,0.0,8.024856e-06,False,OR4D11; olfactory receptor family 4 subfamily D member
hsa:1135,0.0,0.0,8.902420428464209e-07,5.449120946749499e-06,0.0,6.411146e-05,False,CHRNA2; cholinergic receptor nicotinic alpha 2
hsa:220441,2.9389682e-07,0.00024474336071621727,1.2921166198304094e-06,2.3802234530737147e-06,0.0,1.324996e-05,False,RNF152; ring finger protein
hsa:1654,0.0,0.0,3.3859106740935667e-06,8.543451858459923e-06,0.0,5.335855e-05,False,DDX3X; DEAD-box helicase 3
hsa:7456,1.3827419e-07,0.00011514820051783059,6.213430085704679e-06,1.2821616826449203e-05,0.0,0.00011708753,False,WIPF1; WAS/WASL interacting protein family member
hsa:8801,0.0,0.0,0.00010747097335719301,0.00023940487805767534,0.0,0.0012352631,False,SUCLG2; succinate-CoA ligase GDP-forming subunit
hsa:5373,0.0,0.0,1.8361445339064324e-05,3.902711719443939e-05,0.0,0.0003178148,False,PMM2; phosphomannomutase
hsa:6344,1.0835854e-06,0.0009023586319138348,2.076169464994152e-05,6.493738095917094e-05,0.0,0.00051950896,False,SCTR; secretin
hsa:219429,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4C11; olfactory receptor family 4 subfamily C member
hsa:390916,0.0,0.0,1.2307141009649122e-06,3.595505154344062e-06,0.0,1.6131253e-05,False,NUDT19; nudix hydrolase
hsa:3880,5.1943993e-05,0.043256498712165935,0.00029657439465204685,0.0006952965179784922,0.0,0.0047051883,False,KRT19; keratin
hsa:3667,0.0,0.0,4.2496541185380114e-05,0.0001056050025412593,0.0,0.0007849522,False,IRS1; insulin receptor substrate
hsa:1742,4.8220478e-05,0.04015573166481494,0.00022253042722226315,0.00034551209317911717,0.0,0.0016251369,False,DLG4; discs large MAGUK scaffold protein
hsa:487,0.00016600845,0.13824397950372555,0.00030328593983099415,0.0003727509574064393,0.0,0.002567682,False,ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:84671,0.0,0.0,1.020145634022222e-07,2.6641655579458045e-07,0.0,1.2812466e-06,False,ZNF347; zinc finger protein
hsa:100169763,0.0,0.0,4.50061713380117e-08,2.4027983462046313e-07,0.0,2.0947978e-06,False,RNA5S12; RNA
hsa:7374,0.00014392936,0.11985755841840781,0.0005374106501795323,0.0008250605387885095,0.0,0.0033740061,False,UNG; uracil DNA
hsa:10573,4.4222983e-08,3.68268070417235e-05,1.9070876227134494e-07,3.7112287349548055e-07,0.0,2.185506e-06,False,MRPL28; mitochondrial ribosomal protein
hsa:137970,6.278932e-08,5.228797369732002e-05,7.282115587479997e-06,2.7186098933171155e-05,0.0,0.00023185254,False,UNC5D; unc-5 netrin receptor
hsa:3772,0.0,0.0,1.637734175701754e-06,4.036766965193006e-06,0.0,2.8983035e-05,False,KCNJ15; potassium inwardly rectifying channel subfamily J member
hsa:10841,8.73631e-05,0.0727518545338019,0.00021991590289181275,0.00047090620978953887,0.0,0.004781974,False,FTCD; formimidoyltransferase
hsa:6456,3.3428826e-08,2.7837944010546492e-05,3.457985807941926e-07,7.405666468369186e-07,0.0,5.3145263e-06,False,SH3GL2; SH3 domain containing GRB2 like 2
hsa:1589,0.0,0.0,3.681716441099416e-05,0.00014760978730690786,0.0,0.0011858527,False,CYP21A2; cytochrome P450 family 21 subfamily A member
hsa:765,0.0,0.0,4.44488199491228e-06,2.5840067297557585e-05,0.0,0.00029336012,False,CA6; carbonic anhydrase
hsa:97,0.0,0.0,9.384164932230996e-07,3.159822074603558e-06,0.0,1.7951617e-05,False,ACYP1; acylphosphatase
hsa:5705,0.0,0.0,1.9781721042748537e-06,4.823591076178665e-06,0.0,4.8857062e-05,False,PSMC5; proteasome 26S subunit
hsa:4889,0.0,0.0,1.829633179836257e-06,8.067970585467904e-06,0.0,8.745329e-05,False,NPY5R; neuropeptide Y receptor
hsa:57452,8.629704e-06,0.00718640902254806,0.00010744881480175435,0.00020150798718876134,0.0,0.0011583277,False,GALNT16; polypeptide N-acetylgalactosaminyltransferase
hsa:1807,9.715454e-06,0.008090570230885165,9.062542630239767e-05,0.00023658760430824132,0.0,0.001424132,False,DPYS;
hsa:138716,2.0191585e-08,1.6814596262345273e-05,7.053634788116374e-07,1.102425268150619e-06,0.0,4.878795e-06,False,RPP25L; ribonuclease P/MRP subunit p25
hsa:6875,0.0,0.0,1.608066378023392e-07,5.646309080641538e-07,0.0,4.383916e-06,False,TAF4B; TATA-box binding protein associated factor
hsa:390883,-0.0,0.0,8.193420953216375e-07,6.981154387677645e-06,0.0,8.22076e-05,False,OR7G3; olfactory receptor family 7 subfamily G member
hsa:204851,1.7964756e-09,1.4960198473351388e-06,8.322994860329824e-07,2.059635409339335e-06,0.0,1.2542903e-05,False,HIPK1; homeodomain interacting protein kinase
hsa:28227,1.1631522e-05,0.00968618096828886,3.0280858685380116e-05,4.7005681753718415e-05,0.0,0.00024704385,False,PPP2R3B; protein phosphatase 2 regulatory subunit
hsa:4635,0.0,0.0,1.128082521305263e-05,3.674246900860226e-05,0.0,0.00019999447,False,MYL4; myosin light chain
hsa:9020,1.9020112e-05,0.015839048997123725,0.00019609593993333334,0.0003614863292776624,0.0,0.0021684836,False,MAP3K14; mitogen-activated protein kinase kinase kinase
hsa:341276,0.0,0.0,5.3613488187134504e-09,3.578853953155151e-08,0.0,4.082628e-07,False,OR10A2; olfactory receptor family 10 subfamily A member
hsa:3817,1.104342e-05,0.009196437459243988,5.3005433429824575e-05,0.00011227719944135228,0.0,0.00069106155,False,KLK2; kallikrein related peptidase
hsa:2149,0.0,0.0,3.379825988888888e-06,8.52409231188646e-06,0.0,7.544469e-05,False,F2R; coagulation factor II thrombin
hsa:51143,1.3123731e-05,0.010928821992955222,0.00012770718024515787,0.00026276907335937114,0.0,0.0016516409,False,DYNC1LI1; dynein cytoplasmic 1 light intermediate chain
hsa:8717,0.0,0.0,1.9101181385964912e-05,5.758411389625128e-05,0.0,0.00038690824,False,TRADD; TNFRSF1A associated via death
hsa:63934,0.0,0.0,1.0061645722982457e-07,2.0986330102945362e-07,0.0,1.0188882e-06,False,ZNF667; zinc finger protein
hsa:285203,0.0,0.0,7.323708750403511e-05,0.00018124172301882212,0.0,0.0016567565,False,EOGT; EGF domain specific O-linked N-acetylglucosamine
hsa:5980,0.0,0.0,7.142056330429416e-05,0.0002250781966370022,0.0,0.0013038374,False,REV3L; REV3 like
hsa:55788,0.00013219181,0.11008308235032843,0.00048296217381824563,0.0008819817921721551,0.0,0.004707961,False,LMBRD1; LMBR1 domain containing
hsa:1357,4.5769552e-06,0.003811471650137508,2.1923242443222226e-05,5.0880354729778294e-05,0.0,0.0005286525,False,CPA1; carboxypeptidase
hsa:3674,0.000438232,0.364938866822,0.000775609480898246,0.0009190845223852949,0.0,0.0052048624,False,ITGA2B; integrin subunit alpha
hsa:23533,0.0,0.0,5.099223835672515e-07,2.085146573176674e-06,0.0,2.2968581e-05,False,PIK3R5; phosphoinositide-3-kinase regulatory subunit
hsa:951,0.0,0.0,2.283632512847953e-05,5.004927152721707e-05,0.0,0.00033790717,False,CD37; CD37
hsa:26831,0.0,0.0,1.24879137871345e-07,9.253152048823363e-07,0.0,8.4587155e-06,False,RNU5A-1; RNA
hsa:403273,0.0,0.0,4.3607093567251464e-09,5.702367422435133e-08,0.0,7.456813e-07,False,OR5H14; olfactory receptor family 5 subfamily H member
hsa:5644,0.0,0.0,6.477680259929824e-06,3.288249939401093e-05,0.0,0.00038032685,False,PRSS1; serine protease
hsa:8315,3.2846685e-07,0.0002735316454015039,7.704563187017544e-07,1.0737476181540606e-06,0.0,4.923585e-06,False,BRAP; BRCA1 associated
hsa:2259,0.0,0.0,3.161041605964912e-08,8.006365349293663e-08,0.0,6.1361493e-07,False,FGF14; fibroblast growth factor
hsa:84823,0.0,0.0,1.9455696931520468e-06,3.4826213043293007e-06,0.0,1.6833483e-05,False,LMNB2; lamin
hsa:58538,3.1016525e-09,2.5829093918874556e-06,1.768323823793511e-06,6.5761332130557345e-06,0.0,4.5540368e-05,False,MPP4; MAGUK p55 scaffold protein
hsa:3460,0.0,0.0,0.0001878189370146199,0.00039924518755926614,0.0,0.0023461806,False,IFNGR2; interferon gamma receptor
hsa:9037,2.636242e-07,0.00021953375567018455,4.544590059029412e-06,1.451784079768268e-05,0.0,0.00010215747,False,SEMA5A; semaphorin
hsa:1610,8.693333e-06,0.007239396242004916,0.00011511555142035087,0.00024566555664185116,0.0,0.001443921,False,DAO; D-amino acid
hsa:5208,0.0,0.0,6.020659917590645e-05,0.00016915684229894048,0.0,0.0010208308,False,PFKFB2; 6-phosphofructo-2-kinase/fructose-2
hsa:122481,3.43347e-07,0.0002859231300013081,1.965048006532164e-05,4.0438720166934105e-05,0.0,0.000241012,False,AK7; adenylate kinase
hsa:5551,4.8976767e-06,0.004078553334668652,0.00010665533186935674,0.00030189196012020614,0.0,0.0027307663,False,PRF1; perforin
hsa:6403,0.0,0.0,9.460674547923975e-06,2.441039074697032e-05,0.0,0.0002232533,False,SELP; selectin
hsa:4142,0.0,0.0,3.1280104558479533e-07,1.517278258464974e-06,0.0,1.340825e-05,False,MAS1; MAS1 proto-oncogene
hsa:54995,0.00035326486,0.29418225436853646,0.0008308868707181285,0.0011290237194520793,0.0,0.004303315,False,OXSM; 3-oxoacyl-ACP synthase
hsa:253314,3.412501e-08,2.841769309336018e-05,1.1262292733254973e-05,4.240595071360643e-05,0.0,0.0003078171,False,EIF4E1B; eukaryotic translation initiation factor 4E family member
hsa:284406,1.0421696e-09,8.678695140024851e-07,1.9242294957777773e-08,3.3718496541963315e-08,0.0,1.638379e-07,False,ZFP82; ZFP82 zinc finger
hsa:8807,0.0,0.0,1.5617567704350878e-05,3.5986487282294305e-05,0.0,0.00021653828,False,IL18RAP; interleukin 18 receptor accessory
hsa:7425,0.0,0.0,9.983241398099416e-07,2.6958024974954543e-06,0.0,1.616861e-05,False,VGF; VGF nerve growth factor
hsa:79290,4.4911058e-06,0.003739980333315942,0.00010965216493473686,0.0003106288953529415,0.0,0.0021814723,False,OR13A1; olfactory receptor family 13 subfamily A member
hsa:139735,3.4723416e-10,2.891601728588717e-07,1.764004973516374e-08,4.1787578316789304e-08,0.0,3.165229e-07,False,ZFP92; ZFP92 zinc finger
hsa:728358,0.0,0.0,1.351532663197661e-05,8.064846088784262e-05,0.0,0.0007320998,False,DEFA1B; defensin alpha
hsa:2290,0.0,0.0,3.7402573754385964e-09,1.3747098333647785e-08,0.0,1.2242187e-07,False,FOXG1; forkhead box
hsa:4710,7.944273e-07,0.0006615614529164029,1.3022308217719298e-05,2.972349743284122e-05,0.0,0.0001886125,False,NDUFB4; NADH:ubiquinone oxidoreductase subunit
hsa:390649,0.0,0.0,5.024342397660819e-10,4.174127662915976e-09,0.0,4.4858343e-08,False,OR4F15; olfactory receptor family 4 subfamily F member
hsa:57704,0.0,0.0,0.00017550225256140347,0.00028777341324064923,0.0,0.0013907651,False,GBA2; glucosylceramidase beta
hsa:5696,0.0,0.0,6.235605124349121e-06,1.8839819630074176e-05,0.0,0.00012298384,False,PSMB8; proteasome 20S subunit beta
hsa:440153,0.0,0.0,2.3049909587134507e-06,1.0503000965361352e-05,0.0,0.000113306836,False,OR11H12; olfactory receptor family 11 subfamily H member
hsa:8646,1.7874138e-08,1.4884736092161342e-05,9.817560926314617e-06,4.3229047882936096e-05,0.0,0.00035146374,False,CHRD;
hsa:4490,0.0,0.0,1.6310533333333332e-08,2.1328789954575453e-07,0.0,2.7891012e-06,False,MT1B; metallothionein
hsa:8654,0.0,0.0,2.665420441414035e-05,9.260351517297684e-05,0.0,0.00064008415,False,PDE5A; phosphodiesterase
hsa:547,0.0,0.0,3.295891626789474e-06,9.997522954347264e-06,0.0,4.8888858e-05,False,KIF1A; kinesin family member
hsa:144811,1.443285e-06,0.0012018994331796636,3.5846236123959065e-05,0.00011088117642698467,0.0,0.0007135052,False,LACC1; laccase domain containing
hsa:2717,0.00018898396,0.1573768967349125,0.00040502041887953194,0.0006198752711053876,0.0,0.0030484148,False,GLA; galactosidase
hsa:59344,0.0,0.0,7.887448944631581e-07,5.183904319945125e-06,0.0,6.4926084e-05,False,ALOXE3; arachidonate lipoxygenase
hsa:1544,0.0,0.0,1.4552883704678367e-05,7.664163719756312e-05,0.0,0.000814347,False,CYP1A2; cytochrome P450 family 1 subfamily A member
hsa:2766,2.0599238e-08,1.7154070385359086e-05,1.9883626916474273e-06,5.116083177982996e-06,0.0,3.2650743e-05,False,GMPR; guanosine monophosphate
hsa:9212,0.0,0.0,4.9294728342923995e-06,1.2111481073390637e-05,0.0,7.6548495e-05,False,AURKB; aurora kinase
hsa:282770,0.0,0.0,1.1610604678362573e-10,1.518283573991489e-09,0.0,1.9854134e-08,False,OR10AG1; olfactory receptor family 10 subfamily AG member
hsa:5133,0.0,0.0,2.6074378235350875e-06,8.20732805486893e-06,0.0,6.1130944e-05,False,PDCD1; programmed cell death
hsa:119678,0.0,0.0,4.1835207485380114e-08,3.8017190247821554e-07,0.0,4.000239e-06,False,OR52E2; olfactory receptor family 52 subfamily E member
hsa:79744,8.422044e-09,7.013479603691709e-06,5.515585450350879e-08,9.361753999392522e-08,0.0,4.5548413e-07,False,ZNF419; zinc finger protein
hsa:3598,1.7304261e-06,0.001441016950047493,4.1235024466128634e-05,0.00011756225607940829,0.0,0.00087569014,False,IL13RA2; interleukin 13 receptor subunit alpha
hsa:1073,2.6851924e-06,0.0022361011328589572,4.943437440466083e-05,0.00015434735479062124,0.0,0.0009873315,False,CFL2; cofilin
hsa:29956,0.0,0.0,4.518898423122807e-05,0.00011487742082581424,0.0,0.00069101114,False,CERS2; ceramide synthase
hsa:54766,0.0,0.0,3.9091881929649125e-09,1.7668413892209128e-08,0.0,1.4024934e-07,False,BTG4; BTG anti-proliferation factor
hsa:50838,1.5308953e-05,0.0127485714417278,5.10546006877193e-05,0.00010124602233988966,0.0,0.0007833063,False,TAS2R13; taste 2 receptor member
hsa:10220,3.3323806e-06,0.0027750488325444436,1.539551973549707e-05,2.6687064778623607e-05,0.0,0.00014236818,False,GDF11; growth differentiation factor
hsa:55705,0.0,0.0,4.2620447339567256e-07,1.2090183660253256e-06,0.0,6.081466e-06,False,IPO9; importin
hsa:219493,0.0,0.0,2.1870436666666665e-07,2.4639965209258304e-06,0.0,3.201272e-05,False,OR5AR1; olfactory receptor family 5 subfamily AR member
hsa:23262,0.0,0.0,2.2684634908865494e-06,6.204884152171353e-06,0.0,3.714507e-05,False,PPIP5K2; diphosphoinositol pentakisphosphate kinase
hsa:11277,2.5242157e-06,0.002102047356588067,0.00014245002589683916,0.0003330934239384867,0.0,0.0016665609,False,TREX1; three prime repair exonuclease
hsa:9759,0.0,0.0,3.5393448665847955e-05,0.00010764146843260151,0.0,0.00077519356,False,HDAC4; histone deacetylase
hsa:27345,0.0,0.0,7.28870855614035e-06,2.2345996081017812e-05,0.0,0.0001821756,False,KCNMB4; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:51393,2.481464e-06,0.0020664457643886974,0.00015100506835231581,0.0004154657470389882,0.0,0.0032992733,False,TRPV2; transient receptor potential cation channel subfamily V member
hsa:30844,1.634967e-08,1.3615231299206014e-05,6.189153670187134e-07,1.1325900721890598e-06,0.0,7.182178e-06,False,EHD4; EH domain containing
hsa:8932,0.0,0.0,1.7518043209356722e-07,3.7485663747613515e-07,0.0,2.2750505e-06,False,MBD2; methyl-CpG binding domain protein
hsa:5223,0.0,0.0,3.808555153918129e-05,7.728313539708926e-05,0.0,0.00045786356,False,PGAM1; phosphoglycerate mutase
hsa:1843,0.0,0.0,8.110049531122222e-05,0.00023445919950867516,0.0,0.0014945616,False,DUSP1; dual specificity phosphatase
hsa:27248,1.9521278e-07,0.00016256396320298927,1.0572085115365732e-06,2.0446204653721523e-06,0.0,1.2625867e-05,False,ERLEC1; endoplasmic reticulum lectin
hsa:27094,4.029894e-06,0.0033559049767538135,7.592664420918128e-05,0.000131033742389343,0.0,0.00075487624,False,KCNMB3; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:29088,0.0,0.0,5.615424002631577e-08,1.0347303172398606e-07,0.0,6.020134e-07,False,MRPL15; mitochondrial ribosomal protein
hsa:163255,3.224461e-09,2.6851784978087707e-06,5.296249000653801e-08,9.953351439582638e-08,0.0,5.578737e-07,False,ZNF540; zinc finger protein
hsa:85407,3.968372e-08,3.304672367166601e-05,3.359133485695907e-06,6.84813280512691e-06,0.0,3.1600266e-05,False,NKD1; NKD inhibitor of WNT signaling pathway
hsa:6165,0.0,0.0,1.1050695262923977e-06,3.0678190117524555e-06,0.0,1.4769199e-05,False,RPL35A; ribosomal protein
hsa:26147,3.8164157e-07,0.00031781303530542955,2.5302850553152045e-05,7.23857175904591e-05,0.0,0.0004251954,False,PHF19; PHD finger protein
hsa:219482,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5M3; olfactory receptor family 5 subfamily M member
hsa:8809,0.0,0.0,3.3648424705438596e-06,1.0660154931609478e-05,0.0,6.229954e-05,False,IL18R1; interleukin 18 receptor
hsa:147923,6.902218e-09,5.747840448617198e-06,9.678931489976609e-08,2.1538236722662747e-07,0.0,1.084027e-06,False,ZNF420; zinc finger protein
hsa:79334,0.0,0.0,5.532370894736842e-08,5.44224161800504e-07,0.0,6.770886e-06,False,OR11H2; olfactory receptor family 11 subfamily H member
hsa:79623,8.320274e-08,6.928730364757822e-05,5.4164119727076017e-05,0.00011976995608312703,0.0,0.00075549405,False,GALNT14; polypeptide N-acetylgalactosaminyltransferase
hsa:2189,0.0,0.0,0.00015934579250417546,0.00044111966594739306,0.0,0.0028565775,False,FANCG; FA complementation group
hsa:1595,3.4439743e-06,0.0028679787838544212,3.6587613142052634e-05,0.00011001039506865398,0.0,0.0010020271,False,CYP51A1; cytochrome P450 family 51 subfamily A member
hsa:23039,7.284538e-08,6.0662184483145885e-05,3.5305979283216376e-07,6.234064078848966e-07,0.0,2.736025e-06,False,XPO7; exportin
hsa:124583,8.0314595e-07,0.0006688219319576816,0.00010806141702613444,0.0002859697254921148,0.0,0.001586682,False,CANT1; calcium activated nucleotidase
hsa:6541,0.0,0.0,3.0022144322807004e-07,6.020932674114071e-07,0.0,4.0852747e-06,False,SLC7A1; solute carrier family 7 member
hsa:401993,0.0,0.0,2.729085619883041e-07,1.319635674818561e-06,0.0,1.118192e-05,False,OR2T5; olfactory receptor family 2 subfamily T member
hsa:4049,0.00013493728,0.11236937981535564,0.0002892740718105261,0.00045393514838014973,0.0,0.0032386659,False,LTA; lymphotoxin
hsa:79748,0.0,0.0,1.0168403098508774e-08,2.6015847360659764e-08,0.0,2.0113717e-07,False,LMAN1L; lectin
hsa:9831,0.0,0.0,2.1581549789473683e-08,3.791057339019255e-08,0.0,1.5865578e-07,False,ZNF623; zinc finger protein
hsa:4632,0.0,0.0,9.841832937409358e-09,8.757766538115873e-08,0.0,9.712203e-07,False,MYL1; myosin light chain
hsa:54468,7.8375235e-09,6.526718598324166e-06,1.3337932107590645e-06,3.691101943599198e-06,0.0,2.0805746e-05,False,MIOS; meiosis regulator for oocyte
hsa:6095,2.3003925e-06,0.001915657989822349,0.0005278215203450291,0.0015094418950417428,0.0,0.010240337,False,RORA; RAR related orphan receptor
hsa:10772,0.0,0.0,4.854167283508768e-07,1.3367320279056134e-06,0.0,7.199248e-06,False,SRSF10; serine and arginine rich splicing factor
hsa:54457,0.0,0.0,3.8902805787368425e-08,1.3630818409689807e-07,0.0,1.3104208e-06,False,TAF7L; TATA-box binding protein associated factor 7
hsa:1176,2.3784635e-06,0.0019806718232979062,4.510880694378363e-06,9.56613960035896e-06,0.0,0.000103437,False,AP3S1; adaptor related protein complex 3 subunit sigma
hsa:525,0.0,0.0,1.4029691198888888e-05,5.925578391188423e-05,0.0,0.00069193164,False,ATP6V1B1; ATPase H+ transporting V1 subunit
hsa:51729,5.2284104e-08,4.3539727054536406e-05,2.813091938807019e-07,6.097543380888215e-07,0.0,3.7989266e-06,False,WBP11; WW domain binding protein
hsa:9248,0.0,0.0,1.0057004666415204e-07,5.524016503034847e-07,0.0,4.8084767e-06,False,GPR50; G protein-coupled receptor
hsa:169200,2.9410018e-07,0.00024491270929860495,2.7538869737976612e-05,6.434305159076488e-05,0.0,0.0003816539,False,TMEM64; transmembrane protein
hsa:1828,0.0,0.0,2.3513537842105266e-07,1.1709762879500139e-06,0.0,1.314822e-05,False,DSG1; desmoglein
hsa:59272,1.8768485e-06,0.0015629505941751642,1.147974454730994e-05,2.4323045870184825e-05,0.0,0.00019981065,False,ACE2; angiotensin converting enzyme
hsa:26539,0.0,0.0,3.473923838011696e-07,4.310037266997747e-06,0.0,5.63163e-05,False,OR10H1; olfactory receptor family 10 subfamily H member
hsa:23049,2.2465048e-08,1.8707828639218127e-05,5.752963639210523e-07,1.2848546220489129e-06,0.0,6.920306e-06,False,SMG1; SMG1 nonsense mediated mRNA decay associated PI3K related
hsa:1901,0.0,0.0,1.422221327134503e-06,1.2295518221320805e-05,0.0,0.00014902234,False,S1PR1; sphingosine-1-phosphate receptor
hsa:29904,8.3920935e-07,0.0006988538244934811,1.3655569800760234e-06,1.6253432033565406e-06,0.0,7.3311007e-06,False,EEF2K; eukaryotic elongation factor 2
hsa:4609,0.0,0.0,1.721841812865497e-06,2.251600337713067e-05,0.0,0.00029443495,False,MYC; MYC proto-oncogene
hsa:9133,8.8878454e-07,0.0007401376961894899,7.824218316315787e-05,0.000147745566294091,0.0,0.00075925555,False,CCNB2; cyclin
hsa:6788,0.0,0.0,9.827746061988305e-06,3.7529969795524654e-05,0.0,0.00037879116,False,STK3; serine/threonine kinase
hsa:24,7.574615e-07,0.0006307780843737847,6.036700108421056e-05,0.00020569105520913453,0.0,0.001770243,False,ABCA4; ATP binding cassette subfamily A member
hsa:2959,0.0,0.0,1.5968867357894736e-07,4.6926723159644575e-07,0.0,4.387265e-06,False,GTF2B; general transcription factor
hsa:3107,0.0,0.0,0.00012952072359766084,0.00027688881511760057,0.0,0.0023862575,False,HLA-C; major histocompatibility complex
hsa:100529097,0.0,0.0,4.9217375693251456e-08,9.822514715287781e-08,0.0,5.669973e-07,False,RPL36A-HNRNPH2; RPL36A-HNRNPH2
hsa:6041,8.3726945e-07,0.0006972383675945144,1.3679072472807018e-05,3.206943046692998e-05,0.0,0.00019036145,False,RNASEL; ribonuclease
hsa:4891,8.33793e-05,0.06943433445848679,0.00020436917712339186,0.0002628891354036607,0.0,0.001111569,False,SLC11A2; solute carrier family 11 member
hsa:9351,2.4270153e-06,0.0020211034642419004,0.000355229818212807,0.001063346210992486,0.0,0.0093034245,False,NHERF2; NHERF family PDZ scaffold protein
hsa:10885,0.0,0.0,2.1726917565087725e-07,6.186275918647835e-07,0.0,4.9188748e-06,False,WDR3; WD repeat domain
hsa:5281,0.0,0.0,2.459616850520468e-05,7.296133292886108e-05,0.0,0.00054524123,False,PIGF; phosphatidylinositol glycan anchor biosynthesis class
hsa:50613,0.0,0.0,4.987241887134503e-10,3.535470237599733e-09,0.0,3.9737447e-08,False,UBQLN3; ubiquilin
hsa:342892,2.6038181e-08,2.1683364674980675e-05,6.169839966959065e-08,8.92666574572344e-08,0.0,4.1445378e-07,False,ZNF850; zinc finger protein
hsa:54464,0.0,0.0,4.006732328116961e-06,1.5591054458366406e-05,0.0,0.00014632016,False,XRN1; 5'-3' exoribonuclease
hsa:135,0.0,0.0,0.00011982125280333337,0.00027856578674560073,0.0,0.0019277893,False,ADORA2A; adenosine A2a
hsa:10671,0.0,0.0,0.00011056309288672523,0.00027640304866870735,0.0,0.0015830522,False,DCTN6; dynactin subunit
hsa:50,2.3999482e-06,0.001998563264525408,1.629730376362573e-05,2.6397116365181283e-05,0.0,0.0001560473,False,ACO2; aconitase
hsa:1749,0.0,0.0,3.1200187667058485e-06,1.20215013139649e-05,0.0,9.163103e-05,False,DLX5; distal-less homeobox
hsa:5880,0.0,0.0,0.00018654526633918124,0.0004200831452405743,0.0,0.0036051976,False,RAC2; Rac family small GTPase
hsa:84274,9.653949e-06,0.008039351778093295,0.00039032316051350893,0.0006569987511819055,0.0,0.004362137,False,COQ5; coenzyme Q5
hsa:3777,6.2970457e-06,0.005243881601718605,8.158100576253802e-05,0.00015071091770542578,0.0,0.0008658628,False,KCNK3; potassium two pore domain channel subfamily K member
hsa:463,4.8075584e-08,4.003507079986372e-05,3.8623492935122793e-05,8.62359327452108e-05,0.0,0.0004213422,False,ZFHX3; zinc finger homeobox
hsa:5569,0.0,0.0,5.476809413009358e-05,0.0001730677787858122,0.0,0.0011307476,False,PKIA; cAMP-dependent protein kinase inhibitor
hsa:713,3.2683325e-05,0.027217126064447927,0.00046494194078362577,0.0010403985958979875,0.0,0.0066822576,False,C1QB; complement C1q B
hsa:2046,6.296357e-08,5.2433080849567524e-05,5.890611355402332e-06,2.6151795173189587e-05,0.0,0.00023638914,False,EPHA8; EPH receptor
hsa:79153,0.0,0.0,1.0888147504678361e-05,3.326896227249309e-05,0.0,0.00024791114,False,GDPD3; glycerophosphodiester phosphodiesterase domain containing
hsa:23236,0.0,0.0,6.763695052046781e-05,0.0001517115780256651,0.0,0.00088523235,False,PLCB1; phospholipase C beta
hsa:1946,1.1918896e-06,0.0009925492433252863,4.655507286485381e-06,1.0227851556633556e-05,0.0,8.465559e-05,False,EFNA5; ephrin
hsa:5890,0.0,0.0,4.554641242467835e-07,1.3857846853678638e-06,0.0,9.134413e-06,False,RAD51B; RAD51 paralog
hsa:93589,0.0,0.0,1.5560802105263157e-05,5.6504032228362746e-05,0.0,0.00046599694,False,CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:189,6.5967606e-07,0.0005493469984072403,3.904239681079532e-05,0.00010223003220204052,0.0,0.00069746916,False,AGXT; alanine--glyoxylate
hsa:129607,0.0,0.0,8.001510113532163e-06,1.9616191445885827e-05,0.0,9.706073e-05,False,CMPK2; cytidine/uridine monophosphate kinase
hsa:1295,0.0,0.0,1.0502051756933333e-05,3.719086210357468e-05,0.0,0.00029368815,False,COL8A1; collagen type VIII alpha 1
hsa:2925,0.0,0.0,4.899062195906434e-08,1.461712909091702e-07,0.0,8.53178e-07,False,GRPR; gastrin releasing peptide
hsa:153,0.0,0.0,4.798447485380118e-06,1.706322440626216e-05,0.0,0.00013188664,False,ADRB1; adrenoceptor beta
hsa:5976,0.0,0.0,5.839427800409357e-08,1.614497062953528e-07,0.0,8.719303e-07,False,UPF1; UPF1 RNA helicase and
hsa:55512,0.0,0.0,4.560870331755556e-05,0.00012619676433258097,0.0,0.00077315024,False,SMPD3; sphingomyelin phosphodiesterase
hsa:285268,0.0,0.0,3.571610257251462e-08,6.175798307594036e-08,0.0,3.535013e-07,False,ZNF621; zinc finger protein
hsa:121364,0.0,0.0,3.66217167251462e-08,4.6791471395092885e-07,0.0,6.1179244e-06,False,OR10A7; olfactory receptor family 10 subfamily A member
hsa:441272,7.0058024e-07,0.0005834100633990326,1.0865046996374272e-05,2.9454205167695742e-05,0.0,0.00033706424,False,SPDYE3; speedy/RINGO cell cycle regulator family member
hsa:4209,3.262541e-06,0.0027168897193731055,4.662628064912281e-06,6.081024399830315e-06,0.0,4.017806e-05,False,MEF2D; myocyte enhancer factor
hsa:284383,0.0,0.0,9.721063274853801e-08,1.0837410813327513e-06,0.0,1.4105432e-05,False,OR2Z1; olfactory receptor family 2 subfamily Z member
hsa:133686,5.7566966e-05,0.047939044475119576,0.0001475217178292222,0.0002607428561262695,0.0,0.0019243044,False,NADK2; NAD kinase 2
hsa:3064,2.083475e-08,1.735019363150036e-05,4.489963745380118e-08,6.332111607225367e-08,0.0,2.7704206e-07,False,HTT;
hsa:3081,0.0,0.0,1.4477514689107601e-05,3.592004240037851e-05,0.0,0.00018175167,False,HGD; homogentisate
hsa:2028,0.0,0.0,5.554026077192982e-06,1.9021618751247575e-05,0.0,0.00013374409,False,ENPEP; glutamyl
hsa:587,0.00014427937,0.12014903017943021,0.0002053499027467604,0.00020888218400118074,0.0,0.00096273125,False,BCAT2; branched chain amino acid transaminase
hsa:255743,0.0,0.0,1.4703791503099415e-06,4.008069238253878e-06,0.0,2.8199633e-05,False,NPNT;
hsa:11149,0.0,0.0,3.578335173347952e-05,0.00013620983930891093,0.0,0.0009893889,False,BVES; blood vessel epicardial
hsa:1118,0.0,0.0,3.968598216712281e-07,1.1096490396616581e-06,0.0,6.9643615e-06,False,CHIT1; chitinase
hsa:2695,0.0,0.0,5.580904909157893e-06,4.471571544993367e-05,0.0,0.00056921557,False,GIP; gastric inhibitory
hsa:5153,0.0,0.0,4.702384884210526e-05,0.0001395922643220942,0.0,0.0010264697,False,PDE1B; phosphodiesterase
hsa:54556,5.3022564e-08,4.415468158910571e-05,2.2921958402004097e-06,7.79524519609368e-06,0.0,4.682196e-05,False,ING3; inhibitor of growth family member
hsa:23439,0.0,0.0,4.4032371656549694e-05,0.00038989863316104764,0.0,0.0043518753,False,ATP1B4; ATPase Na+/K+ transporting family member beta
hsa:2530,3.9444117e-06,0.0032847193634363506,5.052652972690056e-05,0.00014805418178376545,0.0,0.0010880555,False,FUT8; fucosyltransferase
hsa:10455,3.60985e-06,0.003006112215441585,0.00011326655593178946,0.00033395704587039647,0.0,0.0019401902,False,ECI2; enoyl-CoA delta isomerase
hsa:51330,0.0,0.0,3.385685531093567e-07,4.421031104985759e-06,0.0,5.7812915e-05,False,TNFRSF12A; TNF receptor superfamily member
hsa:150,0.0,0.0,1.6239879697660818e-07,7.434058690658845e-07,0.0,7.5304406e-06,False,ADRA2A; adrenoceptor alpha
hsa:57634,0.0,0.0,8.628971828233917e-06,2.5247588375502942e-05,0.0,0.0001296207,False,EP400; E1A binding protein
hsa:255738,0.0,0.0,3.819249870622807e-07,1.698849466640734e-06,0.0,1.8787614e-05,False,PCSK9; proprotein convertase subtilisin/kexin type
hsa:7786,0.0,0.0,9.890646428461985e-08,2.481253724629334e-07,0.0,1.474549e-06,False,MAP3K12; mitogen-activated protein kinase kinase kinase
hsa:771,4.7838803e-06,0.003983789079058785,4.54066399872222e-05,8.617820001264622e-05,0.0,0.00056579924,False,CA12; carbonic anhydrase
hsa:26037,5.2523626e-07,0.00043739189638872873,1.0106581099941523e-06,1.2015876190934726e-06,0.0,5.783362e-06,False,SIPA1L1; signal induced proliferation associated 1 like
hsa:117283,8.1179135e-09,6.760214118660928e-06,4.901407286976609e-07,2.0452624578034868e-06,0.0,2.0096844e-05,False,IP6K3; inositol hexakisphosphate kinase
hsa:1487,0.0,0.0,1.940282983152047e-05,4.277351833579993e-05,0.0,0.00022428157,False,CTBP1; C-terminal binding protein
hsa:735,0.0,0.0,6.622083677192982e-07,2.9532006759898206e-06,0.0,2.308131e-05,False,C9; complement
hsa:10577,0.0,0.0,4.5443204973391814e-05,0.00012169809506025604,0.0,0.0008552753,False,NPC2; NPC intracellular cholesterol transporter
hsa:23542,0.0,0.0,1.4240305860818716e-07,2.3798527588897038e-07,0.0,8.822199e-07,False,MAPK8IP2; mitogen-activated protein kinase 8 interacting protein
hsa:200315,3.03263e-07,0.000252543072092043,1.5951265805263158e-06,3.850404233592487e-06,0.0,2.798796e-05,False,APOBEC3A; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:4654,0.0,0.0,7.815189496081871e-10,4.20110931351415e-09,0.0,4.862994e-08,False,MYOD1; myogenic differentiation
hsa:27091,1.8216764e-05,0.01517005880748965,6.121984803520468e-05,0.00012625823641234857,0.0,0.0008322665,False,CACNG5; calcium voltage-gated channel auxiliary subunit gamma
hsa:152138,0.0,0.0,2.914349497076024e-10,1.7889642243838029e-09,0.0,1.8702902e-08,False,PYDC2; pyrin domain containing
hsa:391190,0.0,0.0,2.4774630914385967e-06,1.078247640235802e-05,0.0,8.401948e-05,False,OR2L8; olfactory receptor family 2 subfamily L member
hsa:5649,2.7569542e-06,0.002295860963207054,4.6612232483619894e-05,9.619880841198154e-05,0.0,0.0005447615,False,RELN;
hsa:25836,1.013294e-07,8.438232810874873e-05,9.552669895149704e-07,1.3628265506354524e-06,0.0,5.565604e-06,False,NIPBL; NIPBL cohesin loading
hsa:254786,0.0,0.0,2.2402259257309944e-07,2.551174809509716e-06,0.0,3.2994794e-05,False,OR6C3; olfactory receptor family 6 subfamily C member
hsa:931,3.6232314e-07,0.0003017255611981527,3.398213249069473e-05,0.0001253302666179144,0.0,0.0013471076,False,MS4A1; membrane spanning 4-domains
hsa:5887,3.040817e-07,0.00025322484670062284,3.634373938684211e-06,6.507640345833163e-06,0.0,3.280243e-05,False,RAD23B; RAD23 homolog B
hsa:6529,0.0,0.0,1.0183197734795321e-06,2.5478076996345484e-06,0.0,1.2141834e-05,False,SLC6A1; solute carrier family 6 member
hsa:7568,5.8180905e-09,4.845030381482511e-06,3.6746319585497095e-08,6.822647896749562e-08,0.0,6.2872726e-07,False,ZNF20; zinc finger protein
hsa:729020,9.2618485e-08,7.712829040935032e-05,8.331358979767253e-06,2.4100865292657092e-05,0.0,0.0002524452,False,RPEL1; ribulose-5-phosphate-3-epimerase like
hsa:4159,0.0,0.0,3.79799778625731e-09,2.3951293166940974e-08,0.0,2.7582476e-07,False,MC3R; melanocortin 3
hsa:113189,0.0,0.0,0.0003794497802574854,0.0009869584210870893,0.0,0.0056398157,False,CHST14; carbohydrate sulfotransferase
hsa:7040,0.0,0.0,3.871711118713451e-05,0.0001579154736594323,0.0,0.001533242,False,TGFB1; transforming growth factor beta
hsa:6129,3.9928363e-08,3.325045078241085e-05,3.1768465754385956e-07,5.627298847796168e-07,0.0,4.130195e-06,False,RPL7; ribosomal protein
hsa:407011,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR23B; microRNA
hsa:4174,1.8650736e-07,0.00015531450147949675,1.7637871518315788e-05,4.021219641629992e-05,0.0,0.00024996907,False,MCM5; minichromosome maintenance complex component
hsa:5571,0.0,0.0,0.0005406690807678362,0.0015567795790314039,0.0,0.008598241,False,PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma
hsa:25996,4.8094844e-08,4.005110961623265e-05,1.4106532870558482e-06,2.6017033100469417e-06,0.0,1.20876875e-05,False,REXO2; RNA exonuclease
hsa:28958,3.193469e-07,0.00026593698271490574,1.7645019970035094e-06,3.284181920377228e-06,0.0,1.760706e-05,False,COA3; cytochrome c oxidase assembly factor
hsa:2677,5.381081e-06,0.004481109554796078,7.42388656108187e-05,0.00019778363826910314,0.0,0.0014656304,False,GGCX; gamma-glutamyl
hsa:440738,0.0,0.0,4.5434807276023386e-07,1.6184340962053357e-06,0.0,1.339845e-05,False,MAP1LC3C; microtubule associated protein 1 light chain 3
hsa:7096,0.0,0.0,2.8685628664853797e-07,7.731898840257246e-07,0.0,6.5934623e-06,False,TLR1; toll like receptor
hsa:2057,0.0,0.0,8.432989077251465e-05,0.0001258623296167031,0.0,0.0006755693,False,EPOR; erythropoietin
hsa:6015,0.0,0.0,6.508930750026787e-05,0.00019016588867815234,0.0,0.0011151378,False,RING1; ring finger protein
hsa:8945,6.326834e-05,0.052686878879928935,0.00028446127941871344,0.00047203500849092133,0.0,0.0030959921,False,BTRC; beta-transducin repeat containing E3 ubiquitin protein
hsa:1949,3.5360353e-07,0.0002944642827143136,1.4902741938093567e-05,5.05407346026175e-05,0.0,0.00041865802,False,EFNB3; ephrin
hsa:341152,0.0,0.0,1.1372117350877194e-07,1.2150695951254218e-06,0.0,1.5759395e-05,False,OR2AT4; olfactory receptor family 2 subfamily AT member
hsa:84458,2.1865173e-08,1.8208281133023127e-05,7.78394668088111e-05,0.0002688660239956133,0.0,0.0017253571,False,LCOR; ligand dependent nuclear receptor
hsa:9568,2.4366931e-05,0.020291626780038576,0.00018892107641929823,0.0003836913934428198,0.0,0.0022622906,False,GABBR2; gamma-aminobutyric acid type B receptor subunit
hsa:10333,0.0,0.0,4.60186858991228e-06,2.1163888814973122e-05,0.0,0.0002467203,False,TLR6; toll like receptor
hsa:2326,0.0,0.0,7.300825683040936e-06,2.9265497493749015e-05,0.0,0.00023094524,False,FMO1; flavin containing dimethylaniline monoxygenase
hsa:627,0.0,0.0,1.2352835463777778e-05,3.8662922638046886e-05,0.0,0.00030365365,False,BDNF; brain derived neurotrophic
hsa:122740,0.0,0.0,4.968585029239766e-07,5.22038469916477e-06,0.0,6.556588e-05,False,OR4K14; olfactory receptor family 4 subfamily K member
hsa:2570,0.0,0.0,5.006075740584796e-05,0.00012368932610199652,0.0,0.0007465224,False,GABRR2; gamma-aminobutyric acid type A receptor subunit
hsa:113675,0.0,0.0,1.811362530432748e-05,5.655194041908563e-05,0.0,0.00041335818,False,SDSL; serine dehydratase
hsa:51604,0.0,0.0,2.800051423859649e-05,4.676876302045698e-05,0.0,0.00022060736,False,PIGT; phosphatidylinositol glycan anchor biosynthesis class
hsa:22955,0.0,0.0,8.879951764885672e-05,0.00031511474524026145,0.0,0.0019623332,False,SCMH1; Scm polycomb group protein homolog
hsa:2152,0.0,0.0,1.6688198871929821e-06,8.789748015387685e-06,0.0,0.000102359045,False,F3; coagulation factor III
hsa:11021,0.0,0.0,5.230168485011695e-07,8.869607146422163e-07,0.0,3.6223216e-06,False,RAB35; RAB35
hsa:3993,0.0,0.0,1.061762555853801e-06,2.279839971095374e-06,0.0,1.0625435e-05,False,LLGL2; LLGL scribble cell polarity complex component
hsa:406970,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR194-2; microRNA
hsa:186,0.0,0.0,3.4706646957485373e-07,2.432179880821623e-06,0.0,2.5937208e-05,False,AGTR2; angiotensin II receptor type
hsa:6387,0.0,0.0,0.00018123239615087713,0.0003787002464101338,0.0,0.0021259626,False,CXCL12; C-X-C motif chemokine ligand
hsa:10312,0.0,0.0,1.7639843539181287e-05,4.312355405265752e-05,0.0,0.0002482753,False,TCIRG1; T cell immune regulator 1
hsa:54539,0.0,0.0,5.886543004619885e-06,1.1588177627798778e-05,0.0,6.01437e-05,False,NDUFB11; NADH:ubiquinone oxidoreductase subunit
hsa:5593,0.00033223265,0.27666762539538453,0.0005881703971865499,0.0006574854129828789,0.0,0.0030385156,False,PRKG2; protein kinase cGMP-dependent
hsa:7571,0.0,0.0,8.253325210058481e-08,1.574463541867649e-07,0.0,8.183919e-07,False,ZNF23; zinc finger protein
hsa:2582,0.0,0.0,0.0001734092363203509,0.0004330587876086984,0.0,0.0026943851,False,GALE;
hsa:2914,0.0005121122,0.426462800420146,0.0009586845849198827,0.0012989734028163741,0.0,0.007667205,False,GRM4; glutamate metabotropic receptor
hsa:56924,1.4219424e-06,0.001184126326106161,1.6708082959306434e-05,2.8151087730097023e-05,0.0,0.00013819068,False,PAK6; p21 (RAC1) activated kinase
hsa:6729,0.0,0.0,2.3035010578947365e-05,7.675780523374519e-05,0.0,0.00044610188,False,SRP54; signal recognition particle
hsa:8723,2.168735e-08,1.8060198555495955e-05,3.589312209583626e-07,6.723321073120674e-07,0.0,3.6127255e-06,False,SNX4; sorting nexin
hsa:84674,4.778491e-09,3.979301125109818e-06,7.107865235614034e-08,1.1500493627277935e-07,0.0,5.7147537e-07,False,CARD6; caspase recruitment domain family member
hsa:10747,0.0,0.0,1.8449043635035078e-05,3.637501927084226e-05,0.0,0.00017573236,False,MASP2; MBL associated serine protease
hsa:25814,0.0,0.0,2.2858349792046785e-07,5.854264829638467e-07,0.0,2.6896043e-06,False,ATXN10; ataxin
hsa:286410,0.0,0.0,0.0001529286452459883,0.00038116106698551927,0.0,0.0025254535,False,ATP11C; ATPase phospholipid transporting
hsa:406953,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR18A; microRNA
hsa:6196,0.0,0.0,2.043791406491229e-05,7.066067285344495e-05,0.0,0.0006534416,False,RPS6KA2; ribosomal protein S6 kinase
hsa:138881,0.0,0.0,1.853506870409357e-06,4.034667989674472e-06,0.0,3.053853e-05,False,OR1L8; olfactory receptor family 1 subfamily L member
hsa:4619,0.0,0.0,4.560544510421052e-09,2.5523335156074804e-08,0.0,2.5114105e-07,False,MYH1; myosin heavy chain
hsa:55615,5.4491295e-08,4.537777124665318e-05,1.0953988424660817e-06,2.1986086815596703e-06,0.0,1.0643207e-05,False,PRR5; proline rich
hsa:3753,0.0,0.0,3.328971763884211e-08,1.2497757101130273e-07,0.0,1.2271595e-06,False,KCNE1; potassium voltage-gated channel subfamily E regulatory subunit
hsa:4627,3.09384e-06,0.0025764035116754977,3.729871686502924e-05,7.804886036594839e-05,0.0,0.00048413564,False,MYH9; myosin heavy chain
hsa:1950,0.0,0.0,1.1625204678362573e-06,1.3615306106555587e-05,0.0,0.00017681056,False,EGF; epidermal growth
hsa:22888,1.7779053e-08,1.4805553804807227e-05,4.020842612261404e-07,8.507381750365691e-07,0.0,4.165464e-06,False,UBOX5; U-box domain containing
hsa:27101,0.0,0.0,2.4531368912280716e-06,5.59831191067877e-06,0.0,3.0296698e-05,False,CACYBP; calcyclin binding
hsa:114769,0.0,0.0,5.511460556666666e-07,1.2185680678577167e-06,0.0,5.113843e-06,False,CARD16; caspase recruitment domain family member
hsa:10468,0.0,0.0,5.020344197050293e-07,1.6538460965610652e-06,0.0,1.3862717e-05,False,FST;
hsa:57697,1.0451718e-06,0.0008703696040597447,4.548026190199415e-05,0.00013521969090569228,0.0,0.0009911251,False,FANCM; FA complementation group
hsa:695,0.0,0.0,5.168905591169592e-05,0.00011105120312357653,0.0,0.0006081301,False,BTK; Bruton tyrosine
hsa:128866,6.9919037e-07,0.0005822526454495676,0.00024401092911368423,0.0005480999835131687,0.0,0.0033105144,False,CHMP4B; charged multivesicular body protein
hsa:965,0.0,0.0,7.235720630631582e-07,2.286799871883003e-06,0.0,1.4935467e-05,False,CD58; CD58
hsa:26253,0.0,0.0,1.5635842720719297e-06,5.220286146239568e-06,0.0,3.7184658e-05,False,CLEC4E; C-type lectin domain family 4 member
hsa:4060,1.8949834e-07,0.0001578052480518312,7.744577669680696e-07,1.3603473425039276e-06,0.0,7.444224e-06,False,LUM;
hsa:56000,0.0,0.0,2.035506039076023e-07,9.80951499046705e-07,0.0,1.2030146e-05,False,NXF3; nuclear RNA export factor
hsa:8574,7.432951e-05,0.06189809769901449,0.00023988057619000005,0.00046137566272491957,0.0,0.0021201489,False,AKR7A2; aldo-keto reductase family 7 member
hsa:8503,0.00058311666,0.4855919538633178,0.0011602358140409361,0.0012679207691653925,0.0,0.0059583536,True,PIK3R3; phosphoinositide-3-kinase regulatory subunit
hsa:23279,1.9847846e-07,0.0001652834669329845,2.760297480730994e-07,3.12132088290737e-07,0.0,1.3688427e-06,False,NUP160; nucleoporin
hsa:2932,0.00032547602,0.2710410237420695,0.0004905982039959065,0.0006059589232048722,0.0,0.003925075,False,GSK3B; glycogen synthase kinase 3
hsa:83988,1.0821786e-05,0.009011871154617155,1.8082266652046788e-05,2.3614085848171065e-05,0.0,0.00010640641,False,NCALD; neurocalcin
hsa:239,0.0,0.0,7.33378035116959e-05,0.00023855811449011172,0.0,0.0024126202,False,ALOX12; arachidonate 12-lipoxygenase
hsa:7321,0.0,0.0,6.6499991202923975e-06,2.1479947465570442e-05,0.0,0.00013379031,False,UBE2D1; ubiquitin conjugating enzyme E2
hsa:219960,0.0,0.0,2.6798452832163743e-06,1.5750419460230086e-05,0.0,0.00013221403,False,OR10Q1; olfactory receptor family 10 subfamily Q member
hsa:8795,0.0,0.0,9.415785137023393e-05,0.00017611805492773454,0.0,0.0008724627,False,TNFRSF10B; TNF receptor superfamily member
hsa:5141,0.0,0.0,2.0228477704678364e-06,5.6103926564184e-06,0.0,6.0179944e-05,False,PDE4A; phosphodiesterase
hsa:9466,3.665684e-07,0.0003052608127858158,2.027480367926315e-05,4.042569857564187e-05,0.0,0.00019968912,False,IL27RA; interleukin 27 receptor subunit
hsa:29954,0.0,0.0,0.0002695402054979532,0.0005592106491632127,0.0,0.00318724,False,POMT2; protein O-mannosyltransferase
hsa:2898,1.235732e-06,0.0010290591188586952,6.583913542292398e-05,0.00019702993217260046,0.0,0.002134761,False,GRIK2; glutamate ionotropic receptor kainate type subunit
hsa:25902,1.0572032e-06,0.0008803887844990605,1.8242127116198832e-05,5.285267200464344e-05,0.0,0.00035531126,False,MTHFD1L; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1
hsa:9410,0.0,0.0,1.7965535019298243e-07,3.8218308829294844e-07,0.0,2.1584121e-06,False,SNRNP40; small nuclear ribonucleoprotein U5 subunit
hsa:22894,0.0,0.0,4.0165308591812857e-07,9.268590541090742e-07,0.0,7.0963606e-06,False,DIS3; DIS3 homolog
hsa:143,0.0,0.0,1.8296065443957307e-05,6.143141928706067e-05,0.0,0.00044145115,False,PARP4; poly(ADP-ribose) polymerase family member
hsa:4172,0.0,0.0,2.4742770735146208e-05,7.081366418314722e-05,0.0,0.0004367486,False,MCM3; minichromosome maintenance complex component
hsa:55818,0.0,0.0,4.849283756725146e-07,1.0422082690149599e-06,0.0,4.6544133e-06,False,KDM3A; lysine demethylase
hsa:9547,0.0,0.0,9.109915092421052e-06,4.729975429392975e-05,0.0,0.00051701086,False,CXCL14; C-X-C motif chemokine ligand
hsa:7922,0.0,0.0,1.2817879905263157e-08,2.650523438850297e-08,0.0,1.3015674e-07,False,SLC39A7; solute carrier family 39 member
hsa:8689,8.4798097e-07,0.0007061584144435377,7.177919779888303e-06,1.6522083675909008e-05,0.0,0.00013168681,False,KRT36; keratin
hsa:83440,7.917926e-07,0.0006593673994643138,3.204063419108422e-05,9.035760348935836e-05,0.0,0.00045593185,False,ADPGK; ADP dependent
hsa:442590,0.0,0.0,9.333065008573103e-06,2.7540877469822823e-05,0.0,0.00015019262,False,SPDYE5; speedy/RINGO cell cycle regulator family member
hsa:219870,-0.0,0.0,4.05094661754386e-08,4.888678991884086e-07,0.0,6.3742636e-06,False,OR10G9; olfactory receptor family 10 subfamily G member
hsa:23048,8.1887514e-08,6.819204568819863e-05,3.719371330666667e-06,1.2012388021104083e-05,0.0,7.055905e-05,False,FNBP1; formin binding protein
hsa:5232,0.0,0.0,3.291733350877193e-09,3.1659520443661425e-08,0.0,3.8056797e-07,False,PGK2; phosphoglycerate kinase
hsa:3985,0.0,0.0,1.241804020497076e-05,3.626235886567027e-05,0.0,0.00018347558,False,LIMK2; LIM domain kinase
hsa:1994,2.2393142e-06,0.0018647948725935431,1.0935242549356726e-05,3.192457174586555e-05,0.0,0.0003268246,False,ELAVL1; ELAV like RNA binding protein
hsa:2247,0.0,0.0,7.132546870760234e-07,4.1189006249197204e-06,0.0,5.0739753e-05,False,FGF2; fibroblast growth factor
hsa:823,0.0,0.0,2.4681996541929826e-06,5.671984646003367e-06,0.0,4.4426313e-05,False,CAPN1; calpain
hsa:1525,0.0004852282,0.40407507771700557,0.001072338051680116,0.0015528384660833,0.0,0.009965941,False,CXADR; CXADR Ig-like cell adhesion
hsa:5142,0.0,0.0,8.743766026959066e-06,3.127559487887478e-05,0.0,0.0003402376,False,PDE4B; phosphodiesterase
hsa:10061,4.437186e-07,0.00036950784760547906,9.84728014356725e-07,1.4401165042237892e-06,0.0,8.593406e-06,False,ABCF2; ATP binding cassette subfamily F member
hsa:114798,2.8328355e-07,0.0002359051318167395,5.319131937487483e-06,1.1338480999527304e-05,0.0,7.5264674e-05,False,SLITRK1; SLIT and NTRK like family member
hsa:574457,0.0,0.0,1.0300754152046784e-09,8.004121279427154e-09,0.0,7.751372e-08,False,MIR181D; microRNA
hsa:54617,0.0,0.0,1.467234588421053e-07,3.417383632681334e-07,0.0,2.3058149e-06,False,INO80; INO80 complex ATPase
hsa:142678,1.417843e-07,0.00011807125398225256,6.810413267134504e-07,1.0684738328530534e-06,0.0,4.681206e-06,False,MIB2; MIB E3 ubiquitin protein ligase
hsa:10606,3.139336e-09,2.6142904270192736e-06,1.7283341063896503e-06,4.271766519307238e-06,0.0,2.2058708e-05,False,PAICS; phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide
hsa:6634,3.9194795e-08,3.2639570073889154e-05,6.103543144447954e-05,0.0002238407796967296,0.0,0.0017720073,False,SNRPD3; small nuclear ribonucleoprotein D3
hsa:26664,0.0,0.0,3.615793987426901e-06,1.0810645142165138e-05,0.0,0.00010224671,False,OR7C1; olfactory receptor family 7 subfamily C member
hsa:10136,0.0,0.0,1.0939473421052632e-08,1.0294233970529819e-07,0.0,1.3145603e-06,False,CELA3A; chymotrypsin like elastase
hsa:9437,0.0,0.0,2.2968341086919885e-06,1.265636445985103e-05,0.0,0.00010809044,False,NCR1; natural cytotoxicity triggering receptor
hsa:120776,0.0,0.0,3.42495903625731e-07,1.671912730556152e-06,0.0,1.7872346e-05,False,OR2D2; olfactory receptor family 2 subfamily D member
hsa:23659,5.4664923e-07,0.00045522360426741734,5.617426342450291e-05,0.00015558821099321963,0.0,0.00080138486,False,PLA2G15; phospholipase A2 group
hsa:494335,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR423; microRNA
hsa:3177,2.6058558e-07,0.00021700333676078797,4.1217691083511125e-05,0.00014344087372571097,0.0,0.0014551963,False,SLC29A2; solute carrier family 29 member
hsa:5582,2.1751212e-05,0.01811337980632425,0.00013622697557141524,0.00033918882604729294,0.0,0.002022812,False,PRKCG; protein kinase C
hsa:127066,0.0,0.0,3.8870280998245616e-07,3.108467584640956e-06,0.0,3.165384e-05,False,OR14C36; olfactory receptor family 14 subfamily C member
hsa:5161,0.0,0.0,5.451421196491228e-07,2.38297705148687e-06,0.0,1.720019e-05,False,PDHA2; pyruvate dehydrogenase E1 subunit alpha
hsa:10451,7.0073575e-06,0.00583539564766298,6.51854987831813e-05,0.00014345174382182583,0.0,0.0014326108,False,VAV3; vav guanine nucleotide exchange factor
hsa:54187,0.0,0.0,1.364160997619883e-07,3.3796735650958216e-07,0.0,1.92886e-06,False,NANS; N-acetylneuraminate
hsa:9287,-0.0,0.0,0.0,0.0,0.0,0.0,False,TAAR2; trace amine associated receptor
hsa:51477,4.4043898e-07,0.00036677673530330406,2.4886708504549702e-05,7.090488038687341e-05,0.0,0.00036650535,False,ISYNA1; inositol-3-phosphate synthase
hsa:483,0.0,0.0,0.0004180234318713451,0.0008857295880928481,0.0,0.0036186627,False,ATP1B3; ATPase Na+/K+ transporting subunit beta
hsa:406933,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR141; microRNA
hsa:7678,1.3630297e-08,1.135066618053293e-05,1.2285276445555559e-07,2.5199600553700353e-07,0.0,1.5227332e-06,False,ZNF124; zinc finger protein
hsa:1479,0.0,0.0,5.425723083245616e-07,1.646228421462968e-06,0.0,8.305277e-06,False,CSTF3; cleavage stimulation factor subunit
hsa:26974,1.5669219e-08,1.3048583914104295e-05,7.072696986712867e-08,1.2433082411898603e-07,0.0,6.3827906e-07,False,ZNF285; zinc finger protein
hsa:9320,0.0,0.0,2.946353648245615e-08,1.0493102580984704e-07,0.0,8.525188e-07,False,TRIP12; thyroid hormone receptor interactor
hsa:31,3.4823268e-05,0.0289991693052055,0.000620586803968187,0.0010252027160508087,0.0,0.005301116,False,ACACA; acetyl-CoA carboxylase
hsa:7012,0.0,0.0,1.9023656388596493e-08,9.352172352927068e-08,0.0,7.2221604e-07,False,TERC; telomerase RNA
hsa:5981,0.0,0.0,5.5704720077005856e-05,0.00012116605854560952,0.0,0.0007968966,False,RFC1; replication factor C subunit
hsa:101060200,2.6873867e-08,2.2379284420364424e-05,4.524904173313453e-08,5.412199492889343e-08,0.0,2.7689586e-07,False,ZNF891; zinc finger protein
hsa:51318,9.7848584e-08,8.148366930095768e-05,2.6372269346280706e-07,4.841395413216874e-07,0.0,2.755815e-06,False,MRPL35; mitochondrial ribosomal protein
hsa:51660,0.0,0.0,1.3312533436491232e-06,3.5357218556171423e-06,0.0,1.823525e-05,False,MPC1; mitochondrial pyruvate carrier
hsa:23265,0.0,0.0,3.1353685430736836e-07,6.157144622056304e-07,0.0,3.4330271e-06,False,EXOC7; exocyst complex component
hsa:1306,0.0,0.0,2.6664421832923973e-05,7.368846308610476e-05,0.0,0.00045984003,False,COL15A1; collagen type XV alpha 1
hsa:1511,0.0,0.0,0.0,0.0,0.0,0.0,False,CTSG; cathepsin
hsa:1470,0.0,0.0,1.8757220036140347e-06,9.35049260575527e-06,0.0,8.552023e-05,False,CST2; cystatin
hsa:27159,0.0,0.0,2.970858003426901e-07,1.7115940078013658e-06,0.0,1.6583006e-05,False,CHIA; chitinase
hsa:6235,4.935042e-07,0.0004109669387901789,1.2690176405847952e-06,1.803603911857616e-06,0.0,7.2145967e-06,False,RPS29; ribosomal protein
hsa:1409,0.0,0.0,6.925121777426903e-09,2.022583695301226e-08,0.0,1.6102395e-07,False,CRYAA; crystallin alpha
hsa:200576,0.0,0.0,6.493170264499996e-06,1.8812013969323493e-05,0.0,0.00010518363,False,PIKFYVE; phosphoinositide kinase
hsa:26052,1.9117983e-06,0.0015920551333408468,2.860924014822222e-05,7.180723088556204e-05,0.0,0.00044628434,False,DNM3; dynamin
hsa:25874,0.0,0.0,2.7570648998245615e-07,6.983406325279807e-07,0.0,5.829993e-06,False,MPC2; mitochondrial pyruvate carrier
hsa:79899,1.1801298e-07,9.827562385103634e-05,2.4397791015204674e-07,3.737783437192247e-07,0.0,2.0441903e-06,False,PRR5L; proline rich 5
hsa:53615,0.0,0.0,1.4374289436315779e-06,4.76643576163437e-06,0.0,2.759113e-05,False,MBD3; methyl-CpG binding domain protein
hsa:5119,0.0,0.0,3.1927258868397646e-06,6.098540127010883e-06,0.0,2.6210502e-05,False,CHMP1A; charged multivesicular body protein
hsa:7539,0.0,0.0,5.309509743081872e-08,1.299859811070838e-07,0.0,6.822384e-07,False,ZFP37; ZFP37 zinc finger
hsa:3206,0.0,0.0,1.7777385653098827e-07,5.775118588898975e-07,0.0,4.6684445e-06,False,HOXA10; homeobox
hsa:87,3.9624738e-05,0.03299760625385331,0.00015614742567543862,0.0003012852224106007,0.0,0.002257931,False,ACTN1; actinin alpha
hsa:340385,6.823709e-09,5.682461869473437e-06,1.327787328719298e-07,2.3475581890548432e-07,0.0,1.0114725e-06,False,ZNF517; zinc finger protein
hsa:2161,2.8000187e-07,0.00023317230404407022,1.1962097766251465e-05,3.4511758222113264e-05,0.0,0.00031628914,False,F12; coagulation factor
hsa:375,0.0,0.0,2.308904510380116e-05,4.735717484577194e-05,0.0,0.00028373173,False,ARF1; ADP ribosylation factor
hsa:9765,0.0,0.0,0.000142095852864386,0.0002865791598927668,0.0,0.001812251,False,ZFYVE16; zinc finger FYVE-type containing
hsa:9820,0.0,0.0,4.0534083784912255e-07,8.5242889756678e-07,0.0,3.5272662e-06,False,CUL7; cullin
hsa:4846,0.0,0.0,6.4836436502807014e-06,2.8633428057241757e-05,0.0,0.00025262337,False,NOS3; nitric oxide synthase
hsa:5156,0.0,0.0,1.3631970890058483e-05,5.181859418122199e-05,0.0,0.00036331106,False,PDGFRA; platelet derived growth factor receptor
hsa:4544,0.0,0.0,1.1452349079532162e-07,6.391015856092209e-07,0.0,7.046319e-06,False,MTNR1B; melatonin receptor
hsa:60481,7.140503e-07,0.0005946272917904424,2.7368675918888893e-05,7.110846620114992e-05,0.0,0.00032922762,False,ELOVL5; ELOVL fatty acid elongase
hsa:64064,0.0,0.0,1.2464243846970762e-05,3.379565960363526e-05,0.0,0.00024781664,False,OXCT2; 3-oxoacid CoA-transferase
hsa:55697,0.0,0.0,3.4790108924473683e-06,1.3645908208619285e-05,0.0,8.997864e-05,False,VAC14; VAC14 component of PIKFYVE
hsa:4660,1.766825e-06,0.0014713282311031148,1.0238881025058483e-05,2.1156258843184827e-05,0.0,0.00012533598,False,PPP1R12B; protein phosphatase 1 regulatory subunit
hsa:8566,1.1205987e-05,0.009331815562081416,0.00019341800261128654,0.0003352521546483818,0.0,0.001659982,False,PDXK; pyridoxal
hsa:55004,0.0,0.0,4.992808931929824e-07,1.2521233083245027e-06,0.0,6.8102872e-06,False,LAMTOR1; late endosomal/lysosomal adaptor
hsa:64137,0.00024319744,0.20252331679934682,0.0009272647412415203,0.0019954864192119172,0.0,0.013370776,False,ABCG4; ATP binding cassette subfamily G member
hsa:9218,8.855991e-06,0.007374850125335053,0.00022325907815514618,0.00040226343947854674,0.0,0.0017330657,False,VAPA; VAMP associated protein
hsa:9265,0.0,0.0,2.8132548675497075e-06,6.652878492840036e-06,0.0,4.3739987e-05,False,CYTH3; cytohesin
hsa:7134,0.0,0.0,1.0427505057894736e-05,5.4335738587265296e-05,0.0,0.000577664,False,TNNC1; troponin C1
hsa:3113,0.0,0.0,0.0003238240718888888,0.0007304759219166711,0.0,0.0055113873,False,HLA-DPA1; major histocompatibility complex
hsa:55799,0.00072100805,0.6004213766601707,0.0013713370544210534,0.0016754667041602954,0.0,0.009431303,True,CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:491,0.00032729204,0.2725533192406322,0.0004960373468947366,0.0005368307392935631,0.0,0.0029312065,False,ATP2B2; ATPase plasma membrane Ca2+ transporting
hsa:283,0.0,0.0,2.384779277508772e-09,5.272876554911059e-09,0.0,2.9452558e-08,False,ANG;
hsa:1340,0.0,0.0,0.00019018555341812873,0.0003422208568188395,0.0,0.0017663495,False,COX6B1; cytochrome c oxidase subunit
hsa:2319,5.62471e-07,0.00046839922543364515,4.8099906294988316e-06,1.358739258817129e-05,0.0,9.668464e-05,False,FLOT2; flotillin
hsa:6742,4.624537e-05,0.03851095520994385,0.00013456229137748542,0.0002211387845130989,0.0,0.0012029123,False,SSBP1; single stranded DNA binding protein
hsa:1524,0.0,0.0,1.2531260988304092e-07,5.305488657191788e-07,0.0,4.323646e-06,False,CX3CR1; C-X3-C motif chemokine receptor
hsa:3646,4.5698258e-07,0.0003805534623272467,1.273929345277193e-06,1.8764071980619948e-06,0.0,1.069829e-05,False,EIF3E; eukaryotic translation initiation factor 3 subunit
hsa:10201,9.1020854e-07,0.0007579785893300971,4.142577180818714e-05,9.417466549121203e-05,0.0,0.00062941987,False,NME6; NME/NM23 nucleoside diphosphate kinase
hsa:7791,5.2610034e-07,0.00043811146131334303,1.4135389442491225e-06,1.9192608871608775e-06,0.0,1.1331154e-05,False,ZYX;
hsa:406916,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR128-2; microRNA
hsa:6367,0.0,0.0,2.0648673692222234e-05,7.736321844886674e-05,0.0,0.0006896521,False,CCL22; C-C motif chemokine ligand
hsa:92126,3.1462575e-06,0.0026200543246048184,0.00037242109618876025,0.0008470178468215831,0.0,0.0043621194,False,DSEL; dermatan sulfate epimerase
hsa:7128,0.0,0.0,6.566486314619884e-06,1.0954239531916117e-05,0.0,5.7618177e-05,False,TNFAIP3; TNF alpha induced protein
hsa:3939,0.0,0.0,0.000320873796325146,0.0006157932620668579,0.0,0.0034254754,False,LDHA; lactate dehydrogenase
hsa:26530,0.0,0.0,1.9072695210526316e-07,1.7176492493859373e-06,0.0,1.850631e-05,False,OR12D1; olfactory receptor family 12 subfamily D member 1
hsa:57335,6.4149357e-09,5.342054813646639e-06,1.17190403955614e-07,2.279128875312791e-07,0.0,1.1155804e-06,False,ZNF286A; zinc finger protein
hsa:3838,3.398836e-06,0.002830389744139678,1.6365672496553216e-05,3.0127622555483187e-05,0.0,0.00016750213,False,KPNA2; karyopherin subunit alpha
hsa:130013,8.0362446e-07,0.0006692204124364303,1.4637836183829539e-05,3.1016700107711146e-05,0.0,0.00021316015,False,ACMSD; aminocarboxymuconate semialdehyde
hsa:51301,2.8814169e-08,2.3995076085903362e-05,3.5113022754736846e-06,1.0447455507258792e-05,0.0,7.0013615e-05,False,GCNT4; glucosaminyl (N-acetyl) transferase
hsa:84126,0.0,0.0,1.313494737837427e-06,3.7124929883628287e-06,0.0,2.3674587e-05,False,ATRIP; ATR interacting
hsa:8891,0.0,0.0,4.130326524269005e-08,5.6309872099297724e-08,0.0,1.9964932e-07,False,EIF2B3; eukaryotic translation initiation factor 2B subunit
hsa:7471,0.0,0.0,6.231159415380117e-07,2.073586544342079e-06,0.0,1.8338926e-05,False,WNT1; Wnt family member
hsa:23190,3.7831764e-08,3.1504502373257396e-05,2.7974024934619877e-07,5.23557873941422e-07,0.0,2.4303017e-06,False,UBXN4; UBX domain protein
hsa:147694,0.0,0.0,2.0817853266081875e-08,5.056044183444395e-08,0.0,2.243182e-07,False,ZNF548; zinc finger protein
hsa:23746,0.0,0.0,6.236280248070176e-08,4.1240185075753423e-07,0.0,5.227896e-06,False,AIPL1; aryl hydrocarbon receptor interacting protein like
hsa:81494,0.0,0.0,5.2016765425438606e-08,2.0353584454019205e-07,0.0,1.8988222e-06,False,CFHR5; complement factor H related
hsa:2355,1.7378714e-08,1.4472170434800809e-05,5.259889499197664e-06,1.2263134975282967e-05,0.0,7.151036e-05,False,FOSL2; FOS like 2
hsa:57818,0.0,0.0,2.2920268299415204e-06,9.44194890525513e-06,0.0,7.701238e-05,False,G6PC2; glucose-6-phosphatase catalytic subunit
hsa:5921,0.0,0.0,2.9684134749122804e-07,5.702609885057705e-07,0.0,2.476323e-06,False,RASA1; RAS p21 protein activator
hsa:11185,0.0,0.0,3.389213549239765e-05,0.00012934140186020299,0.0,0.0012130105,False,INMT; indolethylamine
hsa:26019,0.0,0.0,5.632505351846197e-07,1.347840954962116e-06,0.0,7.7845125e-06,False,UPF2; UPF2 regulator of nonsense mediated mRNA
hsa:90993,0.0,0.0,2.0012170228070176e-05,9.230824410462619e-05,0.0,0.0007439219,False,CREB3L1; cAMP responsive element binding protein 3 like
hsa:91252,0.0,0.0,7.222182727076024e-08,1.8891342520965873e-07,0.0,1.0558703e-06,False,SLC39A13; solute carrier family 39 member
hsa:1312,1.7578024e-06,0.0014638146368886617,0.00017466527254210532,0.0003820332016416451,0.0,0.0018054427,False,COMT;
hsa:164284,0.0,0.0,5.092734756005849e-08,1.3171939217936715e-07,0.0,8.783415e-07,False,APCDD1L; APC down-regulated 1
hsa:1174,0.0,0.0,7.293044196081867e-07,2.1013805269213323e-06,0.0,1.1061648e-05,False,AP1S1; adaptor related protein complex 1 subunit sigma
hsa:148,0.0,0.0,4.777798346585963e-06,2.0464962190176838e-05,0.0,0.0002177395,False,ADRA1A; adrenoceptor alpha
hsa:699,0.0,0.0,1.8974940540467834e-06,7.290696403386395e-06,0.0,9.110871e-05,False,BUB1; BUB1 mitotic checkpoint serine/threonine
hsa:2519,6.813089e-06,0.00567361803614851,5.751476930350877e-05,0.00011419878741600132,0.0,0.0006291213,False,FUCA2; alpha-L-fucosidase
hsa:54815,0.0,0.0,1.4082957187134507e-07,5.73064076013633e-07,0.0,6.9319835e-06,False,GATAD2A; GATA zinc finger domain containing
hsa:342372,0.0,0.0,2.2538811224970768e-07,6.934338465846238e-07,0.0,6.470827e-06,False,PKD1L3; polycystin 1 like 3
hsa:51616,7.613372e-09,6.340055838857828e-06,1.3044319657397657e-06,2.963179746952091e-06,0.0,1.6998581e-05,False,TAF9B; TATA-box binding protein associated factor
hsa:390327,0.0,0.0,4.036567894736842e-08,3.7290016636441023e-07,0.0,3.6697013e-06,False,OR6C70; olfactory receptor family 6 subfamily C member
hsa:56920,0.0,0.0,2.0379970402923973e-07,4.1490409247198334e-07,0.0,2.469076e-06,False,SEMA3G; semaphorin
hsa:23404,2.7759336e-07,0.00023116661091775935,1.974228339359941e-05,7.085500121387877e-05,0.0,0.0005649649,False,EXOSC2; exosome component
hsa:9249,0.0,0.0,7.057874597836256e-06,2.9895172307208362e-05,0.0,0.00035255516,False,DHRS3; dehydrogenase/reductase
hsa:5618,0.0,0.0,1.7180654212280702e-07,7.401571775108399e-07,0.0,6.2932277e-06,False,PRLR; prolactin
hsa:146433,0.0,0.0,7.778992397660818e-08,1.017235252319242e-06,0.0,1.3302077e-05,False,IL34; interleukin
hsa:6900,2.5424308e-07,0.00021172160296951178,4.39171427022456e-06,1.1589160585436049e-05,0.0,5.3755506e-05,False,CNTN2; contactin
hsa:7481,0.0,0.0,1.2451170983040936e-05,3.356915223552135e-05,0.0,0.00024435268,False,WNT11; Wnt family member
hsa:26333,0.0,0.0,6.224232748538012e-09,8.139240465586054e-08,0.0,1.0643438e-06,False,OR7A17; olfactory receptor family 7 subfamily A member
hsa:199704,1.7097488e-08,1.4237978733234323e-05,1.47085263654386e-07,3.5383055736028414e-07,0.0,1.9120841e-06,False,ZNF585A; zinc finger protein
hsa:2357,0.0,0.0,2.345472789883041e-06,8.304755944504971e-06,0.0,6.131879e-05,False,FPR1; formyl peptide receptor
hsa:51081,1.8531259e-07,0.00015431955357538904,5.273502177397661e-07,8.890258566109278e-07,0.0,4.6917735e-06,False,MRPS7; mitochondrial ribosomal protein
hsa:5530,6.5768836e-05,0.05476917359307847,0.000606605400539181,0.00094795357271735,0.0,0.0043879445,False,PPP3CA; protein phosphatase 3 catalytic subunit
hsa:55968,4.2361847e-08,3.5276941073830624e-05,5.356681970342104e-07,1.1016473094616342e-06,0.0,9.198944e-06,False,NSFL1C; NSFL1
hsa:5894,0.00034223573,0.28499771694490583,0.0008692122216198832,0.0012459851402286427,0.0,0.0070056585,False,RAF1; Raf-1 proto-oncogene
hsa:2810,1.6743115e-07,0.00013942873672325232,3.1456008068290656e-05,0.00011701755805719904,0.0,0.00089836813,False,SFN;
hsa:56901,0.0,0.0,1.799081774035088e-06,3.205755551530619e-06,0.0,1.954684e-05,False,NDUFA4L2; NDUFA4 mitochondrial complex associated like
hsa:10527,0.0,0.0,2.276236742356139e-07,4.472770365592115e-07,0.0,1.9700844e-06,False,IPO7; importin
hsa:406942,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR150; microRNA
hsa:116379,0.0,0.0,3.1208485083269014e-06,1.1907466753447453e-05,0.0,0.00010135941,False,IL22RA2; interleukin 22 receptor subunit alpha
hsa:63917,0.0,0.0,0.00042487070707719306,0.001106893021032527,0.0,0.009562158,False,GALNT11; polypeptide N-acetylgalactosaminyltransferase
hsa:2770,0.00017846635,0.1486183289555725,0.0008093288778947369,0.0012032583693334746,0.0,0.006028649,False,GNAI1; G protein subunit alpha
hsa:2317,0.0,0.0,1.1301504748736841e-06,2.976709105512089e-06,0.0,1.5623054e-05,False,FLNB; filamin
hsa:5269,5.5956457e-07,0.00046597888809931667,1.247529156194737e-05,3.552713695277192e-05,0.0,0.00018081318,False,SERPINB6; serpin family B member
hsa:5972,0.0,0.0,6.21307709348538e-06,2.2284190826060427e-05,0.0,0.00022479203,False,REN;
hsa:6167,2.2710245e-07,0.00018912017094940562,8.667745052444447e-07,1.7094020264712544e-06,0.0,9.708376e-06,False,RPL37; ribosomal protein
hsa:1184,9.396083e-08,7.824613178830981e-05,4.212770200409356e-06,1.050309294867337e-05,0.0,5.666375e-05,False,CLCN5; chloride voltage-gated channel
hsa:55768,0.0,0.0,1.9475103613559064e-07,3.4939815137161157e-07,0.0,1.3382356e-06,False,NGLY1; N-glycanase
hsa:2268,6.253122e-08,5.207304023393359e-05,5.161141922052631e-07,1.0892706277008047e-06,0.0,6.5195673e-06,False,FGR; FGR proto-oncogene
hsa:1647,0.0,0.0,5.310803686356725e-05,0.00011101449588935943,0.0,0.0006492889,False,GADD45A; growth arrest and DNA damage inducible
hsa:9033,5.984518e-05,0.04983623325991398,0.00032272180088818134,0.0006427787924407412,0.0,0.0037108434,False,PKD2L1; polycystin 2 like 1
hsa:6128,1.3714875e-07,0.00011421098735613505,7.881058277076024e-07,1.4175135164545483e-06,0.0,7.146846e-06,False,RPL6; ribosomal protein
hsa:10059,4.7241715e-06,0.003934066416607615,0.00019798124095883043,0.0006603136383921062,0.0,0.0038732972,False,DNM1L; dynamin 1
hsa:2805,3.7309692e-05,0.03106974552282316,0.00050745479241462,0.0008717142620698313,0.0,0.004909079,False,GOT1; glutamic-oxaloacetic transaminase
hsa:72,2.1090483e-07,0.0001756315596932368,2.4507609956750877e-05,7.353706248887208e-05,0.0,0.00062669103,False,ACTG2; actin gamma 2
hsa:641371,1.5956279e-06,0.0013287633894730818,0.00011834338041543864,0.00028166285649908646,0.0,0.0018396522,False,ACOT1; acyl-CoA thioesterase
hsa:10319,0.0,0.0,8.948666173543859e-06,2.9496501871950624e-05,0.0,0.00023449375,False,LAMC3; laminin subunit gamma
hsa:10006,4.2744787e-08,3.5595835380181636e-05,1.6346120911461993e-06,4.636348069822432e-06,0.0,2.9150428e-05,False,ABI1; abl interactor
hsa:441282,0.0,0.0,5.5727843173391825e-06,1.8163955916536247e-05,0.0,0.00012556021,False,AKR1B15; aldo-keto reductase family 1 member
hsa:126295,1.8368159e-08,1.5296133397529897e-05,8.064311577204677e-08,1.685778142783504e-07,0.0,9.4873036e-07,False,ZNF57; zinc finger protein
hsa:7846,0.0,0.0,0.0001301451535906433,0.0002710833624296661,0.0,0.0015865127,False,TUBA1A; tubulin alpha
hsa:553,0.0,0.0,1.3675386391812865e-08,4.8539776050429044e-08,0.0,3.4531558e-07,False,AVPR1B; arginine vasopressin receptor
hsa:64682,4.7459613e-07,0.00039522119306738577,2.4493283836900585e-05,6.132286708849709e-05,0.0,0.00042227955,False,ANAPC1; anaphase promoting complex subunit
hsa:9775,1.06007874e-07,8.827833981035013e-05,2.2773434398362578e-06,3.9161246024385045e-06,0.0,2.0497018e-05,False,EIF4A3; eukaryotic translation initiation factor
hsa:56259,0.0,0.0,9.548673922777775e-07,3.0218579845280885e-06,0.0,2.1779855e-05,False,CTNNBL1; catenin beta like
hsa:6272,5.0182634e-06,0.004178972230714136,6.368179299251462e-05,0.0001219956883556332,0.0,0.0008382858,False,SORT1; sortilin
hsa:2242,0.0,0.0,9.32223726023392e-08,1.823633455243986e-07,0.0,1.1900578e-06,False,FES; FES proto-oncogene
hsa:5516,0.0,0.0,8.574485571169589e-05,0.00021581164718766674,0.0,0.0010655562,False,PPP2CB; protein phosphatase 2 catalytic subunit
hsa:18,0.00047879686,0.39871936217878157,0.0017466948205198825,0.002326121107863994,0.0,0.008439699,False,ABAT; 4-aminobutyrate
hsa:1325,3.323687e-08,2.7678092139574763e-05,1.549047002645614e-05,3.9609651226222755e-05,0.0,0.00029426764,False,CORT;
hsa:199713,0.0,0.0,9.464941849122804e-10,5.412760960727201e-09,0.0,6.26589e-08,False,NLRP7; NLR family pyrin domain containing
hsa:30012,1.2546977e-08,1.0448528561176953e-05,7.562449037203802e-06,2.2688527004883398e-05,0.0,0.00015184146,False,TLX3; T cell leukemia homeobox
hsa:124602,0.0,0.0,2.8816151782514616e-09,7.997298694641702e-09,0.0,8.757842e-08,False,KIF19; kinesin family member
hsa:4772,0.0,0.0,2.4450750795321637e-06,8.555130047528205e-06,0.0,5.2658877e-05,False,NFATC1; nuclear factor of activated T cells
hsa:390157,0.0,0.0,6.336876608187135e-08,8.28654142583236e-07,0.0,1.0836059e-05,False,OR8K1; olfactory receptor family 8 subfamily K member
hsa:55081,0.0,0.0,1.387869414046784e-08,2.7568829020249347e-08,0.0,1.1247873e-07,False,IFT57; intraflagellar transport
hsa:81608,0.0,0.0,4.864339182886549e-07,7.462798612306653e-07,0.0,3.3564306e-06,False,FIP1L1; factor interacting with PAPOLA and
hsa:255967,0.0,0.0,2.035526675081872e-05,8.002844498069217e-05,0.0,0.0006768488,False,PAN3; poly(A) specific ribonuclease subunit
hsa:84333,0.0,0.0,4.180227516432748e-07,8.686752488017216e-07,0.0,6.116133e-06,False,PCGF5; polycomb group ring finger
hsa:2212,0.0,0.0,2.5816923561403512e-06,1.1457110219136519e-05,0.0,0.00010442194,False,FCGR2A; Fc gamma receptor
hsa:23646,0.0,0.0,8.254524455707604e-05,0.00020357096634751146,0.0,0.0011612767,False,PLD3; phospholipase D family member
hsa:3577,0.0,0.0,8.897089705202515e-06,3.172047374179967e-05,0.0,0.0003260125,False,CXCR1; C-X-C motif chemokine receptor
hsa:25805,0.0,0.0,9.476931054561404e-06,4.7595212259251226e-05,0.0,0.00040843216,False,BAMBI; BMP and activin membrane bound
hsa:79823,1.0527892e-07,8.767130142263457e-05,1.507114835657895e-05,3.830847245555573e-05,0.0,0.00020845255,False,CAMKMT; calmodulin-lysine
hsa:389668,8.498874e-08,7.077459991107356e-05,1.8704170224874265e-05,5.560807462818345e-05,0.0,0.0005181656,False,XKR9; XK related
hsa:3312,0.0,0.0,0.00012860612986198826,0.00043445801893291397,0.0,0.0045267837,False,HSPA8; heat shock protein family A (Hsp70) member
hsa:10542,8.64031e-08,7.195241197335648e-05,5.074400453947368e-06,9.92140790017995e-06,0.0,4.6912683e-05,False,LAMTOR5; late endosomal/lysosomal adaptor
hsa:10286,3.412125e-08,2.841456194333177e-05,5.364999959591815e-07,1.4418471742128307e-06,0.0,1.1398175e-05,False,BCAS2; BCAS2 pre-mRNA processing
hsa:256987,6.7374366e-08,5.610618298273673e-05,1.3469918540867251e-05,3.948587659296973e-05,0.0,0.000289293,False,SERINC5; serine incorporator
hsa:2822,4.8852776e-06,0.004068227951073632,2.3452416225730987e-05,4.3692209565260796e-05,0.0,0.0004099559,False,GPLD1; glycosylphosphatidylinositol specific phospholipase
hsa:100507027,5.825192e-09,4.8509441745481395e-06,3.073016613713451e-06,2.2117165530665423e-05,0.0,0.00022609033,False,MRLN;
hsa:8031,7.746126e-06,0.006450607086430091,4.528001223146199e-05,0.00010567954579776971,0.0,0.00061890396,False,NCOA4; nuclear receptor coactivator
hsa:816,0.0016260893,1.3541302015676155,0.002088666473203509,0.00172543761363838,0.0,0.008620598,True,CAMK2B; calcium/calmodulin dependent protein kinase II
hsa:23654,0.0,0.0,3.442456975438597e-07,6.289254373131655e-07,0.0,2.9097525e-06,False,PLXNB2; plexin
hsa:91,0.00010075915,0.08390745090031747,0.00038222646743976604,0.0006200592281127671,0.0,0.0031279726,False,ACVR1B; activin A receptor type
hsa:6331,6.199923e-08,5.163002414254676e-05,5.28284075206316e-07,9.65556120806895e-07,0.0,4.583338e-06,False,SCN5A; sodium voltage-gated channel alpha subunit
hsa:5523,3.0208585e-06,0.002515627972899302,6.85611423122807e-06,1.2887036740149696e-05,0.0,8.945053e-05,False,PPP2R3A; protein phosphatase 2 regulatory subunit
hsa:7368,0.0,0.0,2.4208282541383624e-06,1.0373562256592432e-05,0.0,0.00011990619,False,UGT8; UDP glycosyltransferase
hsa:140564,0.0,0.0,5.106890977134503e-06,1.914328010494407e-05,0.0,0.00015072891,False,APOBEC3D; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:140679,8.145866e-06,0.0067834916375888975,0.00021562189965953224,0.0012968113578798578,0.0,0.016513668,False,SLC32A1; solute carrier family 32 member
hsa:5625,0.0,0.0,1.3343378116046785e-05,3.928120553166164e-05,0.0,0.00029201998,False,PRODH; proline dehydrogenase
hsa:55699,1.7304048e-07,0.0001440999212415683,6.857119868388305e-06,1.4605222757890048e-05,0.0,7.826436e-05,False,IARS2; isoleucyl-tRNA synthetase 2
hsa:5957,0.0,0.0,8.754946287017543e-07,5.923802694595054e-06,0.0,5.5496206e-05,False,RCVRN;
hsa:7099,0.0,0.0,2.3614434226900582e-05,6.40647261549757e-05,0.0,0.0006772135,False,TLR4; toll like receptor
hsa:51377,4.147149e-08,3.453549390738218e-05,1.7929092116543866e-07,3.5690945263325275e-07,0.0,1.9022661e-06,False,UCHL5; ubiquitin C-terminal hydrolase
hsa:3265,0.00066815846,0.5564107396309093,0.00113586138005848,0.0015161751630324938,0.0,0.01053887,True,HRAS; HRas proto-oncogene
hsa:2569,0.0,0.0,1.067915728580117e-06,3.88008019658417e-06,0.0,2.6119664e-05,False,GABRR1; gamma-aminobutyric acid type A receptor subunit
hsa:55191,0.0,0.0,5.2888910336426906e-05,0.00011280387332482516,0.0,0.00047852195,False,NADSYN1; NAD synthetase
hsa:3364,0.0,0.0,2.694014787415205e-07,5.399148753807506e-07,0.0,2.75366e-06,False,HUS1; HUS1 checkpoint clamp
hsa:26035,0.0,0.0,8.40656560736842e-06,2.2393417499836854e-05,0.0,0.00012459296,False,GLCE; glucuronic acid
hsa:407020,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR28; microRNA
hsa:55930,1.2029083e-08,1.0017250951385988e-05,1.2886514781725144e-07,2.606031255565136e-07,0.0,1.3616441e-06,False,MYO5C; myosin
hsa:353514,0.0,0.0,7.252513628619884e-06,2.751269046954764e-05,0.0,0.00024444592,False,LILRA5; leukocyte immunoglobulin like receptor
hsa:6610,0.0,0.0,8.544112813274855e-06,1.8325866813461827e-05,0.0,9.015033e-05,False,SMPD2; sphingomyelin phosphodiesterase
hsa:91120,0.0,0.0,4.819425339467835e-08,7.908524580078827e-08,0.0,3.3994735e-07,False,ZNF682; zinc finger protein
hsa:9296,0.0,0.0,0.00016851824163508771,0.00043690558877929595,0.0,0.0025054112,False,ATP6V1F; ATPase H+ transporting V1 subunit
hsa:1366,0.0,0.0,4.646852220877195e-07,1.3826741918128679e-06,0.0,7.5610174e-06,False,CLDN7; claudin
hsa:116988,1.0498709e-09,8.742827921178586e-07,2.569627190545029e-06,6.680356991905508e-06,0.0,3.835982e-05,False,AGAP3; ArfGAP with GTPase domain
hsa:81617,6.0272384e-08,5.019198853032286e-05,8.013811475959067e-07,1.6845836797536202e-06,0.0,9.091962e-06,False,CAB39L; calcium binding protein 39
hsa:8911,1.7352706e-05,0.014450512203434074,8.287607760286547e-05,0.00014276304628428683,0.0,0.00077763305,False,CACNA1I; calcium voltage-gated channel subunit alpha1
hsa:80032,8.167862e-11,6.801808865255104e-08,3.452631951871345e-09,7.686357726714254e-09,0.0,5.1003642e-08,False,ZNF556; zinc finger protein
hsa:55753,0.0,0.0,5.005132137777779e-06,1.011483377754796e-05,0.0,7.791356e-05,False,OGDHL; oxoglutarate dehydrogenase
hsa:4488,0.0,0.0,5.295406590643275e-09,2.3523517485143717e-08,0.0,2.4975654e-07,False,MSX2; msh homeobox
hsa:1737,0.0,0.0,3.936641821327486e-05,8.324828194816211e-05,0.0,0.0005395422,False,DLAT; dihydrolipoamide
hsa:196294,1.4491476e-06,0.0012067815289659835,0.00021132037008407613,0.0006328274088373262,0.0,0.004358327,False,IMMP1L; inner mitochondrial membrane peptidase subunit
hsa:7466,0.0,0.0,5.850038196092397e-07,1.7017367039717348e-06,0.0,1.2282351e-05,False,WFS1; wolframin ER transmembrane
hsa:56994,0.0,0.0,0.00023641031767883042,0.0005674977734550011,0.0,0.002946233,False,CHPT1; choline phosphotransferase
hsa:10054,1.5394802e-08,1.28200624254483e-05,4.172234073801167e-07,7.553634321409694e-07,0.0,3.9002025e-06,False,UBA2; ubiquitin like modifier activating enzyme
hsa:10396,2.121702e-06,0.0017668529993564394,0.00016363302517016082,0.00036786754772837814,0.0,0.0039733164,False,ATP8A1; ATPase phospholipid transporting
hsa:53919,0.0,0.0,3.040944574327485e-07,8.584563182162694e-07,0.0,5.082364e-06,False,SLCO1C1; solute carrier organic anion transporter family member
hsa:10331,0.0,0.0,1.3030661684210527e-07,6.555349343128329e-07,-0.0,5.564725e-06,False,B3GNT3; UDP-GlcNAc:betaGal beta-1
hsa:56979,0.0,0.0,4.1798788860233917e-07,1.9708288178629704e-06,0.0,1.6785903e-05,False,PRDM9; PR/SET domain
hsa:353500,3.8250332e-07,0.0003185306599163294,1.0740496272397656e-05,3.1000590500366806e-05,0.0,0.00022312491,False,BMP8A; bone morphogenetic protein
hsa:27235,0.0,0.0,0.00010950867345309941,0.0003269810829876341,0.0,0.0021477682,False,COQ2; coenzyme Q2
hsa:100528021,0.0,0.0,5.678149301880117e-06,1.9064252382676982e-05,0.0,0.00017955578,False,ST20-MTHFS; ST20-MTHFS
hsa:8001,0.0,0.0,2.0161104038742693e-08,1.0531253306530539e-07,0.0,8.2723994e-07,False,GLRA3; glycine receptor alpha
hsa:402569,0.0,0.0,1.5436107110877186e-08,1.1400293712686394e-07,0.0,1.2506289e-06,False,KPNA7; karyopherin subunit alpha
hsa:3953,0.0,0.0,1.082253301169591e-06,3.5252292665060516e-06,0.0,1.9846302e-05,False,LEPR; leptin
hsa:3728,9.357844e-06,0.0077927695495925734,3.2852672234175446e-05,7.494771562056889e-05,0.0,0.0006763641,False,JUP; junction
hsa:64284,5.1829496e-09,4.316115103003748e-06,8.757605237753449e-06,1.8803641401861046e-05,0.0,0.00012216401,False,RAB17; RAB17
hsa:1445,1.3486742e-07,0.00011231120371402987,1.243846650935672e-06,2.2866537412354234e-06,0.0,1.379582e-05,False,CSK; C-terminal Src
hsa:3930,7.398992e-08,6.161530322078359e-05,4.219791022330993e-05,0.00010686318427137481,0.0,0.0010508605,False,LBR; lamin B
hsa:79792,4.0302416e-06,0.003356194441580908,1.5937880499994157e-05,3.8289341570502214e-05,0.0,0.00028623006,False,GSDMD; gasdermin
hsa:5230,0.0,0.0,2.451413144853802e-05,6.773442214549971e-05,0.0,0.0005379023,False,PGK1; phosphoglycerate kinase
hsa:3568,4.3290024e-10,3.604988294614995e-07,4.0996006577078365e-06,9.234544829398712e-06,0.0,5.0774215e-05,False,IL5RA; interleukin 5 receptor subunit
hsa:4775,0.0,0.0,0.00012030652358304093,0.0002731164986424934,0.0,0.0013302214,False,NFATC3; nuclear factor of activated T cells
hsa:407044,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR7-2; microRNA
hsa:1739,1.8578983e-06,0.0015471697645825049,4.681916845748538e-05,0.0001538886470550021,0.0,0.0009967966,False,DLG1; discs large MAGUK scaffold protein
hsa:23046,2.5270172e-10,2.104380313185033e-07,1.1484829802161401e-06,4.182158541663309e-06,0.0,3.1901134e-05,False,KIF21B; kinesin family member
hsa:27244,2.0814102e-06,0.0017332998954429444,0.00021127696963808766,0.0005610522272446422,0.0,0.0027873416,False,SESN1; sestrin
hsa:622,1.7881175e-05,0.014890596172679942,0.0002807538478021053,0.0006015890486208973,0.0,0.0034455184,False,BDH1; 3-hydroxybutyrate dehydrogenase
hsa:406999,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR217; microRNA
hsa:132014,0.0,0.0,3.9460981793801163e-07,1.986700110275272e-06,0.0,1.8341792e-05,False,IL17RE; interleukin 17 receptor
hsa:8513,3.0168935e-06,0.0025123261085741285,1.2554950895029242e-05,2.4252091964236327e-05,0.0,0.00020954134,False,LIPF; lipase F
hsa:390265,0.0,0.0,1.540986565631579e-06,1.6198844449873854e-05,0.0,0.00020860913,False,OR10G7; olfactory receptor family 10 subfamily G member
hsa:2686,0.00024817247,0.20666628630090178,0.0009726091150473685,0.001330847435744873,0.0,0.0061475346,False,GGT7; gamma-glutamyltransferase
hsa:5055,0.0,0.0,3.6221767146140355e-08,1.1023475617761187e-07,0.0,7.6216446e-07,False,SERPINB2; serpin family B member
hsa:26496,-0.0,0.0,2.2481425730994153e-09,2.939827886043541e-08,0.0,3.8443238e-07,False,OR10A3; olfactory receptor family 10 subfamily A member
hsa:9411,0.0,0.0,1.3212711731929823e-05,2.7126212542208084e-05,0.0,0.00015301615,False,ARHGAP29; Rho GTPase activating protein
hsa:1522,2.7532044e-06,0.0022927383072558474,6.741051165390646e-06,1.122529863965656e-05,0.0,9.993164e-05,False,CTSZ; cathepsin
hsa:5256,0.0,0.0,2.6887099179801167e-05,8.24518070980389e-05,0.0,0.00038829836,False,PHKA2; phosphorylase kinase regulatory subunit alpha
hsa:1551,5.7813045e-06,0.004814396741869443,3.465132442467836e-05,8.97046350006863e-05,0.0,0.0006443566,False,CYP3A7; cytochrome P450 family 3 subfamily A member
hsa:643,1.255747e-05,0.010457266634913153,0.00029902710872842106,0.00063531419818414,0.0,0.0038249397,False,CXCR5; C-X-C motif chemokine receptor
hsa:4166,1.2508332e-08,1.0416346834355688e-05,5.156214826418366e-06,1.954052420729635e-05,0.0,0.00013853816,False,CHST6; carbohydrate sulfotransferase
hsa:124044,0.0,0.0,7.325716977391814e-05,0.00026628128725937904,0.0,0.0018090684,False,SPATA2L; spermatogenesis associated 2
hsa:56242,3.1311217e-08,2.6074499467856625e-05,1.727417506491228e-07,2.6844279610624177e-07,0.0,1.2381915e-06,False,ZNF253; zinc finger protein
hsa:10056,3.4563726e-07,0.00028783035012473074,1.044931755532398e-05,2.8342026764223396e-05,0.0,0.0001779155,False,FARSB; phenylalanyl-tRNA synthetase subunit
hsa:112817,2.4055064e-06,0.002003191870399854,2.6265831182795334e-05,6.246695122330616e-05,0.0,0.0003670594,False,HOGA1; 4-hydroxy-2-oxoglutarate aldolase
hsa:51107,7.250063e-06,0.006037509300115259,0.0002777882386036491,0.00047420756798702615,0.0,0.0027929917,False,APH1A; aph-1 homolog A
hsa:1811,1.5815091e-07,0.00013170059211163975,6.5462929779608205e-06,1.331113868911307e-05,0.0,9.8679004e-05,False,SLC26A3; solute carrier family 26 member
hsa:63924,0.0,0.0,1.5996371062497075e-05,8.451185134120411e-05,0.0,0.0008281652,False,CIDEC; cell death inducing DFFA like effector
hsa:1363,3.5584068e-07,0.000296327275343585,9.281734593087715e-05,0.0001668740987300953,0.0,0.0009998197,False,CPE; carboxypeptidase
hsa:51497,1.4006013e-06,0.0011663544681616588,0.00010286290196989181,0.0002979034661603108,0.0,0.0020129057,False,NELFCD; negative elongation factor complex member
hsa:653689,0.0005000334,0.41640414750440835,0.0009246626815070172,0.001209626028055729,0.0,0.0066470993,False,GSTT2B; glutathione S-transferase theta
hsa:2348,0.0,0.0,3.6563307360047944e-05,0.00024456268618161026,0.0,0.0030887716,False,FOLR1; folate receptor
hsa:7222,0.0,0.0,1.265451209945614e-06,6.02482407612303e-06,0.0,3.748994e-05,False,TRPC3; transient receptor potential cation channel subfamily C member
hsa:56985,0.0,0.0,2.9261795961988305e-07,1.9074484193148054e-06,0.0,2.2945616e-05,False,ADPRM; ADP-ribose/CDP-alcohol diphosphatase
hsa:55770,0.0,0.0,1.87734460083041e-06,3.271530101493094e-06,0.0,1.3028186e-05,False,EXOC2; exocyst complex component
hsa:116285,0.0,0.0,7.423160114460234e-06,2.321258168438532e-05,0.0,0.00021579076,False,ACSM1; acyl-CoA synthetase medium chain family member
hsa:285362,2.7837098e-07,0.00023181417604677346,1.199812233760234e-06,2.4160610877554255e-06,0.0,1.8310018e-05,False,SUMF1; sulfatase modifying factor
hsa:51495,9.222349e-06,0.007679935726959705,0.0005571301477836257,0.0014849422422132427,0.0,0.0073393523,False,HACD3; 3-hydroxyacyl-CoA dehydratase
hsa:7328,1.5281952e-08,1.2726086286962606e-05,1.4388794821011694e-06,2.4813783737254154e-06,0.0,1.1228144e-05,False,UBE2H; ubiquitin conjugating enzyme E2
hsa:4023,0.0,0.0,1.8382545438596495e-06,1.717084900078358e-05,0.0,0.00021327866,False,LPL; lipoprotein
hsa:5105,0.0,0.0,2.277110732248539e-05,0.00010298391026534913,0.0,0.0010176648,False,PCK1; phosphoenolpyruvate carboxykinase
hsa:9534,4.8503748e-09,4.039162551283304e-06,4.8202062183625715e-08,8.508226877355576e-08,0.0,4.774556e-07,False,ZNF254; zinc finger protein
hsa:7512,0.0,0.0,8.34390094619883e-08,3.3503031120951235e-07,0.0,3.3041765e-06,False,XPNPEP2; X-prolyl aminopeptidase
hsa:79993,4.938664e-07,0.00041126856180621364,6.755503204616957e-06,1.595900210045007e-05,0.0,0.00012990012,False,ELOVL7; ELOVL fatty acid elongase
hsa:63931,0.0,0.0,2.8361505264385956e-08,7.592013624979706e-08,0.0,4.3916182e-07,False,MRPS14; mitochondrial ribosomal protein
hsa:9167,6.341945e-07,0.0005281271613545905,0.00010671791661491228,0.0002425651662630565,0.0,0.0015588395,False,COX7A2L; cytochrome c oxidase subunit 7A2
hsa:7297,0.0,0.0,0.00016923526280175437,0.00040029632686767097,0.0,0.0022398655,False,TYK2; tyrosine kinase
hsa:11006,0.0,0.0,1.4747764790526318e-06,5.148694426704025e-06,0.0,4.8162583e-05,False,LILRB4; leukocyte immunoglobulin like receptor
hsa:10109,1.1815375e-06,0.0009839285044398831,0.00017097005088785672,0.0003300453294245399,0.0,0.0016733763,False,ARPC2; actin related protein 2/3 complex subunit
hsa:442909,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR342; microRNA
hsa:5337,0.0,0.0,2.89761483331579e-05,8.040766937088028e-05,0.0,0.00038201074,False,PLD1; phospholipase
hsa:2033,1.4324411e-05,0.011928691465325655,0.00026354967296032746,0.0003780179605580406,0.0,0.0019706322,False,EP300; E1A binding protein
hsa:730291,0.0,0.0,2.994872897076023e-11,1.886708665313904e-10,0.0,2.0305007e-09,False,ZNF735; zinc finger protein
hsa:9088,0.0,0.0,5.373818376498847e-05,0.00016358124776865812,0.0,0.00087311136,False,PKMYT1; protein kinase
hsa:23269,0.0,0.0,9.274184685028506e-05,0.0003259224113802474,0.0,0.0019133982,False,MGA; MAX dimerization protein
hsa:5701,0.0,0.0,6.908642120812867e-06,1.7004944692114017e-05,0.0,0.00010992662,False,PSMC2; proteasome 26S subunit
hsa:4999,0.0,0.0,1.397633709833567e-06,3.7766671032684933e-06,0.0,1.9598981e-05,False,ORC2; origin recognition complex subunit
hsa:375387,0.0,0.0,2.1352718678602335e-05,9.225504062922434e-05,0.0,0.00075252965,False,NRROS; negative regulator of reactive oxygen
hsa:51733,1.8694054e-05,0.01556752332798444,0.0002231328946392981,0.0004717627237532719,0.0,0.0030318254,False,UPB1; beta-ureidopropionase
hsa:10886,0.0,0.0,1.4675218448276846e-06,8.551931597420385e-06,0.0,8.815948e-05,False,NPFFR2; neuropeptide FF receptor
hsa:127550,0.0,0.0,3.7162366567134504e-06,1.163417240822884e-05,0.0,7.4202195e-05,False,A3GALT2; alpha 1
hsa:8771,1.02844304e-07,8.564386845519561e-05,1.92320960807193e-05,5.0202628833404786e-05,0.0,0.00037936823,False,TNFRSF6B; TNF receptor superfamily member
hsa:94005,1.809039e-06,0.0015064820521933683,8.15990858116959e-05,0.0001853857505748906,0.0,0.0012684641,False,PIGS; phosphatidylinositol glycan anchor biosynthesis class
hsa:50848,1.8755268e-06,0.0015618499449750174,3.045160306617369e-05,7.006109862384055e-05,0.0,0.00041520823,False,F11R; F11
hsa:5714,0.0,0.0,7.786911173760237e-06,1.6339006412387352e-05,0.0,0.00010167782,False,PSMD8; proteasome 26S subunit
hsa:8841,1.1275505e-05,0.009389706861995006,8.520287864912282e-05,0.0001990528338877182,0.0,0.0014133838,False,HDAC3; histone deacetylase
hsa:100169760,0.0,0.0,6.889285926093567e-08,3.8664590093610856e-07,0.0,3.473669e-06,False,RNA5S9; RNA
hsa:389114,8.057014e-09,6.709499897609006e-06,7.190734353391811e-08,1.455995129864356e-07,0.0,7.1458044e-07,False,ZNF662; zinc finger protein
hsa:79717,1.1198995e-05,0.00932599295543284,3.0192743476491213e-05,4.185322958197007e-05,0.0,0.00016696681,False,PPCS; phosphopantothenoylcysteine
hsa:23244,0.0,0.0,7.467343080350877e-07,2.2334049398121177e-06,0.0,1.0777387e-05,False,PDS5A; PDS5 cohesin associated factor
hsa:103910,0.0,0.0,0.00015029929925789478,0.0004019169583232097,0.0,0.0020720183,False,MYL12B; myosin light chain
hsa:4864,0.0,0.0,5.328650754059648e-05,0.00014390428943686156,0.0,0.0006781846,False,NPC1; NPC intracellular cholesterol transporter
hsa:84876,0.0,0.0,3.356307991461989e-05,0.0001439775546484892,0.0,0.0014947394,False,ORAI1; ORAI calcium release-activated calcium modulator
hsa:10892,2.6320429e-06,0.002191840744977297,5.273549900333335e-05,0.00011317004181656965,0.0,0.00072316476,False,MALT1; MALT1
hsa:2897,9.382401e-08,7.8132194568393e-05,6.048321718976609e-06,1.914407199806891e-05,0.0,0.00014087012,False,GRIK1; glutamate ionotropic receptor kainate type subunit
hsa:7704,0.0,0.0,2.8637047899374255e-06,1.12996283061736e-05,0.0,8.366641e-05,False,ZBTB16; zinc finger and BTB domain containing
hsa:7398,4.317938e-07,0.0003595774386004795,0.00013729363841432745,0.0004410787013763393,0.0,0.002677946,False,USP1; ubiquitin specific peptidase
hsa:100287226,0.0,0.0,2.4985224502982463e-09,1.0925037770430006e-08,0.0,1.2397572e-07,False,ZNF729; zinc finger protein
hsa:353497,0.0,0.0,1.334555568582457e-05,4.5316120110658315e-05,0.0,0.0003777556,False,POLN; DNA polymerase
hsa:64816,0.0,0.0,3.67548178905848e-06,1.822458945751058e-05,0.0,0.0001984973,False,CYP3A43; cytochrome P450 family 3 subfamily A member
hsa:51227,0.0,0.0,4.034302285076023e-05,0.00010902244071194215,0.0,0.00077476195,False,PIGP; phosphatidylinositol glycan anchor biosynthesis class
hsa:3673,0.0,0.0,8.673068356725146e-07,6.001881875262343e-06,0.0,5.934876e-05,False,ITGA2; integrin subunit alpha
hsa:80778,1.9052722e-08,1.5866205061598856e-05,1.7309741616374267e-07,2.8013077390187955e-07,0.0,1.1123053e-06,False,ZNF34; zinc finger protein
hsa:6347,0.0,0.0,0.0003353796737590643,0.0007836837509090869,0.0,0.0058158175,False,CCL2; C-C motif chemokine ligand
hsa:93474,1.3488018e-08,1.1232182963806247e-05,7.446357547894739e-08,1.2529947284304163e-07,0.0,6.601587e-07,False,ZNF670; zinc finger protein
hsa:6770,0.0,0.0,4.2995754592397666e-05,0.00011842105691541769,0.0,0.00076604355,False,STAR; steroidogenic acute regulatory
hsa:7070,4.502802e-06,0.0037497203750612353,2.0150123370149707e-05,4.0780054051374846e-05,0.0,0.0002610733,False,THY1; Thy-1 cell surface
hsa:685,0.0,0.0,4.0337964086140354e-08,1.8588787778840205e-07,0.0,2.0872185e-06,False,BTC;
hsa:56548,0.0,0.0,1.9694446417017547e-06,5.778516783628533e-06,0.0,3.9906565e-05,False,CHST7; carbohydrate sulfotransferase
hsa:2752,0.0,0.0,0.00042350204840760255,0.0007618266648874799,0.0,0.0029813384,False,GLUL; glutamate-ammonia
hsa:9435,0.0,0.0,2.2583780272339178e-06,6.344880614882055e-06,0.0,3.1402258e-05,False,CHST2; carbohydrate sulfotransferase
hsa:219869,0.0,0.0,1.860924269005848e-08,2.4334742490536397e-07,0.0,3.1821805e-06,False,OR10G8; olfactory receptor family 10 subfamily G member
hsa:6558,1.0391172e-08,8.653276197613356e-06,2.042975420954386e-05,3.330805284270037e-05,0.0,0.00018166052,False,SLC12A2; solute carrier family 12 member
hsa:126068,0.0,0.0,8.165673335426904e-08,2.437619422768225e-07,0.0,1.4640997e-06,False,ZNF441; zinc finger protein
hsa:58517,0.0,0.0,8.464444009649122e-08,1.4451076289227218e-07,0.0,5.9553213e-07,False,RBM25; RNA binding motif protein
hsa:7298,9.216516e-05,0.07675078280652331,0.0007558856782894439,0.0013089620827293747,0.0,0.006151683,False,TYMS; thymidylate
hsa:9601,0.0,0.0,0.00017682667271035087,0.0005747665213669833,0.0,0.00539191,False,PDIA4; protein disulfide isomerase family A member
hsa:59341,0.0,0.0,1.7578373335105272e-05,5.240703969470298e-05,0.0,0.00035965806,False,TRPV4; transient receptor potential cation channel subfamily V member
hsa:493753,6.759723e-09,5.6291773573144146e-06,8.858479746748536e-07,1.7898609647942222e-06,0.0,8.099521e-06,False,COA5; cytochrome c oxidase assembly factor
hsa:79728,2.2651508e-07,0.0001886310370153131,9.613414901283038e-05,0.00022877314348124537,0.0,0.0014924348,False,PALB2; partner and localizer of
hsa:2206,0.0,0.0,8.995747962573099e-09,7.830093049549427e-08,0.0,9.865023e-07,False,MS4A2; membrane spanning 4-domains
hsa:347148,0.0,0.0,1.7102567022927187e-06,7.99310984092437e-06,0.0,8.587932e-05,False,QRFP; pyroglutamylated RFamide
hsa:6369,2.8211352e-05,0.023493078621361664,0.0002280603683192983,0.0004998285925005364,0.0,0.003019005,False,CCL24; C-C motif chemokine ligand
hsa:80326,4.549362e-06,0.003788493339242839,3.859240340134503e-05,0.00012045150797515555,0.0,0.00088879187,False,WNT10A; Wnt family member
hsa:6295,0.0,0.0,2.7328801061169593e-05,0.00010554616005184042,0.0,0.00086086383,False,SAG; S-antigen visual
hsa:3557,0.0,0.0,2.2522979233918127e-07,7.385868273160443e-07,0.0,7.322564e-06,False,IL1RN; interleukin 1 receptor
hsa:79799,0.0,0.0,1.183570162748538e-05,7.334320232984796e-05,0.0,0.00074916123,False,UGT2A3; UDP glucuronosyltransferase family 2 member
hsa:23162,1.2228251e-07,0.00010183108634593067,3.16135606902924e-07,4.858456765931152e-07,0.0,4.4055314e-06,False,MAPK8IP3; mitogen-activated protein kinase 8 interacting protein
hsa:4715,0.0,0.0,6.294979230175441e-06,1.7809362172302526e-05,0.0,0.00011435562,False,NDUFB9; NADH:ubiquinone oxidoreductase subunit
hsa:5300,3.439629e-06,0.0028643602236899384,0.0002017801166715205,0.00044294154106777975,0.0,0.0029770217,False,PIN1; peptidylprolyl cis/trans isomerase
hsa:3062,0.0,0.0,4.814026783914795e-07,2.979646675995155e-06,0.0,2.9390618e-05,False,HCRTR2; hypocretin receptor
hsa:113220,0.0,0.0,1.6330520182394736e-07,1.0095923223697264e-06,0.0,1.1761367e-05,False,KIF12; kinesin family member
hsa:10565,2.2965228e-10,1.9124354868263536e-07,1.5229249361257896e-06,4.355981738953373e-06,0.0,2.4262668e-05,False,ARFGEF1; ADP ribosylation factor guanine nucleotide exchange factor
hsa:4130,2.6695935e-07,0.0002223111107279653,5.338343520084794e-06,1.0196855841980307e-05,0.0,5.9679984e-05,False,MAP1A; microtubule associated protein
hsa:9049,1.3747707e-06,0.001144843967118074,1.5463034945321638e-05,3.6814817457917475e-05,0.0,0.00023629302,False,AIP; aryl hydrocarbon receptor interacting
hsa:288,1.3947889e-08,1.1615141765592287e-05,7.536399493195963e-07,1.260603391901425e-06,0.0,5.9533386e-06,False,ANK3; ankyrin
hsa:23460,0.0,0.0,3.3776304446198825e-05,7.508156404835291e-05,0.0,0.0003904843,False,ABCA6; ATP binding cassette subfamily A member
hsa:57107,0.0,0.0,4.9901307838919175e-06,1.3242996959169561e-05,0.0,8.429828e-05,False,PDSS2; decaprenyl diphosphate synthase subunit
hsa:391109,0.0,0.0,3.189508152631579e-07,2.6118433840229067e-06,0.0,2.9345252e-05,False,OR10K1; olfactory receptor family 10 subfamily K member
hsa:55224,0.0,0.0,2.648954241345029e-07,7.995471849449366e-07,0.0,5.6282247e-06,False,ETNK2; ethanolamine kinase
hsa:1270,0.0,0.0,2.1244991152614037e-06,5.678628856648849e-06,0.0,3.7227892e-05,False,CNTF; ciliary neurotrophic
hsa:54922,8.873317e-09,7.389278398045758e-06,1.1301182802842103e-06,2.0540458844768983e-06,0.0,9.684024e-06,False,RASIP1; Ras interacting protein
hsa:5365,0.0,0.0,4.683565898304097e-07,1.0813790866697152e-06,0.0,6.8633503e-06,False,PLXNB3; plexin
hsa:197322,0.0,0.0,2.2535582843099417e-05,4.057312359016752e-05,0.0,0.00019734548,False,ACSF3; acyl-CoA synthetase family member
hsa:586,0.0,0.0,7.745385368690058e-05,0.0001325579769143232,0.0,0.0006175071,False,BCAT1; branched chain amino acid transaminase
hsa:23020,3.8793857e-08,3.230568788503513e-05,1.1318020198111108e-06,3.253728981778851e-06,0.0,1.8644152e-05,False,SNRNP200; small nuclear ribonucleoprotein U5 subunit
hsa:10717,2.7306993e-07,0.00022739971252068054,3.985534682548539e-06,8.013585329989484e-06,0.0,3.676821e-05,False,AP4B1; adaptor related protein complex 4 subunit beta
hsa:7018,1.7160917e-06,0.0014290799402157752,3.9644734390233916e-05,8.567576247042359e-05,0.0,0.00056398293,False,TF;
hsa:5431,1.281153e-07,0.00010668835777524367,3.924504225655557e-05,0.00011523061834242293,0.0,0.0008953048,False,POLR2B; RNA polymerase II subunit
hsa:2354,0.0,0.0,3.0233540416959067e-05,9.521208366784783e-05,0.0,0.0006872684,False,FOSB; FosB proto-oncogene
hsa:7136,2.195035e-08,1.8279212506951315e-05,1.7442863859444443e-07,4.866748631375163e-07,0.0,3.1934712e-06,False,TNNI2; troponin I2
hsa:84128,0.0,0.0,2.3429973797165786e-06,4.510599978529902e-06,0.0,1.9652945e-05,False,WDR75; WD repeat domain
hsa:8027,1.8400809e-06,0.001532332277211171,7.751638321362576e-05,0.00021863828128594745,0.0,0.0015089737,False,STAM; signal transducing adaptor
hsa:10791,0.0,0.0,0.00011099947470828069,0.00029636690827849414,0.0,0.0016085851,False,VAMP5; vesicle associated membrane protein
hsa:3725,0.0,0.0,0.00016604217598888886,0.00033417632721813236,0.0,0.0017326738,False,JUN; Jun proto-oncogene
hsa:8890,0.0,0.0,2.8197154447953216e-07,6.841489187436509e-07,0.0,3.5652356e-06,False,EIF2B4; eukaryotic translation initiation factor 2B subunit
hsa:51380,0.0,0.0,0.00018430875542690056,0.00037928310744517424,0.0,0.002099684,False,CSAD; cysteine sulfinic acid
hsa:57555,3.2715648e-06,0.0027244043128907595,1.3561844731140347e-05,2.0442262441171146e-05,0.0,0.00014620912,False,NLGN2; neuroligin
hsa:902,0.0,0.0,9.17476790388889e-06,2.5463947390771634e-05,0.0,0.00017446929,False,CCNH; cyclin
hsa:777,7.036874e-05,0.05859975591762342,0.0002639280507827485,0.0005235169403410573,0.0,0.0042776554,False,CACNA1E; calcium voltage-gated channel subunit alpha1
hsa:2776,0.0011813098,0.9837388866575776,0.0015410364867064327,0.0014929107983506474,0.0,0.007002788,True,GNAQ; G protein subunit alpha
hsa:121278,0.0,0.0,3.7639386658304117e-06,1.629278471780059e-05,0.0,0.0001678231,False,TPH2; tryptophan hydroxylase
hsa:3748,0.0,0.0,5.72510754576608e-08,1.1858594058360562e-07,0.0,5.6790907e-07,False,KCNC3; potassium voltage-gated channel subfamily C member
hsa:2159,5.841056e-08,4.8641549628594994e-05,3.93871158645614e-07,1.0459680219622838e-06,0.0,8.546041e-06,False,F10; coagulation factor
hsa:51773,9.748126e-08,8.117777926025657e-05,5.8570725729742686e-06,1.8860542755767304e-05,0.0,0.00014355266,False,RSF1; remodeling and spacing factor
hsa:2963,5.0746085e-08,4.225893763018879e-05,1.4630082243333343e-06,3.229767839589507e-06,0.0,2.5522431e-05,False,GTF2F2; general transcription factor IIF subunit
hsa:54714,0.0,0.0,2.3107180499555552e-08,1.384206440881497e-07,0.0,1.3673638e-06,False,CNGB3; cyclic nucleotide gated channel subunit beta
hsa:25888,3.2095098e-08,2.6727278461319666e-05,6.48599172982456e-08,7.459524228728502e-08,0.0,3.3683727e-07,False,ZNF473; zinc finger protein
hsa:51503,8.460128e-08,7.045194156266711e-05,2.282339777842105e-07,3.015877847210073e-07,0.0,1.7106114e-06,False,CWC15; CWC15 spliceosome associated protein
hsa:81328,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4A15; olfactory receptor family 4 subfamily A member
hsa:9641,0.0,0.0,1.9429701883801168e-05,7.192679040314791e-05,0.0,0.000451163,False,IKBKE; inhibitor of nuclear factor kappa B kinase subunit
hsa:50616,0.0,0.0,3.3504278494035094e-06,1.751957075784497e-05,0.0,0.0001889674,False,IL22; interleukin
hsa:192134,0.0,0.0,5.231436681137427e-06,1.899210742882551e-05,0.0,0.00014419752,False,B3GNT6; UDP-GlcNAc:betaGal beta-1
hsa:3082,0.0,0.0,2.577365560333332e-05,5.632771599579553e-05,0.0,0.00040672068,False,HGF; hepatocyte growth
hsa:84265,9.2739447e-07,0.0007722902183747176,0.00015648200336181286,0.00045273207782664765,0.0,0.0024408342,False,POLR3GL; RNA polymerase III subunit
hsa:27074,8.00724e-12,6.6680504663552435e-09,2.19924224800655e-07,5.421190471388312e-07,0.0,3.680226e-06,False,LAMP3; lysosomal associated membrane protein
hsa:9969,1.9413099e-07,0.00016166309969521399,1.0650232900440351e-05,2.766234747657545e-05,0.0,0.0002084927,False,MED13; mediator complex subunit
hsa:2044,0.0,0.0,0.0,0.0,0.0,0.0,False,EPHA5; EPH receptor
hsa:2135,1.6217431e-05,0.013505108919257321,9.319495768263163e-05,0.00017910806761980736,0.0,0.0011052199,False,EXTL2; exostosin like glycosyltransferase
hsa:5788,3.390494e-05,0.028234429213904736,0.00016912416864865503,0.00036510977530073346,0.0,0.0029430722,False,PTPRC; protein tyrosine phosphatase receptor type
hsa:8527,0.0,0.0,4.9458027296315774e-05,9.111466350844504e-05,0.0,0.00045370788,False,DGKD; diacylglycerol kinase
hsa:122618,1.4637587e-06,0.0012189489614606963,1.4590511070444434e-05,3.1661994430116534e-05,0.0,0.0001758539,False,PLD4; phospholipase D family member
hsa:9021,0.0,0.0,1.8930556183040934e-05,7.570081162852251e-05,0.0,0.00062426255,False,SOCS3; suppressor of cytokine signaling
hsa:23450,0.0,0.0,6.393080704444442e-07,1.7013174133326596e-06,0.0,1.010009e-05,False,SF3B3; splicing factor 3b subunit
hsa:51264,0.0,0.0,1.5171435011678367e-07,4.570632958730595e-07,0.0,2.1639428e-06,False,MRPL27; mitochondrial ribosomal protein
hsa:9337,0.0,0.0,5.782042124035088e-07,1.5760086632665678e-06,0.0,9.245704e-06,False,CNOT8; CCR4-NOT transcription complex subunit
hsa:2877,1.2114722e-05,0.010088567057046392,3.4880417412339195e-05,8.30691137086821e-05,0.0,0.000937523,False,GPX2; glutathione peroxidase
hsa:27334,0.0,0.0,1.2619802880388303e-06,5.6355514819058665e-06,0.0,5.0004448e-05,False,P2RY10; P2Y receptor family member
hsa:1832,1.4533668e-07,0.00012102950790191414,2.913625234069591e-06,6.425777918442919e-06,0.0,3.730947e-05,False,DSP;
hsa:6748,5.4973913e-08,4.5779672673358445e-05,9.937692148467838e-07,2.423222579738451e-06,0.0,1.578368e-05,False,SSR4; signal sequence receptor subunit
hsa:70,0.0,0.0,1.2482986965964913e-05,3.419499560831857e-05,0.0,0.00023356621,False,ACTC1; actin alpha cardiac muscle
hsa:23166,0.0,0.0,8.571713322177777e-05,0.0002180876752272189,0.0,0.00110039,False,STAB1; stabilin
hsa:5564,0.00012301067,0.10243746352802854,0.0011422986568760233,0.002657010781148722,0.0,0.014807677,False,PRKAB1; protein kinase AMP-activated non-catalytic subunit beta
hsa:7332,4.453492e-08,3.7086573410450236e-05,9.871859562157894e-07,2.024325047962625e-06,0.0,1.0885015e-05,False,UBE2L3; ubiquitin conjugating enzyme E2
hsa:51735,0.0,0.0,3.424789814049124e-05,0.00011436533076471544,0.0,0.0006670249,False,RAPGEF6; Rap guanine nucleotide exchange factor
hsa:6469,0.0,0.0,7.668590352046783e-07,6.529100109086041e-06,0.0,6.2210616e-05,False,SHH; sonic hedgehog signaling
hsa:5699,0.0,0.0,3.916016380198831e-06,9.451890100079102e-06,0.0,7.076816e-05,False,PSMB10; proteasome 20S subunit beta
hsa:389015,-0.0,0.0,7.556506920225145e-07,4.406228002793867e-06,0.0,4.5394452e-05,False,SLC9A4; solute carrier family 9 member
hsa:7067,2.9422547e-06,0.0024501704488026975,5.353139610637424e-05,9.867586371802413e-05,0.0,0.000670907,False,THRA; thyroid hormone receptor
hsa:2012,0.0,0.0,3.4099855017543855e-07,6.849285501802406e-07,0.0,3.6316078e-06,False,EMP1; epithelial membrane protein
hsa:3381,7.958613e-08,6.627556202410683e-05,9.695680118156723e-06,4.0560160480025825e-05,0.0,0.0002895205,False,IBSP; integrin binding
hsa:100271849,2.1356593e-07,0.0001778475978157382,6.983259266007014e-06,2.8145330529368624e-05,0.0,0.00024385583,False,MEF2B; myocyte enhancer factor
hsa:22827,0.0,0.0,9.631918641210525e-08,2.8971427176768624e-07,0.0,2.196143e-06,False,PUF60; poly(U) binding splicing factor
hsa:8908,9.605333e-05,0.0799886667442807,0.00018524497116352624,0.000247581889776509,0.0,0.0012250734,False,GYG2; glycogenin
hsa:27131,3.8426133e-09,3.1999464743267174e-06,5.028760591518129e-07,1.175566881754528e-06,0.0,9.970983e-06,False,SNX5; sorting nexin
hsa:5706,0.0,0.0,4.537197942280702e-06,1.191771088308148e-05,0.0,0.00011453633,False,PSMC6; proteasome 26S subunit
hsa:56649,-0.0,0.0,4.870339933921053e-09,2.659921768457697e-08,0.0,2.9170545e-07,False,TMPRSS4; transmembrane serine protease
hsa:256076,3.7048085e-08,3.085189159583311e-05,3.952294094312867e-06,1.2398005444493943e-05,0.0,0.0001320087,False,COL6A5; collagen type VI alpha 5
hsa:23118,0.0,0.0,2.969441295146198e-05,8.160807860900102e-05,0.0,0.00073959096,False,TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:10369,0.00015964445,0.13294434153010606,0.00033146883596783604,0.0005789979322096571,0.0,0.0039810166,False,CACNG2; calcium voltage-gated channel auxiliary subunit gamma
hsa:5792,2.0331456e-05,0.016931074210649502,8.304769760994151e-05,0.00011002026266204269,0.0,0.0004449432,False,PTPRF; protein tyrosine phosphatase receptor type
hsa:84570,0.0,0.0,6.868304479807015e-06,2.259248534901189e-05,0.0,0.00015098663,False,COL25A1; collagen type XXV alpha 1
hsa:231,0.00012331549,0.10269130319602328,0.0008145040747222222,0.0016086541144078106,0.0,0.01131575,False,AKR1B1; aldo-keto reductase family 1 member
hsa:29074,2.586274e-08,2.153726571430661e-05,1.3536305155713448e-07,1.9375941308492844e-07,0.0,8.314935e-07,False,MRPL18; mitochondrial ribosomal protein
hsa:390264,0.0,0.0,2.2976812280701754e-07,2.2845269120253823e-06,0.0,2.8701996e-05,False,OR10G4; olfactory receptor family 10 subfamily G member
hsa:91522,0.0,0.0,1.2645015463918129e-05,3.341028222507426e-05,0.0,0.00022513627,False,COL23A1; collagen type XXIII alpha 1
hsa:51365,5.1360352e-08,4.277047011276913e-05,5.782836180762575e-06,2.3978485106421697e-05,0.0,0.00019690063,False,PLA1A; phospholipase A1 member
hsa:10350,0.0,0.0,1.073971517497076e-05,2.0241041914398562e-05,0.0,0.00012864289,False,ABCA9; ATP binding cassette subfamily A member
hsa:5091,0.0,0.0,4.280122876407691e-05,0.000154082300744767,0.0,0.0009412204,False,PC; pyruvate
hsa:5604,0.0,0.0,0.0001949049980584795,0.00040805721557392647,0.0,0.0023311437,False,MAP2K1; mitogen-activated protein kinase kinase
hsa:64772,0.0,0.0,4.133797171783625e-05,0.00010122765037646266,0.0,0.00054984394,False,ENGASE;
hsa:389541,0.0,0.0,1.1453461189473687e-06,2.3238208817710223e-06,0.0,1.1695462e-05,False,LAMTOR4; late endosomal/lysosomal adaptor
hsa:1303,0.0,0.0,6.583691637426901e-07,2.1539331437182465e-06,0.0,1.3368155e-05,False,COL12A1; collagen type XII alpha 1
hsa:162239,1.2677604e-08,1.0557308543826228e-05,7.296245907777782e-08,1.0103141903251276e-07,0.0,4.876761e-07,False,ZFP1; ZFP1 zinc finger
hsa:9972,1.8028841e-06,0.001501356542802446,2.016034538701755e-05,3.662890746074273e-05,0.0,0.00018187586,False,NUP153; nucleoporin
hsa:11325,0.0,0.0,1.4747286534883035e-07,2.804087806472588e-07,0.0,1.4350369e-06,False,DDX42; DEAD-box helicase
hsa:2353,0.0,0.0,6.73694857017544e-05,0.0001813593588853618,0.0,0.0010790549,False,FOS; Fos proto-oncogene
hsa:55698,1.8879487e-07,0.0001572194315330848,4.8113355869317526e-05,8.36472429565405e-05,0.0,0.00034814535,False,RADIL; Rap associating with DIL
hsa:55742,1.5915946e-08,1.3254046481407438e-05,5.814481276883041e-07,1.1435875603561445e-06,0.0,9.484417e-06,False,PARVA; parvin
hsa:4922,0.0,0.0,2.4533365060146795e-05,5.333839879676226e-05,0.0,0.00032971616,False,NTS;
hsa:120793,-0.0,0.0,6.002379773216374e-07,4.368987488563623e-06,0.0,4.690985e-05,False,OR56A4; olfactory receptor family 56 subfamily A member
hsa:124872,0.0,0.0,7.79723161447871e-06,4.997637598147805e-05,0.0,0.0005056079,False,B4GALNT2; beta-1
hsa:7389,0.0,0.0,0.00012263923167894736,0.0003344089707241831,0.0,0.0020022914,False,UROD; uroporphyrinogen
hsa:55540,1.4311274e-05,0.01191775159353756,6.991631731964915e-05,0.00014177203453089837,0.0,0.0009520573,False,IL17RB; interleukin 17 receptor
hsa:57007,0.0,0.0,8.050172116959065e-06,2.8533572951446964e-05,0.0,0.00019090308,False,ACKR3; atypical chemokine receptor
hsa:5611,5.8142993e-09,4.841873249570885e-06,3.2748626507836245e-06,9.154036117532173e-06,0.0,4.6220703e-05,False,DNAJC3; DnaJ heat shock protein family (Hsp40) member
hsa:3732,0.0,0.0,9.547976793976608e-06,1.9616434904572323e-05,0.0,0.0001134328,False,CD82; CD82
hsa:5607,0.0,0.0,0.0002752812070343509,0.000964191832058969,0.0,0.0069677564,False,MAP2K5; mitogen-activated protein kinase kinase
hsa:7408,0.0,0.0,7.141859364805266e-05,0.00015415310865875227,0.0,0.0007554132,False,VASP; vasodilator stimulated
hsa:220992,0.0,0.0,2.2428187132397666e-08,5.193616371209996e-08,0.0,2.6185492e-07,False,ZNF485; zinc finger protein
hsa:9934,0.0,0.0,4.13894636491228e-08,1.2634874473489064e-07,0.0,7.202053e-07,False,P2RY14; purinergic receptor
hsa:7757,0.0,0.0,1.0172152071009358e-07,3.1565401803787377e-07,0.0,2.4346268e-06,False,ZNF208; zinc finger protein
hsa:1281,0.0,0.0,8.604736324415204e-05,0.00021557608932710833,0.0,0.0016136813,False,COL3A1; collagen type III alpha 1
hsa:168391,0.0,0.0,2.9148808059274854e-05,0.00018876128934304778,0.0,0.002333735,False,GALNTL5; polypeptide N-acetylgalactosaminyltransferase like
hsa:166824,2.6856032e-06,0.0022364432276546146,2.8027365601286558e-05,7.161509610995787e-05,0.0,0.0004694503,False,RASSF6; Ras association domain family member
hsa:406976,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR199A1; microRNA
hsa:9894,0.0,0.0,2.172106799353217e-05,7.563247437318691e-05,0.0,0.0005414063,False,TELO2; telomere maintenance
hsa:19,0.0,0.0,1.4365539194385962e-05,5.535013495999648e-05,0.0,0.00041849844,False,ABCA1; ATP binding cassette subfamily A member
hsa:54518,2.0137107e-07,0.00016769229562545328,7.840770800994154e-07,1.4151800432898265e-06,0.0,1.2667272e-05,False,APBB1IP; amyloid beta precursor protein binding family B member 1 interacting
hsa:55422,3.09019e-08,2.5733639644404706e-05,1.3969226247368425e-07,2.544727056537615e-07,0.0,1.2939812e-06,False,ZNF331; zinc finger protein
hsa:10092,0.0,0.0,8.497902627508771e-05,0.00027968397079888575,0.0,0.0015381284,False,ARPC5; actin related protein 2/3 complex subunit
hsa:23457,0.0,0.0,0.00031181598039122806,0.001074658603545857,0.0,0.0069378195,False,ABCB9; ATP binding cassette subfamily B member
hsa:7432,0.0,0.0,9.891074882456138e-08,3.047150103938825e-07,0.0,2.2452514e-06,False,VIP; vasoactive intestinal
hsa:51426,0.0,0.0,6.900926687719297e-05,0.00012852064065485967,0.0,0.0009296647,False,POLK; DNA polymerase
hsa:11157,1.0747414e-07,8.949937673257313e-05,5.430166429350875e-06,1.846526850948611e-05,0.0,0.00014737119,False,LSM6; LSM6 homolog
hsa:219931,7.166301e-06,0.005967756271211061,5.6449331915116954e-05,9.673099091262747e-05,0.0,0.0005765198,False,TPCN2; two pore segment channel
hsa:494143,2.4358744e-07,0.00020284809033952776,6.509011984978068e-05,0.0002026824561639248,0.0,0.0015325294,False,CHAC2; ChaC glutathione specific gamma-glutamylcyclotransferase
hsa:959,7.378972e-05,0.061448586136824045,0.00019348425613625734,0.00028959715069566444,0.0,0.0015408476,False,CD40LG; CD40
hsa:10242,0.0,0.0,2.3719930565251457e-05,7.978150099142905e-05,0.0,0.0006049117,False,KCNMB2; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:7561,0.0,0.0,3.816356388555557e-08,8.25126608056694e-08,0.0,3.1700756e-07,False,ZNF14; zinc finger protein
hsa:3306,6.2462414e-07,0.00052015741853919,3.5125652523391823e-06,8.594245430501066e-06,0.0,7.469993e-05,False,HSPA2; heat shock protein family A (Hsp70) member
hsa:27316,0.0,0.0,1.09362057493e-06,2.9004062805577633e-06,0.0,1.7182743e-05,False,RBMX; RNA binding motif protein
hsa:112724,0.0,0.0,3.9604276323350874e-05,0.0001086523996897799,0.0,0.0007899359,False,RDH13; retinol dehydrogenase
hsa:4899,1.1749052e-08,9.784054389256724e-06,2.527608428989474e-06,4.36786547707864e-06,0.0,3.8770027e-05,False,NRF1; nuclear respiratory factor
hsa:1437,0.0,0.0,4.572976848947369e-06,1.2647229468609888e-05,0.0,0.00010457055,False,CSF2; colony stimulating factor
hsa:388753,5.3212995e-07,0.00044313263512260067,8.591091184438597e-07,1.1407850584795885e-06,0.0,5.9109693e-06,False,COA6; cytochrome c oxidase assembly factor
hsa:117,8.962072e-05,0.07463189361016939,0.00040353025567251455,0.0007149773101501151,0.0,0.0034353076,False,ADCYAP1R1; ADCYAP receptor type
hsa:55102,5.2001556e-06,0.004330443445394397,0.000496624444550918,0.0014052692178389541,0.0,0.007335441,False,ATG2B; autophagy related
hsa:138429,6.210735e-07,0.0005172006136091692,1.7298178539450052e-05,5.899539785206899e-05,0.0,0.00040929334,False,PIP5KL1; phosphatidylinositol-4-phosphate 5-kinase like
hsa:6556,0.0,0.0,1.7751198646649126e-07,4.7355796867966384e-07,0.0,3.1147354e-06,False,SLC11A1; solute carrier family 11 member
hsa:2687,0.0,0.0,1.5716870526315794e-05,3.727760292948041e-05,0.0,0.00020759492,False,GGT5; gamma-glutamyltransferase
hsa:3479,0.0,0.0,2.051690710526316e-05,0.00011706112233691769,0.0,0.0014430644,False,IGF1; insulin like growth factor
hsa:5662,0.0,0.0,3.861544027327486e-07,1.0951073912944508e-06,0.0,6.0791244e-06,False,PSD; pleckstrin and Sec7 domain
hsa:124975,0.0,0.0,2.2342668670760235e-06,8.696174458615185e-06,0.0,8.733321e-05,False,GGT6; gamma-glutamyltransferase
hsa:8463,0.0,0.0,2.7582104380116954e-05,5.805249187064897e-05,0.0,0.00037872413,False,TEAD2; TEA domain transcription factor
hsa:81888,4.2287184e-07,0.00035214765261444645,1.588288746389474e-05,2.6005744500024773e-05,0.0,0.00012493235,False,HYI; hydroxypyruvate isomerase
hsa:93432,5.5096e-06,0.004588134094823042,2.790937469877193e-05,6.147166435735226e-05,0.0,0.00048689562,False,MGAM2; maltase-glucoamylase 2
hsa:2821,0.00014639256,0.12190879478808404,0.0005866395175575437,0.0008413017953840204,0.0,0.0036576407,False,GPI; glucose-6-phosphate
hsa:27178,0.0,0.0,2.445023630660234e-05,8.231947027296255e-05,0.0,0.0006610477,False,IL37; interleukin
hsa:6352,8.231855e-06,0.006855099206682797,8.751759413333336e-05,0.00015573462271565498,0.0,0.0008744527,False,CCL5; C-C motif chemokine ligand
hsa:1910,0.0,0.0,1.4426179771929821e-06,4.7475644610512106e-06,0.0,2.6518963e-05,False,EDNRB; endothelin receptor type
hsa:55454,6.4995584e-06,0.005412524592771435,0.000533864747545965,0.0012391433909612185,0.0,0.006118282,False,CSGALNACT2; chondroitin sulfate N-acetylgalactosaminyltransferase
hsa:2241,7.533695e-08,6.27370460459886e-05,4.461076657508773e-06,1.2686147867887128e-05,0.0,7.829743e-05,False,FER; FER tyrosine
hsa:55746,0.0,0.0,1.989825163964913e-07,4.5114477353502535e-07,0.0,2.2153702e-06,False,NUP133; nucleoporin
hsa:4698,1.0539569e-06,0.0008776854195157541,4.751956205906433e-06,5.947327425908799e-06,0.0,2.4039038e-05,False,NDUFA5; NADH:ubiquinone oxidoreductase subunit
hsa:219438,0.0,0.0,7.463388888888889e-08,8.00624908911602e-07,0.0,1.0155001e-05,False,OR5D18; olfactory receptor family 5 subfamily D member
hsa:148327,0.0015127658,1.259759754694035,0.0017267641726081875,0.0013446753619211027,0.0,0.0071232594,True,CREB3L4; cAMP responsive element binding protein 3 like
hsa:23480,1.2496275e-05,0.010406306335448092,0.00017252049104058486,0.0004198107511745364,0.0,0.0028226967,False,SEC61G; SEC61 translocon subunit
hsa:493,0.0,0.0,0.00020219627278070184,0.00035333265012494713,0.0,0.0024335475,False,ATP2B4; ATPase plasma membrane Ca2+ transporting
hsa:9071,3.8745866e-06,0.003226572325178686,1.8689156065333335e-05,4.236305165951875e-05,0.0,0.00034013015,False,CLDN10; claudin
hsa:1183,0.0,0.0,3.402434771111112e-06,1.7522433112984712e-05,0.0,0.00018612768,False,CLCN4; chloride voltage-gated channel
hsa:7056,0.0,0.0,2.286237348538012e-06,4.8059825237916595e-06,0.0,2.5324443e-05,False,THBD;
hsa:81578,0.0,0.0,1.1253852820584798e-06,4.58556448266424e-06,0.0,4.3812695e-05,False,COL21A1; collagen type XXI alpha 1
hsa:554235,0.0,0.0,8.686224938594737e-05,0.0002108969660190887,0.0,0.001309196,False,ASPDH; aspartate dehydrogenase domain
hsa:54480,4.615287e-05,0.03843392558823427,0.0010355573810180124,0.0019977224901943026,0.0,0.009014397,False,CHPF2; chondroitin polymerizing factor
hsa:115019,7.745066e-09,6.449724368602933e-06,1.7467025442103507e-06,5.195798376888153e-06,0.0,3.851254e-05,False,SLC26A9; solute carrier family 26 member
hsa:406957,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181C; microRNA
hsa:64841,5.190777e-07,0.0004322633391230447,1.819535868152047e-05,5.0280625573792874e-05,0.0,0.00028187523,False,GNPNAT1; glucosamine-phosphate N-acetyltransferase
hsa:29949,0.0,0.0,2.5473269473918135e-06,1.1988287465311576e-05,0.0,0.00011510662,False,IL19; interleukin
hsa:10368,0.0,0.0,0.00011093045182488887,0.00026030564497692344,0.0,0.0013925638,False,CACNG3; calcium voltage-gated channel auxiliary subunit gamma
hsa:84892,0.0,0.0,6.211391675906431e-05,0.00011795639605139222,0.0,0.00063026085,False,POMGNT2; protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta
hsa:7508,0.0,0.0,1.6045586045506426e-06,3.6933338664523542e-06,0.0,1.9151299e-05,False,XPC; XPC complex subunit
hsa:64132,0.0,0.0,0.0001430162451695906,0.000401852005358491,0.0,0.0020639685,False,XYLT2; xylosyltransferase
hsa:94274,6.4163186e-07,0.0005343206427310013,3.706544062847369e-05,0.00011862843847991158,0.0,0.00077335484,False,PPP1R14A; protein phosphatase 1 regulatory inhibitor subunit
hsa:1948,0.0,0.0,5.002944382374269e-07,1.3120858003435988e-06,0.0,7.850967e-06,False,EFNB2; ephrin
hsa:10950,2.760659e-07,0.00022989461452882395,2.786165553473684e-06,6.099363358364463e-06,0.0,3.7401198e-05,False,BTG3; BTG anti-proliferation factor
hsa:4294,7.8232944e-08,6.514869277348297e-05,1.709396094035089e-07,2.3228814227367596e-07,0.0,1.2886946e-06,False,MAP3K10; mitogen-activated protein kinase kinase kinase
hsa:10248,1.4201174e-07,0.00011826065524886474,3.929392072695905e-07,7.784289954836255e-07,0.0,6.5078107e-06,False,POP7; POP7 homolog
hsa:1387,0.00011537647,0.0960800631166197,0.00038106434692982436,0.0005847019375606396,0.0,0.002996986,False,CREBBP; CREB binding
hsa:220988,0.0,0.0,1.3657583706432748e-07,2.1819078126166886e-07,0.0,1.0038715e-06,False,HNRNPA3; heterogeneous nuclear ribonucleoprotein
hsa:258010,3.0090746e-08,2.5058148987451008e-05,8.31972115485965e-07,1.563015190694285e-06,0.0,8.074764e-06,False,SVIP; small VCP interacting
hsa:10291,0.0,0.0,3.2435518046900576e-07,8.9478437838115e-07,0.0,5.0460085e-06,False,SF3A1; splicing factor 3a subunit
hsa:167227,4.3405777e-08,3.6146276565628325e-05,1.2187040744738008e-06,2.32568061792249e-06,0.0,1.2638875e-05,False,DCP2; decapping mRNA
hsa:259295,0.00021679775,0.18053890454042437,0.0005545974005847949,0.000757137588394675,0.0,0.0043316092,False,TAS2R20; taste 2 receptor member
hsa:137075,0.0,0.0,3.887789592230995e-06,1.4197692586868447e-05,0.0,0.00011195996,False,CLDN23; claudin
hsa:5704,0.0,0.0,6.703272583426898e-06,1.7021755597055168e-05,0.0,8.990983e-05,False,PSMC4; proteasome 26S subunit
hsa:9127,0.0,0.0,1.0233911003216378e-05,2.686173395588214e-05,0.0,0.00015466163,False,P2RX6; purinergic receptor P2X
hsa:65110,3.3987422e-07,0.0002830311631939501,1.343858853547954e-06,2.033450609309209e-06,0.0,9.985549e-06,False,UPF3A; UPF3A regulator of nonsense mediated mRNA
hsa:3572,0.0,0.0,0.00016146254861247372,0.0004338573975553441,0.0,0.0036398056,False,IL6ST; interleukin 6 cytokine family signal
hsa:4837,0.0,0.0,2.5078051782339185e-05,0.00015706994831456484,0.0,0.0019794374,False,NNMT; nicotinamide
hsa:51434,8.414305e-08,7.007034930800784e-05,2.0919481322807014e-05,5.5883287219495244e-05,0.0,0.0004186989,False,ANAPC7; anaphase promoting complex subunit
hsa:5576,1.196012e-07,9.959821829202658e-05,1.0177407732163741e-06,2.525213044051414e-06,0.0,1.5457323e-05,False,PRKAR2A; protein kinase cAMP-dependent type II regulatory subunit
hsa:406890,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7G; microRNA
hsa:657,3.9546585e-06,0.003293252413465905,5.860916278830409e-05,0.0001450812827110095,0.0,0.0010503434,False,BMPR1A; bone morphogenetic protein receptor type
hsa:5287,3.2989894e-07,0.000274724222168575,1.0457458551046784e-05,2.0350015592258807e-05,0.0,0.00013178978,False,PIK3C2B; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:3822,0.0,0.0,2.7237100706900584e-08,2.08122874359606e-07,0.0,2.681916e-06,False,KLRC2; killer cell lectin like receptor
hsa:27250,9.4602065e-08,7.878012194481734e-05,8.80136593663392e-07,1.5697362991610716e-06,0.0,8.304818e-06,False,PDCD4; programmed cell death
hsa:92960,0.0,0.0,1.620222552272281e-05,6.063749662522673e-05,0.0,0.00037741096,False,PEX11G; peroxisomal biogenesis factor 11
hsa:783,7.687945e-05,0.06402156703503763,0.00018082170241812864,0.00034168462077411855,0.0,0.0021473174,False,CACNB2; calcium voltage-gated channel auxiliary subunit beta
hsa:64109,0.0,0.0,1.141860626783626e-08,3.497425436307917e-08,0.0,2.2080827e-07,False,CRLF2; cytokine receptor like factor
hsa:3292,0.0,0.0,0.00010737090209818714,0.00023084919427226525,0.0,0.0013819677,False,HSD17B1; hydroxysteroid 17-beta dehydrogenase
hsa:376497,0.0,0.0,3.221077426842105e-05,7.531221771999931e-05,0.0,0.00066499884,False,SLC27A1; solute carrier family 27 member
hsa:4638,0.0,0.0,1.2398443282116956e-05,3.358242080668343e-05,0.0,0.0002978424,False,MYLK; myosin light chain
hsa:29926,0.0,0.0,0.0001190071129599415,0.00028927228472048485,0.0,0.0015756603,False,GMPPA; GDP-mannose pyrophosphorylase
hsa:5878,0.0,0.0,0.00010813359614678362,0.0004226278171627627,0.0,0.005237029,False,RAB5C; RAB5C
hsa:5982,1.2514548e-05,0.010421523224934571,0.0002727020266115788,0.0005205265056428984,0.0,0.002615678,False,RFC2; replication factor C subunit
hsa:10298,1.9181609e-05,0.015973536054607326,5.424551505538008e-05,7.822672356133965e-05,0.0,0.00049495755,False,PAK4; p21 (RAC1) activated kinase
hsa:23461,0.0,0.0,0.0001184242397204094,0.00021767597558114705,0.0,0.0011919016,False,ABCA5; ATP binding cassette subfamily A member
hsa:9801,4.069596e-09,3.388966923144234e-06,1.9899171823590635e-07,4.569459257263213e-07,0.0,2.6772475e-06,False,MRPL19; mitochondrial ribosomal protein
hsa:406913,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR126; microRNA
hsa:2862,0.0,0.0,2.1370253045321633e-08,8.103778065625589e-08,0.0,5.1037875e-07,False,MLNR; motilin
hsa:57498,1.6391472e-06,0.0013650042026197408,6.983883235877193e-06,1.4311742606729963e-05,0.0,8.3195875e-05,False,KIDINS220; kinase D interacting substrate
hsa:22929,0.0,0.0,0.00024128099351111116,0.00048534374059682487,0.0,0.00205465,False,SEPHS1; selenophosphate synthetase
hsa:364,0.0,0.0,7.798148935438598e-07,3.0944046985759107e-06,0.0,2.3578477e-05,False,AQP7; aquaporin
hsa:6647,8.5130105e-06,0.007089232199186248,0.00014813587651356727,0.00032340685199383235,0.0,0.0032220942,False,SOD1; superoxide dismutase
hsa:8625,0.0,0.0,0.00038689744556245627,0.000994143972039136,0.0,0.004888604,False,RFXANK; regulatory factor X associated ankyrin containing
hsa:23705,8.765234e-08,7.299271991524276e-05,9.032616567438599e-06,2.3700989138285693e-05,0.0,0.0001618799,False,CADM1; cell adhesion molecule
hsa:284532,0.0,0.0,7.237075222222221e-08,6.867438081759675e-07,0.0,8.658702e-06,False,OR14A16; olfactory receptor family 14 subfamily A member
hsa:11227,0.0,0.0,3.713895395461989e-06,1.3432091971870291e-05,0.0,9.490937e-05,False,GALNT5; polypeptide N-acetylgalactosaminyltransferase
hsa:6198,0.00020187288,0.1681101792413461,0.0002606347152152047,0.0002856728346247556,0.0,0.0017281747,False,RPS6KB1; ribosomal protein S6 kinase
hsa:64601,1.2086133e-06,0.0010064759491045792,0.00022257679042981282,0.00046125276569991373,0.0,0.0022036445,False,VPS16; VPS16 core subunit of CORVET and HOPS
hsa:1869,0.00023313233,0.1941415696018834,0.0005595628618421052,0.0007635225694829915,0.0,0.00459319,False,E2F1; E2F transcription factor
hsa:1392,0.0,0.0,5.44643303766082e-06,2.7859506718225145e-05,0.0,0.00029992775,False,CRH; corticotropin releasing
hsa:715,0.0,0.0,4.3700504724268997e-05,8.134437811716641e-05,0.0,0.00040523385,False,C1R; complement
hsa:548644,4.4772852e-07,0.0003728471191804596,7.762266424192986e-05,0.00021372661948059095,0.0,0.0012551111,False,POLR2J3; RNA polymerase II subunit
hsa:8312,0.0,0.0,3.0031665674514626e-05,6.85225310972867e-05,0.0,0.00039137047,False,AXIN1; axin
hsa:84733,1.2015859e-07,0.00010006238630115853,0.00013147042551966555,0.00044631525480748487,0.0,0.0025542085,False,CBX2; chromobox
hsa:793,1.3296731e-06,0.0011072888204368826,8.172157235900587e-05,0.0002728066860173115,0.0,0.002221966,False,CALB1; calbindin
hsa:2253,2.919844e-06,0.002431507878605432,1.2726738260929824e-05,4.5587414040029085e-05,0.0,0.00053218834,False,FGF8; fibroblast growth factor
hsa:286,6.7782597e-09,5.644613843679215e-06,5.143560096874854e-07,8.683654227078737e-07,0.0,4.602023e-06,False,ANK1; ankyrin
hsa:407017,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26B; microRNA
hsa:81458,0.0,0.0,8.392931052631579e-08,7.354252273498462e-07,0.0,8.323523e-06,False,OR2T7; olfactory receptor family 2 subfamily T member
hsa:8549,1.4992046e-09,1.2484666292245429e-06,9.566481784502925e-08,3.022329192044725e-07,0.0,2.5417696e-06,False,LGR5; leucine rich repeat containing G protein-coupled receptor
hsa:6712,4.663903e-08,3.883877662488651e-05,2.1779141436748544e-07,2.9334991347684256e-07,0.0,1.2525562e-06,False,SPTBN2; spectrin beta
hsa:4897,8.7430635e-07,0.0007280809448517656,1.6599848852280704e-05,2.7470479868286498e-05,0.0,0.00013484759,False,NRCAM; neuronal cell adhesion
hsa:10381,0.0,0.0,0.00048526645902257325,0.0015530639718811163,0.0,0.010812598,False,TUBB3; tubulin beta 3 class
hsa:101954269,0.0,0.0,0.0,0.0,-0.0,-0.0,False,RNVU1-17; RNA
hsa:8559,1.24711494e-08,1.0385382925034834e-05,1.3626053373298245e-07,2.6790373397305266e-07,0.0,1.2983753e-06,False,PRPF18; pre-mRNA processing factor
hsa:8411,0.0,0.0,4.956527681842106e-07,8.665938358954662e-07,0.0,4.828791e-06,False,EEA1; early endosome antigen
hsa:122748,0.0,0.0,3.4447448831578947e-06,1.767668529948334e-05,0.0,0.00016563677,False,OR11H6; olfactory receptor family 11 subfamily H member
hsa:5172,0.0,0.0,1.3892664793680704e-06,9.183734669594915e-06,0.0,0.00011850868,False,SLC26A4; solute carrier family 26 member
hsa:2071,5.6218425e-07,0.00046816043360634545,4.439711661935672e-06,8.768075520311987e-06,0.0,4.272652e-05,False,ERCC3; ERCC excision repair 3
hsa:4047,0.0,0.0,4.7066996636842115e-06,9.487733996876167e-06,0.0,4.026404e-05,False,LSS; lanosterol
hsa:116443,4.292419e-06,0.0035745233706922877,0.00010212737766035087,0.0002465527820993219,0.0,0.002012957,False,GRIN3A; glutamate ionotropic receptor NMDA type subunit
hsa:11214,1.0411642e-07,8.670322644709519e-05,4.0955461857953234e-06,1.2041917961503623e-05,0.0,0.00010244021,False,AKAP13; A-kinase anchoring protein
hsa:23624,0.0,0.0,2.90728686128655e-09,2.961749242033412e-08,0.0,3.8429397e-07,False,CBLC; Cbl proto-oncogene
hsa:23303,2.1409726e-08,1.7829006429036473e-05,6.605264194853801e-08,9.580070443667944e-08,0.0,4.7360083e-07,False,KIF13B; kinesin family member
hsa:900,2.2353736e-07,0.0001861513327433448,0.0001793225400206433,0.000526254792944098,0.0,0.0031338676,False,CCNG1; cyclin
hsa:5789,2.6639563e-10,2.218416713944504e-07,4.95272733489842e-06,1.0214039368915818e-05,0.0,7.9979414e-05,False,PTPRD; protein tyrosine phosphatase receptor type
hsa:10195,3.629315e-07,0.00030223217461072837,8.985400070260233e-05,0.0002082883192545644,0.0,0.001647535,False,ALG3; ALG3 alpha-1
hsa:55176,5.6389794e-08,4.695875135244806e-05,0.00011103632667009938,0.0002256360179277473,0.0,0.001092526,False,SEC61A2; SEC61 translocon subunit alpha
hsa:100132463,0.0,0.0,9.89399850190643e-07,3.813459931656583e-06,0.0,3.236209e-05,False,CLDN24; claudin
hsa:6567,0.0,0.0,2.03147400721462e-06,6.824793662347595e-06,0.0,5.699593e-05,False,SLC16A2; solute carrier family 16 member
hsa:51024,0.0,0.0,3.8663758801461985e-07,1.105621981160287e-06,0.0,6.0434163e-06,False,FIS1; fission
hsa:406915,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR128-1; microRNA
hsa:7755,0.0,0.0,1.5551814307017547e-08,4.796542679599235e-08,0.0,2.1695709e-07,False,ZNF205; zinc finger protein
hsa:4832,0.0,0.0,3.9050624779263157e-05,9.36510693090148e-05,0.0,0.0005449034,False,NME3; NME/NM23 nucleoside diphosphate kinase
hsa:9056,0.0,0.0,2.0344345372900584e-05,5.726631207641595e-05,0.0,0.0004178605,False,SLC7A7; solute carrier family 7 member
hsa:445329,1.9474262e-05,0.01621724362090111,0.00011846329525380112,0.0002257308968034596,0.0,0.0012052176,False,SULT1A4; sulfotransferase family 1A member
hsa:10929,1.3271837e-08,1.1052157659473276e-05,1.2155470593625727e-07,1.9406309508603502e-07,0.0,8.2033614e-07,False,SRSF8; serine and arginine rich splicing factor
hsa:27304,2.8995323e-06,0.0024145932562564744,6.817860254345028e-05,0.00017153053944009611,0.0,0.0012198963,False,MOCS3; molybdenum cofactor synthesis
hsa:4701,0.0,0.0,8.755486813567249e-07,1.7306900598126108e-06,0.0,1.3308968e-05,False,NDUFA7; NADH:ubiquinone oxidoreductase subunit
hsa:1380,3.1671825e-06,0.0026374796741645275,2.944343518646198e-05,7.716138244406798e-05,0.0,0.000618859,False,CR2; complement C3d receptor
hsa:349075,0.0,0.0,4.380817096122807e-08,9.26596327864538e-08,0.0,3.9770953e-07,False,ZNF713; zinc finger protein
hsa:55283,9.174513e-09,7.640100170374841e-06,3.6641366598830424e-08,8.099088477851769e-08,0.0,8.1243707e-07,False,MCOLN3; mucolipin TRP cation channel
hsa:3516,4.235159e-07,0.0003526839952972387,7.651536241865498e-05,0.0001413728304116738,0.0,0.000718336,False,RBPJ; recombination signal binding protein for immunoglobulin kappa J
hsa:23405,0.0,0.0,3.3547619590292394e-07,7.629234689972235e-07,0.0,3.6569018e-06,False,DICER1; dicer 1
hsa:6779,0.0,0.0,1.934720523633918e-05,0.00024187883862655053,0.0,0.0031628546,False,STATH;
hsa:146850,0.0,0.0,2.306819161309941e-06,4.593783919432734e-06,0.0,3.0034587e-05,False,PIK3R6; phosphoinositide-3-kinase regulatory subunit
hsa:23207,1.1505037e-10,9.58085024718684e-08,2.0309004961327488e-07,3.98662665075133e-07,0.0,1.8591246e-06,False,PLEKHM2; pleckstrin homology and RUN domain containing
hsa:4351,0.0,0.0,2.876271413762573e-05,7.305440884118639e-05,0.0,0.00042889157,False,MPI; mannose phosphate
hsa:30000,0.0,0.0,4.0268956261029244e-07,8.406785593782279e-07,0.0,4.3021996e-06,False,TNPO2; transportin
hsa:2006,6.8128825e-06,0.005673446072722747,3.970212326216375e-05,7.689991285519356e-05,0.0,0.0004054212,False,ELN;
hsa:90,0.0,0.0,4.308059998491227e-06,1.3666383653214806e-05,0.0,0.00010453243,False,ACVR1; activin A receptor type
hsa:79818,0.0,0.0,2.3104973625555552e-08,4.697359470680025e-08,0.0,2.9438877e-07,False,ZNF552; zinc finger protein
hsa:169044,4.1127143e-05,0.03424873802471374,0.00016074338701900585,0.00032680305059399717,0.0,0.0021628318,False,COL22A1; collagen type XXII alpha 1
hsa:2591,6.401904e-07,0.0005331202630714392,9.851005227912277e-05,0.00023029167831832329,0.0,0.0020810536,False,GALNT3; polypeptide N-acetylgalactosaminyltransferase
hsa:3105,3.1395837e-05,0.026144966998549218,0.00023837126293216375,0.00045356328657394066,0.0,0.0027788118,False,HLA-A; major histocompatibility complex
hsa:147660,0.0,0.0,2.4410397701251456e-08,5.1143919414800315e-08,0.0,2.7403152e-07,False,ZNF578; zinc finger protein
hsa:91664,0.0,0.0,2.3025155282046787e-08,4.478140066231804e-08,0.0,2.4951112e-07,False,ZNF845; zinc finger protein
hsa:10403,2.8508087e-08,2.374018548404268e-05,2.272361301264035e-06,6.252601773206461e-06,0.0,3.303095e-05,False,NDC80; NDC80 kinetochore complex
hsa:54822,1.8581173e-05,0.015473521374166065,9.819770453192983e-05,0.000181315721551155,0.0,0.0009067856,False,TRPM7; transient receptor potential cation channel subfamily M member
hsa:53842,0.0,0.0,3.30409733602456e-06,1.3968277117938931e-05,0.0,0.00013064666,False,CLDN22; claudin
hsa:5164,0.0,0.0,9.226219293216374e-07,1.5325964005889962e-06,0.0,9.764352e-06,False,PDK2; pyruvate dehydrogenase kinase
hsa:5192,0.0,0.0,9.090014836257311e-08,2.402491414478974e-07,0.0,1.6977559e-06,False,PEX10; peroxisomal biogenesis factor
hsa:32,0.0,0.0,6.133679872748538e-05,0.00021773642385383818,0.0,0.0018826998,False,ACACB; acetyl-CoA carboxylase
hsa:374291,0.0,0.0,4.47920401865497e-06,1.1253320813582741e-05,0.0,6.983676e-05,False,NDUFS7; NADH:ubiquinone oxidoreductase core subunit
hsa:160428,1.0529114e-07,8.768147766022691e-05,6.2022915292807e-06,1.7833682717691225e-05,0.0,0.00017557101,False,ALDH1L2; aldehyde dehydrogenase 1 family member
hsa:4534,0.0,0.0,2.6337530032105277e-07,8.577447900797017e-07,0.0,5.233344e-06,False,MTM1; myotubularin
hsa:4719,1.04853534e-07,8.731706009657454e-05,1.9540896990292392e-06,2.8441826548295737e-06,0.0,1.177946e-05,False,NDUFS1; NADH:ubiquinone oxidoreductase core subunit
hsa:4641,0.0,0.0,1.3122952655614037e-06,3.5371797696224743e-06,0.0,1.8314824e-05,False,MYO1C; myosin
hsa:10540,0.0,0.0,0.00012541116349438594,0.0004836224190718171,0.0,0.0041241474,False,DCTN2; dynactin subunit
hsa:2874,0.0,0.0,2.4221922229029253e-07,4.6431686977956126e-07,0.0,2.0361151e-06,False,GPS2; G protein pathway suppressor
hsa:1557,0.0,0.0,1.4756757442456137e-05,4.917921197234082e-05,0.0,0.0005630005,False,CYP2C19; cytochrome P450 family 2 subfamily C member
hsa:4919,0.0,0.0,6.271816204093567e-08,2.0632110430926334e-07,0.0,1.423261e-06,False,ROR1; receptor tyrosine kinase like orphan receptor
hsa:51241,2.9787904e-08,2.4805956504231828e-05,6.157116745263159e-07,8.601806631896805e-07,0.0,4.071241e-06,False,COX16; cytochrome c oxidase assembly factor
hsa:5684,0.0,0.0,9.097989521660817e-06,3.125108908165301e-05,0.0,0.00022626785,False,PSMA3; proteasome 20S subunit alpha
hsa:10991,0.0,0.0,8.594453501111109e-05,0.0001913724850718982,0.0,0.0012857732,False,SLC38A3; solute carrier family 38 member
hsa:147687,1.7819781e-08,1.483947015543412e-05,5.0835710807017516e-08,8.034583567575544e-08,0.0,3.9609282e-07,False,ZNF417; zinc finger protein
hsa:4666,5.4714735e-07,0.0004556384150259685,5.765720267687719e-06,1.2832362748209673e-05,0.0,6.4374624e-05,False,NACA; nascent polypeptide associated complex subunit
hsa:6376,0.0,0.0,2.408257591766082e-05,6.895501800441746e-05,0.0,0.0005855129,False,CX3CL1; C-X3-C motif chemokine ligand
hsa:84924,0.0,0.0,4.4596522006432744e-08,9.204108504918424e-08,0.0,5.043511e-07,False,ZNF566; zinc finger protein
hsa:57530,7.8486536e-08,6.535987218784596e-05,1.9548857391912516e-05,7.098835525076677e-05,0.0,0.0004869266,False,CGN;
hsa:538,1.5196676e-06,0.0012655072470520374,6.709277878046782e-05,0.00010682767900911948,0.0,0.0007312031,False,ATP7A; ATPase copper transporting
hsa:3459,2.9649598e-05,0.024690781813851655,0.00012039695367251469,0.00023191601985149415,0.0,0.0016916572,False,IFNGR1; interferon gamma receptor
hsa:9414,0.0,0.0,4.265391178967835e-05,0.00015996559413548688,0.0,0.0013366032,False,TJP2; tight junction protein
hsa:1958,0.0,0.0,1.6526076484444443e-05,6.399449317752135e-05,0.0,0.0007585935,False,EGR1; early growth response
hsa:27330,9.1803224e-05,0.07644937963719271,0.0003003617653275441,0.0005475965742363848,0.0,0.0028709648,False,RPS6KA6; ribosomal protein S6 kinase
hsa:10477,1.6367555e-07,0.00013630125080657646,4.808102758106433e-07,7.893708464585524e-07,0.0,4.9388395e-06,False,UBE2E3; ubiquitin conjugating enzyme E2
hsa:207,0.00019095564,0.1590188185136407,0.0006386698467263158,0.0008953408823928657,0.0,0.00378162,False,AKT1; AKT serine/threonine kinase
hsa:8789,2.1335379e-07,0.0001776709376649331,2.517979977894737e-05,6.829868574592097e-05,0.0,0.00042727002,False,FBP2; fructose-bisphosphatase
hsa:345462,0.0,0.0,1.0697469843157895e-07,2.7925110014437495e-07,0.0,1.9160025e-06,False,ZNF879; zinc finger protein
hsa:8318,3.1104847e-08,2.590264429994087e-05,8.740730300701754e-07,1.8351714813603117e-06,0.0,7.846886e-06,False,CDC45; cell division cycle
hsa:390792,0.0,0.0,5.932749880701755e-08,3.785753276094619e-07,0.0,4.2267156e-06,False,KRT39; keratin
hsa:9402,1.9423636e-09,1.6175084684374955e-06,5.7372791976959076e-08,1.2179330892652018e-07,0.0,9.3955623e-07,False,GRAP2; GRB2 related adaptor protein
hsa:441925,0.0,0.0,2.8243354363742696e-05,0.00011677399267215958,0.0,0.0012586879,False,BECN2; beclin
hsa:7078,7.6803225e-08,6.39580904629856e-05,1.1310131736169592e-06,2.480499393277502e-06,0.0,1.1468631e-05,False,TIMP3; TIMP metallopeptidase inhibitor
hsa:8761,0.0,0.0,3.021727027017543e-07,6.233094403845725e-07,0.0,2.6050352e-06,False,PABPC4; poly(A) binding protein cytoplasmic
hsa:117247,2.9727713e-07,0.0002475583228844456,2.6983747620847953e-05,6.199753961365614e-05,0.0,0.00044584743,False,SLC16A10; solute carrier family 16 member
hsa:10135,0.0,0.0,2.486668757327485e-05,8.39311325768212e-05,0.0,0.0008951662,False,NAMPT; nicotinamide
hsa:80319,0.0,0.0,1.4600644406488888e-05,4.688171078002803e-05,0.0,0.00030560282,False,CXXC4; CXXC finger protein
hsa:162417,0.0,0.0,1.2556442751061411e-05,3.335407891815421e-05,0.0,0.00022901893,False,NAGS; N-acetylglutamate
hsa:219957,0.0,0.0,2.773977742690058e-07,3.524078152538908e-06,0.0,4.6071138e-05,False,OR9Q2; olfactory receptor family 9 subfamily Q member
hsa:9839,0.0,0.0,1.9402081373801178e-07,4.4458180326485747e-07,0.0,3.2124274e-06,False,ZEB2; zinc finger E-box binding homeobox
hsa:1103,0.0,0.0,4.432421751707603e-06,1.2242157255384704e-05,0.0,6.251947e-05,False,CHAT; choline
hsa:119765,0.0,0.0,1.1025039181286549e-07,9.226825788788536e-07,0.0,9.747e-06,False,OR4B1; olfactory receptor family 4 subfamily B member
hsa:4077,0.0,0.0,2.8671293353801165e-06,6.575685843930089e-06,0.0,2.9530516e-05,False,NBR1; NBR1 autophagy cargo
hsa:7357,1.059283e-06,0.0008821207434961586,7.096154461520466e-06,1.4869294548880533e-05,0.0,8.2316816e-05,False,UGCG; UDP-glucose ceramide
hsa:147948,1.8261399e-09,1.5207228722787027e-06,1.134394819040936e-07,2.3573158419676513e-07,0.0,1.1464078e-06,False,ZNF582; zinc finger protein
hsa:3767,2.6476835e-05,0.022048654963428206,0.00011994887425549708,0.0003277994210212276,0.0,0.0029199827,False,KCNJ11; potassium inwardly rectifying channel subfamily J member
hsa:246721,4.2705533e-08,3.5563146506986086e-05,1.5292113837309943e-06,5.28864008042532e-06,0.0,4.3196607e-05,False,POLR2J2; RNA polymerase II subunit
hsa:3679,2.1046953e-05,0.017526906245723485,0.00010890722435438597,0.00016641360048876241,0.0,0.00084089796,False,ITGA7; integrin subunit alpha
hsa:26211,0.0,0.0,1.7747961040935672e-07,1.8369911731726948e-06,0.0,2.3751632e-05,False,OR2F1; olfactory receptor family 2 subfamily F member
hsa:54331,0.0,0.0,0.0001491128929732749,0.0002910286095279322,0.0,0.0017962795,False,GNG2; G protein subunit gamma
hsa:6945,7.683306e-07,0.0006398293563880943,2.0587211275801166e-05,5.741516956364611e-05,0.0,0.00046151693,False,MLX; MAX dimerization protein
hsa:4292,0.0,0.0,0.00010674923434684212,0.0002335897341268988,0.0,0.0015097237,False,MLH1; mutL homolog
hsa:22875,8.4725365e-09,7.055527367736802e-06,3.0888350778251467e-07,1.0039790025993498e-06,0.0,6.641659e-06,False,ENPP4; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:51129,0.0,0.0,2.936197205964912e-06,9.356925615488048e-06,0.0,5.851003e-05,False,ANGPTL4; angiopoietin like
hsa:5464,2.8124512e-07,0.00023420762379748036,1.6796744999766088e-06,2.8665120210512814e-06,0.0,1.42785375e-05,False,PPA1; inorganic pyrophosphatase
hsa:9045,4.380613e-07,0.0003647967159417208,1.3234941160058474e-06,1.896495805541964e-06,0.0,8.284241e-06,False,RPL14; ribosomal protein
hsa:2475,0.0002952163,0.2458421612054428,0.0006807730896777779,0.0011989678519770334,0.0,0.005938857,False,MTOR; mechanistic target of rapamycin
hsa:1937,0.0,0.0,6.972504522730994e-05,0.00012394563369252674,0.0,0.00056511624,False,EEF1G; eukaryotic translation elongation factor 1
hsa:8976,2.701563e-06,0.002249733793671487,2.530090822617837e-05,3.571221836856526e-05,0.0,0.00019594871,False,WASL; WASP like actin nucleation promoting
hsa:406935,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR143; microRNA
hsa:54472,0.0,0.0,4.673166833118714e-06,1.149599172561262e-05,0.0,5.542398e-05,False,TOLLIP; toll interacting
hsa:8655,0.0,0.0,0.0001379179092868421,0.000585678218468191,0.0,0.005482402,False,DYNLL1; dynein light chain LC8-type
hsa:283375,0.0,0.0,1.437381635877193e-09,3.748532856472798e-09,0.0,2.3096781e-08,False,SLC39A5; solute carrier family 39 member
hsa:341418,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6C4; olfactory receptor family 6 subfamily C member
hsa:397,0.0,0.0,7.437345134210525e-05,0.0002268869769708161,0.0,0.0017619216,False,ARHGDIB; Rho GDP dissociation inhibitor
hsa:79175,0.0,0.0,5.637774723099418e-08,1.2108821344330084e-07,0.0,5.9828085e-07,False,ZNF343; zinc finger protein
hsa:5364,1.3250776e-07,0.00011034619055550836,8.703453210877191e-07,2.116517035480802e-06,0.0,1.2265301e-05,False,PLXNB1; plexin
hsa:57026,0.0,0.0,0.00022505989549292387,0.0006247644911214283,0.0,0.0031620914,False,PDXP; pyridoxal
hsa:89846,0.0,0.0,1.3749093026269008e-05,4.5983285451182856e-05,0.0,0.00028848447,False,FGD3; FYVE
hsa:2525,0.0,0.0,1.307734077280702e-05,4.650304759987291e-05,0.0,0.0004012066,False,FUT3; fucosyltransferase 3 (Lewis blood
hsa:4248,6.944649e-08,5.783174977036218e-05,0.00014301733128143566,0.00036444934049823197,0.0,0.0017729764,False,MGAT3; beta-1
hsa:10720,0.0,0.0,4.293453945029239e-06,1.809738081576551e-05,0.0,0.00013702783,False,UGT2B11; UDP glucuronosyltransferase family 2 member
hsa:2252,0.0,0.0,8.99369879883041e-07,7.486651546148749e-06,0.0,9.558567e-05,False,FGF7; fibroblast growth factor
hsa:1841,1.0323921e-07,8.597272747996151e-05,0.0001135033281148152,0.0002958250891648361,0.0,0.0016730028,False,DTYMK; deoxythymidylate
hsa:3656,3.4007414e-07,0.00028319764710716284,1.5466596655321638e-06,2.743588095430363e-06,0.0,1.6661937e-05,False,IRAK2; interleukin 1 receptor associated kinase
hsa:91942,2.4597355e-08,2.0483512980609485e-05,4.87872049982456e-07,8.768682612875899e-07,0.0,4.267339e-06,False,NDUFAF2; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:339327,1.2577057e-09,1.0473577761404241e-06,3.503638758374268e-08,7.6260624130969e-08,0.0,3.8427908e-07,False,ZNF546; zinc finger protein
hsa:1385,0.00043743005,0.3642710408205946,0.0015622268926666666,0.0035887325446605023,0.0,0.01812792,False,CREB1; cAMP responsive element binding protein
hsa:10563,0.0,0.0,1.5174977486549706e-05,6.547392127605576e-05,0.0,0.00067284796,False,CXCL13; C-X-C motif chemokine ligand
hsa:22900,0.0,0.0,7.328875561403508e-08,1.9657093607594053e-07,0.0,1.0160251e-06,False,CARD8; caspase recruitment domain family member
hsa:1452,1.413938e-05,0.011774606406573804,0.00021659844166959071,0.00046742920912067255,0.0,0.0024735327,False,CSNK1A1; casein kinase 1 alpha
hsa:494551,0.0,0.0,5.222134942316374e-08,1.8173645734447652e-07,0.0,1.2960207e-06,False,WEE2; WEE2 oocyte meiosis inhibiting
hsa:1337,0.0,0.0,0.000290967644157076,0.0006681166048218353,0.0,0.0033904596,False,COX6A1; cytochrome c oxidase subunit
hsa:10488,0.0,0.0,0.00017009145092339176,0.00037680837676628165,0.0,0.0021849426,False,CREB3; cAMP responsive element binding protein
hsa:3115,0.0,0.0,0.0005192146427766082,0.0011098643130313332,0.0,0.0059196874,False,HLA-DPB1; major histocompatibility complex
hsa:7046,0.00012580343,0.10476314186668433,0.0003084734561228069,0.0003898617666123218,0.0,0.0019057051,False,TGFBR1; transforming growth factor beta receptor
hsa:5602,0.0009900724,0.8244854317524462,0.0013412826059239769,0.0015436751968156083,0.0,0.008817523,True,MAPK10; mitogen-activated protein kinase
hsa:2967,0.0,0.0,4.117398600888889e-06,6.623947924454487e-06,0.0,3.3358665e-05,False,GTF2H3; general transcription factor IIH subunit
hsa:36,0.0,0.0,1.8038594308128651e-06,3.6469533173065988e-06,0.0,3.1054406e-05,False,ACADSB; acyl-CoA dehydrogenase short/branched
hsa:5049,0.0,0.0,7.988802742046782e-06,2.1961200465521755e-05,0.0,0.00021363788,False,PAFAH1B2; platelet activating factor acetylhydrolase 1b catalytic subunit
hsa:4171,0.0,0.0,5.306781009198829e-06,3.075606461912897e-05,0.0,0.00028621298,False,MCM2; minichromosome maintenance complex component
hsa:6123,7.8304746e-10,6.520848608048828e-07,3.0925160478426905e-08,2.471442332473862e-07,0.0,3.2064088e-06,False,RPL3L; ribosomal protein L3
hsa:65251,2.5524574e-08,2.1255657075873704e-05,7.207773107309942e-08,1.0047162350527754e-07,0.0,4.5965476e-07,False,ZNF649; zinc finger protein
hsa:390061,0.0,0.0,1.4142937555555556e-08,1.0437488156637386e-07,0.0,1.1951979e-06,False,OR51Q1; olfactory receptor family 51 subfamily Q member
hsa:9700,0.0,0.0,1.4635405863004852e-05,5.3643536673965685e-05,0.0,0.00052123057,False,ESPL1; extra spindle pole bodies like 1
hsa:7434,8.2336854e-08,6.856623477164713e-05,1.8802562913544435e-05,4.770912525989002e-05,0.0,0.0002534955,False,VIPR2; vasoactive intestinal peptide receptor
hsa:6916,0.0,0.0,1.0064159552596489e-05,3.682643061356866e-05,0.0,0.00037023524,False,TBXAS1; thromboxane A synthase
hsa:2969,1.241035e-06,0.001033475206252489,0.0001172973180085964,0.00031325207900569926,0.0,0.001873594,False,GTF2I; general transcription factor
hsa:5998,0.0,0.0,3.2726738240350884e-07,8.39994527802872e-07,0.0,5.065648e-06,False,RGS3; regulator of G protein signaling
hsa:406904,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR1-1; microRNA
hsa:26084,0.0,0.0,1.5780459377836262e-08,4.900862695090238e-08,0.0,3.5960025e-07,False,ARHGEF26; Rho guanine nucleotide exchange factor
hsa:51809,1.6525632e-05,0.013761764124019658,0.00019474566272485383,0.00040046574080108185,0.0,0.0019782607,False,GALNT7; polypeptide N-acetylgalactosaminyltransferase
hsa:132864,0.0,0.0,5.782010060818716e-07,1.1730144226165646e-06,0.0,8.718199e-06,False,CPEB2; cytoplasmic polyadenylation element binding protein
hsa:3028,1.4076867e-06,0.0011722548539093464,7.835671012140346e-06,1.2336198243236353e-05,0.0,6.905958e-05,False,HSD17B10; hydroxysteroid 17-beta dehydrogenase
hsa:7159,0.0,0.0,2.8469342704596486e-06,5.62666283411663e-06,0.0,3.0930983e-05,False,TP53BP2; tumor protein p53 binding protein
hsa:9732,0.0,0.0,1.1783482179350876e-06,2.672603007001454e-06,0.0,1.5890986e-05,False,DOCK4; dedicator of cytokinesis
hsa:857,0.0,0.0,1.0084099709356726e-05,2.1309964915571515e-05,0.0,0.00014616348,False,CAV1; caveolin
hsa:5090,4.3201734e-07,0.00035976359213168985,1.0788321382252632e-05,3.2288492387848905e-05,0.0,0.00028962802,False,PBX3; PBX homeobox
hsa:1133,1.078879e-07,8.984393647612511e-05,4.415215374405263e-06,1.0213401282442432e-05,0.0,8.058374e-05,False,CHRM5; cholinergic receptor muscarinic
hsa:27242,0.0,0.0,1.6831205402771928e-05,6.713395668747499e-05,0.0,0.00065322197,False,TNFRSF21; TNF receptor superfamily member
hsa:836,0.00039293928,0.3272212334403982,0.0013207211731929831,0.001888486062988938,0.0,0.010434427,False,CASP3; caspase
hsa:51726,7.321097e-08,6.096663053072217e-05,5.880980995625734e-07,1.0666625449410688e-06,0.0,5.5898754e-06,False,DNAJB11; DnaJ heat shock protein family (Hsp40) member
hsa:39,0.00011168116,0.09300278385824512,0.0004050236648502924,0.000569238275856,0.0,0.0030498237,False,ACAT2; acetyl-CoA acetyltransferase
hsa:9530,1.8114504e-06,0.001508490151974887,8.568961745321638e-06,2.1665534488940673e-05,0.0,0.00014268838,False,BAG4; BAG cochaperone
hsa:401994,-0.0,0.0,2.6226165784619884e-05,0.0001875657577626414,0.0,0.0023956522,False,OR14I1; olfactory receptor family 14 subfamily I member
hsa:3087,0.0,0.0,2.1912242561403507e-07,8.351592962294497e-07,0.0,5.9177164e-06,False,HHEX; hematopoietically expressed
hsa:8913,7.1730006e-05,0.05973335380979769,0.00024999151984342083,0.0004003033416748364,0.0,0.0030197953,False,CACNA1G; calcium voltage-gated channel subunit alpha1
hsa:8743,0.0,0.0,2.446970499824562e-05,6.131586268711454e-05,0.0,0.00059890957,False,TNFSF10; TNF superfamily member
hsa:10557,9.512822e-10,7.921827892439145e-07,1.4211261553230177e-06,2.655776950855129e-06,0.0,1.2643368e-05,False,RPP38; ribonuclease P/MRP subunit
hsa:6929,3.271582e-07,0.00027244186362366336,1.3330791053385971e-05,4.669568582921164e-05,0.0,0.0004325888,False,TCF3; transcription factor
hsa:112936,0.0,0.0,1.9420668825380116e-07,3.9174879728776687e-07,0.0,2.8665895e-06,False,VPS26B; VPS26 retromer complex component
hsa:23759,0.0,0.0,1.3053999963207602e-07,6.18567917437733e-07,0.0,6.7812334e-06,False,PPIL2; peptidylprolyl isomerase like
hsa:22926,3.711731e-07,0.0003090953889921523,1.1030427030350874e-06,2.114716680333275e-06,0.0,9.378871e-06,False,ATF6; activating transcription factor
hsa:3108,0.00015394486,0.12819799275605487,0.0002939172145754384,0.0003682078403201758,0.0,0.0015355337,False,HLA-DMA; major histocompatibility complex
hsa:30846,1.257679e-07,0.00010473355416442117,8.06130669926433e-07,1.5221826553306043e-06,0.0,6.8419995e-06,False,EHD2; EH domain containing
hsa:26270,3.3487627e-08,2.7886910700126446e-05,2.595504333647954e-07,4.71336725312926e-07,0.0,2.399749e-06,False,FBXO6; F-box protein
hsa:83439,0.0,0.0,6.679021871345029e-07,8.733954413667273e-06,0.0,0.000114211274,False,TCF7L1; transcription factor 7 like
hsa:10919,0.0,0.0,2.4605863675555575e-05,6.831520720059004e-05,0.0,0.00039498444,False,EHMT2; euchromatic histone lysine methyltransferase
hsa:55958,3.3762984e-08,2.811621497628954e-05,1.684543338906433e-07,3.232307253803775e-07,0.0,1.7355869e-06,False,KLHL9; kelch like family member
hsa:147,0.0,0.0,1.6567484456725143e-06,1.2552099497849888e-05,0.0,0.00014720281,False,ADRA1B; adrenoceptor alpha
hsa:5893,0.0,0.0,2.6636944546888895e-05,8.207825172124771e-05,0.0,0.0007781808,False,RAD52; RAD52 homolog
hsa:55504,0.0,0.0,7.761644771941519e-06,2.5252796827840135e-05,0.0,0.00015671461,False,TNFRSF19; TNF receptor superfamily member
hsa:48,0.0,0.0,1.8139831658538009e-06,6.5642523715424154e-06,0.0,6.3745916e-05,False,ACO1; aconitase
hsa:283209,0.0,0.0,7.612254561871346e-05,0.0001533635852215432,0.0,0.0008050908,False,PGM2L1; phosphoglucomutase 2 like
hsa:8631,2.2476485e-09,1.8717352831472103e-06,4.996669941671344e-07,1.4749589906367415e-06,0.0,1.3950327e-05,False,SKAP1; src kinase associated phosphoprotein
hsa:3397,0.0,0.0,2.9190731799415215e-06,7.6122637537630345e-06,0.0,5.1710347e-05,False,ID1; inhibitor of DNA binding
hsa:57510,5.6493235e-08,4.704489212108872e-05,3.31539609134269e-07,6.141089726491587e-07,0.0,3.0154715e-06,False,XPO5; exportin
hsa:51067,3.759946e-07,0.0003131105059767227,2.5452914534678364e-06,4.925444481863116e-06,0.0,3.0773106e-05,False,YARS2; tyrosyl-tRNA synthetase
hsa:57617,3.8516635e-08,3.207483052514783e-05,3.561698369944443e-05,0.00012257793742586793,0.0,0.0010378986,False,VPS18; VPS18 core subunit of CORVET and HOPS
hsa:830,0.0,0.0,6.068157669707603e-07,1.2625416111135457e-06,0.0,8.167792e-06,False,CAPZA2; capping actin protein of muscle Z-line subunit alpha
hsa:7691,0.0,0.0,2.6836546830099417e-08,6.09846268989817e-08,0.0,3.7345413e-07,False,ZNF132; zinc finger protein
hsa:181,0.0,0.0,5.086577713198831e-07,1.5302363849655638e-06,0.0,1.4079537e-05,False,AGRP; agouti related
hsa:8493,1.3641092e-05,0.011359655745574605,0.0001775555617298831,0.0004225339400476641,0.0,0.0023518747,False,PPM1D; protein phosphatase
hsa:5695,0.0,0.0,6.649902026052635e-06,1.560470069307191e-05,0.0,7.958087e-05,False,PSMB7; proteasome 20S subunit beta
hsa:57122,1.6250665e-08,1.3532784621396743e-05,1.8364988886491233e-07,3.622865541311747e-07,0.0,1.6280061e-06,False,NUP107; nucleoporin
hsa:27445,7.0532355e-06,0.0058736006745256,8.615563253079534e-05,0.00019735054136486982,0.0,0.0016269959,False,PCLO; piccolo presynaptic cytomatrix
hsa:84769,8.2807884e-07,0.0006895848626044566,4.853298518638277e-05,0.0001674977633634779,0.0,0.0012266751,False,MPV17L2; MPV17 mitochondrial inner membrane protein like
hsa:81470,0.0,0.0,2.93557318128655e-08,3.703739626091715e-07,0.0,4.841018e-06,False,OR2G2; olfactory receptor family 2 subfamily G member
hsa:29844,0.0,0.0,5.777650893852047e-06,1.8677511618334494e-05,0.0,0.000100078,False,TFPT; TCF3 fusion
hsa:23658,0.0,0.0,5.752980203941519e-06,2.1497299610883006e-05,0.0,0.00017203485,False,LSM5; LSM5 homolog
hsa:1954,1.4391712e-05,0.011984736552576215,6.037553139711988e-05,0.00011555137598835841,0.0,0.00082253275,False,MEGF8; multiple EGF like domains
hsa:1786,2.481665e-06,0.0020666131476747905,7.640682658012279e-05,0.00018545466235214117,0.0,0.0011987846,False,DNMT1; DNA methyltransferase
hsa:2350,5.9463466e-05,0.04951835990833286,0.00019658792013622507,0.0003185873459530087,0.0,0.0016543325,False,FOLR2; folate receptor
hsa:4035,0.0,0.0,6.117043046023392e-05,0.00013625711661420905,0.0,0.00070106523,False,LRP1; LDL receptor related protein
hsa:6573,0.00055874937,0.4653000281250717,0.0007705520291988299,0.0009140367709802713,0.0,0.0071440744,True,SLC19A1; solute carrier family 19 member
hsa:5900,9.584755e-06,0.007981730290043856,0.00012277773101228073,0.00021028549695068177,0.0,0.0012993156,False,RALGDS; ral guanine nucleotide dissociation
hsa:342574,0.0,0.0,4.1363731973298244e-06,1.391620541978896e-05,0.0,0.000100374054,False,KRT27; keratin
hsa:128239,0.0,0.0,2.2774893040935676e-08,4.907752072773696e-08,0.0,2.3270596e-07,False,IQGAP3; IQ motif containing GTPase activating protein
hsa:5724,0.0,0.0,2.3661633108771932e-06,9.65687377129764e-06,0.0,7.859429e-05,False,PTAFR; platelet activating factor
hsa:1160,0.0,0.0,8.403004656198832e-08,1.7058307179230208e-07,0.0,8.411929e-07,False,CKMT2; creatine kinase
hsa:766,0.0,0.0,2.3673554046666672e-07,6.560819196161193e-07,0.0,4.319224e-06,False,CA7; carbonic anhydrase
hsa:338324,-0.0,0.0,1.4135333584795321e-08,1.394433618270053e-07,0.0,1.7840979e-06,False,S100A7A; S100 calcium binding protein
hsa:160287,6.934373e-05,0.057746176106287836,0.00039883466649748566,0.0007802365713097182,0.0,0.004738019,False,LDHAL6A; lactate dehydrogenase A like
hsa:57680,1.4737721e-07,0.00012272876470177424,6.941321402381873e-06,2.091428849833252e-05,0.0,0.00014151876,False,CHD8; chromodomain helicase DNA binding protein
hsa:57381,1.02385345e-08,8.5261669123842e-06,2.760436033000293e-07,4.27869813424639e-07,0.0,1.667852e-06,False,RHOJ; ras homolog family member
hsa:125061,2.9325945e-06,0.0024421258914876817,0.00013935823944678363,0.00030910704239138243,0.0,0.0026318228,False,AFMID;
hsa:79444,0.0,0.0,6.910452184842106e-05,0.00015188544172582114,0.0,0.0009890227,False,BIRC7; baculoviral IAP repeat containing
hsa:2645,0.000117121934,0.09753360291800023,0.0003199698330918129,0.0005000039692125674,0.0,0.002369415,False,GCK;
hsa:3843,0.0,0.0,2.6917035608187133e-07,5.72696777529043e-07,0.0,2.641468e-06,False,IPO5; importin
hsa:7124,0.00023164028,0.1928990609848911,0.0005699668849047954,0.0008094899109029365,0.0,0.0035661927,False,TNF; tumor necrosis
hsa:9374,0.0,0.0,2.446096135672514e-06,4.797670496018357e-06,0.0,2.666545e-05,False,PPT2; palmitoyl-protein thioesterase
hsa:10413,0.0,0.0,2.55641690448538e-05,7.311521738881276e-05,0.0,0.0005557578,False,YAP1; Yes1 associated transcriptional
hsa:5191,6.3059694e-08,5.25131283669428e-05,1.3089359707192982e-06,2.4790898096790937e-06,0.0,1.4102457e-05,False,PEX7; peroxisomal biogenesis factor
hsa:126375,0.0,0.0,4.669147372514618e-09,9.224706586193613e-09,0.0,5.2179285e-08,False,ZNF792; zinc finger protein
hsa:10921,3.0761328e-08,2.5616577936480814e-05,1.5055649951085373e-06,2.6948882797671037e-06,0.0,1.3892183e-05,False,RNPS1; RNA binding protein with serine rich domain
hsa:65980,1.1692945e-07,9.737331135362026e-05,7.1392965831462e-06,2.135825158103793e-05,0.0,0.00012812279,False,BRD9; bromodomain containing
hsa:1268,1.9774973e-06,0.0016467661508186638,1.8062617579941523e-05,4.941152355206736e-05,0.0,0.0004978566,False,CNR1; cannabinoid receptor
hsa:390190,0.0,0.0,4.455748857620877e-06,2.2364412611417955e-05,0.0,0.0002357133,False,OR5B2; olfactory receptor family 5 subfamily B member
hsa:10490,2.2219501e-06,0.0018503348720062193,9.015847485480702e-05,0.00018493516686219483,0.0,0.00091527903,False,VTI1B; vesicle transport through interaction with t-SNAREs
hsa:367,0.0,0.0,1.671191319304094e-08,6.06213574803444e-08,0.0,4.6128935e-07,False,AR; androgen
hsa:163688,3.9460163e-05,0.03286055598366028,0.00011665637619403507,0.00018068211014889198,0.0,0.0009913995,False,CALML6; calmodulin like
hsa:4074,1.2250698e-06,0.001020180143371215,5.774908206116961e-06,1.004999085303577e-05,0.0,7.415478e-05,False,M6PR; mannose-6-phosphate receptor
hsa:3384,2.1531816e-06,0.0017930677202166454,1.5742463898138015e-05,2.9453367686007035e-05,0.0,0.00027595973,False,ICAM2; intercellular adhesion molecule
hsa:3451,0.0,0.0,4.7440771988304096e-07,2.3972118591588077e-06,0.0,1.93756e-05,False,IFNA17; interferon alpha
hsa:182,0.0,0.0,4.6704643111111115e-06,2.3472734931086337e-05,0.0,0.0002947043,False,JAG1; jagged canonical Notch ligand
hsa:390082,0.0,0.0,7.191232467853802e-06,3.429936444869431e-05,0.0,0.0003089256,False,OR52E5; olfactory receptor family 52 subfamily E member
hsa:56916,1.9926841e-07,0.00016594129990238438,1.6583022895086086e-05,4.840388629244822e-05,0.0,0.00023430602,False,SMARCAD1; SWI/SNF-related
hsa:23478,0.0,0.0,1.7375960265964917e-06,5.792146642243656e-06,0.0,4.9478458e-05,False,SEC11A; SEC11 homolog A
hsa:10351,0.0,0.0,1.2963123337134506e-05,2.4891436576469552e-05,0.0,0.00013573373,False,ABCA8; ATP binding cassette subfamily A member
hsa:80143,0.0,0.0,9.129324044877194e-06,2.3943496041133978e-05,0.0,0.00014438193,False,SIKE1; suppressor of IKBKE
hsa:4852,0.00015352927,0.12785190907512203,0.0003108239441403509,0.000429239171580311,0.0,0.0028428943,False,NPY; neuropeptide
hsa:1496,0.000107333304,0.08938209517794511,0.0002467541981888888,0.00040472873418957413,0.0,0.0020808468,False,CTNNA2; catenin alpha
hsa:7305,0.0,0.0,2.113473809649123e-05,6.039961729347077e-05,0.0,0.00048637053,False,TYROBP; transmembrane immune signaling adaptor
hsa:10014,7.986586e-07,0.0006650850792768329,4.1798586217251454e-05,0.0001857021221361503,0.0,0.0021053215,False,HDAC5; histone deacetylase
hsa:414325,0.0,0.0,2.5123699766081873e-08,1.9052263314169361e-07,0.0,2.0598357e-06,False,DEFB103A; defensin beta
hsa:864,0.0,0.0,2.9889247209356717e-06,1.2098922766831164e-05,0.0,0.00012429882,False,RUNX3; RUNX family transcription factor
hsa:4094,0.0,0.0,4.811807172690057e-06,1.0949341360100692e-05,0.0,6.1434956e-05,False,MAF; MAF bZIP transcription
hsa:406886,0.0,0.0,2.4802347953216374e-09,3.243327848718079e-08,0.0,4.2412015e-07,False,MIRLET7D; microRNA
hsa:5216,1.5184771e-06,0.0012645158550018184,1.667362610639181e-05,3.484552612889277e-05,0.0,0.00017230185,False,PFN1; profilin
hsa:64111,-0.0,0.0,3.7179484754970756e-08,2.4833327083757345e-07,0.0,2.6210496e-06,False,NPVF; neuropeptide VF
hsa:406926,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR135A2; microRNA
hsa:6613,0.0,0.0,2.073355802444444e-06,3.855576724838145e-06,0.0,2.4194156e-05,False,SUMO2; small ubiquitin like modifier
hsa:4973,0.0,0.0,4.4853455379707606e-07,9.40383368819725e-07,0.0,4.7969716e-06,False,OLR1; oxidized low density lipoprotein receptor
hsa:2041,0.0,0.0,4.657943780122808e-06,1.7494738797728312e-05,0.0,0.00012371487,False,EPHA1; EPH receptor
hsa:4643,1.5938582e-08,1.3272896670780607e-05,2.928863649356726e-07,4.3858715827265617e-07,0.0,3.2841913e-06,False,MYO1E; myosin
hsa:6338,0.0,0.0,1.5003778149321641e-05,5.806528461925707e-05,0.0,0.0005618098,False,SCNN1B; sodium channel epithelial 1 subunit
hsa:3709,0.0,0.0,4.700641664327485e-05,0.00015673877922059863,0.0,0.0010159344,False,ITPR2; inositol 1
hsa:127059,0.0,0.0,2.0921822807017543e-07,1.72220511832074e-06,0.0,2.0351628e-05,False,OR2M5; olfactory receptor family 2 subfamily M member
hsa:55567,0.0,0.0,7.452767100643277e-08,3.2209007967851745e-07,0.0,3.6668903e-06,False,DNAH3; dynein axonemal heavy chain
hsa:57232,1.3947624e-09,1.1614921086135498e-06,5.6360155295321646e-08,9.517562514278913e-08,0.0,4.324987e-07,False,ZNF630; zinc finger protein
hsa:4681,0.0,0.0,2.4031083905614033e-06,1.0576007620928116e-05,0.0,8.1974635e-05,False,NBL1; NBL1
hsa:10637,2.7107908e-06,0.0022574182687332346,7.879755675415494e-05,0.00018195213082790448,0.0,0.0017309012,False,LEFTY1; left-right determination factor
hsa:51433,2.0022864e-05,0.01667409339959432,0.00011543270005391806,0.0002447602162243695,0.0,0.001333571,False,ANAPC5; anaphase promoting complex subunit
hsa:10318,9.916815e-08,8.25825414069126e-05,2.1136095087836254e-07,3.005740449187113e-07,0.0,1.6718869e-06,False,TNIP1; TNFAIP3 interacting protein
hsa:143496,-0.0,0.0,1.1280323976608187e-09,1.4750937679330155e-08,-0.0,1.9289354e-07,False,OR52B4; olfactory receptor family 52 subfamily B member
hsa:51454,0.0,0.0,4.9205945842105257e-08,1.4963680432958315e-07,0.0,1.2174111e-06,False,GULP1; GULP PTB domain containing engulfment adaptor
hsa:641339,0.0,0.0,6.226003104385964e-08,1.4458914363740914e-07,0.0,7.147369e-07,False,ZNF674; zinc finger protein
hsa:9698,5.3247927e-08,4.4342353228428274e-05,2.7126260770760237e-07,4.3570787691141915e-07,0.0,2.3680045e-06,False,PUM1; pumilio RNA binding family member
hsa:132430,0.0,0.0,2.2156099846783627e-08,6.464102151906692e-08,0.0,6.005081e-07,False,PABPC4L; poly(A) binding protein cytoplasmic 4
hsa:3236,1.1893563e-09,9.904396309936442e-07,3.2658275839005836e-07,1.0497025872365833e-06,0.0,7.4823115e-06,False,HOXD10; homeobox
hsa:4993,2.8792462e-07,0.00023976999523757958,1.3376515644871346e-05,4.4685789515356585e-05,0.0,0.00030623848,False,OR2C1; olfactory receptor family 2 subfamily C member
hsa:10961,0.0,0.0,1.8618738343567255e-07,3.65871719907727e-07,0.0,2.3677276e-06,False,ERP29; endoplasmic reticulum protein
hsa:6714,0.0001464748,0.12197728036742889,0.00030937775248713445,0.0003896708572587191,0.0,0.0020553493,False,SRC; SRC proto-oncogene
hsa:131,0.0,0.0,2.1267579590643273e-06,2.0538010098179456e-05,0.0,0.0002640053,False,ADH7; alcohol dehydrogenase 7 (class IV)
hsa:59340,0.0,0.0,3.704119940859648e-07,1.172507139296322e-06,0.0,8.7520675e-06,False,HRH4; histamine receptor
hsa:6518,0.0,0.0,2.33847343348538e-05,8.673717160618768e-05,0.0,0.0006271931,False,SLC2A5; solute carrier family 2 member
hsa:593,1.4508228e-06,0.001208176556233961,0.00012192339451590643,0.000325663351654201,0.0,0.001820084,False,BCKDHA; branched chain keto acid dehydrogenase E1 subunit
hsa:374879,1.0866835e-08,9.04938582951872e-06,4.556117617292397e-08,7.97585319662873e-08,0.0,4.3662885e-07,False,ZNF699; zinc finger protein
hsa:119391,7.389051e-05,0.061532519278144134,0.0001556105845498831,0.00020296612366627498,0.0,0.001065697,False,GSTO2; glutathione S-transferase omega
hsa:59352,1.3559874e-09,1.1292021239455587e-06,7.921872258783623e-08,6.179026283169411e-07,0.0,7.971652e-06,False,LGR6; leucine rich repeat containing G protein-coupled receptor
hsa:284217,3.9972405e-05,0.03328712687537662,0.00013650224814093563,0.0002829524049426439,0.0,0.0020596518,False,LAMA1; laminin subunit alpha
hsa:528,2.1779193e-05,0.018136681058703235,0.00035165999957368407,0.000700855929735511,0.0,0.0038729482,False,ATP6V1C1; ATPase H+ transporting V1 subunit
hsa:6366,1.532276e-07,0.00012760069257802877,0.0002033947954094444,0.0005117002295691944,0.0,0.0038789946,False,CCL21; C-C motif chemokine ligand
hsa:5028,0.0,0.0,1.6259706046783625e-06,6.228686492891153e-06,0.0,5.1060048e-05,False,P2RY1; purinergic receptor
hsa:355,0.0,0.0,8.862085303295325e-05,0.00023334924738747123,0.0,0.0019792607,False,FAS; Fas cell surface death
hsa:7316,2.9832881e-05,0.024843411220941365,0.0002291986441415205,0.000521719097191983,0.0,0.004118619,False,UBC; ubiquitin
hsa:5534,0.0,0.0,0.0001773616705964912,0.0003471676686494964,0.0,0.0020702933,False,PPP3R1; protein phosphatase 3 regulatory subunit B
hsa:208,0.0,0.0,0.0004886700192631579,0.0008411112494622749,0.0,0.004121202,False,AKT2; AKT serine/threonine kinase
hsa:406923,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133A2; microRNA
hsa:2846,0.0,0.0,7.166800182789473e-07,2.2138164610758596e-06,0.0,1.9999501e-05,False,LPAR4; lysophosphatidic acid receptor
hsa:1734,0.0,0.0,1.3633632470350874e-07,3.4214293999474235e-07,0.0,3.4213788e-06,False,DIO2; iodothyronine deiodinase
hsa:114131,0.0,0.0,1.262031773817368e-06,3.8520730972655584e-06,0.0,3.129482e-05,False,UCN3; urocortin
hsa:84249,5.595692e-09,4.659827437441655e-06,1.5262662766479535e-07,2.4137966155153915e-07,0.0,1.1819476e-06,False,PSD2; pleckstrin and Sec7 domain containing
hsa:6777,0.00011236559,0.09357274476620936,0.00039614472106783627,0.000586984607880371,0.0,0.0028944216,False,STAT5B; signal transducer and activator of transcription
hsa:9762,0.0,0.0,4.118744248520469e-05,0.00016833028618495194,0.0,0.0018253268,False,LZTS3; leucine zipper tumor suppressor family member
hsa:2168,0.0,0.0,1.0155652080058482e-05,5.176293949224164e-05,0.0,0.00059797766,False,FABP1; fatty acid binding protein
hsa:23283,8.938216e-08,7.44332321338987e-05,5.775206526502924e-07,1.044636168543904e-06,0.0,5.536796e-06,False,CSTF2T; cleavage stimulation factor subunit 2 tau
hsa:5605,0.00017609862,0.14664659548302725,0.0007312875648629241,0.0014134856738001085,0.0,0.010548759,False,MAP2K2; mitogen-activated protein kinase kinase
hsa:11213,0.0,0.0,2.732086421345029e-07,6.45139467134345e-07,0.0,3.507548e-06,False,IRAK3; interleukin 1 receptor associated kinase
hsa:81327,0.0,0.0,1.729515701754386e-08,2.1141427248931995e-07,0.0,2.7586088e-06,False,OR4A16; olfactory receptor family 4 subfamily A member
hsa:79875,0.0,0.0,1.8037775278904084e-05,6.961629248152442e-05,0.0,0.0005563153,False,THSD4; thrombospondin type 1 domain containing
hsa:79053,8.593519e-07,0.0007156275867287936,2.600102154124561e-05,6.887553566608196e-05,0.0,0.00046368636,False,ALG8; ALG8
hsa:5931,0.0,0.0,5.764254929421052e-06,3.9157689264072675e-05,0.0,0.0003331392,False,RBBP7; RB binding protein 7
hsa:2826,0.00012425194,0.1034711344311578,0.0003318953539192983,0.00041945925699831093,0.0,0.0019039116,False,CCR10; C-C motif chemokine receptor
hsa:90592,7.935991e-09,6.608717671574853e-06,9.073174894269008e-08,1.7564136669295372e-07,0.0,1.0865177e-06,False,ZNF700; zinc finger protein
hsa:8722,0.0,0.0,1.827688237777778e-06,3.1021076347728e-06,0.0,1.1754911e-05,False,CTSF; cathepsin
hsa:51246,0.0,0.0,0.00017784407707660817,0.0005122213907996347,0.0,0.0028289496,False,SHISA5; shisa family member
hsa:347344,0.0,0.0,2.2249767469356718e-08,4.684974371738582e-08,0.0,2.3624368e-07,False,ZNF81; zinc finger protein
hsa:22849,7.7669677e-07,0.0006467963067692628,1.646210553766081e-05,4.7514015261882937e-05,0.0,0.00043881993,False,CPEB3; cytoplasmic polyadenylation element binding protein
hsa:23495,0.0,0.0,2.1517658322450302e-05,6.178682461129977e-05,0.0,0.00050531834,False,TNFRSF13B; TNF receptor superfamily member
hsa:10094,0.0,0.0,0.00010435345464259649,0.00024406626270281865,0.0,0.0014569026,False,ARPC3; actin related protein 2/3 complex subunit
hsa:5429,0.0,0.0,3.2857905216959056e-05,6.65666015398908e-05,0.0,0.0005057916,False,POLH; DNA polymerase
hsa:10111,4.9143005e-06,0.0040923968484564985,7.691355645829238e-05,0.0001967394945659959,0.0,0.0013199538,False,RAD50; RAD50 double strand break repair
hsa:278,0.0,0.0,5.228798347368421e-06,6.709622116141752e-05,0.0,0.0008774377,False,AMY1C; amylase alpha
hsa:6323,0.0,0.0,1.305984400625848e-06,5.988041512621136e-06,0.0,6.633512e-05,False,SCN1A; sodium voltage-gated channel alpha subunit
hsa:8467,3.31904e-08,2.7639394123133205e-05,4.905298419157896e-06,1.577107312005081e-05,0.0,0.00011397288,False,SMARCA5; SWI/SNF related
hsa:57209,2.0310532e-08,1.6913649693842462e-05,1.8442717289181286e-07,4.216668104171177e-07,0.0,2.3489033e-06,False,ZNF248; zinc finger protein
hsa:57835,6.30619e-05,0.05251496541932648,0.00014129396864590645,0.00018328345998936855,0.0,0.0010819605,False,SLC4A5; solute carrier family 4 member
hsa:197259,0.0,0.0,1.2594595104152048e-05,4.448652638726991e-05,0.0,0.00034334784,False,MLKL; mixed lineage kinase domain like
hsa:8985,0.0,0.0,1.3739971496608181e-05,2.8106662128802177e-05,0.0,0.00017143777,False,PLOD3; procollagen-lysine
hsa:7038,0.00012018659,0.10008570337583819,0.0003517850876707603,0.0005490939929622836,0.0,0.0038934238,False,TG;
hsa:9108,0.0,0.0,0.00014805058027949708,0.0003773816910656704,0.0,0.0022167796,False,MTMR7; myotubularin related protein
hsa:9446,0.0,0.0,0.0003507774227953216,0.0007550587631480384,0.0,0.0038647032,False,GSTO1; glutathione S-transferase omega
hsa:79465,0.0,0.0,3.629823391076024e-05,0.00012474634860085672,0.0,0.0010893092,False,ULBP3; UL16 binding protein
hsa:5238,3.8454505e-06,0.0032023091601939007,0.00012841707317952218,0.000356971196119073,0.0,0.002318855,False,PGM3; phosphoglucomutase
hsa:6709,2.991383e-07,0.00024910821716592923,2.640943100350878e-06,4.322132456333462e-06,0.0,1.8225091e-05,False,SPTAN1; spectrin alpha
hsa:10053,0.0,0.0,8.979000573941519e-08,2.465545227729578e-07,0.0,2.004453e-06,False,AP1M2; adaptor related protein complex 1 subunit mu
hsa:6543,0.00020461537,0.17039399510342526,0.00047608189770000005,0.0006847153927532138,0.0,0.0034849537,False,SLC8A2; solute carrier family 8 member
hsa:8989,2.0920164e-07,0.00017421322367810655,3.725264646659649e-05,0.0001097128568431216,0.0,0.0010812583,False,TRPA1; transient receptor potential cation channel subfamily A member
hsa:57552,0.0,0.0,2.2294361988304096e-07,1.9095657846937957e-06,0.0,1.9428167e-05,False,NCEH1; neutral cholesterol ester hydrolase
hsa:196,0.0,0.0,1.1418642815789472e-06,4.447502993210828e-06,0.0,4.8849073e-05,False,AHR; aryl hydrocarbon
hsa:1129,6.424908e-07,0.0005350359273069065,3.475826068769006e-05,7.436753830497739e-05,0.0,0.00049489486,False,CHRM2; cholinergic receptor muscarinic
hsa:130075,0.0,0.0,4.820385216040936e-07,2.847347685772753e-06,0.0,3.176801e-05,False,OR9A4; olfactory receptor family 9 subfamily A member
hsa:442904,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR335; microRNA
hsa:84135,0.0,0.0,6.842325131221053e-08,1.54147954013024e-07,0.0,8.499603e-07,False,UTP15; UTP15 small subunit processome
hsa:388585,3.7941918e-06,0.0031596233410552503,2.6042127278222208e-05,5.8812018761980426e-05,0.0,0.00050083286,False,HES5; hes family bHLH transcription factor
hsa:5159,4.0285827e-06,0.0033548129881814047,8.433608048947369e-05,0.00015140679206159058,0.0,0.0008111947,False,PDGFRB; platelet derived growth factor receptor
hsa:133522,0.0,0.0,4.886920518721932e-07,1.1569701409222728e-06,0.0,7.182065e-06,False,PPARGC1B; PPARG coactivator 1
hsa:9945,0.0,0.0,1.6630166107485383e-05,4.3962337438829324e-05,0.0,0.00023339478,False,GFPT2; glutamine-fructose-6-phosphate transaminase
hsa:2922,0.0,0.0,5.786272450792982e-07,3.901689313198324e-06,0.0,3.879393e-05,False,GRP; gastrin releasing
hsa:4684,0.00010698145,0.08908908782100453,0.001260625885133918,0.0019967840948045467,0.0,0.009127565,False,NCAM1; neural cell adhesion molecule
hsa:55929,5.548908e-08,4.620867936662614e-05,1.010071295839181e-05,3.0274506892219966e-05,0.0,0.00015956347,False,DMAP1; DNA methyltransferase 1 associated protein
hsa:57642,5.605892e-06,0.004668321514646387,3.399239200411344e-05,8.242391898672875e-05,0.0,0.00060188316,False,COL20A1; collagen type XX alpha 1
hsa:3117,0.0,0.0,0.00023258586053040943,0.00044623113091812053,0.0,0.0029727018,False,HLA-DQA1; major histocompatibility complex
hsa:1173,8.41808e-06,0.0070101785721192016,3.924741678666667e-05,7.250274442915147e-05,0.0,0.00034607452,False,AP2M1; adaptor related protein complex 2 subunit mu
hsa:10199,3.3628808e-08,2.8004479554424618e-05,1.7139833978327484e-06,2.866927774130545e-06,0.0,1.3610402e-05,False,MPHOSPH10; M-phase phosphoprotein
hsa:9232,1.1895609e-06,0.0009906100121893392,7.96874075768187e-06,1.5156801023525e-05,0.0,0.00010261917,False,PTTG1; PTTG1 regulator of sister chromatid separation
hsa:6874,3.504354e-08,2.91826014006997e-05,1.6107610061099422e-06,4.4894347632320825e-06,0.0,2.7353777e-05,False,TAF4; TATA-box binding protein associated factor
hsa:100169757,0.0,0.0,4.0197064355906436e-08,2.915009575346362e-07,0.0,2.88736e-06,False,RNA5S6; RNA
hsa:1349,0.0,0.0,0.0003077437817973101,0.0009259723997519438,0.0,0.0051570507,False,COX7B; cytochrome c oxidase subunit
hsa:146227,1.4510886e-09,1.2083979018928844e-06,1.0167367364035087e-07,2.3886677926837417e-07,0.0,1.6602071e-06,False,BEAN1; brain expressed associated with NEDD4
hsa:5781,0.00027044045,0.2252100060375138,0.0003553127512748537,0.0003562487265524528,0.0,0.0018243497,False,PTPN11; protein tyrosine phosphatase non-receptor type
hsa:356,5.995048e-06,0.0049923922115762825,2.406357566432747e-05,4.5098852136473676e-05,0.0,0.0002902238,False,FASLG; Fas
hsa:3309,0.0,0.0,0.00015280369394853814,0.00036700863809452887,0.0,0.0018224553,False,HSPA5; heat shock protein family A (Hsp70) member
hsa:9560,8.762462e-05,0.0729696360113099,0.00017902332592748538,0.00028139002929002235,0.0,0.002228867,False,CCL4L2; C-C motif chemokine ligand 4 like
hsa:558,0.0,0.0,6.592712456140351e-09,7.344594320951382e-08,0.0,9.438092e-07,False,AXL; AXL receptor tyrosine
hsa:222545,0.0,0.0,5.764572861403508e-10,3.0750125022242826e-09,0.0,2.8646161e-08,False,GPRC6A; G protein-coupled receptor class C group 6 member
hsa:5610,0.0,0.0,8.869151945380118e-05,0.0002524756614762724,0.0,0.0017535542,False,EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase
hsa:6747,3.4515395e-08,2.8742787243317983e-05,5.211220922124564e-07,9.55972010382621e-07,0.0,4.221537e-06,False,SSR3; signal sequence receptor subunit
hsa:5868,6.0388373e-07,0.0005028857867943067,0.00016574470411728065,0.00030433081936812246,0.0,0.001455019,False,RAB5A; RAB5A
hsa:6948,0.0,0.0,4.765938880175439e-05,0.00015170947062326102,0.0,0.00082806963,False,TCN2; transcobalamin
hsa:170589,0.0,0.0,2.8562599531649126e-06,1.4332882386877686e-05,0.0,0.00017171988,False,GPHA2; glycoprotein hormone subunit alpha
hsa:6715,1.4051899e-07,0.00011701756370500547,8.12797917736614e-05,0.00017924015052267874,0.0,0.0010207677,False,SRD5A1; steroid 5 alpha-reductase
hsa:57505,0.0,0.0,1.562747560350292e-05,5.323142649375512e-05,0.0,0.0002819056,False,AARS2; alanyl-tRNA synthetase 2
hsa:1565,1.0157311e-07,8.458527826125513e-05,0.00022582968207760228,0.00040403203174312703,0.0,0.0018563116,False,CYP2D6; cytochrome P450 family 2 subfamily D member
hsa:25898,0.0,0.0,7.802980221228069e-06,3.044234460083083e-05,0.0,0.00023924785,False,RCHY1; ring finger and CHY zinc finger domain containing
hsa:5332,0.001997893,1.6637507243916605,0.002408069591754386,0.0020381517019224505,0.0,0.00942773,True,PLCB4; phospholipase C beta
hsa:84309,5.8581327e-07,0.000487837563033029,8.826018357970759e-07,9.742910733403326e-07,0.0,4.891061e-06,False,NUDT16L1; nudix hydrolase 16 like
hsa:5327,0.0,0.0,2.7561549350292397e-06,4.929635245209159e-06,0.0,2.3733888e-05,False,PLAT; plasminogen activator
hsa:407046,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR9-1; microRNA
hsa:112399,4.861302e-06,0.0040482622062275745,1.6365534336415206e-05,2.9249695421759746e-05,0.0,0.00014091872,False,EGLN3; egl-9 family hypoxia inducible factor
hsa:10975,3.7465514e-07,0.00031199506708920797,3.175678769829824e-05,6.152402149499929e-05,0.0,0.00028798662,False,UQCR11; ubiquinol-cytochrome c reductase
hsa:9254,0.00028894586,0.2406204355713601,0.0009520991344853798,0.0016460796316943441,0.0,0.010083226,False,CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:3816,1.6202443e-05,0.013492627622282366,7.018085059442688e-05,0.0001408196623772074,0.0,0.0013460387,False,KLK1; kallikrein
hsa:56949,3.9847783e-09,3.318334757249347e-06,1.8186846208187135e-07,3.630500294383531e-07,0.0,1.544578e-06,False,XAB2; XPA binding protein
hsa:51065,0.0,0.0,2.0582802991052628e-07,3.561887368086752e-07,0.0,1.7023958e-06,False,RPS27L; ribosomal protein S27
hsa:219927,0.0,0.0,1.1786552719573098e-07,2.3861552025439094e-07,0.0,1.4542537e-06,False,MRPL21; mitochondrial ribosomal protein
hsa:57580,4.106158e-07,0.0003419414026159865,7.524307475555554e-07,9.152573927100872e-07,0.0,4.650777e-06,False,PREX1; phosphatidylinositol-3
hsa:50807,1.0526551e-06,0.0008766013420936835,8.083308158947367e-06,1.9132078370885647e-05,0.0,0.00011457529,False,ASAP1; ArfGAP with SH3 domain
hsa:1501,0.0,0.0,1.5056936590959056e-05,5.0990090573956014e-05,0.0,0.00032372057,False,CTNND2; catenin delta
hsa:154810,0.0,0.0,6.064987106877777e-07,1.7460798204712751e-06,0.0,9.177982e-06,False,AMOTL1; angiomotin like
hsa:4670,0.0,0.0,3.710634767953217e-08,9.185039409785816e-08,0.0,8.2771703e-07,False,HNRNPM; heterogeneous nuclear ribonucleoprotein
hsa:28998,1.6602957e-08,1.3826156724005535e-05,1.2531195985906427e-07,2.851098552169614e-07,0.0,1.6251655e-06,False,MRPL13; mitochondrial ribosomal protein
hsa:4507,0.0,0.0,3.1065643716959055e-07,9.059427441233218e-07,0.0,4.644686e-06,False,MTAP; methylthioadenosine
hsa:3916,1.2971594e-07,0.00010802129500435966,2.484764232070175e-06,4.596187688034762e-06,0.0,1.6750142e-05,False,LAMP1; lysosomal associated membrane protein
hsa:8431,7.440991e-07,0.000619650510134518,1.6478828370614037e-05,4.747439227615917e-05,0.0,0.00038789547,False,NR0B2; nuclear receptor subfamily 0 group B member
hsa:54207,3.557471e-07,0.0002962493463489949,7.49780902760643e-05,0.0001917740296194623,0.0,0.0012652365,False,KCNK10; potassium two pore domain channel subfamily K member
hsa:2880,0.0,0.0,1.7066096178947363e-06,9.0158371786752e-06,0.0,9.606663e-05,False,GPX5; glutathione peroxidase
hsa:9217,2.3809084e-06,0.001982707820293774,0.00016982507348052624,0.00033721349415171255,0.0,0.001711394,False,VAPB; VAMP associated protein B and
hsa:406947,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR155; microRNA
hsa:730,4.9765543e-08,4.144238866445517e-05,2.992561187407603e-05,9.249130615276805e-05,0.0,0.0005859635,False,C7; complement
hsa:2182,0.0,0.0,8.953286440818718e-05,0.00025833929400584913,0.0,0.0020302213,False,ACSL4; acyl-CoA synthetase long chain family member
hsa:725,0.0,0.0,4.494064567473684e-07,1.8414107054741869e-06,0.0,1.2586602e-05,False,C4BPB; complement component 4 binding protein
hsa:7507,1.2415038e-07,0.000103386560070284,4.8219420605555546e-06,1.044689208865294e-05,0.0,7.39017e-05,False,XPA; XPA
hsa:79228,1.4825621e-09,1.2346075429618208e-06,2.6895742200760235e-07,5.729126429174006e-07,0.0,2.8091024e-06,False,THOC6; THO complex subunit
hsa:3355,0.0,0.0,1.0225103818187131e-05,3.637699308298346e-05,0.0,0.00026121858,False,HTR1F; 5-hydroxytryptamine receptor
hsa:3073,0.0,0.0,0.0003151845865643276,0.000851823844959085,0.0,0.0040394543,False,HEXA; hexosaminidase subunit
hsa:4145,2.5968363e-09,2.1625223549266947e-06,1.138879669614971e-06,2.8536819817626503e-06,0.0,2.6159001e-05,False,MATK; megakaryocyte-associated tyrosine
hsa:1621,0.0,0.0,0.00015522470532105265,0.00038369736837760474,0.0,0.0021136862,False,DBH; dopamine
hsa:60489,1.2484549e-06,0.0010396541477673319,2.4419625997894734e-05,7.146664090291842e-05,0.0,0.0004969289,False,APOBEC3G; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:5663,0.0,0.0,0.00021493088509178361,0.0006113400182239704,0.0,0.0037119598,False,PSEN1; presenilin
hsa:7976,3.2248518e-05,0.02685503937551085,0.0001256164765730994,0.00022619854912947151,0.0,0.0022341756,False,FZD3; frizzled class receptor
hsa:23786,0.0,0.0,1.2214467008029236e-05,2.811114042701661e-05,0.0,0.00018965323,False,BCL2L13; BCL2 like
hsa:219958,0.0,0.0,7.483102105263158e-09,6.91485709450408e-08,0.0,6.830095e-07,False,OR1S2; olfactory receptor family 1 subfamily S member
hsa:10990,0.0,0.0,3.2687510637485374e-06,9.194189620750593e-06,0.0,6.125908e-05,False,LILRB5; leukocyte immunoglobulin like receptor
hsa:58476,1.0750698e-07,8.95267243301617e-05,5.639906506534504e-07,1.5185389892185843e-06,0.0,1.5455345e-05,False,TP53INP2; tumor protein p53 inducible nuclear protein
hsa:126070,4.3863107e-08,3.652711934288719e-05,8.13938783149123e-08,1.2422342136182577e-07,0.0,7.2645247e-07,False,ZNF440; zinc finger protein
hsa:11168,0.0,0.0,8.943131771773683e-06,2.0719086060880765e-05,0.0,0.00012661557,False,PSIP1; PC4 and SRSF1 interacting protein
hsa:8148,0.0,0.0,5.610281723391812e-07,2.681051455545898e-06,0.0,2.359588e-05,False,TAF15; TATA-box binding protein associated factor
hsa:8323,0.0,0.0,3.3638691657228066e-06,1.2122269553138194e-05,0.0,0.00010890874,False,FZD6; frizzled class receptor
hsa:51466,2.1087308e-07,0.00017560511979605544,1.1480212461403509e-06,1.5257435974279362e-06,0.0,6.9836137e-06,False,EVL;
hsa:400916,0.0,0.0,4.1461532383625736e-08,7.932647200782044e-08,0.0,6.5650175e-07,False,CHCHD10; coiled-coil-helix-coiled-coil-helix domain containing
hsa:55741,5.3702127e-08,4.4720589489839014e-05,2.3335724570292393e-07,4.337617768356209e-07,0.0,3.218397e-06,False,EDEM2; ER degradation enhancing alpha-mannosidase like protein
hsa:23765,0.0,0.0,8.226041016315789e-06,2.5643301611348467e-05,0.0,0.00016235492,False,IL17RA; interleukin 17 receptor
hsa:9377,9.714063e-06,0.008089411871925186,0.0005652899091002049,0.0015469475994521833,0.0,0.0089722,False,COX5A; cytochrome c oxidase subunit
hsa:10636,3.3857492e-07,0.0002819491676535472,8.455472266076026e-07,1.0566786780681353e-06,0.0,4.706985e-06,False,RGS14; regulator of G protein signaling
hsa:80781,0.0,0.0,1.3506075192690056e-05,2.4859810465512658e-05,0.0,0.00017536794,False,COL18A1; collagen type XVIII alpha 1
hsa:7478,1.3591927e-06,0.0011318713460695127,3.850687296473684e-06,7.507593659961688e-06,0.0,6.0801696e-05,False,WNT8A; Wnt family member
hsa:5052,0.0,0.0,1.8628586401286556e-05,4.089030807085582e-05,0.0,0.00018308879,False,PRDX1; peroxiredoxin
hsa:51021,6.128264e-09,5.10332819088076e-06,1.0762067776064326e-07,2.0570510004031326e-07,0.0,1.2186604e-06,False,MRPS16; mitochondrial ribosomal protein
hsa:5864,2.9232291e-05,0.024343268296589362,0.00011174289488801174,0.00024951191862799063,0.0,0.0023439664,False,RAB3A; RAB3A
hsa:10713,1.1704398e-08,9.746868651658673e-06,2.1478813887894735e-07,4.074311606447558e-07,0.0,2.0737623e-06,False,USP39; ubiquitin specific peptidase
hsa:54344,0.0,0.0,3.101618176081872e-05,0.00010107611107864782,0.0,0.0007935557,False,DPM3; dolichyl-phosphate mannosyltransferase subunit 3
hsa:3175,0.0,0.0,1.4610035372070172e-05,4.8410102608061796e-05,0.0,0.0005184397,False,ONECUT1; one cut homeobox
hsa:2861,2.9190741e-10,2.4308667423270086e-07,2.883504171076024e-09,7.28531241058155e-09,0.0,5.5711773e-08,False,GPR37; G protein-coupled receptor
hsa:5729,0.0,0.0,2.625085725842106e-07,8.119689101159589e-07,0.0,4.3468003e-06,False,PTGDR; prostaglandin D2
hsa:2948,0.0,0.0,0.00014521422922222219,0.00023739366155450093,0.0,0.0010683796,False,GSTM4; glutathione S-transferase mu
hsa:64421,1.6493917e-05,0.01373535337318161,8.804803712439183e-05,0.00013743232457532687,0.0,0.0005817125,False,DCLRE1C; DNA cross-link repair
hsa:10162,8.3174755e-06,0.006926399906418856,5.234854047526314e-05,0.00010711018912414439,0.0,0.00055347395,False,LPCAT3; lysophosphatidylcholine acyltransferase
hsa:407015,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26A1; microRNA
hsa:5460,3.78865e-09,3.1550083923245464e-06,1.0562213156900586e-07,2.2176059683173787e-07,0.0,1.2179282e-06,False,POU5F1; POU class 5 homeobox
hsa:255061,0.0,0.0,7.709725699949713e-07,3.3833692431841623e-06,0.0,2.9917239e-05,False,TAC4; tachykinin precursor
hsa:22802,0.0,0.0,1.556579964883041e-06,5.649330112493706e-06,0.0,5.039714e-05,False,CLCA4; chloride channel accessory
hsa:26686,0.0,0.0,6.183601947368422e-07,4.110855973503138e-06,0.0,3.548591e-05,False,OR4E2; olfactory receptor family 4 subfamily E member
hsa:6205,0.0,0.0,1.6711862884210526e-07,3.99540682573377e-07,0.0,2.006946e-06,False,RPS11; ribosomal protein
hsa:51606,0.0,0.0,0.00014383098013198828,0.00028706215566487827,0.0,0.0018262822,False,ATP6V1H; ATPase H+ transporting V1 subunit
hsa:1788,9.3905786e-05,0.07820029375050028,0.0004327369288251288,0.000777287038454622,0.0,0.0053568445,False,DNMT3A; DNA methyltransferase 3
hsa:10874,0.0,0.0,1.4310801229739037e-05,3.2598375797362835e-05,0.0,0.00016367952,False,NMU; neuromedin
hsa:27294,9.043547e-06,0.007531037884571408,5.197738046482454e-05,0.0001034612114853046,0.0,0.00070714497,False,DHDH; dihydrodiol
hsa:51324,5.8216393e-10,4.847985654147625e-07,7.877425166319883e-07,1.6966235266172352e-06,0.0,1.3441781e-05,False,SPG21; SPG21 abhydrolase domain containing
hsa:399,0.0,0.0,4.361610523774854e-06,1.8394099530892734e-05,0.0,0.0002023276,False,RHOH; ras homolog family member
hsa:54511,5.1548654e-06,0.0042927279105495165,0.00015551287979941524,0.00039480133999939573,0.0,0.0021404135,False,HMGCLL1; 3-hydroxy-3-methylglutaryl-CoA lyase like
hsa:80271,2.0504608e-07,0.00017075267000468512,1.9134878507134497e-06,3.141494338907873e-06,0.0,1.5681457e-05,False,ITPKC; inositol-trisphosphate 3-kinase
hsa:3543,0.0,0.0,0.000143877950257193,0.00035638883128724733,0.0,0.0021122016,False,IGLL1; immunoglobulin lambda like polypeptide
hsa:27189,6.473416e-07,0.0005390754439446239,7.612031167076025e-06,1.7509934941646608e-05,0.0,0.00016330779,False,IL17C; interleukin
hsa:53833,7.397033e-05,0.061598989596034506,0.00020633509205836252,0.0003509609834286838,0.0,0.001713764,False,IL20RB; interleukin 20 receptor subunit
hsa:8974,0.0,0.0,3.382195487060819e-06,1.457560052948154e-05,0.0,0.00011880114,False,P4HA2; prolyl 4-hydroxylase subunit alpha
hsa:51164,1.1102454e-06,0.0009245598180195378,0.0002262682253095731,0.0005036088521269582,0.0,0.0026984273,False,DCTN4; dynactin subunit
hsa:80153,0.0,0.0,2.8584755128654965e-07,5.558296814885343e-07,0.0,2.985605e-06,False,EDC3; enhancer of mRNA decapping
hsa:144124,0.0,0.0,1.175064201754386e-07,1.3895231931852467e-06,0.0,1.8089371e-05,False,OR10A5; olfactory receptor family 10 subfamily A member
hsa:282617,0.0,0.0,1.3168702576959064e-06,4.848936836426188e-06,0.0,3.595569e-05,False,IFNL3; interferon lambda
hsa:5603,0.0,0.0,9.532159378947369e-05,0.00023446784805585262,0.0,0.0014171508,False,MAPK13; mitogen-activated protein kinase
hsa:253152,0.0,0.0,9.489501720116962e-08,2.1637684607763454e-07,0.0,1.1622199e-06,False,EPHX4; epoxide hydrolase
hsa:51,1.3900533e-05,0.01157570593028765,0.00011782993991040932,0.00024063019929396624,0.0,0.0016789715,False,ACOX1; acyl-CoA oxidase
hsa:8704,0.0,0.0,0.0005790596687959063,0.001273740026045086,0.0,0.0059758113,False,B4GALT2; beta-1
hsa:55750,6.2773256e-06,0.0052274596358475225,8.225150941883037e-05,0.00017835809573452837,0.0,0.0009168983,False,AGK; acylglycerol
hsa:84612,4.600788e-08,3.8313184779027e-05,1.997513153746783e-06,3.505092631890281e-06,0.0,2.0072508e-05,False,PARD6B; par-6 family cell polarity regulator
hsa:22885,8.5331656e-08,7.106016412467532e-05,4.7284242221754395e-06,1.4449497722500403e-05,0.0,0.00010232926,False,ABLIM3; actin binding LIM protein family member
hsa:51548,7.108896e-06,0.005919952104354425,0.00017354297300350882,0.0004441013878910431,0.0,0.0029933057,False,SIRT6; sirtuin
hsa:10269,0.0,0.0,2.692649695205463e-05,6.804168156852911e-05,0.0,0.000398967,False,ZMPSTE24; zinc metallopeptidase
hsa:55014,0.0,0.0,2.0781407377280706e-05,5.7161815834549416e-05,0.0,0.00040937585,False,STX17; syntaxin
hsa:29102,1.6632251e-06,0.0013850551380636459,6.6485494956725175e-06,1.1169276632973926e-05,0.0,5.279777e-05,False,DROSHA; drosha ribonuclease
hsa:406948,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR15A; microRNA
hsa:2521,4.8844277e-07,0.0004067520194581838,3.3909474444795314e-06,4.777776555059462e-06,0.0,2.1722146e-05,False,FUS; FUS RNA binding
hsa:57689,1.1549573e-06,0.0009617937719970169,4.5641380449095e-06,6.876045052122632e-06,0.0,3.0514728e-05,False,LRRC4C; leucine rich repeat containing
hsa:6624,0.0,0.0,1.20111058502924e-07,2.6210858807121104e-07,0.0,1.1920935e-06,False,FSCN1; fascin actin-bundling protein
hsa:6890,0.0,0.0,0.00013195618849064328,0.00040841631193787683,0.0,0.0023507604,False,TAP1; transporter 1
hsa:30849,1.9544233e-07,0.0001627551215777291,4.0382603232122796e-05,0.00010424832290791836,0.0,0.00049433287,False,PIK3R4; phosphoinositide-3-kinase regulatory subunit
hsa:1311,0.0,0.0,2.749728201970759e-06,8.64934876189187e-06,0.0,6.213121e-05,False,COMP; cartilage oligomeric matrix
hsa:55718,3.5787432e-06,0.0029802079447756855,0.00031446255625543863,0.0006263250539171181,0.0,0.0030648818,False,POLR3E; RNA polymerase III subunit
hsa:3778,0.00013390816,0.11151237739055814,0.0003240851117654968,0.000502176165572712,0.0,0.0029450015,False,KCNMA1; potassium calcium-activated channel subfamily M alpha
hsa:6100,5.566316e-09,4.635364495092024e-06,3.913286041298246e-07,1.0227441746173944e-06,0.0,6.0471084e-06,False,RP9; RP9 pre-mRNA splicing
hsa:51547,3.8699425e-05,0.032227049385172644,0.00020584891066795314,0.00047107353780737656,0.0,0.0030966555,False,SIRT7; sirtuin
hsa:10274,7.5150135e-09,6.2581475356478595e-06,5.367751977502925e-07,1.2735926858236462e-06,0.0,6.345811e-06,False,STAG1; STAG1 cohesin complex
hsa:53373,0.0,0.0,1.1714570279532161e-06,2.721176763850698e-06,0.0,1.8159348e-05,False,TPCN1; two pore segment channel
hsa:55054,0.0,0.0,0.0006000853945788889,0.0014327170626252962,0.0,0.006039393,False,ATG16L1; autophagy related 16 like
hsa:5265,0.0,0.0,1.2612389499122806e-06,6.004633350399731e-06,0.0,7.1985945e-05,False,SERPINA1; serpin family A member
hsa:9170,1.3709669e-05,0.011416763425228424,0.00010522640429140348,0.0002022335369779382,0.0,0.0011670026,False,LPAR2; lysophosphatidic acid receptor
hsa:55120,8.542706e-06,0.007113961206013026,0.00011188055165465495,0.00017051387933941353,0.0,0.0007755546,False,FANCL; FA complementation group
hsa:2837,0.0,0.0,3.6632943663621644e-07,1.4977244747051572e-06,0.0,1.7371847e-05,False,UTS2R; urotensin 2
hsa:128368,0.0,0.0,2.684202937192983e-07,2.445934233979058e-06,0.0,3.098349e-05,False,OR10Z1; olfactory receptor family 10 subfamily Z member
hsa:219952,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6Q1; olfactory receptor family 6 subfamily Q member
hsa:8648,6.778919e-06,0.005645162877512655,3.1508370870350886e-05,5.891057940536811e-05,0.0,0.00032210271,False,NCOA1; nuclear receptor coactivator
hsa:2250,0.0,0.0,5.7473889493567247e-08,3.2422213875892135e-07,0.0,3.750867e-06,False,FGF5; fibroblast growth factor
hsa:79966,4.1399042e-05,0.034475162642153896,0.000523869896411462,0.001432187757899107,0.0,0.009419735,False,SCD5; stearoyl-CoA desaturase
hsa:406893,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR101-1; microRNA
hsa:4628,1.9202484e-05,0.01599091976653368,0.0002053283745881327,0.000401148853091941,0.0,0.002968352,False,MYH10; myosin heavy chain
hsa:366,0.0,0.0,3.629921038011695e-07,1.6657528809284103e-06,0.0,1.6368322e-05,False,AQP9; aquaporin
hsa:1234,0.0,0.0,4.4176387380584796e-05,0.00013335280870722883,0.0,0.0012470296,False,CCR5; C-C motif chemokine receptor
hsa:3350,0.0,0.0,5.097756430409357e-06,2.2407554586512893e-05,0.0,0.0002603862,False,HTR1A; 5-hydroxytryptamine receptor
hsa:6362,0.00016482174,0.13725574358611492,0.0005720642300197073,0.001023244365262,0.0,0.0058442554,False,CCL18; C-C motif chemokine ligand
hsa:50846,0.0,0.0,9.281661099415203e-08,3.5690103612510436e-07,0.0,2.904994e-06,False,DHH; desert hedgehog signaling
hsa:10159,3.8339498e-05,0.03192731921595031,0.0003619953827674854,0.0006151246252498767,0.0,0.0027344108,False,ATP6AP2; ATPase H+ transporting accessory protein
hsa:85464,2.2793779e-07,0.00018981580256236652,2.0782128235327486e-05,6.332319319132823e-05,0.0,0.000381627,False,SSH2; slingshot protein phosphatase
hsa:1586,0.0,0.0,4.352095672333333e-06,2.863177332760759e-05,0.0,0.00035921598,False,CYP17A1; cytochrome P450 family 17 subfamily A member
hsa:64131,2.1772612e-05,0.018131200713400845,0.0002972230048913217,0.0006045529770911766,0.0,0.003344984,False,XYLT1; xylosyltransferase
hsa:84735,1.8659683e-05,0.015538900786062494,0.00011129810926222219,0.00020641896868048727,0.0,0.0015247602,False,CNDP1; carnosine dipeptidase
hsa:127068,0.0,0.0,4.2884982046783627e-07,3.814869305517224e-06,0.0,4.7453075e-05,False,OR2T34; olfactory receptor family 2 subfamily T member
hsa:6431,0.0,0.0,2.7972224387719304e-07,4.4998136929834486e-07,0.0,2.3819005e-06,False,SRSF6; serine and arginine rich splicing factor
hsa:23095,4.7933952e-08,3.991712637411267e-05,1.4059383087403513e-06,4.0198113741831895e-06,0.0,1.7777567e-05,False,KIF1B; kinesin family member
hsa:5478,8.619688e-06,0.007178068171834079,0.0004132012755409358,0.001117888236299631,0.0,0.00732027,False,PPIA; peptidylprolyl isomerase
hsa:23673,2.4992255e-08,2.0812367008859382e-05,1.570973903235088e-06,4.1914637157635335e-06,0.0,2.8367982e-05,False,STX12; syntaxin
hsa:54552,3.9902492e-08,3.322890663815952e-05,5.203713103421053e-07,1.236882759505721e-06,0.0,8.349492e-06,False,GNL3L; G protein nucleolar 3
hsa:214,6.24494e-06,0.005200490441070896,2.0884389010116947e-05,4.005363066275444e-05,0.0,0.0003525914,False,ALCAM; activated leukocyte cell adhesion
hsa:1549,0.0,0.0,2.3914682297660826e-05,6.756523490938893e-05,0.0,0.00048292862,False,CYP2A7; cytochrome P450 family 2 subfamily A member
hsa:4211,2.7860694e-06,0.0023201067236610965,5.423707080517548e-05,9.063631767838888e-05,0.0,0.00054904475,False,MEIS1; Meis homeobox
hsa:10642,0.0,0.0,2.093423536081871e-08,3.678676089844655e-08,0.0,1.4014509e-07,False,IGF2BP1; insulin like growth factor 2 mRNA binding protein
hsa:51094,3.7488503e-06,0.003121865085998546,4.1007267160935676e-05,6.864183472363016e-05,0.0,0.00045658552,False,ADIPOR1; adiponectin receptor
hsa:3293,9.909395e-07,0.0008252075115901151,2.585305740430994e-05,7.69537807205116e-05,0.0,0.0004946498,False,HSD17B3; hydroxysteroid 17-beta dehydrogenase
hsa:84105,2.6426247e-07,0.000220065276715034,1.9101076601111112e-06,3.4781424845737447e-06,0.0,2.2966004e-05,False,PCBD2; pterin-4 alpha-carbinolamine dehydratase
hsa:3034,5.0557026e-07,0.00042101498243693735,4.119249739443276e-06,8.55603264514602e-06,0.0,7.018859e-05,False,HAL; histidine
hsa:5933,7.1124805e-07,0.0005922937106289756,5.1720419033532156e-05,0.00010178412457639014,0.0,0.00057142624,False,RBL1; RB transcriptional corepressor like
hsa:54925,0.0,0.0,4.686022685672513e-08,9.137058311102773e-08,0.0,4.2740461e-07,False,ZSCAN32; zinc finger and SCAN domain containing
hsa:2261,0.0,0.0,5.097590550292396e-07,2.8438680079341372e-06,0.0,3.50435e-05,False,FGFR3; fibroblast growth factor receptor
hsa:23019,1.0384713e-07,8.647897448136358e-05,2.281604045350292e-05,8.739105300925091e-05,0.0,0.0007342473,False,CNOT1; CCR4-NOT transcription complex subunit
hsa:1613,0.0,0.0,5.790744584625731e-05,0.0001910322253291265,0.0,0.0012404729,False,DAPK3; death associated protein kinase
hsa:8091,0.0,0.0,3.417335411081871e-09,1.4566316934269239e-08,0.0,1.3256697e-07,False,HMGA2; high mobility group AT-hook
hsa:6181,0.0,0.0,6.575362408321636e-07,1.2835990966580307e-06,0.0,5.666108e-06,False,RPLP2; ribosomal protein lateral stalk subunit
hsa:3651,0.0,0.0,1.2691963145029239e-05,0.00012842596384268963,0.0,0.0016588435,False,PDX1; pancreatic and duodenal homeobox
hsa:6192,2.6746788e-08,2.2273459044178125e-05,3.991295774296492e-07,6.812362416567919e-07,0.0,2.9910125e-06,False,RPS4Y1; ribosomal protein S4 Y-linked
hsa:9311,3.3125845e-05,0.02758563577470658,0.0001329711425587134,0.00019538734425978855,0.0,0.0009109685,False,ASIC3; acid sensing ion channel subunit
hsa:83447,2.8425865e-07,0.0002367171489424586,5.390255028915204e-06,1.5155155937449593e-05,0.0,0.00012014119,False,SLC25A31; solute carrier family 25 member
hsa:144125,0.0,0.0,6.430376766081871e-07,3.820327595415043e-06,0.0,3.6340767e-05,False,OR2AG1; olfactory receptor family 2 subfamily AG member
hsa:51311,0.0,0.0,1.0513791549599412e-06,2.185662388639582e-06,0.0,1.2186189e-05,False,TLR8; toll like receptor
hsa:65109,0.0,0.0,2.1671130509274848e-07,4.3377376446838973e-07,0.0,1.6751889e-06,False,UPF3B; UPF3B regulator of nonsense mediated mRNA
hsa:570,0.00018748632,0.15612973303051095,0.00039945360339181305,0.0009557393180679862,0.0,0.01023588,False,BAAT; bile acid-CoA:amino acid
hsa:29915,1.5597028e-08,1.2988466666311463e-05,4.352020535816958e-06,1.452332662009076e-05,0.0,8.528866e-05,False,HCFC2; host cell factor
hsa:4622,0.0,0.0,1.2466299611754386e-09,9.429895473457331e-09,0.0,9.640209e-08,False,MYH4; myosin heavy chain
hsa:2796,1.9951183e-05,0.01661440085566173,4.736458649991227e-05,6.798056787985212e-05,0.0,0.00040232018,False,GNRH1; gonadotropin releasing hormone
hsa:4190,0.00015582735,0.12976564132440166,0.0006200352108245612,0.0010538439662542297,0.0,0.0069792527,False,MDH1; malate dehydrogenase
hsa:26088,3.4375518e-07,0.0002862630429849775,2.7578979833479534e-06,5.352987220763503e-06,0.0,3.9978633e-05,False,GGA1; golgi associated
hsa:2950,0.0,0.0,0.0002260808967836257,0.0005712922946472392,0.0,0.0034318736,False,GSTP1; glutathione S-transferase pi
hsa:10555,0.0,0.0,1.771047699239766e-05,6.250220663509377e-05,0.0,0.00047583127,False,AGPAT2; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:58498,2.962381e-07,0.0002466930678807169,2.6739429744629225e-05,6.083514782775463e-05,0.0,0.0004232511,False,MYL7; myosin light chain
hsa:729092,1.6813376e-08,1.40013837074705e-05,3.1108750889333333e-07,6.659219738946343e-07,0.0,3.966743e-06,False,AGAP5; ArfGAP with GTPase domain
hsa:126,0.0,0.0,1.7473713603856138e-05,6.425597894330375e-05,0.0,0.0005430671,False,ADH1C; alcohol dehydrogenase 1C (class I)
hsa:27306,0.0,0.0,1.057242458596491e-06,4.9931296899395485e-06,0.0,3.7852413e-05,False,HPGDS; hematopoietic prostaglandin D
hsa:401667,0.0,0.0,5.385716959064327e-09,7.04273878892236e-08,0.0,9.209576e-07,False,OR51A2; olfactory receptor family 51 subfamily A member
hsa:57863,6.7683177e-06,0.005636334616662603,2.9096972735894923e-05,4.217312216140958e-05,0.0,0.00017469627,False,CADM3; cell adhesion molecule
hsa:80835,0.0,0.0,1.527018588888889e-07,5.991370045786003e-07,0.0,3.4435402e-06,False,TAS1R1; taste 1 receptor member
hsa:3881,0.0,0.0,3.388409921672515e-07,1.9145174401412332e-06,0.0,2.0543874e-05,False,KRT31; keratin
hsa:3077,0.0,0.0,4.716916026804268e-06,2.1072336815883477e-05,0.0,0.00018144051,False,HFE; homeostatic iron
hsa:162998,0.0,0.0,3.201759472321636e-05,0.00014399277783340696,0.0,0.0012185225,False,OR7D2; olfactory receptor family 7 subfamily D member
hsa:7472,0.0,0.0,0.0,0.0,0.0,0.0,False,WNT2; Wnt family member
hsa:7015,0.0,0.0,2.0847932602429827e-05,0.00012308946643461405,0.0,0.0014658826,False,TERT; telomerase reverse
hsa:5539,0.0,0.0,3.0333198469288907e-06,1.9205453681469677e-05,0.0,0.00023298961,False,PPY; pancreatic
hsa:4792,0.0,0.0,5.7483557457660835e-05,0.00019185997613621128,0.0,0.0017146495,False,NFKBIA; NFKB inhibitor
hsa:5291,0.0,0.0,0.00011302293176608187,0.00024470371549600644,0.0,0.001214402,False,PIK3CB; phosphatidylinositol-4
hsa:5318,5.873481e-07,0.0004891156968091211,1.3527878482315786e-05,5.037616350597013e-05,0.0,0.00051901065,False,PKP2; plakophilin
hsa:9855,1.0790612e-07,8.985910922972023e-05,2.8485423066491225e-05,7.099368400565514e-05,0.0,0.00038175474,False,FARP2; FERM
hsa:283111,0.0,0.0,2.3808990865497073e-07,3.086556157660736e-06,0.0,4.0362498e-05,False,OR51V1; olfactory receptor family 51 subfamily V member
hsa:3362,5.0305844e-06,0.004189232576325853,2.927443317508186e-05,5.347626118752431e-05,0.0,0.00036166684,False,HTR6; 5-hydroxytryptamine receptor
hsa:4760,0.0,0.0,6.063810770342689e-05,0.00021526942243994932,0.0,0.0019318806,False,NEUROD1; neuronal differentiation
hsa:29906,0.0,0.0,6.723083665146199e-06,1.4685141128588971e-05,0.0,8.575058e-05,False,ST8SIA5; ST8 alpha-N-acetyl-neuraminide alpha-2
hsa:5434,0.0,0.0,9.925707129976607e-05,0.0003348834285578109,0.0,0.001781759,False,POLR2E; RNA polymerase II
hsa:407055,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR99A; microRNA
hsa:64900,0.0,0.0,1.817518375274854e-05,5.9027909049937196e-05,0.0,0.0004845853,False,LPIN3; lipin
hsa:4286,0.0,0.0,1.5100534929678355e-05,5.447390606272376e-05,0.0,0.0003373864,False,MITF; melanocyte inducing transcription
hsa:406905,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR1-2; microRNA
hsa:6730,0.0,0.0,0.00010283250483473679,0.00025393683455690466,0.0,0.0014986184,False,SRP68; signal recognition particle
hsa:55339,6.795176e-08,5.658700937622197e-05,4.604582178964916e-07,1.1235716662135523e-06,0.0,5.5377077e-06,False,WDR33; WD repeat domain
hsa:915,0.00013813048,0.11502852563203723,0.0004202518457678361,0.000654828907666921,0.0,0.004117684,False,CD3D; CD3 delta subunit of T-cell receptor
hsa:5441,0.0,0.0,6.400731792105263e-06,2.1037944840753063e-05,0.0,0.00018615482,False,POLR2L; RNA polymerase II
hsa:1302,7.852073e-05,0.06538834733254582,0.0001675800146292398,0.00023165543471254614,0.0,0.0013165553,False,COL11A2; collagen type XI alpha 2
hsa:57153,4.8983043e-08,4.0790759702425426e-05,9.529148422467841e-06,2.762422001631962e-05,0.0,0.00017294241,False,SLC44A2; solute carrier family 44 member
hsa:2632,0.0,0.0,2.9984229469005852e-05,4.681826499631362e-05,0.0,0.00020305718,False,GBE1; 1
hsa:123,0.0,0.0,1.6964084579064322e-06,3.6868691952054173e-06,0.0,1.8644818e-05,False,PLIN2; perilipin
hsa:406955,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR181B1; microRNA
hsa:1056,0.00032269498,0.26872510526467247,0.0006226315162210524,0.0006937343321340724,0.0,0.0034302047,False,CEL; carboxyl ester
hsa:2026,3.2280248e-06,0.0026881462617638903,0.00022460820805146186,0.0004286181552604057,0.0,0.0019969945,False,ENO2; enolase
hsa:8386,0.0,0.0,8.494889148304094e-07,7.198140243244976e-06,0.0,9.279543e-05,False,OR1D5; olfactory receptor family 1 subfamily D member
hsa:4982,0.0,0.0,1.9111349788040936e-05,7.32698677161122e-05,0.0,0.0006815397,False,TNFRSF11B; TNF receptor superfamily member
hsa:206358,1.5489352e-06,0.0012898799190125504,3.150083264192983e-05,6.436410580347883e-05,0.0,0.00060469226,False,SLC36A1; solute carrier family 36 member
hsa:5600,0.00069473416,0.5785417246867733,0.0008121545599590638,0.0006113736580066891,0.0,0.0028173586,True,MAPK11; mitogen-activated protein kinase
hsa:55957,0.0,0.0,4.585172260719299e-06,1.4243808742956883e-05,0.0,9.238992e-05,False,LIN37; lin-37 DREAM MuvB core complex
hsa:5361,1.3946843e-07,0.0001161427070630247,1.6972936144619888e-05,5.9512060114214464e-05,0.0,0.0004911211,False,PLXNA1; plexin
hsa:4005,0.0,0.0,1.0209172808245612e-06,1.950839202876732e-06,0.0,8.547183e-06,False,LMO2; LIM domain only
hsa:2120,0.0,0.0,7.267353393567253e-08,1.386035035071476e-07,0.0,8.037832e-07,False,ETV6; ETS variant transcription factor
hsa:85320,3.7542475e-06,0.0031263596186935833,4.90286706137427e-05,9.063754771658206e-05,0.0,0.00047980552,False,ABCC11; ATP binding cassette subfamily C member
hsa:3552,0.0,0.0,1.0071299375438599e-06,4.3181756044077435e-06,0.0,3.1961827e-05,False,IL1A; interleukin 1
hsa:388523,2.369025e-10,1.9728118872491938e-07,8.296545942251463e-09,2.743494278200283e-08,0.0,2.414191e-07,False,ZNF728; zinc finger protein
hsa:246,7.4698773e-06,0.006220560244713715,6.088538580287775e-05,0.00019440689435763387,0.0,0.0017727041,False,ALOX15; arachidonate
hsa:79711,0.0,0.0,1.000864457236842e-07,2.0844278607492014e-07,0.0,1.1670586e-06,False,IPO4; importin
hsa:2815,0.0,0.0,3.564511296198831e-07,2.3532830434840603e-06,0.0,2.5980326e-05,False,GP9; glycoprotein IX
hsa:7482,1.0364563e-05,0.008631117481893675,4.5623212922807004e-05,9.100192135150486e-05,0.0,0.0009017873,False,WNT2B; Wnt family member
hsa:6202,3.3747207e-09,2.8103076637460217e-06,8.452236659456138e-07,2.0259046750601415e-06,0.0,1.0928715e-05,False,RPS8; ribosomal protein
hsa:51035,4.422343e-09,3.6827179282165704e-06,5.86776581511696e-07,1.4158068377578245e-06,0.0,7.176596e-06,False,UBXN1; UBX domain protein
hsa:5168,0.0,0.0,2.6792914218011695e-05,7.619717278046457e-05,0.0,0.00048456102,False,ENPP2; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:9776,8.328891e-06,0.006935906194490485,0.00016064366893959068,0.0003375853827614737,0.0,0.0020656758,False,ATG13; autophagy related
hsa:9533,7.464338e-06,0.006215947377864679,0.0004019690898989478,0.0008900073623668845,0.0,0.0051629813,False,POLR1C; RNA polymerase I and III subunit
hsa:7454,0.0,0.0,1.8102988930596484e-05,5.904815849625433e-05,0.0,0.0004185612,False,WAS; WASP actin nucleation promoting
hsa:3812,0.0,0.0,1.266601354808187e-06,7.243554702558512e-06,0.0,8.796197e-05,False,KIR3DL2; killer cell immunoglobulin like receptor
hsa:22989,0.0,0.0,3.5395969259397664e-07,1.2401046666420274e-06,0.0,8.853677e-06,False,MYH15; myosin heavy chain
hsa:23430,0.0,0.0,1.0031006613695905e-06,4.510700381073677e-06,0.0,4.3255648e-05,False,TPSD1; tryptase delta
hsa:4704,1.2720085e-06,0.0010592684709878604,1.0054066881461983e-05,2.5271176616930607e-05,0.0,0.00015773217,False,NDUFA9; NADH:ubiquinone oxidoreductase subunit
hsa:64411,1.1104315e-06,0.0009247147932908909,3.45054869700117e-05,0.0001148235104783179,0.0,0.0007632983,False,ARAP3; ArfGAP with RhoGAP domain
hsa:381,5.7793596e-08,4.812777121207139e-05,1.3733397052046787e-06,3.919931079102932e-06,0.0,2.285536e-05,False,ARF5; ADP ribosylation factor
hsa:9177,8.39752e-06,0.006993057177282996,5.09838614229649e-05,0.00011963041116538931,0.0,0.00088136445,False,HTR3B; 5-hydroxytryptamine receptor
hsa:5468,0.0,0.0,2.4179763107777777e-05,5.724265458579485e-05,0.0,0.00045373864,False,PPARG; peroxisome proliferator activated receptor
hsa:3112,9.568698e-05,0.0796835878046774,0.00016381336885608192,0.00020498715695877755,0.0,0.00091434375,False,HLA-DOB; major histocompatibility complex
hsa:112398,3.7879383e-07,0.00031544157222513486,4.836774029795319e-05,0.0001573330469741795,0.0,0.0008636358,False,EGLN2; egl-9 family hypoxia inducible factor
hsa:57474,0.0,0.0,1.1077142034502924e-08,2.374657655211706e-08,0.0,1.3210925e-07,False,ZNF490; zinc finger protein
hsa:4720,0.0,0.0,4.308593057871344e-06,6.844934777489539e-06,0.0,3.0663716e-05,False,NDUFS2; NADH:ubiquinone oxidoreductase core subunit
hsa:51305,0.0,0.0,1.2820972046315787e-06,4.4668114439391125e-06,0.0,3.776429e-05,False,KCNK9; potassium two pore domain channel subfamily K member
hsa:1676,0.0,0.0,1.4818403640304092e-06,3.288584386829119e-06,0.0,1.7373834e-05,False,DFFA; DNA fragmentation factor subunit
hsa:8540,1.7178183e-07,0.0001430517770970843,2.2903628299005834e-05,4.799053566004347e-05,0.0,0.00023860174,False,AGPS; alkylglycerone phosphate
hsa:999,0.0,0.0,5.111517201754386e-07,4.702710994418149e-06,0.0,5.224469e-05,False,CDH1; cadherin
hsa:2526,0.0,0.0,4.56160263877193e-05,7.310656366129764e-05,0.0,0.0004141216,False,FUT4; fucosyltransferase
hsa:55669,0.0,0.0,1.9445946036729816e-06,4.186354993224791e-06,0.0,1.9539813e-05,False,MFN1; mitofusin
hsa:2812,0.00012639424,0.1052551404699518,0.0002867070691859065,0.00037690852975021854,0.0,0.0021579608,False,GP1BB; glycoprotein Ib platelet subunit
hsa:79869,7.4386906e-09,6.1945894371097124e-06,0.00010710191647691876,0.000310796947317326,0.0,0.002148358,False,CPSF7; cleavage and polyadenylation specific factor
hsa:2890,0.0003627771,0.30210359759892336,0.0011252162830853803,0.0018749186595665719,0.0,0.010353352,False,GRIA1; glutamate ionotropic receptor AMPA type subunit
hsa:7139,0.0,0.0,8.826390475350876e-05,0.0003454769225566123,0.0,0.0030059123,False,TNNT2; troponin T2
hsa:2100,0.0,0.0,9.699409265497075e-07,2.437606697396158e-06,0.0,1.4652499e-05,False,ESR2; estrogen receptor
hsa:64135,0.0,0.0,3.5336434332748545e-07,1.744078993250901e-06,0.0,1.860568e-05,False,IFIH1; interferon induced with helicase C domain
hsa:79602,0.0,0.0,1.5626427037894737e-05,3.334966887496151e-05,0.0,0.00017728224,False,ADIPOR2; adiponectin receptor
hsa:2909,5.798224e-06,0.0048284865006209595,4.4062646288304096e-05,7.621323941400297e-05,0.0,0.00034135385,False,ARHGAP35; Rho GTPase activating protein
hsa:1634,0.0,0.0,7.5247639732163746e-06,2.1855024896354082e-05,0.0,0.00011874363,False,DCN;
hsa:3558,0.0,0.0,1.5482103343099413e-05,4.059756840224268e-05,0.0,0.00038751587,False,IL2; interleukin
hsa:29935,0.0,0.0,1.5963877800631582e-06,4.487458633267166e-06,0.0,3.3513264e-05,False,RPA4; replication protein
hsa:3726,0.0,0.0,4.672974990214035e-05,0.00015788197426471024,0.0,0.0010828152,False,JUNB; JunB proto-oncogene
hsa:9380,0.0,0.0,3.6166399140350876e-05,6.633971217841976e-05,0.0,0.00030217058,False,GRHPR; glyoxylate and hydroxypyruvate
hsa:9525,3.916771e-08,3.261701496789992e-05,0.00016094507084933338,0.00036095333278368343,0.0,0.002208447,False,VPS4B; vacuolar protein sorting 4 homolog
hsa:343637,0.0,0.0,1.6895401971616964e-06,5.777513995483025e-06,0.0,3.946307e-05,False,RSPO4; R-spondin
hsa:138882,0.0,0.0,1.4323785902339181e-07,1.8370903504233095e-06,0.0,2.4024546e-05,False,OR1N2; olfactory receptor family 1 subfamily N member
hsa:3911,2.9285686e-06,0.0024387733125250805,9.127830603969007e-05,0.00017321644867233815,0.0,0.0010329178,False,LAMA5; laminin subunit alpha
hsa:3938,1.9754682e-06,0.0016450764123817887,9.464216281994153e-06,3.644970486335827e-05,0.0,0.0004513738,False,LCT;
hsa:26330,0.0,0.0,1.0011100181505847e-07,5.785807781337035e-07,0.0,5.3324848e-06,False,GAPDHS; glyceraldehyde-3-phosphate dehydrogenase
hsa:55582,0.0,0.0,6.152911508187133e-08,1.2839372850899586e-07,0.0,5.942671e-07,False,KIF27; kinesin family member
hsa:80150,6.9446883e-06,0.0057832077042160365,3.8186839943859654e-05,6.785053905672838e-05,0.0,0.00042415387,False,ASRGL1; asparaginase and isoaspartyl peptidase
hsa:9939,1.187846e-07,9.891819246404769e-05,6.606471913888889e-07,1.0577641969751323e-06,0.0,5.268934e-06,False,RBM8A; RNA binding motif protein
hsa:2864,0.0,0.0,7.720713044346785e-08,3.699445267883227e-07,-0.0,4.1641656e-06,False,FFAR1; free fatty acid receptor
hsa:3614,0.0,0.0,3.4169013373894736e-05,9.882020406955335e-05,0.0,0.0006540309,False,IMPDH1; inosine monophosphate dehydrogenase
hsa:9984,0.0,0.0,3.003106024335088e-07,5.594697463432967e-07,0.0,2.712443e-06,False,THOC1; THO complex subunit
hsa:10640,0.0,0.0,1.7486408274853797e-07,3.103575576405635e-07,0.0,1.3158335e-06,False,EXOC5; exocyst complex component
hsa:1733,2.7178139e-08,2.2632667739897602e-05,7.655053847502924e-07,2.014547377814611e-06,0.0,1.633355e-05,False,DIO1; iodothyronine deiodinase
hsa:5406,0.0,0.0,5.658252971929824e-07,2.9611285054993364e-06,0.0,2.4726847e-05,False,PNLIP; pancreatic
hsa:80208,1.894723e-08,1.577835631723791e-05,7.225551853093564e-08,1.3094226818640607e-07,0.0,6.8515266e-07,False,SPG11; SPG11 vesicle trafficking associated
hsa:344787,0.0,0.0,3.308101078959065e-09,8.590212286175328e-09,0.0,5.773633e-08,False,ZNF860; zinc finger protein
hsa:7709,3.4651227e-06,0.002885590170359967,1.2369676284011693e-05,2.9953446633943194e-05,0.0,0.0002555892,False,ZBTB17; zinc finger and BTB domain containing
hsa:51465,0.0,0.0,5.849076353333335e-07,1.5019326865065496e-06,0.0,8.630278e-06,False,UBE2J1; ubiquitin conjugating enzyme E2
hsa:22941,1.6081934e-07,0.0001339227343111912,7.5986775348304106e-06,1.7186471824030497e-05,0.0,0.00014365434,False,SHANK2; SH3 and multiple ankyrin repeat domains
hsa:83860,3.204382e-08,2.6684576570054542e-05,4.381083181403509e-07,9.343593140147499e-07,0.0,7.1957793e-06,False,TAF3; TATA-box binding protein associated factor
hsa:22933,1.0543816e-07,8.780390895734846e-05,5.818151630795324e-05,0.00010542820607247878,0.0,0.00068245956,False,SIRT2; sirtuin
hsa:7528,9.61238e-08,8.00473508247334e-05,0.00011019228078598813,0.00034971528675149647,0.0,0.0018507213,False,YY1; YY1 transcription
hsa:3358,0.0,0.0,8.471909403333334e-06,2.1947775717788996e-05,0.0,0.00014967495,False,HTR2C; 5-hydroxytryptamine receptor
hsa:9886,1.7216385e-07,0.00014336990527098157,3.346524658238011e-07,4.7063451338868684e-07,0.0,2.7645299e-06,False,RHOBTB1; Rho related BTB domain containing
hsa:6604,0.0,0.0,6.828806712853801e-06,2.0179288087094268e-05,0.0,0.00010758623,False,SMARCD3; SWI/SNF related
hsa:10021,0.00012960959,0.10793273175821033,0.00031901371425555557,0.0004936253505542855,0.0,0.003710178,False,HCN4; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:81341,0.0,0.0,2.834157894736842e-10,3.706142355958774e-09,0.0,4.84641e-08,False,OR10W1; olfactory receptor family 10 subfamily W member
hsa:6296,0.0,0.0,8.56571813769006e-06,2.043429769302284e-05,0.0,0.0002030809,False,ACSM3; acyl-CoA synthetase medium chain family member
hsa:79685,8.889305e-09,7.4025924476878444e-06,3.2527685535403514e-07,5.856670829175098e-07,0.0,2.5902598e-06,False,SAP30L; SAP30
hsa:2529,1.7426573e-05,0.014512025144697014,0.0002217754956165497,0.00048503435769801874,0.0,0.0035276904,False,FUT7; fucosyltransferase
hsa:55012,1.3529314e-05,0.011266572317948075,1.7225833965789474e-05,2.2198137476873984e-05,0.0,0.0001842501,False,PPP2R3C; protein phosphatase 2 regulatory subunit
hsa:220,0.0,0.0,9.29309946614035e-06,3.754510129051078e-05,0.0,0.00041965905,False,ALDH1A3; aldehyde dehydrogenase 1 family member
hsa:442918,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR373; microRNA
hsa:722,0.0,0.0,1.5224643366081872e-07,6.584305187545468e-07,0.0,4.1108224e-06,False,C4BPA; complement component 4 binding protein
hsa:6812,0.0,0.0,3.856459505204679e-06,9.132861777534352e-06,0.0,6.495598e-05,False,STXBP1; syntaxin binding protein
hsa:219965,0.0,0.0,4.500055789473684e-09,5.8845865279832954e-08,0.0,7.6950954e-07,False,OR5B17; olfactory receptor family 5 subfamily B member
hsa:1489,0.0,0.0,3.053920301169591e-08,1.1376840125604901e-07,0.0,7.9855135e-07,False,CTF1; cardiotrophin
hsa:4144,0.0,0.0,2.5682582410409345e-05,6.190820796068089e-05,0.0,0.0003764945,False,MAT2A; methionine adenosyltransferase
hsa:10585,0.0,0.0,0.00018612457211695914,0.000438559386406855,0.0,0.002577253,False,POMT1; protein O-mannosyltransferase
hsa:5872,0.0,0.0,4.0864424679678355e-07,9.556654043157913e-07,0.0,5.2006717e-06,False,RAB13; RAB13
hsa:3181,0.0,0.0,3.9577849735087703e-08,8.34240644016775e-08,0.0,5.3375567e-07,False,HNRNPA2B1; heterogeneous nuclear ribonucleoprotein
hsa:2209,0.0,0.0,1.525544330643275e-05,5.192110600611724e-05,0.0,0.00039609213,False,FCGR1A; Fc gamma receptor
hsa:4116,0.0,0.0,9.785753800701755e-07,1.879342449234533e-06,0.0,9.0909225e-06,False,MAGOH; mago homolog
hsa:5051,0.0,0.0,2.5901441479883034e-06,1.374419465013157e-05,0.0,0.00015405728,False,PAFAH2; platelet activating factor acetylhydrolase
hsa:1942,0.0,0.0,2.109717473099414e-06,6.1426861273438274e-06,0.0,4.026947e-05,False,EFNA1; ephrin
hsa:11017,0.0,0.0,1.5863885360818717e-07,3.4410522785336994e-07,0.0,2.3082343e-06,False,SNRNP27; small nuclear ribonucleoprotein U4/U6.U5 subunit
hsa:246243,2.5807505e-08,2.1491268620737644e-05,1.669541032141871e-05,3.8396626315583424e-05,0.0,0.00026632095,False,RNASEH1; ribonuclease
hsa:407018,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR27A; microRNA
hsa:1639,0.0,0.0,0.00015644700726939476,0.0004499442286647185,0.0,0.0027273363,False,DCTN1; dynactin subunit
hsa:1163,2.2823258e-06,0.0019006128972111,1.7946058853567253e-05,3.794748925010939e-05,0.0,0.00019662411,False,CKS1B; CDC28 protein kinase regulatory subunit
hsa:5439,0.0,0.0,0.00022557641281573088,0.0008140347508219051,0.0,0.004822568,False,POLR2J; RNA polymerase II subunit
hsa:3659,0.0,0.0,2.3709549609181282e-05,6.137702601530595e-05,0.0,0.0003788302,False,IRF1; interferon regulatory factor
hsa:27443,4.5003973e-11,3.747717854722586e-08,7.8105651516e-08,3.185184197024771e-07,0.0,2.240827e-06,False,CECR2; CECR2 histone acetyl-lysine
hsa:407008,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR223; microRNA
hsa:5542,0.0,0.0,2.8449272253508766e-07,2.305949960510635e-06,0.0,2.9527817e-05,False,PRB1; proline rich protein BstNI subfamily
hsa:2799,0.0,0.0,6.045734416561403e-05,0.00015290497543826983,0.0,0.0010264933,False,GNS; glucosamine
hsa:51100,0.0,0.0,1.773563835573099e-07,4.0058772694043164e-07,0.0,1.9175634e-06,False,SH3GLB1; SH3 domain containing GRB2 like
hsa:9247,-0.0,0.0,8.321798149883042e-08,3.497077730933985e-07,0.0,2.4001563e-06,False,GCM2; glial cells missing transcription factor
hsa:4694,0.0,0.0,4.176754436608187e-06,5.869322102263018e-06,0.0,2.693501e-05,False,NDUFA1; NADH:ubiquinone oxidoreductase subunit
hsa:3762,0.0,0.0,2.7038126813052627e-05,0.00011155116234482093,0.0,0.0008756385,False,KCNJ5; potassium inwardly rectifying channel subfamily J member
hsa:93129,6.0422906e-07,0.0005031733612728469,3.2024502245988893e-06,1.0433809626101533e-05,0.0,9.665574e-05,False,ORAI3; ORAI calcium release-activated calcium modulator
hsa:6554,1.2980222e-06,0.001080931449044797,1.2791919119858768e-05,3.996613682577811e-05,0.0,0.00041822784,False,SLC10A1; solute carrier family 10 member
hsa:10945,0.0,0.0,2.976111902277193e-05,9.721731007274388e-05,0.0,0.0005521712,False,KDELR1; KDEL endoplasmic reticulum protein retention receptor
hsa:6432,1.3717037e-07,0.00011422899146879842,3.004628865701754e-07,4.1951351332595963e-07,0.0,2.2639483e-06,False,SRSF7; serine and arginine rich splicing factor
hsa:10170,0.0,0.0,6.2959788140760246e-06,4.3472411248576676e-05,0.0,0.0005618954,False,DHRS9; dehydrogenase/reductase
hsa:5368,0.0,0.0,4.882308109979007e-06,1.4891575152209364e-05,0.0,0.000109252804,False,PNOC;
hsa:55786,0.0,0.0,2.704631229239766e-08,6.479686752850473e-08,0.0,4.794127e-07,False,ZNF415; zinc finger protein
hsa:29110,5.04185e-06,0.004198614034772679,0.00012866252356801165,0.00032620751512032006,0.0,0.001462504,False,TBK1; TANK binding kinase
hsa:6844,6.386765e-05,0.053185955880867,0.00023038280159842105,0.00040032025915094074,0.0,0.0020661773,False,VAMP2; vesicle associated membrane protein
hsa:6159,2.0461714e-07,0.00017039546907564608,1.8638144691052635e-06,3.4600028504928625e-06,0.0,1.3266517e-05,False,RPL29; ribosomal protein
hsa:9420,0.0,0.0,8.971285305847953e-06,3.288037000717658e-05,0.0,0.00020041715,False,CYP7B1; cytochrome P450 family 7 subfamily B member
hsa:338442,0.0,0.0,5.200840390467835e-08,1.0605654802041284e-07,0.0,7.2865305e-07,False,HCAR2; hydroxycarboxylic acid receptor
hsa:83539,3.5244894e-09,2.9350279481237126e-06,3.3129904515679526e-06,1.6280449775794242e-05,0.0,0.00014256831,False,CHST9; carbohydrate sulfotransferase
hsa:80347,1.3921902e-05,0.011593501022031563,5.391200900520469e-05,9.681035892261211e-05,0.0,0.0005056992,False,COASY; Coenzyme A
hsa:26737,0.0,0.0,5.5869736539999995e-06,3.0443365160643717e-05,0.0,0.0003109995,False,OR1L1; olfactory receptor family 1 subfamily L member
hsa:8439,0.0,0.0,7.184654988830407e-07,1.5570899936834509e-06,0.0,1.3224837e-05,False,NSMAF; neutral sphingomyelinase activation associated
hsa:91442,0.0,0.0,3.882590322356724e-06,1.0510814667423435e-05,0.0,6.720942e-05,False,FAAP24; FA core complex associated protein
hsa:80144,3.688894e-08,3.0719363172622606e-05,1.1940444722070174e-05,4.2356780611847364e-05,0.0,0.00027227472,False,FRAS1; Fraser extracellular matrix complex subunit
hsa:26835,0.0,0.0,1.1653245999616963e-07,4.379484235267489e-07,0.0,3.1920192e-06,False,RNU4-1; RNA
hsa:89853,1.08425455e-08,9.029158683610454e-06,3.307712951976607e-07,6.984671590960346e-07,0.0,3.7657896e-06,False,MVB12B; multivesicular body subunit
hsa:919,7.8556905e-06,0.006541847216027929,3.6793776751245604e-05,6.0555079825324673e-05,0.0,0.00033629584,False,CD247; CD247
hsa:8289,0.0,0.0,8.809380312865492e-07,1.8577435609374769e-06,0.0,9.0350395e-06,False,ARID1A; AT-rich interaction domain
hsa:656,0.0,0.0,9.021855909549713e-06,2.0277294799007704e-05,0.0,0.00011563884,False,BMP8B; bone morphogenetic protein
hsa:3170,0.0,0.0,5.024665186783625e-05,0.00028272408645721605,0.0,0.0029825107,False,FOXA2; forkhead box
hsa:57666,0.0,0.0,6.491490680104091e-06,4.587134748422613e-05,0.0,0.00037645444,False,FBRSL1; fibrosin like
hsa:127069,0.0,0.0,4.0754699918128653e-07,3.0375436276822547e-06,0.0,3.5080677e-05,False,OR2T10; olfactory receptor family 2 subfamily T member
hsa:50839,1.1828549e-05,0.00985025572803561,0.0001557403935050292,0.00030497542413472433,0.0,0.0019171597,False,TAS2R10; taste 2 receptor member
hsa:2581,7.053499e-09,5.873820104853389e-06,2.399156038719299e-06,6.118123715401537e-06,0.0,5.295889e-05,False,GALC;
hsa:218,0.0,0.0,9.77810529122807e-06,2.5254282745451336e-05,0.0,0.00015514118,False,ALDH3A1; aldehyde dehydrogenase 3 family member
hsa:29109,1.0615607e-07,8.840175042460823e-05,4.427261285051462e-07,1.0629368376634656e-06,0.0,5.6679905e-06,False,FHOD1; formin homology 2 domain containing
hsa:2954,0.0,0.0,0.00010016017764923979,0.0002969420654627689,0.0,0.0023876242,False,GSTZ1; glutathione S-transferase zeta
hsa:1361,2.2934175e-06,0.0019098495399691127,1.8023895529859646e-05,9.158689616861066e-05,0.0,0.0010538963,False,CPB2; carboxypeptidase
hsa:10023,7.8763065e-07,0.0006559015245013493,1.0532954683894735e-05,3.061602053311417e-05,0.0,0.00023755233,False,FRAT1; FRAT regulator of WNT signaling pathway
hsa:440503,7.0228054e-08,5.848259927589547e-05,1.027658366361228e-05,3.4257715367377695e-05,0.0,0.0002642444,False,PLIN5; perilipin
hsa:4953,0.00017661473,0.14707638746206003,0.00043079031991134477,0.0005616766151283881,0.0,0.0029646582,False,ODC1; ornithine decarboxylase
hsa:8651,0.0,0.0,5.470197519883039e-06,1.8147405638122004e-05,0.0,0.00011677648,False,SOCS1; suppressor of cytokine signaling
hsa:84790,0.0,0.0,5.104230148461987e-05,0.00016048506488751987,0.0,0.0012573653,False,TUBA1C; tubulin alpha
hsa:56270,0.0,0.0,2.0502637386666667e-07,5.973720480155873e-07,0.0,3.4592963e-06,False,WDR45B; WD repeat domain
hsa:8061,0.0,0.0,6.025911284696198e-06,3.070247978423872e-05,0.0,0.00026147236,False,FOSL1; FOS like 1
hsa:361,3.2618627e-06,0.0027163248632389907,5.600230129983625e-05,0.00020771370017708577,0.0,0.002361359,False,AQP4; aquaporin
hsa:716,0.0,0.0,2.2299718042573094e-05,4.801651418489285e-05,0.0,0.0002675151,False,C1S; complement
hsa:6152,5.8907574e-07,0.0004905543936269627,1.1036740093801176e-06,1.2176565565756344e-06,0.0,5.411028e-06,False,RPL24; ribosomal protein
hsa:26707,0.0,0.0,2.925546990643275e-07,2.526081980806155e-06,0.0,2.4232831e-05,False,OR2J2; olfactory receptor family 2 subfamily J member
hsa:6633,9.8964215e-09,8.241271399174132e-06,4.400018877401171e-07,1.324853520198501e-06,0.0,7.1279783e-06,False,SNRPD2; small nuclear ribonucleoprotein D2
hsa:126374,0.0,0.0,7.277246316374268e-05,0.00020787789235819502,0.0,0.0011786328,False,WTIP; WT1 interacting
hsa:9627,3.1175773e-09,2.5961708115609775e-06,3.3348875290467847e-08,6.492443537855149e-08,0.0,3.6118206e-07,False,SNCAIP; synuclein alpha interacting
hsa:158131,-0.0,0.0,1.1227834933661813e-05,3.306932021505798e-05,0.0,0.00024445914,False,OR1Q1; olfactory receptor family 1 subfamily Q member
hsa:1856,9.8187884e-05,0.08176622228091511,0.00040799276574000003,0.0007796049181438042,0.0,0.0047120606,False,DVL2; dishevelled segment polarity protein
hsa:5562,0.0,0.0,0.00012924037494385963,0.0003352031677175862,0.0,0.0017267045,False,PRKAA1; protein kinase AMP-activated catalytic subunit alpha
hsa:282763,0.0,0.0,1.1339929113918127e-06,5.519819184032785e-06,0.0,5.6611843e-05,False,OR51B5; olfactory receptor family 51 subfamily B member
hsa:1457,9.288388e-06,0.007734929880344345,0.00011047535668695908,0.0002607106358576001,0.0,0.0015466472,False,CSNK2A1; casein kinase 2 alpha
hsa:2328,0.0,0.0,3.10034017045614e-05,0.00012532533395681776,0.0,0.0011081743,False,FMO3; flavin containing dimethylaniline monoxygenase
hsa:7319,0.0,0.0,6.453203588128654e-07,1.5810221990551039e-06,0.0,1.0336171e-05,False,UBE2A; ubiquitin conjugating enzyme E2
hsa:7158,0.0,0.0,4.675494294152047e-08,1.120150309032597e-07,0.0,7.669235e-07,False,TP53BP1; tumor protein p53 binding protein
hsa:127064,0.0,0.0,1.644931025146199e-08,1.1893765580461482e-07,0.0,1.3204349e-06,False,OR2T12; olfactory receptor family 2 subfamily T member
hsa:3661,3.220579e-06,0.0026819457519549695,0.0002202374071046783,0.0004647268244734676,0.0,0.0021743118,False,IRF3; interferon regulatory factor
hsa:57620,1.031202e-06,0.000858736215850463,2.0248949110786552e-05,7.621535225194047e-05,0.0,0.00070177455,False,STIM2; stromal interaction molecule
hsa:11255,1.6332405e-07,0.00013600853824408002,2.3239750370585385e-05,5.318665263071437e-05,0.0,0.000380981,False,HRH3; histamine receptor
hsa:100534599,0.0,0.0,1.7145053018713455e-08,4.093276553473995e-08,0.0,2.034978e-07,False,ISY1-RAB43; ISY1-RAB43
hsa:22949,0.0,0.0,2.118554945672515e-06,8.479667136917639e-06,0.0,8.7243134e-05,False,PTGR1; prostaglandin reductase
hsa:9882,0.0,0.0,1.1558414609298244e-05,4.121488592932378e-05,0.0,0.00025672687,False,TBC1D4; TBC1 domain family member
hsa:3955,0.0,0.0,6.067952726339181e-05,0.00014906558357813247,0.0,0.00079976727,False,LFNG; LFNG O-fucosylpeptide
hsa:140775,0.0,0.0,8.651006271625731e-07,2.613921139913383e-06,0.0,1.7241087e-05,False,SMCR8; SMCR8-C9orf72 complex
hsa:10238,3.5943415e-08,2.9931974707033898e-05,4.814100490992922e-05,0.00013572821878435782,0.0,0.0007758198,False,DCAF7; DDB1 and CUL4 associated factor
hsa:2690,0.0,0.0,1.545892404692399e-06,5.4705424336591895e-06,0.0,4.8781756e-05,False,GHR; growth hormone
hsa:219982,0.0,0.0,2.9678815789473685e-08,2.77489580330542e-07,0.0,2.963271e-06,False,OR5A1; olfactory receptor family 5 subfamily A member
hsa:5137,0.0,0.0,2.373360628070176e-06,8.614407355752605e-06,0.0,5.044736e-05,False,PDE1C; phosphodiesterase
hsa:727897,0.0,0.0,4.2661714872514616e-06,2.4864401922411847e-05,0.0,0.00029929023,False,MUC5B; mucin 5B
hsa:1111,9.320316e-06,0.007761518007500493,0.0001226052313931813,0.0002314870528211448,0.0,0.0011420463,False,CHEK1; checkpoint kinase
hsa:2323,1.13538455e-07,9.454945122314356e-05,9.34111546911696e-06,1.8359916694595586e-05,0.0,0.00010839183,False,FLT3LG; fms related receptor tyrosine kinase 3
hsa:2151,0.0,0.0,8.505800677101168e-08,3.0078565768666865e-07,0.0,3.163215e-06,False,F2RL2; coagulation factor II thrombin receptor like
hsa:10723,1.0504036e-06,0.000874726399463639,1.3109439118391808e-05,2.9306649816543406e-05,0.0,0.00016486083,False,SLC12A7; solute carrier family 12 member
hsa:23355,2.190364e-09,1.824031462986964e-06,5.893598826254851e-05,0.00016183808707389747,0.0,0.0010805357,False,VPS8; VPS8 subunit of CORVET
hsa:26232,1.2924387e-07,0.0001076281774527873,6.415912042777778e-07,1.2344624526502724e-06,0.0,8.115175e-06,False,FBXO2; F-box protein
hsa:3310,0.0,0.0,3.1505547165847974e-05,9.50919383437023e-05,0.0,0.00072036503,False,HSPA6; heat shock protein family A (Hsp70) member
hsa:7403,0.0,0.0,8.31218827684386e-06,3.0155685805467494e-05,0.0,0.00027499077,False,KDM6A; lysine demethylase
hsa:8726,0.0,0.0,3.260817739377779e-06,2.232392758553874e-05,0.0,0.00020724176,False,EED; embryonic ectoderm
hsa:26532,0.0,0.0,9.865452573099415e-08,1.1307783575145088e-06,0.0,1.4629285e-05,False,OR10H3; olfactory receptor family 10 subfamily H member
hsa:1028,0.0,0.0,8.0925866977462e-07,1.585714107333503e-06,0.0,7.2173675e-06,False,CDKN1C; cyclin dependent kinase inhibitor
hsa:7484,0.0,0.0,1.4319573997134502e-07,8.223023227423827e-07,0.0,9.236961e-06,False,WNT9B; Wnt family member
hsa:6429,0.0,0.0,3.306226022017543e-07,6.071184548661631e-07,0.0,2.8990082e-06,False,SRSF4; serine and arginine rich splicing factor
hsa:196335,0.0,0.0,1.5447848457719294e-05,6.579891196091646e-05,0.0,0.00057168584,False,OR56B4; olfactory receptor family 56 subfamily B member
hsa:26863,0.0,0.0,1.4863096075918127e-08,5.138148584671255e-08,0.0,3.4668943e-07,False,RNVU1-18; RNA
hsa:9755,2.291635e-06,0.0019083651583399527,0.0002128238251159649,0.00048081694197256523,0.0,0.0034086336,False,TBKBP1; TBK1 binding protein
hsa:1780,7.0536834e-07,0.0005873973664445207,1.7689551661871345e-05,6.097595698498079e-05,0.0,0.00040497593,False,DYNC1I1; dynein cytoplasmic 1 intermediate chain
hsa:163049,9.975917e-09,8.307471488824015e-06,8.936540385380115e-08,1.520238861997612e-07,0.0,9.712148e-07,False,ZNF791; zinc finger protein
hsa:4763,4.4349697e-08,3.6932328463186295e-05,1.2589717912690054e-06,1.6589110848673188e-06,0.0,8.73773e-06,False,NF1; neurofibromin
hsa:5394,0.0,0.0,3.3898841821052636e-07,5.931111408420588e-07,0.0,3.7778295e-06,False,EXOSC10; exosome component
hsa:1289,0.0,0.0,6.451856981222222e-05,0.00021735762767616744,0.0,0.0017432617,False,COL5A1; collagen type V alpha 1
hsa:15,0.0,0.0,6.741966607469531e-06,1.670698940401009e-05,0.0,8.757718e-05,False,AANAT; aralkylamine
hsa:79957,0.0,0.0,9.83467974434035e-06,1.9364450160872523e-05,0.0,0.00010301271,False,PAQR6; progestin and adipoQ receptor family member
hsa:217,0.0,0.0,0.00024783107529999997,0.000732126046654248,0.0,0.0034992392,False,ALDH2; aldehyde dehydrogenase 2 family
hsa:1351,3.7177754e-06,0.0030959873801427278,0.0002900190331710117,0.0007710686701025135,0.0,0.004107384,False,COX8A; cytochrome c oxidase subunit
hsa:130,5.3130556e-05,0.04424461221513448,0.00011418844624269007,0.00014499882196274166,0.0,0.00064223364,False,ADH6; alcohol dehydrogenase 6 (class
hsa:916,3.6444806e-05,0.0303495093995592,0.00016828979063654973,0.0003983423240823829,0.0,0.003439565,False,CD3E; CD3 epsilon subunit of T-cell receptor
hsa:6146,1.2254914e-07,0.00010205312318956771,1.4520512784327486e-06,2.769439491567758e-06,0.0,1.225709e-05,False,RPL22; ribosomal protein
hsa:27072,5.408134e-06,0.0045036380126999625,0.0002444250751120176,0.0005404924849141973,0.0,0.004032505,False,VPS41; VPS41 subunit of HOPS
hsa:7252,8.163295e-06,0.0067980056838243185,4.6908344231403526e-05,8.99541260763504e-05,0.0,0.00048375074,False,TSHB; thyroid stimulating hormone subunit
hsa:10971,1.9423749e-06,0.001617517878542634,1.7992340244994153e-05,2.5451628231033585e-05,0.0,0.0001181554,False,YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:284,7.147463e-08,5.952068876467654e-05,3.371808870312866e-06,8.100242872797529e-06,0.0,6.0753402e-05,False,ANGPT1; angiopoietin
hsa:6891,0.0,0.0,2.3209161181871345e-05,5.4484468558682124e-05,0.0,0.00031623105,False,TAP2; transporter 2
hsa:5440,1.7129669e-05,0.014264777546815256,0.00017400349211403514,0.0003734028381637377,0.0,0.0015611104,False,POLR2K; RNA polymerase II
hsa:123263,5.942746e-08,4.9488375815800156e-05,1.802824654566959e-05,5.048765672011837e-05,0.0,0.0003305902,False,MTFMT; mitochondrial methionyl-tRNA
hsa:80315,0.0,0.0,3.24960800122807e-06,1.4040773453934586e-05,0.0,0.00017295155,False,CPEB4; cytoplasmic polyadenylation element binding protein
hsa:407025,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29B2; microRNA
hsa:5702,0.0,0.0,4.871300005847953e-06,1.293243344835175e-05,0.0,8.041337e-05,False,PSMC3; proteasome 26S subunit
hsa:1778,0.0,0.0,0.00037954070234093556,0.0009774260261740813,0.0,0.0067908033,False,DYNC1H1; dynein cytoplasmic 1 heavy chain
hsa:54677,3.6182062e-08,3.0130708632786624e-05,7.64013920119123e-05,0.0002698578321068031,0.0,0.0017402157,False,CROT; carnitine
hsa:124944,0.0,0.0,5.04505847573099e-07,1.6429484185396083e-06,0.0,1.719938e-05,False,C17orf49; chromosome 17 open reading frame
hsa:190,0.0,0.0,8.074692312450295e-06,3.6753447256061985e-05,0.0,0.00040819944,False,NR0B1; nuclear receptor subfamily 0 group B member
hsa:55552,0.0,0.0,6.073806540467835e-08,1.307287471865761e-07,0.0,6.6605406e-07,False,ZNF823; zinc finger protein
hsa:283899,0.0,0.0,8.414312304545617e-06,2.702262703271282e-05,0.0,0.00016367718,False,INO80E; INO80 complex subunit
hsa:9635,0.0,0.0,1.727524960409357e-07,5.378994712540245e-07,0.0,3.800033e-06,False,CLCA2; chloride channel accessory
hsa:10273,1.8298996e-07,0.0001523853772481314,6.982910104795324e-07,1.4213308084086818e-06,0.0,1.0700966e-05,False,STUB1; STIP1 homology and U-box containing protein
hsa:27165,8.643264e-05,0.0719770114871435,0.00028063106864093564,0.0004533216796980101,0.0,0.0030184921,False,GLS2; glutaminase
hsa:30832,2.7736946e-09,2.309801575955888e-06,3.021342714192983e-08,5.2899748282892967e-08,0.0,3.0409385e-07,False,ZNF354C; zinc finger protein
hsa:51701,6.3695993e-06,0.005304300805628536,4.302945385369007e-05,7.873655350549865e-05,0.0,0.0003812456,False,NLK; nemo like
hsa:3801,2.0835994e-08,1.735122957581827e-05,1.4325563054736842e-07,2.397757455875576e-07,0.0,1.267419e-06,False,KIFC3; kinesin family member
hsa:6597,0.0,0.0,2.00595494128655e-06,4.132188050755357e-06,0.0,2.1425245e-05,False,SMARCA4; SWI/SNF related
hsa:125115,0.0,0.0,7.347918036257311e-08,3.3365202999927884e-07,0.0,3.5176922e-06,False,KRT40; keratin
hsa:9631,6.972299e-09,5.80620058828238e-06,8.68811966274854e-08,1.5529656246202253e-07,0.0,7.798867e-07,False,NUP155; nucleoporin
hsa:2875,0.0,0.0,5.4811234166660815e-05,0.0001359440877489672,0.0,0.0008145007,False,GPT; glutamic--pyruvic
hsa:133022,0.0,0.0,1.3916504100865496e-07,3.4780387945751745e-07,0.0,2.2213978e-06,False,TRAM1L1; translocation associated membrane protein 1 like
hsa:5546,7.2785238e-06,0.00606121010722393,4.908155387415204e-05,9.498605830071315e-05,0.0,0.00055288384,False,PRCC; proline rich mitotic checkpoint control
hsa:284098,3.843573e-05,0.03200745667061363,7.646037073333335e-05,0.00011869896690653267,0.0,0.00080955797,False,PIGW; phosphatidylinositol glycan anchor biosynthesis class
hsa:5294,0.0,0.0,6.212990926923979e-06,1.7008226285205577e-05,0.0,0.00012146692,False,PIK3CG; phosphatidylinositol-4
hsa:3446,0.0,0.0,6.013816657309942e-07,3.766794314395307e-06,0.0,3.5409834e-05,False,IFNA10; interferon alpha
hsa:26263,4.7759285e-09,3.977167196400296e-06,1.5536877755964915e-07,3.4390214259857557e-07,0.0,2.2932122e-06,False,FBXO22; F-box protein
hsa:8842,0.0,0.0,3.033674278653568e-06,9.40259602309867e-06,0.0,6.974741e-05,False,PROM1; prominin
hsa:338707,0.0,0.0,4.669657168132515e-05,0.00013067590586128842,0.0,0.0010218964,False,B4GALNT4; beta-1
hsa:641,1.570154e-07,0.00013075499313058622,0.0002297717766104427,0.0006194050712499588,0.0,0.0039464375,False,BLM; BLM RecQ like
hsa:6434,0.0,0.0,4.318931680734972e-06,1.0016688160208448e-05,0.0,8.2255865e-05,False,TRA2B; transformer 2 beta
hsa:90987,5.3847837e-09,4.484192988096662e-06,1.5971127665087713e-07,3.990462022759432e-07,0.0,2.2833199e-06,False,ZNF251; zinc finger protein
hsa:79094,1.6930408e-06,0.0014098842417610133,4.9869390970754964e-05,0.00013935210302984987,0.0,0.0009994173,False,CHAC1; ChaC glutathione specific gamma-glutamylcyclotransferase
hsa:27128,7.5974576e-08,6.326803079812045e-05,3.864132841988304e-06,1.0590621092879239e-05,0.0,0.000119064316,False,CYTH4; cytohesin
hsa:7311,1.6030363e-06,0.0013349327543322525,6.669424208830414e-06,1.2794350355123385e-05,0.0,6.644132e-05,False,UBA52; ubiquitin A-52 residue ribosomal protein fusion product
hsa:100526842,2.440962e-08,2.0327176158645712e-05,2.258605925263158e-07,3.058099591060534e-07,0.0,1.4282956e-06,False,RPL17-C18orf32; RPL17-C18orf32
hsa:826,2.373267e-07,0.00019763444240631617,4.970672447491228e-06,1.656164837097014e-05,0.0,0.00013684202,False,CAPNS1; calpain small subunit
hsa:6227,0.0,0.0,6.47460591771345e-07,1.6125893742745096e-06,0.0,7.1385393e-06,False,RPS21; ribosomal protein
hsa:51367,0.0,0.0,2.8950314836185965e-07,9.025844092457944e-07,0.0,4.6761675e-06,False,POP5; POP5 homolog
hsa:4913,0.0,0.0,1.1426564507456138e-06,2.949365312172112e-06,0.0,2.7610364e-05,False,NTHL1; nth like DNA glycosylase
hsa:7617,0.0,0.0,5.564508592283044e-08,1.1669172570165936e-07,0.0,7.251771e-07,False,ZNF66; zinc finger protein
hsa:160065,0.0,0.0,4.4742120740818137e-07,1.6454714499833636e-06,0.0,1.2334688e-05,False,PATE1; prostate and testis expressed
hsa:10818,0.0,0.0,3.1867562606315794e-06,8.085078151506606e-06,0.0,3.943085e-05,False,FRS2; fibroblast growth factor receptor substrate
hsa:51690,0.0,0.0,7.807009559473684e-07,2.481261737067479e-06,0.0,1.5299396e-05,False,LSM7; LSM7 homolog
hsa:1282,0.0,0.0,0.0001349568506625731,0.00032124593643833487,0.0,0.0025576397,False,COL4A1; collagen type IV alpha 1
hsa:29994,2.6487411e-08,2.2057462155635778e-05,1.4163964072573094e-06,4.778527076385866e-06,0.0,2.5532783e-05,False,BAZ2B; bromodomain adjacent to zinc finger domain
hsa:119694,0.0,0.0,3.943046666666667e-08,3.7324211325122485e-07,0.0,4.568835e-06,False,OR51F2; olfactory receptor family 51 subfamily F member
hsa:1673,0.0,0.0,0.0,0.0,0.0,0.0,False,DEFB4A; defensin beta
hsa:6726,1.4046835e-06,0.0011697539310994195,0.00034397330205063734,0.0009336675437062855,0.0,0.006310611,False,SRP9; signal recognition particle
hsa:646625,0.0,0.0,2.2126041118362573e-09,2.4699532186423146e-08,0.0,3.2235513e-07,False,URAD; ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-)
hsa:406892,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR100; microRNA
hsa:64098,6.022205e-08,5.0150072757575503e-05,4.117533479257309e-07,6.837222946257312e-07,0.0,2.7151866e-06,False,PARVG; parvin
hsa:1981,2.5224415e-06,0.0021005698868060436,8.522419252760232e-05,0.0002522836683017539,0.0,0.0022090948,False,EIF4G1; eukaryotic translation initiation factor 4 gamma
hsa:54579,0.0,0.0,3.0116794035087723e-06,2.389066751437627e-05,0.0,0.0002716087,False,UGT1A5; UDP glucuronosyltransferase family 1 member
hsa:6234,8.392653e-08,6.98900417005207e-05,8.849658870877193e-07,1.977362478498714e-06,0.0,9.594003e-06,False,RPS28; ribosomal protein
hsa:10888,6.525555e-10,5.434173330757764e-07,5.938445019289473e-07,1.5948015497582986e-06,0.0,1.3802151e-05,False,GPR83; G protein-coupled receptor
hsa:2798,0.0,0.0,2.716410492175439e-06,8.702763598146979e-06,0.0,6.7833666e-05,False,GNRHR; gonadotropin releasing hormone
hsa:3781,1.6030892e-05,0.013349768069483438,7.303733141367252e-05,0.00012342698671993505,0.0,0.0006066431,False,KCNN2; potassium calcium-activated channel subfamily N member
hsa:6357,0.0,0.0,2.8498963316140345e-06,8.852125616679718e-06,0.0,6.181419e-05,False,CCL13; C-C motif chemokine ligand
hsa:7172,0.0,0.0,1.2041126964555559e-05,3.914697953734299e-05,0.0,0.0002523118,False,TPMT; thiopurine
hsa:8776,1.4893178e-06,0.0012402333701551555,6.318575017004097e-05,0.0001976506895730948,0.0,0.0011957637,False,MTMR1; myotubularin related protein
hsa:5682,0.0,0.0,2.3029764508187134e-06,1.1042882826822136e-05,0.0,0.0001218522,False,PSMA1; proteasome 20S subunit alpha
hsa:50832,4.1329455e-05,0.03441721388230628,0.00023036256961801165,0.0004552217725306824,0.0,0.0025360566,False,TAS2R4; taste 2 receptor member
hsa:83452,0.0,0.0,3.765036866555555e-08,1.0522632992427666e-07,0.0,6.8017084e-07,False,RAB33B; RAB33B
hsa:8943,0.0,0.0,2.193787739532164e-06,8.685966262603714e-06,0.0,9.485456e-05,False,AP3D1; adaptor related protein complex 3 subunit delta
hsa:8874,0.0,0.0,3.502067133364502e-05,8.573353790115003e-05,0.0,0.0004177559,False,ARHGEF7; Rho guanine nucleotide exchange factor
hsa:8451,8.9931706e-07,0.0007489086803110969,6.998948216725147e-06,1.3017194665355208e-05,0.0,6.611852e-05,False,CUL4A; cullin
hsa:6534,6.596513e-08,5.4932637945120214e-05,2.2292685586854378e-06,1.1408106298409661e-05,0.0,0.00013348079,False,SLC6A7; solute carrier family 6 member
hsa:65018,0.0,0.0,6.625417103274856e-06,2.0477493477126818e-05,0.0,0.00010676769,False,PINK1; PTEN induced kinase
hsa:3920,5.268944e-07,0.0004387727168962048,2.761415743748538e-06,5.035110268359489e-06,0.0,4.0802475e-05,False,LAMP2; lysosomal associated membrane protein
hsa:3779,0.0,0.0,2.8483593567251465e-07,3.7247131772560216e-06,0.0,4.8706945e-05,False,KCNMB1; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:23286,8.563821e-06,0.00713154477857949,0.00010404844019555555,0.00016473371288608694,0.0,0.0007750611,False,WWC1; WW and C2 domain containing
hsa:8608,2.35076e-05,0.019576016597840522,0.00010071739962456142,0.0002019712610882957,0.0,0.0012270351,False,RDH16; retinol dehydrogenase
hsa:27434,2.1803082e-06,0.0018156574687168317,6.399335669468713e-05,0.00011585202467413532,0.0,0.00076908275,False,POLM; DNA polymerase
hsa:1408,0.0,0.0,0.00013053608003391813,0.0002863423700614511,0.0,0.001223215,False,CRY2; cryptochrome circadian regulator
hsa:5993,0.00011831057,0.09852344271724775,0.0007384075229976612,0.001216421860915252,0.0,0.005862539,False,RFX5; regulatory factor
hsa:100529239,0.0,0.0,2.2913795725637437e-07,5.201454353753204e-07,0.0,2.8102816e-06,False,RPS10-NUDT3; RPS10-NUDT3
hsa:1374,0.0,0.0,0.00011634634027543859,0.0004361337358429058,0.0,0.0045278086,False,CPT1A; carnitine palmitoyltransferase
hsa:51268,0.0,0.0,0.00011616995777619884,0.00026849674634825833,0.0,0.0016065175,False,PIPOX; pipecolic acid and sarcosine
hsa:406938,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR146A; microRNA
hsa:9901,8.574945e-08,7.140808319248653e-05,2.663200924131753e-05,9.001848095315658e-05,0.0,0.00065677264,False,SRGAP3; SLIT-ROBO Rho GTPase activating protein
hsa:2997,0.0,0.0,6.72289759145614e-05,0.000155476083290463,0.0,0.0009507284,False,GYS1; glycogen synthase
hsa:57522,0.0,0.0,1.5771306343099415e-07,3.274998479735374e-07,0.0,2.330727e-06,False,SRGAP1; SLIT-ROBO Rho GTPase activating protein
hsa:2272,9.5301965e-07,0.0007936296553654209,3.1896381306666655e-05,9.284894006634088e-05,0.0,0.0008670124,False,FHIT; fragile histidine triad diadenosine
hsa:79898,3.8603263e-09,3.214697022319603e-06,4.721462321485381e-08,1.1762353749905544e-07,0.0,6.643344e-07,False,ZNF613; zinc finger protein
hsa:6231,3.3141782e-07,0.0002759890735396265,1.8106809329555548e-06,3.48723574803915e-06,0.0,1.8895551e-05,False,RPS26; ribosomal protein
hsa:219956,0.0,0.0,9.728266432748537e-09,1.1356464450911147e-07,0.0,1.4740242e-06,False,OR9Q1; olfactory receptor family 9 subfamily Q member
hsa:6652,0.00015209388,0.12665658422424939,0.0003224856610918129,0.0005851018227744911,0.0,0.004777481,False,SORD; sorbitol
hsa:64080,5.498066e-08,4.578529125560357e-05,5.9733746973742686e-06,1.5207993903914106e-05,0.0,7.935102e-05,False,RBKS;
hsa:51373,2.8698606e-08,2.3898840689431742e-05,2.0513905353169584e-07,3.504686473345027e-07,0.0,1.7895236e-06,False,MRPS17; mitochondrial ribosomal protein
hsa:66008,0.0,0.0,0.0001542229758543509,0.00047849790424855324,0.0,0.0029121663,False,TRAK2; trafficking kinesin protein
hsa:3486,0.0,0.0,2.5079524109473687e-05,6.596553365156444e-05,0.0,0.0005470212,False,IGFBP3; insulin like growth factor binding protein
hsa:120103,3.4083077e-05,0.028382773275769393,0.00013408846615076023,0.000285852650962724,0.0,0.0023966855,False,SLC36A4; solute carrier family 36 member
hsa:55808,0.0,0.0,7.13263836051462e-07,2.346027821751507e-06,0.0,2.1166525e-05,False,ST6GALNAC1; ST6 N-acetylgalactosaminide alpha-2
hsa:686,0.0,0.0,3.422968920818713e-05,8.922924995381062e-05,0.0,0.0005299029,False,BTD;
hsa:10734,1.8662064e-07,0.0001554088357016293,7.2480776081169585e-06,1.4429448474732283e-05,0.0,5.523936e-05,False,STAG3; STAG3 cohesin complex
hsa:7365,0.0,0.0,1.07940214448538e-05,9.937134968960863e-05,0.0,0.0012743351,False,UGT2B10; UDP glucuronosyltransferase family 2 member
hsa:5623,1.1717832e-08,9.758055850988905e-06,2.0553920049619874e-07,4.312693970368824e-07,0.0,2.8967418e-06,False,PSPN;
hsa:6419,0.0,0.0,1.5231973176608193e-05,4.10201163492227e-05,0.0,0.00024784522,False,SETMAR; SET domain and mariner transposase fusion
hsa:4879,0.0,0.0,2.6986450390292386e-06,1.2451349624141431e-05,0.0,0.00012225,False,NPPB; natriuretic peptide
hsa:1669,0.0,0.0,6.1720235614035085e-06,2.086497170619081e-05,0.0,0.00017630056,False,DEFA4; defensin alpha
hsa:64121,1.2211433e-07,0.00010169103400237264,2.3699824602105267e-06,5.6977048758634125e-06,0.0,3.2949818e-05,False,RRAGC; Ras related GTP binding
hsa:443,0.0,0.0,1.9122660315573098e-05,6.154750603256999e-05,0.0,0.00048555984,False,ASPA;
hsa:3363,0.0,0.0,2.512069450116959e-06,1.0703171188210497e-05,0.0,0.00012338014,False,HTR7; 5-hydroxytryptamine receptor
hsa:5261,0.0,0.0,7.52353843026316e-06,1.961946530694398e-05,0.0,0.00018079669,False,PHKG2; phosphorylase kinase catalytic subunit gamma
hsa:9623,0.0,0.0,1.0427076455438595e-08,3.070567084245971e-08,0.0,1.7912743e-07,False,TCL1B; TCL1 family AKT coactivator
hsa:1208,0.0,0.0,9.557415433333332e-06,2.8656727640815312e-05,0.0,0.00022019589,False,CLPS;
hsa:59283,2.1062922e-06,0.0017540204473064896,1.618336539596491e-05,3.5891210531760644e-05,0.0,0.00019707288,False,CACNG8; calcium voltage-gated channel auxiliary subunit gamma
hsa:55201,0.0,0.0,0.00012826565210939187,0.0003869822577310467,0.0,0.0026373523,False,MAP1S; microtubule associated protein
hsa:1493,0.0,0.0,1.9015461954970767e-06,8.022233802819414e-06,0.0,8.883866e-05,False,CTLA4; cytotoxic T-lymphocyte associated protein
hsa:5020,0.0,0.0,6.942445397082279e-07,2.153312208984926e-06,0.0,1.5625998e-05,False,OXT; oxytocin/neurophysin I
hsa:26341,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5H1; olfactory receptor family 5 subfamily H member
hsa:353355,0.0,0.0,1.8798101795321635e-08,3.4863793712886576e-08,0.0,1.5536405e-07,False,ZNF233; zinc finger protein
hsa:406907,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR124-1; microRNA
hsa:3710,0.0,0.0,0.0,0.0,0.0,0.0,False,ITPR3; inositol 1
hsa:23632,0.0,0.0,6.560100117640936e-05,0.00018105793147733505,0.0,0.0013404284,False,CA14; carbonic anhydrase
hsa:6199,0.00010357987,0.08625641300354625,0.00027594736216374265,0.00041272991040346114,0.0,0.002311423,False,RPS6KB2; ribosomal protein S6 kinase
hsa:7430,1.0414368e-05,0.008672592728480118,6.725530354736841e-05,0.00011201893897897499,0.0,0.0006358665,False,EZR;
hsa:6608,0.0,0.0,2.0955040145380118e-05,6.371648095084137e-05,0.0,0.00044809564,False,SMO; smoothened
hsa:5179,0.0,0.0,3.563837289688304e-07,3.1057078020054696e-06,0.0,4.0240233e-05,False,PENK;
hsa:57826,0.0,0.0,7.157021973099416e-07,1.2145619324529487e-06,0.0,6.3937528e-06,False,RAP2C; RAP2C
hsa:51295,0.0,0.0,9.214525405497077e-08,1.8794394486407354e-07,0.0,7.7552323e-07,False,ECSIT; ECSIT signaling
hsa:3654,0.0,0.0,4.636337033222223e-05,0.00011018765394209596,0.0,0.00072630984,False,IRAK1; interleukin 1 receptor associated kinase
hsa:81061,0.0,0.0,3.833497284666667e-06,2.1289639225655964e-05,0.0,0.00018453787,False,OR11H1; olfactory receptor family 11 subfamily H member
hsa:1612,8.979441e-06,0.007477653442092331,0.00011016383682479529,0.00025777169864237617,0.0,0.0023186079,False,DAPK1; death associated protein kinase
hsa:22845,5.0802992e-08,4.230632708621719e-05,1.5505090227508778e-05,5.435421800671491e-05,0.0,0.00029223942,False,DOLK; dolichol
hsa:343173,0.0,0.0,5.159289941520468e-08,4.290615486931072e-07,0.0,4.1535986e-06,False,OR2T3; olfactory receptor family 2 subfamily T member
hsa:3797,3.319177e-08,2.7640534994287176e-05,1.6554871191812874e-07,3.812266259571045e-07,0.0,2.2789566e-06,False,KIF3C; kinesin family member
hsa:3663,0.0,0.0,3.853280949789475e-06,8.085737057923088e-06,0.0,5.4189317e-05,False,IRF5; interferon regulatory factor
hsa:80310,0.0,0.0,4.074981476023392e-07,3.3149295073402724e-06,0.0,4.0751198e-05,False,PDGFD; platelet derived growth factor
hsa:4176,0.0,0.0,3.7022364276023395e-06,2.228606731958936e-05,0.0,0.00025169653,False,MCM7; minichromosome maintenance complex component
hsa:54583,0.0,0.0,1.686645716181286e-06,4.733001761051247e-06,0.0,2.7776821e-05,False,EGLN1; egl-9 family hypoxia inducible factor
hsa:55193,2.5071373e-07,0.00020878252734377422,4.2912367583654975e-06,1.322995851926792e-05,0.0,8.415399e-05,False,PBRM1; polybromo
hsa:165679,1.3223561e-07,0.00011011955691714876,5.100369625900584e-06,1.40875460580773e-05,0.0,0.000104272185,False,SPTSSB; serine palmitoyltransferase small subunit
hsa:4542,7.5361175e-09,6.275721947934984e-06,6.258566600953216e-07,1.4647314637319682e-06,0.0,7.9984175e-06,False,MYO1F; myosin
hsa:155066,5.0368976e-06,0.004194489910463982,0.00047364811994485376,0.001450053374962104,0.0,0.008671661,False,ATP6V0E2; ATPase H+ transporting V0 subunit
hsa:54852,6.816584e-10,5.676528506720131e-07,1.3759837190233912e-08,3.1533911960564305e-08,0.0,1.8053518e-07,False,PAQR5; progestin and adipoQ receptor family member
hsa:1572,0.0,0.0,1.1611143775438594e-09,1.089089483492619e-08,0.0,1.3707407e-07,False,CYP2F1; cytochrome P450 family 2 subfamily F member
hsa:27297,8.08135e-08,6.729765766516297e-05,0.00018257957413256727,0.0006633865181449498,0.0,0.0045136716,False,CRCP; CGRP receptor
hsa:390152,0.0,0.0,0.0,0.0,0.0,0.0,False,OR8H3; olfactory receptor family 8 subfamily H member
hsa:33,6.576327e-07,0.0005476453849173321,6.060868453251465e-06,3.0363472826535443e-05,0.0,0.00038549802,False,ACADL; acyl-CoA dehydrogenase long
hsa:8491,0.0,0.0,5.855740376175439e-08,1.7129679209190825e-07,0.0,1.30905e-06,False,MAP4K3; mitogen-activated protein kinase kinase kinase kinase
hsa:25851,0.0,0.0,1.3104565004678364e-07,2.095284615630269e-07,0.0,9.687585e-07,False,TECPR1; tectonin beta-propeller repeat containing
hsa:391195,-0.0,0.0,1.3420545701754385e-07,1.0899917121801874e-06,0.0,1.2411325e-05,False,OR2T33; olfactory receptor family 2 subfamily T member
hsa:26224,0.0,0.0,0.00032951741717210533,0.00093630707895895,0.0,0.0045107696,False,FBXL3; F-box and leucine rich repeat protein
hsa:1460,0.0,0.0,7.966962889690058e-05,0.00015540746713536233,0.0,0.00092822534,False,CSNK2B; casein kinase 2
hsa:4671,1.561223e-06,0.0013001126172357185,3.436655578920468e-05,5.7208706218742074e-05,0.0,0.0003079553,False,NAIP; NLR family apoptosis inhibitory
hsa:10097,1.1454846e-06,0.0009539053558070884,6.532730897093563e-05,0.0001334350429015462,0.0,0.00064139324,False,ACTR2; actin related protein
hsa:1182,0.0,0.0,6.131553869152043e-06,2.0730327723150622e-05,0.0,0.00018934018,False,CLCN3; chloride voltage-gated channel
hsa:406985,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR200C; microRNA
hsa:9538,0.0,0.0,5.61024384360468e-05,0.00010717439409846461,0.0,0.0005692406,False,EI24; EI24 autophagy associated transmembrane
hsa:5986,0.00022987966,0.19143289998408752,0.000836933152582866,0.0010148840948164142,0.0,0.004707115,False,RFNG; RFNG O-fucosylpeptide
hsa:84914,0.0,0.0,1.2128374961988307e-07,2.1386060704231582e-07,0.0,9.923889e-07,False,ZNF587; zinc finger protein
hsa:79731,0.0,0.0,1.0980791725893567e-05,3.5062576179991465e-05,0.0,0.00023182215,False,NARS2; asparaginyl-tRNA synthetase 2
hsa:63036,0.0,0.0,5.939862120643275e-06,1.853011660960829e-05,0.0,0.00016802925,False,CELA2A; chymotrypsin like elastase
hsa:55680,0.0,0.0,1.4805950505877196e-07,3.408361163245491e-07,0.0,1.7888119e-06,False,RUFY2; RUN and FYVE domain containing
hsa:3313,0.0,0.0,1.0326412844327484e-06,2.125305091986947e-06,0.0,1.0583337e-05,False,HSPA9; heat shock protein family A (Hsp70) member
hsa:23389,4.2476367e-07,0.0003537230790927043,3.3802745712099437e-06,8.337368657241768e-06,0.0,6.307669e-05,False,MED13L; mediator complex subunit
hsa:147837,0.0,0.0,2.323160363450292e-09,4.3925397099322774e-09,0.0,2.018862e-08,False,ZNF563; zinc finger protein
hsa:150572,0.0,0.0,4.476772595561404e-07,2.567417544437845e-06,0.0,2.194491e-05,False,SMYD1; SET and MYND domain containing
hsa:1606,0.0,0.0,0.00013831752259614038,0.0003421735888272379,0.0,0.0020905696,False,DGKA; diacylglycerol kinase
hsa:55769,5.31563e-08,4.426605059979709e-05,8.950586891637426e-08,1.5070702663496466e-07,0.0,1.2176913e-06,False,ZNF83; zinc finger protein
hsa:23438,1.4492779e-06,0.0012068900366385108,2.379402531754971e-05,7.56345666664606e-05,0.0,0.00039543913,False,HARS2; histidyl-tRNA synthetase 2
hsa:55114,0.0,0.0,1.1011370134093567e-06,3.5827234836906116e-06,0.0,1.6834367e-05,False,ARHGAP17; Rho GTPase activating protein
hsa:10599,0.0,0.0,9.402660145198831e-06,4.07780394377888e-05,0.0,0.000402777,False,SLCO1B1; solute carrier organic anion transporter family member
hsa:9184,9.6777924e-08,8.059207433036756e-05,2.0911142512981884e-05,7.208645144479935e-05,0.0,0.00048172227,False,BUB3; BUB3 mitotic checkpoint
hsa:9896,0.0,0.0,2.5352889064801174e-05,8.904725738204008e-05,0.0,0.0006280845,False,FIG4; FIG4 phosphoinositide
hsa:2626,2.0106742e-07,0.00016743943027807906,6.787278274520472e-06,4.0182317888033844e-05,0.0,0.00048997375,False,GATA4; GATA binding protein
hsa:6627,0.0,0.0,4.2128759100935694e-07,1.1540444768526287e-06,0.0,6.5998993e-06,False,SNRPA1; small nuclear ribonucleoprotein polypeptide
hsa:27087,0.0,0.0,0.00015639979109707605,0.00032879108632467575,0.0,0.001470844,False,B3GAT1; beta-1
hsa:56955,0.0,0.0,1.7090409646245614e-06,1.7634629992892344e-05,0.0,0.00022988152,False,MEPE; matrix extracellular
hsa:2947,0.0001254668,0.10448281233634814,0.00026993094122807013,0.0003626185336124777,0.0,0.0019786442,False,GSTM3; glutathione S-transferase mu
hsa:22977,1.2705437e-06,0.0010580486548810474,2.2489957317865494e-05,4.3095054617480135e-05,0.0,0.00027625955,False,AKR7A3; aldo-keto reductase family 7 member
hsa:29093,0.0,0.0,1.4301867687726901e-07,2.6474642782322523e-07,0.0,1.0587404e-06,False,MRPL22; mitochondrial ribosomal protein
hsa:3118,0.0,0.0,0.00010452524574403509,0.00023383839224962158,0.0,0.0013080208,False,HLA-DQA2; major histocompatibility complex
hsa:6472,2.0023557e-05,0.016674670497192644,0.00027279884140374267,0.0006576492176017097,0.0,0.005175607,False,SHMT2; serine hydroxymethyltransferase
hsa:5726,3.3841204e-06,0.00281813528899125,9.294983204561404e-05,0.00030132342156155947,0.0,0.0028371844,False,TAS2R38; taste 2 receptor member
hsa:26271,0.0,0.0,4.2935451734502944e-07,8.723782070433711e-07,0.0,4.085742e-06,False,FBXO5; F-box protein
hsa:7122,2.0721293e-06,0.0017255712012145714,1.9242187473333335e-05,5.599784024203773e-05,0.0,0.00043217494,False,CLDN5; claudin
hsa:6359,0.0,0.0,4.628528492159066e-05,0.00034991523229522956,0.0,0.0038347912,False,CCL15; C-C motif chemokine ligand
hsa:5567,0.0055344263,4.608808262363027,0.005421108913076023,0.0037430537052313777,0.0,0.014597563,True,PRKACB; protein kinase cAMP-activated catalytic subunit
hsa:2693,0.0,0.0,3.436767711111111e-08,3.185231442911126e-07,0.0,3.903358e-06,False,GHSR; growth hormone secretagogue
hsa:145482,8.487892e-06,0.007068314701316927,5.146303566070174e-05,0.00013366584573130952,0.0,0.0009438015,False,PTGR2; prostaglandin reductase
hsa:480,6.3347965e-05,0.052753186811049214,0.00021986218635847957,0.00037901793372106373,0.0,0.0021762683,False,ATP1A4; ATPase Na+/K+ transporting subunit alpha
hsa:891,2.2227106e-05,0.018509681804095724,0.00015859619184269003,0.0002608781886328496,0.0,0.0009439431,False,CCNB1; cyclin
hsa:26659,-0.0,0.0,1.268085907017544e-06,9.779430403678693e-06,0.0,0.00011684279,False,OR7A5; olfactory receptor family 7 subfamily A member
hsa:79852,2.819022e-08,2.347548089199986e-05,1.285648786093568e-07,2.6882155835318535e-07,0.0,1.9391848e-06,False,EPHX3; epoxide hydrolase
hsa:9076,0.0,0.0,1.7393707978947372e-07,5.068250441712925e-07,0.0,3.676538e-06,False,CLDN1; claudin
hsa:55589,0.0,0.0,4.3465476048830406e-07,7.603608663738621e-07,0.0,3.719973e-06,False,BMP2K; BMP2 inducible
hsa:27349,1.0259698e-06,0.0008543790873455019,6.024614304488306e-05,0.00017467827413414062,0.0,0.0014033838,False,MCAT; malonyl-CoA-acyl carrier protein
hsa:122809,1.0215342e-05,0.008506853296151773,0.00019081421951403513,0.0003505226536879119,0.0,0.0016427704,False,SOCS4; suppressor of cytokine signaling
hsa:64806,0.0,0.0,1.2341344654502926e-06,4.345430589282496e-06,0.0,4.1191095e-05,False,IL25; interleukin
hsa:8867,3.2299278e-07,0.000268973099008944,7.328294626278538e-05,0.00025415575855908723,0.0,0.0016085574,False,SYNJ1; synaptojanin
hsa:8744,0.0,0.0,6.102359652339182e-08,5.755871223674774e-07,0.0,7.47247e-06,False,TNFSF9; TNF superfamily member
hsa:940,5.53231e-06,0.0046070459078935795,5.674418349272517e-05,0.00012616907584211105,0.0,0.0007998422,False,CD28; CD28
hsa:993,2.6571468e-06,0.002212746084657678,1.4135458262807017e-05,4.0540662047917595e-05,0.0,0.00028564443,False,CDC25A; cell division cycle
hsa:93134,3.786434e-10,3.1531630124141844e-07,8.834677272426899e-08,1.5265226743333102e-07,0.0,6.279303e-07,False,ZNF561; zinc finger protein
hsa:2005,2.7328557e-08,2.275792873058206e-05,6.986289217555554e-06,2.1680121435050274e-05,0.0,0.0001367511,False,ELK4; ETS transcription factor
hsa:8877,0.0,0.0,1.0885240745029236e-05,2.7969399358434603e-05,0.0,0.0002466781,False,SPHK1; sphingosine kinase
hsa:6318,0.0,0.0,8.171520602339181e-08,9.09017674620441e-07,0.0,1.1828756e-05,False,SERPINB4; serpin family B member
hsa:10317,3.628944e-05,0.030220127948677778,0.0002082728466534503,0.0004204497458458437,0.0,0.0033916156,False,B3GALT5; beta-1
hsa:80270,0.0,0.0,2.1270424934502934e-05,5.076262229227147e-05,0.0,0.00028898526,False,HSD3B7; hydroxy-delta-5-steroid dehydrogenase
hsa:440193,3.946603e-07,0.0003286544174355834,4.733998437295318e-06,1.3882001957521876e-05,0.0,8.499174e-05,False,CCDC88C; coiled-coil domain containing
hsa:6372,0.0,0.0,7.376958705263158e-07,4.5570029134926196e-06,0.0,4.73359e-05,False,CXCL6; C-X-C motif chemokine ligand
hsa:10161,4.7621853e-07,0.00039657225099453856,1.2833623146257311e-05,3.894039727513608e-05,0.0,0.00023981431,False,LPAR6; lysophosphatidic acid receptor
hsa:6147,1.2885592e-07,0.00010730511105557396,9.120676573450295e-07,1.7312546079950425e-06,0.0,7.700527e-06,False,RPL23A; ribosomal protein
hsa:440138,0.0,0.0,1.2935107745073101e-05,4.10324974021308e-05,0.0,0.00029365093,False,ALG11; ALG11
hsa:26693,0.0,0.0,6.007340040935672e-08,6.609437857195626e-07,0.0,8.5375605e-06,False,OR2V1; olfactory receptor family 2 subfamily V member
hsa:478,0.0017532326,1.460009123750408,0.0021242892998830413,0.00198956705247985,0.0,0.013740299,True,ATP1A3; ATPase Na+/K+ transporting subunit alpha
hsa:138802,0.0,0.0,1.4821226042690058e-06,1.1853149473010729e-05,0.0,0.00011325852,False,OR13C8; olfactory receptor family 13 subfamily C member
hsa:5154,0.0,0.0,4.0778612553216384e-05,0.00010542467983991632,0.0,0.000636979,False,PDGFA; platelet derived growth factor subunit
hsa:8898,0.0,0.0,3.4547554809298247e-06,8.85828001860179e-06,0.0,4.2543437e-05,False,MTMR2; myotubularin related protein
hsa:1671,0.0,0.0,1.2618707959272516e-05,7.85678184532172e-05,0.0,0.0009798724,False,DEFA6; defensin alpha
hsa:406900,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR106B; microRNA
hsa:55255,0.0,0.0,1.504350400037427e-06,3.969771917900291e-06,0.0,3.1269075e-05,False,WDR41; WD repeat domain
hsa:9227,0.0,0.0,3.370876857894737e-07,1.7951214502893997e-06,0.0,1.3670966e-05,False,LRAT; lecithin retinol
hsa:4338,1.2244303e-05,0.010196475980405849,7.964196644795322e-05,0.00017318462696068682,0.0,0.0010845356,False,MOCS2; molybdenum cofactor synthesis
hsa:3783,0.0,0.0,3.3884429649122813e-07,2.940779299011966e-06,0.0,3.2842985e-05,False,KCNN4; potassium calcium-activated channel subfamily N member
hsa:5167,0.0,0.0,2.3370505340877198e-05,8.556718565966515e-05,0.0,0.00095162133,False,ENPP1; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:196513,0.0,0.0,2.8399478510997072e-05,0.000109161784595689,0.0,0.00094367564,False,DCP1B; decapping mRNA
hsa:4783,0.0,0.0,0.00015012984313684215,0.0003040634181328949,0.0,0.002116688,False,NFIL3; nuclear factor
hsa:29927,1.2791864e-05,0.010652458863572575,0.00014078266713011699,0.00024263277910561426,0.0,0.0016484549,False,SEC61A1; SEC61 translocon subunit alpha
hsa:81448,0.0,0.0,1.4894355730994153e-07,1.8321729200916528e-06,0.0,2.3917595e-05,False,OR6K2; olfactory receptor family 6 subfamily K member
hsa:6279,8.033375e-08,6.689814457310705e-05,4.261734042552046e-06,1.046414108709854e-05,0.0,9.131941e-05,False,S100A8; S100 calcium binding protein
hsa:9794,4.1502393e-05,0.03456122846305451,0.00025015251373421057,0.0004400949307953042,0.0,0.0028979746,False,MAML1; mastermind like transcriptional coactivator
hsa:9114,0.0,0.0,3.55703528619883e-05,0.00010388956582594637,0.0,0.0005295233,False,ATP6V0D1; ATPase H+ transporting V0 subunit
hsa:55757,6.92297e-08,5.765121731965493e-05,3.288708045847952e-07,7.693531334426494e-07,0.0,6.087109e-06,False,UGGT2; UDP-glucose glycoprotein glucosyltransferase
hsa:22821,0.0,0.0,8.480352971754386e-07,1.6308288654027268e-06,0.0,9.2608625e-06,False,RASA3; RAS p21 protein activator
hsa:63875,1.0669941e-08,8.885421825876699e-06,1.1402730203163506e-07,2.3085727323468218e-07,0.0,1.3672864e-06,False,MRPL17; mitochondrial ribosomal protein
hsa:10766,3.7590027e-08,3.1303195241763236e-05,5.651547057719297e-07,1.1549654074350212e-06,0.0,4.795408e-06,False,TOB2; transducer of ERBB2
hsa:93034,4.5803542e-08,3.814302176453085e-05,1.789861462153918e-05,0.00010073001636353003,0.0,0.0011908051,False,NT5C1B; 5'-nucleotidase
hsa:3039,9.939373e-06,0.008277039375356393,8.682371167809354e-05,0.00015274905273641916,0.0,0.00076849887,False,HBA1; hemoglobin subunit alpha
hsa:3190,0.0,0.0,9.366842578128653e-07,2.062295906446269e-06,0.0,1.0330863e-05,False,HNRNPK; heterogeneous nuclear ribonucleoprotein
hsa:5586,1.9077014e-07,0.00015886434289388797,5.871051064619882e-07,1.021880083235559e-06,0.0,7.6815195e-06,False,PKN2; protein kinase
hsa:3172,6.1109716e-07,0.000508892789865967,5.51756137159766e-05,0.00022821147233454057,0.0,0.002457126,False,HNF4A; hepatocyte nuclear factor 4
hsa:6204,5.3094364e-08,4.421447323060569e-05,1.1886756473617544e-06,2.07828351892243e-06,0.0,1.0376134e-05,False,RPS10; ribosomal protein
hsa:55869,1.0077847e-05,0.008392353968184644,5.887721685789476e-05,0.0001327340117081091,0.0,0.0008017491,False,HDAC8; histone deacetylase
hsa:442185,0.0,0.0,7.956500584795321e-08,9.886049023654049e-07,0.0,1.2913204e-05,False,OR2J1; olfactory receptor family 2 subfamily J member
hsa:91782,0.0,0.0,0.00017924565916191987,0.0006093836687226621,0.0,0.0037376063,False,CHMP7; charged multivesicular body protein
hsa:4831,0.0,0.0,1.3834481048362573e-05,4.932128574733386e-05,0.0,0.0003435562,False,NME2; NME/NM23 nucleoside diphosphate kinase
hsa:5978,3.9665977e-08,3.303194814109311e-05,8.943888730760232e-07,4.257528744114694e-06,0.0,4.6658643e-05,False,REST; RE1 silencing transcription
hsa:152687,5.851778e-09,4.873083736956474e-06,6.693529954508775e-08,1.0627663053390397e-07,0.0,4.7736137e-07,False,ZNF595; zinc finger protein
hsa:53,3.3307977e-05,0.02773730668347642,0.00011146022116976614,0.00017109100173441348,0.0,0.0009790371,False,ACP2; acid phosphatase 2
hsa:406928,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR137; microRNA
hsa:23511,3.9223803e-08,3.266372656325728e-05,2.480310362900586e-07,5.905958878450904e-07,0.0,3.2355504e-06,False,NUP188; nucleoporin
hsa:4729,0.0,0.0,5.38385933614035e-06,8.568610348279882e-06,0.0,3.832869e-05,False,NDUFV2; NADH:ubiquinone oxidoreductase core subunit
hsa:1509,0.0,0.0,4.591570001181286e-06,1.0089032057161566e-05,0.0,5.2860596e-05,False,CTSD; cathepsin
hsa:10140,1.5210301e-07,0.0001266641872561003,4.381558851327486e-07,7.502229003749082e-07,0.0,5.1323814e-06,False,TOB1; transducer of ERBB2
hsa:4689,2.0254095e-06,0.0016866651631567608,3.0018045228187145e-05,7.942888504720155e-05,0.0,0.0005729148,False,NCF4; neutrophil cytosolic factor
hsa:55272,0.0,0.0,1.8578456319181283e-07,1.151205417061545e-06,0.0,1.4322254e-05,False,IMP3; IMP U3 small nucleolar ribonucleoprotein
hsa:3040,2.8122051e-06,0.0023418712975434228,0.0004643692625674269,0.0009093850385619679,0.0,0.005438997,False,HBA2; hemoglobin subunit alpha
hsa:3764,9.370444e-08,7.803262233198419e-05,5.5325379821024e-05,0.0001898068808298654,0.0,0.001426675,False,KCNJ8; potassium inwardly rectifying channel subfamily J member
hsa:5744,0.0,0.0,4.279363865269006e-07,2.05252721759291e-06,0.0,1.6117017e-05,False,PTHLH; parathyroid hormone like
hsa:662,5.47299e-07,0.0004557647019679389,3.150563753579416e-05,6.144722974473318e-05,0.0,0.00037794796,False,BNIP1; BCL2 interacting protein
hsa:23288,6.7294565e-07,0.0005603972848714705,0.00010402812790178365,0.000247490235853636,0.0,0.0013632543,False,IQCE; IQ motif containing
hsa:8449,8.035178e-09,6.691315910369541e-06,7.730648344801162e-07,2.5219041966827517e-06,0.0,1.41983055e-05,False,DHX16; DEAH-box helicase
hsa:26219,0.0,0.0,3.550247330175439e-07,1.918957967127003e-06,0.0,1.644491e-05,False,OR1J4; olfactory receptor family 1 subfamily J member
hsa:3795,0.0,0.0,0.0001496058038788538,0.0004828919150451995,0.0,0.0027942737,False,KHK;
hsa:23594,1.9932658e-07,0.00016598974112503134,1.0506289749450287e-06,1.7566212452413228e-06,0.0,1.0560615e-05,False,ORC6; origin recognition complex subunit
hsa:8851,3.388816e-05,0.02822045562415029,0.00038927758406081875,0.0008031089859332065,0.0,0.0057559717,False,CDK5R1; cyclin dependent kinase 5 regulatory subunit
hsa:5096,1.7508332e-06,0.0014580110170008948,0.0005113734432460821,0.0015260229303650326,0.0,0.0088620605,False,PCCB; propionyl-CoA carboxylase subunit
hsa:259292,0.0,0.0,2.3008187615204687e-05,5.62816884403639e-05,0.0,0.0003615971,False,TAS2R46; taste 2 receptor member
hsa:9587,0.0,0.0,7.870628700146198e-07,1.454127853871764e-06,0.0,7.2143835e-06,False,MAD2L1BP; MAD2L1 binding
hsa:415117,0.0,0.0,1.0969706443415204e-06,3.5379986220207766e-06,0.0,2.6273814e-05,False,STX19; syntaxin
hsa:2260,0.0,0.0,6.816653538011695e-06,2.2307302955409357e-05,0.0,0.00021583003,False,FGFR1; fibroblast growth factor receptor
hsa:3426,0.0,0.0,8.814175459064329e-07,1.7412227933441623e-06,0.0,7.644002e-06,False,CFI; complement factor
hsa:2030,0.0,0.0,1.8955707752631576e-06,3.83554251486603e-06,0.0,2.1992897e-05,False,SLC29A1; solute carrier family 29 member 1 (Augustine blood
hsa:2819,0.0,0.0,7.409881575783628e-07,3.245471319990838e-06,0.0,3.3705855e-05,False,GPD1; glycerol-3-phosphate dehydrogenase
hsa:10380,0.0,0.0,0.00011263219429163744,0.00029325183908862455,0.0,0.0017660088,False,BPNT1; 3'(2')
hsa:285521,1.1985351e-08,9.98083301174703e-06,2.8375072660134513e-07,5.356617891261045e-07,0.0,2.882013e-06,False,COX18; cytochrome c oxidase assembly factor
hsa:4714,0.0,0.0,6.946077131169592e-06,1.6469945518615295e-05,0.0,0.00010294359,False,NDUFB8; NADH:ubiquinone oxidoreductase subunit
hsa:3913,0.0,0.0,9.725614526549706e-05,0.0002041633980471536,0.0,0.0012109202,False,LAMB2; laminin subunit beta
hsa:2670,0.0,0.0,1.0121626184269006e-07,2.657370913536453e-07,0.0,1.8648234e-06,False,GFAP; glial fibrillary acidic
hsa:2978,2.9398325e-05,0.024481533552923738,0.00011180339873742689,0.0002499445640492009,0.0,0.001929793,False,GUCA1A; guanylate cyclase activator
hsa:2720,0.0,0.0,0.00011326961448479531,0.00019897490034683968,0.0,0.0011834827,False,GLB1; galactosidase beta
hsa:4052,1.1265636e-07,9.381488425923092e-05,6.716099179578949e-06,2.4344846283703007e-05,0.0,0.0001872398,False,LTBP1; latent transforming growth factor beta binding protein
hsa:6632,0.0,0.0,2.7164837610526313e-06,9.34915000656667e-06,0.0,6.393005e-05,False,SNRPD1; small nuclear ribonucleoprotein D1
hsa:2557,0.0,0.0,9.60352670575438e-05,0.000313790675301902,0.0,0.0028619806,False,GABRA4; gamma-aminobutyric acid type A receptor subunit
hsa:10912,0.0,0.0,4.370136051830409e-05,0.00010767967828354669,0.0,0.0006201078,False,GADD45G; growth arrest and DNA damage inducible
hsa:2254,5.50506e-07,0.0004584353397714269,2.6064736443561413e-05,6.454126920146891e-05,0.0,0.00036164714,False,FGF9; fibroblast growth factor
hsa:5515,6.639865e-05,0.05529365288137469,0.0005308594015497076,0.0009507684276739116,0.0,0.0077030784,False,PPP2CA; protein phosphatase 2 catalytic subunit
hsa:2892,0.0,0.0,5.767300608771929e-06,2.79277299050819e-05,0.0,0.00021740492,False,GRIA3; glutamate ionotropic receptor AMPA type subunit
hsa:957,0.0,0.0,3.74553614843614e-05,0.00012757725901055373,0.0,0.0008371548,False,ENTPD5; ectonucleoside triphosphate diphosphohydrolase 5
hsa:57152,0.0,0.0,2.3706303035087724e-07,1.6616669490369262e-06,0.0,2.0575148e-05,False,SLURP1; secreted LY6/PLAUR domain containing
hsa:58500,1.3197234e-08,1.0990031812247328e-05,8.767920476725147e-08,1.1932526324449e-07,0.0,4.3735955e-07,False,ZNF250; zinc finger protein
hsa:1149,-0.0,0.0,3.796280116040935e-08,1.456018592091666e-07,0.0,1.3788025e-06,False,CIDEA; cell death inducing DFFA like effector
hsa:5308,0.0,0.0,1.431222557735088e-07,1.130576712884005e-06,0.0,1.3458517e-05,False,PITX2; paired like homeodomain
hsa:810,0.0,0.0,6.639737210526317e-07,2.9512882130291603e-06,0.0,3.132219e-05,False,CALML3; calmodulin like
hsa:760,3.8795384e-05,0.03230695949835784,0.00025327938404935674,0.00037982397120565084,0.0,0.0020092214,False,CA2; carbonic anhydrase
hsa:113451,0.0,0.0,3.5807680861695916e-07,9.492583898293832e-07,0.0,8.659049e-06,False,AZIN2; antizyme inhibitor
hsa:3280,0.0,0.0,1.4571055251461987e-05,6.983718171357145e-05,0.0,0.00053990656,False,HES1; hes family bHLH transcription factor
hsa:240,0.0,0.0,2.118087636750293e-05,4.815495968203083e-05,0.0,0.0002720482,False,ALOX5; arachidonate
hsa:7363,0.0,0.0,3.323174452152048e-05,0.00014945157176925145,0.0,0.0011819198,False,UGT2B4; UDP glucuronosyltransferase family 2 member
hsa:441024,6.3667187e-07,0.00053019019782956,6.984083615885966e-06,3.057314454948881e-05,0.0,0.00038178355,False,MTHFD2L; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2
hsa:1593,0.0,0.0,6.186194026783626e-05,0.00020411843034507713,0.0,0.0011039646,False,CYP27A1; cytochrome P450 family 27 subfamily A member
hsa:128178,3.5968093e-08,2.9952525377353347e-05,3.4718633608538015e-07,1.0748943612788283e-06,0.0,9.128009e-06,False,EDARADD; EDAR associated via death
hsa:6667,0.0,0.0,4.8172707652631574e-05,0.00012068473442636576,0.0,0.0010830483,False,SP1; Sp1 transcription
hsa:6206,2.061297e-07,0.0001716550574498412,1.4721790925695911e-06,2.764497636816213e-06,0.0,1.1545362e-05,False,RPS12; ribosomal protein
hsa:2137,0.0,0.0,5.318732076666667e-05,0.00013308815018552315,0.0,0.00093533704,False,EXTL3; exostosin like glycosyltransferase
hsa:2895,1.9582303e-06,0.0016307215051810575,1.1057729271339182e-05,2.339382001442048e-05,0.0,0.00017196176,False,GRID2; glutamate ionotropic receptor delta type subunit
hsa:11009,0.0,0.0,9.566130557157895e-06,4.0855703562088134e-05,0.0,0.00035861132,False,IL24; interleukin
hsa:1636,9.844292e-05,0.08197860419012944,0.0005053270934157896,0.0007682355902746738,0.0,0.0038647675,False,ACE; angiotensin I converting
hsa:50837,0.0,0.0,3.292078547251462e-05,7.90981796896708e-05,0.0,0.00058130326,False,TAS2R7; taste 2 receptor member
hsa:90338,0.0,0.0,3.750034289707603e-08,8.888588032298934e-08,0.0,4.6817794e-07,False,ZNF160; zinc finger protein
hsa:147111,2.3341512e-07,0.00019437706372862126,1.082931526432924e-05,3.72276973209921e-05,0.0,0.0002749936,False,NOTUM; notum
hsa:84706,0.0,0.0,4.347655380058479e-05,8.551930139595543e-05,0.0,0.00042075926,False,GPT2; glutamic--pyruvic transaminase
hsa:3840,3.3425785e-08,2.7835411609685755e-05,4.91203921766082e-07,8.774351616252701e-07,0.0,5.0813123e-06,False,KPNA4; karyopherin subunit alpha
hsa:2516,0.0,0.0,3.4213314167941533e-06,1.3204425207544221e-05,0.0,9.665409e-05,False,NR5A1; nuclear receptor subfamily 5 group A member
hsa:28984,1.3659364e-08,1.1374871802308418e-05,4.8309967015649115e-06,1.5338559981704535e-05,0.0,9.144699e-05,False,RGCC; regulator of cell
hsa:1203,2.9350824e-07,0.0002444197696848236,2.443310913233919e-06,4.860814386806628e-06,0.0,2.216802e-05,False,CLN5; CLN5 intracellular trafficking
hsa:974,4.864038e-07,0.00040505406175248443,8.322840584713458e-06,2.106173356273233e-05,0.0,0.00015942626,False,CD79B; CD79b
hsa:51166,9.087217e-05,0.07567404193545006,0.0001546115029646783,0.00019286093060484304,0.0,0.00091427815,False,AADAT; aminoadipate
hsa:3174,0.0,0.0,1.6729074061988305e-05,5.8044409101330166e-05,0.0,0.00050405046,False,HNF4G; hepatocyte nuclear factor 4
hsa:84076,0.0,0.0,2.1321720621821636e-05,9.067590565784258e-05,0.0,0.0008329321,False,TKTL2; transketolase like
hsa:405753,0.0,0.0,1.6018796815171925e-06,7.147523942074941e-06,0.0,6.920736e-05,False,DUOXA2; dual oxidase maturation factor
hsa:338675,-0.0,0.0,0.0,0.0,0.0,0.0,False,OR5AP2; olfactory receptor family 5 subfamily AP member
hsa:6280,1.1044013e-07,9.196931281575596e-05,3.6150552360736846e-05,0.0001156412499508105,0.0,0.00063633424,False,S100A9; S100 calcium binding protein
hsa:1965,0.0,0.0,2.1865002388888886e-06,4.959256138645925e-06,0.0,3.3093176e-05,False,EIF2S1; eukaryotic translation initiation factor 2 subunit
hsa:29116,5.6491155e-07,0.0004704315999554108,2.214943981362572e-05,5.459366880564104e-05,0.0,0.00041720388,False,MYLIP; myosin regulatory light chain interacting
hsa:27127,0.0,0.0,3.540384168967251e-08,8.905115147913894e-08,0.0,5.4326085e-07,False,SMC1B; structural maintenance of chromosomes
hsa:201163,4.4188987e-06,0.0036798496782051724,5.352660662923976e-06,5.572492035498872e-06,0.0,2.7771326e-05,False,FLCN;
hsa:23645,3.038328e-07,0.00025301757456177405,1.1954500586374267e-06,2.0232693469401665e-06,0.0,1.3586786e-05,False,PPP1R15A; protein phosphatase 1 regulatory subunit
hsa:1352,0.0,0.0,1.3491687987619884e-05,4.173929496042772e-05,0.0,0.00024286227,False,COX10; cytochrome c oxidase assembly factor heme A:farnesyltransferase
hsa:27102,9.834993e-08,8.190116651961296e-05,1.2466768316198828e-06,2.3695087863113564e-06,0.0,1.830938e-05,False,EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase
hsa:1031,0.0,0.0,1.0618231099918133e-05,2.1944955295204095e-05,0.0,0.000110304434,False,CDKN2C; cyclin dependent kinase inhibitor
hsa:57192,0.0,0.0,3.483010682046783e-06,7.022758621056752e-06,0.0,5.0721763e-05,False,MCOLN1; mucolipin TRP cation channel
hsa:51347,0.0,0.0,5.679925133076024e-07,1.164927115647028e-06,0.0,6.2574522e-06,False,TAOK3; TAO kinase
hsa:9040,0.0,0.0,3.0771185128654975e-07,9.479730235514846e-07,0.0,5.2333885e-06,False,UBE2M; ubiquitin conjugating enzyme E2
hsa:6505,0.0,0.0,6.905181758596493e-05,0.00015045146775909303,0.0,0.0009934021,False,SLC1A1; solute carrier family 1 member
hsa:3303,0.0,0.0,7.628702706456139e-05,0.00018313842290389992,0.0,0.0012129729,False,HSPA1A; heat shock protein family A (Hsp70) member
hsa:8535,0.0,0.0,4.904302723909756e-05,0.00016498773146556491,0.0,0.00090708444,False,CBX4; chromobox
hsa:1515,6.63113e-07,0.0005522091193590083,1.7489006220614034e-06,2.7472803010855143e-06,0.0,2.0486736e-05,False,CTSV; cathepsin
hsa:2171,2.7992812e-06,0.002331108885348693,0.0002307993756853218,0.0007245336166556686,0.0,0.00694508,False,FABP5; fatty acid binding protein
hsa:1290,0.0,0.0,8.710485485380118e-07,5.580893606456183e-06,0.0,5.6991783e-05,False,COL5A2; collagen type V alpha 2
hsa:200186,2.376652e-05,0.019791632918413994,4.912436377555557e-05,7.62534441336341e-05,0.0,0.0004433391,False,CRTC2; CREB regulated transcription coactivator
hsa:81889,6.5198597e-06,0.005429430554492655,8.404795956747896e-05,0.00022309672487083536,0.0,0.0013205723,False,FAHD1; fumarylacetoacetate hydrolase domain containing
hsa:79369,0.00012448618,0.10366619841590648,0.000471906747459532,0.0008271833136389499,0.0,0.0049999407,False,B3GNT4; UDP-GlcNAc:betaGal beta-1
hsa:2559,0.0,0.0,5.296866565497076e-06,2.9269416990002475e-05,0.0,0.00034001342,False,GABRA6; gamma-aminobutyric acid type A receptor subunit
hsa:6324,2.7125775e-08,2.2589061479235968e-05,1.6194798184152048e-07,3.1833980440751343e-07,0.0,2.0659268e-06,False,SCN1B; sodium voltage-gated channel beta subunit
hsa:286365,0.0,0.0,6.282754212865498e-06,2.306935553336168e-05,0.0,0.00020921623,False,OR13D1; olfactory receptor family 13 subfamily D member
hsa:1588,0.0,0.0,1.694345595847953e-08,8.283622692011537e-08,0.0,7.39522e-07,False,CYP19A1; cytochrome P450 family 19 subfamily A member
hsa:92,6.418808e-05,0.053452794817995676,0.00022646816416695904,0.0003649373371693547,0.0,0.001734957,False,ACVR2A; activin A receptor type
hsa:6883,5.765158e-07,0.00048009507009296175,1.562105078447661e-06,3.876645099556733e-06,0.0,4.3764463e-05,False,TAF12; TATA-box binding protein associated factor
hsa:26864,0.0,0.0,1.7971229859649123e-07,1.2029962790050182e-06,0.0,1.3054118e-05,False,RNVU1-7; RNA
hsa:253260,1.9215483e-08,1.600174471845371e-05,4.78158384457895e-07,1.3466617653756884e-06,0.0,7.432731e-06,False,RICTOR; RPTOR independent companion of MTOR complex
hsa:58985,5.0684906e-07,0.00042207990654766404,1.3511496157195034e-05,4.550371544946495e-05,0.0,0.00032836723,False,IL22RA1; interleukin 22 receptor subunit alpha
hsa:22856,0.0,0.0,1.3676534813216371e-05,3.518732901103662e-05,0.0,0.0002818945,False,CHSY1; chondroitin sulfate synthase
hsa:3445,0.0,0.0,0.0,0.0,0.0,0.0,False,IFNA8; interferon alpha
hsa:5737,2.9167263e-06,0.002428911605615119,1.6212799235263166e-05,3.913935934014395e-05,0.0,0.00032232367,False,PTGFR; prostaglandin F
hsa:9699,5.119811e-06,0.004263536265454853,5.6966605571592386e-05,0.00013496830058563663,0.0,0.0011270846,False,RIMS2; regulating synaptic membrane exocytosis
hsa:1137,1.2057368e-05,0.01004080536057578,0.00023221479847929823,0.0006830223046450796,0.0,0.0054427637,False,CHRNA4; cholinergic receptor nicotinic alpha 4
hsa:6531,8.382457e-07,0.0006980513423858007,2.3379162040506434e-05,8.799004046264418e-05,0.0,0.0008056947,False,SLC6A3; solute carrier family 6 member
hsa:9586,0.0,0.0,0.0003159158719415205,0.0007225084281660588,0.0,0.0038198996,False,CREB5; cAMP responsive element binding protein
hsa:10379,0.0,0.0,2.151570913099416e-05,5.4001494344056406e-05,0.0,0.00039942903,False,IRF9; interferon regulatory factor
hsa:146540,1.0605757e-09,8.831972428689585e-07,1.0631531499232746e-07,1.8861053923234592e-07,0.0,9.324882e-07,False,ZNF785; zinc finger protein
hsa:114609,0.0,0.0,1.6670379825321638e-05,4.0009505920913394e-05,0.0,0.0001926751,False,TIRAP; TIR domain containing adaptor
hsa:7516,7.2221724e-07,0.0006014283328577385,3.629227923581286e-05,8.59767848156399e-05,0.0,0.0006398518,False,XRCC2; X-ray repair cross complementing
hsa:26985,4.4363375e-07,0.00036943718854167307,2.237513169824561e-06,4.145113709579781e-06,0.0,3.4579178e-05,False,AP3M1; adaptor related protein complex 3 subunit mu
hsa:4624,0.0,0.0,6.456272856436548e-05,0.000161202149067011,0.0,0.0009012469,False,MYH6; myosin heavy chain
hsa:29889,0.0,0.0,6.364288685663157e-07,1.3062957358348492e-06,0.0,7.1437407e-06,False,GNL2; G protein nucleolar
hsa:353,0.0,0.0,1.0416130259736843e-06,2.3650431561972745e-06,0.0,1.6905824e-05,False,APRT; adenine
hsa:904,1.4983983e-06,0.0012477951807490354,3.4251550056883045e-05,7.880701294090772e-05,0.0,0.0005453565,False,CCNT1; cyclin
hsa:163071,1.08936644e-10,9.071728083926237e-08,9.630865647368422e-09,2.5309730896892727e-08,0.0,1.8122223e-07,False,ZNF114; zinc finger protein
hsa:5908,0.0,0.0,6.111684067134503e-05,0.00019156643682864382,0.0,0.0016437165,False,RAP1B; RAP1B
hsa:54894,2.4526425e-09,2.042444583392991e-06,8.230997115137422e-07,4.0883784117906284e-06,0.0,4.452515e-05,False,RNF43; ring finger protein
hsa:10262,6.861404e-09,5.713852481260926e-06,1.50990833668421e-07,2.7201029120613225e-07,0.0,1.4241085e-06,False,SF3B4; splicing factor 3b subunit
hsa:56919,1.335292e-07,0.0001111967974398223,3.8296802360935674e-07,5.935237811846835e-07,0.0,3.2031141e-06,False,DHX33; DEAH-box helicase
hsa:2204,0.0,0.0,5.249566974619883e-08,2.0413288102423296e-07,0.0,1.6741166e-06,False,FCAR; Fc alpha
hsa:2356,1.2980389e-05,0.010809453560143381,0.00014767630064485378,0.00025771238365846573,0.0,0.001264597,False,FPGS; folylpolyglutamate
hsa:2308,0.0,0.0,1.998824619298246e-05,5.90200478259185e-05,0.0,0.00039461968,False,FOXO1; forkhead box
hsa:4830,1.8965375e-06,0.0015793466614382997,0.0005783145161853803,0.001154157925637792,0.0,0.005418006,False,NME1; NME/NM23 nucleoside diphosphate kinase
hsa:7005,0.0,0.0,8.088914213450293e-05,0.000233874096567367,0.0,0.0014100434,False,TEAD3; TEA domain transcription factor
hsa:8392,0.0,0.0,1.9024219819976606e-05,7.59095078247725e-05,0.0,0.0006686591,False,OR3A3; olfactory receptor family 3 subfamily A member
hsa:6906,0.0,0.0,1.0377214143584796e-06,8.907417104633055e-06,-0.0,0.00010442191,False,SERPINA7; serpin family A member
hsa:23562,0.0,0.0,5.527777376315789e-08,2.3123080924657599e-07,0.0,2.014054e-06,False,CLDN14; claudin
hsa:80198,2.9319932e-07,0.0002441625157308936,7.652258446635088e-05,0.00017185922861461518,0.0,0.0009927076,False,MUS81; MUS81 structure-specific endonuclease
hsa:120892,1.5660431e-09,1.304126568366555e-06,3.1262691247339197e-08,5.9313054717189785e-08,0.0,3.0732085e-07,False,LRRK2; leucine rich repeat kinase
hsa:84447,0.0,0.0,9.217930996549706e-07,2.2992814268540315e-06,0.0,1.39335e-05,False,SYVN1; synoviolin
hsa:285641,0.0,0.0,1.441606442222222e-07,6.748536896209934e-07,0.0,4.940871e-06,False,SLC36A3; solute carrier family 36 member
hsa:51802,0.0,0.0,5.767728380116959e-08,7.17879312034401e-07,0.0,9.382884e-06,False,ASIC5; acid sensing ion channel subunit family member
hsa:8536,1.8013116e-05,0.015000470392333827,5.629224751760233e-05,9.198298599947194e-05,0.0,0.0005618812,False,CAMK1; calcium/calmodulin dependent protein kinase
hsa:10956,0.0,0.0,4.434370666807017e-07,1.1873591790638545e-06,0.0,6.1292994e-06,False,OS9; OS9 endoplasmic reticulum
hsa:23096,3.0515677e-09,2.54120114110475e-06,2.1923777883801166e-07,4.762517946001223e-07,0.0,3.0997205e-06,False,IQSEC2; IQ motif and Sec7 domain ArfGEF
hsa:30845,0.0,0.0,8.129597535906433e-07,1.7942604668324528e-06,0.0,1.1477674e-05,False,EHD3; EH domain containing
hsa:51289,0.0,0.0,1.2114880656842103e-07,5.076500127423298e-07,0.0,4.3977657e-06,False,RXFP3; relaxin family peptide receptor
hsa:340273,0.0,0.0,9.128876724561403e-07,4.510137696361503e-06,0.0,4.7020494e-05,False,ABCB5; ATP binding cassette subfamily B member
hsa:2213,0.0,0.0,2.6773387932046782e-05,0.00013067757779586684,0.0,0.0013172758,False,FCGR2B; Fc gamma receptor
hsa:115650,0.00024258236,0.20201110728884805,0.0005085422005754389,0.0007588241278314241,0.0,0.0039779753,False,TNFRSF13C; TNF receptor superfamily member
hsa:1459,0.0,0.0,1.1466308966842103e-05,2.343175986837603e-05,0.0,0.000108736436,False,CSNK2A2; casein kinase 2 alpha
hsa:26687,0.0,0.0,2.209256041695907e-06,2.071279546819045e-05,0.0,0.0002566882,False,OR4E1; olfactory receptor family 4 subfamily E member
hsa:51449,0.0,0.0,2.5197975729611108e-05,7.346707361262513e-05,0.0,0.000501401,False,PCYOX1; prenylcysteine oxidase
hsa:63893,7.605457e-08,6.33346460149749e-05,4.794209323274852e-07,8.604675419528702e-07,0.0,4.27335e-06,False,UBE2O; ubiquitin conjugating enzyme E2
hsa:65260,0.0,0.0,3.9088069966666666e-07,5.945121601339502e-07,0.0,3.141401e-06,False,COA7; cytochrome c oxidase assembly factor
hsa:3416,9.736111e-05,0.08107772402730082,0.0005199969625004095,0.0009280101827013211,0.0,0.0046205716,False,IDE; insulin degrading
hsa:6487,8.36887e-05,0.06969198813369702,0.00045303218291187116,0.0009710642651718356,0.0,0.006379498,False,ST3GAL3; ST3 beta-galactoside alpha-2
hsa:22835,0.0,0.0,7.262415509356728e-08,1.159241880573663e-07,0.0,4.620873e-07,False,ZFP30; ZFP30 zinc finger
hsa:6882,0.0,0.0,6.425487635380118e-07,1.7683823412416702e-06,0.0,1.4592037e-05,False,TAF11; TATA-box binding protein associated factor
hsa:5532,0.00018667398,0.15545325472889404,0.0006513144940994153,0.0010212693667487518,0.0,0.0049582166,False,PPP3CB; protein phosphatase 3 catalytic subunit
hsa:7296,0.0,0.0,7.146863712865497e-05,0.0001827146094116179,0.0,0.00096921355,False,TXNRD1; thioredoxin reductase
hsa:359,0.0,0.0,4.836806802660234e-06,1.6771020627095097e-05,0.0,0.00013190258,False,AQP2; aquaporin
hsa:9367,0.0,0.0,1.8516620843426913e-07,3.91684421785731e-07,0.0,2.730163e-06,False,RAB9A; RAB9A
hsa:55894,0.0,0.0,9.356603883040935e-09,7.891545764950009e-08,0.0,9.4894284e-07,False,DEFB103B; defensin beta
hsa:10963,5.173709e-09,4.30841996870786e-06,3.563113839865496e-08,6.541317071155794e-08,0.0,3.090232e-07,False,STIP1; stress induced phosphoprotein
hsa:1280,1.7733471e-05,0.014767595272734076,4.639547804982456e-05,7.698185174855573e-05,0.0,0.00051898987,False,COL2A1; collagen type II alpha 1
hsa:10075,9.8717344e-08,8.22071315080541e-05,3.8521809007719293e-07,5.404046901290228e-07,0.0,2.0671105e-06,False,HUWE1; HECT
hsa:2648,8.602895e-06,0.007164083756294954,0.00023710761023742696,0.0005282114996403658,0.0,0.0034455245,False,KAT2A; lysine acetyltransferase
hsa:9487,1.7471455e-05,0.014549400749903173,6.099648144894739e-05,0.00012391096798886357,0.0,0.0008540732,False,PIGL; phosphatidylinositol glycan anchor biosynthesis class
hsa:8940,0.0,0.0,5.883017353967776e-05,0.0001231338239272217,0.0,0.0006687492,False,TOP3B; DNA topoisomerase III
hsa:2072,0.0,0.0,2.0318083041643275e-05,5.2505768689149964e-05,0.0,0.00030284518,False,ERCC4; ERCC excision repair 4
hsa:6879,3.3235875e-07,0.0002767726355067097,2.5400340263508764e-06,5.206415812039172e-06,0.0,2.9212442e-05,False,TAF7; TATA-box binding protein associated factor
hsa:10933,1.00068924e-07,8.333266335789454e-05,9.533113376789475e-06,2.691066026122062e-05,0.0,0.00016479516,False,MORF4L1; mortality factor 4 like
hsa:90353,0.0,0.0,2.3110600378947364e-05,6.70655189379427e-05,0.0,0.0006170664,False,CTU1; cytosolic thiouridylase subunit
hsa:51478,6.218805e-05,0.05178726450115436,0.00038616722560005803,0.0005952061659747907,0.0,0.0034451722,False,HSD17B7; hydroxysteroid 17-beta dehydrogenase
hsa:28965,0.0,0.0,3.076909344444445e-07,1.5081857927186362e-06,0.0,1.4274409e-05,False,SLC27A6; solute carrier family 27 member
hsa:5195,5.8183467e-08,4.84524373271583e-05,0.00013197979616723563,0.0004633570403776556,0.0,0.0026170898,False,PEX14; peroxisomal biogenesis factor
hsa:1650,7.0393867e-07,0.0005862068049389041,4.017446424277192e-05,8.934367629075765e-05,0.0,0.00047389945,False,DDOST; dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic
hsa:2330,2.3478875e-05,0.019552095777477196,0.00013249901393464918,0.0002031333448804408,0.0,0.0010895574,False,FMO5; flavin containing dimethylaniline monoxygenase
hsa:406952,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR17; microRNA
hsa:8525,2.644942e-06,0.002202582504905882,0.0001389406382232163,0.0003376346716057276,0.0,0.0022880812,False,DGKZ; diacylglycerol kinase
hsa:3910,0.0,0.0,5.9073206766081865e-05,0.0001391309725167139,0.0,0.000969361,False,LAMA4; laminin subunit alpha
hsa:85015,5.9148517e-09,4.925608528857273e-06,7.736244912524442e-05,0.0002818886331535922,0.0,0.002038029,False,USP45; ubiquitin specific peptidase
hsa:1845,0.0,0.0,9.626918942982456e-08,1.7634143798118777e-07,0.0,7.3078144e-07,False,DUSP3; dual specificity phosphatase
hsa:5889,2.0545987e-07,0.0001710972547308171,0.00012822968431783143,0.00032069199103073605,0.0,0.0018467506,False,RAD51C; RAD51 paralog
hsa:3773,0.0,0.0,1.62610922525731e-06,5.69806439226312e-06,0.0,6.183736e-05,False,KCNJ16; potassium inwardly rectifying channel subfamily J member
hsa:22863,0.0,0.0,3.7937642150701734e-07,6.795197707648209e-07,0.0,3.1837747e-06,False,ATG14; autophagy related
hsa:29920,9.804171e-06,0.008164449549254995,0.00017239324650730994,0.00023231847687241755,0.0,0.0012797046,False,PYCR2; pyrroline-5-carboxylate reductase
hsa:7188,1.0444908e-05,0.008698024994934288,8.35927269192398e-05,0.0001726636702081756,0.0,0.0009518753,False,TRAF5; TNF receptor associated factor
hsa:10512,1.8362035e-08,1.529103362019639e-05,2.212206408863157e-07,5.241062580637371e-07,0.0,4.4294684e-06,False,SEMA3C; semaphorin
hsa:101447996,0.0,0.0,0.0,0.0,0.0,0.0,False,RNVU1-8; RNA
hsa:2833,0.0,0.0,1.5788411633315794e-05,4.644884689790843e-05,0.0,0.00037563435,False,CXCR3; C-X-C motif chemokine receptor
hsa:57403,5.5473426e-09,4.6195643456374875e-06,4.038166481022806e-07,9.757786701341899e-07,0.0,9.041647e-06,False,RAB22A; RAB22A
hsa:50511,0.0,0.0,1.4311562643098427e-05,3.922799561843028e-05,0.0,0.00033742635,False,SYCP3; synaptonemal complex protein
hsa:128371,0.0,0.0,4.552646783625732e-09,5.953358176637992e-08,0.0,7.785026e-07,False,OR6K6; olfactory receptor family 6 subfamily K member
hsa:347733,3.411544e-05,0.02840972365033574,0.0006987804558633977,0.0020783215065420303,0.0,0.014762564,False,TUBB2B; tubulin beta 2B class
hsa:838,0.0,0.0,1.873397550994152e-08,5.09804536233073e-08,0.0,4.3901227e-07,False,CASP5; caspase
hsa:10326,0.0,0.0,6.340883645915204e-06,2.4355437744284058e-05,0.0,0.0002232396,False,SIRPB1; signal regulatory protein beta
hsa:441608,0.0,0.0,1.088779545614035e-07,1.277225897085426e-06,0.0,1.6643535e-05,False,OR5B3; olfactory receptor family 5 subfamily B member
hsa:4586,0.0,0.0,6.739334686549707e-08,3.747262068335335e-07,0.0,3.9199927e-06,False,MUC5AC; mucin 5AC
hsa:8564,2.2672044e-08,1.8880205110303503e-05,3.286877351207602e-05,0.00011378969914094952,0.0,0.0009931886,False,KMO; kynurenine
hsa:7140,0.0,0.0,5.460036259707604e-09,1.5518997210729142e-08,0.0,9.134104e-08,False,TNNT3; troponin T3
hsa:29941,1.5206949e-08,1.2663627338669806e-05,1.4399861325964913e-07,2.649301427461606e-07,0.0,1.6641585e-06,False,PKN3; protein kinase
hsa:1576,0.0,0.0,2.4728072300818718e-05,7.272949568787112e-05,0.0,0.0005909761,False,CYP3A4; cytochrome P450 family 3 subfamily A member
hsa:4589,0.0,0.0,4.6966755539473686e-07,2.8019809013510753e-06,0.0,2.5247162e-05,False,MUC7; mucin 7
hsa:27231,0.0,0.0,9.349563426987721e-06,5.134386081847894e-05,0.0,0.000606722,False,NMRK2; nicotinamide riboside kinase
hsa:728957,0.0,0.0,1.3312547895321641e-10,7.507015640277154e-10,0.0,7.3482673e-09,False,ZNF705D; zinc finger protein
hsa:10526,0.0,0.0,5.604798896064328e-08,1.8508428429072703e-07,0.0,1.0054786e-06,False,IPO8; importin
hsa:8175,0.0,0.0,2.5508430178771927e-07,4.4982181253187734e-07,0.0,1.8008177e-06,False,SF3A2; splicing factor 3a subunit
hsa:10130,4.4744557e-08,3.72611491813295e-05,1.2346843034222217e-06,2.77877200057486e-06,0.0,1.5958285e-05,False,PDIA6; protein disulfide isomerase family A member
hsa:2730,0.0,0.0,2.2350573358362578e-06,4.266592330077949e-06,0.0,2.3869088e-05,False,GCLM; glutamate-cysteine ligase modifier
hsa:2653,4.3128483e-05,0.035915359247548996,0.00011440849520251462,0.00020152224189698927,0.0,0.0009996253,False,GCSH; glycine cleavage system protein
hsa:80381,2.3085879e-07,0.00019224827310305515,1.1416127413491227e-05,2.4350152772737988e-05,0.0,0.0001477889,False,CD276; CD276
hsa:8837,8.313377e-08,6.92298686961262e-05,2.662631239747368e-05,8.617934261987376e-05,0.0,0.0005461645,False,CFLAR; CASP8 and FADD like apoptosis
hsa:4436,0.0,0.0,3.903084015052631e-05,0.00011683368748913864,0.0,0.0010720856,False,MSH2; mutS homolog
hsa:85365,1.6022826e-08,1.3343051086470363e-05,4.334068087292395e-06,1.5586619397724892e-05,0.0,0.00011860487,False,ALG2; ALG2
hsa:1545,0.0,0.0,2.1460894898245613e-05,0.0001707454462158107,0.0,0.002134914,False,CYP1B1; cytochrome P450 family 1 subfamily B member
hsa:10554,9.926717e-05,0.08266500057601188,0.00040347702831228076,0.0006941426383530664,0.0,0.003553826,False,AGPAT1; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:51808,0.0,0.0,2.175913735425146e-07,3.1887149164407094e-07,0.0,1.1324278e-06,False,PHAX; phosphorylated adaptor for RNA
hsa:23064,0.0,0.0,1.4350293708011693e-08,2.2525527232216452e-08,0.0,1.2161146e-07,False,SETX;
hsa:9887,0.0,0.0,1.1223177790584797e-07,3.054380867781248e-07,0.0,1.4592932e-06,False,SMG7; SMG7 nonsense mediated mRNA decay
hsa:546,0.0,0.0,1.3420008930029242e-06,2.5471804949660298e-06,0.0,1.1774501e-05,False,ATRX; ATRX chromatin
hsa:3858,1.0213384e-05,0.00850522276642953,0.00011782439919327483,0.0003039244989010893,0.0,0.0015860813,False,KRT10; keratin
hsa:219874,0.0,0.0,3.86291396374269e-06,3.083191561499564e-05,0.0,0.00028644287,False,OR6T1; olfactory receptor family 6 subfamily T member
hsa:629,0.0,0.0,2.332572161988304e-07,2.81996059508505e-06,0.0,3.6837777e-05,False,CFB; complement factor
hsa:406978,0.0,0.0,1.0974769005847953e-09,1.4351372707558059e-08,-0.0,1.8766855e-07,False,MIR199B; microRNA
hsa:101954266,0.0,0.0,4.496300488435086e-08,2.290586246072236e-07,0.0,2.2901465e-06,False,RNVU1-14; RNA
hsa:9128,3.9719104e-09,3.3076189792039764e-06,9.202462316549708e-08,1.617811725773092e-07,0.0,7.8927536e-07,False,PRPF4; pre-mRNA processing factor
hsa:7360,3.7210415e-05,0.030987072336288432,0.00022564591538362566,0.0003316998075771712,0.0,0.0019185978,False,UGP2; UDP-glucose pyrophosphorylase
hsa:118672,8.202431e-05,0.06830596292205143,0.0003057556888093566,0.000615442124429903,0.0,0.0035033221,False,PSTK; phosphoseryl-tRNA
hsa:7562,0.0,0.0,7.293560736865499e-08,1.4553619848607334e-07,0.0,7.6123143e-07,False,ZNF708; zinc finger protein
hsa:23186,0.0,0.0,4.058069737134503e-08,8.576176092739188e-08,0.0,4.1967755e-07,False,RCOR1; REST corepressor
hsa:331,0.00012930167,0.10767631055694744,0.000681107158780117,0.0011911344757394877,0.0,0.006033924,False,XIAP; X-linked inhibitor of
hsa:1143,1.6411168e-05,0.013666443922729211,4.824516545836258e-05,8.205690127294804e-05,0.0,0.0005712169,False,CHRNB4; cholinergic receptor nicotinic beta 4
hsa:5583,0.0,0.0,8.639909356222223e-05,0.00020171769703645562,0.0,0.0009780806,False,PRKCH; protein kinase C
hsa:343702,6.691187e-07,0.0005572103820519949,0.00023799529758018748,0.000535936329548365,0.0,0.002844902,False,XKR7; XK related
hsa:7743,7.715441e-09,6.425054070839188e-06,6.1503832819883e-08,9.496280451538199e-08,0.0,3.8705227e-07,False,ZNF189; zinc finger protein
hsa:6066,0.0,0.0,5.099602795321637e-11,4.34046427008188e-10,0.0,4.1304684e-09,False,RNU2-1; RNA
hsa:7019,5.811955e-08,4.839921027493331e-05,2.18260311151579e-06,4.113958068398317e-06,0.0,3.0156876e-05,False,TFAM; transcription factor A
hsa:846,0.0,0.0,1.019521936648304e-06,4.431709737371373e-06,0.0,4.8753456e-05,False,CASR; calcium sensing
hsa:81282,0.0,0.0,8.350229824561404e-10,1.0919342388180742e-08,0.0,1.4278893e-07,False,OR51G2; olfactory receptor family 51 subfamily G member
hsa:27300,1.9002924e-08,1.5824735644281083e-05,6.325110226725147e-08,8.027624662546837e-08,0.0,3.1720683e-07,False,ZNF544; zinc finger protein
hsa:55660,2.1758774e-08,1.8119677081993093e-05,6.708998924152047e-07,1.79528521203006e-06,0.0,1.0141793e-05,False,PRPF40A; pre-mRNA processing factor 40 homolog
hsa:6118,0.0,0.0,0.00011967927115622221,0.0002753696537414224,0.0,0.0014968378,False,RPA2; replication protein
hsa:407042,-0.0,0.0,0.0,0.0,0.0,0.0,False,MIR34C; microRNA
hsa:2274,0.0,0.0,7.25202449497076e-05,0.00028877340630916327,0.0,0.0026162863,False,FHL2; four and a half LIM domains
hsa:55630,0.0,0.0,1.973246847076023e-05,6.482638351087074e-05,0.0,0.00044507967,False,SLC39A4; solute carrier family 39 member
hsa:113835,0.0,0.0,1.7683205958251463e-08,3.713489434552891e-08,0.0,1.699763e-07,False,ZNF257; zinc finger protein
hsa:5608,3.3286902e-05,0.027719756421016647,0.00017196135044152044,0.0003376028450541851,0.0,0.0020650441,False,MAP2K6; mitogen-activated protein kinase kinase
hsa:4125,0.0,0.0,1.5137238888888888e-05,3.52169832784976e-05,0.0,0.0003016306,False,MAN2B1; mannosidase alpha class 2B member
hsa:64969,8.8873584e-08,7.400971411346007e-05,2.3940437156678364e-07,3.653502022596113e-07,0.0,2.0775178e-06,False,MRPS5; mitochondrial ribosomal protein
hsa:7337,0.0,0.0,1.1563153319070174e-06,2.492955941150112e-06,0.0,1.0926673e-05,False,UBE3A; ubiquitin protein ligase
hsa:5506,0.0,0.0,2.5487935854970756e-08,1.257130085136461e-07,0.0,1.1723486e-06,False,PPP1R3A; protein phosphatase 1 regulatory subunit
hsa:51429,0.0,0.0,1.5281034282666667e-07,4.4464482585190044e-07,0.0,2.2337108e-06,False,SNX9; sorting nexin
hsa:26762,0.0,0.0,4.727170444163744e-06,1.4090747736490398e-05,0.0,9.854662e-05,False,HAVCR1; hepatitis A virus cellular receptor
hsa:6628,0.0,0.0,0.00021261823627644158,0.0007101684323949666,0.0,0.0057269856,False,SNRPB; small nuclear ribonucleoprotein polypeptides B and
hsa:348,0.0,0.0,3.315058592707603e-05,0.0001018059951465933,0.0,0.0005739213,False,APOE; apolipoprotein
hsa:10627,0.0,0.0,1.920013091532164e-05,7.467277667050758e-05,0.0,0.0005654766,False,MYL12A; myosin light chain
hsa:195814,0.0,0.0,4.031528706210526e-06,2.5741908907259053e-05,0.0,0.00029952094,False,SDR16C5; short chain dehydrogenase/reductase family 16C member
hsa:219873,-0.0,0.0,9.852110637426901e-08,9.50681618984199e-07,0.0,1.1350557e-05,False,OR10S1; olfactory receptor family 10 subfamily S member
hsa:51684,1.930096e-05,0.016072925918182036,0.00010949706817017545,0.00017253381772314334,0.0,0.0010322104,False,SUFU; SUFU negative regulator of hedgehog
hsa:11051,0.0,0.0,2.1503895275730999e-07,5.948153636950743e-07,0.0,3.013351e-06,False,NUDT21; nudix hydrolase
hsa:2027,3.9199062e-06,0.0032643123429519803,9.599023443204673e-05,0.00018189618508985853,0.0,0.00095562317,False,ENO3; enolase
hsa:8529,-0.0,0.0,6.0538841786599985e-06,4.4769927046711035e-05,0.0,0.00052825996,False,CYP4F2; cytochrome P450 family 4 subfamily F member
hsa:1373,0.0,0.0,3.522352331052632e-05,8.596834772773089e-05,0.0,0.0007824062,False,CPS1; carbamoyl-phosphate synthase
hsa:83943,3.4738697e-08,2.892874257939359e-05,4.602430011372807e-05,0.00016242193031961398,0.0,0.0013444285,False,IMMP2L; inner mitochondrial membrane peptidase subunit
hsa:5689,1.6927268e-06,0.0014096227574235342,4.557835629684209e-06,6.79289992533962e-06,0.0,3.721202e-05,False,PSMB1; proteasome 20S subunit beta
hsa:4762,0.0,0.0,5.125490682105263e-10,4.580203432216917e-09,0.0,4.8033776e-08,False,NEUROG1; neurogenin
hsa:1672,2.9456081e-05,0.024529630015966534,0.00023840093422163752,0.0006487646075441627,0.0,0.006110297,False,DEFB1; defensin beta
hsa:10383,4.944822e-06,0.004117813708986326,4.8892084985497046e-05,0.00010156789771449765,0.0,0.000797762,False,TUBB4B; tubulin beta 4B class
hsa:5971,0.0,0.0,3.722553644687719e-05,9.933849026931785e-05,0.0,0.00071492116,False,RELB; RELB proto-oncogene
hsa:22934,4.432665e-07,0.0003691313601246693,4.364982134461345e-05,0.00011636667309446069,0.0,0.0006673321,False,RPIA; ribose 5-phosphate isomerase
hsa:3906,0.0,0.0,1.3597924078362573e-07,8.53147300433156e-07,-0.0,9.200937e-06,False,LALBA; lactalbumin
hsa:688,1.18120775e-08,9.836539042478968e-06,1.7352324853918127e-07,4.0807250967575057e-07,0.0,2.7692276e-06,False,KLF5; KLF transcription factor
hsa:727936,2.2206254e-07,0.00018492317245480717,1.1529181926539762e-05,3.072845177302187e-05,0.0,0.00019107581,False,GXYLT2; glucoside xylosyltransferase
hsa:64834,0.0,0.0,2.1770506157017544e-05,7.573853224732983e-05,0.0,0.00041596076,False,ELOVL1; ELOVL fatty acid elongase
hsa:345611,0.0,0.0,1.9506195174818715e-06,8.218422815303624e-06,0.0,5.859575e-05,False,IRGM; immunity related GTPase
hsa:113612,2.7936687e-06,0.002326435061004422,2.7953070120292393e-05,6.758921864380217e-05,0.0,0.00049583876,False,CYP2U1; cytochrome P450 family 2 subfamily U member
hsa:7380,0.0,0.0,7.127853733056139e-06,2.4659266874984994e-05,-0.0,0.00018834854,False,UPK3A; uroplakin
hsa:762,0.0,0.0,7.144633096467837e-05,0.00015660257199574804,0.0,0.0009305319,False,CA4; carbonic anhydrase
hsa:53981,0.0,0.0,1.3166371789219882e-07,3.507455078444547e-07,0.0,1.7759787e-06,False,CPSF2; cleavage and polyadenylation specific factor
hsa:9415,4.8259344e-06,0.0040188097429975644,4.643963606649124e-05,9.306932206992918e-05,0.0,0.000579196,False,FADS2; fatty acid desaturase
hsa:10288,0.0,0.0,3.638363047836258e-06,9.880897488138071e-06,0.0,5.08405e-05,False,LILRB2; leukocyte immunoglobulin like receptor
hsa:2788,0.0,0.0,7.584022645029239e-05,0.00026714299812747325,0.0,0.0018222299,False,GNG7; G protein subunit gamma
hsa:406922,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133A1; microRNA
hsa:23200,1.9744292e-08,1.64421118236064e-05,9.557708472529904e-05,0.00020982104377986052,0.0,0.0009724291,False,ATP11B; ATPase phospholipid transporting 11B
hsa:2065,0.0,0.0,1.275637397064328e-06,3.057456994263642e-06,0.0,2.5847885e-05,False,ERBB3; erb-b2 receptor tyrosine kinase
hsa:83706,0.0,0.0,4.5365108692690075e-07,1.0786719192462374e-06,0.0,6.298946e-06,False,FERMT3; FERM domain containing kindlin
hsa:25796,0.0,0.0,5.6960646727754395e-05,0.00017941529480672722,0.0,0.0010450884,False,PGLS;
hsa:90827,0.0,0.0,5.211121157134503e-10,3.064191630414678e-09,0.0,2.9366955e-08,False,ZNF479; zinc finger protein
hsa:5831,4.724389e-08,3.9342475403127154e-05,0.00017375094195608772,0.0003508090758742351,0.0,0.0024931422,False,PYCR1; pyrroline-5-carboxylate reductase
hsa:10093,1.0082094e-07,8.395890668761946e-05,1.1983028775339183e-05,2.5253542239795095e-05,0.0,0.00018462168,False,ARPC4; actin related protein 2/3 complex subunit
hsa:6513,0.0,0.0,5.4636462754385975e-05,0.00015989397988676757,0.0,0.00087616936,False,SLC2A1; solute carrier family 2 member
hsa:143471,0.0,0.0,2.7111534125321633e-08,1.2452826712782276e-07,0.0,1.3713055e-06,False,PSMA8; proteasome 20S subunit alpha
hsa:2532,0.0,0.0,1.553368610688889e-05,4.3165368080101234e-05,0.0,0.00035669268,False,ACKR1; atypical chemokine receptor 1 (Duffy blood
hsa:5861,0.0,0.0,3.089029837076023e-05,7.064402148052604e-05,0.0,0.00038000144,False,RAB1A; RAB1A
hsa:284309,2.153353e-09,1.7932104540237915e-06,6.733294655894737e-08,1.0985938338571525e-07,0.0,4.2283335e-07,False,ZNF776; zinc finger protein
hsa:3061,0.0,0.0,5.314527609894446e-06,1.8549355311207903e-05,0.0,0.00018105003,False,HCRTR1; hypocretin receptor
hsa:814,3.983314e-05,0.03317115357518867,0.0004748858977953216,0.000856904874526902,0.0,0.0050067306,False,CAMK4; calcium/calmodulin dependent protein kinase
hsa:79837,2.133486e-08,1.776666156785907e-05,7.65122878282807e-05,0.0002173218385631808,0.0,0.0013866089,False,PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:27090,1.7044312e-06,0.0014193696277406984,6.914681871228071e-05,0.00015400486689413,0.0,0.0012404959,False,ST6GALNAC4; ST6 N-acetylgalactosaminide alpha-2
hsa:28973,6.718069e-08,5.5944898777177545e-05,2.0122653761403511e-07,2.663642175286791e-07,0.0,1.4235377e-06,False,MRPS18B; mitochondrial ribosomal protein
hsa:79784,0.0,0.0,3.145579890643274e-08,2.0355528433353984e-07,0.0,2.005598e-06,False,MYH14; myosin heavy chain
hsa:26692,0.0,0.0,9.078923976608186e-08,9.384570609501055e-07,0.0,1.2079864e-05,False,OR2W1; olfactory receptor family 2 subfamily W member
hsa:390155,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5T1; olfactory receptor family 5 subfamily T member
hsa:11197,0.0,0.0,3.1444933253976616e-07,3.037196985640977e-06,0.0,3.959029e-05,False,WIF1; WNT inhibitory factor
hsa:4731,0.0,0.0,1.015579853766082e-06,2.7128977679712244e-06,0.0,1.8315954e-05,False,NDUFV3; NADH:ubiquinone oxidoreductase subunit
hsa:10686,0.0,0.0,2.286101024666667e-07,2.0542000773711863e-06,0.0,2.6620115e-05,False,CLDN16; claudin
hsa:468,0.0,0.0,0.0003507823301929824,0.0005398170406890766,0.0,0.0036111106,False,ATF4; activating transcription factor
hsa:123041,0.0,0.0,2.5166998076023385e-06,6.741192439785046e-06,0.0,4.7011243e-05,False,SLC24A4; solute carrier family 24 member
hsa:55334,0.0,0.0,5.989886819292398e-08,1.510296053458691e-07,0.0,1.0584138e-06,False,SLC39A9; solute carrier family 39 member
hsa:644672,0.0,0.0,1.1227416315789474e-07,7.714543616387301e-07,0.0,7.069582e-06,False,CLDN25; claudin
hsa:406983,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR200A; microRNA
hsa:7915,4.8358004e-05,0.04027025680811475,0.00025540519328801173,0.000511564207160008,0.0,0.0029692396,False,ALDH5A1; aldehyde dehydrogenase 5 family member
hsa:9668,0.0,0.0,6.036478069625732e-08,1.0057515132950339e-07,0.0,4.4273818e-07,False,ZNF432; zinc finger protein
hsa:4485,0.0,0.0,1.7655726464196494e-05,6.637336232070722e-05,0.0,0.0005265333,False,MST1; macrophage stimulating
hsa:3448,0.0,0.0,3.0252245327485386e-06,1.112066045138851e-05,0.0,8.4369516e-05,False,IFNA14; interferon alpha
hsa:5826,0.0,0.0,0.0001884435162339181,0.0003342135136105646,0.0,0.0014563961,False,ABCD4; ATP binding cassette subfamily D member
hsa:1438,0.0,0.0,6.943129988888888e-06,2.0407621128823223e-05,0.0,0.00014289546,False,CSF2RA; colony stimulating factor 2 receptor subunit
hsa:3714,7.2305476e-05,0.06021257798715137,0.00023866979075520456,0.00036382061096729764,0.0,0.0019617728,False,JAG2; jagged canonical Notch ligand
hsa:1947,0.0,0.0,1.1570179643274854e-07,2.589986817464124e-07,0.0,1.0690834e-06,False,EFNB1; ephrin
hsa:7652,0.0,0.0,5.164760375146197e-09,1.9320142807074975e-08,0.0,1.9544152e-07,False,ZNF99; zinc finger protein
hsa:442902,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR330; microRNA
hsa:55278,0.0,0.0,6.856104240736844e-07,1.2105602930217128e-06,0.0,5.73951e-06,False,QRSL1; glutaminyl-tRNA amidotransferase subunit
hsa:23152,0.0,0.0,1.7487802260877188e-07,4.4769995220091e-07,0.0,2.0918922e-06,False,CIC; capicua transcriptional
hsa:346171,0.0,0.0,7.77910677881871e-09,2.514156871043165e-08,0.0,1.6801262e-07,False,ZFP57; ZFP57 zinc finger
hsa:100289462,0.0,0.0,0.0,0.0,0.0,0.0,False,DEFB4B; defensin beta
hsa:9734,7.184351e-07,0.000598278745685277,3.089404572507603e-05,0.00010563086187098272,0.0,0.0008408999,False,HDAC9; histone deacetylase
hsa:7307,0.0,0.0,2.284437669128655e-06,7.536266523410783e-06,0.0,4.0828225e-05,False,U2AF1; U2 small nuclear RNA auxiliary factor
